{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyNkZ219ob4zYNLY1lkRSCI3",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/samiksha261/Gene-BRAC1/blob/main/brca_1_text_summarization.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "pip install beautifulsoup4 lxml"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "41f1D6ryqYXm",
        "outputId": "a8550933-2d73-4deb-c393-a1e4a62dbc03"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Looking in indexes: https://pypi.org/simple, https://us-python.pkg.dev/colab-wheels/public/simple/\n",
            "Requirement already satisfied: beautifulsoup4 in /usr/local/lib/python3.10/dist-packages (4.11.2)\n",
            "Requirement already satisfied: lxml in /usr/local/lib/python3.10/dist-packages (4.9.2)\n",
            "Requirement already satisfied: soupsieve>1.2 in /usr/local/lib/python3.10/dist-packages (from beautifulsoup4) (2.4.1)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import bs4 as bs\n",
        "import urllib.request"
      ],
      "metadata": {
        "id": "9xCdz9Axqake"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "source = urllib.request.urlopen('https://en.wikipedia.org/wiki/BRCA1').read()\n"
      ],
      "metadata": {
        "id": "Qwy1YXd7qdLb"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "source"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "qAbhosh6qz1-",
        "outputId": "097beeb5-7b54-47a3-cab5-8b1d0acac3fe"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "b'<!DOCTYPE html>\\n<html class=\"client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-language-alert-in-sidebar-enabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled\" lang=\"en\" dir=\"ltr\">\\n<head>\\n<meta charset=\"UTF-8\"/>\\n<title>BRCA1 - Wikipedia</title>\\n<script>document.documentElement.className=\"client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-language-alert-in-sidebar-enabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled\";(function(){var cookie=document.cookie.match(/(?:^|; )enwikimwclientprefs=([^;]+)/);if(cookie){var featureName=cookie[1];document.documentElement.className=document.documentElement.className.replace(featureName+\\'-enabled\\',featureName+\\'-disabled\\');}}());RLCONF={\"wgBreakFrames\":false,\"wgSeparatorTransformTable\":[\"\",\"\"],\"wgDigitTransformTable\":[\"\",\"\"],\"wgDefaultDateFormat\":\"dmy\",\"wgMonthNames\":[\"\",\"January\",\"February\",\"March\",\"April\",\"May\",\"June\",\"July\",\"August\",\"September\",\"October\",\"November\",\"December\"],\"wgRequestId\":\\n\"267efca1-adbc-4467-8001-9e4890145f94\",\"wgCSPNonce\":false,\"wgCanonicalNamespace\":\"\",\"wgCanonicalSpecialPageName\":false,\"wgNamespaceNumber\":0,\"wgPageName\":\"BRCA1\",\"wgTitle\":\"BRCA1\",\"wgCurRevisionId\":1146808968,\"wgRevisionId\":1146808968,\"wgArticleId\":412097,\"wgIsArticle\":true,\"wgIsRedirect\":false,\"wgAction\":\"view\",\"wgUserName\":null,\"wgUserGroups\":[\"*\"],\"wgCategories\":[\"Webarchive template wayback links\",\"CS1 Chinese-language sources (zh)\",\"Articles with short description\",\"Short description is different from Wikidata\",\"All articles with unsourced statements\",\"Articles with unsourced statements from January 2016\",\"Articles with unsourced statements from May 2019\",\"Dynamic lists\",\"Commons category link is on Wikidata\",\"Genes on human chromosome 17\",\"Breast cancer\",\"Tumor markers\",\"Tumor suppressor genes\"],\"wgPageContentLanguage\":\"en\",\"wgPageContentModel\":\"wikitext\",\"wgRelevantPageName\":\"BRCA1\",\"wgRelevantArticleId\":412097,\"wgIsProbablyEditable\":true,\"wgRelevantPageIsProbablyEditable\":true,\\n\"wgRestrictionEdit\":[],\"wgRestrictionMove\":[],\"wgFlaggedRevsParams\":{\"tags\":{\"status\":{\"levels\":1}}},\"wgVisualEditor\":{\"pageLanguageCode\":\"en\",\"pageLanguageDir\":\"ltr\",\"pageVariantFallbacks\":\"en\"},\"wgMFDisplayWikibaseDescriptions\":{\"search\":true,\"watchlist\":true,\"tagline\":false,\"nearby\":true},\"wgWMESchemaEditAttemptStepOversample\":false,\"wgWMEPageLength\":100000,\"wgNoticeProject\":\"wikipedia\",\"wgMediaViewerOnClick\":true,\"wgMediaViewerEnabledByDefault\":true,\"wgPopupsFlags\":10,\"wgULSCurrentAutonym\":\"English\",\"wgEditSubmitButtonLabelPublish\":true,\"wgCentralAuthMobileDomain\":false,\"wgULSPosition\":\"interlanguage\",\"wgULSisCompactLinksEnabled\":true,\"wgULSisLanguageSelectorEmpty\":false,\"wgWikibaseItemId\":\"Q17487737\",\"GEHomepageSuggestedEditsEnableTopics\":true,\"wgGETopicsMatchModeEnabled\":false,\"wgGEStructuredTaskRejectionReasonTextInputEnabled\":false,\"wgGELevelingUpEnabledForUser\":false};RLSTATE={\"skins.vector.user.styles\":\"ready\",\"ext.globalCssJs.user.styles\":\"ready\",\"site.styles\":\"ready\",\\n\"user.styles\":\"ready\",\"skins.vector.user\":\"ready\",\"ext.globalCssJs.user\":\"ready\",\"user\":\"ready\",\"user.options\":\"loading\",\"ext.cite.styles\":\"ready\",\"mediawiki.page.gallery.styles\":\"ready\",\"mediawiki.ui.button\":\"ready\",\"skins.vector.styles\":\"ready\",\"skins.vector.icons\":\"ready\",\"mediawiki.ui.icon\":\"ready\",\"jquery.makeCollapsible.styles\":\"ready\",\"ext.visualEditor.desktopArticleTarget.noscript\":\"ready\",\"ext.wikimediaBadges\":\"ready\",\"ext.uls.interlanguage\":\"ready\",\"wikibase.client.init\":\"ready\"};RLPAGEMODULES=[\"ext.cite.ux-enhancements\",\"site\",\"mediawiki.page.ready\",\"jquery.makeCollapsible\",\"mediawiki.toc\",\"skins.vector.js\",\"mmv.head\",\"mmv.bootstrap.autostart\",\"ext.visualEditor.desktopArticleTarget.init\",\"ext.visualEditor.targetLoader\",\"ext.eventLogging\",\"ext.wikimediaEvents\",\"ext.navigationTiming\",\"ext.cx.eventlogging.campaigns\",\"ext.centralNotice.geoIP\",\"ext.centralNotice.startUp\",\"ext.gadget.ReferenceTooltips\",\"ext.gadget.charinsert\",\"ext.gadget.extra-toolbar-buttons\",\\n\"ext.gadget.switcher\",\"ext.centralauth.centralautologin\",\"ext.popups\",\"ext.echo.centralauth\",\"ext.uls.compactlinks\",\"ext.uls.interface\",\"ext.cx.uls.quick.actions\",\"wikibase.client.vector-2022\",\"ext.growthExperiments.SuggestedEditSession\"];</script>\\n<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement(\"user.options@12s5i\",function($,jQuery,require,module){mw.user.tokens.set({\"patrolToken\":\"+\\\\\\\\\",\"watchToken\":\"+\\\\\\\\\",\"csrfToken\":\"+\\\\\\\\\"});});});</script>\\n<link rel=\"stylesheet\" href=\"/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cmediawiki.page.gallery.styles%7Cmediawiki.ui.button%2Cicon%7Cskins.vector.icons%2Cstyles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022\"/>\\n<script async=\"\" src=\"/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022\"></script>\\n<meta name=\"ResourceLoaderDynamicStyles\" content=\"\"/>\\n<link rel=\"stylesheet\" href=\"/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022\"/>\\n<meta name=\"generator\" content=\"MediaWiki 1.41.0-wmf.6\"/>\\n<meta name=\"referrer\" content=\"origin\"/>\\n<meta name=\"referrer\" content=\"origin-when-crossorigin\"/>\\n<meta name=\"referrer\" content=\"origin-when-cross-origin\"/>\\n<meta name=\"robots\" content=\"max-image-preview:standard\"/>\\n<meta name=\"format-detection\" content=\"telephone=no\"/>\\n<meta property=\"og:image\" content=\"https://upload.wikimedia.org/wikipedia/commons/e/e1/Protein_BRCA1_PDB_1jm7.png\"/>\\n<meta property=\"og:image:width\" content=\"1200\"/>\\n<meta property=\"og:image:height\" content=\"813\"/>\\n<meta property=\"og:image\" content=\"https://upload.wikimedia.org/wikipedia/commons/e/e1/Protein_BRCA1_PDB_1jm7.png\"/>\\n<meta property=\"og:image:width\" content=\"800\"/>\\n<meta property=\"og:image:height\" content=\"542\"/>\\n<meta property=\"og:image\" content=\"https://upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Protein_BRCA1_PDB_1jm7.png/640px-Protein_BRCA1_PDB_1jm7.png\"/>\\n<meta property=\"og:image:width\" content=\"640\"/>\\n<meta property=\"og:image:height\" content=\"434\"/>\\n<meta name=\"viewport\" content=\"width=1000\"/>\\n<meta property=\"og:title\" content=\"BRCA1 - Wikipedia\"/>\\n<meta property=\"og:type\" content=\"website\"/>\\n<link rel=\"preconnect\" href=\"//upload.wikimedia.org\"/>\\n<link rel=\"alternate\" media=\"only screen and (max-width: 720px)\" href=\"//en.m.wikipedia.org/wiki/BRCA1\"/>\\n<link rel=\"alternate\" type=\"application/x-wiki\" title=\"Edit this page\" href=\"/w/index.php?title=BRCA1&amp;action=edit\"/>\\n<link rel=\"apple-touch-icon\" href=\"/static/apple-touch/wikipedia.png\"/>\\n<link rel=\"icon\" href=\"/static/favicon/wikipedia.ico\"/>\\n<link rel=\"search\" type=\"application/opensearchdescription+xml\" href=\"/w/opensearch_desc.php\" title=\"Wikipedia (en)\"/>\\n<link rel=\"EditURI\" type=\"application/rsd+xml\" href=\"//en.wikipedia.org/w/api.php?action=rsd\"/>\\n<link rel=\"canonical\" href=\"https://en.wikipedia.org/wiki/BRCA1\"/>\\n<link rel=\"license\" href=\"https://creativecommons.org/licenses/by-sa/3.0/\"/>\\n<link rel=\"alternate\" type=\"application/atom+xml\" title=\"Wikipedia Atom feed\" href=\"/w/index.php?title=Special:RecentChanges&amp;feed=atom\"/>\\n<link rel=\"dns-prefetch\" href=\"//meta.wikimedia.org\" />\\n<link rel=\"dns-prefetch\" href=\"//login.wikimedia.org\"/>\\n</head>\\n<body class=\"skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-BRCA1 rootpage-BRCA1 skin-vector-2022 action-view\"><a class=\"mw-jump-link\" href=\"#bodyContent\">Jump to content</a>\\n<div class=\"vector-header-container\">\\n\\t<header class=\"vector-header mw-header\">\\n\\t\\t<div class=\"vector-header-start\">\\n\\t\\t\\t<nav class=\"vector-main-menu-landmark\" aria-label=\"Site\" role=\"navigation\">\\n\\t\\t\\t\\t\\n<div id=\"vector-main-menu-dropdown\" class=\"vector-menu vector-dropdown vector-menu-dropdown vector-main-menu-dropdown mw-ui-icon-flush-left mw-ui-icon-flush-right\"  >\\n\\t<input type=\"checkbox\"\\n\\t\\tid=\"vector-main-menu-dropdown-checkbox\"\\n\\t\\trole=\"button\"\\n\\t\\taria-haspopup=\"true\"\\n\\t\\tdata-event-name=\"ui.dropdown-vector-main-menu-dropdown\"\\n\\t\\tclass=\"vector-menu-checkbox \"\\n\\t\\t\\n\\t\\taria-label=\"Main menu\"\\n\\t\\t\\n\\t/>\\n\\t<label\\n\\t\\tid=\"vector-main-menu-dropdown-label\"\\n\\t\\tfor=\"vector-main-menu-dropdown-checkbox\"\\n\\t\\tclass=\"vector-menu-heading mw-ui-button mw-ui-quiet mw-ui-icon-element \"\\n\\t\\taria-hidden=\"true\"\\n\\t\\t\\n\\t>\\n\\t\\t<span class=\"mw-ui-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu\"></span>\\n\\n\\t\\t<span class=\"vector-menu-heading-label\">Main menu</span>\\n\\t</label>\\n\\t<div class=\"vector-menu-content vector-dropdown-content\">\\n\\n\\n\\t\\t\\t\\t<div id=\"vector-main-menu-unpinned-container\" class=\"vector-unpinned-container\">\\n\\t\\t\\n<div id=\"vector-main-menu\" class=\"vector-main-menu vector-pinnable-element\">\\n\\t<div\\n\\tclass=\"vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned\"\\n\\tdata-feature-name=\"main-menu-pinned\"\\n\\tdata-pinnable-element-id=\"vector-main-menu\"\\n\\tdata-pinned-container-id=\"vector-main-menu-pinned-container\"\\n\\tdata-unpinned-container-id=\"vector-main-menu-unpinned-container\"\\n>\\n\\t<div class=\"vector-pinnable-header-label\">Main menu</div>\\n\\t<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-pin-button\" data-event-name=\"pinnable-header.vector-main-menu.pin\">move to sidebar</button>\\n\\t<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button\" data-event-name=\"pinnable-header.vector-main-menu.unpin\">hide</button>\\n</div>\\n\\n\\t\\n<div id=\"p-navigation\" class=\"vector-menu mw-portlet mw-portlet-navigation\"  >\\n\\t<div class=\"vector-menu-heading\">\\n\\t\\tNavigation\\n\\t</div>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"n-mainpage-description\" class=\"mw-list-item\"><a href=\"/wiki/Main_Page\" title=\"Visit the main page [z]\" accesskey=\"z\"><span>Main page</span></a></li><li id=\"n-contents\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:Contents\" title=\"Guides to browsing Wikipedia\"><span>Contents</span></a></li><li id=\"n-currentevents\" class=\"mw-list-item\"><a href=\"/wiki/Portal:Current_events\" title=\"Articles related to current events\"><span>Current events</span></a></li><li id=\"n-randompage\" class=\"mw-list-item\"><a href=\"/wiki/Special:Random\" title=\"Visit a randomly selected article [x]\" accesskey=\"x\"><span>Random article</span></a></li><li id=\"n-aboutsite\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:About\" title=\"Learn about Wikipedia and how it works\"><span>About Wikipedia</span></a></li><li id=\"n-contactpage\" class=\"mw-list-item\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\" title=\"How to contact Wikipedia\"><span>Contact us</span></a></li><li id=\"n-sitesupport\" class=\"mw-list-item\"><a href=\"https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en\" title=\"Support us by donating to the Wikimedia Foundation\"><span>Donate</span></a></li></ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n\\t\\n\\t\\n<div id=\"p-interaction\" class=\"vector-menu mw-portlet mw-portlet-interaction\"  >\\n\\t<div class=\"vector-menu-heading\">\\n\\t\\tContribute\\n\\t</div>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"n-help\" class=\"mw-list-item\"><a href=\"/wiki/Help:Contents\" title=\"Guidance on how to use and edit Wikipedia\"><span>Help</span></a></li><li id=\"n-introduction\" class=\"mw-list-item\"><a href=\"/wiki/Help:Introduction\" title=\"Learn how to edit Wikipedia\"><span>Learn to edit</span></a></li><li id=\"n-portal\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:Community_portal\" title=\"The hub for editors\"><span>Community portal</span></a></li><li id=\"n-recentchanges\" class=\"mw-list-item\"><a href=\"/wiki/Special:RecentChanges\" title=\"A list of recent changes to Wikipedia [r]\" accesskey=\"r\"><span>Recent changes</span></a></li><li id=\"n-upload\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:File_upload_wizard\" title=\"Add images or other media for use on Wikipedia\"><span>Upload file</span></a></li></ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n\\t\\n<div class=\"vector-main-menu-action vector-main-menu-action-lang-alert\">\\n\\t<div class=\"vector-main-menu-action-item\">\\n\\t\\t<div class=\"vector-main-menu-action-heading vector-menu-heading\">Languages</div>\\n\\t\\t<div class=\"vector-main-menu-action-content vector-menu-content\">\\n\\t\\t\\t<div class=\"mw-message-box-notice vector-language-sidebar-alert mw-message-box\">Language links are at the top of the page across from the title.</div>\\n\\t\\t</div>\\n\\t</div>\\n</div>\\n\\n</div>\\n\\n\\t\\t\\t\\t</div>\\n\\n\\t</div>\\n</div>\\n\\t\\t</nav>\\n\\t\\t\\t\\n<a href=\"/wiki/Main_Page\" class=\"mw-logo\">\\n\\t<img class=\"mw-logo-icon\" src=\"/static/images/icons/wikipedia.png\" alt=\"\"\\n\\t\\taria-hidden=\"true\" height=\"50\" width=\"50\">\\n\\t<span class=\"mw-logo-container\">\\n\\t\\t<img class=\"mw-logo-wordmark\" alt=\"Wikipedia\"\\n\\t\\t\\tsrc=\"/static/images/mobile/copyright/wikipedia-wordmark-en.svg\" style=\"width: 7.5em; height: 1.125em;\">\\n\\t\\t<img class=\"mw-logo-tagline\"\\n\\t\\t\\talt=\"The Free Encyclopedia\"\\n\\t\\t\\tsrc=\"/static/images/mobile/copyright/wikipedia-tagline-en.svg\" width=\"117\" height=\"13\" style=\"width: 7.3125em; height: 0.8125em;\">\\n\\t</span>\\n</a>\\n\\n\\t\\t</div>\\n\\t\\t<div class=\"vector-header-end\">\\n\\t\\t\\t\\n<div id=\"p-search\" role=\"search\" class=\"vector-search-box-vue  vector-search-box-collapses  vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box\">\\n\\t<a href=\"/wiki/Special:Search\"\\n\\t\\n\\t\\t\\n\\t\\t\\n\\t\\t\\n\\t\\ttitle=\"Search Wikipedia [f]\"\\n\\t\\taccesskey=\"f\"\\n\\t\\tclass=\"mw-ui-button mw-ui-quiet mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search search-toggle\">\\n\\t\\t<span>Search</span>\\n\\t</a>\\n\\t\\n\\t<div>\\n\\t\\t<form action=\"/w/index.php\" id=\"searchform\"\\n\\t\\t\\tclass=\"vector-search-box-form\">\\n\\t\\t\\t<div id=\"simpleSearch\"\\n\\t\\t\\t\\tclass=\"vector-search-box-inner\"\\n\\t\\t\\t\\t data-search-loc=\"header-moved\">\\n\\t\\t\\t\\t<input class=\"vector-search-box-input\"\\n\\t\\t\\t\\t\\t type=\"search\" name=\"search\" placeholder=\"Search Wikipedia\" aria-label=\"Search Wikipedia\" autocapitalize=\"sentences\" title=\"Search Wikipedia [f]\" accesskey=\"f\" id=\"searchInput\"\\n\\t\\t\\t\\t>\\n\\t\\t\\t\\t<input type=\"hidden\" name=\"title\" value=\"Special:Search\">\\n\\t\\t\\t\\t<input id=\"mw-searchButton\"\\n\\t\\t\\t\\t\\t class=\"searchButton mw-fallbackSearchButton\" type=\"submit\" name=\"fulltext\" title=\"Search Wikipedia for this text\" value=\"Search\">\\n\\t\\t\\t\\t<input id=\"searchButton\"\\n\\t\\t\\t\\t\\t class=\"searchButton\" type=\"submit\" name=\"go\" title=\"Go to a page with this exact name if it exists\" value=\"Go\">\\n\\t\\t\\t</div>\\n\\t\\t</form>\\n\\t</div>\\n</div>\\n\\n\\t\\t\\t<nav class=\"vector-user-links\" aria-label=\"Personal tools\" role=\"navigation\" >\\n\\t\\n<div id=\"p-vector-user-menu-overflow\" class=\"vector-menu mw-portlet mw-portlet-vector-user-menu-overflow\"  >\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"pt-createaccount-2\" class=\"user-links-collapsible-item mw-list-item\"><a href=\"/w/index.php?title=Special:CreateAccount&amp;returnto=BRCA1\" title=\"You are encouraged to create an account and log in; however, it is not mandatory\"><span>Create account</span></a></li><li id=\"pt-login-2\" class=\"user-links-collapsible-item mw-list-item\"><a href=\"/w/index.php?title=Special:UserLogin&amp;returnto=BRCA1\" title=\"You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]\" accesskey=\"o\"><span>Log in</span></a></li></ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n\\t\\n<div id=\"vector-user-links-dropdown\" class=\"vector-menu vector-dropdown vector-menu-dropdown vector-user-menu mw-ui-icon-flush-right vector-user-menu-logged-out\"  title=\"Log in and more options\" >\\n\\t<input type=\"checkbox\"\\n\\t\\tid=\"vector-user-links-dropdown-checkbox\"\\n\\t\\trole=\"button\"\\n\\t\\taria-haspopup=\"true\"\\n\\t\\tdata-event-name=\"ui.dropdown-vector-user-links-dropdown\"\\n\\t\\tclass=\"vector-menu-checkbox \"\\n\\t\\t\\n\\t\\taria-label=\"Personal tools\"\\n\\t\\t\\n\\t/>\\n\\t<label\\n\\t\\tid=\"vector-user-links-dropdown-label\"\\n\\t\\tfor=\"vector-user-links-dropdown-checkbox\"\\n\\t\\tclass=\"vector-menu-heading mw-ui-button mw-ui-quiet mw-ui-icon-element \"\\n\\t\\taria-hidden=\"true\"\\n\\t\\t\\n\\t>\\n\\t\\t<span class=\"mw-ui-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis\"></span>\\n\\n\\t\\t<span class=\"vector-menu-heading-label\">Personal tools</span>\\n\\t</label>\\n\\t<div class=\"vector-menu-content vector-dropdown-content\">\\n\\n\\n\\t\\t\\n<div id=\"p-personal\" class=\"vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item\"  title=\"User menu\" >\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"pt-createaccount\" class=\"user-links-collapsible-item mw-list-item\"><a href=\"/w/index.php?title=Special:CreateAccount&amp;returnto=BRCA1\" title=\"You are encouraged to create an account and log in; however, it is not mandatory\"><span class=\"mw-ui-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd\"></span> <span>Create account</span></a></li><li id=\"pt-login\" class=\"user-links-collapsible-item mw-list-item\"><a href=\"/w/index.php?title=Special:UserLogin&amp;returnto=BRCA1\" title=\"You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]\" accesskey=\"o\"><span class=\"mw-ui-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn\"></span> <span>Log in</span></a></li></ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n<div id=\"p-user-menu-anon-editor\" class=\"vector-menu mw-portlet mw-portlet-user-menu-anon-editor\"  >\\n\\t<div class=\"vector-menu-heading\">\\n\\t\\tPages for logged out editors <a href=\"/wiki/Help:Introduction\" aria-label=\"Learn more about editing\"><span>learn more</span></a>\\n\\t</div>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"pt-anoncontribs\" class=\"mw-list-item\"><a href=\"/wiki/Special:MyContributions\" title=\"A list of edits made from this IP address [y]\" accesskey=\"y\"><span>Contributions</span></a></li><li id=\"pt-anontalk\" class=\"mw-list-item\"><a href=\"/wiki/Special:MyTalk\" title=\"Discussion about edits from this IP address [n]\" accesskey=\"n\"><span>Talk</span></a></li></ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n\\t\\n\\t</div>\\n</div>\\n</nav>\\n\\n\\t\\t</div>\\n\\t</header>\\n</div>\\n<div class=\"mw-page-container\">\\n\\t<div class=\"mw-page-container-inner\">\\n\\t\\t<div class=\"vector-main-menu-container \">\\n\\t\\t\\t<div id=\"mw-navigation\">\\n\\t\\t\\t\\t<nav id=\"mw-panel\" class=\"vector-main-menu-landmark\" aria-label=\"Site\" role=\"navigation\">\\n\\t\\t\\t\\t\\t<div id=\"vector-main-menu-pinned-container\" class=\"vector-pinned-container\">\\n\\t\\t\\t\\t\\n\\t\\t\\t\\t\\t</div>\\n\\t\\t</nav>\\n\\t\\t\\t</div>\\n\\t\\t</div>\\n\\t\\t<div class=\"vector-sitenotice-container\">\\n\\t\\t\\t<div id=\"siteNotice\"><!-- CentralNotice --></div>\\n\\t\\t</div>\\n\\t\\t<input type=\"checkbox\" id=\"vector-toc-collapsed-checkbox\" class=\"vector-menu-checkbox\">\\n\\t\\t<nav id=\"mw-panel-toc\" role=\"navigation\" aria-label=\"Contents\" data-event-name=\"ui.sidebar-toc\" class=\"mw-table-of-contents-container vector-toc-landmark vector-sticky-pinned-container\">\\n\\t\\t\\t<div id=\"vector-toc-pinned-container\" class=\"vector-pinned-container\">\\n\\t\\t\\t\\t\\t<div id=\"vector-toc\" class=\"vector-toc vector-pinnable-element\">\\n\\t<div\\n\\tclass=\"vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned\"\\n\\tdata-feature-name=\"toc-pinned\"\\n\\tdata-pinnable-element-id=\"vector-toc\"\\n\\t\\n\\t\\n>\\n\\t<h2 class=\"vector-pinnable-header-label\">Contents</h2>\\n\\t<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-pin-button\" data-event-name=\"pinnable-header.vector-toc.pin\">move to sidebar</button>\\n\\t<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button\" data-event-name=\"pinnable-header.vector-toc.unpin\">hide</button>\\n</div>\\n\\n\\n\\t<ul class=\"vector-toc-contents\" id=\"mw-panel-toc-list\">\\n\\t\\t<li id=\"toc-mw-content-text\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-1\">\\n\\t\\t\\t<a href=\"#\" class=\"vector-toc-link\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">(Top)</div>\\n\\t\\t\\t</a>\\n\\t\\t</li>\\n\\t\\t<li id=\"toc-Discovery\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Discovery\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">1</span>Discovery</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Discovery-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Gene_location\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Gene_location\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">2</span>Gene location</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Gene_location-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Protein_structure\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Protein_structure\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">3</span>Protein structure</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t\\t<button aria-controls=\"toc-Protein_structure-sublist\" class=\"mw-ui-icon mw-ui-icon-wikimedia-expand mw-ui-icon-small vector-toc-toggle\">\\n\\t\\t\\t\\tToggle Protein structure subsection\\n\\t\\t\\t</button>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Protein_structure-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t<li id=\"toc-Zinc_ring_finger_domain\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-2\">\\n\\t\\t\\t<a class=\"vector-toc-link\" href=\"#Zinc_ring_finger_domain\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t\\t<span class=\"vector-toc-numb\">3.1</span>Zinc ring finger domain</div>\\n\\t\\t\\t</a>\\n\\t\\t\\t\\n\\t\\t\\t<ul id=\"toc-Zinc_ring_finger_domain-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t</ul>\\n\\t\\t</li>\\n\\t\\t<li id=\"toc-Serine_cluster_domain\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-2\">\\n\\t\\t\\t<a class=\"vector-toc-link\" href=\"#Serine_cluster_domain\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t\\t<span class=\"vector-toc-numb\">3.2</span>Serine cluster domain</div>\\n\\t\\t\\t</a>\\n\\t\\t\\t\\n\\t\\t\\t<ul id=\"toc-Serine_cluster_domain-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t</ul>\\n\\t\\t</li>\\n\\t\\t<li id=\"toc-BRCT_domains\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-2\">\\n\\t\\t\\t<a class=\"vector-toc-link\" href=\"#BRCT_domains\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t\\t<span class=\"vector-toc-numb\">3.3</span>BRCT domains</div>\\n\\t\\t\\t</a>\\n\\t\\t\\t\\n\\t\\t\\t<ul id=\"toc-BRCT_domains-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t</ul>\\n\\t\\t</li>\\n\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Function_and_mechanism\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Function_and_mechanism\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">4</span>Function and mechanism</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t\\t<button aria-controls=\"toc-Function_and_mechanism-sublist\" class=\"mw-ui-icon mw-ui-icon-wikimedia-expand mw-ui-icon-small vector-toc-toggle\">\\n\\t\\t\\t\\tToggle Function and mechanism subsection\\n\\t\\t\\t</button>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Function_and_mechanism-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t<li id=\"toc-Transcription\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-2\">\\n\\t\\t\\t<a class=\"vector-toc-link\" href=\"#Transcription\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t\\t<span class=\"vector-toc-numb\">4.1</span>Transcription</div>\\n\\t\\t\\t</a>\\n\\t\\t\\t\\n\\t\\t\\t<ul id=\"toc-Transcription-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t</ul>\\n\\t\\t</li>\\n\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Mutations_and_cancer_risk\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Mutations_and_cancer_risk\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">5</span>Mutations and cancer risk</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Mutations_and_cancer_risk-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Low_expression_of_BRCA1_in_breast_and_ovarian_cancers\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Low_expression_of_BRCA1_in_breast_and_ovarian_cancers\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">6</span>Low expression of <i>BRCA1</i> in breast and ovarian cancers</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t\\t<button aria-controls=\"toc-Low_expression_of_BRCA1_in_breast_and_ovarian_cancers-sublist\" class=\"mw-ui-icon mw-ui-icon-wikimedia-expand mw-ui-icon-small vector-toc-toggle\">\\n\\t\\t\\t\\tToggle Low expression of <i>BRCA1</i> in breast and ovarian cancers subsection\\n\\t\\t\\t</button>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Low_expression_of_BRCA1_in_breast_and_ovarian_cancers-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t<li id=\"toc-Mutation_of_BRCA1_in_breast_and_ovarian_cancer\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-2\">\\n\\t\\t\\t<a class=\"vector-toc-link\" href=\"#Mutation_of_BRCA1_in_breast_and_ovarian_cancer\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t\\t<span class=\"vector-toc-numb\">6.1</span>Mutation of <i>BRCA1</i> in breast and ovarian cancer</div>\\n\\t\\t\\t</a>\\n\\t\\t\\t\\n\\t\\t\\t<ul id=\"toc-Mutation_of_BRCA1_in_breast_and_ovarian_cancer-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t</ul>\\n\\t\\t</li>\\n\\t\\t<li id=\"toc-BRCA1_promoter_hypermethylation_in_breast_and_ovarian_cancer\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-2\">\\n\\t\\t\\t<a class=\"vector-toc-link\" href=\"#BRCA1_promoter_hypermethylation_in_breast_and_ovarian_cancer\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t\\t<span class=\"vector-toc-numb\">6.2</span><i>BRCA1</i> promoter hypermethylation in breast and ovarian cancer</div>\\n\\t\\t\\t</a>\\n\\t\\t\\t\\n\\t\\t\\t<ul id=\"toc-BRCA1_promoter_hypermethylation_in_breast_and_ovarian_cancer-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t</ul>\\n\\t\\t</li>\\n\\t\\t<li id=\"toc-MicroRNA_repression_of_BRCA1_in_breast_cancers\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-2\">\\n\\t\\t\\t<a class=\"vector-toc-link\" href=\"#MicroRNA_repression_of_BRCA1_in_breast_cancers\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t\\t<span class=\"vector-toc-numb\">6.3</span>MicroRNA repression of BRCA1 in breast cancers</div>\\n\\t\\t\\t</a>\\n\\t\\t\\t\\n\\t\\t\\t<ul id=\"toc-MicroRNA_repression_of_BRCA1_in_breast_cancers-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t</ul>\\n\\t\\t</li>\\n\\t\\t<li id=\"toc-MicroRNA_repression_of_BRCA1_in_ovarian_cancers\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-2\">\\n\\t\\t\\t<a class=\"vector-toc-link\" href=\"#MicroRNA_repression_of_BRCA1_in_ovarian_cancers\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t\\t<span class=\"vector-toc-numb\">6.4</span>MicroRNA repression of BRCA1 in ovarian cancers</div>\\n\\t\\t\\t</a>\\n\\t\\t\\t\\n\\t\\t\\t<ul id=\"toc-MicroRNA_repression_of_BRCA1_in_ovarian_cancers-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t</ul>\\n\\t\\t</li>\\n\\t\\t<li id=\"toc-Deficiency_of_BRCA1_expression_is_likely_tumorigenic\"\\n\\t\\t\\tclass=\"vector-toc-list-item vector-toc-level-2\">\\n\\t\\t\\t<a class=\"vector-toc-link\" href=\"#Deficiency_of_BRCA1_expression_is_likely_tumorigenic\">\\n\\t\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t\\t<span class=\"vector-toc-numb\">6.5</span>Deficiency of <i>BRCA1</i> expression is likely tumorigenic</div>\\n\\t\\t\\t</a>\\n\\t\\t\\t\\n\\t\\t\\t<ul id=\"toc-Deficiency_of_BRCA1_expression_is_likely_tumorigenic-sublist\" class=\"vector-toc-list\">\\n\\t\\t\\t</ul>\\n\\t\\t</li>\\n\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Germ-line_mutations_and_founder_effect\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Germ-line_mutations_and_founder_effect\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">7</span>Germ-line mutations and founder effect</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Germ-line_mutations_and_founder_effect-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Female_fertility\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Female_fertility\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">8</span>Female fertility</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Female_fertility-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Cancer_chemotherapy\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Cancer_chemotherapy\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">9</span>Cancer chemotherapy</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Cancer_chemotherapy-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Patents,_enforcement,_litigation,_and_controversy\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Patents,_enforcement,_litigation,_and_controversy\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">10</span>Patents, enforcement, litigation, and controversy</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Patents,_enforcement,_litigation,_and_controversy-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-Interactions\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#Interactions\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">11</span>Interactions</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-Interactions-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-References\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#References\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">12</span>References</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-References-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n\\t<li id=\"toc-External_links\"\\n\\t\\tclass=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\">\\n\\t\\t<a class=\"vector-toc-link\" href=\"#External_links\">\\n\\t\\t\\t<div class=\"vector-toc-text\">\\n\\t\\t\\t<span class=\"vector-toc-numb\">13</span>External links</div>\\n\\t\\t</a>\\n\\t\\t\\n\\t\\t<ul id=\"toc-External_links-sublist\" class=\"vector-toc-list\">\\n\\t\\t</ul>\\n\\t</li>\\n</ul>\\n</div>\\n\\n\\t\\t\\t</div>\\n\\t\\t</nav>\\n\\t\\t<div class=\"mw-content-container\">\\n\\t\\t\\t<main id=\"content\" class=\"mw-body\" role=\"main\">\\n\\t\\t\\t\\t<header class=\"mw-body-header vector-page-titlebar\">\\n\\t\\t\\t\\t\\t<label\\n\\t\\t\\t\\t\\t\\tid=\"vector-toc-collapsed-button\"\\n\\t\\t\\t\\t\\t\\tclass=\"mw-ui-button mw-ui-quiet mw-ui-icon mw-ui-icon-flush-left mw-ui-icon-element mw-ui-icon-wikimedia-listBullet\"\\n\\t\\t\\t\\t\\t\\tfor=\"vector-toc-collapsed-checkbox\"\\n\\t\\t\\t\\t\\t\\trole=\"button\"\\n\\t\\t\\t\\t\\t\\taria-controls=\"toc-toggle-list\"\\n\\t\\t\\t\\t\\t\\tdata-event-name=\"vector.toc-toggle-list\"\\n\\t\\t\\t\\t\\t\\ttabindex=\"0\"\\n\\t\\t\\t\\t\\t\\ttitle=\"Table of Contents\">\\n\\t\\t\\t\\t\\t\\tToggle the table of contents\\n\\t\\t\\t\\t\\t</label>\\n\\t\\t\\t\\t\\n\\t\\t\\t\\t\\t<nav role=\"navigation\" aria-label=\"Contents\" class=\"vector-toc-landmark\">\\n\\t\\t\\t\\t\\t\\t\\n<div id=\"vector-page-titlebar-toc\" class=\"vector-menu vector-dropdown vector-menu-dropdown vector-page-titlebar-toc mw-ui-icon-flush-left\"  >\\n\\t<input type=\"checkbox\"\\n\\t\\tid=\"vector-page-titlebar-toc-checkbox\"\\n\\t\\trole=\"button\"\\n\\t\\taria-haspopup=\"true\"\\n\\t\\tdata-event-name=\"ui.dropdown-vector-page-titlebar-toc\"\\n\\t\\tclass=\"vector-menu-checkbox \"\\n\\t\\t\\n\\t\\taria-label=\"Toggle the table of contents\"\\n\\t\\t\\n\\t/>\\n\\t<label\\n\\t\\tid=\"vector-page-titlebar-toc-label\"\\n\\t\\tfor=\"vector-page-titlebar-toc-checkbox\"\\n\\t\\tclass=\"vector-menu-heading mw-ui-button mw-ui-quiet mw-ui-icon-element \"\\n\\t\\taria-hidden=\"true\"\\n\\t\\t\\n\\t>\\n\\t\\t<span class=\"mw-ui-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet\"></span>\\n\\n\\t\\t<span class=\"vector-menu-heading-label\">Toggle the table of contents</span>\\n\\t</label>\\n\\t<div class=\"vector-menu-content vector-dropdown-content\">\\n\\n\\n\\t\\t\\t\\t\\t\\t\\t<div id=\"vector-page-titlebar-toc-unpinned-container\" class=\"vector-unpinned-container\">\\n\\t\\t\\t</div>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\t\\t\\t\\t\\t</nav>\\n\\t\\t\\t\\t\\t<h1 id=\"firstHeading\" class=\"firstHeading mw-first-heading\"><span class=\"mw-page-title-main\">BRCA1</span></h1>\\n\\t\\t\\t\\t\\n\\t\\t\\t\\t\\t\\t\\t\\n<div id=\"p-lang-btn\" class=\"vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-lang\"  >\\n\\t<input type=\"checkbox\"\\n\\t\\tid=\"p-lang-btn-checkbox\"\\n\\t\\trole=\"button\"\\n\\t\\taria-haspopup=\"true\"\\n\\t\\tdata-event-name=\"ui.dropdown-p-lang-btn\"\\n\\t\\tclass=\"vector-menu-checkbox mw-interlanguage-selector\"\\n\\t\\taria-label=\"Go to an article in another language. Available in 23 languages\"\\n\\t\\t\\n\\t\\t\\n\\t/>\\n\\t<label\\n\\t\\tid=\"p-lang-btn-label\"\\n\\t\\tfor=\"p-lang-btn-checkbox\"\\n\\t\\tclass=\"vector-menu-heading mw-ui-button mw-ui-quiet mw-ui-progressive mw-portlet-lang-heading-23\"\\n\\t\\taria-hidden=\"true\"\\n\\t\\t\\n\\t>\\n\\t\\t<span class=\"mw-ui-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive\"></span>\\n\\n\\t\\t<span class=\"vector-menu-heading-label\">23 languages</span>\\n\\t</label>\\n\\t<div class=\"vector-menu-content vector-dropdown-content\">\\n\\n\\t\\t<div class=\"vector-menu-content\">\\n\\t\\t\\t\\n\\t\\t\\t<ul class=\"vector-menu-content-list\"><li class=\"interlanguage-link interwiki-ar mw-list-item\"><a href=\"https://ar.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Arabic\" lang=\"ar\" hreflang=\"ar\" class=\"interlanguage-link-target\"><span>\\xd8\\xa7\\xd9\\x84\\xd8\\xb9\\xd8\\xb1\\xd8\\xa8\\xd9\\x8a\\xd8\\xa9</span></a></li><li class=\"interlanguage-link interwiki-bs mw-list-item\"><a href=\"https://bs.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Bosnian\" lang=\"bs\" hreflang=\"bs\" class=\"interlanguage-link-target\"><span>Bosanski</span></a></li><li class=\"interlanguage-link interwiki-ca mw-list-item\"><a href=\"https://ca.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Catalan\" lang=\"ca\" hreflang=\"ca\" class=\"interlanguage-link-target\"><span>Catal\\xc3\\xa0</span></a></li><li class=\"interlanguage-link interwiki-cy mw-list-item\"><a href=\"https://cy.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Welsh\" lang=\"cy\" hreflang=\"cy\" class=\"interlanguage-link-target\"><span>Cymraeg</span></a></li><li class=\"interlanguage-link interwiki-de mw-list-item\"><a href=\"https://de.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 German\" lang=\"de\" hreflang=\"de\" class=\"interlanguage-link-target\"><span>Deutsch</span></a></li><li class=\"interlanguage-link interwiki-et mw-list-item\"><a href=\"https://et.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Estonian\" lang=\"et\" hreflang=\"et\" class=\"interlanguage-link-target\"><span>Eesti</span></a></li><li class=\"interlanguage-link interwiki-es mw-list-item\"><a href=\"https://es.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Spanish\" lang=\"es\" hreflang=\"es\" class=\"interlanguage-link-target\"><span>Espa\\xc3\\xb1ol</span></a></li><li class=\"interlanguage-link interwiki-fa mw-list-item\"><a href=\"https://fa.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Persian\" lang=\"fa\" hreflang=\"fa\" class=\"interlanguage-link-target\"><span>\\xd9\\x81\\xd8\\xa7\\xd8\\xb1\\xd8\\xb3\\xdb\\x8c</span></a></li><li class=\"interlanguage-link interwiki-fr mw-list-item\"><a href=\"https://fr.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 French\" lang=\"fr\" hreflang=\"fr\" class=\"interlanguage-link-target\"><span>Fran\\xc3\\xa7ais</span></a></li><li class=\"interlanguage-link interwiki-gl mw-list-item\"><a href=\"https://gl.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Galician\" lang=\"gl\" hreflang=\"gl\" class=\"interlanguage-link-target\"><span>Galego</span></a></li><li class=\"interlanguage-link interwiki-ko mw-list-item\"><a href=\"https://ko.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Korean\" lang=\"ko\" hreflang=\"ko\" class=\"interlanguage-link-target\"><span>\\xed\\x95\\x9c\\xea\\xb5\\xad\\xec\\x96\\xb4</span></a></li><li class=\"interlanguage-link interwiki-it mw-list-item\"><a href=\"https://it.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Italian\" lang=\"it\" hreflang=\"it\" class=\"interlanguage-link-target\"><span>Italiano</span></a></li><li class=\"interlanguage-link interwiki-nl mw-list-item\"><a href=\"https://nl.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Dutch\" lang=\"nl\" hreflang=\"nl\" class=\"interlanguage-link-target\"><span>Nederlands</span></a></li><li class=\"interlanguage-link interwiki-ja mw-list-item\"><a href=\"https://ja.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Japanese\" lang=\"ja\" hreflang=\"ja\" class=\"interlanguage-link-target\"><span>\\xe6\\x97\\xa5\\xe6\\x9c\\xac\\xe8\\xaa\\x9e</span></a></li><li class=\"interlanguage-link interwiki-pl mw-list-item\"><a href=\"https://pl.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Polish\" lang=\"pl\" hreflang=\"pl\" class=\"interlanguage-link-target\"><span>Polski</span></a></li><li class=\"interlanguage-link interwiki-pt mw-list-item\"><a href=\"https://pt.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Portuguese\" lang=\"pt\" hreflang=\"pt\" class=\"interlanguage-link-target\"><span>Portugu\\xc3\\xaas</span></a></li><li class=\"interlanguage-link interwiki-ru mw-list-item\"><a href=\"https://ru.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Russian\" lang=\"ru\" hreflang=\"ru\" class=\"interlanguage-link-target\"><span>\\xd0\\xa0\\xd1\\x83\\xd1\\x81\\xd1\\x81\\xd0\\xba\\xd0\\xb8\\xd0\\xb9</span></a></li><li class=\"interlanguage-link interwiki-sl mw-list-item\"><a href=\"https://sl.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Slovenian\" lang=\"sl\" hreflang=\"sl\" class=\"interlanguage-link-target\"><span>Sloven\\xc5\\xa1\\xc4\\x8dina</span></a></li><li class=\"interlanguage-link interwiki-fi mw-list-item\"><a href=\"https://fi.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Finnish\" lang=\"fi\" hreflang=\"fi\" class=\"interlanguage-link-target\"><span>Suomi</span></a></li><li class=\"interlanguage-link interwiki-ta mw-list-item\"><a href=\"https://ta.wikipedia.org/wiki/%E0%AE%AA%E0%AE%BF%E0%AE%86%E0%AE%B0%E0%AF%8D%E0%AE%9A%E0%AE%BF%E0%AE%8F1\" title=\"\\xe0\\xae\\xaa\\xe0\\xae\\xbf\\xe0\\xae\\x86\\xe0\\xae\\xb0\\xe0\\xaf\\x8d\\xe0\\xae\\x9a\\xe0\\xae\\xbf\\xe0\\xae\\x8f1 \\xe2\\x80\\x93 Tamil\" lang=\"ta\" hreflang=\"ta\" class=\"interlanguage-link-target\"><span>\\xe0\\xae\\xa4\\xe0\\xae\\xae\\xe0\\xae\\xbf\\xe0\\xae\\xb4\\xe0\\xaf\\x8d</span></a></li><li class=\"interlanguage-link interwiki-uk mw-list-item\"><a href=\"https://uk.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Ukrainian\" lang=\"uk\" hreflang=\"uk\" class=\"interlanguage-link-target\"><span>\\xd0\\xa3\\xd0\\xba\\xd1\\x80\\xd0\\xb0\\xd1\\x97\\xd0\\xbd\\xd1\\x81\\xd1\\x8c\\xd0\\xba\\xd0\\xb0</span></a></li><li class=\"interlanguage-link interwiki-ur mw-list-item\"><a href=\"https://ur.wikipedia.org/wiki/%D8%A8%D8%B1%D8%B3%D8%A7_1\" title=\"\\xd8\\xa8\\xd8\\xb1\\xd8\\xb3\\xd8\\xa7 1 \\xe2\\x80\\x93 Urdu\" lang=\"ur\" hreflang=\"ur\" class=\"interlanguage-link-target\"><span>\\xd8\\xa7\\xd8\\xb1\\xd8\\xaf\\xd9\\x88</span></a></li><li class=\"interlanguage-link interwiki-zh mw-list-item\"><a href=\"https://zh.wikipedia.org/wiki/BRCA1\" title=\"BRCA1 \\xe2\\x80\\x93 Chinese\" lang=\"zh\" hreflang=\"zh\" class=\"interlanguage-link-target\"><span>\\xe4\\xb8\\xad\\xe6\\x96\\x87</span></a></li></ul>\\n\\t\\t\\t<div class=\"after-portlet after-portlet-lang\"><span class=\"wb-langlinks-edit wb-langlinks-link\"><a href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q17487737#sitelinks-wikipedia\" title=\"Edit interlanguage links\" class=\"wbc-editpage\">Edit links</a></span></div>\\n\\t\\t</div>\\n\\n\\t</div>\\n</div>\\n\\t\\t\\t\\t</header>\\n\\t\\t\\t\\t<div class=\"vector-page-toolbar\">\\n\\t\\t\\t\\t\\t<div class=\"vector-page-toolbar-container\">\\n\\t\\t\\t\\t\\t\\t<div id=\"left-navigation\">\\n\\t\\t\\t\\t\\t\\t\\t<nav aria-label=\"Namespaces\">\\n\\t\\t\\t\\t\\t\\t\\t\\t\\n<div id=\"p-associated-pages\" class=\"vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages\"  >\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\">\\n\\t\\t\\t<li id=\"ca-nstab-main\" class=\"selected vector-tab-noicon mw-list-item\"><a data-mw=\"interface\" href=\"/wiki/BRCA1\" title=\"View the content page [c]\" accesskey=\"c\" class=\"\"><span>Article</span></a>\\n</li>\\n<li id=\"ca-talk\" class=\"vector-tab-noicon mw-list-item\"><a data-mw=\"interface\" href=\"/wiki/Talk:BRCA1\" rel=\"discussion\" title=\"Discuss improvements to the content page [t]\" accesskey=\"t\" class=\"\"><span>Talk</span></a>\\n</li>\\n\\n\\t\\t</ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n\\t\\t\\t\\t\\t\\t\\t\\t\\n\\n<div id=\"p-variants\" class=\"vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-variants emptyPortlet\"  >\\n\\t<input type=\"checkbox\"\\n\\t\\tid=\"p-variants-checkbox\"\\n\\t\\trole=\"button\"\\n\\t\\taria-haspopup=\"true\"\\n\\t\\tdata-event-name=\"ui.dropdown-p-variants\"\\n\\t\\tclass=\"vector-menu-checkbox\"\\n\\t\\taria-label=\"Change language variant\"\\n\\t\\t\\n\\t\\t\\n\\t/>\\n\\t<label\\n\\t\\tid=\"p-variants-label\"\\n\\t\\tfor=\"p-variants-checkbox\"\\n\\t\\tclass=\"vector-menu-heading \"\\n\\t\\taria-hidden=\"true\"\\n\\t\\t\\n\\t>\\n\\t\\t\\n\\t\\t<span class=\"vector-menu-heading-label\">English</span>\\n\\t</label>\\n\\t<div class=\"vector-menu-content vector-dropdown-content\">\\n\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"></ul>\\n\\t\\t\\n\\t</div>\\n\\n\\t</div>\\n</div>\\n\\t\\t\\t\\t\\t\\t\\t</nav>\\n\\t\\t\\t\\t\\t\\t</div>\\n\\t\\t\\t\\t\\t\\t<div id=\"right-navigation\" class=\"vector-collapsible\">\\n\\t\\t\\t\\t\\t\\t\\t<nav aria-label=\"Views\">\\n\\t\\t\\t\\t\\t\\t\\t\\t\\n<div id=\"p-views\" class=\"vector-menu vector-menu-tabs mw-portlet mw-portlet-views\"  >\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\">\\n\\t\\t\\t<li id=\"ca-view\" class=\"selected vector-tab-noicon mw-list-item\"><a data-mw=\"interface\" href=\"/wiki/BRCA1\" class=\"\"><span>Read</span></a>\\n</li>\\n<li id=\"ca-edit\" class=\"vector-tab-noicon mw-list-item\"><a data-mw=\"interface\" href=\"/w/index.php?title=BRCA1&amp;action=edit\" title=\"Edit this page [e]\" accesskey=\"e\" class=\"\"><span>Edit</span></a>\\n</li>\\n<li id=\"ca-history\" class=\"vector-tab-noicon mw-list-item\"><a data-mw=\"interface\" href=\"/w/index.php?title=BRCA1&amp;action=history\" title=\"Past revisions of this page [h]\" accesskey=\"h\" class=\"\"><span>View history</span></a>\\n</li>\\n\\n\\t\\t</ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n\\t\\t\\t\\t\\t\\t\\t</nav>\\n\\t\\t\\t\\t\\n\\t\\t\\t\\t\\t\\t\\t<nav class=\"vector-page-tools-landmark\" aria-label=\"More options\">\\n\\t\\t\\t\\t\\t\\t\\t\\t\\n<div id=\"vector-page-tools-dropdown\" class=\"vector-menu vector-dropdown vector-menu-dropdown vector-page-tools-dropdown\"  >\\n\\t<input type=\"checkbox\"\\n\\t\\tid=\"vector-page-tools-dropdown-checkbox\"\\n\\t\\trole=\"button\"\\n\\t\\taria-haspopup=\"true\"\\n\\t\\tdata-event-name=\"ui.dropdown-vector-page-tools-dropdown\"\\n\\t\\tclass=\"vector-menu-checkbox \"\\n\\t\\t\\n\\t\\taria-label=\"Tools\"\\n\\t\\t\\n\\t/>\\n\\t<label\\n\\t\\tid=\"vector-page-tools-dropdown-label\"\\n\\t\\tfor=\"vector-page-tools-dropdown-checkbox\"\\n\\t\\tclass=\"vector-menu-heading \"\\n\\t\\taria-hidden=\"true\"\\n\\t\\t\\n\\t>\\n\\t\\t\\n\\t\\t<span class=\"vector-menu-heading-label\">Tools</span>\\n\\t</label>\\n\\t<div class=\"vector-menu-content vector-dropdown-content\">\\n\\n\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<div id=\"vector-page-tools-unpinned-container\" class=\"vector-unpinned-container\">\\n\\t\\t\\t\\t\\t\\t\\n<div id=\"vector-page-tools\" class=\"vector-page-tools vector-pinnable-element\">\\n\\t<div\\n\\tclass=\"vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned\"\\n\\tdata-feature-name=\"page-tools-pinned\"\\n\\tdata-pinnable-element-id=\"vector-page-tools\"\\n\\tdata-pinned-container-id=\"vector-page-tools-pinned-container\"\\n\\tdata-unpinned-container-id=\"vector-page-tools-unpinned-container\"\\n>\\n\\t<div class=\"vector-pinnable-header-label\">Tools</div>\\n\\t<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-pin-button\" data-event-name=\"pinnable-header.vector-page-tools.pin\">move to sidebar</button>\\n\\t<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button\" data-event-name=\"pinnable-header.vector-page-tools.unpin\">hide</button>\\n</div>\\n\\n\\t\\n<div id=\"p-cactions\" class=\"vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items\"  title=\"More options\" >\\n\\t<div class=\"vector-menu-heading\">\\n\\t\\tActions\\n\\t</div>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"ca-more-view\" class=\"selected vector-more-collapsible-item mw-list-item\"><a href=\"/wiki/BRCA1\"><span>Read</span></a></li><li id=\"ca-more-edit\" class=\"vector-more-collapsible-item mw-list-item\"><a href=\"/w/index.php?title=BRCA1&amp;action=edit\"><span>Edit</span></a></li><li id=\"ca-more-history\" class=\"vector-more-collapsible-item mw-list-item\"><a href=\"/w/index.php?title=BRCA1&amp;action=history\"><span>View history</span></a></li></ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n<div id=\"p-tb\" class=\"vector-menu mw-portlet mw-portlet-tb\"  >\\n\\t<div class=\"vector-menu-heading\">\\n\\t\\tGeneral\\n\\t</div>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"t-whatlinkshere\" class=\"mw-list-item\"><a href=\"/wiki/Special:WhatLinksHere/BRCA1\" title=\"List of all English Wikipedia pages containing links to this page [j]\" accesskey=\"j\"><span>What links here</span></a></li><li id=\"t-recentchangeslinked\" class=\"mw-list-item\"><a href=\"/wiki/Special:RecentChangesLinked/BRCA1\" rel=\"nofollow\" title=\"Recent changes in pages linked from this page [k]\" accesskey=\"k\"><span>Related changes</span></a></li><li id=\"t-upload\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:File_Upload_Wizard\" title=\"Upload files [u]\" accesskey=\"u\"><span>Upload file</span></a></li><li id=\"t-specialpages\" class=\"mw-list-item\"><a href=\"/wiki/Special:SpecialPages\" title=\"A list of all special pages [q]\" accesskey=\"q\"><span>Special pages</span></a></li><li id=\"t-permalink\" class=\"mw-list-item\"><a href=\"/w/index.php?title=BRCA1&amp;oldid=1146808968\" title=\"Permanent link to this revision of this page\"><span>Permanent link</span></a></li><li id=\"t-info\" class=\"mw-list-item\"><a href=\"/w/index.php?title=BRCA1&amp;action=info\" title=\"More information about this page\"><span>Page information</span></a></li><li id=\"t-cite\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Special:CiteThisPage&amp;page=BRCA1&amp;id=1146808968&amp;wpFormIdentifier=titleform\" title=\"Information on how to cite this page\"><span>Cite this page</span></a></li><li id=\"t-wikibase\" class=\"mw-list-item\"><a href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q17487737\" title=\"Structured data on this page hosted by Wikidata [g]\" accesskey=\"g\"><span>Wikidata item</span></a></li></ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n<div id=\"p-coll-print_export\" class=\"vector-menu mw-portlet mw-portlet-coll-print_export\"  >\\n\\t<div class=\"vector-menu-heading\">\\n\\t\\tPrint/export\\n\\t</div>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"coll-download-as-rl\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Special:DownloadAsPdf&amp;page=BRCA1&amp;action=show-download-screen\" title=\"Download this page as a PDF file\"><span>Download as PDF</span></a></li><li id=\"t-print\" class=\"mw-list-item\"><a href=\"/w/index.php?title=BRCA1&amp;printable=yes\" title=\"Printable version of this page [p]\" accesskey=\"p\"><span>Printable version</span></a></li></ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n<div id=\"p-wikibase-otherprojects\" class=\"vector-menu mw-portlet mw-portlet-wikibase-otherprojects\"  >\\n\\t<div class=\"vector-menu-heading\">\\n\\t\\tIn other projects\\n\\t</div>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t\\n\\t\\t<ul class=\"vector-menu-content-list\"><li class=\"wb-otherproject-link wb-otherproject-commons mw-list-item\"><a href=\"https://commons.wikimedia.org/wiki/Category:BRCA1\" hreflang=\"en\"><span>Wikimedia Commons</span></a></li></ul>\\n\\t\\t\\n\\t</div>\\n</div>\\n\\n</div>\\n\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</div>\\n\\t\\t\\t\\t\\n\\t</div>\\n</div>\\n\\t\\t\\t\\t\\t\\t\\t</nav>\\n\\t\\t\\t\\t\\t\\t</div>\\n\\t\\t\\t\\t\\t</div>\\n\\t\\t\\t\\t</div>\\n\\t\\t\\t\\t<div class=\"vector-column-end\">\\n\\t\\t\\t\\t\\t<nav class=\"vector-page-tools-landmark vector-sticky-pinned-container\" aria-label=\"More options\">\\n\\t\\t\\t\\t\\t\\t<div id=\"vector-page-tools-pinned-container\" class=\"vector-pinned-container\">\\n\\t\\t\\t\\n\\t\\t\\t\\t\\t\\t</div>\\n\\t</nav>\\n\\t\\t\\t\\t</div>\\n\\t\\t\\t\\t<div id=\"bodyContent\" class=\"vector-body\" aria-labelledby=\"firstHeading\" data-mw-ve-target-container>\\n\\t\\t\\t\\t\\t<div class=\"vector-body-before-content\">\\n\\t\\t\\t\\t\\t\\t\\t<div class=\"mw-indicators\">\\n\\t\\t</div>\\n\\n\\t\\t\\t\\t\\t\\t<div id=\"siteSub\" class=\"noprint\">From Wikipedia, the free encyclopedia</div>\\n\\t\\t\\t\\t\\t</div>\\n\\t\\t\\t\\t\\t<div id=\"contentSub\"><div id=\"mw-content-subtitle\"></div></div>\\n\\t\\t\\t\\t\\t\\n\\t\\t\\t\\t\\t\\n\\t\\t\\t\\t\\t<div id=\"mw-content-text\" class=\"mw-body-content mw-content-ltr\" lang=\"en\" dir=\"ltr\"><div class=\"mw-parser-output\"><div class=\"shortdescription nomobile noexcerpt noprint searchaux\" style=\"display:none\">Gene known for its role in breast cancer</div>\\n<table class=\"infobox\" style=\"width:26.4em\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;font-size:125%;font-weight:bold\">BRCA1</th></tr><tr><td colspan=\"4\" style=\"text-align:center\"><a href=\"/wiki/File:Protein_BRCA1_PDB_1jm7.png\" class=\"image\"><img alt=\"Protein BRCA1 PDB 1jm7.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Protein_BRCA1_PDB_1jm7.png/250px-Protein_BRCA1_PDB_1jm7.png\" decoding=\"async\" width=\"250\" height=\"169\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Protein_BRCA1_PDB_1jm7.png/375px-Protein_BRCA1_PDB_1jm7.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Protein_BRCA1_PDB_1jm7.png/500px-Protein_BRCA1_PDB_1jm7.png 2x\" data-file-width=\"744\" data-file-height=\"504\" /></a></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Available structures</th></tr><tr><th rowspan=\"2\" style=\"background-color:#c3fdb8;width:43px\"><a href=\"/wiki/Protein_Data_Bank\" title=\"Protein Data Bank\">PDB</a></th><td colspan=\"2\" style=\"background-color:#eee\">Ortholog search: <span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/pdbe/searchResults.html?display=both&amp;term=P48754%20or%20P38398\">PDBe</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/search?q=rcsb_polymer_entity_container_identifiers.reference_sequence_identifiers.database_name:UniProt%20AND%20rcsb_polymer_entity_container_identifiers.reference_sequence_identifiers.database_accession:P48754,P38398\">RCSB</a> </span></td></tr><tr><td><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr style=\"background-color:#ddd;text-align:center\"><th colspan=\"2\">List of PDB id codes</th></tr><tr><td colspan=\"2\" style=\"background-color:#eee\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/1JM7\">1JM7</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/1JNX\">1JNX</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/1N5O\">1N5O</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/1OQA\">1OQA</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/1T15\">1T15</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/1T29\">1T29</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/1T2U\">1T2U</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/1T2V\">1T2V</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/1Y98\">1Y98</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/2ING\">2ING</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3COJ\">3COJ</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3K0H\">3K0H</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3K0K\">3K0K</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3K15\">3K15</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3PXA\">3PXA</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3PXB\">3PXB</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3PXC\">3PXC</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3PXD\">3PXD</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3PXE\">3PXE</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/4IFI\">4IFI</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/4IGK\">4IGK</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/4JLU\">4JLU</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/4OFB\">4OFB</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/4U4A\">4U4A</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/4Y18\">4Y18</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/4Y2G\">4Y2G</a></span></p></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Identifiers</th></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><span class=\"plainlinks\"><a href=\"/wiki/Gene_nomenclature\" title=\"Gene nomenclature\">Aliases</a></span></th><td colspan=\"3\" style=\"background:#eee\"><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/1100\">BRCA1</a></span>, breast cancer 1, early onset, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53, FANCS, breast cancer 1, DNA repair associated, BRCA1 DNA repair associated, Genes</td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">External IDs</th><td colspan=\"3\" style=\"background-color:#eee\"><span class=\"plainlinks\"><a href=\"/wiki/Mendelian_Inheritance_in_Man\" class=\"mw-redirect\" title=\"Mendelian Inheritance in Man\">OMIM</a>: <a rel=\"nofollow\" class=\"external text\" href=\"https://omim.org/entry/113705\">113705</a> <a href=\"/wiki/Mouse_Genome_Informatics\" title=\"Mouse Genome Informatics\">MGI</a>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.informatics.jax.org/marker/MGI:104537\">104537</a> <a href=\"/wiki/HomoloGene\" title=\"HomoloGene\">HomoloGene</a>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=homologene&amp;dopt=HomoloGene&amp;list_uids=5276\">5276</a> <a href=\"/wiki/GeneCards\" title=\"GeneCards\">GeneCards</a>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.genecards.org/cgi-bin/carddisp.pl?gene=BRCA1\">BRCA1</a> </span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Gene location (<a href=\"/wiki/Human_genome\" title=\"Human genome\">Human</a>)</th></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><a href=\"/wiki/File:Ideogram_human_chromosome_17.svg\" class=\"image\" title=\"Chromosome 17 (human)\"><img alt=\"Chromosome 17 (human)\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/00/Ideogram_human_chromosome_17.svg/300px-Ideogram_human_chromosome_17.svg.png\" decoding=\"async\" width=\"300\" height=\"120\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/00/Ideogram_human_chromosome_17.svg/450px-Ideogram_human_chromosome_17.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/00/Ideogram_human_chromosome_17.svg/600px-Ideogram_human_chromosome_17.svg.png 2x\" data-file-width=\"474\" data-file-height=\"189\" /></a></td></tr><tr><th scope=\"row\" width=\"15%\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Chromosome\" title=\"Chromosome\">Chr.</a></th><td colspan=\"3\" width=\"85%\" style=\"background-color:#eee\"><span class=\"plainlinks\"><a href=\"/wiki/Chromosome_17_(human)\" class=\"mw-redirect\" title=\"Chromosome 17 (human)\">Chromosome 17 (human)</a><sup id=\"cite_ref-refGRCh38Ensembl_1-0\" class=\"reference\"><a href=\"#cite_note-refGRCh38Ensembl-1\">&#91;1&#93;</a></sup></span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><div align=\"center\"><div style=\"position: relative; width: 300px;\"><a href=\"/wiki/File:Human_chromosome_17_ideogram.svg\" class=\"image\" title=\"Chromosome 17 (human)\"><img alt=\"Chromosome 17 (human)\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Human_chromosome_17_ideogram.svg/300px-Human_chromosome_17_ideogram.svg.png\" decoding=\"async\" width=\"300\" height=\"58\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Human_chromosome_17_ideogram.svg/450px-Human_chromosome_17_ideogram.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Human_chromosome_17_ideogram.svg/600px-Human_chromosome_17_ideogram.svg.png 2x\" data-file-width=\"1125\" data-file-height=\"216\" /></a><div style=\"position: absolute; left: 146.89004298083px; top: 2px; padding: 0;\"><a href=\"/wiki/File:HSR_1996_II_3.5e.svg\" class=\"image\" title=\"Genomic location for BRCA1\"><img alt=\"Genomic location for BRCA1\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/14px-HSR_1996_II_3.5e.svg.png\" decoding=\"async\" width=\"14\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/21px-HSR_1996_II_3.5e.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/28px-HSR_1996_II_3.5e.svg.png 2x\" data-file-width=\"142\" data-file-height=\"142\" /></a></div><div style=\"position: absolute; left: 152.9px; top: 19px; padding: 0;\"><a href=\"/wiki/File:Red_rectangle_2x18.png\" class=\"image\" title=\"Genomic location for BRCA1\"><img alt=\"Genomic location for BRCA1\" src=\"//upload.wikimedia.org/wikipedia/commons/6/6a/Red_rectangle_2x18.png\" decoding=\"async\" width=\"2\" height=\"18\" data-file-width=\"2\" data-file-height=\"18\" /></a></div></div></div></td></tr><tr><th scope=\"row\" rowspan=\"2\" width=\"15%\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Locus_(genetics)\" title=\"Locus (genetics)\">Band</a></th><td rowspan=\"2\" width=\"35%\" style=\"background-color:#eee\"><span class=\"plainlinks\">17q21.31</span></td><th scope=\"row\" style=\"background-color:#c3fdb8\">Start</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">43,044,295 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup id=\"cite_ref-refGRCh38Ensembl_1-1\" class=\"reference\"><a href=\"#cite_note-refGRCh38Ensembl-1\">&#91;1&#93;</a></sup></span></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">End</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">43,170,245 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup id=\"cite_ref-refGRCh38Ensembl_1-2\" class=\"reference\"><a href=\"#cite_note-refGRCh38Ensembl-1\">&#91;1&#93;</a></sup></span></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Gene location (<a href=\"/wiki/Laboratory_mouse\" title=\"Laboratory mouse\">Mouse</a>)</th></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><a href=\"/wiki/File:Ideogram_house_mouse_chromosome_11.svg\" class=\"image\" title=\"Chromosome 11 (mouse)\"><img alt=\"Chromosome 11 (mouse)\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Ideogram_house_mouse_chromosome_11.svg/260px-Ideogram_house_mouse_chromosome_11.svg.png\" decoding=\"async\" width=\"260\" height=\"111\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Ideogram_house_mouse_chromosome_11.svg/390px-Ideogram_house_mouse_chromosome_11.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Ideogram_house_mouse_chromosome_11.svg/520px-Ideogram_house_mouse_chromosome_11.svg.png 2x\" data-file-width=\"470\" data-file-height=\"200\" /></a></td></tr><tr><th scope=\"row\" width=\"15%\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Chromosome\" title=\"Chromosome\">Chr.</a></th><td colspan=\"3\" width=\"85%\" style=\"background-color:#eee\"><span class=\"plainlinks\">Chromosome 11 (mouse)<sup id=\"cite_ref-refGRCm38Ensembl_2-0\" class=\"reference\"><a href=\"#cite_note-refGRCm38Ensembl-2\">&#91;2&#93;</a></sup></span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><div align=\"center\"><div style=\"position: relative; width: 300px;\"><a href=\"/wiki/File:Ideogram_of_house_mouse_chromosome_11.svg\" class=\"image\" title=\"Chromosome 11 (mouse)\"><img alt=\"Chromosome 11 (mouse)\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Ideogram_of_house_mouse_chromosome_11.svg/300px-Ideogram_of_house_mouse_chromosome_11.svg.png\" decoding=\"async\" width=\"300\" height=\"58\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Ideogram_of_house_mouse_chromosome_11.svg/450px-Ideogram_of_house_mouse_chromosome_11.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Ideogram_of_house_mouse_chromosome_11.svg/600px-Ideogram_of_house_mouse_chromosome_11.svg.png 2x\" data-file-width=\"1200\" data-file-height=\"231\" /></a><div style=\"position: absolute; left: 238.92974423631px; top: 2px; padding: 0;\"><a href=\"/wiki/File:HSR_1996_II_3.5e.svg\" class=\"image\" title=\"Genomic location for BRCA1\"><img alt=\"Genomic location for BRCA1\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/14px-HSR_1996_II_3.5e.svg.png\" decoding=\"async\" width=\"14\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/21px-HSR_1996_II_3.5e.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/28px-HSR_1996_II_3.5e.svg.png 2x\" data-file-width=\"142\" data-file-height=\"142\" /></a></div><div style=\"position: absolute; left: 244.9px; top: 19px; padding: 0;\"><a href=\"/wiki/File:Red_rectangle_2x18.png\" class=\"image\" title=\"Genomic location for BRCA1\"><img alt=\"Genomic location for BRCA1\" src=\"//upload.wikimedia.org/wikipedia/commons/6/6a/Red_rectangle_2x18.png\" decoding=\"async\" width=\"2\" height=\"18\" data-file-width=\"2\" data-file-height=\"18\" /></a></div></div></div></td></tr><tr><th scope=\"row\" rowspan=\"2\" width=\"15%\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Locus_(genetics)\" title=\"Locus (genetics)\">Band</a></th><td rowspan=\"2\" width=\"35%\" style=\"background-color:#eee\"><span class=\"plainlinks\">11 65.18 cM&#124;11 D</span></td><th scope=\"row\" style=\"background-color:#c3fdb8\">Start</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">101,379,590 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup id=\"cite_ref-refGRCm38Ensembl_2-1\" class=\"reference\"><a href=\"#cite_note-refGRCm38Ensembl-2\">&#91;2&#93;</a></sup></span></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">End</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">101,442,781 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup id=\"cite_ref-refGRCm38Ensembl_2-2\" class=\"reference\"><a href=\"#cite_note-refGRCm38Ensembl-2\">&#91;2&#93;</a></sup></span></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\"><a href=\"/wiki/Gene_expression\" title=\"Gene expression\">RNA expression</a> pattern</th></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a rel=\"nofollow\" class=\"external text\" href=\"https://bgee.org/\">Bgee</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th><b><a href=\"/wiki/Human_genome\" title=\"Human genome\">Human</a></b></th><th><b><a href=\"/wiki/Laboratory_mouse\" title=\"Laboratory mouse\">Mouse</a> (ortholog)</b></th></tr><tr><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:center\"><tbody><tr><td colspan=\"1\"><span class=\"plainlinks\" style=\"margin:-3px\"><a rel=\"nofollow\" class=\"external text\" href=\"https://bgee.org/gene/ENSG00000012048\">Top expressed in</a></span></td></tr><tr><td colspan=\"1\"><div class=\"plainlinks\" style=\"margin:-12px 0px -10px 0px\"><ul style=\"line-height:15%;margin:9px\"><li style=\"line-height: 137%;\">ganglionic eminence</li><br /><li style=\"line-height: 137%;\">secondary oocyte</li><br /><li style=\"line-height: 137%;\">bone marrow cells</li><br /><li style=\"line-height: 137%;\">sural nerve</li><br /><li style=\"line-height: 137%;\">cancellous bone</li><br /><li style=\"line-height: 137%;\">stromal cell of endometrium</li><br /><li style=\"line-height: 137%;\">testicle</li><br /><li style=\"line-height: 137%;\">rectum</li><br /><li style=\"line-height: 137%;\">right lobe of thyroid gland</li><br /><li style=\"line-height: 137%;\">appendix</li></ul></div></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:center\"><tbody><tr><td colspan=\"1\"><span class=\"plainlinks\" style=\"margin:-3px\"><a rel=\"nofollow\" class=\"external text\" href=\"https://bgee.org/gene/ENSMUSG00000017146\">Top expressed in</a></span></td></tr><tr><td colspan=\"1\"><div class=\"plainlinks\" style=\"margin:-12px 0px -10px 0px\"><ul style=\"line-height:15%;margin:9px\"><li style=\"line-height: 137%;\">secondary oocyte</li><br /><li style=\"line-height: 137%;\">primitive streak</li><br /><li style=\"line-height: 137%;\">maxillary prominence</li><br /><li style=\"line-height: 137%;\">Paneth cell</li><br /><li style=\"line-height: 137%;\">iris</li><br /><li style=\"line-height: 137%;\">abdominal wall</li><br /><li style=\"line-height: 137%;\">hair follicle</li><br /><li style=\"line-height: 137%;\">ectoderm</li><br /><li style=\"line-height: 137%;\">somite</li><br /><li style=\"line-height: 137%;\">medullary collecting duct</li></ul></div></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://bgee.org/gene/ENSG00000012048\">More reference expression data</a></span></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a rel=\"nofollow\" class=\"external text\" href=\"http://biogps.org/\">BioGPS</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><a href=\"/wiki/File:PBB_GE_BRCA1_204531_s_at_fs.png\" class=\"image\"><img alt=\"PBB GE BRCA1 204531 s at fs.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/PBB_GE_BRCA1_204531_s_at_fs.png/250px-PBB_GE_BRCA1_204531_s_at_fs.png\" decoding=\"async\" width=\"250\" height=\"181\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/PBB_GE_BRCA1_204531_s_at_fs.png/375px-PBB_GE_BRCA1_204531_s_at_fs.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/ad/PBB_GE_BRCA1_204531_s_at_fs.png/500px-PBB_GE_BRCA1_204531_s_at_fs.png 2x\" data-file-width=\"732\" data-file-height=\"530\" /></a><br /><br /><a href=\"/wiki/File:PBB_GE_BRCA1_211851_x_at_fs.png\" class=\"image\"><img alt=\"PBB GE BRCA1 211851 x at fs.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/PBB_GE_BRCA1_211851_x_at_fs.png/250px-PBB_GE_BRCA1_211851_x_at_fs.png\" decoding=\"async\" width=\"250\" height=\"181\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/PBB_GE_BRCA1_211851_x_at_fs.png/375px-PBB_GE_BRCA1_211851_x_at_fs.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0f/PBB_GE_BRCA1_211851_x_at_fs.png/500px-PBB_GE_BRCA1_211851_x_at_fs.png 2x\" data-file-width=\"732\" data-file-height=\"530\" /></a></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"http://biogps.org/gene/672/\">More reference expression data</a></span></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\"><a href=\"/wiki/Gene_ontology\" class=\"mw-redirect\" title=\"Gene ontology\">Gene ontology</a></th></tr><tr><td style=\"background-color:#c3fdb8;font-weight:bold\">Molecular function</td><td style=\"background-color:#eee\"><div class=\"plainlinks\">\\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0015631\">tubulin binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0046872\">metal ion binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0019899\">enzyme binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0008270\">zinc ion binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0003684\">damaged DNA binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005515\">protein binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0003713\">transcription coactivator activity</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0050681\">androgen receptor binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0003723\">RNA binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0031625\">ubiquitin protein ligase binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0004842\">ubiquitin-protein transferase activity</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0003677\">DNA binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0016740\">transferase activity</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0070063\">RNA polymerase binding</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0042802\">identical protein binding</a></li></ul>\\n</div></td></tr><tr><td style=\"background-color:#c3fdb8;font-weight:bold\">Cellular component</td><td style=\"background-color:#eee\"><div class=\"plainlinks\">\\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0031436\">BRCA1-BARD1 complex</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000794\">condensed nuclear chromosome</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0070531\">BRCA1-A complex</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000151\">ubiquitin ligase complex</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005886\">plasma membrane</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005654\">nucleoplasm</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000793\">condensed chromosome</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005737\">cytoplasm</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005694\">chromosome</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005634\">nucleus</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000800\">lateral element</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0032991\">protein-containing complex</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:1990904\">ribonucleoprotein complex</a></li></ul>\\n</div></td></tr><tr><td style=\"background-color:#c3fdb8;font-weight:bold\">Biological process</td><td style=\"background-color:#eee\"><div class=\"plainlinks\">\\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0010212\">response to ionizing radiation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0007098\">centrosome cycle</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0007059\">chromosome segregation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0085020\">protein K6-linked ubiquitination</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0008630\">intrinsic apoptotic signaling pathway in response to DNA damage</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0007049\">cell cycle</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006303\">double-strand break repair via nonhomologous end joining</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006915\">apoptotic process</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0042981\">regulation of apoptotic process</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006349\">regulation of gene expression by genetic imprinting</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006355\">regulation of transcription, DNA-templated</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045717\">negative regulation of fatty acid biosynthetic process</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006351\">transcription, DNA-templated</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006359\">regulation of transcription by RNA polymerase III</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006633\">fatty acid biosynthetic process</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0044030\">regulation of DNA methylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0033147\">negative regulation of intracellular estrogen receptor signaling pathway</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051865\">protein autoubiquitination</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051574\">positive regulation of histone H3-K9 methylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006310\">DNA recombination</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045766\">positive regulation of angiogenesis</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0043627\">response to estrogen</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0071681\">cellular response to indole-3-methanol</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:1902042\">negative regulation of extrinsic apoptotic signaling pathway via death domain receptors</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045892\">negative regulation of transcription, DNA-templated</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0031398\">positive regulation of protein ubiquitination</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0030521\">androgen receptor signaling pathway</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0046600\">negative regulation of centriole replication</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006301\">postreplication repair</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006629\">lipid metabolism</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0071356\">cellular response to tumor necrosis factor</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045739\">positive regulation of DNA repair</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006631\">fatty acid metabolic process</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0010628\">positive regulation of gene expression</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051572\">negative regulation of histone H3-K4 methylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0042127\">regulation of cell population proliferation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:2000378\">negative regulation of reactive oxygen species metabolic process</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0010575\">positive regulation of vascular endothelial growth factor production</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006978\">DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045944\">positive regulation of transcription by RNA polymerase II</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0070512\">positive regulation of histone H4-K20 methylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000729\">DNA double-strand break processing</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000724\">double-strand break repair via homologous recombination</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0035067\">negative regulation of histone acetylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0016567\">protein ubiquitination</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051571\">positive regulation of histone H3-K4 methylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006281\">DNA repair</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006302\">double-strand break repair</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0035066\">positive regulation of histone acetylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0009048\">dosage compensation by inactivation of X chromosome</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051573\">negative regulation of histone H3-K9 methylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:2000617\">positive regulation of histone H3-K9 acetylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045893\">positive regulation of transcription, DNA-templated</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0043009\">chordate embryonic development</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:2000620\">positive regulation of histone H4-K16 acetylation</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006974\">cellular response to DNA damage stimulus</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0016579\">protein deubiquitination</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006260\">DNA replication</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0044818\">mitotic G2/M transition checkpoint</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006357\">regulation of transcription by RNA polymerase II</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0070317\">negative regulation of G0 to G1 transition</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006366\">transcription by RNA polymerase II</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0007095\">mitotic G2 DNA damage checkpoint signaling</a></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:1901796\">regulation of signal transduction by p53 class mediator</a></li></ul>\\n</div></td></tr><tr><td colspan=\"4\" style=\"background-color:#eee;text-align:center\">Sources:<a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/\">Amigo</a> / <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/QuickGO/\">QuickGO</a></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\"><a href=\"/wiki/Orthologs\" class=\"mw-redirect\" title=\"Orthologs\">Orthologs</a></th></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">Species</th><td><b>Human</b></td><td><b>Mouse</b></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Entrez\" title=\"Entrez\">Entrez</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=retrieve&amp;dopt=default&amp;list_uids=672&amp;rn=1\">672</a></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=retrieve&amp;dopt=default&amp;list_uids=12189&amp;rn=1\">12189</a></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Ensembl\" class=\"mw-redirect\" title=\"Ensembl\">Ensembl</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000012048;db=core\">ENSG00000012048</a></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ensembl.org/Mus_musculus/geneview?gene=ENSMUSG00000017146;db=core\">ENSMUSG00000017146</a></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/UniProt\" title=\"UniProt\">UniProt</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.uniprot.org/uniprot/P38398\">P38398</a></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.uniprot.org/uniprot/P48754\">P48754</a></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">RefSeq (mRNA)</th><td><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\" class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007294\">NM_007294</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007295\">NM_007295</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007296\">NM_007296</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007297\">NM_007297</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007298\">NM_007298</a><br /></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007299\">NM_007299</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007300\">NM_007300</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007301\">NM_007301</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007302\">NM_007302</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007303\">NM_007303</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007305\">NM_007305</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007306\">NM_007306</a></span></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\" class=\"plainlinks\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_009764\">NM_009764</a></span></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">RefSeq (protein)</th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\" class=\"plainlinks\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009225\">NP_009225</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009228\">NP_009228</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009229\">NP_009229</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009230\">NP_009230</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009231\">NP_009231</a></span></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\" class=\"plainlinks\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_033894\">NP_033894</a></span></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">Location (UCSC)</th><td><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://genome.ucsc.edu/cgi-bin/hgTracks?org=Human&amp;db=hg38&amp;position=chr17:43044295-43170245\">Chr 17: 43.04 \\xe2\\x80\\x93 43.17 Mb</a></span></td><td><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://genome.ucsc.edu/cgi-bin/hgTracks?org=Mouse&amp;db=mm0&amp;position=chr11:101379590-101442781\">Chr 11: 101.38 \\xe2\\x80\\x93 101.44 Mb</a></span></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/PubMed\" title=\"PubMed\">PubMed</a> search</th><td><span class=\"plainlinks\"><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup></span></td><td><span class=\"plainlinks\"><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup></span></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;font-size:x-small;background-color:#eee\"><a href=\"/wiki/Wikidata\" title=\"Wikidata\">Wikidata</a></td></tr><tr><td colspan=\"4\" style=\"text-align:center;font-size:x-small;background-color:#eee\"><table style=\"padding:0;border:none;margin:0;width:100%;text-align:center\"><tbody><tr><td colspan=\"2\" style=\"background-color:#eee;text-align:center;font-size:x-small\"><a href=\"https://www.wikidata.org/wiki/Q227339\" class=\"extiw\" title=\"d:Q227339\">View/Edit Human</a></td><td colspan=\"2\" style=\"background-color:#eee;text-align:center;font-size:x-small\"><a href=\"https://www.wikidata.org/wiki/Q14862219\" class=\"extiw\" title=\"d:Q14862219\">View/Edit Mouse</a></td></tr></tbody></table></td></tr></tbody></table>\\n<p><b>Breast cancer type 1 susceptibility protein</b> is a <a href=\"/wiki/Protein\" title=\"Protein\">protein</a> that in humans is encoded by the <i><b>BRCA1</b></i>  (<span class=\"rt-commentedText nowrap\"><span class=\"IPA nopopups noexcerpt\" lang=\"en-fonipa\"><a href=\"/wiki/Help:IPA/English\" title=\"Help:IPA/English\">/<span style=\"border-bottom:1px dotted\"><span title=\"/\\xcb\\x8c/: secondary stress follows\">\\xcb\\x8c</span><span title=\"&#39;b&#39; in &#39;buy&#39;\">b</span><span title=\"&#39;r&#39; in &#39;rye&#39;\">r</span><span title=\"/\\xc3\\xa6/: &#39;a&#39; in &#39;bad&#39;\">\\xc3\\xa6</span><span title=\"&#39;k&#39; in &#39;kind&#39;\">k</span><span title=\"/\\xc9\\x99/: &#39;a&#39; in &#39;about&#39;\">\\xc9\\x99</span><span title=\"/\\xcb\\x88/: primary stress follows\">\\xcb\\x88</span><span title=\"&#39;w&#39; in &#39;wind&#39;\">w</span><span title=\"/\\xca\\x8c/: &#39;u&#39; in &#39;cut&#39;\">\\xca\\x8c</span><span title=\"&#39;n&#39; in &#39;nigh&#39;\">n</span></span>/</a></span></span>) <a href=\"/wiki/Gene\" title=\"Gene\">gene</a>.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> <a href=\"/wiki/Ortholog\" class=\"mw-redirect\" title=\"Ortholog\">Orthologs</a> are common in other <a href=\"/wiki/Vertebrate\" title=\"Vertebrate\">vertebrate</a> species, whereas <a href=\"/wiki/Invertebrate\" title=\"Invertebrate\">invertebrate</a> genomes may encode a more distantly related gene.<sup id=\"cite_ref-Ensembl_6-0\" class=\"reference\"><a href=\"#cite_note-Ensembl-6\">&#91;6&#93;</a></sup> <i>BRCA1</i> is a human <a href=\"/wiki/Tumor_suppressor_gene\" title=\"Tumor suppressor gene\">tumor suppressor gene</a><sup id=\"cite_ref-pmid10193517_7-0\" class=\"reference\"><a href=\"#cite_note-pmid10193517-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-pmid15546503_8-0\" class=\"reference\"><a href=\"#cite_note-pmid15546503-8\">&#91;8&#93;</a></sup> (also known as a <a href=\"/wiki/Caretaker_gene\" title=\"Caretaker gene\">caretaker gene</a>) and is responsible for repairing DNA.<sup id=\"cite_ref-CAP_9-0\" class=\"reference\"><a href=\"#cite_note-CAP-9\">&#91;9&#93;</a></sup>\\n</p><p><i>BRCA1</i> and <i><a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a></i> are unrelated proteins,<sup id=\"cite_ref-Irminger-Finger_2016_10-0\" class=\"reference\"><a href=\"#cite_note-Irminger-Finger_2016-10\">&#91;10&#93;</a></sup> but both are normally expressed in the cells of <a href=\"/wiki/Breast\" title=\"Breast\">breast</a> and other tissue, where they help repair damaged <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a>, or destroy cells if DNA cannot be repaired. They are involved in the repair of <a href=\"/wiki/Chromosome\" title=\"Chromosome\">chromosomal</a> damage with an important role in the error-free <a href=\"/wiki/DNA_repair\" title=\"DNA repair\">repair</a> of DNA double-strand breaks.<sup id=\"cite_ref-Friedenson2007_11-0\" class=\"reference\"><a href=\"#cite_note-Friedenson2007-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-scivee.tv_12-0\" class=\"reference\"><a href=\"#cite_note-scivee.tv-12\">&#91;12&#93;</a></sup> If <i>BRCA1</i> or <i>BRCA2</i> itself is damaged by a <a href=\"/wiki/BRCA_mutation\" title=\"BRCA mutation\">BRCA mutation</a>, damaged DNA is not repaired properly, and this increases the risk for <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a>.<sup id=\"cite_ref-urlBreast_and_Ovarian_Cancer_Genetic_Screening_13-0\" class=\"reference\"><a href=\"#cite_note-urlBreast_and_Ovarian_Cancer_Genetic_Screening-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-pmid17683622_14-0\" class=\"reference\"><a href=\"#cite_note-pmid17683622-14\">&#91;14&#93;</a></sup> <i>BRCA1</i> and <i>BRCA2</i> have been described as \"breast cancer susceptibility genes\" and \"breast cancer susceptibility proteins\".  The predominant allele has a normal, tumor suppressive function whereas high <a href=\"/wiki/Penetrance\" title=\"Penetrance\">penetrance</a> mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer.<sup id=\"cite_ref-O&#39;Donovan_2010_15-0\" class=\"reference\"><a href=\"#cite_note-O&#39;Donovan_2010-15\">&#91;15&#93;</a></sup>\\n</p><p><i>BRCA1</i> combines with other tumor suppressors, DNA damage sensors and signal transducers to form a large multi-subunit protein complex known as the <i>BRCA1</i>-associated genome surveillance complex (BASC).<sup id=\"cite_ref-pmid10783165_16-0\" class=\"reference\"><a href=\"#cite_note-pmid10783165-16\">&#91;16&#93;</a></sup> The <i>BRCA1</i> protein associates with <a href=\"/wiki/RNA_polymerase_II\" title=\"RNA polymerase II\">RNA polymerase II</a>, and through the <a href=\"/wiki/C-terminus\" title=\"C-terminus\">C-terminal</a> domain, also interacts with <a href=\"/wiki/Histone_deacetylase\" title=\"Histone deacetylase\">histone deacetylase</a> complexes. Thus, this protein plays a role in transcription, and <a href=\"/wiki/DNA_repair\" title=\"DNA repair\">DNA repair</a> of double-strand DNA breaks<sup id=\"cite_ref-pmid17683622_14-1\" class=\"reference\"><a href=\"#cite_note-pmid17683622-14\">&#91;14&#93;</a></sup> <a href=\"/wiki/Ubiquitin\" title=\"Ubiquitin\">ubiquitination</a>, <a href=\"/wiki/Transcriptional_regulation\" title=\"Transcriptional regulation\">transcriptional regulation</a> as well as other functions.<sup id=\"cite_ref-Starita2003_17-0\" class=\"reference\"><a href=\"#cite_note-Starita2003-17\">&#91;17&#93;</a></sup>\\n</p><p>Methods to test for the likelihood of a patient with mutations in <i>BRCA1</i> and <i><a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a></i> developing cancer were covered by <a href=\"/wiki/Biological_patent\" title=\"Biological patent\">patents</a> owned or controlled by <a href=\"/wiki/Myriad_Genetics\" title=\"Myriad Genetics\">Myriad Genetics</a>.<sup id=\"cite_ref-US_5747282_18-0\" class=\"reference\"><a href=\"#cite_note-US_5747282-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-US_5837492_19-0\" class=\"reference\"><a href=\"#cite_note-US_5837492-19\">&#91;19&#93;</a></sup>  Myriad\\'s business model of offering the diagnostic test exclusively led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012;<sup id=\"cite_ref-MyriadInvestorPage_20-0\" class=\"reference\"><a href=\"#cite_note-MyriadInvestorPage-20\">&#91;20&#93;</a></sup> it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs, which in turn led to the landmark <i><a href=\"/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics\" class=\"mw-redirect\" title=\"Association for Molecular Pathology v. Myriad Genetics\">Association for Molecular Pathology v. Myriad Genetics</a></i> lawsuit.<sup id=\"cite_ref-SchwartzNYTimes_21-0\" class=\"reference\"><a href=\"#cite_note-SchwartzNYTimes-21\">&#91;21&#93;</a></sup>\\n</p>\\n<meta property=\"mw:PageProp/toc\" />\\n<h2><span class=\"mw-headline\" id=\"Discovery\">Discovery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=1\" title=\"Edit section: Discovery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<p>The first evidence for the existence of a gene encoding a DNA repair enzyme involved in breast cancer susceptibility was provided by <a href=\"/wiki/Mary-Claire_King\" title=\"Mary-Claire King\">Mary-Claire King</a>\\'s laboratory at <a href=\"/wiki/University_of_California,_Berkeley\" title=\"University of California, Berkeley\">UC Berkeley</a> in 1990.<sup id=\"cite_ref-pmid2270482_22-0\" class=\"reference\"><a href=\"#cite_note-pmid2270482-22\">&#91;22&#93;</a></sup>  Four years later, after an international race to find it,<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup> the gene was cloned in 1994 by scientists at University of Utah, National Institute of Environmental Health Sciences (NIEHS) and <a href=\"/wiki/Myriad_Genetics\" title=\"Myriad Genetics\">Myriad Genetics</a>.<sup id=\"cite_ref-US_5747282_18-1\" class=\"reference\"><a href=\"#cite_note-US_5747282-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-pmid7545954_24-0\" class=\"reference\"><a href=\"#cite_note-pmid7545954-24\">&#91;24&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Gene_location\">Gene location</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=2\" title=\"Edit section: Gene location\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<p>The human <i>BRCA1</i> gene is located on the long (q) arm of <a href=\"/wiki/Chromosome_17_(human)\" class=\"mw-redirect\" title=\"Chromosome 17 (human)\">chromosome 17</a> at region 2 band 1, from <a href=\"/wiki/Base_pair\" title=\"Base pair\">base pair</a> 41,196,312 to base pair 41,277,500 (Build GRCh37/hg19) <a rel=\"nofollow\" class=\"external text\" href=\"http://genome.ucsc.edu/cgi-bin/hgTracks?db=hg19&amp;singleSearch=knownCanonical&amp;position=BRCA1\">(map)</a>.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> <i>BRCA1</i> <a href=\"/wiki/Orthologs\" class=\"mw-redirect\" title=\"Orthologs\">orthologs</a> have been identified in most <a href=\"/wiki/Vertebrate\" title=\"Vertebrate\">vertebrates</a> for which complete genome data are available.<sup id=\"cite_ref-Ensembl_6-1\" class=\"reference\"><a href=\"#cite_note-Ensembl-6\">&#91;6&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Protein_structure\">Protein structure</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=3\" title=\"Edit section: Protein structure\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<p>The BRCA1 <a href=\"/wiki/Protein\" title=\"Protein\">protein</a> contains the following domains:<sup id=\"cite_ref-pmid9553742_26-0\" class=\"reference\"><a href=\"#cite_note-pmid9553742-26\">&#91;26&#93;</a></sup>\\n</p>\\n<ul><li>Zinc finger, C3HC4 type (<a href=\"/wiki/RING_finger_domain\" title=\"RING finger domain\">RING finger</a>)</li>\\n<li>BRCA1 C Terminus (<a href=\"/wiki/BRCT_domain\" title=\"BRCT domain\">BRCT</a>) domain</li></ul>\\n<p>This protein also contains <a href=\"/wiki/Nuclear_localization_signal\" class=\"mw-redirect\" title=\"Nuclear localization signal\">nuclear localization signals</a> and <a href=\"/wiki/Nuclear_export_signal\" title=\"Nuclear export signal\">nuclear export signal</a> motifs.<sup id=\"cite_ref-pmid16108063_27-0\" class=\"reference\"><a href=\"#cite_note-pmid16108063-27\">&#91;27&#93;</a></sup>\\n</p><p>The human <a href=\"/wiki/BRCA1_protein\" class=\"mw-redirect\" title=\"BRCA1 protein\">BRCA1 protein</a> consists of four major protein domains; the <a href=\"/wiki/RING_finger_domain\" title=\"RING finger domain\">Znf C3HC4- RING domain</a>, the BRCA1 serine domain and two <a href=\"/wiki/BRCT_domain\" title=\"BRCT domain\">BRCT</a> domains. These domains encode approximately 27% of BRCA1 protein. There are six known isoforms of BRCA1,<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> with isoforms 1 and 2 comprising 1863 amino acids each.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (January 2016)\">citation needed</span></a></i>&#93;</sup>\\n</p><p>BRCA1 is unrelated to <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a>, i.e. they are not <a href=\"/wiki/Sequence_homology\" title=\"Sequence homology\">homologs</a> or <a href=\"/wiki/Paralogy\" class=\"mw-redirect\" title=\"Paralogy\">paralogs</a>.<sup id=\"cite_ref-Irminger-Finger_2016_10-1\" class=\"reference\"><a href=\"#cite_note-Irminger-Finger_2016-10\">&#91;10&#93;</a></sup>\\n</p>\\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:442px;\"><a href=\"/wiki/File:BRCA1partB.png\" class=\"image\"><img alt=\"text\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/27/BRCA1partB.png/440px-BRCA1partB.png\" decoding=\"async\" width=\"440\" height=\"177\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/2/27/BRCA1partB.png 1.5x\" data-file-width=\"555\" data-file-height=\"223\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:BRCA1partB.png\" class=\"internal\" title=\"Enlarge\"></a></div>Domain map of BRCA1; RING, serine containing domain (SCD), and BRCT domains are indicated. Horizontal black lines indicate protein-binding domains for the listed partners. Red circles mark phosphorylation sites.<sup id=\"cite_ref-pmid22737296_29-0\" class=\"reference\"><a href=\"#cite_note-pmid22737296-29\">&#91;29&#93;</a></sup></div></div></div>\\n<h3><span class=\"mw-headline\" id=\"Zinc_ring_finger_domain\">Zinc ring finger domain</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=4\" title=\"Edit section: Zinc ring finger domain\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\\n<p>The <a href=\"/wiki/RING_finger_domain\" title=\"RING finger domain\">RING motif</a>, a <a href=\"/wiki/Zn_finger\" class=\"mw-redirect\" title=\"Zn finger\">Zn finger</a> found in eukaryotic peptides, is 40\\xe2\\x80\\x9360 amino acids long and consists of eight conserved metal-binding residues, two quartets of <a href=\"/wiki/Cysteine\" title=\"Cysteine\">cysteine</a> or <a href=\"/wiki/Histidine\" title=\"Histidine\">histidine</a> residues that coordinate two zinc atoms.<sup id=\"cite_ref-pmid11573085_30-0\" class=\"reference\"><a href=\"#cite_note-pmid11573085-30\">&#91;30&#93;</a></sup>  This motif contains a short anti-parallel <a href=\"/wiki/Beta-sheet\" class=\"mw-redirect\" title=\"Beta-sheet\">beta-sheet</a>, two zinc-binding loops and a central <a href=\"/wiki/Alpha_helix\" title=\"Alpha helix\">alpha helix</a> in a small domain.  This RING domain interacts with associated proteins, including <a href=\"/wiki/BARD1\" title=\"BARD1\">BARD1</a>, which also contains a RING motif, to form a heterodimer. The BRCA1 RING motif is flanked by alpha helices formed by residues 8\\xe2\\x80\\x9322 and 81\\xe2\\x80\\x9396 of the BRCA1 protein. It interacts with a homologous region in BARD1 also consisting of a RING finger flanked by two <a href=\"/wiki/Alpha-helices\" class=\"mw-redirect\" title=\"Alpha-helices\">alpha-helices</a> formed from residues 36\\xe2\\x80\\x9348 and 101\\xe2\\x80\\x93116. These four helices combine to form a <a href=\"/wiki/Heterodimerization\" class=\"mw-redirect\" title=\"Heterodimerization\">heterodimerization</a> interface and stabilize the BRCA1-BARD1 heterodimer complex. Additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression.<sup id=\"cite_ref-pmid11573085_30-1\" class=\"reference\"><a href=\"#cite_note-pmid11573085-30\">&#91;30&#93;</a></sup>\\n</p><p>The ring domain is an important element of <a href=\"/wiki/Ubiquitin_ligase#Individual_E3_ubiquitin_ligases\" title=\"Ubiquitin ligase\">ubiquitin E3 ligases</a>, which catalyze protein ubiquitination. <a href=\"/wiki/Ubiquitin\" title=\"Ubiquitin\">Ubiquitin</a> is a small regulatory protein found in all tissues that direct proteins to compartments within the cell. BRCA1 polypeptides, in particular, Lys-48-linked polyubiquitin chains are dispersed throughout the resting cell nucleus, but at the start of <a href=\"/wiki/DNA_replication\" title=\"DNA replication\">DNA replication</a>, they gather in restrained groups that also contain <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a> and BARD1. BARD1 is thought to be involved in the recognition and binding of protein targets for ubiquitination.<sup id=\"cite_ref-pmid11573079_31-0\" class=\"reference\"><a href=\"#cite_note-pmid11573079-31\">&#91;31&#93;</a></sup> It attaches to proteins and labels them for destruction. Ubiquitination occurs via the BRCA1 fusion protein and is abolished by zinc <a href=\"/wiki/Chelation\" title=\"Chelation\">chelation</a>.<sup id=\"cite_ref-pmid11573085_30-2\" class=\"reference\"><a href=\"#cite_note-pmid11573085-30\">&#91;30&#93;</a></sup> The enzyme activity of the fusion protein is dependent on the proper folding of the ring domain.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (January 2016)\">citation needed</span></a></i>&#93;</sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Serine_cluster_domain\">Serine cluster domain</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=5\" title=\"Edit section: Serine cluster domain\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\\n<p>BRCA1 serine cluster domain (SCD) spans amino acids 1280\\xe2\\x80\\x931524. A portion of the domain is located in exons 11\\xe2\\x80\\x9313. High rates of mutation occur in exons 11\\xe2\\x80\\x9313. Reported phosphorylation sites of BRCA1 are concentrated in the SCD, where they are phosphorylated by <a href=\"/wiki/Ataxia_telangiectasia_mutated\" class=\"mw-redirect\" title=\"Ataxia telangiectasia mutated\">ATM/ATR kinases</a> both <a href=\"/wiki/In_vitro\" title=\"In vitro\">in vitro</a> and <a href=\"/wiki/In_vivo\" title=\"In vivo\">in vivo</a>. ATM/ATR are kinases activated by <a href=\"/wiki/DNA_damage\" class=\"mw-redirect\" title=\"DNA damage\">DNA damage</a>. Mutation of serine residues may affect localization of BRCA1 to sites of DNA damage and DNA damage response function.<sup id=\"cite_ref-pmid22737296_29-1\" class=\"reference\"><a href=\"#cite_note-pmid22737296-29\">&#91;29&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"BRCT_domains\">BRCT domains</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=6\" title=\"Edit section: BRCT domains\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\\n<p>The dual repeat <a href=\"/wiki/BRCT_domain\" title=\"BRCT domain\">BRCT domain</a> of the BRCA1 protein is an elongated structure approximately 70 \\xc3\\x85 long and 30\\xe2\\x80\\x9335 \\xc3\\x85 wide.<sup id=\"cite_ref-Williams_2001_32-0\" class=\"reference\"><a href=\"#cite_note-Williams_2001-32\">&#91;32&#93;</a></sup> The 85\\xe2\\x80\\x9395 amino acid domains in BRCT can be found as single modules or as multiple tandem repeats containing two domains.<sup id=\"cite_ref-pmid10946236_33-0\" class=\"reference\"><a href=\"#cite_note-pmid10946236-33\">&#91;33&#93;</a></sup> Both of these possibilities can occur in a single protein in a variety of different conformations.<sup id=\"cite_ref-Williams_2001_32-1\" class=\"reference\"><a href=\"#cite_note-Williams_2001-32\">&#91;32&#93;</a></sup> The C-terminal BRCT region of the BRCA1 protein is essential for repair of DNA, transcription regulation and tumor suppressor function.<sup id=\"cite_ref-pmid11877378_34-0\" class=\"reference\"><a href=\"#cite_note-pmid11877378-34\">&#91;34&#93;</a></sup> In BRCA1 the dual <a href=\"/wiki/Tandem_repeat\" title=\"Tandem repeat\">tandem repeat</a> BRCT domains are arranged in a head-to-tail-fashion in the three-dimensional structure, burying 1600 \\xc3\\x85 of hydrophobic, solvent-accessible surface area in the interface. These all contribute to the tightly packed knob-in-hole structure that comprises the interface. These homologous domains interact to control cellular responses to <a href=\"/wiki/DNA_damage\" class=\"mw-redirect\" title=\"DNA damage\">DNA damage</a>. A <a href=\"/wiki/Missense_mutation\" title=\"Missense mutation\">missense mutation</a> at the interface of these two proteins can perturb the <a href=\"/wiki/Cell_cycle\" title=\"Cell cycle\">cell cycle</a>, resulting a greater risk of developing cancer.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (May 2019)\">citation needed</span></a></i>&#93;</sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Function_and_mechanism\">Function and mechanism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=7\" title=\"Edit section: Function and mechanism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<p>BRCA1 is part of a complex that repairs <a href=\"/wiki/Double-strand_breaks\" class=\"mw-redirect\" title=\"Double-strand breaks\">double-strand breaks</a> in DNA. The strands of the DNA double helix are continuously breaking as they become damaged. Sometimes only one strand is broken, sometimes both strands are broken simultaneously. DNA cross-linking agents are an important source of chromosome/DNA damage. Double-strand breaks occur as intermediates after the crosslinks are removed, and indeed, biallelic mutations in <i>BRCA1</i> have been identified to be responsible for <a href=\"/wiki/Fanconi_anemia\" title=\"Fanconi anemia\">Fanconi Anemia</a>, Complementation Group S (FA-S),<sup id=\"cite_ref-Sawyer_2014_35-0\" class=\"reference\"><a href=\"#cite_note-Sawyer_2014-35\">&#91;35&#93;</a></sup> a genetic disease associated with hypersensitivity to DNA crosslinking agents. BRCA1 is part of a protein complex that repairs DNA when both strands are broken. When this happens, it is difficult for the repair mechanism to \"know\" how to replace the correct DNA sequence, and there are multiple ways to attempt the repair. The double-strand repair mechanism in which BRCA1 participates is <a href=\"/wiki/Homology_directed_repair\" title=\"Homology directed repair\">homology-directed repair</a>, where the repair proteins copy the identical sequence from the intact <a href=\"/wiki/Sister_chromatid\" class=\"mw-redirect\" title=\"Sister chromatid\">sister chromatid</a>.<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup> FA-S is almost always a lethal condition in utero; only a handful cases of biallelic BRCA1 mutations have been reported in literature despite the high carrier frequencies in the Ashkenazim, and none since 2013.<sup id=\"cite_ref-Domchek_2013_37-0\" class=\"reference\"><a href=\"#cite_note-Domchek_2013-37\">&#91;37&#93;</a></sup>\\n</p><p>In the nucleus of many types of normal cells, the BRCA1 protein interacts with <a href=\"/wiki/RAD51\" title=\"RAD51\">RAD51</a> during repair of DNA double-strand breaks.<sup id=\"cite_ref-pmid17052168_38-0\" class=\"reference\"><a href=\"#cite_note-pmid17052168-38\">&#91;38&#93;</a></sup> These breaks can be caused by natural radiation or other exposures, but also occur when <a href=\"/wiki/Chromosome\" title=\"Chromosome\">chromosomes</a> exchange genetic material (homologous recombination, e.g., \"crossing over\" during meiosis). The <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a> protein, which has a function similar to that of BRCA1, also interacts with the RAD51 protein. By influencing DNA damage repair, these three proteins play a role in maintaining the stability of the human genome.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (January 2016)\">citation needed</span></a></i>&#93;</sup>\\n</p><p>BRCA1 is also involved in another type of DNA repair, termed <a href=\"/wiki/DNA_mismatch_repair\" title=\"DNA mismatch repair\">mismatch repair</a>.  BRCA1 interacts with the DNA mismatch repair protein <a href=\"/wiki/MSH2\" title=\"MSH2\">MSH2</a>.<sup id=\"cite_ref-pmid11498787_39-0\" class=\"reference\"><a href=\"#cite_note-pmid11498787-39\">&#91;39&#93;</a></sup>  MSH2, <a href=\"/wiki/MSH6\" title=\"MSH6\">MSH6</a>, <a href=\"/wiki/Poly_(ADP-ribose)_polymerase\" title=\"Poly (ADP-ribose) polymerase\">PARP</a> and some other proteins involved in single-strand repair are reported to be elevated in BRCA1-deficient mammary tumors.<sup id=\"cite_ref-pmid22366898_40-0\" class=\"reference\"><a href=\"#cite_note-pmid22366898-40\">&#91;40&#93;</a></sup>\\n</p><p>A protein called <a href=\"/wiki/Valosin-containing_protein\" title=\"Valosin-containing protein\">valosin-containing protein</a> (VCP, also known as p97) plays a role to recruit BRCA1 to the damaged DNA sites.  After ionizing radiation, VCP is recruited to DNA lesions and cooperates with the ubiquitin ligase RNF8 to orchestrate assembly of signaling complexes for efficient DSB repair.<sup id=\"cite_ref-pmid22020440_41-0\" class=\"reference\"><a href=\"#cite_note-pmid22020440-41\">&#91;41&#93;</a></sup>  BRCA1 interacts with VCP.<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup> BRCA1 also interacts with <a href=\"/wiki/Myc\" title=\"Myc\">c-Myc</a>, and other proteins that are critical to maintain genome stability.<sup id=\"cite_ref-pmid9788437_43-0\" class=\"reference\"><a href=\"#cite_note-pmid9788437-43\">&#91;43&#93;</a></sup>\\n</p><p>BRCA1 directly binds to DNA, with higher affinity for branched DNA structures. This ability to bind to DNA contributes to its ability to inhibit the nuclease activity of the <a href=\"/wiki/Mre11-Rad50-Nbs1\" class=\"mw-redirect\" title=\"Mre11-Rad50-Nbs1\">MRN</a> complex as well as the nuclease activity of Mre11 alone.<sup id=\"cite_ref-Paull2001_44-0\" class=\"reference\"><a href=\"#cite_note-Paull2001-44\">&#91;44&#93;</a></sup> This may explain a role for BRCA1 to promote lower fidelity DNA repair by <a href=\"/wiki/Non-homologous_end_joining\" title=\"Non-homologous end joining\">non-homologous end joining</a> (NHEJ).<sup id=\"cite_ref-Durant2005_45-0\" class=\"reference\"><a href=\"#cite_note-Durant2005-45\">&#91;45&#93;</a></sup> BRCA1 also colocalizes with \\xce\\xb3-H2AX (histone H2AX phosphorylated on serine-139) in DNA double-strand break repair foci, indicating it may play a role in recruiting repair factors.<sup id=\"cite_ref-Starita2003_17-1\" class=\"reference\"><a href=\"#cite_note-Starita2003-17\">&#91;17&#93;</a></sup><sup id=\"cite_ref-Ye2001_46-0\" class=\"reference\"><a href=\"#cite_note-Ye2001-46\">&#91;46&#93;</a></sup>\\n</p><p><a href=\"/wiki/Formaldehyde\" title=\"Formaldehyde\">Formaldehyde</a> and <a href=\"/wiki/Acetaldehyde\" title=\"Acetaldehyde\">acetaldehyde</a> are common environmental sources of DNA cross links that often require repairs mediated by BRCA1 containing pathways.<sup id=\"cite_ref-Ridpath_2007_47-0\" class=\"reference\"><a href=\"#cite_note-Ridpath_2007-47\">&#91;47&#93;</a></sup>\\n</p><p>This DNA repair function is essential; mice with loss-of-function mutations in both BRCA1 alleles are not viable, and as of 2015 only two adults were known to have loss-of-function mutations in both alleles (leading to FA-S); both had congenital or developmental issues, and both had cancer. One was presumed to have survived to adulthood because one of the BRCA1 mutations was <a href=\"/wiki/Hypomorphic\" class=\"mw-redirect\" title=\"Hypomorphic\">hypomorphic</a>.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Transcription\">Transcription</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=8\" title=\"Edit section: Transcription\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\\n<p>BRCA1 was shown to co-purify with the human RNA Polymerase II holoenzyme in HeLa extracts, implying it is a component of the holoenzyme.<sup id=\"cite_ref-Scully1997_49-0\" class=\"reference\"><a href=\"#cite_note-Scully1997-49\">&#91;49&#93;</a></sup> Later research, however, contradicted this assumption, instead showing that the predominant complex including BRCA1 in HeLa cells is a 2 megadalton complex containing SWI/SNF.<sup id=\"cite_ref-Bochar2000_50-0\" class=\"reference\"><a href=\"#cite_note-Bochar2000-50\">&#91;50&#93;</a></sup> SWI/SNF is a chromatin remodeling complex. Artificial tethering of BRCA1 to chromatin was shown to decondense heterochromatin, though the SWI/SNF interacting domain was not necessary for this role.<sup id=\"cite_ref-Ye2001_46-1\" class=\"reference\"><a href=\"#cite_note-Ye2001-46\">&#91;46&#93;</a></sup> BRCA1 interacts with the NELF-B (<a href=\"/wiki/Cofactor_of_BRCA1\" title=\"Cofactor of BRCA1\">COBRA1</a>) subunit of the <a href=\"/wiki/Negative_elongation_factor\" title=\"Negative elongation factor\">NELF</a> complex.<sup id=\"cite_ref-Ye2001_46-2\" class=\"reference\"><a href=\"#cite_note-Ye2001-46\">&#91;46&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Mutations_and_cancer_risk\">Mutations and cancer risk</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=9\" title=\"Edit section: Mutations and cancer risk\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:312px;\"><a href=\"/wiki/File:BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg\" class=\"image\"><img src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/19/BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg/310px-BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg\" decoding=\"async\" width=\"310\" height=\"193\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/19/BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg/465px-BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/19/BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg/620px-BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg 2x\" data-file-width=\"5945\" data-file-height=\"3705\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Absolute risk of cancers in BRCA1 or <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a> mutation.<sup id=\"cite_ref-Petrucelli_2016_51-0\" class=\"reference\"><a href=\"#cite_note-Petrucelli_2016-51\">&#91;51&#93;</a></sup></div></div></div>\\n<style data-mw-deduplicate=\"TemplateStyles:r1033289096\">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role=\"note\" class=\"hatnote navigation-not-searchable\">Further information: <a href=\"/wiki/BRCA_mutation\" title=\"BRCA mutation\">BRCA mutation</a></div>\\n<p>Certain variations of the <i>BRCA1</i> gene lead to an increased risk for <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a> as part of a <a href=\"/wiki/Hereditary_breast%E2%80%93ovarian_cancer_syndrome\" title=\"Hereditary breast\\xe2\\x80\\x93ovarian cancer syndrome\">hereditary breast\\xe2\\x80\\x93ovarian cancer syndrome</a>. Researchers have identified hundreds of <a href=\"/wiki/Mutation\" title=\"Mutation\">mutations</a> in the <i>BRCA1</i> gene, many of which are associated with an increased risk of cancer. Females with an abnormal BRCA1 or BRCA2 gene have up to an 80% risk of developing breast cancer by age 90; increased risk of developing ovarian cancer is about 55% for females with BRCA1 mutations and about 25% for females with BRCA2 mutations.<sup id=\"cite_ref-urlGenetics_52-0\" class=\"reference\"><a href=\"#cite_note-urlGenetics-52\">&#91;52&#93;</a></sup>\\n</p><p>These mutations can be changes in one or a small number of DNA <a href=\"/wiki/Base_pair\" title=\"Base pair\">base pairs</a> (the building-blocks of DNA), and can be identified with PCR and DNA sequencing.<sup id=\"cite_ref-53\" class=\"reference\"><a href=\"#cite_note-53\">&#91;53&#93;</a></sup>\\n</p><p>In some cases, large segments of DNA are rearranged. Those large segments, also called large rearrangements, can be a deletion or a duplication of one or several exons in the gene. Classical methods for mutation detection (sequencing) are unable to reveal these types of mutation.<sup id=\"cite_ref-pmid15832305_54-0\" class=\"reference\"><a href=\"#cite_note-pmid15832305-54\">&#91;54&#93;</a></sup> Other methods have been proposed: traditional <a href=\"/wiki/Quantitative_PCR\" class=\"mw-redirect\" title=\"Quantitative PCR\">quantitative PCR</a>,<sup id=\"cite_ref-pmid14984472_55-0\" class=\"reference\"><a href=\"#cite_note-pmid14984472-55\">&#91;55&#93;</a></sup> <a href=\"/wiki/Multiplex_ligation-dependent_probe_amplification\" title=\"Multiplex ligation-dependent probe amplification\">multiplex ligation-dependent probe amplification</a> (MLPA),<sup id=\"cite_ref-pmid12670888_56-0\" class=\"reference\"><a href=\"#cite_note-pmid12670888-56\">&#91;56&#93;</a></sup> and Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF).<sup id=\"cite_ref-pmid12203994_57-0\" class=\"reference\"><a href=\"#cite_note-pmid12203994-57\">&#91;57&#93;</a></sup> Newer methods have also been recently proposed: heteroduplex analysis (HDA) by multi-capillary electrophoresis or also dedicated oligonucleotides array based on <a href=\"/wiki/Comparative_genomic_hybridization\" title=\"Comparative genomic hybridization\">comparative genomic hybridization</a> (array-CGH).<sup id=\"cite_ref-pmid17718857_58-0\" class=\"reference\"><a href=\"#cite_note-pmid17718857-58\">&#91;58&#93;</a></sup>\\n</p><p>Some results suggest that <a href=\"/wiki/Methylation\" title=\"Methylation\">hypermethylation</a> of the BRCA1 <a href=\"/wiki/Promoter_(biology)\" class=\"mw-redirect\" title=\"Promoter (biology)\">promoter</a>, which has been reported in some cancers, could be considered as an inactivating mechanism for BRCA1 expression.<sup id=\"cite_ref-pmid18567944_59-0\" class=\"reference\"><a href=\"#cite_note-pmid18567944-59\">&#91;59&#93;</a></sup>\\n</p><p>A mutated <i>BRCA1</i> gene usually makes a <a href=\"/wiki/Protein\" title=\"Protein\">protein</a> that does not function properly. Researchers believe that the defective BRCA1 protein is unable to help fix DNA damage leading to mutations in other genes. These mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor. Thus, BRCA1 inactivating mutations lead to a predisposition for cancer.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (January 2016)\">citation needed</span></a></i>&#93;</sup>\\n</p><p>BRCA1 mRNA <a href=\"/wiki/Three_prime_untranslated_region\" title=\"Three prime untranslated region\">3\\' UTR</a> can be bound by an <a href=\"/wiki/MiRNA\" class=\"mw-redirect\" title=\"MiRNA\">miRNA</a>, <a href=\"/wiki/Mir-17_microRNA_precursor_family\" title=\"Mir-17 microRNA precursor family\">Mir-17 microRNA</a>. It has been suggested that variations in this miRNA along with <a href=\"/wiki/Mir-30_microRNA_precursor\" title=\"Mir-30 microRNA precursor\">Mir-30 microRNA</a> could confer susceptibility to breast cancer.<sup id=\"cite_ref-60\" class=\"reference\"><a href=\"#cite_note-60\">&#91;60&#93;</a></sup>\\n</p><p>In addition to breast cancer, mutations in the <i>BRCA1</i> gene also increase the risk of <a href=\"/wiki/Ovarian_cancer\" title=\"Ovarian cancer\">ovarian</a> and <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate cancers</a>. Moreover, precancerous lesions (<a href=\"/wiki/Dysplasia\" title=\"Dysplasia\">dysplasia</a>) within the <a href=\"/wiki/Fallopian_tube\" title=\"Fallopian tube\">Fallopian tube</a> have been linked to <i>BRCA1</i> gene mutations. Pathogenic mutations anywhere in a model pathway containing BRCA1 and BRCA2 greatly increase risks for a subset of leukemias and lymphomas.<sup id=\"cite_ref-pmid17683622_14-2\" class=\"reference\"><a href=\"#cite_note-pmid17683622-14\">&#91;14&#93;</a></sup>\\n</p><p>Women who have inherited a defective BRCA1 or BRCA2 gene are at a greatly elevated risk to develop breast and ovarian cancer. Their risk of developing breast and/or ovarian cancer is so high, and so specific to those cancers, that many mutation carriers choose to have <a href=\"/wiki/Prophylactic_surgery\" title=\"Prophylactic surgery\">prophylactic surgery</a>. There has been much conjecture to explain such apparently striking tissue specificity. Major determinants of where BRCA1/2 hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation or the carcinogen. The target tissue may have receptors for the pathogen, may become selectively exposed to an inflammatory process or to a carcinogen. An innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets. This theory also fits data for several tumor suppressors beyond BRCA1 or BRCA2. A major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery.<sup id=\"cite_ref-Levin2012_61-0\" class=\"reference\"><a href=\"#cite_note-Levin2012-61\">&#91;61&#93;</a></sup>\\n</p><p>As aforementioned, biallelic and homozygous inheritance of the BRCA1 gene leads to FA-S, which is almost always an embryonically lethal condition.\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Low_expression_of_BRCA1_in_breast_and_ovarian_cancers\">Low expression of <i>BRCA1</i> in breast and ovarian cancers</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=10\" title=\"Edit section: Low expression of BRCA1 in breast and ovarian cancers\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<p>BRCA1 expression is reduced or undetectable in the majority of high grade, ductal breast cancers.<sup id=\"cite_ref-pmid9988281_62-0\" class=\"reference\"><a href=\"#cite_note-pmid9988281-62\">&#91;62&#93;</a></sup>  It has long been noted that loss of BRCA1 activity, either by germ-line mutations or by down-regulation of gene expression, leads to tumor formation in specific target tissues.  In particular, decreased BRCA1 expression contributes to both sporadic and inherited breast tumor progression.<sup id=\"cite_ref-pmid12559046_63-0\" class=\"reference\"><a href=\"#cite_note-pmid12559046-63\">&#91;63&#93;</a></sup>  Reduced expression of BRCA1 is tumorigenic because it plays an important role in the repair of DNA damages, especially double-strand breaks, by the potentially error-free pathway of homologous recombination.<sup id=\"cite_ref-Jacinto_64-0\" class=\"reference\"><a href=\"#cite_note-Jacinto-64\">&#91;64&#93;</a></sup>  Since cells that lack the BRCA1 protein tend to repair DNA damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer.<sup id=\"cite_ref-Jacinto_64-1\" class=\"reference\"><a href=\"#cite_note-Jacinto-64\">&#91;64&#93;</a></sup>\\n</p><p>Similarly, BRCA1 expression is low in the majority (55%) of sporadic <a href=\"/wiki/Ovarian_cancer#Epithelial_carcinoma\" title=\"Ovarian cancer\">epithelial ovarian cancers (EOCs)</a> where EOCs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers.<sup id=\"cite_ref-Sun_65-0\" class=\"reference\"><a href=\"#cite_note-Sun-65\">&#91;65&#93;</a></sup>  In <a href=\"/wiki/Ovarian_cancer#Serous_carcinoma\" title=\"Ovarian cancer\">serous ovarian carcinomas</a>, a sub-category constituting about 2/3 of EOCs, low BRCA1 expression occurs in more than 50% of cases.<sup id=\"cite_ref-pmid22790015_66-0\" class=\"reference\"><a href=\"#cite_note-pmid22790015-66\">&#91;66&#93;</a></sup>  Bowtell<sup id=\"cite_ref-pmid20944665_67-0\" class=\"reference\"><a href=\"#cite_note-pmid20944665-67\">&#91;67&#93;</a></sup> reviewed the literature indicating that deficient homologous recombination repair caused by BRCA1 deficiency is tumorigenic.  In particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy.  Especially noted was that BRCA1 deficiency could be the cause of tumorigenesis whether due to BRCA1 mutation or any other event that causes a deficiency of BRCA1 expression.\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Mutation_of_BRCA1_in_breast_and_ovarian_cancer\">Mutation of <i>BRCA1</i> in breast and ovarian cancer</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=11\" title=\"Edit section: Mutation of BRCA1 in breast and ovarian cancer\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\\n<p>Only about 3%\\xe2\\x80\\x938% of all women with breast cancer carry a mutation in BRCA1 or BRCA2.<sup id=\"cite_ref-pmid9653432_68-0\" class=\"reference\"><a href=\"#cite_note-pmid9653432-68\">&#91;68&#93;</a></sup>  Similarly, <i>BRCA1</i> mutations are only seen in about 18% of ovarian cancers (13% germline mutations and 5% somatic mutations).<sup id=\"cite_ref-pmid24240112_69-0\" class=\"reference\"><a href=\"#cite_note-pmid24240112-69\">&#91;69&#93;</a></sup>\\n</p><p>Thus, while BRCA1 expression is low in the majority of these cancers, <i>BRCA1</i> mutation is not a major cause of reduced expression. Certain latent viruses, which are frequently detected in breast cancer tumors, can decrease the expression of the BRCA1 gene and cause the development of breast tumors.<sup id=\"cite_ref-pmid30579323_70-0\" class=\"reference\"><a href=\"#cite_note-pmid30579323-70\">&#91;70&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"BRCA1_promoter_hypermethylation_in_breast_and_ovarian_cancer\"><i>BRCA1</i> promoter hypermethylation in breast and ovarian cancer</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=12\" title=\"Edit section: BRCA1 promoter hypermethylation in breast and ovarian cancer\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\\n<p><i>BRCA1</i> <a href=\"/wiki/DNA_methylation\" title=\"DNA methylation\">promoter hypermethylation</a> was present in only 13% of unselected primary breast carcinomas.<sup id=\"cite_ref-pmid10749912_71-0\" class=\"reference\"><a href=\"#cite_note-pmid10749912-71\">&#91;71&#93;</a></sup>  Similarly, <i>BRCA1</i> promoter hypermethylation was present in only 5% to 15% of EOC cases.<sup id=\"cite_ref-Sun_65-1\" class=\"reference\"><a href=\"#cite_note-Sun-65\">&#91;65&#93;</a></sup>\\n</p><p>Thus, while BRCA1 expression is low in these cancers, <i>BRCA1</i> promoter methylation is only a minor cause of reduced expression.\\n</p>\\n<h3><span class=\"mw-headline\" id=\"MicroRNA_repression_of_BRCA1_in_breast_cancers\">MicroRNA repression of BRCA1 in breast cancers</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=13\" title=\"Edit section: MicroRNA repression of BRCA1 in breast cancers\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\\n<p>There are a number of specific <a href=\"/wiki/MicroRNA#DNA_repair_and_cancer\" title=\"MicroRNA\">microRNAs</a>, when overexpressed, that directly reduce expression of specific DNA repair proteins (see <a href=\"/wiki/MicroRNA#DNA_repair_and_cancer\" title=\"MicroRNA\">MicroRNA section DNA repair and cancer</a>)  In the case of breast cancer, microRNA-182 (miR-182) specifically targets BRCA1.<sup id=\"cite_ref-Moskwa_72-0\" class=\"reference\"><a href=\"#cite_note-Moskwa-72\">&#91;72&#93;</a></sup>  Breast cancers can be <a href=\"/wiki/Breast_cancer_classification\" title=\"Breast cancer classification\">classified</a> based on receptor status or histology, with <a href=\"/wiki/Triple-negative_breast_cancer\" title=\"Triple-negative breast cancer\">triple-negative breast cancer</a> (15%\\xe2\\x80\\x9325% of breast cancers), <a href=\"/wiki/Breast_cancer#HER2_and_cancer\" title=\"Breast cancer\">HER2+</a> (15%\\xe2\\x80\\x9330% of breast cancers), <a href=\"/wiki/Estrogen_receptor#Cancer\" title=\"Estrogen receptor\">ER+</a>/<a href=\"/wiki/Progesterone_receptor\" title=\"Progesterone receptor\">PR+</a> (about 70% of breast cancers), and <a href=\"/wiki/Invasive_lobular_carcinoma\" title=\"Invasive lobular carcinoma\">Invasive lobular carcinoma</a> (about 5%\\xe2\\x80\\x9310% of invasive breast cancer).  All four types of breast cancer were found to have an average of about 100-fold increase in miR-182, compared to normal breast tissue.<sup id=\"cite_ref-pmid23249749_73-0\" class=\"reference\"><a href=\"#cite_note-pmid23249749-73\">&#91;73&#93;</a></sup>  In breast cancer cell lines, there is an inverse correlation of BRCA1 protein levels with miR-182 expression.<sup id=\"cite_ref-Moskwa_72-1\" class=\"reference\"><a href=\"#cite_note-Moskwa-72\">&#91;72&#93;</a></sup> Thus it appears that much of the reduction or absence of BRCA1 in high grade ductal breast cancers may be due to over-expressed miR-182.\\n</p><p>In addition to miR-182, a pair of almost identical microRNAs, miR-146a and miR-146b-5p, also repress BRCA1 expression.  These two microRNAs are over-expressed in triple-negative tumors and their over-expression results in BRCA1 inactivation.<sup id=\"cite_ref-pmid21472990_74-0\" class=\"reference\"><a href=\"#cite_note-pmid21472990-74\">&#91;74&#93;</a></sup>  Thus, miR-146a and/or miR-146b-5p may also contribute to reduced expression of BRCA1 in these triple-negative breast cancers.\\n</p>\\n<h3><span class=\"mw-headline\" id=\"MicroRNA_repression_of_BRCA1_in_ovarian_cancers\">MicroRNA repression of BRCA1 in ovarian cancers</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=14\" title=\"Edit section: MicroRNA repression of BRCA1 in ovarian cancers\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\\n<p>In both <a href=\"/wiki/Ovarian_cancer#Pathophysiology\" title=\"Ovarian cancer\">serous tubal intraepithelial carcinoma</a> (the precursor lesion to <a href=\"/wiki/Ovarian_cancer#Pathophysiology\" title=\"Ovarian cancer\">high grade serous ovarian carcinoma (HG-SOC)</a>), and in HG-SOC itself, miR-182 is overexpressed in about 70% of cases.<sup id=\"cite_ref-Liu_75-0\" class=\"reference\"><a href=\"#cite_note-Liu-75\">&#91;75&#93;</a></sup>  In cells with over-expressed miR-182, BRCA1 remained low, even after exposure to ionizing radiation (which normally raises BRCA1 expression).<sup id=\"cite_ref-Liu_75-1\" class=\"reference\"><a href=\"#cite_note-Liu-75\">&#91;75&#93;</a></sup>  Thus much of the reduced or absent BRCA1 in HG-SOC may be due to over-expressed miR-182.\\n</p><p>Another microRNA known to reduce expression of BRCA1 in ovarian cancer cells is miR-9.<sup id=\"cite_ref-Sun_65-2\" class=\"reference\"><a href=\"#cite_note-Sun-65\">&#91;65&#93;</a></sup>  Among 58 tumors from patients with stage IIIC or stage IV serous ovarian cancers (HG-SOG), an inverse correlation was found between expressions of miR-9 and BRCA1,<sup id=\"cite_ref-Sun_65-3\" class=\"reference\"><a href=\"#cite_note-Sun-65\">&#91;65&#93;</a></sup> so that increased miR-9 may also contribute to reduced expression of BRCA1 in these ovarian cancers.\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Deficiency_of_BRCA1_expression_is_likely_tumorigenic\">Deficiency of <i>BRCA1</i> expression is likely tumorigenic</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=15\" title=\"Edit section: Deficiency of BRCA1 expression is likely tumorigenic\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\\n<p>DNA damage appears to be the primary underlying cause of cancer,<sup id=\"cite_ref-pmid18403632_76-0\" class=\"reference\"><a href=\"#cite_note-pmid18403632-76\">&#91;76&#93;</a></sup> and deficiencies in DNA repair appears to underlie many forms of cancer.<sup id=\"cite_ref-pmid18082599_77-0\" class=\"reference\"><a href=\"#cite_note-pmid18082599-77\">&#91;77&#93;</a></sup>  If DNA repair is deficient, DNA damage tends to accumulate. Such excess DNA damage may increase <a href=\"/wiki/Mutational\" class=\"mw-redirect\" title=\"Mutational\">mutational</a> errors during <a href=\"/wiki/DNA_replication\" title=\"DNA replication\">DNA replication</a> due to error-prone <a href=\"/wiki/DNA_repair#Translesion_synthesis\" title=\"DNA repair\">translesion synthesis</a>. Excess DNA damage may also increase <a href=\"/wiki/Epigenetics\" title=\"Epigenetics\">epigenetic</a> alterations due to errors during DNA repair.<sup id=\"cite_ref-Hagan_78-0\" class=\"reference\"><a href=\"#cite_note-Hagan-78\">&#91;78&#93;</a></sup><sup id=\"cite_ref-Cuozzo_79-0\" class=\"reference\"><a href=\"#cite_note-Cuozzo-79\">&#91;79&#93;</a></sup> Such mutations and epigenetic alterations may give rise to <a href=\"/wiki/Cancer\" title=\"Cancer\">cancer</a>.  The frequent microRNA-induced deficiency of <i>BRCA1</i> in breast and ovarian cancers likely contribute to the progression of those cancers.\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Germ-line_mutations_and_founder_effect\">Germ-line mutations and founder effect</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=16\" title=\"Edit section: Germ-line mutations and founder effect\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<p>All germ-line BRCA1 mutations identified to date have been inherited, suggesting the possibility of a large \"founder\" effect in which a certain mutation is common to a well-defined population group and can, in theory, be traced back to a common ancestor. Given the complexity of mutation screening for BRCA1, these common mutations may simplify the methods required for mutation screening in certain populations. Analysis of mutations that occur with high frequency also permits the study of their clinical expression.<sup id=\"cite_ref-Lacroix2005_80-0\" class=\"reference\"><a href=\"#cite_note-Lacroix2005-80\">&#91;80&#93;</a></sup> Examples of manifestations of a founder effect are seen among <a href=\"/wiki/Ashkenazi_Jews\" title=\"Ashkenazi Jews\">Ashkenazi Jews</a>. Three mutations in BRCA1 have been reported to account for the majority of Ashkenazi Jewish patients with inherited BRCA1-related breast and/or ovarian cancer: 185delAG, 188del11 and 5382insC in the BRCA1 gene.<sup id=\"cite_ref-Struewing1995_81-0\" class=\"reference\"><a href=\"#cite_note-Struewing1995-81\">&#91;81&#93;</a></sup><sup id=\"cite_ref-Tonin1995_82-0\" class=\"reference\"><a href=\"#cite_note-Tonin1995-82\">&#91;82&#93;</a></sup> In fact, it has been shown that if a Jewish woman does not carry a BRCA1 185delAG, BRCA1 5382insC founder mutation, it is highly unlikely that a different BRCA1 mutation will be found.<sup id=\"cite_ref-Narod2004_83-0\" class=\"reference\"><a href=\"#cite_note-Narod2004-83\">&#91;83&#93;</a></sup> Additional examples of founder mutations in BRCA1 are given in Table 1 (mainly derived from<sup id=\"cite_ref-Lacroix2005_80-1\" class=\"reference\"><a href=\"#cite_note-Lacroix2005-80\">&#91;80&#93;</a></sup>).\\n</p>\\n<link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1033289096\"/><div role=\"note\" class=\"hatnote navigation-not-searchable plainlinks\">This is a <a href=\"/wiki/Wikipedia:WikiProject_Lists#Dynamic_lists\" title=\"Wikipedia:WikiProject Lists\">dynamic list</a> and may never be able to satisfy particular standards for completeness. You can help by <a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=BRCA1&amp;action=edit\">adding missing items</a> with <a href=\"/wiki/Wikipedia:Reliable_sources\" title=\"Wikipedia:Reliable sources\">reliable sources</a>.</div>\\n<table class=\"wikitable\">\\n\\n<tbody><tr>\\n<th>Population or subgroup</th>\\n<th>BRCA1 mutation(s)<sup id=\"cite_ref-denDunnen2000_84-0\" class=\"reference\"><a href=\"#cite_note-denDunnen2000-84\">&#91;84&#93;</a></sup></th>\\n<th>Reference(s)\\n</th></tr>\\n<tr>\\n<td>African-Americans</td>\\n<td>943ins10, M1775R</td>\\n<td><sup id=\"cite_ref-Neuhausen2000_85-0\" class=\"reference\"><a href=\"#cite_note-Neuhausen2000-85\">&#91;85&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Afrikaners</td>\\n<td>E881X, 1374delC</td>\\n<td><sup id=\"cite_ref-Reeves2004_86-0\" class=\"reference\"><a href=\"#cite_note-Reeves2004-86\">&#91;86&#93;</a></sup><sup id=\"cite_ref-Francies2015_87-0\" class=\"reference\"><a href=\"#cite_note-Francies2015-87\">&#91;87&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Ashkenazi Jewish</td>\\n<td>185delAG, 188del11, 5382insC</td>\\n<td><sup id=\"cite_ref-Struewing1995_81-1\" class=\"reference\"><a href=\"#cite_note-Struewing1995-81\">&#91;81&#93;</a></sup><sup id=\"cite_ref-Tonin1995_82-1\" class=\"reference\"><a href=\"#cite_note-Tonin1995-82\">&#91;82&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Austrians</td>\\n<td>2795delA, C61G, 5382insC, Q1806stop</td>\\n<td><sup id=\"cite_ref-Wagner1998_88-0\" class=\"reference\"><a href=\"#cite_note-Wagner1998-88\">&#91;88&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Belgians</td>\\n<td>2804delAA, IVS5+3A&gt;G</td>\\n<td><sup id=\"cite_ref-Peelen1997_89-0\" class=\"reference\"><a href=\"#cite_note-Peelen1997-89\">&#91;89&#93;</a></sup><sup id=\"cite_ref-Claes1999_90-0\" class=\"reference\"><a href=\"#cite_note-Claes1999-90\">&#91;90&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Dutch</td>\\n<td>Exon 2 deletion, exon 13 deletion, 2804delAA</td>\\n<td><sup id=\"cite_ref-Peelen1997_89-1\" class=\"reference\"><a href=\"#cite_note-Peelen1997-89\">&#91;89&#93;</a></sup><sup id=\"cite_ref-PetrijBosch_91-0\" class=\"reference\"><a href=\"#cite_note-PetrijBosch-91\">&#91;91&#93;</a></sup><sup id=\"cite_ref-Verhoog_92-0\" class=\"reference\"><a href=\"#cite_note-Verhoog-92\">&#91;92&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Finns</td>\\n<td>3745delT, IVS11-2A&gt;G</td>\\n<td><sup id=\"cite_ref-Huusko_93-0\" class=\"reference\"><a href=\"#cite_note-Huusko-93\">&#91;93&#93;</a></sup><sup id=\"cite_ref-Paakkonen_94-0\" class=\"reference\"><a href=\"#cite_note-Paakkonen-94\">&#91;94&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>French</td>\\n<td>3600del11, G1710X</td>\\n<td><sup id=\"cite_ref-Muller_95-0\" class=\"reference\"><a href=\"#cite_note-Muller-95\">&#91;95&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>French Canadians</td>\\n<td>C4446T</td>\\n<td><sup id=\"cite_ref-Tonin1999_96-0\" class=\"reference\"><a href=\"#cite_note-Tonin1999-96\">&#91;96&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Germans</td>\\n<td>5382insC, 4184del4</td>\\n<td><sup id=\"cite_ref-Backe1999_97-0\" class=\"reference\"><a href=\"#cite_note-Backe1999-97\">&#91;97&#93;</a></sup><sup id=\"cite_ref-urlBrca1_98-0\" class=\"reference\"><a href=\"#cite_note-urlBrca1-98\">&#91;98&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Greeks</td>\\n<td>5382insC</td>\\n<td><sup id=\"cite_ref-Ladopoulou2002_99-0\" class=\"reference\"><a href=\"#cite_note-Ladopoulou2002-99\">&#91;99&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Hungarians</td>\\n<td>300T&gt;G, 5382insC, 185delAG</td>\\n<td><sup id=\"cite_ref-VanDerLooij2000_100-0\" class=\"reference\"><a href=\"#cite_note-VanDerLooij2000-100\">&#91;100&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Italians</td>\\n<td>5083del19</td>\\n<td><sup id=\"cite_ref-Baudi2001_101-0\" class=\"reference\"><a href=\"#cite_note-Baudi2001-101\">&#91;101&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Japanese</td>\\n<td>L63X, Q934X</td>\\n<td><sup id=\"cite_ref-Sekine2001_102-0\" class=\"reference\"><a href=\"#cite_note-Sekine2001-102\">&#91;102&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Native North Americans</td>\\n<td>1510insG, 1506A&gt;G</td>\\n<td><sup id=\"cite_ref-Liede2002b_103-0\" class=\"reference\"><a href=\"#cite_note-Liede2002b-103\">&#91;103&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Northern Irish</td>\\n<td>2800delAA</td>\\n<td><sup id=\"cite_ref-TSNI2003_104-0\" class=\"reference\"><a href=\"#cite_note-TSNI2003-104\">&#91;104&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Norwegians</td>\\n<td>816delGT, 1135insA, 1675delA, 3347delAG</td>\\n<td><sup id=\"cite_ref-Borg1999_105-0\" class=\"reference\"><a href=\"#cite_note-Borg1999-105\">&#91;105&#93;</a></sup><sup id=\"cite_ref-Heimdal2003_106-0\" class=\"reference\"><a href=\"#cite_note-Heimdal2003-106\">&#91;106&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Pakistanis</td>\\n<td>2080insA, 3889delAG, 4184del4, 4284delAG, IVS14-1A&gt;G</td>\\n<td><sup id=\"cite_ref-Liede2002_107-0\" class=\"reference\"><a href=\"#cite_note-Liede2002-107\">&#91;107&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Poles</td>\\n<td>300T&gt;G, 5382insC, C61G, 4153delA</td>\\n<td><sup id=\"cite_ref-Gorski2000_108-0\" class=\"reference\"><a href=\"#cite_note-Gorski2000-108\">&#91;108&#93;</a></sup><sup id=\"cite_ref-Perkowska2003_109-0\" class=\"reference\"><a href=\"#cite_note-Perkowska2003-109\">&#91;109&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Russians</td>\\n<td>5382insC, 4153delA</td>\\n<td><sup id=\"cite_ref-Gayther1997_110-0\" class=\"reference\"><a href=\"#cite_note-Gayther1997-110\">&#91;110&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Scots</td>\\n<td>2800delAA</td>\\n<td><sup id=\"cite_ref-TSNI2003_104-1\" class=\"reference\"><a href=\"#cite_note-TSNI2003-104\">&#91;104&#93;</a></sup><sup id=\"cite_ref-Liede2000_111-0\" class=\"reference\"><a href=\"#cite_note-Liede2000-111\">&#91;111&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Spaniards</td>\\n<td>R71G</td>\\n<td><sup id=\"cite_ref-Vega2001_112-0\" class=\"reference\"><a href=\"#cite_note-Vega2001-112\">&#91;112&#93;</a></sup><sup id=\"cite_ref-Campos2003_113-0\" class=\"reference\"><a href=\"#cite_note-Campos2003-113\">&#91;113&#93;</a></sup>\\n</td></tr>\\n<tr>\\n<td>Swedes</td>\\n<td>Q563X, 3171ins5, 1201del11, 2594delC</td>\\n<td><sup id=\"cite_ref-Neuhausen2000_85-1\" class=\"reference\"><a href=\"#cite_note-Neuhausen2000-85\">&#91;85&#93;</a></sup><sup id=\"cite_ref-Bergman2001_114-0\" class=\"reference\"><a href=\"#cite_note-Bergman2001-114\">&#91;114&#93;</a></sup>\\n</td></tr></tbody></table>\\n<h2><span class=\"mw-headline\" id=\"Female_fertility\">Female fertility</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=17\" title=\"Edit section: Female fertility\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<p>As women age, reproductive performance declines, leading to menopause. This decline is tied to a reduction in the number of ovarian follicles. Although about 1 million oocytes are present at birth in the human ovary, only about 500 (about 0.05%) of these ovulate. The decline in ovarian reserve appears to occur at a constantly increasing rate with age,<sup id=\"cite_ref-pmid18192670_115-0\" class=\"reference\"><a href=\"#cite_note-pmid18192670-115\">&#91;115&#93;</a></sup> and leads to nearly complete exhaustion of the reserve by about age 52. As ovarian reserve and fertility decline with age, there is also a parallel increase in pregnancy failure and meiotic errors, resulting in chromosomally abnormal conceptions.<sup id=\"cite_ref-116\" class=\"reference\"><a href=\"#cite_note-116\">&#91;116&#93;</a></sup>\\n</p><p>Women with a germ-line <i>BRCA1</i> mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women.<sup id=\"cite_ref-pmid19996028_117-0\" class=\"reference\"><a href=\"#cite_note-pmid19996028-117\">&#91;117&#93;</a></sup> Furthermore, women with an inherited <i>BRCA1</i> mutation undergo menopause prematurely.<sup id=\"cite_ref-pmid16773440_118-0\" class=\"reference\"><a href=\"#cite_note-pmid16773440-118\">&#91;118&#93;</a></sup>  Since BRCA1 is a key DNA repair protein, these findings suggest that naturally occurring DNA damages in oocytes are repaired less efficiently in women with a <i>BRCA1</i> defect, and that this repair inefficiency leads to early reproductive failure.<sup id=\"cite_ref-pmid19996028_117-1\" class=\"reference\"><a href=\"#cite_note-pmid19996028-117\">&#91;117&#93;</a></sup>\\n</p><p>As noted above, the BRCA1 protein plays a key role in homologous recombinational repair.  This is the only known cellular process that can accurately repair DNA double-strand breaks. DNA double-strand breaks accumulate with age in humans and mice in primordial follicles.<sup id=\"cite_ref-Titus_119-0\" class=\"reference\"><a href=\"#cite_note-Titus-119\">&#91;119&#93;</a></sup>  Primordial follicles contain oocytes that are at an intermediate (prophase I) stage of meiosis.  Meiosis is the general process in eukaryotic organisms by which germ cells are formed, and it is likely an adaptation for removing DNA damages, especially double-strand breaks, from germ line DNA.<sup id=\"cite_ref-120\" class=\"reference\"><a href=\"#cite_note-120\">&#91;120&#93;</a></sup> (Also see article <a href=\"/wiki/Meiosis\" title=\"Meiosis\">Meiosis</a>).  Homologous recombinational repair employing BRCA1 is especially promoted during meiosis.  It was found that expression of four key genes necessary for homologous recombinational repair of DNA double-strand breaks (<i>BRCA1, MRE11, RAD51</i> and <i>ATM</i>) decline with age in the oocytes of humans and mice,<sup id=\"cite_ref-Titus_119-1\" class=\"reference\"><a href=\"#cite_note-Titus-119\">&#91;119&#93;</a></sup> leading to the hypothesis that DNA double-strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging.\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Cancer_chemotherapy\">Cancer chemotherapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=18\" title=\"Edit section: Cancer chemotherapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<p>Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide.  At diagnosis, almost 70% of persons with NSCLC have locally advanced or metastatic disease.  Persons with NSCLC are often treated with therapeutic platinum compounds (e.g. cisplatin, carboplatin or oxaliplatin) that cause inter-strand cross-links in DNA.  Among individuals with NSCLC, low expression of <i>BRCA1</i> in the primary tumor correlated with improved survival after platinum-containing chemotherapy.<sup id=\"cite_ref-Taron_121-0\" class=\"reference\"><a href=\"#cite_note-Taron-121\">&#91;121&#93;</a></sup><sup id=\"cite_ref-Papadaki_122-0\" class=\"reference\"><a href=\"#cite_note-Papadaki-122\">&#91;122&#93;</a></sup>  This correlation implies that low BRCA1 in cancer, and the consequent low level of DNA repair, causes vulnerability of cancer to treatment by the DNA cross-linking agents.  High BRCA1 may protect cancer cells by acting in a pathway that removes the damages in DNA introduced by the platinum drugs.  Thus the level of <i>BRCA1</i> expression is a potentially important tool for tailoring chemotherapy in lung cancer management.<sup id=\"cite_ref-Taron_121-1\" class=\"reference\"><a href=\"#cite_note-Taron-121\">&#91;121&#93;</a></sup><sup id=\"cite_ref-Papadaki_122-1\" class=\"reference\"><a href=\"#cite_note-Papadaki-122\">&#91;122&#93;</a></sup>\\n</p><p>Level of <i>BRCA1</i> expression is also relevant to ovarian cancer treatment.  Patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their <i>BRCA1</i> expression was low compared to patients with higher <i>BRCA1</i> expression (46 compared to 33 months).<sup id=\"cite_ref-pmid19035454_123-0\" class=\"reference\"><a href=\"#cite_note-pmid19035454-123\">&#91;123&#93;</a></sup>\\n</p>\\n<h2><span id=\"Patents.2C_enforcement.2C_litigation.2C_and_controversy\"></span><span class=\"mw-headline\" id=\"Patents,_enforcement,_litigation,_and_controversy\">Patents, enforcement, litigation, and controversy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=19\" title=\"Edit section: Patents, enforcement, litigation, and controversy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1033289096\"/><div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics\" class=\"mw-redirect\" title=\"Association for Molecular Pathology v. Myriad Genetics\">Association for Molecular Pathology v. Myriad Genetics</a></div>\\n<p>A patent application for the isolated BRCA1 gene and cancer promoting mutations discussed above, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the University of Utah, National Institute of Environmental Health Sciences (NIEHS) and <a href=\"/wiki/Myriad_Genetics\" title=\"Myriad Genetics\">Myriad Genetics</a> in 1994;<sup id=\"cite_ref-US_5747282_18-2\" class=\"reference\"><a href=\"#cite_note-US_5747282-18\">&#91;18&#93;</a></sup> over the next year, Myriad, (in collaboration with investigators at Endo Recherche, Inc., HSC Research &amp; Development Limited Partnership, and University of Pennsylvania), isolated and sequenced the <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a> gene and identified key mutations, and the first BRCA2 patent was filed in the U.S. by Myriad and other institutions in 1995.<sup id=\"cite_ref-US_5837492_19-1\" class=\"reference\"><a href=\"#cite_note-US_5837492-19\">&#91;19&#93;</a></sup>  Myriad is the exclusive licensee of these <a href=\"/wiki/Biological_patent\" title=\"Biological patent\">patents</a> and has enforced them in the US against clinical diagnostic labs.<sup id=\"cite_ref-SchwartzNYTimes_21-1\" class=\"reference\"><a href=\"#cite_note-SchwartzNYTimes-21\">&#91;21&#93;</a></sup>  This business model led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012;<sup id=\"cite_ref-MyriadInvestorPage_20-1\" class=\"reference\"><a href=\"#cite_note-MyriadInvestorPage-20\">&#91;20&#93;</a></sup> it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs, which in turn led to the landmark <i><a href=\"/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics\" class=\"mw-redirect\" title=\"Association for Molecular Pathology v. Myriad Genetics\">Association for Molecular Pathology v. Myriad Genetics</a></i> lawsuit.<sup id=\"cite_ref-SchwartzNYTimes_21-2\" class=\"reference\"><a href=\"#cite_note-SchwartzNYTimes-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-url_BRCA1_patent_legal_battle_124-0\" class=\"reference\"><a href=\"#cite_note-url_BRCA1_patent_legal_battle-124\">&#91;124&#93;</a></sup>  The patents began to expire in 2014.\\n</p><p>According to an article published in the journal, <i>Genetic Medicine</i>, in 2010, \"The patent story outside the United States is more complicated.... For example, patents have been obtained but the patents are being ignored by provincial health systems in Canada. In Australia and the UK, Myriad\\'s licensee permitted use by health systems but announced a change of plans in August 2008. Only a single mutation has been patented in Myriad\\'s lone European-wide patent, although some patents remain under review of an opposition proceeding. In effect, the United States is the only jurisdiction where Myriad\\'s strong patent position has conferred sole-provider status.\"<sup id=\"cite_ref-125\" class=\"reference\"><a href=\"#cite_note-125\">&#91;125&#93;</a></sup><sup id=\"cite_ref-pmid12509391_126-0\" class=\"reference\"><a href=\"#cite_note-pmid12509391-126\">&#91;126&#93;</a></sup>  Peter Meldrum, CEO of Myriad Genetics, has acknowledged that Myriad has \"other competitive advantages that may make such [patent] enforcement unnecessary\" in Europe.<sup id=\"cite_ref-127\" class=\"reference\"><a href=\"#cite_note-127\">&#91;127&#93;</a></sup>\\n</p><p>As with any gene, finding variation in BRCA1 is not hard. The real value comes from understanding what the clinical consequences of any particular variant are. Myriad has a large, proprietary database of such genotype-phenotype correlations. In response, parallel open-source databases are being developed.\\n</p><p>Legal decisions surrounding the BRCA1 and BRCA2 patents will affect the field of genetic testing in general.<sup id=\"cite_ref-urlGenetics_and_Patenting_128-0\" class=\"reference\"><a href=\"#cite_note-urlGenetics_and_Patenting-128\">&#91;128&#93;</a></sup>  A June 2013 article, in  <i>Association for Molecular Pathology v. Myriad Genetics</i> (No. 12-398), quoted the <a href=\"/wiki/Supreme_Court_of_the_United_States\" title=\"Supreme Court of the United States\">US Supreme Court</a>\\'s unanimous ruling that, \"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating Myriad\\'s patents on the BRCA1 and BRCA2 genes. However, the Court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection.<sup id=\"cite_ref-129\" class=\"reference\"><a href=\"#cite_note-129\">&#91;129&#93;</a></sup>  The <a href=\"/wiki/Federal_Court_of_Australia\" title=\"Federal Court of Australia\">Federal Court of Australia</a> came to the opposite conclusion, upholding the validity of an Australian Myriad Genetics patent over the BRCA1 gene in February 2013.<sup id=\"cite_ref-130\" class=\"reference\"><a href=\"#cite_note-130\">&#91;130&#93;</a></sup>  The Federal Court also rejected an appeal in September 2014.<sup id=\"cite_ref-131\" class=\"reference\"><a href=\"#cite_note-131\">&#91;131&#93;</a></sup> Yvonne D\\'Arcy won her case against US-based biotech company Myriad Genetics in the <a href=\"/wiki/High_Court_of_Australia\" title=\"High Court of Australia\">High Court of Australia</a>. In their unanimous decision on October 7, 2015, the \"high court found that an isolated nucleic acid, coding for a BRCA1 protein, with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a \\'patentable invention.\\'\"<sup id=\"cite_ref-theguardian_2015_oct_07_132-0\" class=\"reference\"><a href=\"#cite_note-theguardian_2015_oct_07-132\">&#91;132&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Interactions\">Interactions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=20\" title=\"Edit section: Interactions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<p>BRCA1 has been shown to <a href=\"/wiki/Protein%E2%80%93protein_interaction\" title=\"Protein\\xe2\\x80\\x93protein interaction\">interact</a> with the following proteins:\\n</p>\\n<style data-mw-deduplicate=\"TemplateStyles:r1147244281\">.mw-parser-output .div-col{margin-top:0.3em;column-width:30em}.mw-parser-output .div-col-small{font-size:90%}.mw-parser-output .div-col-rules{column-rule:1px solid #aaa}.mw-parser-output .div-col dl,.mw-parser-output .div-col ol,.mw-parser-output .div-col ul{margin-top:0}.mw-parser-output .div-col li,.mw-parser-output .div-col dd{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style><div class=\"div-col\" style=\"column-width: 20em;\">\\n<ul><li><a href=\"/wiki/Abl_gene\" class=\"mw-redirect\" title=\"Abl gene\">ABL1</a><sup id=\"cite_ref-pmid12024016_133-0\" class=\"reference\"><a href=\"#cite_note-pmid12024016-133\">&#91;133&#93;</a></sup></li>\\n<li><a href=\"/wiki/AKT1\" title=\"AKT1\">AKT1</a><sup id=\"cite_ref-pmid10542266_134-0\" class=\"reference\"><a href=\"#cite_note-pmid10542266-134\">&#91;134&#93;</a></sup><sup id=\"cite_ref-pmid19074868_135-0\" class=\"reference\"><a href=\"#cite_note-pmid19074868-135\">&#91;135&#93;</a></sup></li>\\n<li><a href=\"/wiki/Androgen_receptor\" title=\"Androgen receptor\">AR</a><sup id=\"cite_ref-pmid11016951_136-0\" class=\"reference\"><a href=\"#cite_note-pmid11016951-136\">&#91;136&#93;</a></sup></li>\\n<li><a href=\"/wiki/Ataxia_telangiectasia_and_Rad3_related\" title=\"Ataxia telangiectasia and Rad3 related\">ATR</a><sup id=\"cite_ref-pmid10608806_137-0\" class=\"reference\"><a href=\"#cite_note-pmid10608806-137\">&#91;137&#93;</a></sup><sup id=\"cite_ref-pmid11114888_138-0\" class=\"reference\"><a href=\"#cite_note-pmid11114888-138\">&#91;138&#93;</a></sup><sup id=\"cite_ref-pmid11016625_139-0\" class=\"reference\"><a href=\"#cite_note-pmid11016625-139\">&#91;139&#93;</a></sup><sup id=\"cite_ref-pmid11278964_140-0\" class=\"reference\"><a href=\"#cite_note-pmid11278964-140\">&#91;140&#93;</a></sup></li>\\n<li><a href=\"/wiki/Ataxia_telangiectasia_mutated\" class=\"mw-redirect\" title=\"Ataxia telangiectasia mutated\">ATM</a><sup id=\"cite_ref-pmid10783165_16-1\" class=\"reference\"><a href=\"#cite_note-pmid10783165-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-pmid10608806_137-1\" class=\"reference\"><a href=\"#cite_note-pmid10608806-137\">&#91;137&#93;</a></sup><sup id=\"cite_ref-pmid11114888_138-1\" class=\"reference\"><a href=\"#cite_note-pmid11114888-138\">&#91;138&#93;</a></sup><sup id=\"cite_ref-pmid11016625_139-1\" class=\"reference\"><a href=\"#cite_note-pmid11016625-139\">&#91;139&#93;</a></sup><sup id=\"cite_ref-pmid11278964_140-1\" class=\"reference\"><a href=\"#cite_note-pmid11278964-140\">&#91;140&#93;</a></sup><sup id=\"cite_ref-pmid10866324_141-0\" class=\"reference\"><a href=\"#cite_note-pmid10866324-141\">&#91;141&#93;</a></sup><sup id=\"cite_ref-pmid10550055_142-0\" class=\"reference\"><a href=\"#cite_note-pmid10550055-142\">&#91;142&#93;</a></sup></li>\\n<li><a href=\"/wiki/ATF1\" title=\"ATF1\">ATF1</a><sup id=\"cite_ref-pmid10945975_143-0\" class=\"reference\"><a href=\"#cite_note-pmid10945975-143\">&#91;143&#93;</a></sup></li>\\n<li><a href=\"/wiki/BACH1\" title=\"BACH1\">BACH1</a><sup id=\"cite_ref-pmid11301010_144-0\" class=\"reference\"><a href=\"#cite_note-pmid11301010-144\">&#91;144&#93;</a></sup></li>\\n<li><a href=\"/wiki/BARD1\" title=\"BARD1\">BARD1</a><sup id=\"cite_ref-pmid11573085_30-3\" class=\"reference\"><a href=\"#cite_note-pmid11573085-30\">&#91;30&#93;</a></sup><sup id=\"cite_ref-pmid11498787_39-1\" class=\"reference\"><a href=\"#cite_note-pmid11498787-39\">&#91;39&#93;</a></sup><sup id=\"cite_ref-pmid9788437_43-1\" class=\"reference\"><a href=\"#cite_note-pmid9788437-43\">&#91;43&#93;</a></sup><sup id=\"cite_ref-pmid11301010_144-1\" class=\"reference\"><a href=\"#cite_note-pmid11301010-144\">&#91;144&#93;</a></sup></li>\\n<li><a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a><sup id=\"cite_ref-pmid14636569_145-0\" class=\"reference\"><a href=\"#cite_note-pmid14636569-145\">&#91;145&#93;</a></sup><sup id=\"cite_ref-pmid9774970_146-0\" class=\"reference\"><a href=\"#cite_note-pmid9774970-146\">&#91;146&#93;</a></sup><sup id=\"cite_ref-pmid14499622_147-0\" class=\"reference\"><a href=\"#cite_note-pmid14499622-147\">&#91;147&#93;</a></sup><sup id=\"cite_ref-pmid11477095_148-0\" class=\"reference\"><a href=\"#cite_note-pmid11477095-148\">&#91;148&#93;</a></sup></li>\\n<li><a href=\"/wiki/BRCC3\" title=\"BRCC3\">BRCC3</a><sup id=\"cite_ref-pmid14636569_145-1\" class=\"reference\"><a href=\"#cite_note-pmid14636569-145\">&#91;145&#93;</a></sup></li>\\n<li><a href=\"/wiki/BRE_(gene)\" title=\"BRE (gene)\">BRE</a><sup id=\"cite_ref-pmid14636569_145-2\" class=\"reference\"><a href=\"#cite_note-pmid14636569-145\">&#91;145&#93;</a></sup></li>\\n<li><a href=\"/wiki/BRIP1\" title=\"BRIP1\">BRIP1</a><sup id=\"cite_ref-pmid11877378_34-1\" class=\"reference\"><a href=\"#cite_note-pmid11877378-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-pmid14578343_149-0\" class=\"reference\"><a href=\"#cite_note-pmid14578343-149\">&#91;149&#93;</a></sup><sup id=\"cite_ref-pmid15208681_150-0\" class=\"reference\"><a href=\"#cite_note-pmid15208681-150\">&#91;150&#93;</a></sup><sup id=\"cite_ref-pmid15242590_151-0\" class=\"reference\"><a href=\"#cite_note-pmid15242590-151\">&#91;151&#93;</a></sup><sup id=\"cite_ref-pmid14576433_152-0\" class=\"reference\"><a href=\"#cite_note-pmid14576433-152\">&#91;152&#93;</a></sup><sup id=\"cite_ref-pmid15133502_153-0\" class=\"reference\"><a href=\"#cite_note-pmid15133502-153\">&#91;153&#93;</a></sup></li>\\n<li><a href=\"/wiki/C-jun\" class=\"mw-redirect\" title=\"C-jun\">C-jun</a><sup id=\"cite_ref-pmid12080089_154-0\" class=\"reference\"><a href=\"#cite_note-pmid12080089-154\">&#91;154&#93;</a></sup></li>\\n<li><a href=\"/wiki/CHEK2\" title=\"CHEK2\">CHEK2</a><sup id=\"cite_ref-pmid10724175_155-0\" class=\"reference\"><a href=\"#cite_note-pmid10724175-155\">&#91;155&#93;</a></sup><sup id=\"cite_ref-pmid18804494_156-0\" class=\"reference\"><a href=\"#cite_note-pmid18804494-156\">&#91;156&#93;</a></sup></li>\\n<li><a href=\"/wiki/CLSPN\" title=\"CLSPN\">CLSPN</a><sup id=\"cite_ref-pmid15096610_157-0\" class=\"reference\"><a href=\"#cite_note-pmid15096610-157\">&#91;157&#93;</a></sup></li>\\n<li><a href=\"/wiki/Cofactor_of_BRCA1\" title=\"Cofactor of BRCA1\">COBRA1</a><sup id=\"cite_ref-pmid11739404_158-0\" class=\"reference\"><a href=\"#cite_note-pmid11739404-158\">&#91;158&#93;</a></sup></li>\\n<li><a href=\"/wiki/CREB-binding_protein\" title=\"CREB-binding protein\">CREBBP</a><sup id=\"cite_ref-pmid12700228_159-0\" class=\"reference\"><a href=\"#cite_note-pmid12700228-159\">&#91;159&#93;</a></sup><sup id=\"cite_ref-pmid10655477_160-0\" class=\"reference\"><a href=\"#cite_note-pmid10655477-160\">&#91;160&#93;</a></sup><sup id=\"cite_ref-pmid9926942_161-0\" class=\"reference\"><a href=\"#cite_note-pmid9926942-161\">&#91;161&#93;</a></sup><sup id=\"cite_ref-pmid11782371_162-0\" class=\"reference\"><a href=\"#cite_note-pmid11782371-162\">&#91;162&#93;</a></sup><sup id=\"cite_ref-pmid9443979_163-0\" class=\"reference\"><a href=\"#cite_note-pmid9443979-163\">&#91;163&#93;</a></sup></li>\\n<li><a href=\"/wiki/CSNK2B\" title=\"CSNK2B\">CSNK2B</a><sup id=\"cite_ref-pmid10403822_164-0\" class=\"reference\"><a href=\"#cite_note-pmid10403822-164\">&#91;164&#93;</a></sup></li>\\n<li><a href=\"/wiki/CSTF2\" title=\"CSTF2\">CSTF2</a><sup id=\"cite_ref-pmid11257228_165-0\" class=\"reference\"><a href=\"#cite_note-pmid11257228-165\">&#91;165&#93;</a></sup><sup id=\"cite_ref-pmid10477523_166-0\" class=\"reference\"><a href=\"#cite_note-pmid10477523-166\">&#91;166&#93;</a></sup></li>\\n<li><a href=\"/wiki/Cyclin-dependent_kinase_2\" title=\"Cyclin-dependent kinase 2\">CDK2</a><sup id=\"cite_ref-pmid9244350_167-0\" class=\"reference\"><a href=\"#cite_note-pmid9244350-167\">&#91;167&#93;</a></sup><sup id=\"cite_ref-pmid8764100_168-0\" class=\"reference\"><a href=\"#cite_note-pmid8764100-168\">&#91;168&#93;</a></sup><sup id=\"cite_ref-pmid10373534_169-0\" class=\"reference\"><a href=\"#cite_note-pmid10373534-169\">&#91;169&#93;</a></sup></li>\\n<li><a href=\"/wiki/DHX9\" class=\"mw-redirect\" title=\"DHX9\">DHX9</a><sup id=\"cite_ref-pmid12592385_170-0\" class=\"reference\"><a href=\"#cite_note-pmid12592385-170\">&#91;170&#93;</a></sup><sup id=\"cite_ref-pmid9662397_171-0\" class=\"reference\"><a href=\"#cite_note-pmid9662397-171\">&#91;171&#93;</a></sup></li>\\n<li><a href=\"/wiki/ELK4\" title=\"ELK4\">ELK4</a><sup id=\"cite_ref-pmid11313879_172-0\" class=\"reference\"><a href=\"#cite_note-pmid11313879-172\">&#91;172&#93;</a></sup></li>\\n<li><a href=\"/wiki/EP300\" title=\"EP300\">EP300</a><sup id=\"cite_ref-pmid10655477_160-1\" class=\"reference\"><a href=\"#cite_note-pmid10655477-160\">&#91;160&#93;</a></sup><sup id=\"cite_ref-pmid11782371_162-1\" class=\"reference\"><a href=\"#cite_note-pmid11782371-162\">&#91;162&#93;</a></sup></li>\\n<li><a href=\"/wiki/Estrogen_receptor_alpha\" title=\"Estrogen receptor alpha\">ESR1</a><sup id=\"cite_ref-pmid11782371_162-2\" class=\"reference\"><a href=\"#cite_note-pmid11782371-162\">&#91;162&#93;</a></sup><sup id=\"cite_ref-pmid11493692_173-0\" class=\"reference\"><a href=\"#cite_note-pmid11493692-173\">&#91;173&#93;</a></sup><sup id=\"cite_ref-pmid11244506_174-0\" class=\"reference\"><a href=\"#cite_note-pmid11244506-174\">&#91;174&#93;</a></sup><sup id=\"cite_ref-pmid12400015_175-0\" class=\"reference\"><a href=\"#cite_note-pmid12400015-175\">&#91;175&#93;</a></sup></li>\\n<li><a href=\"/wiki/FANCA\" title=\"FANCA\">FANCA</a><sup id=\"cite_ref-pmid12354784_176-0\" class=\"reference\"><a href=\"#cite_note-pmid12354784-176\">&#91;176&#93;</a></sup></li>\\n<li><a href=\"/wiki/FANCD2\" title=\"FANCD2\">FANCD2</a><sup id=\"cite_ref-pmid12887909_177-0\" class=\"reference\"><a href=\"#cite_note-pmid12887909-177\">&#91;177&#93;</a></sup><sup id=\"cite_ref-pmid14499622_147-1\" class=\"reference\"><a href=\"#cite_note-pmid14499622-147\">&#91;147&#93;</a></sup></li>\\n<li><a href=\"/wiki/FHL2\" title=\"FHL2\">FHL2</a><sup id=\"cite_ref-pmid14550570_178-0\" class=\"reference\"><a href=\"#cite_note-pmid14550570-178\">&#91;178&#93;</a></sup><sup id=\"cite_ref-pmid14986435_179-0\" class=\"reference\"><a href=\"#cite_note-pmid14986435-179\">&#91;179&#93;</a></sup></li>\\n<li><a href=\"/wiki/H2AFX\" title=\"H2AFX\">H2AFX</a><sup id=\"cite_ref-pmid12485996_180-0\" class=\"reference\"><a href=\"#cite_note-pmid12485996-180\">&#91;180&#93;</a></sup><sup id=\"cite_ref-pmid11927591_181-0\" class=\"reference\"><a href=\"#cite_note-pmid11927591-181\">&#91;181&#93;</a></sup><sup id=\"cite_ref-pmid10959836_182-0\" class=\"reference\"><a href=\"#cite_note-pmid10959836-182\">&#91;182&#93;</a></sup></li>\\n<li><a href=\"/wiki/JUNB\" title=\"JUNB\">JUNB</a><sup id=\"cite_ref-pmid12080089_154-1\" class=\"reference\"><a href=\"#cite_note-pmid12080089-154\">&#91;154&#93;</a></sup></li>\\n<li><a href=\"/wiki/JunD\" title=\"JunD\">JunD</a><sup id=\"cite_ref-pmid12080089_154-2\" class=\"reference\"><a href=\"#cite_note-pmid12080089-154\">&#91;154&#93;</a></sup></li>\\n<li><a href=\"/wiki/LMO4\" title=\"LMO4\">LMO4</a><sup id=\"cite_ref-pmid12925972_183-0\" class=\"reference\"><a href=\"#cite_note-pmid12925972-183\">&#91;183&#93;</a></sup><sup id=\"cite_ref-pmid11751867_184-0\" class=\"reference\"><a href=\"#cite_note-pmid11751867-184\">&#91;184&#93;</a></sup></li>\\n<li><a href=\"/wiki/MAP3K3\" title=\"MAP3K3\">MAP3K3</a><sup id=\"cite_ref-pmid15205325_185-0\" class=\"reference\"><a href=\"#cite_note-pmid15205325-185\">&#91;185&#93;</a></sup></li>\\n<li><a href=\"/wiki/MED1\" title=\"MED1\">MED1</a><sup id=\"cite_ref-pmid15208681_150-1\" class=\"reference\"><a href=\"#cite_note-pmid15208681-150\">&#91;150&#93;</a></sup></li>\\n<li><a href=\"/wiki/MED17\" title=\"MED17\">MED17</a><sup id=\"cite_ref-pmid11504724_186-0\" class=\"reference\"><a href=\"#cite_note-pmid11504724-186\">&#91;186&#93;</a></sup><sup id=\"cite_ref-pmid15208681_150-2\" class=\"reference\"><a href=\"#cite_note-pmid15208681-150\">&#91;150&#93;</a></sup><sup id=\"cite_ref-pmid12154023_187-0\" class=\"reference\"><a href=\"#cite_note-pmid12154023-187\">&#91;187&#93;</a></sup></li>\\n<li><a href=\"/wiki/MED21\" title=\"MED21\">MED21</a><sup id=\"cite_ref-pmid9159119_188-0\" class=\"reference\"><a href=\"#cite_note-pmid9159119-188\">&#91;188&#93;</a></sup></li>\\n<li><a href=\"/wiki/MED24\" title=\"MED24\">MED24</a><sup id=\"cite_ref-pmid15208681_150-3\" class=\"reference\"><a href=\"#cite_note-pmid15208681-150\">&#91;150&#93;</a></sup></li>\\n<li><a href=\"/wiki/MRE11A\" title=\"MRE11A\">MRE11A</a><sup id=\"cite_ref-pmid10783165_16-2\" class=\"reference\"><a href=\"#cite_note-pmid10783165-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-pmid11504724_186-1\" class=\"reference\"><a href=\"#cite_note-pmid11504724-186\">&#91;186&#93;</a></sup><sup id=\"cite_ref-pmid10426999_189-0\" class=\"reference\"><a href=\"#cite_note-pmid10426999-189\">&#91;189&#93;</a></sup><sup id=\"cite_ref-pmid11353843_190-0\" class=\"reference\"><a href=\"#cite_note-pmid11353843-190\">&#91;190&#93;</a></sup></li>\\n<li><a href=\"/wiki/MSH2\" title=\"MSH2\">MSH2</a><sup id=\"cite_ref-pmid10783165_16-3\" class=\"reference\"><a href=\"#cite_note-pmid10783165-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-pmid11498787_39-2\" class=\"reference\"><a href=\"#cite_note-pmid11498787-39\">&#91;39&#93;</a></sup></li>\\n<li><a href=\"/wiki/MSH3\" title=\"MSH3\">MSH3</a><sup id=\"cite_ref-pmid11498787_39-3\" class=\"reference\"><a href=\"#cite_note-pmid11498787-39\">&#91;39&#93;</a></sup><sup id=\"cite_ref-pmid14578343_149-1\" class=\"reference\"><a href=\"#cite_note-pmid14578343-149\">&#91;149&#93;</a></sup></li>\\n<li><a href=\"/wiki/MSH6\" title=\"MSH6\">MSH6</a><sup id=\"cite_ref-pmid10783165_16-4\" class=\"reference\"><a href=\"#cite_note-pmid10783165-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-pmid11498787_39-4\" class=\"reference\"><a href=\"#cite_note-pmid11498787-39\">&#91;39&#93;</a></sup></li>\\n<li><a href=\"/wiki/Myc\" title=\"Myc\">Myc</a><sup id=\"cite_ref-pmid9788437_43-2\" class=\"reference\"><a href=\"#cite_note-pmid9788437-43\">&#91;43&#93;</a></sup><sup id=\"cite_ref-pmid11916966_191-0\" class=\"reference\"><a href=\"#cite_note-pmid11916966-191\">&#91;191&#93;</a></sup><sup id=\"cite_ref-pmid14612409_192-0\" class=\"reference\"><a href=\"#cite_note-pmid14612409-192\">&#91;192&#93;</a></sup><sup id=\"cite_ref-pmid12646176_193-0\" class=\"reference\"><a href=\"#cite_note-pmid12646176-193\">&#91;193&#93;</a></sup></li>\\n<li><a href=\"/wiki/Nibrin\" title=\"Nibrin\">NBN</a><sup id=\"cite_ref-pmid10783165_16-5\" class=\"reference\"><a href=\"#cite_note-pmid10783165-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-pmid11504724_186-2\" class=\"reference\"><a href=\"#cite_note-pmid11504724-186\">&#91;186&#93;</a></sup><sup id=\"cite_ref-pmid10426999_189-1\" class=\"reference\"><a href=\"#cite_note-pmid10426999-189\">&#91;189&#93;</a></sup></li>\\n<li><a href=\"/wiki/N-myc-interactor\" title=\"N-myc-interactor\">NMI</a><sup id=\"cite_ref-pmid11916966_191-1\" class=\"reference\"><a href=\"#cite_note-pmid11916966-191\">&#91;191&#93;</a></sup></li>\\n<li><a href=\"/wiki/NPM1\" title=\"NPM1\">NPM1</a><sup id=\"cite_ref-pmid15184379_194-0\" class=\"reference\"><a href=\"#cite_note-pmid15184379-194\">&#91;194&#93;</a></sup></li>\\n<li><a href=\"/wiki/Nuclear_receptor_coactivator_2\" title=\"Nuclear receptor coactivator 2\">NCOA2</a><sup id=\"cite_ref-pmid14578343_149-2\" class=\"reference\"><a href=\"#cite_note-pmid14578343-149\">&#91;149&#93;</a></sup><sup id=\"cite_ref-pmid11085509_195-0\" class=\"reference\"><a href=\"#cite_note-pmid11085509-195\">&#91;195&#93;</a></sup></li>\\n<li><a href=\"/wiki/NUFIP1\" title=\"NUFIP1\">NUFIP1</a><sup id=\"cite_ref-pmid15107825_196-0\" class=\"reference\"><a href=\"#cite_note-pmid15107825-196\">&#91;196&#93;</a></sup></li>\\n<li><a href=\"/wiki/P53\" title=\"P53\">P53</a><sup id=\"cite_ref-pmid14636569_145-3\" class=\"reference\"><a href=\"#cite_note-pmid14636569-145\">&#91;145&#93;</a></sup><sup id=\"cite_ref-pmid9926942_161-1\" class=\"reference\"><a href=\"#cite_note-pmid9926942-161\">&#91;161&#93;</a></sup><sup id=\"cite_ref-pmid14710355_197-0\" class=\"reference\"><a href=\"#cite_note-pmid14710355-197\">&#91;197&#93;</a></sup><sup id=\"cite_ref-pmid9482880_198-0\" class=\"reference\"><a href=\"#cite_note-pmid9482880-198\">&#91;198&#93;</a></sup><sup id=\"cite_ref-pmid9582019_199-0\" class=\"reference\"><a href=\"#cite_note-pmid9582019-199\">&#91;199&#93;</a></sup></li>\\n<li><a href=\"/wiki/PALB2\" title=\"PALB2\">PALB2</a><sup id=\"cite_ref-pmid19369211_200-0\" class=\"reference\"><a href=\"#cite_note-pmid19369211-200\">&#91;200&#93;</a></sup></li>\\n<li><a href=\"/wiki/POLR2A\" title=\"POLR2A\">POLR2A</a><sup id=\"cite_ref-pmid11504724_186-3\" class=\"reference\"><a href=\"#cite_note-pmid11504724-186\">&#91;186&#93;</a></sup><sup id=\"cite_ref-pmid9159119_188-1\" class=\"reference\"><a href=\"#cite_note-pmid9159119-188\">&#91;188&#93;</a></sup><sup id=\"cite_ref-pmid14506230_201-0\" class=\"reference\"><a href=\"#cite_note-pmid14506230-201\">&#91;201&#93;</a></sup><sup id=\"cite_ref-pmid12955082_202-0\" class=\"reference\"><a href=\"#cite_note-pmid12955082-202\">&#91;202&#93;</a></sup></li>\\n<li><a href=\"/wiki/PPP1CA\" title=\"PPP1CA\">PPP1CA</a><sup id=\"cite_ref-pmid12438214_203-0\" class=\"reference\"><a href=\"#cite_note-pmid12438214-203\">&#91;203&#93;</a></sup></li>\\n<li><a href=\"/wiki/Rad50\" title=\"Rad50\">Rad50</a><sup id=\"cite_ref-pmid10783165_16-6\" class=\"reference\"><a href=\"#cite_note-pmid10783165-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-pmid11504724_186-4\" class=\"reference\"><a href=\"#cite_note-pmid11504724-186\">&#91;186&#93;</a></sup><sup id=\"cite_ref-pmid10426999_189-2\" class=\"reference\"><a href=\"#cite_note-pmid10426999-189\">&#91;189&#93;</a></sup></li>\\n<li><a href=\"/wiki/RAD51\" title=\"RAD51\">RAD51</a><sup id=\"cite_ref-pmid11498787_39-5\" class=\"reference\"><a href=\"#cite_note-pmid11498787-39\">&#91;39&#93;</a></sup><sup id=\"cite_ref-pmid14636569_145-4\" class=\"reference\"><a href=\"#cite_note-pmid14636569-145\">&#91;145&#93;</a></sup><sup id=\"cite_ref-pmid9774970_146-1\" class=\"reference\"><a href=\"#cite_note-pmid9774970-146\">&#91;146&#93;</a></sup><sup id=\"cite_ref-pmid9008167_204-0\" class=\"reference\"><a href=\"#cite_note-pmid9008167-204\">&#91;204&#93;</a></sup></li>\\n<li><a href=\"/wiki/RBBP4\" title=\"RBBP4\">RBBP4</a><sup id=\"cite_ref-pmid10220405_205-0\" class=\"reference\"><a href=\"#cite_note-pmid10220405-205\">&#91;205&#93;</a></sup></li>\\n<li><a href=\"/wiki/RBBP7\" title=\"RBBP7\">RBBP7</a><sup id=\"cite_ref-pmid10220405_205-1\" class=\"reference\"><a href=\"#cite_note-pmid10220405-205\">&#91;205&#93;</a></sup><sup id=\"cite_ref-pmid11394910_206-0\" class=\"reference\"><a href=\"#cite_note-pmid11394910-206\">&#91;206&#93;</a></sup><sup id=\"cite_ref-pmid11746496_207-0\" class=\"reference\"><a href=\"#cite_note-pmid11746496-207\">&#91;207&#93;</a></sup></li>\\n<li><a href=\"/wiki/RBBP8\" title=\"RBBP8\">RBBP8</a><sup id=\"cite_ref-pmid9738006_208-0\" class=\"reference\"><a href=\"#cite_note-pmid9738006-208\">&#91;208&#93;</a></sup><sup id=\"cite_ref-pmid14578343_149-3\" class=\"reference\"><a href=\"#cite_note-pmid14578343-149\">&#91;149&#93;</a></sup><sup id=\"cite_ref-pmid10196224_209-0\" class=\"reference\"><a href=\"#cite_note-pmid10196224-209\">&#91;209&#93;</a></sup><sup id=\"cite_ref-pmid9811458_210-0\" class=\"reference\"><a href=\"#cite_note-pmid9811458-210\">&#91;210&#93;</a></sup><sup id=\"cite_ref-pmid10910365_211-0\" class=\"reference\"><a href=\"#cite_note-pmid10910365-211\">&#91;211&#93;</a></sup><sup id=\"cite_ref-pmid11689934_212-0\" class=\"reference\"><a href=\"#cite_note-pmid11689934-212\">&#91;212&#93;</a></sup><sup id=\"cite_ref-pmid10764811_213-0\" class=\"reference\"><a href=\"#cite_note-pmid10764811-213\">&#91;213&#93;</a></sup></li>\\n<li><a href=\"/wiki/RELA\" title=\"RELA\">RELA</a><sup id=\"cite_ref-pmid12700228_159-1\" class=\"reference\"><a href=\"#cite_note-pmid12700228-159\">&#91;159&#93;</a></sup></li>\\n<li><a href=\"/wiki/Retinoblastoma_protein\" title=\"Retinoblastoma protein\">RB1</a><sup id=\"cite_ref-pmid10220405_205-2\" class=\"reference\"><a href=\"#cite_note-pmid10220405-205\">&#91;205&#93;</a></sup><sup id=\"cite_ref-pmid11521194_214-0\" class=\"reference\"><a href=\"#cite_note-pmid11521194-214\">&#91;214&#93;</a></sup><sup id=\"cite_ref-pmid10518542_215-0\" class=\"reference\"><a href=\"#cite_note-pmid10518542-215\">&#91;215&#93;</a></sup></li>\\n<li><a href=\"/wiki/Retinoblastoma-like_protein_1\" title=\"Retinoblastoma-like protein 1\">RBL1</a><sup id=\"cite_ref-pmid11521194_214-1\" class=\"reference\"><a href=\"#cite_note-pmid11521194-214\">&#91;214&#93;</a></sup></li>\\n<li><a href=\"/wiki/Retinoblastoma-like_protein_2\" title=\"Retinoblastoma-like protein 2\">RBL2</a><sup id=\"cite_ref-pmid11521194_214-2\" class=\"reference\"><a href=\"#cite_note-pmid11521194-214\">&#91;214&#93;</a></sup></li>\\n<li><a href=\"/wiki/RPL31\" class=\"mw-redirect\" title=\"RPL31\">RPL31</a><sup id=\"cite_ref-pmid11746496_207-1\" class=\"reference\"><a href=\"#cite_note-pmid11746496-207\">&#91;207&#93;</a></sup></li>\\n<li><a href=\"/wiki/SMARCA4\" title=\"SMARCA4\">SMARCA4</a><sup id=\"cite_ref-pmid10943845_216-0\" class=\"reference\"><a href=\"#cite_note-pmid10943845-216\">&#91;216&#93;</a></sup><sup id=\"cite_ref-pmid15034933_217-0\" class=\"reference\"><a href=\"#cite_note-pmid15034933-217\">&#91;217&#93;</a></sup></li>\\n<li><a href=\"/wiki/SMARCB1\" title=\"SMARCB1\">SMARCB1</a><sup id=\"cite_ref-pmid10943845_216-1\" class=\"reference\"><a href=\"#cite_note-pmid10943845-216\">&#91;216&#93;</a></sup></li>\\n<li><a href=\"/wiki/STAT1\" title=\"STAT1\">STAT1</a><sup id=\"cite_ref-pmid10792030_218-0\" class=\"reference\"><a href=\"#cite_note-pmid10792030-218\">&#91;218&#93;</a></sup></li>\\n<li><a href=\"/wiki/TOPBP1\" title=\"TOPBP1\">TOPBP1</a><sup id=\"cite_ref-isbn978-90-481-3471-7_219-0\" class=\"reference\"><a href=\"#cite_note-isbn978-90-481-3471-7-219\">&#91;219&#93;</a></sup></li>\\n<li><a href=\"/wiki/UBE2D1\" title=\"UBE2D1\">UBE2D1</a><sup id=\"cite_ref-pmid12485996_180-1\" class=\"reference\"><a href=\"#cite_note-pmid12485996-180\">&#91;180&#93;</a></sup><sup id=\"cite_ref-pmid12732733_220-0\" class=\"reference\"><a href=\"#cite_note-pmid12732733-220\">&#91;220&#93;</a></sup><sup id=\"cite_ref-pmid14638690_221-0\" class=\"reference\"><a href=\"#cite_note-pmid14638690-221\">&#91;221&#93;</a></sup><sup id=\"cite_ref-pmid12438698_222-0\" class=\"reference\"><a href=\"#cite_note-pmid12438698-222\">&#91;222&#93;</a></sup><sup id=\"cite_ref-pmid11927591_181-1\" class=\"reference\"><a href=\"#cite_note-pmid11927591-181\">&#91;181&#93;</a></sup><sup id=\"cite_ref-pmid14636569_145-5\" class=\"reference\"><a href=\"#cite_note-pmid14636569-145\">&#91;145&#93;</a></sup><sup id=\"cite_ref-pmid15184379_194-1\" class=\"reference\"><a href=\"#cite_note-pmid15184379-194\">&#91;194&#93;</a></sup><sup id=\"cite_ref-pmid12887909_177-1\" class=\"reference\"><a href=\"#cite_note-pmid12887909-177\">&#91;177&#93;</a></sup><sup id=\"cite_ref-pmid12890688_223-0\" class=\"reference\"><a href=\"#cite_note-pmid12890688-223\">&#91;223&#93;</a></sup><sup id=\"cite_ref-pmid11278247_224-0\" class=\"reference\"><a href=\"#cite_note-pmid11278247-224\">&#91;224&#93;</a></sup></li>\\n<li><a href=\"/wiki/USF2\" title=\"USF2\">USF2</a><sup id=\"cite_ref-pmid14502648_225-0\" class=\"reference\"><a href=\"#cite_note-pmid14502648-225\">&#91;225&#93;</a></sup></li>\\n<li><a href=\"/wiki/Valosin-containing_protein\" title=\"Valosin-containing protein\">VCP</a><sup id=\"cite_ref-pmid10855792_226-0\" class=\"reference\"><a href=\"#cite_note-pmid10855792-226\">&#91;226&#93;</a></sup></li>\\n<li><a href=\"/wiki/XIST_(gene)\" class=\"mw-redirect\" title=\"XIST (gene)\">XIST</a><sup id=\"cite_ref-pmid15065664_227-0\" class=\"reference\"><a href=\"#cite_note-pmid15065664-227\">&#91;227&#93;</a></sup><sup id=\"cite_ref-pmid12419249_228-0\" class=\"reference\"><a href=\"#cite_note-pmid12419249-228\">&#91;228&#93;</a></sup></li>\\n<li><a href=\"/wiki/ZNF350\" title=\"ZNF350\">ZNF350</a><sup id=\"cite_ref-pmid11090615_229-0\" class=\"reference\"><a href=\"#cite_note-pmid11090615-229\">&#91;229&#93;</a></sup></li></ul>\\n</div>\\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=21\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<style data-mw-deduplicate=\"TemplateStyles:r1011085734\">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class=\"reflist reflist-columns references-column-width\" style=\"column-width: 30em;\">\\n<ol class=\"references\">\\n<li id=\"cite_note-refGRCh38Ensembl-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-refGRCh38Ensembl_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-refGRCh38Ensembl_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-refGRCh38Ensembl_1-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000012048\">GRCh38: Ensembl release 89: ENSG00000012048</a> - <a href=\"/wiki/Ensembl_genome_database_project\" title=\"Ensembl genome database project\">Ensembl</a>, May 2017</span>\\n</li>\\n<li id=\"cite_note-refGRCm38Ensembl-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-refGRCm38Ensembl_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-refGRCm38Ensembl_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-refGRCm38Ensembl_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000017146\">GRCm38: Ensembl release 89: ENSMUSG00000017146</a> - <a href=\"/wiki/Ensembl_genome_database_project\" title=\"Ensembl genome database project\">Ensembl</a>, May 2017</span>\\n</li>\\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><style data-mw-deduplicate=\"TemplateStyles:r1133582631\">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:\"\\\\\"\"\"\\\\\"\"\"\\'\"\"\\'\"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url(\"//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url(\"//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url(\"//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url(\"//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg\")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=Link&amp;LinkName=gene_pubmed&amp;from_uid=672\">\"Human PubMed Reference:\"</a>. <i>National Center for Biotechnology Information, U.S. National Library of Medicine</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Center+for+Biotechnology+Information%2C+U.S.+National+Library+of+Medicine&amp;rft.atitle=Human+PubMed+Reference%3A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3Fdb%3Dgene%26cmd%3DLink%26LinkName%3Dgene_pubmed%26from_uid%3D672&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=Link&amp;LinkName=gene_pubmed&amp;from_uid=12189\">\"Mouse PubMed Reference:\"</a>. <i>National Center for Biotechnology Information, U.S. National Library of Medicine</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Center+for+Biotechnology+Information%2C+U.S.+National+Library+of+Medicine&amp;rft.atitle=Mouse+PubMed+Reference%3A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3Fdb%3Dgene%26cmd%3DLink%26LinkName%3Dgene_pubmed%26from_uid%3D12189&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHamel2007\" class=\"citation web cs1\">Hamel PJ (2007-05-29). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.healthcentral.com/breast-cancer/c/78/9925/brca1-brca2\">\"BRCA1 and BRCA2: No Longer the Only Troublesome Genes Out There\"</a>. HealthCentral<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-07-02</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BRCA1+and+BRCA2%3A+No+Longer+the+Only+Troublesome+Genes+Out+There&amp;rft.pub=HealthCentral&amp;rft.date=2007-05-29&amp;rft.aulast=Hamel&amp;rft.aufirst=PJ&amp;rft_id=http%3A%2F%2Fwww.healthcentral.com%2Fbreast-cancer%2Fc%2F78%2F9925%2Fbrca1-brca2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Ensembl-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ensembl_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ensembl_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ensembl.org/Multi/GeneTree/Image?gt=ENSGT00440000034289\">\"BRCA1 gene tree\"</a>. Ensembl.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BRCA1+gene+tree&amp;rft.pub=Ensembl&amp;rft_id=http%3A%2F%2Fwww.ensembl.org%2FMulti%2FGeneTree%2FImage%3Fgt%3DENSGT00440000034289&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10193517-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10193517_7-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFDuncanReevesCooke1998\" class=\"citation journal cs1\">Duncan JA, Reeves JR, Cooke TG (October 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC395646\">\"BRCA1 and BRCA2 proteins: roles in health and disease\"</a>. <i>Molecular Pathology</i>. <b>51</b> (5): 237\\xe2\\x80\\x9347. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1136%2Fmp.51.5.237\">10.1136/mp.51.5.237</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC395646\">395646</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10193517\">10193517</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Pathology&amp;rft.atitle=BRCA1+and+BRCA2+proteins%3A+roles+in+health+and+disease&amp;rft.volume=51&amp;rft.issue=5&amp;rft.pages=237-47&amp;rft.date=1998-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC395646%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10193517&amp;rft_id=info%3Adoi%2F10.1136%2Fmp.51.5.237&amp;rft.aulast=Duncan&amp;rft.aufirst=JA&amp;rft.au=Reeves%2C+JR&amp;rft.au=Cooke%2C+TG&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC395646&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15546503-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15546503_8-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYoshidaMiki2004\" class=\"citation journal cs1\">Yoshida K, Miki Y (November 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1349-7006.2004.tb02195.x\">\"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage\"</a>. <i>Cancer Science</i>. <b>95</b> (11): 866\\xe2\\x80\\x9371. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1349-7006.2004.tb02195.x\">10.1111/j.1349-7006.2004.tb02195.x</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15546503\">15546503</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:24297965\">24297965</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Science&amp;rft.atitle=Role+of+BRCA1+and+BRCA2+as+regulators+of+DNA+repair%2C+transcription%2C+and+cell+cycle+in+response+to+DNA+damage&amp;rft.volume=95&amp;rft.issue=11&amp;rft.pages=866-71&amp;rft.date=2004-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24297965%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15546503&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1349-7006.2004.tb02195.x&amp;rft.aulast=Yoshida&amp;rft.aufirst=K&amp;rft.au=Miki%2C+Y&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fj.1349-7006.2004.tb02195.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-CAP-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-CAP_9-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFCheck2006\" class=\"citation web cs1\">Check W (2006-09-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cap.org/apps/cap.portal?_nfpb=true&amp;cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&amp;_windowLabel=cntvwrPtlt&amp;cntvwrPtlt{actionForm.contentReference}=cap_today%2Ffeature_stories%2F0906BRCA.html&amp;_state=maximized&amp;_pageLabel=cntvwr\">\"BRCA: What we know now\"</a>. College of American Pathologists<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-08-23</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BRCA%3A+What+we+know+now&amp;rft.pub=College+of+American+Pathologists&amp;rft.date=2006-09-01&amp;rft.aulast=Check&amp;rft.aufirst=W&amp;rft_id=http%3A%2F%2Fwww.cap.org%2Fapps%2Fcap.portal%3F_nfpb%3Dtrue%26cntvwrPtlt_actionOverride%3D%252Fportlets%252FcontentViewer%252Fshow%26_windowLabel%3DcntvwrPtlt%26cntvwrPtlt%7BactionForm.contentReference%7D%3Dcap_today%252Ffeature_stories%252F0906BRCA.html%26_state%3Dmaximized%26_pageLabel%3Dcntvwr&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Irminger-Finger_2016-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Irminger-Finger_2016_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Irminger-Finger_2016_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFIrminger-FingerRatajskaPilyugin2016\" class=\"citation journal cs1\">Irminger-Finger I, Ratajska M, Pilyugin M (2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.biocel.2015.12.008\">\"New concepts on BARD1: Regulator of BRCA pathways and beyond\"</a>. <i>The International Journal of Biochemistry &amp; Cell Biology</i>. <b>72</b>: 1\\xe2\\x80\\x9317. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.biocel.2015.12.008\">10.1016/j.biocel.2015.12.008</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/26738429\">26738429</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+International+Journal+of+Biochemistry+%26+Cell+Biology&amp;rft.atitle=New+concepts+on+BARD1%3A+Regulator+of+BRCA+pathways+and+beyond&amp;rft.volume=72&amp;rft.pages=1-17&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.1016%2Fj.biocel.2015.12.008&amp;rft_id=info%3Apmid%2F26738429&amp;rft.aulast=Irminger-Finger&amp;rft.aufirst=I&amp;rft.au=Ratajska%2C+M&amp;rft.au=Pilyugin%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.biocel.2015.12.008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Friedenson2007-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Friedenson2007_11-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFFriedenson2007\" class=\"citation journal cs1\">Friedenson B (August 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959234\">\"The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers\"</a>. <i>BMC Cancer</i>. <b>7</b>: 152\\xe2\\x80\\x93162. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186%2F1471-2407-7-152\">10.1186/1471-2407-7-152</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959234\">1959234</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17683622\">17683622</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Cancer&amp;rft.atitle=The+BRCA1%2F2+pathway+prevents+hematologic+cancers+in+addition+to+breast+and+ovarian+cancers&amp;rft.volume=7&amp;rft.pages=152-162&amp;rft.date=2007-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1959234%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17683622&amp;rft_id=info%3Adoi%2F10.1186%2F1471-2407-7-152&amp;rft.aulast=Friedenson&amp;rft.aufirst=B&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1959234&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-scivee.tv-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-scivee.tv_12-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFFriedenson2008\" class=\"citation web cs1\">Friedenson B (2008-06-08). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.scivee.tv/node/6090\">\"Breast cancer genes protect against some leukemias and lymphomas\"</a> <span class=\"cs1-format\">(video)</span>. SciVee.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Breast+cancer+genes+protect+against+some+leukemias+and+lymphomas&amp;rft.pub=SciVee&amp;rft.date=2008-06-08&amp;rft.aulast=Friedenson&amp;rft.aufirst=B&amp;rft_id=http%3A%2F%2Fwww.scivee.tv%2Fnode%2F6090&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-urlBreast_and_Ovarian_Cancer_Genetic_Screening-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlBreast_and_Ovarian_Cancer_Genetic_Screening_13-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pamf.org/health/guidelines/geneticscreening.html\">\"Breast and Ovarian Cancer Genetic Screening\"</a>. Palo Alto Medical Foundation. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20081004080235/http://www.pamf.org/health/guidelines/geneticscreening.html\">Archived</a> from the original on 4 October 2008<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-10-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Breast+and+Ovarian+Cancer+Genetic+Screening&amp;rft.pub=Palo+Alto+Medical+Foundation&amp;rft_id=http%3A%2F%2Fwww.pamf.org%2Fhealth%2Fguidelines%2Fgeneticscreening.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid17683622-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid17683622_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid17683622_14-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid17683622_14-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFFriedenson2007\" class=\"citation journal cs1\">Friedenson B (2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959234\">\"The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers\"</a>. <i>BMC Cancer</i>. <b>7</b>: 152. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186%2F1471-2407-7-152\">10.1186/1471-2407-7-152</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959234\">1959234</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17683622\">17683622</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Cancer&amp;rft.atitle=The+BRCA1%2F2+pathway+prevents+hematologic+cancers+in+addition+to+breast+and+ovarian+cancers&amp;rft.volume=7&amp;rft.pages=152&amp;rft.date=2007&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1959234%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17683622&amp;rft_id=info%3Adoi%2F10.1186%2F1471-2407-7-152&amp;rft.aulast=Friedenson&amp;rft.aufirst=B&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1959234&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-O&#39;Donovan_2010-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-O&#39;Donovan_2010_15-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFO&#39;DonovanLivingston2010\" class=\"citation journal cs1\">O\\'Donovan PJ, Livingston DM (April 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fcarcin%2Fbgq069\">\"BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair\"</a>. <i>Carcinogenesis</i>. <b>31</b> (6): 961\\xe2\\x80\\x937. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fcarcin%2Fbgq069\">10.1093/carcin/bgq069</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/20400477\">20400477</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Carcinogenesis&amp;rft.atitle=BRCA1+and+BRCA2%3A+breast%2Fovarian+cancer+susceptibility+gene+products+and+participants+in+DNA+double-strand+break+repair&amp;rft.volume=31&amp;rft.issue=6&amp;rft.pages=961-7&amp;rft.date=2010-04&amp;rft_id=info%3Adoi%2F10.1093%2Fcarcin%2Fbgq069&amp;rft_id=info%3Apmid%2F20400477&amp;rft.aulast=O%27Donovan&amp;rft.aufirst=PJ&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fcarcin%252Fbgq069&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10783165-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10783165_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWangCortezYazdiNeff2000\" class=\"citation journal cs1\">Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J (April 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC316544\">\"BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures\"</a>. <i>Genes Dev</i>. <b>14</b> (8): 927\\xe2\\x80\\x9339. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2Fgad.14.8.927\">10.1101/gad.14.8.927</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC316544\">316544</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10783165\">10783165</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes+Dev.&amp;rft.atitle=BASC%2C+a+super+complex+of+BRCA1-associated+proteins+involved+in+the+recognition+and+repair+of+aberrant+DNA+structures&amp;rft.volume=14&amp;rft.issue=8&amp;rft.pages=927-39&amp;rft.date=2000-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC316544%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10783165&amp;rft_id=info%3Adoi%2F10.1101%2Fgad.14.8.927&amp;rft.aulast=Wang&amp;rft.aufirst=Y&amp;rft.au=Cortez%2C+D&amp;rft.au=Yazdi%2C+P&amp;rft.au=Neff%2C+N&amp;rft.au=Elledge%2C+SJ&amp;rft.au=Qin%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC316544&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Starita2003-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Starita2003_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Starita2003_17-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFStaritaParvin2003\" class=\"citation journal cs1\">Starita LM, Parvin JD (2003). \"The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair\". <i>Current Opinion in Cell Biology</i>. <b>15</b> (3): 345\\xe2\\x80\\x93350. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0955-0674%2803%2900042-5\">10.1016/S0955-0674(03)00042-5</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12787778\">12787778</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Cell+Biology&amp;rft.atitle=The+multiple+nuclear+functions+of+BRCA1%3A+transcription%2C+ubiquitination+and+DNA+repair&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=345-350&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1016%2FS0955-0674%2803%2900042-5&amp;rft_id=info%3Apmid%2F12787778&amp;rft.aulast=Starita&amp;rft.aufirst=LM&amp;rft.au=Parvin%2C+JD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-US_5747282-18\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-US_5747282_18-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-US_5747282_18-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-US_5747282_18-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><style data-mw-deduplicate=\"TemplateStyles:r1041539562\">.mw-parser-output .citation{word-wrap:break-word}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}</style><span class=\"citation patent\" id=\"CITEREFSkolnick_HS,_Goldgar_DE,_Miki_Y,_Swenson_J,_Kamb_A,_Harshman_KD,_Shattuck-Eidens_DM,_Tavtigian_SV,_Wiseman_RW,_Futreal_PA1998\"><a rel=\"nofollow\" class=\"external text\" href=\"https://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=US5747282\">US&#32;patent 5747282</a>,&#32;Skolnick HS, Goldgar DE, Miki Y, Swenson J, Kamb A, Harshman KD, Shattuck-Eidens DM, Tavtigian SV, Wiseman RW, Futreal PA,&#32;\"7Q-linked breast and ovarian cancer susceptibility gene\",&#32;issued 1998-05-05,&#32; assigned to Myriad Genetics, Inc., The United States of America as represented by the Secretary of Health and Human Services,&#32;and University of Utah Research Foundation</span><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&amp;rft.number=5747282&amp;rft.cc=US&amp;rft.title=7Q-linked+breast+and+ovarian+cancer+susceptibility+gene&amp;rft.inventor=Skolnick+HS%2C+Goldgar+DE%2C+Miki+Y%2C+Swenson+J%2C+Kamb+A%2C+Harshman+KD%2C+Shattuck-Eidens+DM%2C+Tavtigian+SV%2C+Wiseman+RW%2C+Futreal+PA&amp;rft.assignee=Myriad+Genetics%2C+Inc.%2C+The+United+States+of+America+as+represented+by+the+Secretary+of+Health+and+Human+Services%2C&amp;rft.date=1998-05-05&amp;rft.appldate=1995-06-07\"><span style=\"display: none;\">&#160;</span></span></span>\\n</li>\\n<li id=\"cite_note-US_5837492-19\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-US_5837492_19-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-US_5837492_19-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1041539562\"/><span class=\"citation patent\" id=\"CITEREFTavtigian_SV,_Kamb_A,_Simard_J,_Couch_F,_Rommens_JM,_Weber_BL1998\"><a rel=\"nofollow\" class=\"external text\" href=\"https://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=US5837492\">US&#32;patent 5837492</a>,&#32;Tavtigian SV, Kamb A, Simard J, Couch F, Rommens JM, Weber BL,&#32;\"Chromosome 13-linked breast cancer susceptibility gene\",&#32;issued 1998-11-17,&#32; assigned to Myriad Genetics, Inc., Endo Recherche, Inc., HSC Research &amp; Development Limited Partnership, Trustees of the University of Pennsylvania</span><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&amp;rft.number=5837492&amp;rft.cc=US&amp;rft.title=Chromosome+13-linked+breast+cancer+susceptibility+gene&amp;rft.inventor=Tavtigian+SV%2C+Kamb+A%2C+Simard+J%2C+Couch+F%2C+Rommens+JM%2C+Weber+BL&amp;rft.assignee=Myriad+Genetics%2C+Inc.%2C+Endo+Recherche%2C+Inc.%2C+HSC+Research+%26+Development+Limited+Partnership%2C+Trustees+of+the+University+of+Pennsylvania&amp;rft.date=1998-11-17&amp;rft.appldate=1996-04-29\"><span style=\"display: none;\">&#160;</span></span></span>\\n</li>\\n<li id=\"cite_note-MyriadInvestorPage-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-MyriadInvestorPage_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-MyriadInvestorPage_20-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://investor.myriad.com/index.cfm\">Myriad Investor Page\\xe2\\x80\\x94see \"Myriad at a glance\"</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20121018224334/http://investor.myriad.com/index.cfm\">Archived</a> 2012-10-18 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a> accessed October 2012</span>\\n</li>\\n<li id=\"cite_note-SchwartzNYTimes-21\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SchwartzNYTimes_21-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SchwartzNYTimes_21-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-SchwartzNYTimes_21-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSchwartz2009\" class=\"citation web cs1\">Schwartz J (2009-05-12). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2009/05/13/health/13patent.html\">\"Cancer Patients Challenge the Patenting of a Gene\"</a>. <i>The New York Times</i>. Health.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Cancer+Patients+Challenge+the+Patenting+of+a+Gene&amp;rft.date=2009-05-12&amp;rft.aulast=Schwartz&amp;rft.aufirst=J&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F05%2F13%2Fhealth%2F13patent.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid2270482-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid2270482_22-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHallLeeNewmanMorrow1990\" class=\"citation journal cs1\">Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (December 1990). \"Linkage of early-onset familial breast cancer to chromosome 17q21\". <i>Science</i>. <b>250</b> (4988): 1684\\xe2\\x80\\x939. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1990Sci...250.1684H\">1990Sci...250.1684H</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.2270482\">10.1126/science.2270482</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/2270482\">2270482</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Linkage+of+early-onset+familial+breast+cancer+to+chromosome+17q21&amp;rft.volume=250&amp;rft.issue=4988&amp;rft.pages=1684-9&amp;rft.date=1990-12&amp;rft_id=info%3Apmid%2F2270482&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.2270482&amp;rft_id=info%3Abibcode%2F1990Sci...250.1684H&amp;rft.aulast=Hall&amp;rft.aufirst=JM&amp;rft.au=Lee%2C+MK&amp;rft.au=Newman%2C+B&amp;rft.au=Morrow%2C+JE&amp;rft.au=Anderson%2C+LA&amp;rft.au=Huey%2C+B&amp;rft.au=King%2C+MC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://scienceblog.cancerresearchuk.org/2012/02/28/high-impact-science-tracking-down-the-brca-genes-part-1/\">High-Impact Science: Tracking down the BRCA genes (Part 1)</a> \\xe2\\x80\\x93 Cancer Research UK science blog, 2012</span>\\n</li>\\n<li id=\"cite_note-pmid7545954-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid7545954_24-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFMikiSwensenShattuck-EidensFutreal1994\" class=\"citation journal cs1\">Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W (October 1994). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.7545954\">\"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1\"</a>. <i>Science</i>. <b>266</b> (5182): 66\\xe2\\x80\\x9371. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1994Sci...266...66M\">1994Sci...266...66M</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.7545954\">10.1126/science.7545954</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/7545954\">7545954</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=A+strong+candidate+for+the+breast+and+ovarian+cancer+susceptibility+gene+BRCA1&amp;rft.volume=266&amp;rft.issue=5182&amp;rft.pages=66-71&amp;rft.date=1994-10&amp;rft_id=info%3Apmid%2F7545954&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.7545954&amp;rft_id=info%3Abibcode%2F1994Sci...266...66M&amp;rft.aulast=Miki&amp;rft.aufirst=Y&amp;rft.au=Swensen%2C+J&amp;rft.au=Shattuck-Eidens%2C+D&amp;rft.au=Futreal%2C+PA&amp;rft.au=Harshman%2C+K&amp;rft.au=Tavtigian%2C+S&amp;rft.au=Liu%2C+Q&amp;rft.au=Cochran%2C+C&amp;rft.au=Bennett%2C+LM&amp;rft.au=Ding%2C+W&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1126%252Fscience.7545954&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\">National Center for Biotechnology Information, U.S. National Library of Medicine  <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/gene/672\">EntrezGene reference information for BRCA1 breast cancer 1, early onset (Homo sapiens)</a></span>\\n</li>\\n<li id=\"cite_note-pmid9553742-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9553742_26-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPaterson1998\" class=\"citation journal cs1\">Paterson JW (February 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1155%2F1998%2F298530\">\"BRCA1: a review of structure and putative functions\"</a>. <i>Dis. Markers</i>. <b>13</b> (4): 261\\xe2\\x80\\x9374. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1155%2F1998%2F298530\">10.1155/1998/298530</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9553742\">9553742</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Dis.+Markers&amp;rft.atitle=BRCA1%3A+a+review+of+structure+and+putative+functions&amp;rft.volume=13&amp;rft.issue=4&amp;rft.pages=261-74&amp;rft.date=1998-02&amp;rft_id=info%3Adoi%2F10.1155%2F1998%2F298530&amp;rft_id=info%3Apmid%2F9553742&amp;rft.aulast=Paterson&amp;rft.aufirst=JW&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1155%252F1998%252F298530&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid16108063-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16108063_27-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHenderson2005\" class=\"citation journal cs1\">Henderson BR (September 2005). \"Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking\". <i>BioEssays</i>. <b>27</b> (9): 884\\xe2\\x80\\x9393. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fbies.20277\">10.1002/bies.20277</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/16108063\">16108063</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:10138907\">10138907</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioEssays&amp;rft.atitle=Regulation+of+BRCA1%2C+BRCA2+and+BARD1+intracellular+trafficking&amp;rft.volume=27&amp;rft.issue=9&amp;rft.pages=884-93&amp;rft.date=2005-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A10138907%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16108063&amp;rft_id=info%3Adoi%2F10.1002%2Fbies.20277&amp;rft.aulast=Henderson&amp;rft.aufirst=BR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><span class=\"plain links\">Universal protein resource accession number <a rel=\"nofollow\" class=\"external text\" href=\"https://www.uniprot.org/uniprot/P38398\">P38398</a> for \"Breast cancer type 1 susceptibility protein\" at <a href=\"/wiki/UniProt\" title=\"UniProt\">UniProt</a>.</span></span>\\n</li>\\n<li id=\"cite_note-pmid22737296-29\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid22737296_29-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid22737296_29-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFClarkRodriguezSnyderHankins2012\" class=\"citation journal cs1\">Clark SL, Rodriguez AM, Snyder RR, Hankins GD, Boehning D (April 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380633\">\"Structure-Function Of The Tumor Suppressor BRCA1\"</a>. <i>Comput Struct Biotechnol J</i>. <b>1</b> (1): e201204005. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.5936%2Fcsbj.201204005\">10.5936/csbj.201204005</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380633\">3380633</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22737296\">22737296</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Comput+Struct+Biotechnol+J&amp;rft.atitle=Structure-Function+Of+The+Tumor+Suppressor+BRCA1&amp;rft.volume=1&amp;rft.issue=1&amp;rft.pages=e201204005&amp;rft.date=2012-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3380633%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22737296&amp;rft_id=info%3Adoi%2F10.5936%2Fcsbj.201204005&amp;rft.aulast=Clark&amp;rft.aufirst=SL&amp;rft.au=Rodriguez%2C+AM&amp;rft.au=Snyder%2C+RR&amp;rft.au=Hankins%2C+GD&amp;rft.au=Boehning%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3380633&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11573085-30\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11573085_30-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11573085_30-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11573085_30-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid11573085_30-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBrzovicRajagopalHoytKing2001\" class=\"citation journal cs1\">Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE (October 2001). \"Structure of a BRCA1-BARD1 heterodimeric RING-RING complex\". <i>Nature Structural &amp; Molecular Biology</i>. <b>8</b> (10): 833\\xe2\\x80\\x937. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fnsb1001-833\">10.1038/nsb1001-833</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11573085\">11573085</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:37617901\">37617901</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.atitle=Structure+of+a+BRCA1-BARD1+heterodimeric+RING-RING+complex&amp;rft.volume=8&amp;rft.issue=10&amp;rft.pages=833-7&amp;rft.date=2001-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A37617901%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11573085&amp;rft_id=info%3Adoi%2F10.1038%2Fnsb1001-833&amp;rft.aulast=Brzovic&amp;rft.aufirst=PS&amp;rft.au=Rajagopal%2C+P&amp;rft.au=Hoyt%2C+DW&amp;rft.au=King%2C+MC&amp;rft.au=Klevit%2C+RE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11573079-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11573079_31-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBaer2001\" class=\"citation journal cs1\">Baer R (October 2001). \"With the ends in sight: images from the BRCA1 tumor suppressor\". <i>Nature Structural &amp; Molecular Biology</i>. <b>8</b> (10): 822\\xe2\\x80\\x934. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fnsb1001-822\">10.1038/nsb1001-822</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11573079\">11573079</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:20552445\">20552445</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.atitle=With+the+ends+in+sight%3A+images+from+the+BRCA1+tumor+suppressor&amp;rft.volume=8&amp;rft.issue=10&amp;rft.pages=822-4&amp;rft.date=2001-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20552445%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11573079&amp;rft_id=info%3Adoi%2F10.1038%2Fnsb1001-822&amp;rft.aulast=Baer&amp;rft.aufirst=R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Williams_2001-32\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Williams_2001_32-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Williams_2001_32-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWilliamsGreenGlover2001\" class=\"citation journal cs1\">Williams RS, Green R, Glover JN (October 2001). \"Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1\". <i>Nature Structural &amp; Molecular Biology</i>. <b>8</b> (10): 838\\xe2\\x80\\x9342. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fnsb1001-838\">10.1038/nsb1001-838</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11573086\">11573086</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:19275284\">19275284</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.atitle=Crystal+structure+of+the+BRCT+repeat+region+from+the+breast+cancer-associated+protein+BRCA1&amp;rft.volume=8&amp;rft.issue=10&amp;rft.pages=838-42&amp;rft.date=2001-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19275284%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11573086&amp;rft_id=info%3Adoi%2F10.1038%2Fnsb1001-838&amp;rft.aulast=Williams&amp;rft.aufirst=RS&amp;rft.au=Green%2C+R&amp;rft.au=Glover%2C+JN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10946236-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10946236_33-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHuytonBatesZhangSternberg2000\" class=\"citation journal cs1\">Huyton T, Bates PA, Zhang X, Sternberg MJ, Freemont PS (August 2000). \"The BRCA1 C-terminal domain: structure and function\". <i>Mutat. Res</i>. <b>460</b> (3\\xe2\\x80\\x934): 319\\xe2\\x80\\x9332. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0921-8777%2800%2900034-3\">10.1016/S0921-8777(00)00034-3</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10946236\">10946236</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mutat.+Res.&amp;rft.atitle=The+BRCA1+C-terminal+domain%3A+structure+and+function&amp;rft.volume=460&amp;rft.issue=3%E2%80%934&amp;rft.pages=319-32&amp;rft.date=2000-08&amp;rft_id=info%3Adoi%2F10.1016%2FS0921-8777%2800%2900034-3&amp;rft_id=info%3Apmid%2F10946236&amp;rft.aulast=Huyton&amp;rft.aufirst=T&amp;rft.au=Bates%2C+PA&amp;rft.au=Zhang%2C+X&amp;rft.au=Sternberg%2C+MJ&amp;rft.au=Freemont%2C+PS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11877378-34\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11877378_34-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11877378_34-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFJooJeffreyCantorFinnin2002\" class=\"citation journal cs1\">Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP (March 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155350\">\"Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure\"</a>. <i>Genes Dev</i>. <b>16</b> (5): 583\\xe2\\x80\\x9393. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2Fgad.959202\">10.1101/gad.959202</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155350\">155350</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11877378\">11877378</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes+Dev.&amp;rft.atitle=Structure+of+the+53BP1+BRCT+region+bound+to+p53+and+its+comparison+to+the+Brca1+BRCT+structure&amp;rft.volume=16&amp;rft.issue=5&amp;rft.pages=583-93&amp;rft.date=2002-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC155350%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11877378&amp;rft_id=info%3Adoi%2F10.1101%2Fgad.959202&amp;rft.aulast=Joo&amp;rft.aufirst=WS&amp;rft.au=Jeffrey%2C+PD&amp;rft.au=Cantor%2C+SB&amp;rft.au=Finnin%2C+MS&amp;rft.au=Livingston%2C+DM&amp;rft.au=Pavletich%2C+NP&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC155350&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Sawyer_2014-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Sawyer_2014_35-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSawyerTianKahkonenSchwartzentruber2014\" class=\"citation journal cs1\">Sawyer SL, Tian L, Kahkonen M, Schwartzentruber J, Kircher M, Majewski J, Dyment DA, Innes AM, Boycott KM, Moreau LA, Moilanen JS, Greenberg RA (2014). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320660\">\"Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype\"</a>. <i>Cancer Discov</i>. <b>5</b> (2): 135\\xe2\\x80\\x9342. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F2159-8290.CD-14-1156\">10.1158/2159-8290.CD-14-1156</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320660\">4320660</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/25472942\">25472942</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Discov&amp;rft.atitle=Biallelic+Mutations+in+BRCA1+Cause+a+New+Fanconi+Anemia+Subtype&amp;rft.volume=5&amp;rft.issue=2&amp;rft.pages=135-42&amp;rft.date=2014&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4320660%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25472942&amp;rft_id=info%3Adoi%2F10.1158%2F2159-8290.CD-14-1156&amp;rft.aulast=Sawyer&amp;rft.aufirst=SL&amp;rft.au=Tian%2C+L&amp;rft.au=Kahkonen%2C+M&amp;rft.au=Schwartzentruber%2C+J&amp;rft.au=Kircher%2C+M&amp;rft.au=Majewski%2C+J&amp;rft.au=Dyment%2C+DA&amp;rft.au=Innes%2C+AM&amp;rft.au=Boycott%2C+KM&amp;rft.au=Moreau%2C+LA&amp;rft.au=Moilanen%2C+JS&amp;rft.au=Greenberg%2C+RA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4320660&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20180212073520/http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/D/DNArepair.html#DSBs\">\"Kimball\\'s Biologh Pages\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/D/DNArepair.html#DSBs\">the original</a> on 2018-02-12<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-02-25</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Kimball%27s+Biologh+Pages&amp;rft_id=http%3A%2F%2Fusers.rcn.com%2Fjkimball.ma.ultranet%2FBiologyPages%2FD%2FDNArepair.html%23DSBs&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Domchek_2013-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Domchek_2013_37-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFDomchekTangStopferLilli2013\" class=\"citation journal cs1\">Domchek SM, Tang J, Stopfer J, Lilli DR, Hamel N, Tischkowitz M,  et&#160;al. (April 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625496\">\"Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer\"</a>. <i>Cancer Discovery</i>. <b>3</b> (4): 399\\xe2\\x80\\x93405. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F2159-8290.CD-12-0421\">10.1158/2159-8290.CD-12-0421</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625496\">3625496</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/23269703\">23269703</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Discovery&amp;rft.atitle=Biallelic+deleterious+BRCA1+mutations+in+a+woman+with+early-onset+ovarian+cancer&amp;rft.volume=3&amp;rft.issue=4&amp;rft.pages=399-405&amp;rft.date=2013-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3625496%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23269703&amp;rft_id=info%3Adoi%2F10.1158%2F2159-8290.CD-12-0421&amp;rft.aulast=Domchek&amp;rft.aufirst=SM&amp;rft.au=Tang%2C+J&amp;rft.au=Stopfer%2C+J&amp;rft.au=Lilli%2C+DR&amp;rft.au=Hamel%2C+N&amp;rft.au=Tischkowitz%2C+M&amp;rft.au=Monteiro%2C+AN&amp;rft.au=Messick%2C+TE&amp;rft.au=Powers%2C+J&amp;rft.au=Yonker%2C+A&amp;rft.au=Couch%2C+FJ&amp;rft.au=Goldgar%2C+DE&amp;rft.au=Davidson%2C+HR&amp;rft.au=Nathanson%2C+KL&amp;rft.au=Foulkes%2C+WD&amp;rft.au=Greenberg%2C+RA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3625496&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid17052168-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17052168_38-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBoulton2006\" class=\"citation journal cs1\">Boulton SJ (November 2006). \"Cellular functions of the BRCA tumour-suppressor proteins\". <i>Biochem. Soc. Trans</i>. <b>34</b> (Pt 5): 633\\xe2\\x80\\x9345. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1042%2FBST0340633\">10.1042/BST0340633</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17052168\">17052168</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochem.+Soc.+Trans.&amp;rft.atitle=Cellular+functions+of+the+BRCA+tumour-suppressor+proteins&amp;rft.volume=34&amp;rft.issue=Pt+5&amp;rft.pages=633-45&amp;rft.date=2006-11&amp;rft_id=info%3Adoi%2F10.1042%2FBST0340633&amp;rft_id=info%3Apmid%2F17052168&amp;rft.aulast=Boulton&amp;rft.aufirst=SJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11498787-39\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11498787_39-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWangZhangGuerretteChen2001\" class=\"citation journal cs1\">Wang Q, Zhang H, Guerrette S, Chen J, Mazurek A, Wilson T, Slupianek A, Skorski T, Fishel R, Greene MI (August 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204625\">\"Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1\"</a>. <i>Oncogene</i>. <b>20</b> (34): 4640\\xe2\\x80\\x939. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204625\">10.1038/sj.onc.1204625</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11498787\">11498787</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Adenosine+nucleotide+modulates+the+physical+interaction+between+hMSH2+and+BRCA1&amp;rft.volume=20&amp;rft.issue=34&amp;rft.pages=4640-9&amp;rft.date=2001-08&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1204625&amp;rft_id=info%3Apmid%2F11498787&amp;rft.aulast=Wang&amp;rft.aufirst=Q&amp;rft.au=Zhang%2C+H&amp;rft.au=Guerrette%2C+S&amp;rft.au=Chen%2C+J&amp;rft.au=Mazurek%2C+A&amp;rft.au=Wilson%2C+T&amp;rft.au=Slupianek%2C+A&amp;rft.au=Skorski%2C+T&amp;rft.au=Fishel%2C+R&amp;rft.au=Greene%2C+MI&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1204625&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid22366898-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22366898_40-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWarmoesJaspersPhamPiersma2012\" class=\"citation journal cs1\">Warmoes M, Jaspers JE, Pham TV, Piersma SR, Oudgenoeg G, Massink MP, Waisfisz Q, Rottenberg S, Boven E, Jonkers J, Jimenez CR (July 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394939\">\"Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer\"</a>. <i>Mol. Cell. Proteomics</i>. <b>11</b> (7): M111.013334-1-M111.013334-19. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fmcp.M111.013334\">10.1074/mcp.M111.013334</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394939\">3394939</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22366898\">22366898</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell.+Proteomics&amp;rft.atitle=Proteomics+of+mouse+BRCA1-deficient+mammary+tumors+identifies+DNA+repair+proteins+with+potential+diagnostic+and+prognostic+value+in+human+breast+cancer&amp;rft.volume=11&amp;rft.issue=7&amp;rft.pages=M111.013334-1-M111.013334-19&amp;rft.date=2012-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3394939%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22366898&amp;rft_id=info%3Adoi%2F10.1074%2Fmcp.M111.013334&amp;rft.aulast=Warmoes&amp;rft.aufirst=M&amp;rft.au=Jaspers%2C+JE&amp;rft.au=Pham%2C+TV&amp;rft.au=Piersma%2C+SR&amp;rft.au=Oudgenoeg%2C+G&amp;rft.au=Massink%2C+MP&amp;rft.au=Waisfisz%2C+Q&amp;rft.au=Rottenberg%2C+S&amp;rft.au=Boven%2C+E&amp;rft.au=Jonkers%2C+J&amp;rft.au=Jimenez%2C+CR&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3394939&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid22020440-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22020440_41-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFMeerangRitzPaliwalGarajova2011\" class=\"citation journal cs1\">Meerang M, Ritz D, Paliwal S, Garajova Z, Bosshard M, Mailand N, Janscak P, H\\xc3\\xbcbscher U, Meyer H, Ramadan K (November 2011). \"The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks\". <i>Nat. Cell Biol</i>. <b>13</b> (11): 1376\\xe2\\x80\\x9382. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fncb2367\">10.1038/ncb2367</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22020440\">22020440</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:22109822\">22109822</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Cell+Biol.&amp;rft.atitle=The+ubiquitin-selective+segregase+VCP%2Fp97+orchestrates+the+response+to+DNA+double-strand+breaks&amp;rft.volume=13&amp;rft.issue=11&amp;rft.pages=1376-82&amp;rft.date=2011-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22109822%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22020440&amp;rft_id=info%3Adoi%2F10.1038%2Fncb2367&amp;rft.aulast=Meerang&amp;rft.aufirst=M&amp;rft.au=Ritz%2C+D&amp;rft.au=Paliwal%2C+S&amp;rft.au=Garajova%2C+Z&amp;rft.au=Bosshard%2C+M&amp;rft.au=Mailand%2C+N&amp;rft.au=Janscak%2C+P&amp;rft.au=H%C3%BCbscher%2C+U&amp;rft.au=Meyer%2C+H&amp;rft.au=Ramadan%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFZhangWangKajinoGreene2000\" class=\"citation journal cs1\">Zhang H, Wang Q, Kajino K, Greene MI (2000). \"VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells\". <i>DNA Cell Biol</i>. <b>19</b> (5): 253\\xe2\\x80\\x93263. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1089%2F10445490050021168\">10.1089/10445490050021168</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10855792\">10855792</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=DNA+Cell+Biol&amp;rft.atitle=VCP%2C+a+weak+ATPase+involved+in+multiple+cellular+events%2C+interacts+physically+with+BRCA1+in+the+nucleus+of+living+cells&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=253-263&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1089%2F10445490050021168&amp;rft_id=info%3Apmid%2F10855792&amp;rft.aulast=Zhang&amp;rft.aufirst=H&amp;rft.au=Wang%2C+Q&amp;rft.au=Kajino%2C+K&amp;rft.au=Greene%2C+MI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9788437-43\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9788437_43-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9788437_43-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid9788437_43-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWangZhangKajinoGreene1998\" class=\"citation journal cs1\">Wang Q, Zhang H, Kajino K, Greene MI (October 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202403\">\"BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells\"</a>. <i>Oncogene</i>. <b>17</b> (15): 1939\\xe2\\x80\\x9348. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202403\">10.1038/sj.onc.1202403</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9788437\">9788437</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+binds+c-Myc+and+inhibits+its+transcriptional+and+transforming+activity+in+cells&amp;rft.volume=17&amp;rft.issue=15&amp;rft.pages=1939-48&amp;rft.date=1998-10&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1202403&amp;rft_id=info%3Apmid%2F9788437&amp;rft.aulast=Wang&amp;rft.aufirst=Q&amp;rft.au=Zhang%2C+H&amp;rft.au=Kajino%2C+K&amp;rft.au=Greene%2C+MI&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1202403&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Paull2001-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Paull2001_44-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPaullCortezBowersElledge2001\" class=\"citation journal cs1\">Paull TT, Cortez D, Bowers B, Elledge SJ, Gellert M (2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33426\">\"Direct DNA binding by Brca1\"</a>. <i>Proceedings of the National Academy of Sciences</i>. <b>98</b> (11): 6086\\xe2\\x80\\x936091. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.111125998\">10.1073/pnas.111125998</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33426\">33426</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11353843\">11353843</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.atitle=Direct+DNA+binding+by+Brca1&amp;rft.volume=98&amp;rft.issue=11&amp;rft.pages=6086-6091&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33426%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11353843&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.111125998&amp;rft.aulast=Paull&amp;rft.aufirst=TT&amp;rft.au=Cortez%2C+D&amp;rft.au=Bowers%2C+B&amp;rft.au=Elledge%2C+SJ&amp;rft.au=Gellert%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33426&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Durant2005-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Durant2005_45-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFDurantNickoloff2005\" class=\"citation journal cs1\">Durant ST, Nickoloff JA (2005). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.4161%2Fcc.4.9.2027\">\"Good timing in the cell cycle for precise DNA repair by BRCA1\"</a>. <i>Cell Cycle</i>. <b>4</b> (9): 1216\\xe2\\x80\\x9322. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.4161%2Fcc.4.9.2027\">10.4161/cc.4.9.2027</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/16103751\">16103751</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Cycle&amp;rft.atitle=Good+timing+in+the+cell+cycle+for+precise+DNA+repair+by+BRCA1&amp;rft.volume=4&amp;rft.issue=9&amp;rft.pages=1216-22&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.4161%2Fcc.4.9.2027&amp;rft_id=info%3Apmid%2F16103751&amp;rft.aulast=Durant&amp;rft.aufirst=ST&amp;rft.au=Nickoloff%2C+JA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.4161%252Fcc.4.9.2027&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Ye2001-46\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ye2001_46-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ye2001_46-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Ye2001_46-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYeHuZhongNye2001\" class=\"citation journal cs1\">Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R (2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150890\">\"BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations\"</a>. <i>The Journal of Cell Biology</i>. <b>155</b> (6): 911\\xe2\\x80\\x93922. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1083%2Fjcb.200108049\">10.1083/jcb.200108049</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150890\">2150890</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11739404\">11739404</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Cell+Biology&amp;rft.atitle=BRCA1-induced+large-scale+chromatin+unfolding+and+allele-specific+effects+of+cancer-predisposing+mutations&amp;rft.volume=155&amp;rft.issue=6&amp;rft.pages=911-922&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2150890%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11739404&amp;rft_id=info%3Adoi%2F10.1083%2Fjcb.200108049&amp;rft.aulast=Ye&amp;rft.aufirst=Q&amp;rft.au=Hu%2C+YF&amp;rft.au=Zhong%2C+H&amp;rft.au=Nye%2C+AC&amp;rft.au=Belmont%2C+AS&amp;rft.au=Li%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2150890&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Ridpath_2007-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ridpath_2007_47-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFRidpathNakamuraTanoLuke2007\" class=\"citation journal cs1\">Ridpath JR, Nakamura A, Tano K, Luke AM, Sonoda E, Arakawa H, Buerstedde JM, Gillespie DA, Sale JE, Yamazoe M, Bishop DK, Takata M, Takeda S, Watanabe M, Swenberg JA, Nakamura J (December 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-07-3028\">\"Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde\"</a>. <i>Cancer Res</i>. <b>67</b> (23): 11117\\xe2\\x80\\x9322. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-07-3028\">10.1158/0008-5472.CAN-07-3028</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18056434\">18056434</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Cells+deficient+in+the+FANC%2FBRCA+pathway+are+hypersensitive+to+plasma+levels+of+formaldehyde&amp;rft.volume=67&amp;rft.issue=23&amp;rft.pages=11117-22&amp;rft.date=2007-12&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-07-3028&amp;rft_id=info%3Apmid%2F18056434&amp;rft.aulast=Ridpath&amp;rft.aufirst=JR&amp;rft.au=Nakamura%2C+A&amp;rft.au=Tano%2C+K&amp;rft.au=Luke%2C+AM&amp;rft.au=Sonoda%2C+E&amp;rft.au=Arakawa%2C+H&amp;rft.au=Buerstedde%2C+JM&amp;rft.au=Gillespie%2C+DA&amp;rft.au=Sale%2C+JE&amp;rft.au=Yamazoe%2C+M&amp;rft.au=Bishop%2C+DK&amp;rft.au=Takata%2C+M&amp;rft.au=Takeda%2C+S&amp;rft.au=Watanabe%2C+M&amp;rft.au=Swenberg%2C+JA&amp;rft.au=Nakamura%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1158%252F0008-5472.CAN-07-3028&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPrakashZhangFengJasin2015\" class=\"citation journal cs1\">Prakash R, Zhang Y, Feng W, Jasin M (April 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382744\">\"Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins\"</a>. <i>Cold Spring Harbor Perspectives in Biology</i>. <b>7</b> (4): a016600. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2Fcshperspect.a016600\">10.1101/cshperspect.a016600</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382744\">4382744</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/25833843\">25833843</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cold+Spring+Harbor+Perspectives+in+Biology&amp;rft.atitle=Homologous+recombination+and+human+health%3A+the+roles+of+BRCA1%2C+BRCA2%2C+and+associated+proteins&amp;rft.volume=7&amp;rft.issue=4&amp;rft.pages=a016600&amp;rft.date=2015-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4382744%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25833843&amp;rft_id=info%3Adoi%2F10.1101%2Fcshperspect.a016600&amp;rft.aulast=Prakash&amp;rft.aufirst=R&amp;rft.au=Zhang%2C+Y&amp;rft.au=Feng%2C+W&amp;rft.au=Jasin%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4382744&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Scully1997-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Scully1997_49-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFScullyAndersonChaoWei1997\" class=\"citation journal cs1\">Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD (1997). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20825\">\"BRCA1 is a component of the RNA polymerase II holoenzyme\"</a>. <i>Proceedings of the National Academy of Sciences</i>. <b>94</b> (11): 5605\\xe2\\x80\\x9310. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1997PNAS...94.5605S\">1997PNAS...94.5605S</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.94.11.5605\">10.1073/pnas.94.11.5605</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20825\">20825</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9159119\">9159119</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.atitle=BRCA1+is+a+component+of+the+RNA+polymerase+II+holoenzyme&amp;rft.volume=94&amp;rft.issue=11&amp;rft.pages=5605-10&amp;rft.date=1997&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC20825%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9159119&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.94.11.5605&amp;rft_id=info%3Abibcode%2F1997PNAS...94.5605S&amp;rft.aulast=Scully&amp;rft.aufirst=R&amp;rft.au=Anderson%2C+SF&amp;rft.au=Chao%2C+DM&amp;rft.au=Wei%2C+W&amp;rft.au=Ye%2C+L&amp;rft.au=Young%2C+RA&amp;rft.au=Livingston%2C+DM&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC20825&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Bochar2000-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bochar2000_50-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBocharWangBeniyaKinev2000\" class=\"citation journal cs1\">Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R (2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2900030-1\">\"BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer\"</a>. <i>Cell</i>. <b>102</b> (2): 257\\xe2\\x80\\x93265. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2900030-1\">10.1016/S0092-8674(00)00030-1</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10943845\">10943845</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=BRCA1+Is+Associated+with+a+Human+SWI%2FSNF-Related+Complex+Linking+Chromatin+Remodeling+to+Breast+Cancer&amp;rft.volume=102&amp;rft.issue=2&amp;rft.pages=257-265&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2800%2900030-1&amp;rft_id=info%3Apmid%2F10943845&amp;rft.aulast=Bochar&amp;rft.aufirst=DA&amp;rft.au=Wang%2C+L&amp;rft.au=Beniya%2C+H&amp;rft.au=Kinev%2C+A&amp;rft.au=Xue%2C+Y&amp;rft.au=Lane%2C+WS&amp;rft.au=Wang%2C+W&amp;rft.au=Kashanchi%2C+F&amp;rft.au=Shiekhattar%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252800%252900030-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Petrucelli_2016-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Petrucelli_2016_51-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPetrucelliDalyPal2016\" class=\"citation book cs1\">Petrucelli N, Daly MB, Pal T (December 2016) [September 1998]. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK1247/\">\"BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer\"</a>.  In Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Mirzaa G, Amemiya A (eds.). <i>GeneReviews</i>. University of Washington, Seattle. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/20301425\">20301425</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=BRCA1-+and+BRCA2-Associated+Hereditary+Breast+and+Ovarian+Cancer&amp;rft.btitle=GeneReviews&amp;rft.pub=University+of+Washington%2C+Seattle&amp;rft.date=2016-12&amp;rft_id=info%3Apmid%2F20301425&amp;rft.aulast=Petrucelli&amp;rft.aufirst=N&amp;rft.au=Daly%2C+MB&amp;rft.au=Pal%2C+T&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1247%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-urlGenetics-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlGenetics_52-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.breastcancer.org/risk/factors/genetics\">\"Genetics\"</a>. Breastcancer.org. 2012-09-17.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Genetics&amp;rft.pub=Breastcancer.org&amp;rft.date=2012-09-17&amp;rft_id=http%3A%2F%2Fwww.breastcancer.org%2Frisk%2Ffactors%2Fgenetics&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFElstrodtHollestelleNagelGorin2006\" class=\"citation journal cs1\">Elstrodt, Fons; Hollestelle, Antoinette; Nagel, Jord H.A.; Gorin, Michael; Wasielewski, Marijke; van den Ouweland, Ans; Merajver, Sofia D.; Ethier, Stephen P.; Schutte, Mieke (2006-01-01). <a rel=\"nofollow\" class=\"external text\" href=\"https://aacrjournals.org/cancerres/article/66/1/41/525599/BRCA1-Mutation-Analysis-of-41-Human-Breast-Cancer\">\"BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants\"</a>. <i>Cancer Research</i>. <b>66</b> (1): 41\\xe2\\x80\\x9345. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-05-2853\">10.1158/0008-5472.CAN-05-2853</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://www.worldcat.org/issn/0008-5472\">0008-5472</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=BRCA1+Mutation+Analysis+of+41+Human+Breast+Cancer+Cell+Lines+Reveals+Three+New+Deleterious+Mutants&amp;rft.volume=66&amp;rft.issue=1&amp;rft.pages=41-45&amp;rft.date=2006-01-01&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-05-2853&amp;rft.issn=0008-5472&amp;rft.aulast=Elstrodt&amp;rft.aufirst=Fons&amp;rft.au=Hollestelle%2C+Antoinette&amp;rft.au=Nagel%2C+Jord+H.A.&amp;rft.au=Gorin%2C+Michael&amp;rft.au=Wasielewski%2C+Marijke&amp;rft.au=van+den+Ouweland%2C+Ans&amp;rft.au=Merajver%2C+Sofia+D.&amp;rft.au=Ethier%2C+Stephen+P.&amp;rft.au=Schutte%2C+Mieke&amp;rft_id=https%3A%2F%2Faacrjournals.org%2Fcancerres%2Farticle%2F66%2F1%2F41%2F525599%2FBRCA1-Mutation-Analysis-of-41-Human-Breast-Cancer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15832305-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15832305_54-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFMazoyer2005\" class=\"citation journal cs1\">Mazoyer S (May 2005). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.20169\">\"Genomic rearrangements in the BRCA1 and BRCA2 genes\"</a>. <i>Hum. Mutat</i>. <b>25</b> (5): 415\\xe2\\x80\\x9322. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.20169\">10.1002/humu.20169</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15832305\">15832305</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:32023181\">32023181</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=Genomic+rearrangements+in+the+BRCA1+and+BRCA2+genes&amp;rft.volume=25&amp;rft.issue=5&amp;rft.pages=415-22&amp;rft.date=2005-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32023181%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15832305&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.20169&amp;rft.aulast=Mazoyer&amp;rft.aufirst=S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.20169&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14984472-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14984472_55-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBarroisBi\\xc3\\xa8cheMazoyerChamp\\xc3\\xa8me2004\" class=\"citation journal cs1\">Barrois M, Bi\\xc3\\xa8che I, Mazoyer S, Champ\\xc3\\xa8me MH, Bressac-de Paillerets B, Lidereau R (February 2004). \"Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families\". <i>Clin. Genet</i>. <b>65</b> (2): 131\\xe2\\x80\\x936. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1111%2Fj.0009-9163.2004.00200.x\">10.1111/j.0009-9163.2004.00200.x</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14984472\">14984472</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:11583160\">11583160</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Genet.&amp;rft.atitle=Real-time+PCR-based+gene+dosage+assay+for+detecting+BRCA1+rearrangements+in+breast-ovarian+cancer+families&amp;rft.volume=65&amp;rft.issue=2&amp;rft.pages=131-6&amp;rft.date=2004-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A11583160%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14984472&amp;rft_id=info%3Adoi%2F10.1111%2Fj.0009-9163.2004.00200.x&amp;rft.aulast=Barrois&amp;rft.aufirst=M&amp;rft.au=Bi%C3%A8che%2C+I&amp;rft.au=Mazoyer%2C+S&amp;rft.au=Champ%C3%A8me%2C+MH&amp;rft.au=Bressac-de+Paillerets%2C+B&amp;rft.au=Lidereau%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12670888-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12670888_56-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHogervorstNederlofGilleMcElgunn2003\" class=\"citation journal cs1\">Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van\\'t Veer LJ, Pals G (April 2003). \"Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method\". <i>Cancer Res</i>. <b>63</b> (7): 1449\\xe2\\x80\\x9353. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12670888\">12670888</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Large+genomic+deletions+and+duplications+in+the+BRCA1+gene+identified+by+a+novel+quantitative+method&amp;rft.volume=63&amp;rft.issue=7&amp;rft.pages=1449-53&amp;rft.date=2003-04&amp;rft_id=info%3Apmid%2F12670888&amp;rft.aulast=Hogervorst&amp;rft.aufirst=FB&amp;rft.au=Nederlof%2C+PM&amp;rft.au=Gille%2C+JJ&amp;rft.au=McElgunn%2C+CJ&amp;rft.au=Grippeling%2C+M&amp;rft.au=Pruntel%2C+R&amp;rft.au=Regnerus%2C+R&amp;rft.au=van+Welsem%2C+T&amp;rft.au=van+Spaendonk%2C+R&amp;rft.au=Menko%2C+FH&amp;rft.au=Kluijt%2C+I&amp;rft.au=Dommering%2C+C&amp;rft.au=Verhoef%2C+S&amp;rft.au=Schouten%2C+JP&amp;rft.au=van%27t+Veer%2C+LJ&amp;rft.au=Pals%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12203994-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12203994_57-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFCasilliDi_RoccoGadTournier2002\" class=\"citation journal cs1\">Casilli F, Di Rocco ZC, Gad S, Tournier I, Stoppa-Lyonnet D, Frebourg T, Tosi M (September 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.10108\">\"Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments\"</a>. <i>Hum. Mutat</i>. <b>20</b> (3): 218\\xe2\\x80\\x9326. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.10108\">10.1002/humu.10108</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12203994\">12203994</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:24737909\">24737909</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=Rapid+detection+of+novel+BRCA1+rearrangements+in+high-risk+breast-ovarian+cancer+families+using+multiplex+PCR+of+short+fluorescent+fragments&amp;rft.volume=20&amp;rft.issue=3&amp;rft.pages=218-26&amp;rft.date=2002-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24737909%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12203994&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.10108&amp;rft.aulast=Casilli&amp;rft.aufirst=F&amp;rft.au=Di+Rocco%2C+ZC&amp;rft.au=Gad%2C+S&amp;rft.au=Tournier%2C+I&amp;rft.au=Stoppa-Lyonnet%2C+D&amp;rft.au=Frebourg%2C+T&amp;rft.au=Tosi%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.10108&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid17718857-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17718857_58-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFRouleauLefolTozluAndrieu2007\" class=\"citation journal cs1\">Rouleau E, Lefol C, Tozlu S, Andrieu C, Guy C, Copigny F, Nogues C, Bieche I, Lidereau R (September 2007). \"High-resolution oligonucleotide array-CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1\". <i>Clin. Genet</i>. <b>72</b> (3): 199\\xe2\\x80\\x93207. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1399-0004.2007.00849.x\">10.1111/j.1399-0004.2007.00849.x</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17718857\">17718857</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:2393567\">2393567</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Genet.&amp;rft.atitle=High-resolution+oligonucleotide+array-CGH+applied+to+the+detection+and+characterization+of+large+rearrangements+in+the+hereditary+breast+cancer+gene+BRCA1&amp;rft.volume=72&amp;rft.issue=3&amp;rft.pages=199-207&amp;rft.date=2007-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2393567%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17718857&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1399-0004.2007.00849.x&amp;rft.aulast=Rouleau&amp;rft.aufirst=E&amp;rft.au=Lefol%2C+C&amp;rft.au=Tozlu%2C+S&amp;rft.au=Andrieu%2C+C&amp;rft.au=Guy%2C+C&amp;rft.au=Copigny%2C+F&amp;rft.au=Nogues%2C+C&amp;rft.au=Bieche%2C+I&amp;rft.au=Lidereau%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid18567944-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18567944_59-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFTapiaSmalleyKohenMu\\xc3\\xb1oz2008\" class=\"citation journal cs1\">Tapia T, Smalley SV, Kohen P, Mu\\xc3\\xb1oz A, Solis LM, Corvalan A, Faundez P, Devoto L, Camus M, Alvarez M, Carvallo P (2008). \"Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors\". <i>Epigenetics</i>. <b>3</b> (3): 157\\xe2\\x80\\x9363. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.4161%2Fepi.3.3.6387\">10.4161/epi.3.3.6387</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18567944\">18567944</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:35616414\">35616414</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Epigenetics&amp;rft.atitle=Promoter+hypermethylation+of+BRCA1+correlates+with+absence+of+expression+in+hereditary+breast+cancer+tumors&amp;rft.volume=3&amp;rft.issue=3&amp;rft.pages=157-63&amp;rft.date=2008&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A35616414%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18567944&amp;rft_id=info%3Adoi%2F10.4161%2Fepi.3.3.6387&amp;rft.aulast=Tapia&amp;rft.aufirst=T&amp;rft.au=Smalley%2C+SV&amp;rft.au=Kohen%2C+P&amp;rft.au=Mu%C3%B1oz%2C+A&amp;rft.au=Solis%2C+LM&amp;rft.au=Corvalan%2C+A&amp;rft.au=Faundez%2C+P&amp;rft.au=Devoto%2C+L&amp;rft.au=Camus%2C+M&amp;rft.au=Alvarez%2C+M&amp;rft.au=Carvallo%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-60\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFShenAmbrosoneZhao2009\" class=\"citation journal cs1\">Shen J, Ambrosone CB, Zhao H (March 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.24008\">\"Novel genetic variants in microRNA genes and familial breast cancer\"</a>. <i>Int. J. Cancer</i>. <b>124</b> (5): 1178\\xe2\\x80\\x9382. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.24008\">10.1002/ijc.24008</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19048628\">19048628</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.atitle=Novel+genetic+variants+in+microRNA+genes+and+familial+breast+cancer&amp;rft.volume=124&amp;rft.issue=5&amp;rft.pages=1178-82&amp;rft.date=2009-03&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.24008&amp;rft_id=info%3Apmid%2F19048628&amp;rft.aulast=Shen&amp;rft.aufirst=J&amp;rft.au=Ambrosone%2C+CB&amp;rft.au=Zhao%2C+H&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fijc.24008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Levin2012-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Levin2012_61-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLevinLechFriedenson2012\" class=\"citation journal cs1\">Levin B, Lech D, Friedenson B (2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521784\">\"Evidence that BRCA1- or BRCA2-associated cancers are not inevitable\"</a>. <i>Mol Med</i>. <b>18</b> (9): 1327\\xe2\\x80\\x9337. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.2119%2Fmolmed.2012.00280\">10.2119/molmed.2012.00280</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521784\">3521784</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22972572\">22972572</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol+Med&amp;rft.atitle=Evidence+that+BRCA1-+or+BRCA2-associated+cancers+are+not+inevitable&amp;rft.volume=18&amp;rft.issue=9&amp;rft.pages=1327-37&amp;rft.date=2012&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3521784%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22972572&amp;rft_id=info%3Adoi%2F10.2119%2Fmolmed.2012.00280&amp;rft.aulast=Levin&amp;rft.aufirst=B&amp;rft.au=Lech%2C+D&amp;rft.au=Friedenson%2C+B&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3521784&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9988281-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9988281_62-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWilsonRamosVillase\\xc3\\xb1orAnders1999\" class=\"citation journal cs1\">Wilson CA, Ramos L, Villase\\xc3\\xb1or MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ (1999). \"Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas\". <i>Nat. Genet</i>. <b>21</b> (2): 236\\xe2\\x80\\x9340. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2F6029\">10.1038/6029</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9988281\">9988281</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:7988460\">7988460</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Genet.&amp;rft.atitle=Localization+of+human+BRCA1+and+its+loss+in+high-grade%2C+non-inherited+breast+carcinomas&amp;rft.volume=21&amp;rft.issue=2&amp;rft.pages=236-40&amp;rft.date=1999&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7988460%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9988281&amp;rft_id=info%3Adoi%2F10.1038%2F6029&amp;rft.aulast=Wilson&amp;rft.aufirst=CA&amp;rft.au=Ramos%2C+L&amp;rft.au=Villase%C3%B1or%2C+MR&amp;rft.au=Anders%2C+KH&amp;rft.au=Press%2C+MF&amp;rft.au=Clarke%2C+K&amp;rft.au=Karlan%2C+B&amp;rft.au=Chen%2C+JJ&amp;rft.au=Scully%2C+R&amp;rft.au=Livingston%2C+D&amp;rft.au=Zuch%2C+RH&amp;rft.au=Kanter%2C+MH&amp;rft.au=Cohen%2C+S&amp;rft.au=Calzone%2C+FJ&amp;rft.au=Slamon%2C+DJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12559046-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12559046_63-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFMuellerRoskelley2003\" class=\"citation journal cs1\">Mueller CR, Roskelley CD (2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154136\">\"Regulation of BRCA1 expression and its relationship to sporadic breast cancer\"</a>. <i>Breast Cancer Res</i>. <b>5</b> (1): 45\\xe2\\x80\\x9352. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186%2Fbcr557\">10.1186/bcr557</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154136\">154136</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12559046\">12559046</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Breast+Cancer+Res.&amp;rft.atitle=Regulation+of+BRCA1+expression+and+its+relationship+to+sporadic+breast+cancer&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=45-52&amp;rft.date=2003&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC154136%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12559046&amp;rft_id=info%3Adoi%2F10.1186%2Fbcr557&amp;rft.aulast=Mueller&amp;rft.aufirst=CR&amp;rft.au=Roskelley%2C+CD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC154136&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Jacinto-64\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Jacinto_64-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Jacinto_64-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFJacintoEsteller2007\" class=\"citation journal cs1\">Jacinto FV, Esteller M (2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fmutage%2Fgem009\">\"Mutator pathways unleashed by epigenetic silencing in human cancer\"</a>. <i>Mutagenesis</i>. <b>22</b> (4): 247\\xe2\\x80\\x9353. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fmutage%2Fgem009\">10.1093/mutage/gem009</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17412712\">17412712</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mutagenesis&amp;rft.atitle=Mutator+pathways+unleashed+by+epigenetic+silencing+in+human+cancer&amp;rft.volume=22&amp;rft.issue=4&amp;rft.pages=247-53&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1093%2Fmutage%2Fgem009&amp;rft_id=info%3Apmid%2F17412712&amp;rft.aulast=Jacinto&amp;rft.aufirst=FV&amp;rft.au=Esteller%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fmutage%252Fgem009&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Sun-65\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sun_65-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sun_65-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Sun_65-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Sun_65-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSunLiYangZhou2013\" class=\"citation journal cs1\">Sun C, Li N, Yang Z, Zhou B, He Y, Weng D, Fang Y, Wu P, Chen P, Yang X, Ma D, Zhou J, Chen G (2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2Fdjt302\">\"miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition\"</a>. <i>J. Natl. Cancer Inst</i>. <b>105</b> (22): 1750\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2Fdjt302\">10.1093/jnci/djt302</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/24168967\">24168967</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.atitle=miR-9+regulation+of+BRCA1+and+ovarian+cancer+sensitivity+to+cisplatin+and+PARP+inhibition&amp;rft.volume=105&amp;rft.issue=22&amp;rft.pages=1750-8&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjt302&amp;rft_id=info%3Apmid%2F24168967&amp;rft.aulast=Sun&amp;rft.aufirst=C&amp;rft.au=Li%2C+N&amp;rft.au=Yang%2C+Z&amp;rft.au=Zhou%2C+B&amp;rft.au=He%2C+Y&amp;rft.au=Weng%2C+D&amp;rft.au=Fang%2C+Y&amp;rft.au=Wu%2C+P&amp;rft.au=Chen%2C+P&amp;rft.au=Yang%2C+X&amp;rft.au=Ma%2C+D&amp;rft.au=Zhou%2C+J&amp;rft.au=Chen%2C+G&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fjnci%252Fdjt302&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid22790015-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22790015_66-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFMcMillenAponteLiuHelenowski2012\" class=\"citation journal cs1\">McMillen BD, Aponte MM, Liu Z, Helenowski IB, Scholtens DM, Buttin BM, Wei JJ (2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fmodpathol.2012.118\">\"Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma\"</a>. <i>Mod. Pathol</i>. <b>25</b> (12): 1644\\xe2\\x80\\x9353. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fmodpathol.2012.118\">10.1038/modpathol.2012.118</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22790015\">22790015</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mod.+Pathol.&amp;rft.atitle=Expression+analysis+of+MIR182+and+its+associated+target+genes+in+advanced+ovarian+carcinoma&amp;rft.volume=25&amp;rft.issue=12&amp;rft.pages=1644-53&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1038%2Fmodpathol.2012.118&amp;rft_id=info%3Apmid%2F22790015&amp;rft.aulast=McMillen&amp;rft.aufirst=BD&amp;rft.au=Aponte%2C+MM&amp;rft.au=Liu%2C+Z&amp;rft.au=Helenowski%2C+IB&amp;rft.au=Scholtens%2C+DM&amp;rft.au=Buttin%2C+BM&amp;rft.au=Wei%2C+JJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fmodpathol.2012.118&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid20944665-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid20944665_67-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBowtell2010\" class=\"citation journal cs1\">Bowtell DD (2010). \"The genesis and evolution of high-grade serous ovarian cancer\". <i>Nat. Rev. Cancer</i>. <b>10</b> (11): 803\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fnrc2946\">10.1038/nrc2946</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/20944665\">20944665</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:22688947\">22688947</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Rev.+Cancer&amp;rft.atitle=The+genesis+and+evolution+of+high-grade+serous+ovarian+cancer&amp;rft.volume=10&amp;rft.issue=11&amp;rft.pages=803-8&amp;rft.date=2010&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22688947%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20944665&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc2946&amp;rft.aulast=Bowtell&amp;rft.aufirst=DD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9653432-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9653432_68-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBrodyBiesecker1998\" class=\"citation journal cs1\">Brody LC, Biesecker BB (1998). \"Breast cancer susceptibility genes. BRCA1 and BRCA2\". <i>Medicine (Baltimore)</i>. <b>77</b> (3): 208\\xe2\\x80\\x9326. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1097%2F00005792-199805000-00006\">10.1097/00005792-199805000-00006</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9653432\">9653432</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medicine+%28Baltimore%29&amp;rft.atitle=Breast+cancer+susceptibility+genes.+BRCA1+and+BRCA2&amp;rft.volume=77&amp;rft.issue=3&amp;rft.pages=208-26&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1097%2F00005792-199805000-00006&amp;rft_id=info%3Apmid%2F9653432&amp;rft.aulast=Brody&amp;rft.aufirst=LC&amp;rft.au=Biesecker%2C+BB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid24240112-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid24240112_69-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPenningtonWalshHarrellLee2014\" class=\"citation journal cs1\">Pennington KP, Walsh T, Harrell MI, Lee MK, Pennil CC, Rendi MH, Thornton A, Norquist BM, Casadei S, Nord AS, Agnew KJ, Pritchard CC, Scroggins S, Garcia RL, King MC, Swisher EM (2014). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944197\">\"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas\"</a>. <i>Clin. Cancer Res</i>. <b>20</b> (3): 764\\xe2\\x80\\x9375. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F1078-0432.CCR-13-2287\">10.1158/1078-0432.CCR-13-2287</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944197\">3944197</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/24240112\">24240112</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Cancer+Res.&amp;rft.atitle=Germline+and+somatic+mutations+in+homologous+recombination+genes+predict+platinum+response+and+survival+in+ovarian%2C+fallopian+tube%2C+and+peritoneal+carcinomas&amp;rft.volume=20&amp;rft.issue=3&amp;rft.pages=764-75&amp;rft.date=2014&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3944197%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24240112&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-13-2287&amp;rft.aulast=Pennington&amp;rft.aufirst=KP&amp;rft.au=Walsh%2C+T&amp;rft.au=Harrell%2C+MI&amp;rft.au=Lee%2C+MK&amp;rft.au=Pennil%2C+CC&amp;rft.au=Rendi%2C+MH&amp;rft.au=Thornton%2C+A&amp;rft.au=Norquist%2C+BM&amp;rft.au=Casadei%2C+S&amp;rft.au=Nord%2C+AS&amp;rft.au=Agnew%2C+KJ&amp;rft.au=Pritchard%2C+CC&amp;rft.au=Scroggins%2C+S&amp;rft.au=Garcia%2C+RL&amp;rft.au=King%2C+MC&amp;rft.au=Swisher%2C+EM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3944197&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid30579323-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid30579323_70-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPolanskySchwab2019\" class=\"citation journal cs1\">Polansky H, Schwab H (August 2019). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716096\">\"How latent viruses cause breast cancer: An explanation based on the microcompetition model\"</a>. <i>Bosnian Journal of Basic Medical Sciences</i>. <b>19</b> (3): 221\\xe2\\x80\\x93226. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.17305%2Fbjbms.2018.3950\">10.17305/bjbms.2018.3950</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716096\">6716096</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/30579323\">30579323</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bosnian+Journal+of+Basic+Medical+Sciences&amp;rft.atitle=How+latent+viruses+cause+breast+cancer%3A+An+explanation+based+on+the+microcompetition+model&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=221-226&amp;rft.date=2019-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6716096%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30579323&amp;rft_id=info%3Adoi%2F10.17305%2Fbjbms.2018.3950&amp;rft.aulast=Polansky&amp;rft.aufirst=H&amp;rft.au=Schwab%2C+H&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6716096&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10749912-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10749912_71-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFEstellerSilvaDominguezBonilla2000\" class=\"citation journal cs1\">Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, <a href=\"/wiki/Stephen_B._Baylin\" title=\"Stephen B. Baylin\">Baylin SB</a>, <a href=\"/wiki/James_G._Herman\" title=\"James G. Herman\">Herman JG</a> (2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2F92.7.564\">\"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors\"</a>. <i>J. Natl. Cancer Inst</i>. <b>92</b> (7): 564\\xe2\\x80\\x939. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2F92.7.564\">10.1093/jnci/92.7.564</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10749912\">10749912</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.atitle=Promoter+hypermethylation+and+BRCA1+inactivation+in+sporadic+breast+and+ovarian+tumors&amp;rft.volume=92&amp;rft.issue=7&amp;rft.pages=564-9&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2F92.7.564&amp;rft_id=info%3Apmid%2F10749912&amp;rft.aulast=Esteller&amp;rft.aufirst=M&amp;rft.au=Silva%2C+JM&amp;rft.au=Dominguez%2C+G&amp;rft.au=Bonilla%2C+F&amp;rft.au=Matias-Guiu%2C+X&amp;rft.au=Lerma%2C+E&amp;rft.au=Bussaglia%2C+E&amp;rft.au=Prat%2C+J&amp;rft.au=Harkes%2C+IC&amp;rft.au=Repasky%2C+EA&amp;rft.au=Gabrielson%2C+E&amp;rft.au=Schutte%2C+M&amp;rft.au=Baylin%2C+SB&amp;rft.au=Herman%2C+JG&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fjnci%252F92.7.564&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Moskwa-72\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Moskwa_72-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Moskwa_72-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFMoskwaBuffaPanPanchakshari2011\" class=\"citation journal cs1\">Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, Muschel RJ, Beech J, Kulshrestha R, Abdelmohsen K, Weinstock DM, Gorospe M, Harris AL, Helleday T, Chowdhury D (2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249932\">\"miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors\"</a>. <i>Mol. Cell</i>. <b>41</b> (2): 210\\xe2\\x80\\x9320. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.molcel.2010.12.005\">10.1016/j.molcel.2010.12.005</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249932\">3249932</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/21195000\">21195000</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=miR-182-mediated+downregulation+of+BRCA1+impacts+DNA+repair+and+sensitivity+to+PARP+inhibitors&amp;rft.volume=41&amp;rft.issue=2&amp;rft.pages=210-20&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3249932%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21195000&amp;rft_id=info%3Adoi%2F10.1016%2Fj.molcel.2010.12.005&amp;rft.aulast=Moskwa&amp;rft.aufirst=P&amp;rft.au=Buffa%2C+FM&amp;rft.au=Pan%2C+Y&amp;rft.au=Panchakshari%2C+R&amp;rft.au=Gottipati%2C+P&amp;rft.au=Muschel%2C+RJ&amp;rft.au=Beech%2C+J&amp;rft.au=Kulshrestha%2C+R&amp;rft.au=Abdelmohsen%2C+K&amp;rft.au=Weinstock%2C+DM&amp;rft.au=Gorospe%2C+M&amp;rft.au=Harris%2C+AL&amp;rft.au=Helleday%2C+T&amp;rft.au=Chowdhury%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3249932&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid23249749-73\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23249749_73-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFKrishnanSteptoeMartinWani2013\" class=\"citation journal cs1\">Krishnan K, Steptoe AL, Martin HC, Wani S, Nones K, Waddell N, Mariasegaram M, Simpson PT, Lakhani SR, Gabrielli B, Vlassov A, Cloonan N, Grimmond SM (2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543090\">\"MicroRNA-182-5p targets a network of genes involved in DNA repair\"</a>. <i>RNA</i>. <b>19</b> (2): 230\\xe2\\x80\\x9342. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1261%2Frna.034926.112\">10.1261/rna.034926.112</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543090\">3543090</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/23249749\">23249749</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=RNA&amp;rft.atitle=MicroRNA-182-5p+targets+a+network+of+genes+involved+in+DNA+repair&amp;rft.volume=19&amp;rft.issue=2&amp;rft.pages=230-42&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3543090%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23249749&amp;rft_id=info%3Adoi%2F10.1261%2Frna.034926.112&amp;rft.aulast=Krishnan&amp;rft.aufirst=K&amp;rft.au=Steptoe%2C+AL&amp;rft.au=Martin%2C+HC&amp;rft.au=Wani%2C+S&amp;rft.au=Nones%2C+K&amp;rft.au=Waddell%2C+N&amp;rft.au=Mariasegaram%2C+M&amp;rft.au=Simpson%2C+PT&amp;rft.au=Lakhani%2C+SR&amp;rft.au=Gabrielli%2C+B&amp;rft.au=Vlassov%2C+A&amp;rft.au=Cloonan%2C+N&amp;rft.au=Grimmond%2C+SM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3543090&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid21472990-74\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21472990_74-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFGarciaBuissonBertrandRimokh2011\" class=\"citation journal cs1\">Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS, Lidereau R, Mika\\xc3\\xa9lian I, Mazoyer S (2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377076\">\"Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers\"</a>. <i>EMBO Mol Med</i>. <b>3</b> (5): 279\\xe2\\x80\\x9390. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Femmm.201100136\">10.1002/emmm.201100136</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377076\">3377076</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/21472990\">21472990</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EMBO+Mol+Med&amp;rft.atitle=Down-regulation+of+BRCA1+expression+by+miR-146a+and+miR-146b-5p+in+triple+negative+sporadic+breast+cancers&amp;rft.volume=3&amp;rft.issue=5&amp;rft.pages=279-90&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3377076%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21472990&amp;rft_id=info%3Adoi%2F10.1002%2Femmm.201100136&amp;rft.aulast=Garcia&amp;rft.aufirst=AI&amp;rft.au=Buisson%2C+M&amp;rft.au=Bertrand%2C+P&amp;rft.au=Rimokh%2C+R&amp;rft.au=Rouleau%2C+E&amp;rft.au=Lopez%2C+BS&amp;rft.au=Lidereau%2C+R&amp;rft.au=Mika%C3%A9lian%2C+I&amp;rft.au=Mazoyer%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3377076&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Liu-75\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Liu_75-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Liu_75-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLiuLiuSeguraShao2012\" class=\"citation journal cs1\">Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, Hernando E, Wei JJ (2012). \"MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma\". <i>J. Pathol</i>. <b>228</b> (2): 204\\xe2\\x80\\x9315. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fpath.4000\">10.1002/path.4000</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22322863\">22322863</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:206325689\">206325689</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Pathol.&amp;rft.atitle=MiR-182+overexpression+in+tumourigenesis+of+high-grade+serous+ovarian+carcinoma&amp;rft.volume=228&amp;rft.issue=2&amp;rft.pages=204-15&amp;rft.date=2012&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A206325689%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22322863&amp;rft_id=info%3Adoi%2F10.1002%2Fpath.4000&amp;rft.aulast=Liu&amp;rft.aufirst=Z&amp;rft.au=Liu%2C+J&amp;rft.au=Segura%2C+MF&amp;rft.au=Shao%2C+C&amp;rft.au=Lee%2C+P&amp;rft.au=Gong%2C+Y&amp;rft.au=Hernando%2C+E&amp;rft.au=Wei%2C+JJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid18403632-76\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18403632_76-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFKastan2008\" class=\"citation journal cs1\">Kastan MB (2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F1541-7786.MCR-08-0020\">\"DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture\"</a>. <i>Mol. Cancer Res</i>. <b>6</b> (4): 517\\xe2\\x80\\x9324. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F1541-7786.MCR-08-0020\">10.1158/1541-7786.MCR-08-0020</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18403632\">18403632</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cancer+Res.&amp;rft.atitle=DNA+damage+responses%3A+mechanisms+and+roles+in+human+disease%3A+2007+G.H.A.+Clowes+Memorial+Award+Lecture&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=517-24&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1158%2F1541-7786.MCR-08-0020&amp;rft_id=info%3Apmid%2F18403632&amp;rft.aulast=Kastan&amp;rft.aufirst=MB&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1158%252F1541-7786.MCR-08-0020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid18082599-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18082599_77-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHarperElledge2007\" class=\"citation journal cs1\">Harper JW, Elledge SJ (2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.molcel.2007.11.015\">\"The DNA damage response: ten years after\"</a>. <i>Mol. Cell</i>. <b>28</b> (5): 739\\xe2\\x80\\x9345. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.molcel.2007.11.015\">10.1016/j.molcel.2007.11.015</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18082599\">18082599</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=The+DNA+damage+response%3A+ten+years+after&amp;rft.volume=28&amp;rft.issue=5&amp;rft.pages=739-45&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1016%2Fj.molcel.2007.11.015&amp;rft_id=info%3Apmid%2F18082599&amp;rft.aulast=Harper&amp;rft.aufirst=JW&amp;rft.au=Elledge%2C+SJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.molcel.2007.11.015&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Hagan-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Hagan_78-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFO&#39;HaganMohammadBaylin2008\" class=\"citation journal cs1\">O\\'Hagan HM, Mohammad HP, Baylin SB (2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723\">\"Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island\"</a>. <i>PLOS Genetics</i>. <b>4</b> (8): e1000155. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1371%2Fjournal.pgen.1000155\">10.1371/journal.pgen.1000155</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723\">2491723</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18704159\">18704159</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+Genetics&amp;rft.atitle=Double+strand+breaks+can+initiate+gene+silencing+and+SIRT1-dependent+onset+of+DNA+methylation+in+an+exogenous+promoter+CpG+island&amp;rft.volume=4&amp;rft.issue=8&amp;rft.pages=e1000155&amp;rft.date=2008&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2491723%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18704159&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pgen.1000155&amp;rft.aulast=O%27Hagan&amp;rft.aufirst=HM&amp;rft.au=Mohammad%2C+HP&amp;rft.au=Baylin%2C+SB&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2491723&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Cuozzo-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Cuozzo_79-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFCuozzoPorcelliniAngrisanoMorano2007\" class=\"citation journal cs1\">Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV (Jul 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100\">\"DNA damage, homology-directed repair, and DNA methylation\"</a>. <i>PLOS Genetics</i>. <b>3</b> (7): e110. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1371%2Fjournal.pgen.0030110\">10.1371/journal.pgen.0030110</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100\">1913100</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17616978\">17616978</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+Genetics&amp;rft.atitle=DNA+damage%2C+homology-directed+repair%2C+and+DNA+methylation&amp;rft.volume=3&amp;rft.issue=7&amp;rft.pages=e110&amp;rft.date=2007-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1913100%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17616978&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pgen.0030110&amp;rft.aulast=Cuozzo&amp;rft.aufirst=C&amp;rft.au=Porcellini%2C+A&amp;rft.au=Angrisano%2C+T&amp;rft.au=Morano%2C+A&amp;rft.au=Lee%2C+B&amp;rft.au=Di+Pardo%2C+A&amp;rft.au=Messina%2C+S&amp;rft.au=Iuliano%2C+R&amp;rft.au=Fusco%2C+A&amp;rft.au=Santillo%2C+MR&amp;rft.au=Muller%2C+MT&amp;rft.au=Chiariotti%2C+L&amp;rft.au=Gottesman%2C+ME&amp;rft.au=Avvedimento%2C+EV&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1913100&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Lacroix2005-80\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Lacroix2005_80-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Lacroix2005_80-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLacroixLeclercq2005\" class=\"citation journal cs1\">Lacroix M, Leclercq G (2005). \"The \"portrait\" of hereditary breast cancer\". <i>Breast Cancer Research and Treatment</i>. <b>89</b> (3): 297\\xe2\\x80\\x93304. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1007%2Fs10549-004-2172-4\">10.1007/s10549-004-2172-4</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15754129\">15754129</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:23327569\">23327569</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Breast+Cancer+Research+and+Treatment&amp;rft.atitle=The+%22portrait%22+of+hereditary+breast+cancer&amp;rft.volume=89&amp;rft.issue=3&amp;rft.pages=297-304&amp;rft.date=2005&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23327569%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15754129&amp;rft_id=info%3Adoi%2F10.1007%2Fs10549-004-2172-4&amp;rft.aulast=Lacroix&amp;rft.aufirst=M&amp;rft.au=Leclercq%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Struewing1995-81\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Struewing1995_81-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Struewing1995_81-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFStruewingAbeliovichPeretzAvishai1995\" class=\"citation journal cs1\">Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (October 1995). \"The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals\". <i>Nat. Genet</i>. <b>11</b> (2): 198\\xe2\\x80\\x93200. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fng1095-198\">10.1038/ng1095-198</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/7550349\">7550349</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:21387351\">21387351</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Genet.&amp;rft.atitle=The+carrier+frequency+of+the+BRCA1+185delAG+mutation+is+approximately+1+percent+in+Ashkenazi+Jewish+individuals&amp;rft.volume=11&amp;rft.issue=2&amp;rft.pages=198-200&amp;rft.date=1995-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21387351%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F7550349&amp;rft_id=info%3Adoi%2F10.1038%2Fng1095-198&amp;rft.aulast=Struewing&amp;rft.aufirst=JP&amp;rft.au=Abeliovich%2C+D&amp;rft.au=Peretz%2C+T&amp;rft.au=Avishai%2C+N&amp;rft.au=Kaback%2C+MM&amp;rft.au=Collins%2C+FS&amp;rft.au=Brody%2C+LC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Tonin1995-82\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Tonin1995_82-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Tonin1995_82-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFToninSerovaLenoirLynch1995\" class=\"citation journal cs1\">Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, Narod S (1995). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801236\">\"BRCA1 mutations in Ashkenazi Jewish women\"</a>. <i>American Journal of Human Genetics</i>. <b>57</b> (1): 189. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801236\">1801236</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/7611288\">7611288</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=BRCA1+mutations+in+Ashkenazi+Jewish+women&amp;rft.volume=57&amp;rft.issue=1&amp;rft.pages=189&amp;rft.date=1995&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1801236%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F7611288&amp;rft.aulast=Tonin&amp;rft.aufirst=P&amp;rft.au=Serova%2C+O&amp;rft.au=Lenoir%2C+G&amp;rft.au=Lynch%2C+H&amp;rft.au=Durocher%2C+F&amp;rft.au=Simard%2C+J&amp;rft.au=Morgan%2C+K&amp;rft.au=Narod%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1801236&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Narod2004-83\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Narod2004_83-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFNarodFoulkes2004\" class=\"citation journal cs1\">Narod SA, Foulkes WD (2004). \"BRCA1 and BRCA2: 1994 and beyond\". <i>Nature Reviews Cancer</i>. <b>4</b> (9): 665\\xe2\\x80\\x93676. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fnrc1431\">10.1038/nrc1431</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15343273\">15343273</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:30686068\">30686068</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.atitle=BRCA1+and+BRCA2%3A+1994+and+beyond&amp;rft.volume=4&amp;rft.issue=9&amp;rft.pages=665-676&amp;rft.date=2004&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A30686068%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15343273&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc1431&amp;rft.aulast=Narod&amp;rft.aufirst=SA&amp;rft.au=Foulkes%2C+WD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-denDunnen2000-84\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-denDunnen2000_84-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFden_DunnenAntonarakis2000\" class=\"citation journal cs1\">den Dunnen JT, Antonarakis SE (2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291098-1004%28200001%2915%3A1%3C7%3A%3AAID-HUMU4%3E3.0.CO%3B2-N\">\"Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion\"</a>. <i>Human Mutation</i>. <b>15</b> (1): 7\\xe2\\x80\\x9312. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291098-1004%28200001%2915%3A1%3C7%3A%3AAID-HUMU4%3E3.0.CO%3B2-N\">10.1002/(SICI)1098-1004(200001)15:1&#60;7::AID-HUMU4&#62;3.0.CO;2-N</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10612815\">10612815</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Mutation&amp;rft.atitle=Mutation+nomenclature+extensions+and+suggestions+to+describe+complex+mutations%3A+a+discussion&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=7-12&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291098-1004%28200001%2915%3A1%3C7%3A%3AAID-HUMU4%3E3.0.CO%3B2-N&amp;rft_id=info%3Apmid%2F10612815&amp;rft.aulast=den+Dunnen&amp;rft.aufirst=JT&amp;rft.au=Antonarakis%2C+SE&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252F%2528SICI%25291098-1004%2528200001%252915%253A1%253C7%253A%253AAID-HUMU4%253E3.0.CO%253B2-N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Neuhausen2000-85\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Neuhausen2000_85-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Neuhausen2000_85-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFNeuhausen2000\" class=\"citation journal cs1\">Neuhausen SL (2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139426\">\"Founder populations and their uses for breast cancer genetics\"</a>. <i>Cancer Research</i>. <b>2</b> (2): 77\\xe2\\x80\\x9381. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186%2Fbcr36\">10.1186/bcr36</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139426\">139426</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11250694\">11250694</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Founder+populations+and+their+uses+for+breast+cancer+genetics&amp;rft.volume=2&amp;rft.issue=2&amp;rft.pages=77-81&amp;rft.date=2000&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC139426%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11250694&amp;rft_id=info%3Adoi%2F10.1186%2Fbcr36&amp;rft.aulast=Neuhausen&amp;rft.aufirst=SL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC139426&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Reeves2004-86\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Reeves2004_86-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFReevesYawitchvan_der_Merwevan_den_Berg2004\" class=\"citation journal cs1\">Reeves MD, Yawitch TM, van der Merwe NC, van den Berg HJ, Dreyer G, van Rensburg EJ (July 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.20186\">\"BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families\"</a>. <i>Int. J. Cancer</i>. <b>110</b> (5): 677\\xe2\\x80\\x9382. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.20186\">10.1002/ijc.20186</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15146556\">15146556</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:22970255\">22970255</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.atitle=BRCA1+mutations+in+South+African+breast+and%2For+ovarian+cancer+families%3A+evidence+of+a+novel+founder+mutation+in+Afrikaner+families&amp;rft.volume=110&amp;rft.issue=5&amp;rft.pages=677-82&amp;rft.date=2004-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22970255%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15146556&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.20186&amp;rft.aulast=Reeves&amp;rft.aufirst=MD&amp;rft.au=Yawitch%2C+TM&amp;rft.au=van+der+Merwe%2C+NC&amp;rft.au=van+den+Berg%2C+HJ&amp;rft.au=Dreyer%2C+G&amp;rft.au=van+Rensburg%2C+EJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fijc.20186&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Francies2015-87\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Francies2015_87-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFFranciesWainsteinDe_LeeneerCairns2015\" class=\"citation journal cs1\">Francies FZ, Wainstein T, De Leeneer K, Cairns A, Murdoch M, Nietz S, Cubasch H, Poppe B, Van Maerken T, Crombez B, Coene I, Kerr R, Slabbert JP, Vral A, Krause A, Baeyens A (Nov 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647511\">\"BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer\"</a>. <i>BMC Cancer</i>. <b>15</b>: 912. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186%2Fs12885-015-1913-6\">10.1186/s12885-015-1913-6</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647511\">4647511</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/26577449\">26577449</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Cancer&amp;rft.atitle=BRCA1%2C+BRCA2+and+PALB2+mutations+and+CHEK2+c.1100delC+in+different+South+African+ethnic+groups+diagnosed+with+premenopausal+and%2For+triple+negative+breast+cancer&amp;rft.volume=15&amp;rft.pages=912&amp;rft.date=2015-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4647511%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26577449&amp;rft_id=info%3Adoi%2F10.1186%2Fs12885-015-1913-6&amp;rft.aulast=Francies&amp;rft.aufirst=FZ&amp;rft.au=Wainstein%2C+T&amp;rft.au=De+Leeneer%2C+K&amp;rft.au=Cairns%2C+A&amp;rft.au=Murdoch%2C+M&amp;rft.au=Nietz%2C+S&amp;rft.au=Cubasch%2C+H&amp;rft.au=Poppe%2C+B&amp;rft.au=Van+Maerken%2C+T&amp;rft.au=Crombez%2C+B&amp;rft.au=Coene%2C+I&amp;rft.au=Kerr%2C+R&amp;rft.au=Slabbert%2C+JP&amp;rft.au=Vral%2C+A&amp;rft.au=Krause%2C+A&amp;rft.au=Baeyens%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4647511&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Wagner1998-88\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Wagner1998_88-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWagnerM\\xc3\\xb6slingerMuhrLangbauer1998\" class=\"citation journal cs1\">Wagner TM, M\\xc3\\xb6slinger RA, Muhr D, Langbauer G, Hirtenlehner K, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Ropp E, Kubista E, Amirimani B, Helbich T, Becherer A, Scheiner O, Breiteneder H, Borg A, Devilee P, Oefner P, Zielinski C (1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291097-0215%2819980729%2977%3A3%3C354%3A%3AAID-IJC8%3E3.0.CO%3B2-N\">\"BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics\"</a>. <i>International Journal of Cancer</i>. <b>77</b> (3): 354\\xe2\\x80\\x93360. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291097-0215%2819980729%2977%3A3%3C354%3A%3AAID-IJC8%3E3.0.CO%3B2-N\">10.1002/(SICI)1097-0215(19980729)77:3&#60;354::AID-IJC8&#62;3.0.CO;2-N</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9663595\">9663595</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Cancer&amp;rft.atitle=BRCA1-related+breast+cancer+in+Austrian+breast+and+ovarian+cancer+families%3A+specific+BRCA1+mutations+and+pathological+characteristics&amp;rft.volume=77&amp;rft.issue=3&amp;rft.pages=354-360&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-0215%2819980729%2977%3A3%3C354%3A%3AAID-IJC8%3E3.0.CO%3B2-N&amp;rft_id=info%3Apmid%2F9663595&amp;rft.aulast=Wagner&amp;rft.aufirst=TM&amp;rft.au=M%C3%B6slinger%2C+RA&amp;rft.au=Muhr%2C+D&amp;rft.au=Langbauer%2C+G&amp;rft.au=Hirtenlehner%2C+K&amp;rft.au=Concin%2C+H&amp;rft.au=Doeller%2C+W&amp;rft.au=Haid%2C+A&amp;rft.au=Lang%2C+AH&amp;rft.au=Mayer%2C+P&amp;rft.au=Ropp%2C+E&amp;rft.au=Kubista%2C+E&amp;rft.au=Amirimani%2C+B&amp;rft.au=Helbich%2C+T&amp;rft.au=Becherer%2C+A&amp;rft.au=Scheiner%2C+O&amp;rft.au=Breiteneder%2C+H&amp;rft.au=Borg%2C+A&amp;rft.au=Devilee%2C+P&amp;rft.au=Oefner%2C+P&amp;rft.au=Zielinski%2C+C&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252F%2528SICI%25291097-0215%252819980729%252977%253A3%253C354%253A%253AAID-IJC8%253E3.0.CO%253B2-N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Peelen1997-89\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Peelen1997_89-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Peelen1997_89-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPeelenvan_VlietPetrij-BoschMieremet1997\" class=\"citation journal cs1\">Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AM, Hogervorst F, Brohet R, Ligtenberg MJ, Teugels E, van der Luijt R, van der Hout AH, Gille JJ, Pals G, Jedema I, Olmer R, van Leeuwen I, Newman B, Plandsoen M, van der Est M, Brink G, Hageman S, Arts PJ, Bakker MM, Devilee P (1997). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712432\">\"A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families\"</a>. <i>American Journal of Human Genetics</i>. <b>60</b> (5): 1041\\xe2\\x80\\x931049. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712432\">1712432</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9150151\">9150151</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=A+high+proportion+of+novel+mutations+in+BRCA1+with+strong+founder+effects+among+Dutch+and+Belgian+hereditary+breast+and+ovarian+cancer+families&amp;rft.volume=60&amp;rft.issue=5&amp;rft.pages=1041-1049&amp;rft.date=1997&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1712432%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9150151&amp;rft.aulast=Peelen&amp;rft.aufirst=T&amp;rft.au=van+Vliet%2C+M&amp;rft.au=Petrij-Bosch%2C+A&amp;rft.au=Mieremet%2C+R&amp;rft.au=Szabo%2C+C&amp;rft.au=van+den+Ouweland%2C+AM&amp;rft.au=Hogervorst%2C+F&amp;rft.au=Brohet%2C+R&amp;rft.au=Ligtenberg%2C+MJ&amp;rft.au=Teugels%2C+E&amp;rft.au=van+der+Luijt%2C+R&amp;rft.au=van+der+Hout%2C+AH&amp;rft.au=Gille%2C+JJ&amp;rft.au=Pals%2C+G&amp;rft.au=Jedema%2C+I&amp;rft.au=Olmer%2C+R&amp;rft.au=van+Leeuwen%2C+I&amp;rft.au=Newman%2C+B&amp;rft.au=Plandsoen%2C+M&amp;rft.au=van+der+Est%2C+M&amp;rft.au=Brink%2C+G&amp;rft.au=Hageman%2C+S&amp;rft.au=Arts%2C+PJ&amp;rft.au=Bakker%2C+MM&amp;rft.au=Devilee%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1712432&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Claes1999-90\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Claes1999_90-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFClaesMachackovaDe_VosPoppe1999\" class=\"citation journal cs1\">Claes K, Machackova E, De Vos M, Poppe B, De Paepe A, Messiaen L (1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851655\">\"Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A &gt; G\"</a>. <i>Disease Markers</i>. <b>15</b> (1\\xe2\\x80\\x933): 69\\xe2\\x80\\x9373. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1155%2F1999%2F241046\">10.1155/1999/241046</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851655\">3851655</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10595255\">10595255</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Disease+Markers&amp;rft.atitle=Mutation+analysis+of+the+BRCA1+and+BRCA2+genes+in+the+Belgian+patient+population+and+identification+of+a+Belgian+founder+mutation+BRCA1+IVS5+%2B+3A+%3E+G&amp;rft.volume=15&amp;rft.issue=1%E2%80%933&amp;rft.pages=69-73&amp;rft.date=1999&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3851655%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10595255&amp;rft_id=info%3Adoi%2F10.1155%2F1999%2F241046&amp;rft.aulast=Claes&amp;rft.aufirst=K&amp;rft.au=Machackova%2C+E&amp;rft.au=De+Vos%2C+M&amp;rft.au=Poppe%2C+B&amp;rft.au=De+Paepe%2C+A&amp;rft.au=Messiaen%2C+L&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3851655&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-PetrijBosch-91\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PetrijBosch_91-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPetrij-BoschPeelenvan_Vlietvan_Eijk1997\" class=\"citation journal cs1\">Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Dr\\xc3\\xbcsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van \\'t Veer LJ, Bakker E, van Ommen GJ, Devilee P (1997). <a rel=\"nofollow\" class=\"external text\" href=\"https://repub.eur.nl/pub/54808/ng1197-341.pdf\">\"BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Nature Genetics</i>. <b>17</b> (3): 341\\xe2\\x80\\x93345. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fng1197-341\">10.1038/ng1197-341</a>. <a href=\"/wiki/Hdl_(identifier)\" class=\"mw-redirect\" title=\"Hdl (identifier)\">hdl</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://hdl.handle.net/1765%2F54808\">1765/54808</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9354803\">9354803</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:13028232\">13028232</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Genetics&amp;rft.atitle=BRCA1+genomic+deletions+are+major+founder+mutations+in+Dutch+breast+cancer+patients&amp;rft.volume=17&amp;rft.issue=3&amp;rft.pages=341-345&amp;rft.date=1997&amp;rft_id=info%3Ahdl%2F1765%2F54808&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13028232%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9354803&amp;rft_id=info%3Adoi%2F10.1038%2Fng1197-341&amp;rft.aulast=Petrij-Bosch&amp;rft.aufirst=A&amp;rft.au=Peelen%2C+T&amp;rft.au=van+Vliet%2C+M&amp;rft.au=van+Eijk%2C+R&amp;rft.au=Olmer%2C+R&amp;rft.au=Dr%C3%BCsedau%2C+M&amp;rft.au=Hogervorst%2C+FB&amp;rft.au=Hageman%2C+S&amp;rft.au=Arts%2C+PJ&amp;rft.au=Ligtenberg%2C+MJ&amp;rft.au=Meijers-Heijboer%2C+H&amp;rft.au=Klijn%2C+JG&amp;rft.au=Vasen%2C+HF&amp;rft.au=Cornelisse%2C+CJ&amp;rft.au=van+%27t+Veer%2C+LJ&amp;rft.au=Bakker%2C+E&amp;rft.au=van+Ommen%2C+GJ&amp;rft.au=Devilee%2C+P&amp;rft_id=https%3A%2F%2Frepub.eur.nl%2Fpub%2F54808%2Fng1197-341.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Verhoog-92\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Verhoog_92-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFVerhoogvan_den_OuwelandBernsvan_Veghel-Plandsoen2001\" class=\"citation journal cs1\">Verhoog LC, van den Ouweland AM, Berns E, van Veghel-Plandsoen MM, van Staveren IL, Wagner A, Bartels CC, Tilanus-Linthorst MM, Devilee P, Seynaeve C, Halley DJ, Niermeijer MF, Klijn JG, Meijers-Heijboer H (2001). \"Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families\". <i>European Journal of Cancer</i>. <b>37</b> (16): 2082\\xe2\\x80\\x932090. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0959-8049%2801%2900244-1\">10.1016/S0959-8049(01)00244-1</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11597388\">11597388</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Cancer&amp;rft.atitle=Large+regional+differences+in+the+frequency+of+distinct+BRCA1%2FBRCA2+mutations+in+517+Dutch+breast+and%2For+ovarian+cancer+families&amp;rft.volume=37&amp;rft.issue=16&amp;rft.pages=2082-2090&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1016%2FS0959-8049%2801%2900244-1&amp;rft_id=info%3Apmid%2F11597388&amp;rft.aulast=Verhoog&amp;rft.aufirst=LC&amp;rft.au=van+den+Ouweland%2C+AM&amp;rft.au=Berns%2C+E&amp;rft.au=van+Veghel-Plandsoen%2C+MM&amp;rft.au=van+Staveren%2C+IL&amp;rft.au=Wagner%2C+A&amp;rft.au=Bartels%2C+CC&amp;rft.au=Tilanus-Linthorst%2C+MM&amp;rft.au=Devilee%2C+P&amp;rft.au=Seynaeve%2C+C&amp;rft.au=Halley%2C+DJ&amp;rft.au=Niermeijer%2C+MF&amp;rft.au=Klijn%2C+JG&amp;rft.au=Meijers-Heijboer%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Huusko-93\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Huusko_93-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHuuskoP\\xc3\\xa4\\xc3\\xa4kk\\xc3\\xb6nenLaunonenP\\xc3\\xb6yh\\xc3\\xb6nen1998\" class=\"citation journal cs1\">Huusko P, P\\xc3\\xa4\\xc3\\xa4kk\\xc3\\xb6nen K, Launonen V, P\\xc3\\xb6yh\\xc3\\xb6nen M, Blanco G, Kauppila A, Puistola U, Kiviniemi H, Kujala M, Leisti J, Winqvist R (1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377159\">\"Evidence of founder mutations in Finnish BRCA1 and BRCA2 families\"</a>. <i>American Journal of Human Genetics</i>. <b>62</b> (6): 1544\\xe2\\x80\\x931548. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1086%2F301880\">10.1086/301880</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377159\">1377159</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9585608\">9585608</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=Evidence+of+founder+mutations+in+Finnish+BRCA1+and+BRCA2+families&amp;rft.volume=62&amp;rft.issue=6&amp;rft.pages=1544-1548&amp;rft.date=1998&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1377159%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9585608&amp;rft_id=info%3Adoi%2F10.1086%2F301880&amp;rft.aulast=Huusko&amp;rft.aufirst=P&amp;rft.au=P%C3%A4%C3%A4kk%C3%B6nen%2C+K&amp;rft.au=Launonen%2C+V&amp;rft.au=P%C3%B6yh%C3%B6nen%2C+M&amp;rft.au=Blanco%2C+G&amp;rft.au=Kauppila%2C+A&amp;rft.au=Puistola%2C+U&amp;rft.au=Kiviniemi%2C+H&amp;rft.au=Kujala%2C+M&amp;rft.au=Leisti%2C+J&amp;rft.au=Winqvist%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1377159&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Paakkonen-94\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Paakkonen_94-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFP\\xc3\\xa4\\xc3\\xa4kk\\xc3\\xb6nenSauramoSarantausVahteristo2001\" class=\"citation journal cs1\">P\\xc3\\xa4\\xc3\\xa4kk\\xc3\\xb6nen K, Sauramo S, Sarantaus L, Vahteristo P, Hartikainen A, Vehmanen P, Ignatius J, Ollikainen V, K\\xc3\\xa4\\xc3\\xa4ri\\xc3\\xa4inen H, Vauramo E, Nevanlinna H, Krahe R, Holli K, Kere J (2001). \"Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population\". <i>Genetic Epidemiology</i>. <b>20</b> (2): 239\\xe2\\x80\\x93246. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2F1098-2272%28200102%2920%3A2%3C239%3A%3AAID-GEPI6%3E3.0.CO%3B2-Y\">10.1002/1098-2272(200102)20:2&#60;239::AID-GEPI6&#62;3.0.CO;2-Y</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11180449\">11180449</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:41804152\">41804152</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+Epidemiology&amp;rft.atitle=Involvement+of+BRCA1+and+BRCA2+in+breast+cancer+in+a+western+Finnish+sub-population&amp;rft.volume=20&amp;rft.issue=2&amp;rft.pages=239-246&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A41804152%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11180449&amp;rft_id=info%3Adoi%2F10.1002%2F1098-2272%28200102%2920%3A2%3C239%3A%3AAID-GEPI6%3E3.0.CO%3B2-Y&amp;rft.aulast=P%C3%A4%C3%A4kk%C3%B6nen&amp;rft.aufirst=K&amp;rft.au=Sauramo%2C+S&amp;rft.au=Sarantaus%2C+L&amp;rft.au=Vahteristo%2C+P&amp;rft.au=Hartikainen%2C+A&amp;rft.au=Vehmanen%2C+P&amp;rft.au=Ignatius%2C+J&amp;rft.au=Ollikainen%2C+V&amp;rft.au=K%C3%A4%C3%A4ri%C3%A4inen%2C+H&amp;rft.au=Vauramo%2C+E&amp;rft.au=Nevanlinna%2C+H&amp;rft.au=Krahe%2C+R&amp;rft.au=Holli%2C+K&amp;rft.au=Kere%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Muller-95\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Muller_95-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFMullerBonaiti-Pelli\\xc3\\xa9AbecassisStoppa-Lyonnet2004\" class=\"citation journal cs1\">Muller D, Bonaiti-Pelli\\xc3\\xa9 C, Abecassis J, Stoppa-Lyonnet D, Fricker JP (2004). \"BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect\". <i>Familial Cancer</i>. <b>3</b> (1): 15\\xe2\\x80\\x9320. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1023%2FB%3AFAME.0000026819.44213.df\">10.1023/B:FAME.0000026819.44213.df</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15131401\">15131401</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:24615109\">24615109</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Familial+Cancer&amp;rft.atitle=BRCA1+testing+in+breast+and%2For+ovarian+cancer+families+from+northeastern+France+identifies+two+common+mutations+with+a+founder+effect&amp;rft.volume=3&amp;rft.issue=1&amp;rft.pages=15-20&amp;rft.date=2004&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24615109%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15131401&amp;rft_id=info%3Adoi%2F10.1023%2FB%3AFAME.0000026819.44213.df&amp;rft.aulast=Muller&amp;rft.aufirst=D&amp;rft.au=Bonaiti-Pelli%C3%A9%2C+C&amp;rft.au=Abecassis%2C+J&amp;rft.au=Stoppa-Lyonnet%2C+D&amp;rft.au=Fricker%2C+JP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Tonin1999-96\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Tonin1999_96-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFToninMes-MassonNarodGhadirian1999\" class=\"citation journal cs1\">Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P, Provencher D (1999). \"Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history\". <i>Clinical Genetics</i>. <b>55</b> (5): 318\\xe2\\x80\\x93324. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1034%2Fj.1399-0004.1999.550504.x\">10.1034/j.1399-0004.1999.550504.x</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10422801\">10422801</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:23931343\">23931343</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Genetics&amp;rft.atitle=Founder+BRCA1+and+BRCA2+mutations+in+French+Canadian+ovarian+cancer+cases+unselected+for+family+history&amp;rft.volume=55&amp;rft.issue=5&amp;rft.pages=318-324&amp;rft.date=1999&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23931343%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10422801&amp;rft_id=info%3Adoi%2F10.1034%2Fj.1399-0004.1999.550504.x&amp;rft.aulast=Tonin&amp;rft.aufirst=PN&amp;rft.au=Mes-Masson%2C+AM&amp;rft.au=Narod%2C+SA&amp;rft.au=Ghadirian%2C+P&amp;rft.au=Provencher%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Backe1999-97\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Backe1999_97-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBackeHofferbertSkawranD\\xc3\\xb6rk1999\" class=\"citation journal cs1\">Backe J, Hofferbert S, Skawran B, D\\xc3\\xb6rk T, Stuhrmann M, Karstens JH, Untch M, Meindl A, Burgemeister R, Chang-Claude J, Weber BH (1999). \"Frequency of BRCA1 mutation 5382insC in German breast cancer patients\". <i>Gynecologic Oncology</i>. <b>72</b> (3): 402\\xe2\\x80\\x93406. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1006%2Fgyno.1998.5270\">10.1006/gyno.1998.5270</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10053113\">10053113</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gynecologic+Oncology&amp;rft.atitle=Frequency+of+BRCA1+mutation+5382insC+in+German+breast+cancer+patients&amp;rft.volume=72&amp;rft.issue=3&amp;rft.pages=402-406&amp;rft.date=1999&amp;rft_id=info%3Adoi%2F10.1006%2Fgyno.1998.5270&amp;rft_id=info%3Apmid%2F10053113&amp;rft.aulast=Backe&amp;rft.aufirst=J&amp;rft.au=Hofferbert%2C+S&amp;rft.au=Skawran%2C+B&amp;rft.au=D%C3%B6rk%2C+T&amp;rft.au=Stuhrmann%2C+M&amp;rft.au=Karstens%2C+JH&amp;rft.au=Untch%2C+M&amp;rft.au=Meindl%2C+A&amp;rft.au=Burgemeister%2C+R&amp;rft.au=Chang-Claude%2C+J&amp;rft.au=Weber%2C+BH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-urlBrca1-98\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlBrca1_98-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://mutview.dmb.med.keio.ac.jp/MutationView/jsp/mutview/html/brca1.html\">\"Mutation data of the BRCA1 gene\"</a>. <i>KMDB/MutationView (Keio Mutation Databases)</i>. Keio University.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=KMDB%2FMutationView+%28Keio+Mutation+Databases%29&amp;rft.atitle=Mutation+data+of+the+BRCA1+gene&amp;rft_id=http%3A%2F%2Fmutview.dmb.med.keio.ac.jp%2FMutationView%2Fjsp%2Fmutview%2Fhtml%2Fbrca1.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Ladopoulou2002-99\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ladopoulou2002_99-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLadopoulouKroupisKonstantopoulouIoannidou-Mouzaka2002\" class=\"citation journal cs1\">Ladopoulou A, Kroupis C, Konstantopoulou I, Ioannidou-Mouzaka L, Schofield AC, Pantazidis A, Armaou S, Tsiagas I, Lianidou E, Efstathiou E, Tsionou C, Panopoulos C, Mihalatos M, Nasioulas G, Skarlos D, Haites NE, Fountzilas G, Pandis N, Yannoukakos D (2002). \"Germ line BRCA1 and BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed\". <i>Cancer Letters</i>. <b>185</b> (1): 61\\xe2\\x80\\x9370. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0304-3835%2801%2900845-X\">10.1016/S0304-3835(01)00845-X</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12142080\">12142080</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Letters&amp;rft.atitle=Germ+line+BRCA1+and+BRCA2+mutations+in+Greek+breast%2Fovarian+cancer+families%3A+5382insC+is+the+most+frequent+mutation+observed&amp;rft.volume=185&amp;rft.issue=1&amp;rft.pages=61-70&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1016%2FS0304-3835%2801%2900845-X&amp;rft_id=info%3Apmid%2F12142080&amp;rft.aulast=Ladopoulou&amp;rft.aufirst=A&amp;rft.au=Kroupis%2C+C&amp;rft.au=Konstantopoulou%2C+I&amp;rft.au=Ioannidou-Mouzaka%2C+L&amp;rft.au=Schofield%2C+AC&amp;rft.au=Pantazidis%2C+A&amp;rft.au=Armaou%2C+S&amp;rft.au=Tsiagas%2C+I&amp;rft.au=Lianidou%2C+E&amp;rft.au=Efstathiou%2C+E&amp;rft.au=Tsionou%2C+C&amp;rft.au=Panopoulos%2C+C&amp;rft.au=Mihalatos%2C+M&amp;rft.au=Nasioulas%2C+G&amp;rft.au=Skarlos%2C+D&amp;rft.au=Haites%2C+NE&amp;rft.au=Fountzilas%2C+G&amp;rft.au=Pandis%2C+N&amp;rft.au=Yannoukakos%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-VanDerLooij2000-100\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-VanDerLooij2000_100-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFVan_Der_LooijSzaboBesznyakLiszka2000\" class=\"citation journal cs1\">Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E (2000). \"Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary\". <i>International Journal of Cancer</i>. <b>86</b> (5): 737\\xe2\\x80\\x93740. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291097-0215%2820000601%2986%3A5%3C737%3A%3AAID-IJC21%3E3.0.CO%3B2-1\">10.1002/(SICI)1097-0215(20000601)86:5&#60;737::AID-IJC21&#62;3.0.CO;2-1</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10797299\">10797299</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:25394976\">25394976</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Cancer&amp;rft.atitle=Prevalence+of+founder+BRCA1+and+BRCA2+mutations+among+breast+and+ovarian+cancer+patients+in+Hungary&amp;rft.volume=86&amp;rft.issue=5&amp;rft.pages=737-740&amp;rft.date=2000&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25394976%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10797299&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-0215%2820000601%2986%3A5%3C737%3A%3AAID-IJC21%3E3.0.CO%3B2-1&amp;rft.aulast=Van+Der+Looij&amp;rft.aufirst=M&amp;rft.au=Szabo%2C+C&amp;rft.au=Besznyak%2C+I&amp;rft.au=Liszka%2C+G&amp;rft.au=Csokay%2C+B&amp;rft.au=Pulay%2C+T&amp;rft.au=Toth%2C+J&amp;rft.au=Devilee%2C+P&amp;rft.au=King%2C+MC&amp;rft.au=Olah%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Baudi2001-101\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Baudi2001_101-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBaudiQuaresimaGrandinettiCuda2001\" class=\"citation journal cs1\">Baudi F, Quaresima B, Grandinetti C, Cuda G, Faniello C, Tassone P, Barbieri V, Bisegna R, Ricevuto E, Conforti S, Viel A, Marchetti P, Ficorella C, Radice P, Costanzo F, Venuta S (2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.1167\">\"Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer\"</a>. <i>Human Mutation</i>. <b>18</b> (2): 163\\xe2\\x80\\x93164. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.1167\">10.1002/humu.1167</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11462242\">11462242</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:2995\">2995</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Mutation&amp;rft.atitle=Evidence+of+a+founder+mutation+of+BRCA1+in+a+highly+homogeneous+population+from+southern+Italy+with+breast%2Fovarian+cancer&amp;rft.volume=18&amp;rft.issue=2&amp;rft.pages=163-164&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2995%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11462242&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.1167&amp;rft.aulast=Baudi&amp;rft.aufirst=F&amp;rft.au=Quaresima%2C+B&amp;rft.au=Grandinetti%2C+C&amp;rft.au=Cuda%2C+G&amp;rft.au=Faniello%2C+C&amp;rft.au=Tassone%2C+P&amp;rft.au=Barbieri%2C+V&amp;rft.au=Bisegna%2C+R&amp;rft.au=Ricevuto%2C+E&amp;rft.au=Conforti%2C+S&amp;rft.au=Viel%2C+A&amp;rft.au=Marchetti%2C+P&amp;rft.au=Ficorella%2C+C&amp;rft.au=Radice%2C+P&amp;rft.au=Costanzo%2C+F&amp;rft.au=Venuta%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.1167&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Sekine2001-102\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Sekine2001_102-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSekineNagataTsujiHirai2001\" class=\"citation journal cs1\">Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesaki N, Satoh S, Enomoto T, Motoyama S, Tanaka K (2001). \"Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population\". <i>Clinical Cancer Research</i>. <b>7</b> (10): 3144\\xe2\\x80\\x933150. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11595708\">11595708</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=Mutational+analysis+of+BRCA1+and+BRCA2+and+clinicopathologic+analysis+of+ovarian+cancer+in+82+ovarian+cancer+families%3A+two+common+founder+mutations+of+BRCA1+in+Japanese+population&amp;rft.volume=7&amp;rft.issue=10&amp;rft.pages=3144-3150&amp;rft.date=2001&amp;rft_id=info%3Apmid%2F11595708&amp;rft.aulast=Sekine&amp;rft.aufirst=M&amp;rft.au=Nagata%2C+H&amp;rft.au=Tsuji%2C+S&amp;rft.au=Hirai%2C+Y&amp;rft.au=Fujimoto%2C+S&amp;rft.au=Hatae%2C+M&amp;rft.au=Kobayashi%2C+I&amp;rft.au=Fujii%2C+T&amp;rft.au=Nagata%2C+I&amp;rft.au=Ushijima%2C+K&amp;rft.au=Obata%2C+K&amp;rft.au=Suzuki%2C+M&amp;rft.au=Yoshinaga%2C+M&amp;rft.au=Umesaki%2C+N&amp;rft.au=Satoh%2C+S&amp;rft.au=Enomoto%2C+T&amp;rft.au=Motoyama%2C+S&amp;rft.au=Tanaka%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Liede2002b-103\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Liede2002b_103-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLiedeJackHegeleNarod2002\" class=\"citation journal cs1\">Liede A, Jack E, Hegele RA, Narod SA (2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9027\">\"A BRCA1 mutation in Native North American families\"</a>. <i>Human Mutation</i>. <b>19</b> (4): 460. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9027\">10.1002/humu.9027</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11933205\">11933205</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:37710898\">37710898</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Mutation&amp;rft.atitle=A+BRCA1+mutation+in+Native+North+American+families&amp;rft.volume=19&amp;rft.issue=4&amp;rft.pages=460&amp;rft.date=2002&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A37710898%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11933205&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.9027&amp;rft.aulast=Liede&amp;rft.aufirst=A&amp;rft.au=Jack%2C+E&amp;rft.au=Hegele%2C+RA&amp;rft.au=Narod%2C+SA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.9027&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-TSNI2003-104\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-TSNI2003_104-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-TSNI2003_104-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFThe_Scottish/Northern_Irish_BRCA1/BRCA2_Consortium2003\" class=\"citation journal cs1\">The Scottish/Northern Irish BRCA1/BRCA2 Consortium (2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747571\">\"BRCA1 and BRCA2 mutations in Scotland and Northern Ireland\"</a>. <i>British Journal of Cancer</i>. <b>88</b> (8): 1256\\xe2\\x80\\x931262. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.bjc.6600840\">10.1038/sj.bjc.6600840</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747571\">2747571</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12698193\">12698193</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Cancer&amp;rft.atitle=BRCA1+and+BRCA2+mutations+in+Scotland+and+Northern+Ireland&amp;rft.volume=88&amp;rft.issue=8&amp;rft.pages=1256-1262&amp;rft.date=2003&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2747571%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12698193&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bjc.6600840&amp;rft.au=The+Scottish%2FNorthern+Irish+BRCA1%2FBRCA2+Consortium&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2747571&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Borg1999-105\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Borg1999_105-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBorgD\\xc3\\xb8rumHeimdalMaehle1999\" class=\"citation journal cs1\">Borg A, D\\xc3\\xb8rum A, Heimdal K, Maehle L, Hovig E, M\\xc3\\xb8ller P (1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851406\">\"BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations\"</a>. <i>Disease Markers</i>. <b>15</b> (1\\xe2\\x80\\x933): 79\\xe2\\x80\\x9384. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1155%2F1999%2F278269\">10.1155/1999/278269</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851406\">3851406</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10595257\">10595257</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Disease+Markers&amp;rft.atitle=BRCA1+1675delA+and+1135insA+account+for+one+third+of+Norwegian+familial+breast-ovarian+cancer+and+are+associated+with+later+disease+onset+than+less+frequent+mutations&amp;rft.volume=15&amp;rft.issue=1%E2%80%933&amp;rft.pages=79-84&amp;rft.date=1999&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3851406%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10595257&amp;rft_id=info%3Adoi%2F10.1155%2F1999%2F278269&amp;rft.aulast=Borg&amp;rft.aufirst=A&amp;rft.au=D%C3%B8rum%2C+A&amp;rft.au=Heimdal%2C+K&amp;rft.au=Maehle%2C+L&amp;rft.au=Hovig%2C+E&amp;rft.au=M%C3%B8ller%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3851406&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Heimdal2003-106\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Heimdal2003_106-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHeimdalMaehleApoldPedersen2003\" class=\"citation journal cs1\">Heimdal K, Maehle L, Apold J, Pedersen JC, M\\xc3\\xb8ller P (2003). \"The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer\". <i>European Journal of Cancer</i>. <b>39</b> (15): 2205\\xe2\\x80\\x932213. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0959-8049%2803%2900548-3\">10.1016/S0959-8049(03)00548-3</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14522380\">14522380</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Cancer&amp;rft.atitle=The+Norwegian+founder+mutations+in+BRCA1%3A+high+penetrance+confirmed+in+an+incident+cancer+series+and+differences+observed+in+the+risk+of+ovarian+cancer&amp;rft.volume=39&amp;rft.issue=15&amp;rft.pages=2205-2213&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1016%2FS0959-8049%2803%2900548-3&amp;rft_id=info%3Apmid%2F14522380&amp;rft.aulast=Heimdal&amp;rft.aufirst=K&amp;rft.au=Maehle%2C+L&amp;rft.au=Apold%2C+J&amp;rft.au=Pedersen%2C+JC&amp;rft.au=M%C3%B8ller%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Liede2002-107\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Liede2002_107-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLiedeMalikAzizRios_Pd_Pde2002\" class=\"citation journal cs1\">Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA (2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC379195\">\"Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan\"</a>. <i>American Journal of Human Genetics</i>. <b>71</b> (3): 595\\xe2\\x80\\x93606. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1086%2F342506\">10.1086/342506</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC379195\">379195</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12181777\">12181777</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=Contribution+of+BRCA1+and+BRCA2+Mutations+to+Breast+and+Ovarian+Cancer+in+Pakistan&amp;rft.volume=71&amp;rft.issue=3&amp;rft.pages=595-606&amp;rft.date=2002&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC379195%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12181777&amp;rft_id=info%3Adoi%2F10.1086%2F342506&amp;rft.aulast=Liede&amp;rft.aufirst=A&amp;rft.au=Malik%2C+IA&amp;rft.au=Aziz%2C+Z&amp;rft.au=Rios+Pd+Pde%2C+L&amp;rft.au=Kwan%2C+E&amp;rft.au=Narod%2C+SA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC379195&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Gorski2000-108\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Gorski2000_108-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFG\\xc3\\xb3rskiByrskiHuzarskiJakubowska2000\" class=\"citation journal cs1\">G\\xc3\\xb3rski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluza\\xc5\\x84ska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubi\\xc5\\x84ski J (2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1378051\">\"Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer\"</a>. <i>American Journal of Human Genetics</i>. <b>66</b> (6): 1963\\xe2\\x80\\x931968. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1086%2F302922\">10.1086/302922</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1378051\">1378051</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10788334\">10788334</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=Founder+mutations+in+the+BRCA1+gene+in+Polish+families+with+breast-ovarian+cancer&amp;rft.volume=66&amp;rft.issue=6&amp;rft.pages=1963-1968&amp;rft.date=2000&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1378051%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10788334&amp;rft_id=info%3Adoi%2F10.1086%2F302922&amp;rft.aulast=G%C3%B3rski&amp;rft.aufirst=B&amp;rft.au=Byrski%2C+T&amp;rft.au=Huzarski%2C+T&amp;rft.au=Jakubowska%2C+A&amp;rft.au=Menkiszak%2C+J&amp;rft.au=Gronwald%2C+J&amp;rft.au=Pluza%C5%84ska%2C+A&amp;rft.au=Bebenek%2C+M&amp;rft.au=Fischer-Maliszewska%2C+L&amp;rft.au=Grzybowska%2C+E&amp;rft.au=Narod%2C+SA&amp;rft.au=Lubi%C5%84ski%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1378051&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Perkowska2003-109\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Perkowska2003_109-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPerkowskaBroZekWysockaHaraldsson2003\" class=\"citation journal cs1\">Perkowska M, BroZek I, Wysocka B, Haraldsson K, Sandberg T, Johansson U, Sellberg G, Borg A, Limon J (May 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9139\">\"BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland\"</a>. <i>Hum. Mutat</i>. <b>21</b> (5): 553\\xe2\\x80\\x934. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9139\">10.1002/humu.9139</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12673801\">12673801</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:7001156\">7001156</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=BRCA1+and+BRCA2+mutation+analysis+in+breast-ovarian+cancer+families+from+northeastern+Poland&amp;rft.volume=21&amp;rft.issue=5&amp;rft.pages=553-4&amp;rft.date=2003-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7001156%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12673801&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.9139&amp;rft.aulast=Perkowska&amp;rft.aufirst=M&amp;rft.au=BroZek%2C+I&amp;rft.au=Wysocka%2C+B&amp;rft.au=Haraldsson%2C+K&amp;rft.au=Sandberg%2C+T&amp;rft.au=Johansson%2C+U&amp;rft.au=Sellberg%2C+G&amp;rft.au=Borg%2C+A&amp;rft.au=Limon%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.9139&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Gayther1997-110\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Gayther1997_110-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFGaytherHarringtonRussellKharkevich1997\" class=\"citation journal cs1\">Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BA (May 1997). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712436\">\"Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia\"</a>. <i>Am. J. Hum. Genet</i>. <b>60</b> (5): 1239\\xe2\\x80\\x9342. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712436\">1712436</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9150173\">9150173</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Hum.+Genet.&amp;rft.atitle=Frequently+occurring+germ-line+mutations+of+the+BRCA1+gene+in+ovarian+cancer+families+from+Russia&amp;rft.volume=60&amp;rft.issue=5&amp;rft.pages=1239-42&amp;rft.date=1997-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1712436%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9150173&amp;rft.aulast=Gayther&amp;rft.aufirst=SA&amp;rft.au=Harrington%2C+P&amp;rft.au=Russell%2C+P&amp;rft.au=Kharkevich%2C+G&amp;rft.au=Garkavtseva%2C+RF&amp;rft.au=Ponder%2C+BA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1712436&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Liede2000-111\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Liede2000_111-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLiedeCohenBlackDavidson2000\" class=\"citation journal cs1\">Liede A, Cohen B, Black DM, Davidson RH, Renwick A, Hoodfar E, Olopade OI, Micek M, Anderson V, De Mey R, Fordyce A, Warner E, Dann JL, King MC, Weber B, Narod SA, Steel CM (February 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363321\">\"Evidence of a founder BRCA1 mutation in Scotland\"</a>. <i>Br. J. Cancer</i>. <b>82</b> (3): 705\\xe2\\x80\\x9311. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1054%2Fbjoc.1999.0984\">10.1054/bjoc.1999.0984</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363321\">2363321</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10682686\">10682686</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br.+J.+Cancer&amp;rft.atitle=Evidence+of+a+founder+BRCA1+mutation+in+Scotland&amp;rft.volume=82&amp;rft.issue=3&amp;rft.pages=705-11&amp;rft.date=2000-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2363321%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10682686&amp;rft_id=info%3Adoi%2F10.1054%2Fbjoc.1999.0984&amp;rft.aulast=Liede&amp;rft.aufirst=A&amp;rft.au=Cohen%2C+B&amp;rft.au=Black%2C+DM&amp;rft.au=Davidson%2C+RH&amp;rft.au=Renwick%2C+A&amp;rft.au=Hoodfar%2C+E&amp;rft.au=Olopade%2C+OI&amp;rft.au=Micek%2C+M&amp;rft.au=Anderson%2C+V&amp;rft.au=De+Mey%2C+R&amp;rft.au=Fordyce%2C+A&amp;rft.au=Warner%2C+E&amp;rft.au=Dann%2C+JL&amp;rft.au=King%2C+MC&amp;rft.au=Weber%2C+B&amp;rft.au=Narod%2C+SA&amp;rft.au=Steel%2C+CM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2363321&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Vega2001-112\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Vega2001_112-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFVegaCamposBressac-De-PailleretsBond2001\" class=\"citation journal cs1\">Vega A, Campos B, Bressac-De-Paillerets B, Bond PM, Janin N, Douglas FS, Dom\\xc3\\xa8nech M, Baena M, Pericay C, Alonso C, Carracedo A, Baiget M, Diez O (June 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.1136\">\"The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript\"</a>. <i>Hum. Mutat</i>. <b>17</b> (6): 520\\xe2\\x80\\x931. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.1136\">10.1002/humu.1136</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11385711\">11385711</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:39462456\">39462456</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=The+R71G+BRCA1+is+a+founder+Spanish+mutation+and+leads+to+aberrant+splicing+of+the+transcript&amp;rft.volume=17&amp;rft.issue=6&amp;rft.pages=520-1&amp;rft.date=2001-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39462456%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11385711&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.1136&amp;rft.aulast=Vega&amp;rft.aufirst=A&amp;rft.au=Campos%2C+B&amp;rft.au=Bressac-De-Paillerets%2C+B&amp;rft.au=Bond%2C+PM&amp;rft.au=Janin%2C+N&amp;rft.au=Douglas%2C+FS&amp;rft.au=Dom%C3%A8nech%2C+M&amp;rft.au=Baena%2C+M&amp;rft.au=Pericay%2C+C&amp;rft.au=Alonso%2C+C&amp;rft.au=Carracedo%2C+A&amp;rft.au=Baiget%2C+M&amp;rft.au=Diez%2C+O&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.1136&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Campos2003-113\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Campos2003_113-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFCamposD\\xc3\\xadezOdefreyDom\\xc3\\xa8nech2003\" class=\"citation journal cs1\">Campos B, D\\xc3\\xadez O, Odefrey F, Dom\\xc3\\xa8nech M, Moncoutier V, Mart\\xc3\\xadnez-Ferrandis JI, Osorio A, Balma\\xc3\\xb1a J, Barroso A, Armengod ME, Ben\\xc3\\xadtez J, Alonso C, Stoppa-Lyonnet D, Goldgar D, Baiget M (April 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9133\">\"Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain\"</a>. <i>Hum. Mutat</i>. <b>21</b> (4): 452. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9133\">10.1002/humu.9133</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12655574\">12655574</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:34333797\">34333797</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=Haplotype+analysis+of+the+BRCA2+9254delATCAT+recurrent+mutation+in+breast%2Fovarian+cancer+families+from+Spain&amp;rft.volume=21&amp;rft.issue=4&amp;rft.pages=452&amp;rft.date=2003-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34333797%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12655574&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.9133&amp;rft.aulast=Campos&amp;rft.aufirst=B&amp;rft.au=D%C3%ADez%2C+O&amp;rft.au=Odefrey%2C+F&amp;rft.au=Dom%C3%A8nech%2C+M&amp;rft.au=Moncoutier%2C+V&amp;rft.au=Mart%C3%ADnez-Ferrandis%2C+JI&amp;rft.au=Osorio%2C+A&amp;rft.au=Balma%C3%B1a%2C+J&amp;rft.au=Barroso%2C+A&amp;rft.au=Armengod%2C+ME&amp;rft.au=Ben%C3%ADtez%2C+J&amp;rft.au=Alonso%2C+C&amp;rft.au=Stoppa-Lyonnet%2C+D&amp;rft.au=Goldgar%2C+D&amp;rft.au=Baiget%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.9133&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Bergman2001-114\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bergman2001_114-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBergmanEinbeigiOlofssonTaib2001\" class=\"citation journal cs1\">Bergman A, Einbeigi Z, Olofsson U, Taib Z, Wallgren A, Karlsson P, Wahlstr\\xc3\\xb6m J, Martinsson T, Nordling M (October 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.ejhg.5200704\">\"The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation\"</a>. <i>Eur. J. Hum. Genet</i>. <b>9</b> (10): 787\\xe2\\x80\\x9393. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.ejhg.5200704\">10.1038/sj.ejhg.5200704</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11781691\">11781691</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Eur.+J.+Hum.+Genet.&amp;rft.atitle=The+western+Swedish+BRCA1+founder+mutation+3171ins5%3B+a+3.7+cM+conserved+haplotype+of+today+is+a+reminiscence+of+a+1500-year-old+mutation&amp;rft.volume=9&amp;rft.issue=10&amp;rft.pages=787-93&amp;rft.date=2001-10&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.ejhg.5200704&amp;rft_id=info%3Apmid%2F11781691&amp;rft.aulast=Bergman&amp;rft.aufirst=A&amp;rft.au=Einbeigi%2C+Z&amp;rft.au=Olofsson%2C+U&amp;rft.au=Taib%2C+Z&amp;rft.au=Wallgren%2C+A&amp;rft.au=Karlsson%2C+P&amp;rft.au=Wahlstr%C3%B6m%2C+J&amp;rft.au=Martinsson%2C+T&amp;rft.au=Nordling%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.ejhg.5200704&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid18192670-115\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18192670_115-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHansenKnowltonThyerCharleston2008\" class=\"citation journal cs1\">Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA (March 2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fhumrep%2Fdem408\">\"A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause\"</a>. <i>Hum. Reprod</i>. <b>23</b> (3): 699\\xe2\\x80\\x93708. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fhumrep%2Fdem408\">10.1093/humrep/dem408</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18192670\">18192670</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Reprod.&amp;rft.atitle=A+new+model+of+reproductive+aging%3A+the+decline+in+ovarian+non-growing+follicle+number+from+birth+to+menopause&amp;rft.volume=23&amp;rft.issue=3&amp;rft.pages=699-708&amp;rft.date=2008-03&amp;rft_id=info%3Adoi%2F10.1093%2Fhumrep%2Fdem408&amp;rft_id=info%3Apmid%2F18192670&amp;rft.aulast=Hansen&amp;rft.aufirst=KR&amp;rft.au=Knowlton%2C+NS&amp;rft.au=Thyer%2C+AC&amp;rft.au=Charleston%2C+JS&amp;rft.au=Soules%2C+MR&amp;rft.au=Klein%2C+NA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fhumrep%252Fdem408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-116\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-116\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHassoldHunt2009\" class=\"citation journal cs1\">Hassold T, Hunt P (December 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894811\">\"Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew\"</a>. <i>Current Opinion in Pediatrics</i>. <b>21</b> (6): 703\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1097%2FMOP.0b013e328332c6ab\">10.1097/MOP.0b013e328332c6ab</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894811\">2894811</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19881348\">19881348</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Pediatrics&amp;rft.atitle=Maternal+age+and+chromosomally+abnormal+pregnancies%3A+what+we+know+and+what+we+wish+we+knew&amp;rft.volume=21&amp;rft.issue=6&amp;rft.pages=703-8&amp;rft.date=2009-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2894811%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19881348&amp;rft_id=info%3Adoi%2F10.1097%2FMOP.0b013e328332c6ab&amp;rft.aulast=Hassold&amp;rft.aufirst=T&amp;rft.au=Hunt%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2894811&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid19996028-117\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid19996028_117-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid19996028_117-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFOktayKimBaradBabayev2010\" class=\"citation journal cs1\">Oktay K, Kim JY, Barad D, Babayev SN (January 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040011\">\"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks\"</a>. <i>J. Clin. Oncol</i>. <b>28</b> (2): 240\\xe2\\x80\\x934. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1200%2FJCO.2009.24.2057\">10.1200/JCO.2009.24.2057</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040011\">3040011</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19996028\">19996028</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.atitle=Association+of+BRCA1+mutations+with+occult+primary+ovarian+insufficiency%3A+a+possible+explanation+for+the+link+between+infertility+and+breast%2Fovarian+cancer+risks&amp;rft.volume=28&amp;rft.issue=2&amp;rft.pages=240-4&amp;rft.date=2010-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3040011%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19996028&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2009.24.2057&amp;rft.aulast=Oktay&amp;rft.aufirst=K&amp;rft.au=Kim%2C+JY&amp;rft.au=Barad%2C+D&amp;rft.au=Babayev%2C+SN&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3040011&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid16773440-118\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16773440_118-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFRzepka-G\\xc3\\xb3rskaTarnowskiChudecka-G\\xc5\\x82azG\\xc3\\xb3rski2006\" class=\"citation journal cs1\">Rzepka-G\\xc3\\xb3rska I, Tarnowski B, Chudecka-G\\xc5\\x82az A, G\\xc3\\xb3rski B, Zieli\\xc5\\x84ska D, To\\xc5\\x82oczko-Grabarek A (November 2006). \"Premature menopause in patients with BRCA1 gene mutation\". <i>Breast Cancer Res. Treat</i>. <b>100</b> (1): 59\\xe2\\x80\\x9363. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1007%2Fs10549-006-9220-1\">10.1007/s10549-006-9220-1</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/16773440\">16773440</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:19572648\">19572648</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Breast+Cancer+Res.+Treat.&amp;rft.atitle=Premature+menopause+in+patients+with+BRCA1+gene+mutation&amp;rft.volume=100&amp;rft.issue=1&amp;rft.pages=59-63&amp;rft.date=2006-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19572648%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16773440&amp;rft_id=info%3Adoi%2F10.1007%2Fs10549-006-9220-1&amp;rft.aulast=Rzepka-G%C3%B3rska&amp;rft.aufirst=I&amp;rft.au=Tarnowski%2C+B&amp;rft.au=Chudecka-G%C5%82az%2C+A&amp;rft.au=G%C3%B3rski%2C+B&amp;rft.au=Zieli%C5%84ska%2C+D&amp;rft.au=To%C5%82oczko-Grabarek%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Titus-119\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Titus_119-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Titus_119-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFTitusLiStobezkiAkula2013\" class=\"citation journal cs1\">Titus S, Li F, Stobezki R, Akula K, Unsal E, Jeong K, Dickler M, Robson M, Moy F, Goswami S, Oktay K (February 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130338\">\"Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans\"</a>. <i>Sci Transl Med</i>. <b>5</b> (172): 172ra21. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscitranslmed.3004925\">10.1126/scitranslmed.3004925</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130338\">5130338</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/23408054\">23408054</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sci+Transl+Med&amp;rft.atitle=Impairment+of+BRCA1-related+DNA+double-strand+break+repair+leads+to+ovarian+aging+in+mice+and+humans&amp;rft.volume=5&amp;rft.issue=172&amp;rft.pages=172ra21&amp;rft.date=2013-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5130338%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23408054&amp;rft_id=info%3Adoi%2F10.1126%2Fscitranslmed.3004925&amp;rft.aulast=Titus&amp;rft.aufirst=S&amp;rft.au=Li%2C+F&amp;rft.au=Stobezki%2C+R&amp;rft.au=Akula%2C+K&amp;rft.au=Unsal%2C+E&amp;rft.au=Jeong%2C+K&amp;rft.au=Dickler%2C+M&amp;rft.au=Robson%2C+M&amp;rft.au=Moy%2C+F&amp;rft.au=Goswami%2C+S&amp;rft.au=Oktay%2C+K&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5130338&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-120\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-120\">^</a></b></span> <span class=\"reference-text\">Bernstein H; Hopf FA; Michod RE (1987). The Molecular Basis of the Evolution of Sex. Adv. Genet. Advances in Genetics. Vol. 24. pp. 323\\xe2\\x80\\x9370. doi:10.1016/S0065-2660(08)60012-7. ISBN 9780120176243. PMID 3324702</span>\\n</li>\\n<li id=\"cite_note-Taron-121\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Taron_121-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Taron_121-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFTaronRosellFelipMendez2004\" class=\"citation journal cs1\">Taron M, Rosell R, Felip E, Mendez P, Souglakos J, Ronco MS, Queralt C, Majo J, Sanchez JM, Sanchez JJ, Maestre J (October 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fhmg%2Fddh260\">\"BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer\"</a>. <i>Hum. Mol. Genet</i>. <b>13</b> (20): 2443\\xe2\\x80\\x939. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fhmg%2Fddh260\">10.1093/hmg/ddh260</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15317748\">15317748</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mol.+Genet.&amp;rft.atitle=BRCA1+mRNA+expression+levels+as+an+indicator+of+chemoresistance+in+lung+cancer&amp;rft.volume=13&amp;rft.issue=20&amp;rft.pages=2443-9&amp;rft.date=2004-10&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2Fddh260&amp;rft_id=info%3Apmid%2F15317748&amp;rft.aulast=Taron&amp;rft.aufirst=M&amp;rft.au=Rosell%2C+R&amp;rft.au=Felip%2C+E&amp;rft.au=Mendez%2C+P&amp;rft.au=Souglakos%2C+J&amp;rft.au=Ronco%2C+MS&amp;rft.au=Queralt%2C+C&amp;rft.au=Majo%2C+J&amp;rft.au=Sanchez%2C+JM&amp;rft.au=Sanchez%2C+JJ&amp;rft.au=Maestre%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fhmg%252Fddh260&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-Papadaki-122\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Papadaki_122-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Papadaki_122-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPapadakiSfakianakiIoannidisLagoudaki2012\" class=\"citation journal cs1\">Papadaki C, Sfakianaki M, Ioannidis G, Lagoudaki E, Trypaki M, Tryfonidis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J (April 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1097%2FJTO.0b013e318244bdd4\">\"ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer\"</a>. <i>J Thorac Oncol</i>. <b>7</b> (4): 663\\xe2\\x80\\x9371. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1097%2FJTO.0b013e318244bdd4\">10.1097/JTO.0b013e318244bdd4</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22425915\">22425915</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Thorac+Oncol&amp;rft.atitle=ERCC1+and+BRAC1+mRNA+expression+levels+in+the+primary+tumor+could+predict+the+effectiveness+of+the+second-line+cisplatin-based+chemotherapy+in+pretreated+patients+with+metastatic+non-small+cell+lung+cancer&amp;rft.volume=7&amp;rft.issue=4&amp;rft.pages=663-71&amp;rft.date=2012-04&amp;rft_id=info%3Adoi%2F10.1097%2FJTO.0b013e318244bdd4&amp;rft_id=info%3Apmid%2F22425915&amp;rft.aulast=Papadaki&amp;rft.aufirst=C&amp;rft.au=Sfakianaki%2C+M&amp;rft.au=Ioannidis%2C+G&amp;rft.au=Lagoudaki%2C+E&amp;rft.au=Trypaki%2C+M&amp;rft.au=Tryfonidis%2C+K&amp;rft.au=Mavroudis%2C+D&amp;rft.au=Stathopoulos%2C+E&amp;rft.au=Georgoulias%2C+V&amp;rft.au=Souglakos%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1097%252FJTO.0b013e318244bdd4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid19035454-123\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19035454_123-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWeberpalsGarbuioO&#39;BrienClark-Knowles2009\" class=\"citation journal cs1\">Weberpals J, Garbuio K, O\\'Brien A, Clark-Knowles K, Doucette S, Antoniouk O, Goss G, Dimitroulakos J (February 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.23987\">\"The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer\"</a>. <i>Int. J. Cancer</i>. <b>124</b> (4): 806\\xe2\\x80\\x9315. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.23987\">10.1002/ijc.23987</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19035454\">19035454</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:13357407\">13357407</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.atitle=The+DNA+repair+proteins+BRCA1+and+ERCC1+as+predictive+markers+in+sporadic+ovarian+cancer&amp;rft.volume=124&amp;rft.issue=4&amp;rft.pages=806-15&amp;rft.date=2009-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13357407%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19035454&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.23987&amp;rft.aulast=Weberpals&amp;rft.aufirst=J&amp;rft.au=Garbuio%2C+K&amp;rft.au=O%27Brien%2C+A&amp;rft.au=Clark-Knowles%2C+K&amp;rft.au=Doucette%2C+S&amp;rft.au=Antoniouk%2C+O&amp;rft.au=Goss%2C+G&amp;rft.au=Dimitroulakos%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fijc.23987&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-url_BRCA1_patent_legal_battle-124\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-url_BRCA1_patent_legal_battle_124-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://edition.cnn.com/2009/HEALTH/05/12/us.genes.lawsuit/index.html\">\"ACLU sues over patents on breast cancer genes\"</a>. CNN. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090515095043/http://edition.cnn.com/2009/HEALTH/05/12/us.genes.lawsuit/index.html\">Archived</a> from the original on 15 May 2009<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-05-14</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=ACLU+sues+over+patents+on+breast+cancer+genes&amp;rft_id=http%3A%2F%2Fedition.cnn.com%2F2009%2FHEALTH%2F05%2F12%2Fus.genes.lawsuit%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-125\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-125\">^</a></b></span> <span class=\"reference-text\">Robert Cook-Deegan, MD et al (2010) <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047448/\">Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Inherited Susceptibility to Cancer: Comparing Breast and Ovarian Cancers to Colon Cancers: Patents and Licensing for Breast, Ovarian and Colon Cancer Testing</a> Genet Med.12(4 Suppl): S15\\xe2\\x80\\x93S38.</span>\\n</li>\\n<li id=\"cite_note-pmid12509391-126\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12509391_126-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBenowitz2003\" class=\"citation journal cs1\">Benowitz S (January 2003). \"European groups oppose Myriad\\'s latest patent on BRCA1\". <i>J. Natl. Cancer Inst</i>. <b>95</b> (1): 8\\xe2\\x80\\x939. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2F95.1.8\">10.1093/jnci/95.1.8</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12509391\">12509391</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.atitle=European+groups+oppose+Myriad%27s+latest+patent+on+BRCA1&amp;rft.volume=95&amp;rft.issue=1&amp;rft.pages=8-9&amp;rft.date=2003-01&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2F95.1.8&amp;rft_id=info%3Apmid%2F12509391&amp;rft.aulast=Benowitz&amp;rft.aufirst=S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-127\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-127\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFConleyVorhousCook-Deegan2011\" class=\"citation web cs1\">Conley J, Vorhous D, Cook-Deegan J (2011-03-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.genomicslawreport.com/index.php/2011/03/01/how-will-myriad-respond-to-the-next-generation-of-brca-testing/\">\"How Will Myriad Respond to the Next Generation of BRCA Testing?\"</a>. Robinson, Bradshaw, and Hinson<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-12-09</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=How+Will+Myriad+Respond+to+the+Next+Generation+of+BRCA+Testing%3F&amp;rft.pub=Robinson%2C+Bradshaw%2C+and+Hinson&amp;rft.date=2011-03-01&amp;rft.aulast=Conley&amp;rft.aufirst=J&amp;rft.au=Vorhous%2C+D&amp;rft.au=Cook-Deegan%2C+J&amp;rft_id=http%3A%2F%2Fwww.genomicslawreport.com%2Findex.php%2F2011%2F03%2F01%2Fhow-will-myriad-respond-to-the-next-generation-of-brca-testing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-urlGenetics_and_Patenting-128\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlGenetics_and_Patenting_128-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ornl.gov/sci/techresources/Human_Genome/elsi/patents.shtml\">\"Genetics and Patenting\"</a>. <i>Human Genome Project Information</i>. U.S. Department of Energy Genome Programs. 2010-07-07.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Human+Genome+Project+Information&amp;rft.atitle=Genetics+and+Patenting&amp;rft.date=2010-07-07&amp;rft_id=http%3A%2F%2Fwww.ornl.gov%2Fsci%2Ftechresources%2FHuman_Genome%2Felsi%2Fpatents.shtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-129\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-129\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLiptak2013\" class=\"citation news cs1\">Liptak A (June 13, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2013/06/14/us/supreme-court-rules-human-genes-may-not-be-patented.html\">\"Supreme Court Rules Human Genes May Not Be Patented\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 13,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Supreme+Court+Rules+Human+Genes+May+Not+Be+Patented&amp;rft.date=2013-06-13&amp;rft.aulast=Liptak&amp;rft.aufirst=Adam&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2013%2F06%2F14%2Fus%2Fsupreme-court-rules-human-genes-may-not-be-patented.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-130\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-130\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFCorderoy2013\" class=\"citation news cs1\">Corderoy A (February 15, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.smh.com.au/national/health/landmark-patent-ruling-over-breast-cancer-gene-brca1-20130215-2egsq.html\">\"Landmark patent ruling over breast cancer gene BRCA1\"</a>. <i><a href=\"/wiki/Sydney_Morning_Herald\" class=\"mw-redirect\" title=\"Sydney Morning Herald\">Sydney Morning Herald</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 14,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sydney+Morning+Herald&amp;rft.atitle=Landmark+patent+ruling+over+breast+cancer+gene+BRCA1&amp;rft.date=2013-02-15&amp;rft.aulast=Corderoy&amp;rft.aufirst=Amy&amp;rft_id=http%3A%2F%2Fwww.smh.com.au%2Fnational%2Fhealth%2Flandmark-patent-ruling-over-breast-cancer-gene-brca1-20130215-2egsq.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-131\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-131\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/world/2014/sep/05/court-rules-breast-cancer-gene-brca1-patented-australia\">\"Australian federal court rules isolated genetic material can be patented\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i>. 5 September 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 September</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Australian+federal+court+rules+isolated+genetic+material+can+be+patented&amp;rft.date=2014-09-05&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fworld%2F2014%2Fsep%2F05%2Fcourt-rules-breast-cancer-gene-brca1-patented-australia&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-theguardian_2015_oct_07-132\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-theguardian_2015_oct_07_132-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/society/2015/oct/07/patient-wins-high-court-challenge-against-companys-cancer-gene-patent\">\"Patient wins high court challenge against company\\'s cancer gene patent\"</a>. <i>The Guardian</i>. 7 October 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 October</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Patient+wins+high+court+challenge+against+company%27s+cancer+gene+patent&amp;rft.date=2015-10-07&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fsociety%2F2015%2Foct%2F07%2Fpatient-wins-high-court-challenge-against-companys-cancer-gene-patent&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12024016-133\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12024016_133-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFForayMarotRandrianarisonVenezia2002\" class=\"citation journal cs1\">Foray N, Marot D, Randrianarison V, Venezia ND, Picard D, Perricaudet M, Favaudon V, Jeggo P (June 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC133860\">\"Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation\"</a>. <i>Mol. Cell. Biol</i>. <b>22</b> (12): 4020\\xe2\\x80\\x9332. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1128%2FMCB.22.12.4020-4032.2002\">10.1128/MCB.22.12.4020-4032.2002</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC133860\">133860</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12024016\">12024016</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell.+Biol.&amp;rft.atitle=Constitutive+association+of+BRCA1+and+c-Abl+and+its+ATM-dependent+disruption+after+irradiation&amp;rft.volume=22&amp;rft.issue=12&amp;rft.pages=4020-32&amp;rft.date=2002-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC133860%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12024016&amp;rft_id=info%3Adoi%2F10.1128%2FMCB.22.12.4020-4032.2002&amp;rft.aulast=Foray&amp;rft.aufirst=N&amp;rft.au=Marot%2C+D&amp;rft.au=Randrianarison%2C+V&amp;rft.au=Venezia%2C+ND&amp;rft.au=Picard%2C+D&amp;rft.au=Perricaudet%2C+M&amp;rft.au=Favaudon%2C+V&amp;rft.au=Jeggo%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC133860&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10542266-134\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10542266_134-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFAltiokBattAltiokPapautsky1999\" class=\"citation journal cs1\">Altiok S, Batt D, Altiok N, Papautsky A, Downward J, Roberts TM, Avraham H (November 1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.45.32274\">\"Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells\"</a>. <i>J. Biol. Chem</i>. <b>274</b> (45): 32274\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.45.32274\">10.1074/jbc.274.45.32274</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10542266\">10542266</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Heregulin+induces+phosphorylation+of+BRCA1+through+phosphatidylinositol+3-Kinase%2FAKT+in+breast+cancer+cells&amp;rft.volume=274&amp;rft.issue=45&amp;rft.pages=32274-8&amp;rft.date=1999-11&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.274.45.32274&amp;rft_id=info%3Apmid%2F10542266&amp;rft.aulast=Altiok&amp;rft.aufirst=S&amp;rft.au=Batt%2C+D&amp;rft.au=Altiok%2C+N&amp;rft.au=Papautsky%2C+A&amp;rft.au=Downward%2C+J&amp;rft.au=Roberts%2C+TM&amp;rft.au=Avraham%2C+H&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.274.45.32274&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid19074868-135\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19074868_135-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFXiangOhashiHuangPandita2008\" class=\"citation journal cs1\">Xiang T, Ohashi A, Huang Y, Pandita TK, Ludwig T, Powell SN, Yang Q (December 2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605656\">\"Negative Regulation of AKT Activation by BRCA1\"</a>. <i>Cancer Res</i>. <b>68</b> (24): 10040\\xe2\\x80\\x934. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-08-3009\">10.1158/0008-5472.CAN-08-3009</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605656\">2605656</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19074868\">19074868</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Negative+Regulation+of+AKT+Activation+by+BRCA1&amp;rft.volume=68&amp;rft.issue=24&amp;rft.pages=10040-4&amp;rft.date=2008-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2605656%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19074868&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-08-3009&amp;rft.aulast=Xiang&amp;rft.aufirst=T&amp;rft.au=Ohashi%2C+A&amp;rft.au=Huang%2C+Y&amp;rft.au=Pandita%2C+TK&amp;rft.au=Ludwig%2C+T&amp;rft.au=Powell%2C+SN&amp;rft.au=Yang%2C+Q&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2605656&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11016951-136\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11016951_136-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYehHuRahmanLin2000\" class=\"citation journal cs1\">Yeh S, Hu YC, Rahman M, Lin HK, Hsu CL, Ting HJ, Kang HY, Chang C (October 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17187\">\"Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>97</b> (21): 11256\\xe2\\x80\\x9361. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000PNAS...9711256Y\">2000PNAS...9711256Y</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.190353897\">10.1073/pnas.190353897</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17187\">17187</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11016951\">11016951</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Increase+of+androgen-induced+cell+death+and+androgen+receptor+transactivation+by+BRCA1+in+prostate+cancer+cells&amp;rft.volume=97&amp;rft.issue=21&amp;rft.pages=11256-61&amp;rft.date=2000-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC17187%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11016951&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.190353897&amp;rft_id=info%3Abibcode%2F2000PNAS...9711256Y&amp;rft.aulast=Yeh&amp;rft.aufirst=S&amp;rft.au=Hu%2C+YC&amp;rft.au=Rahman%2C+M&amp;rft.au=Lin%2C+HK&amp;rft.au=Hsu%2C+CL&amp;rft.au=Ting%2C+HJ&amp;rft.au=Kang%2C+HY&amp;rft.au=Chang%2C+C&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC17187&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10608806-137\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10608806_137-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10608806_137-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFKimLimCanmanKastan1999\" class=\"citation journal cs1\">Kim ST, Lim DS, Canman CE, Kastan MB (December 1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.53.37538\">\"Substrate specificities and identification of putative substrates of ATM kinase family members\"</a>. <i>J. Biol. Chem</i>. <b>274</b> (53): 37538\\xe2\\x80\\x9343. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.53.37538\">10.1074/jbc.274.53.37538</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10608806\">10608806</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Substrate+specificities+and+identification+of+putative+substrates+of+ATM+kinase+family+members&amp;rft.volume=274&amp;rft.issue=53&amp;rft.pages=37538-43&amp;rft.date=1999-12&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.274.53.37538&amp;rft_id=info%3Apmid%2F10608806&amp;rft.aulast=Kim&amp;rft.aufirst=ST&amp;rft.au=Lim%2C+DS&amp;rft.au=Canman%2C+CE&amp;rft.au=Kastan%2C+MB&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.274.53.37538&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11114888-138\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11114888_138-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11114888_138-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFTibbettsCortezBrumbaughScully2000\" class=\"citation journal cs1\">Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, Abraham RT (December 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317107\">\"Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress\"</a>. <i>Genes Dev</i>. <b>14</b> (23): 2989\\xe2\\x80\\x933002. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2Fgad.851000\">10.1101/gad.851000</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317107\">317107</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11114888\">11114888</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes+Dev.&amp;rft.atitle=Functional+interactions+between+BRCA1+and+the+checkpoint+kinase+ATR+during+genotoxic+stress&amp;rft.volume=14&amp;rft.issue=23&amp;rft.pages=2989-3002&amp;rft.date=2000-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC317107%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11114888&amp;rft_id=info%3Adoi%2F10.1101%2Fgad.851000&amp;rft.aulast=Tibbetts&amp;rft.aufirst=RS&amp;rft.au=Cortez%2C+D&amp;rft.au=Brumbaugh%2C+KM&amp;rft.au=Scully%2C+R&amp;rft.au=Livingston%2C+D&amp;rft.au=Elledge%2C+SJ&amp;rft.au=Abraham%2C+RT&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC317107&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11016625-139\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11016625_139-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11016625_139-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChen2000\" class=\"citation journal cs1\">Chen J (September 2000). \"Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage\". <i>Cancer Res</i>. <b>60</b> (18): 5037\\xe2\\x80\\x939. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11016625\">11016625</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Ataxia+telangiectasia-related+protein+is+involved+in+the+phosphorylation+of+BRCA1+following+deoxyribonucleic+acid+damage&amp;rft.volume=60&amp;rft.issue=18&amp;rft.pages=5037-9&amp;rft.date=2000-09&amp;rft_id=info%3Apmid%2F11016625&amp;rft.aulast=Chen&amp;rft.aufirst=J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11278964-140\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11278964_140-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11278964_140-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFGateiZhouHobsonScott2001\" class=\"citation journal cs1\">Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK (May 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M011681200\">\"Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies\"</a>. <i>J. Biol. Chem</i>. <b>276</b> (20): 17276\\xe2\\x80\\x9380. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M011681200\">10.1074/jbc.M011681200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11278964\">11278964</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Ataxia+telangiectasia+mutated+%28ATM%29+kinase+and+ATM+and+Rad3+related+kinase+mediate+phosphorylation+of+Brca1+at+distinct+and+overlapping+sites.+In+vivo+assessment+using+phospho-specific+antibodies&amp;rft.volume=276&amp;rft.issue=20&amp;rft.pages=17276-80&amp;rft.date=2001-05&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M011681200&amp;rft_id=info%3Apmid%2F11278964&amp;rft.aulast=Gatei&amp;rft.aufirst=M&amp;rft.au=Zhou%2C+BB&amp;rft.au=Hobson%2C+K&amp;rft.au=Scott%2C+S&amp;rft.au=Young%2C+D&amp;rft.au=Khanna%2C+KK&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M011681200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10866324-141\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10866324_141-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFGateiScottFilippovitchSoronika2000\" class=\"citation journal cs1\">Gatei M, Scott SP, Filippovitch I, Soronika N, Lavin MF, Weber B, Khanna KK (June 2000). \"Role for ATM in DNA damage-induced phosphorylation of BRCA1\". <i>Cancer Res</i>. <b>60</b> (12): 3299\\xe2\\x80\\x93304. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10866324\">10866324</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Role+for+ATM+in+DNA+damage-induced+phosphorylation+of+BRCA1&amp;rft.volume=60&amp;rft.issue=12&amp;rft.pages=3299-304&amp;rft.date=2000-06&amp;rft_id=info%3Apmid%2F10866324&amp;rft.aulast=Gatei&amp;rft.aufirst=M&amp;rft.au=Scott%2C+SP&amp;rft.au=Filippovitch%2C+I&amp;rft.au=Soronika%2C+N&amp;rft.au=Lavin%2C+MF&amp;rft.au=Weber%2C+B&amp;rft.au=Khanna%2C+KK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10550055-142\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10550055_142-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFCortezWangQinElledge1999\" class=\"citation journal cs1\">Cortez D, Wang Y, Qin J, Elledge SJ (November 1999). \"Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks\". <i>Science</i>. <b>286</b> (5442): 1162\\xe2\\x80\\x936. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.286.5442.1162\">10.1126/science.286.5442.1162</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10550055\">10550055</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Requirement+of+ATM-dependent+phosphorylation+of+brca1+in+the+DNA+damage+response+to+double-strand+breaks&amp;rft.volume=286&amp;rft.issue=5442&amp;rft.pages=1162-6&amp;rft.date=1999-11&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.286.5442.1162&amp;rft_id=info%3Apmid%2F10550055&amp;rft.aulast=Cortez&amp;rft.aufirst=D&amp;rft.au=Wang%2C+Y&amp;rft.au=Qin%2C+J&amp;rft.au=Elledge%2C+SJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10945975-143\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10945975_143-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHouvrasBenezraZhangManfredi2000\" class=\"citation journal cs1\">Houvras Y, Benezra M, Zhang H, Manfredi JJ, Weber BL, Licht JD (November 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M002539200\">\"BRCA1 physically and functionally interacts with ATF1\"</a>. <i>J. Biol. Chem</i>. <b>275</b> (46): 36230\\xe2\\x80\\x937. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M002539200\">10.1074/jbc.M002539200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10945975\">10945975</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=BRCA1+physically+and+functionally+interacts+with+ATF1&amp;rft.volume=275&amp;rft.issue=46&amp;rft.pages=36230-7&amp;rft.date=2000-11&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M002539200&amp;rft_id=info%3Apmid%2F10945975&amp;rft.aulast=Houvras&amp;rft.aufirst=Y&amp;rft.au=Benezra%2C+M&amp;rft.au=Zhang%2C+H&amp;rft.au=Manfredi%2C+JJ&amp;rft.au=Weber%2C+BL&amp;rft.au=Licht%2C+JD&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M002539200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11301010-144\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11301010_144-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11301010_144-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFCantorBellGanesanKass2001\" class=\"citation journal cs1\">Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, Livingston DM (April 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2801%2900304-X\">\"BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function\"</a>. <i>Cell</i>. <b>105</b> (1): 149\\xe2\\x80\\x9360. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2801%2900304-X\">10.1016/S0092-8674(01)00304-X</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11301010\">11301010</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=BACH1%2C+a+novel+helicase-like+protein%2C+interacts+directly+with+BRCA1+and+contributes+to+its+DNA+repair+function&amp;rft.volume=105&amp;rft.issue=1&amp;rft.pages=149-60&amp;rft.date=2001-04&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2801%2900304-X&amp;rft_id=info%3Apmid%2F11301010&amp;rft.aulast=Cantor&amp;rft.aufirst=SB&amp;rft.au=Bell%2C+DW&amp;rft.au=Ganesan%2C+S&amp;rft.au=Kass%2C+EM&amp;rft.au=Drapkin%2C+R&amp;rft.au=Grossman%2C+S&amp;rft.au=Wahrer%2C+DC&amp;rft.au=Sgroi%2C+DC&amp;rft.au=Lane%2C+WS&amp;rft.au=Haber%2C+DA&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252801%252900304-X&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14636569-145\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid14636569_145-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFDongHakimiChenKumaraswamy2003\" class=\"citation journal cs1\">Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, Shiekhattar R (November 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2803%2900424-6\">\"Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair\"</a>. <i>Mol. Cell</i>. <b>12</b> (5): 1087\\xe2\\x80\\x9399. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2803%2900424-6\">10.1016/S1097-2765(03)00424-6</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14636569\">14636569</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=Regulation+of+BRCC%2C+a+holoenzyme+complex+containing+BRCA1+and+BRCA2%2C+by+a+signalosome-like+subunit+and+its+role+in+DNA+repair&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=1087-99&amp;rft.date=2003-11&amp;rft_id=info%3Adoi%2F10.1016%2FS1097-2765%2803%2900424-6&amp;rft_id=info%3Apmid%2F14636569&amp;rft.aulast=Dong&amp;rft.aufirst=Y&amp;rft.au=Hakimi%2C+MA&amp;rft.au=Chen%2C+X&amp;rft.au=Kumaraswamy%2C+E&amp;rft.au=Cooch%2C+NS&amp;rft.au=Godwin%2C+AK&amp;rft.au=Shiekhattar%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS1097-2765%252803%252900424-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9774970-146\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9774970_146-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9774970_146-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChenSilverWalpitaCantor1998\" class=\"citation journal cs1\">Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R (September 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2800%2980276-2\">\"Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells\"</a>. <i>Mol. Cell</i>. <b>2</b> (3): 317\\xe2\\x80\\x9328. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2800%2980276-2\">10.1016/S1097-2765(00)80276-2</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9774970\">9774970</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=Stable+interaction+between+the+products+of+the+BRCA1+and+BRCA2+tumor+suppressor+genes+in+mitotic+and+meiotic+cells&amp;rft.volume=2&amp;rft.issue=3&amp;rft.pages=317-28&amp;rft.date=1998-09&amp;rft_id=info%3Adoi%2F10.1016%2FS1097-2765%2800%2980276-2&amp;rft_id=info%3Apmid%2F9774970&amp;rft.aulast=Chen&amp;rft.aufirst=J&amp;rft.au=Silver%2C+DP&amp;rft.au=Walpita%2C+D&amp;rft.au=Cantor%2C+SB&amp;rft.au=Gazdar%2C+AF&amp;rft.au=Tomlinson%2C+G&amp;rft.au=Couch%2C+FJ&amp;rft.au=Weber%2C+BL&amp;rft.au=Ashley%2C+T&amp;rft.au=Livingston%2C+DM&amp;rft.au=Scully%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS1097-2765%252800%252980276-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14499622-147\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid14499622_147-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid14499622_147-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFReuterMedhurstWaisfiszZhi2003\" class=\"citation journal cs1\">Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, Gross HJ, Joenje H, Hoatlin ME, Mathew CG, Huber PA (October 2003). \"Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport\". <i>Exp. Cell Res</i>. <b>289</b> (2): 211\\xe2\\x80\\x9321. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0014-4827%2803%2900261-1\">10.1016/S0014-4827(03)00261-1</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14499622\">14499622</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Exp.+Cell+Res.&amp;rft.atitle=Yeast+two-hybrid+screens+imply+involvement+of+Fanconi+anemia+proteins+in+transcription+regulation%2C+cell+signaling%2C+oxidative+metabolism%2C+and+cellular+transport&amp;rft.volume=289&amp;rft.issue=2&amp;rft.pages=211-21&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1016%2FS0014-4827%2803%2900261-1&amp;rft_id=info%3Apmid%2F14499622&amp;rft.aulast=Reuter&amp;rft.aufirst=TY&amp;rft.au=Medhurst%2C+AL&amp;rft.au=Waisfisz%2C+Q&amp;rft.au=Zhi%2C+Y&amp;rft.au=Herterich%2C+S&amp;rft.au=Hoehn%2C+H&amp;rft.au=Gross%2C+HJ&amp;rft.au=Joenje%2C+H&amp;rft.au=Hoatlin%2C+ME&amp;rft.au=Mathew%2C+CG&amp;rft.au=Huber%2C+PA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11477095-148\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11477095_148-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSarkisianMasterHuberHa2001\" class=\"citation journal cs1\">Sarkisian CJ, Master SR, Huber LJ, Ha SI, Chodosh LA (October 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M106281200\">\"Analysis of murine Brca2 reveals conservation of protein\\xe2\\x80\\x93protein interactions but differences in nuclear localization signals\"</a>. <i>J. Biol. Chem</i>. <b>276</b> (40): 37640\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M106281200\">10.1074/jbc.M106281200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11477095\">11477095</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Analysis+of+murine+Brca2+reveals+conservation+of+protein%E2%80%93protein+interactions+but+differences+in+nuclear+localization+signals&amp;rft.volume=276&amp;rft.issue=40&amp;rft.pages=37640-8&amp;rft.date=2001-10&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M106281200&amp;rft_id=info%3Apmid%2F11477095&amp;rft.aulast=Sarkisian&amp;rft.aufirst=CJ&amp;rft.au=Master%2C+SR&amp;rft.au=Huber%2C+LJ&amp;rft.au=Ha%2C+SI&amp;rft.au=Chodosh%2C+LA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M106281200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14578343-149\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid14578343_149-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid14578343_149-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid14578343_149-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid14578343_149-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFRodriguezYuChenSongyang2003\" class=\"citation journal cs1\">Rodriguez M, Yu X, Chen J, Songyang Z (December 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C300407200\">\"Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains\"</a>. <i>J. Biol. Chem</i>. <b>278</b> (52): 52914\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C300407200\">10.1074/jbc.C300407200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14578343\">14578343</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Phosphopeptide+binding+specificities+of+BRCA1+COOH-terminal+%28BRCT%29+domains&amp;rft.volume=278&amp;rft.issue=52&amp;rft.pages=52914-8&amp;rft.date=2003-12&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.C300407200&amp;rft_id=info%3Apmid%2F14578343&amp;rft.aulast=Rodriguez&amp;rft.aufirst=M&amp;rft.au=Yu%2C+X&amp;rft.au=Chen%2C+J&amp;rft.au=Songyang%2C+Z&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.C300407200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15208681-150\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid15208681_150-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid15208681_150-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid15208681_150-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid15208681_150-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWadaOishiTakadaYanagisawa2004\" class=\"citation journal cs1\">Wada O, Oishi H, Takada I, Yanagisawa J, Yano T, Kato S (August 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1207786\">\"BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220\"</a>. <i>Oncogene</i>. <b>23</b> (35): 6000\\xe2\\x80\\x935. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1207786\">10.1038/sj.onc.1207786</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15208681\">15208681</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+function+mediates+a+TRAP%2FDRIP+complex+through+direct+interaction+with+TRAP220&amp;rft.volume=23&amp;rft.issue=35&amp;rft.pages=6000-5&amp;rft.date=2004-08&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1207786&amp;rft_id=info%3Apmid%2F15208681&amp;rft.aulast=Wada&amp;rft.aufirst=O&amp;rft.au=Oishi%2C+H&amp;rft.au=Takada%2C+I&amp;rft.au=Yanagisawa%2C+J&amp;rft.au=Yano%2C+T&amp;rft.au=Kato%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1207786&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15242590-151\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15242590_151-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBotuyanNomin\\xc3\\xa9YuJuranic2004\" class=\"citation journal cs1\">Botuyan MV, Nomin\\xc3\\xa9 Y, Yu X, Juranic N, Macura S, Chen J, Mer G (July 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652423\">\"Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains\"</a>. <i>Structure</i>. <b>12</b> (7): 1137\\xe2\\x80\\x9346. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.str.2004.06.002\">10.1016/j.str.2004.06.002</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652423\">3652423</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15242590\">15242590</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Structure&amp;rft.atitle=Structural+basis+of+BACH1+phosphopeptide+recognition+by+BRCA1+tandem+BRCT+domains&amp;rft.volume=12&amp;rft.issue=7&amp;rft.pages=1137-46&amp;rft.date=2004-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3652423%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15242590&amp;rft_id=info%3Adoi%2F10.1016%2Fj.str.2004.06.002&amp;rft.aulast=Botuyan&amp;rft.aufirst=MV&amp;rft.au=Nomin%C3%A9%2C+Y&amp;rft.au=Yu%2C+X&amp;rft.au=Juranic%2C+N&amp;rft.au=Macura%2C+S&amp;rft.au=Chen%2C+J&amp;rft.au=Mer%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3652423&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14576433-152\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14576433_152-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYuChiniHeMer2003\" class=\"citation journal cs1\">Yu X, Chini CC, He M, Mer G, Chen J (October 2003). \"The BRCT domain is a phospho-protein binding domain\". <i>Science</i>. <b>302</b> (5645): 639\\xe2\\x80\\x9342. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2003Sci...302..639Y\">2003Sci...302..639Y</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.1088753\">10.1126/science.1088753</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14576433\">14576433</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:29407635\">29407635</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=The+BRCT+domain+is+a+phospho-protein+binding+domain&amp;rft.volume=302&amp;rft.issue=5645&amp;rft.pages=639-42&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1088753&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A29407635%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14576433&amp;rft_id=info%3Abibcode%2F2003Sci...302..639Y&amp;rft.aulast=Yu&amp;rft.aufirst=X&amp;rft.au=Chini%2C+CC&amp;rft.au=He%2C+M&amp;rft.au=Mer%2C+G&amp;rft.au=Chen%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15133502-153\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15133502_153-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFClappertonMankeLoweryHo2004\" class=\"citation journal cs1\">Clapperton JA, Manke IA, Lowery DM, Ho T, Haire LF, Yaffe MB, Smerdon SJ (June 2004). \"Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer\". <i>Nature Structural &amp; Molecular Biology</i>. <b>11</b> (6): 512\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fnsmb775\">10.1038/nsmb775</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15133502\">15133502</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:7354915\">7354915</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.atitle=Structure+and+mechanism+of+BRCA1+BRCT+domain+recognition+of+phosphorylated+BACH1+with+implications+for+cancer&amp;rft.volume=11&amp;rft.issue=6&amp;rft.pages=512-8&amp;rft.date=2004-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7354915%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15133502&amp;rft_id=info%3Adoi%2F10.1038%2Fnsmb775&amp;rft.aulast=Clapperton&amp;rft.aufirst=JA&amp;rft.au=Manke%2C+IA&amp;rft.au=Lowery%2C+DM&amp;rft.au=Ho%2C+T&amp;rft.au=Haire%2C+LF&amp;rft.au=Yaffe%2C+MB&amp;rft.au=Smerdon%2C+SJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12080089-154\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12080089_154-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12080089_154-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid12080089_154-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHuLi2002\" class=\"citation journal cs1\">Hu YF, Li R (June 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC186344\">\"JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction\"</a>. <i>Genes Dev</i>. <b>16</b> (12): 1509\\xe2\\x80\\x9317. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2Fgad.995502\">10.1101/gad.995502</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC186344\">186344</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12080089\">12080089</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes+Dev.&amp;rft.atitle=JunB+potentiates+function+of+BRCA1+activation+domain+1+%28AD1%29+through+a+coiled-coil-mediated+interaction&amp;rft.volume=16&amp;rft.issue=12&amp;rft.pages=1509-17&amp;rft.date=2002-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC186344%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12080089&amp;rft_id=info%3Adoi%2F10.1101%2Fgad.995502&amp;rft.aulast=Hu&amp;rft.aufirst=YF&amp;rft.au=Li%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC186344&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10724175-155\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10724175_155-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLeeCollinsBrownLee2000\" class=\"citation journal cs1\">Lee JS, Collins KM, Brown AL, Lee CH, Chung JH (March 2000). \"hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response\". <i>Nature</i>. <b>404</b> (6774): 201\\xe2\\x80\\x934. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000Natur.404..201L\">2000Natur.404..201L</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2F35004614\">10.1038/35004614</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10724175\">10724175</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:4345911\">4345911</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=hCds1-mediated+phosphorylation+of+BRCA1+regulates+the+DNA+damage+response&amp;rft.volume=404&amp;rft.issue=6774&amp;rft.pages=201-4&amp;rft.date=2000-03&amp;rft_id=info%3Adoi%2F10.1038%2F35004614&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4345911%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10724175&amp;rft_id=info%3Abibcode%2F2000Natur.404..201L&amp;rft.aulast=Lee&amp;rft.aufirst=JS&amp;rft.au=Collins%2C+KM&amp;rft.au=Brown%2C+AL&amp;rft.au=Lee%2C+CH&amp;rft.au=Chung%2C+JH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid18804494-156\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18804494_156-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChabalier-TasteRaccaDozierLarminat2008\" class=\"citation journal cs1\">Chabalier-Taste C, Racca C, Dozier C, Larminat F (December 2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.bbamcr.2008.08.006\">\"BRCA1 is regulated by Chk2 in response to spindle damage\"</a>. <i>Biochim. Biophys. Acta</i>. <b>1783</b> (12): 2223\\xe2\\x80\\x9333. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.bbamcr.2008.08.006\">10.1016/j.bbamcr.2008.08.006</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18804494\">18804494</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochim.+Biophys.+Acta&amp;rft.atitle=BRCA1+is+regulated+by+Chk2+in+response+to+spindle+damage&amp;rft.volume=1783&amp;rft.issue=12&amp;rft.pages=2223-33&amp;rft.date=2008-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbamcr.2008.08.006&amp;rft_id=info%3Apmid%2F18804494&amp;rft.aulast=Chabalier-Taste&amp;rft.aufirst=C&amp;rft.au=Racca%2C+C&amp;rft.au=Dozier%2C+C&amp;rft.au=Larminat%2C+F&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.bbamcr.2008.08.006&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15096610-157\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15096610_157-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLinLiStewartElledge2004\" class=\"citation journal cs1\">Lin SY, Li K, Stewart GS, Elledge SJ (April 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC404071\">\"Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>101</b> (17): 6484\\xe2\\x80\\x939. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2004PNAS..101.6484L\">2004PNAS..101.6484L</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.0401847101\">10.1073/pnas.0401847101</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC404071\">404071</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15096610\">15096610</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Human+Claspin+works+with+BRCA1+to+both+positively+and+negatively+regulate+cell+proliferation&amp;rft.volume=101&amp;rft.issue=17&amp;rft.pages=6484-9&amp;rft.date=2004-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC404071%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15096610&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0401847101&amp;rft_id=info%3Abibcode%2F2004PNAS..101.6484L&amp;rft.aulast=Lin&amp;rft.aufirst=SY&amp;rft.au=Li%2C+K&amp;rft.au=Stewart%2C+GS&amp;rft.au=Elledge%2C+SJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC404071&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11739404-158\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11739404_158-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYeHuZhongNye2001\" class=\"citation journal cs1\">Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R (December 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150890\">\"BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations\"</a>. <i>J. Cell Biol</i>. <b>155</b> (6): 911\\xe2\\x80\\x9321. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1083%2Fjcb.200108049\">10.1083/jcb.200108049</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150890\">2150890</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11739404\">11739404</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Cell+Biol.&amp;rft.atitle=BRCA1-induced+large-scale+chromatin+unfolding+and+allele-specific+effects+of+cancer-predisposing+mutations&amp;rft.volume=155&amp;rft.issue=6&amp;rft.pages=911-21&amp;rft.date=2001-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2150890%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11739404&amp;rft_id=info%3Adoi%2F10.1083%2Fjcb.200108049&amp;rft.aulast=Ye&amp;rft.aufirst=Q&amp;rft.au=Hu%2C+YF&amp;rft.au=Zhong%2C+H&amp;rft.au=Nye%2C+AC&amp;rft.au=Belmont%2C+AS&amp;rft.au=Li%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2150890&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12700228-159\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12700228_159-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12700228_159-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBenezraChevallierMorrisonMacLachlan2003\" class=\"citation journal cs1\">Benezra M, Chevallier N, Morrison DJ, MacLachlan TK, El-Deiry WS, Licht JD (July 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M303076200\">\"BRCA1 augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunit\"</a>. <i>J. Biol. Chem</i>. <b>278</b> (29): 26333\\xe2\\x80\\x9341. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M303076200\">10.1074/jbc.M303076200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12700228\">12700228</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=BRCA1+augments+transcription+by+the+NF-kappaB+transcription+factor+by+binding+to+the+Rel+domain+of+the+p65%2FRelA+subunit&amp;rft.volume=278&amp;rft.issue=29&amp;rft.pages=26333-41&amp;rft.date=2003-07&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M303076200&amp;rft_id=info%3Apmid%2F12700228&amp;rft.aulast=Benezra&amp;rft.aufirst=M&amp;rft.au=Chevallier%2C+N&amp;rft.au=Morrison%2C+DJ&amp;rft.au=MacLachlan%2C+TK&amp;rft.au=El-Deiry%2C+WS&amp;rft.au=Licht%2C+JD&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M303076200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10655477-160\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10655477_160-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10655477_160-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPaoJanknechtRuffnerHunter2000\" class=\"citation journal cs1\">Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM (February 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15508\">\"CBP/p300 interact with and function as transcriptional coactivators of BRCA1\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>97</b> (3): 1020\\xe2\\x80\\x935. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000PNAS...97.1020P\">2000PNAS...97.1020P</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.97.3.1020\">10.1073/pnas.97.3.1020</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15508\">15508</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10655477\">10655477</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=CBP%2Fp300+interact+with+and+function+as+transcriptional+coactivators+of+BRCA1&amp;rft.volume=97&amp;rft.issue=3&amp;rft.pages=1020-5&amp;rft.date=2000-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC15508%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10655477&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.97.3.1020&amp;rft_id=info%3Abibcode%2F2000PNAS...97.1020P&amp;rft.aulast=Pao&amp;rft.aufirst=GM&amp;rft.au=Janknecht%2C+R&amp;rft.au=Ruffner%2C+H&amp;rft.au=Hunter%2C+T&amp;rft.au=Verma%2C+IM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC15508&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9926942-161\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9926942_161-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9926942_161-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChaiCuiShaoShyam1999\" class=\"citation journal cs1\">Chai YL, Cui J, Shao N, Shyam E, Reddy P, Rao VN (January 1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202323\">\"The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter\"</a>. <i>Oncogene</i>. <b>18</b> (1): 263\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202323\">10.1038/sj.onc.1202323</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9926942\">9926942</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=The+second+BRCT+domain+of+BRCA1+proteins+interacts+with+p53+and+stimulates+transcription+from+the+p21WAF1%2FCIP1+promoter&amp;rft.volume=18&amp;rft.issue=1&amp;rft.pages=263-8&amp;rft.date=1999-01&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1202323&amp;rft_id=info%3Apmid%2F9926942&amp;rft.aulast=Chai&amp;rft.aufirst=YL&amp;rft.au=Cui%2C+J&amp;rft.au=Shao%2C+N&amp;rft.au=Shyam%2C+E&amp;rft.au=Reddy%2C+P&amp;rft.au=Rao%2C+VN&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1202323&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11782371-162\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11782371_162-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11782371_162-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11782371_162-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFFanMaWangYuan2002\" class=\"citation journal cs1\">Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM (January 2002). \"p300 Modulates the BRCA1 inhibition of estrogen receptor activity\". <i>Cancer Res</i>. <b>62</b> (1): 141\\xe2\\x80\\x9351. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11782371\">11782371</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=p300+Modulates+the+BRCA1+inhibition+of+estrogen+receptor+activity&amp;rft.volume=62&amp;rft.issue=1&amp;rft.pages=141-51&amp;rft.date=2002-01&amp;rft_id=info%3Apmid%2F11782371&amp;rft.aulast=Fan&amp;rft.aufirst=S&amp;rft.au=Ma%2C+YX&amp;rft.au=Wang%2C+C&amp;rft.au=Yuan%2C+RQ&amp;rft.au=Meng%2C+Q&amp;rft.au=Wang%2C+JA&amp;rft.au=Erdos%2C+M&amp;rft.au=Goldberg%2C+ID&amp;rft.au=Webb%2C+P&amp;rft.au=Kushner%2C+PJ&amp;rft.au=Pestell%2C+RG&amp;rft.au=Rosen%2C+EM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9443979-163\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9443979_163-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFNeishAndersonSchlegelWei1998\" class=\"citation journal cs1\">Neish AS, Anderson SF, Schlegel BP, Wei W, Parvin JD (February 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC147327\">\"Factors associated with the mammalian RNA polymerase II holoenzyme\"</a>. <i>Nucleic Acids Res</i>. <b>26</b> (3): 847\\xe2\\x80\\x9353. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fnar%2F26.3.847\">10.1093/nar/26.3.847</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC147327\">147327</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9443979\">9443979</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nucleic+Acids+Res.&amp;rft.atitle=Factors+associated+with+the+mammalian+RNA+polymerase+II+holoenzyme&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=847-53&amp;rft.date=1998-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC147327%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9443979&amp;rft_id=info%3Adoi%2F10.1093%2Fnar%2F26.3.847&amp;rft.aulast=Neish&amp;rft.aufirst=AS&amp;rft.au=Anderson%2C+SF&amp;rft.au=Schlegel%2C+BP&amp;rft.au=Wei%2C+W&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC147327&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10403822-164\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10403822_164-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFO&#39;BrienLemkeCockeRao1999\" class=\"citation journal cs1\">O\\'Brien KA, Lemke SJ, Cocke KS, Rao RN, Beckmann RP (July 1999). \"Casein kinase 2 binds to and phosphorylates BRCA1\". <i>Biochem. Biophys. Res. Commun</i>. <b>260</b> (3): 658\\xe2\\x80\\x9364. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1006%2Fbbrc.1999.0892\">10.1006/bbrc.1999.0892</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10403822\">10403822</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochem.+Biophys.+Res.+Commun.&amp;rft.atitle=Casein+kinase+2+binds+to+and+phosphorylates+BRCA1&amp;rft.volume=260&amp;rft.issue=3&amp;rft.pages=658-64&amp;rft.date=1999-07&amp;rft_id=info%3Adoi%2F10.1006%2Fbbrc.1999.0892&amp;rft_id=info%3Apmid%2F10403822&amp;rft.aulast=O%27Brien&amp;rft.aufirst=KA&amp;rft.au=Lemke%2C+SJ&amp;rft.au=Cocke%2C+KS&amp;rft.au=Rao%2C+RN&amp;rft.au=Beckmann%2C+RP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11257228-165\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11257228_165-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFKleimanManley2001\" class=\"citation journal cs1\">Kleiman FE, Manley JL (March 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2801%2900270-7\">\"The BARD1-CstF-50 interaction links mRNA 3\\' end formation to DNA damage and tumor suppression\"</a>. <i>Cell</i>. <b>104</b> (5): 743\\xe2\\x80\\x9353. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2801%2900270-7\">10.1016/S0092-8674(01)00270-7</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11257228\">11257228</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=The+BARD1-CstF-50+interaction+links+mRNA+3%27+end+formation+to+DNA+damage+and+tumor+suppression&amp;rft.volume=104&amp;rft.issue=5&amp;rft.pages=743-53&amp;rft.date=2001-03&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2801%2900270-7&amp;rft_id=info%3Apmid%2F11257228&amp;rft.aulast=Kleiman&amp;rft.aufirst=FE&amp;rft.au=Manley%2C+JL&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252801%252900270-7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10477523-166\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10477523_166-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFKleimanManley1999\" class=\"citation journal cs1\">Kleiman FE, Manley JL (September 1999). \"Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50\". <i>Science</i>. <b>285</b> (5433): 1576\\xe2\\x80\\x939. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.285.5433.1576\">10.1126/science.285.5433.1576</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10477523\">10477523</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Functional+interaction+of+BRCA1-associated+BARD1+with+polyadenylation+factor+CstF-50&amp;rft.volume=285&amp;rft.issue=5433&amp;rft.pages=1576-9&amp;rft.date=1999-09&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.285.5433.1576&amp;rft_id=info%3Apmid%2F10477523&amp;rft.aulast=Kleiman&amp;rft.aufirst=FE&amp;rft.au=Manley%2C+JL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9244350-167\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9244350_167-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWangShaoDingCui1997\" class=\"citation journal cs1\">Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN (Jul 1997). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1201252\">\"BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases\"</a>. <i>Oncogene</i>. <b>15</b> (2): 143\\xe2\\x80\\x9357. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1201252\">10.1038/sj.onc.1201252</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9244350\">9244350</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+proteins+are+transported+to+the+nucleus+in+the+absence+of+serum+and+splice+variants+BRCA1a%2C+BRCA1b+are+tyrosine+phosphoproteins+that+associate+with+E2F%2C+cyclins+and+cyclin+dependent+kinases&amp;rft.volume=15&amp;rft.issue=2&amp;rft.pages=143-57&amp;rft.date=1997-07&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1201252&amp;rft_id=info%3Apmid%2F9244350&amp;rft.aulast=Wang&amp;rft.aufirst=H&amp;rft.au=Shao%2C+N&amp;rft.au=Ding%2C+QM&amp;rft.au=Cui%2C+J&amp;rft.au=Reddy%2C+ES&amp;rft.au=Rao%2C+VN&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1201252&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid8764100-168\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid8764100_168-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChenFarmerChenJones1996\" class=\"citation journal cs1\">Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH (July 1996). \"BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner\". <i>Cancer Res</i>. <b>56</b> (14): 3168\\xe2\\x80\\x9372. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/8764100\">8764100</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=BRCA1+is+a+220-kDa+nuclear+phosphoprotein+that+is+expressed+and+phosphorylated+in+a+cell+cycle-dependent+manner&amp;rft.volume=56&amp;rft.issue=14&amp;rft.pages=3168-72&amp;rft.date=1996-07&amp;rft_id=info%3Apmid%2F8764100&amp;rft.aulast=Chen&amp;rft.aufirst=Y&amp;rft.au=Farmer%2C+AA&amp;rft.au=Chen%2C+CF&amp;rft.au=Jones%2C+DC&amp;rft.au=Chen%2C+PL&amp;rft.au=Lee%2C+WH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10373534-169\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10373534_169-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFRuffnerJiangCraigHunter1999\" class=\"citation journal cs1\">Ruffner H, Jiang W, Craig AG, Hunter T, Verma IM (July 1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC84283\">\"BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site\"</a>. <i>Mol. Cell. Biol</i>. <b>19</b> (7): 4843\\xe2\\x80\\x9354. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1128%2FMCB.19.7.4843\">10.1128/MCB.19.7.4843</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC84283\">84283</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10373534\">10373534</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell.+Biol.&amp;rft.atitle=BRCA1+is+phosphorylated+at+serine+1497+in+vivo+at+a+cyclin-dependent+kinase+2+phosphorylation+site&amp;rft.volume=19&amp;rft.issue=7&amp;rft.pages=4843-54&amp;rft.date=1999-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC84283%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10373534&amp;rft_id=info%3Adoi%2F10.1128%2FMCB.19.7.4843&amp;rft.aulast=Ruffner&amp;rft.aufirst=H&amp;rft.au=Jiang%2C+W&amp;rft.au=Craig%2C+AG&amp;rft.au=Hunter%2C+T&amp;rft.au=Verma%2C+IM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC84283&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12592385-170\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12592385_170-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSchlegelStaritaParvin2003\" class=\"citation journal cs1\">Schlegel BP, Starita LM, Parvin JD (February 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1206195\">\"Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells\"</a>. <i>Oncogene</i>. <b>22</b> (7): 983\\xe2\\x80\\x9391. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1206195\">10.1038/sj.onc.1206195</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12592385\">12592385</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Overexpression+of+a+protein+fragment+of+RNA+helicase+A+causes+inhibition+of+endogenous+BRCA1+function+and+defects+in+ploidy+and+cytokinesis+in+mammary+epithelial+cells&amp;rft.volume=22&amp;rft.issue=7&amp;rft.pages=983-91&amp;rft.date=2003-02&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1206195&amp;rft_id=info%3Apmid%2F12592385&amp;rft.aulast=Schlegel&amp;rft.aufirst=BP&amp;rft.au=Starita%2C+LM&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1206195&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9662397-171\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9662397_171-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFAndersonSchlegelNakajimaWolpin1998\" class=\"citation journal cs1\">Anderson SF, Schlegel BP, Nakajima T, Wolpin ES, Parvin JD (July 1998). \"BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A\". <i>Nat. Genet</i>. <b>19</b> (3): 254\\xe2\\x80\\x936. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2F930\">10.1038/930</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9662397\">9662397</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:10953768\">10953768</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Genet.&amp;rft.atitle=BRCA1+protein+is+linked+to+the+RNA+polymerase+II+holoenzyme+complex+via+RNA+helicase+A&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=254-6&amp;rft.date=1998-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A10953768%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9662397&amp;rft_id=info%3Adoi%2F10.1038%2F930&amp;rft.aulast=Anderson&amp;rft.aufirst=SF&amp;rft.au=Schlegel%2C+BP&amp;rft.au=Nakajima%2C+T&amp;rft.au=Wolpin%2C+ES&amp;rft.au=Parvin%2C+JD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11313879-172\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11313879_172-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChaiChipitsynaCuiLiao2001\" class=\"citation journal cs1\">Chai Y, Chipitsyna G, Cui J, Liao B, Liu S, Aysola K, Yezdani M, Reddy ES, Rao VN (March 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204256\">\"c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells\"</a>. <i>Oncogene</i>. <b>20</b> (11): 1357\\xe2\\x80\\x9367. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204256\">10.1038/sj.onc.1204256</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11313879\">11313879</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=c-Fos+oncogene+regulator+Elk-1+interacts+with+BRCA1+splice+variants+BRCA1a%2F1b+and+enhances+BRCA1a%2F1b-mediated+growth+suppression+in+breast+cancer+cells&amp;rft.volume=20&amp;rft.issue=11&amp;rft.pages=1357-67&amp;rft.date=2001-03&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1204256&amp;rft_id=info%3Apmid%2F11313879&amp;rft.aulast=Chai&amp;rft.aufirst=Y&amp;rft.au=Chipitsyna%2C+G&amp;rft.au=Cui%2C+J&amp;rft.au=Liao%2C+B&amp;rft.au=Liu%2C+S&amp;rft.au=Aysola%2C+K&amp;rft.au=Yezdani%2C+M&amp;rft.au=Reddy%2C+ES&amp;rft.au=Rao%2C+VN&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1204256&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11493692-173\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11493692_173-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFZhengAnnabAfshariLee2001\" class=\"citation journal cs1\">Zheng L, Annab LA, Afshari CA, Lee WH, Boyer TG (August 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55496\">\"BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>98</b> (17): 9587\\xe2\\x80\\x9392. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2001PNAS...98.9587Z\">2001PNAS...98.9587Z</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.171174298\">10.1073/pnas.171174298</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55496\">55496</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11493692\">11493692</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1+mediates+ligand-independent+transcriptional+repression+of+the+estrogen+receptor&amp;rft.volume=98&amp;rft.issue=17&amp;rft.pages=9587-92&amp;rft.date=2001-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC55496%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11493692&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.171174298&amp;rft_id=info%3Abibcode%2F2001PNAS...98.9587Z&amp;rft.aulast=Zheng&amp;rft.aufirst=L&amp;rft.au=Annab%2C+LA&amp;rft.au=Afshari%2C+CA&amp;rft.au=Lee%2C+WH&amp;rft.au=Boyer%2C+TG&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC55496&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11244506-174\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11244506_174-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFFanMaWangYuan2001\" class=\"citation journal cs1\">Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM (January 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204073\">\"Role of direct interaction in BRCA1 inhibition of estrogen receptor activity\"</a>. <i>Oncogene</i>. <b>20</b> (1): 77\\xe2\\x80\\x9387. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204073\">10.1038/sj.onc.1204073</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11244506\">11244506</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Role+of+direct+interaction+in+BRCA1+inhibition+of+estrogen+receptor+activity&amp;rft.volume=20&amp;rft.issue=1&amp;rft.pages=77-87&amp;rft.date=2001-01&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1204073&amp;rft_id=info%3Apmid%2F11244506&amp;rft.aulast=Fan&amp;rft.aufirst=S&amp;rft.au=Ma%2C+YX&amp;rft.au=Wang%2C+C&amp;rft.au=Yuan%2C+RQ&amp;rft.au=Meng%2C+Q&amp;rft.au=Wang%2C+JA&amp;rft.au=Erdos%2C+M&amp;rft.au=Goldberg%2C+ID&amp;rft.au=Webb%2C+P&amp;rft.au=Kushner%2C+PJ&amp;rft.au=Pestell%2C+RG&amp;rft.au=Rosen%2C+EM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1204073&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12400015-175\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12400015_175-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFKawaiLiChunAvraham2002\" class=\"citation journal cs1\">Kawai H, Li H, Chun P, Avraham S, Avraham HK (October 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1205971\">\"Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells\"</a>. <i>Oncogene</i>. <b>21</b> (50): 7730\\xe2\\x80\\x939. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1205971\">10.1038/sj.onc.1205971</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12400015\">12400015</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Direct+interaction+between+BRCA1+and+the+estrogen+receptor+regulates+vascular+endothelial+growth+factor+%28VEGF%29+transcription+and+secretion+in+breast+cancer+cells&amp;rft.volume=21&amp;rft.issue=50&amp;rft.pages=7730-9&amp;rft.date=2002-10&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1205971&amp;rft_id=info%3Apmid%2F12400015&amp;rft.aulast=Kawai&amp;rft.aufirst=H&amp;rft.au=Li%2C+H&amp;rft.au=Chun%2C+P&amp;rft.au=Avraham%2C+S&amp;rft.au=Avraham%2C+HK&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1205971&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12354784-176\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12354784_176-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFFoliasMatkovicBruunReid2002\" class=\"citation journal cs1\">Folias A, Matkovic M, Bruun D, Reid S, Hejna J, Grompe M, D\\'Andrea A, Moses R (October 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fhmg%2F11.21.2591\">\"BRCA1 interacts directly with the Fanconi anemia protein FANCA\"</a>. <i>Hum. Mol. Genet</i>. <b>11</b> (21): 2591\\xe2\\x80\\x937. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Fhmg%2F11.21.2591\">10.1093/hmg/11.21.2591</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12354784\">12354784</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mol.+Genet.&amp;rft.atitle=BRCA1+interacts+directly+with+the+Fanconi+anemia+protein+FANCA&amp;rft.volume=11&amp;rft.issue=21&amp;rft.pages=2591-7&amp;rft.date=2002-10&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2F11.21.2591&amp;rft_id=info%3Apmid%2F12354784&amp;rft.aulast=Folias&amp;rft.aufirst=A&amp;rft.au=Matkovic%2C+M&amp;rft.au=Bruun%2C+D&amp;rft.au=Reid%2C+S&amp;rft.au=Hejna%2C+J&amp;rft.au=Grompe%2C+M&amp;rft.au=D%27Andrea%2C+A&amp;rft.au=Moses%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fhmg%252F11.21.2591&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12887909-177\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12887909_177-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12887909_177-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFVandenbergGergelyOngPace2003\" class=\"citation journal cs1\">Vandenberg CJ, Gergely F, Ong CY, Pace P, Mallery DL, Hiom K, Patel KJ (July 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2803%2900281-8\">\"BRCA1-independent ubiquitination of FANCD2\"</a>. <i>Mol. Cell</i>. <b>12</b> (1): 247\\xe2\\x80\\x9354. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2803%2900281-8\">10.1016/S1097-2765(03)00281-8</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12887909\">12887909</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=BRCA1-independent+ubiquitination+of+FANCD2&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=247-54&amp;rft.date=2003-07&amp;rft_id=info%3Adoi%2F10.1016%2FS1097-2765%2803%2900281-8&amp;rft_id=info%3Apmid%2F12887909&amp;rft.aulast=Vandenberg&amp;rft.aufirst=CJ&amp;rft.au=Gergely%2C+F&amp;rft.au=Ong%2C+CY&amp;rft.au=Pace%2C+P&amp;rft.au=Mallery%2C+DL&amp;rft.au=Hiom%2C+K&amp;rft.au=Patel%2C+KJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS1097-2765%252803%252900281-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14550570-178\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14550570_178-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYanZhuZhongLu2003\" class=\"citation journal cs1\">Yan J, Zhu J, Zhong H, Lu Q, Huang C, Ye Q (October 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0014-5793%2803%2900978-5\">\"BRCA1 interacts with FHL2 and enhances FHL2 transactivation function\"</a>. <i>FEBS Lett</i>. <b>553</b> (1\\xe2\\x80\\x932): 183\\xe2\\x80\\x939. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0014-5793%2803%2900978-5\">10.1016/S0014-5793(03)00978-5</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14550570\">14550570</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:31566004\">31566004</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FEBS+Lett.&amp;rft.atitle=BRCA1+interacts+with+FHL2+and+enhances+FHL2+transactivation+function&amp;rft.volume=553&amp;rft.issue=1%E2%80%932&amp;rft.pages=183-9&amp;rft.date=2003-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31566004%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14550570&amp;rft_id=info%3Adoi%2F10.1016%2FS0014-5793%2803%2900978-5&amp;rft.aulast=Yan&amp;rft.aufirst=J&amp;rft.au=Zhu%2C+J&amp;rft.au=Zhong%2C+H&amp;rft.au=Lu%2C+Q&amp;rft.au=Huang%2C+C&amp;rft.au=Ye%2C+Q&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0014-5793%252803%252900978-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14986435-179\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14986435_179-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYanYeZhuZhong2003\" class=\"citation journal cs1 cs1-prop-foreign-lang-source\">Yan JH, Ye QN, Zhu JH, Zhong HJ, Zheng HY, Huang CF (December 2003). \"[Isolation and characterization of a BRCA1-interacting protein]\". <i>Yi Chuan Xue Bao</i> (in Chinese). <b>30</b> (12): 1161\\xe2\\x80\\x936. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14986435\">14986435</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Yi+Chuan+Xue+Bao&amp;rft.atitle=%5BIsolation+and+characterization+of+a+BRCA1-interacting+protein%5D&amp;rft.volume=30&amp;rft.issue=12&amp;rft.pages=1161-6&amp;rft.date=2003-12&amp;rft_id=info%3Apmid%2F14986435&amp;rft.aulast=Yan&amp;rft.aufirst=JH&amp;rft.au=Ye%2C+QN&amp;rft.au=Zhu%2C+JH&amp;rft.au=Zhong%2C+HJ&amp;rft.au=Zheng%2C+HY&amp;rft.au=Huang%2C+CF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12485996-180\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12485996_180-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12485996_180-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFMalleryVandenbergHiom2002\" class=\"citation journal cs1\">Mallery DL, Vandenberg CJ, Hiom K (December 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139111\">\"Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains\"</a>. <i>EMBO J</i>. <b>21</b> (24): 6755\\xe2\\x80\\x9362. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Femboj%2Fcdf691\">10.1093/emboj/cdf691</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139111\">139111</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12485996\">12485996</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EMBO+J.&amp;rft.atitle=Activation+of+the+E3+ligase+function+of+the+BRCA1%2FBARD1+complex+by+polyubiquitin+chains&amp;rft.volume=21&amp;rft.issue=24&amp;rft.pages=6755-62&amp;rft.date=2002-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC139111%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12485996&amp;rft_id=info%3Adoi%2F10.1093%2Femboj%2Fcdf691&amp;rft.aulast=Mallery&amp;rft.aufirst=DL&amp;rft.au=Vandenberg%2C+CJ&amp;rft.au=Hiom%2C+K&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC139111&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11927591-181\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11927591_181-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11927591_181-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChenKleimanManleyOuchi2002\" class=\"citation journal cs1\">Chen A, Kleiman FE, Manley JL, Ouchi T, Pan ZQ (June 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M201252200\">\"Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase\"</a>. <i>J. Biol. Chem</i>. <b>277</b> (24): 22085\\xe2\\x80\\x9392. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M201252200\">10.1074/jbc.M201252200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11927591\">11927591</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Autoubiquitination+of+the+BRCA1%2ABARD1+RING+ubiquitin+ligase&amp;rft.volume=277&amp;rft.issue=24&amp;rft.pages=22085-92&amp;rft.date=2002-06&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M201252200&amp;rft_id=info%3Apmid%2F11927591&amp;rft.aulast=Chen&amp;rft.aufirst=A&amp;rft.au=Kleiman%2C+FE&amp;rft.au=Manley%2C+JL&amp;rft.au=Ouchi%2C+T&amp;rft.au=Pan%2C+ZQ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M201252200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10959836-182\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10959836_182-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPaullRogakouYamazakiKirchgessner2000\" class=\"citation journal cs1\">Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM (2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0960-9822%2800%2900610-2\">\"A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage\"</a>. <i>Curr. Biol</i>. <b>10</b> (15): 886\\xe2\\x80\\x9395. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0960-9822%2800%2900610-2\">10.1016/S0960-9822(00)00610-2</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10959836\">10959836</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Curr.+Biol.&amp;rft.atitle=A+critical+role+for+histone+H2AX+in+recruitment+of+repair+factors+to+nuclear+foci+after+DNA+damage&amp;rft.volume=10&amp;rft.issue=15&amp;rft.pages=886-95&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1016%2FS0960-9822%2800%2900610-2&amp;rft_id=info%3Apmid%2F10959836&amp;rft.aulast=Paull&amp;rft.aufirst=TT&amp;rft.au=Rogakou%2C+EP&amp;rft.au=Yamazaki%2C+V&amp;rft.au=Kirchgessner%2C+CU&amp;rft.au=Gellert%2C+M&amp;rft.au=Bonner%2C+WM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0960-9822%252800%252900610-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12925972-183\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12925972_183-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSutherlandVisvaderChoongSum2003\" class=\"citation journal cs1\">Sutherland KD, Visvader JE, Choong DY, Sum EY, Lindeman GJ, Campbell IG (October 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.11343\">\"Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas\"</a>. <i>Int. J. Cancer</i>. <b>107</b> (1): 155\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.11343\">10.1002/ijc.11343</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12925972\">12925972</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:20908722\">20908722</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.atitle=Mutational+analysis+of+the+LMO4+gene%2C+encoding+a+BRCA1-interacting+protein%2C+in+breast+carcinomas&amp;rft.volume=107&amp;rft.issue=1&amp;rft.pages=155-8&amp;rft.date=2003-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20908722%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12925972&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.11343&amp;rft.aulast=Sutherland&amp;rft.aufirst=KD&amp;rft.au=Visvader%2C+JE&amp;rft.au=Choong%2C+DY&amp;rft.au=Sum%2C+EY&amp;rft.au=Lindeman%2C+GJ&amp;rft.au=Campbell%2C+IG&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fijc.11343&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11751867-184\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11751867_184-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSumPengYuChen2002\" class=\"citation journal cs1\">Sum EY, Peng B, Yu X, Chen J, Byrne J, Lindeman GJ, Visvader JE (March 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M110603200\">\"The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity\"</a>. <i>J. Biol. Chem</i>. <b>277</b> (10): 7849\\xe2\\x80\\x9356. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M110603200\">10.1074/jbc.M110603200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11751867\">11751867</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=The+LIM+domain+protein+LMO4+interacts+with+the+cofactor+CtIP+and+the+tumor+suppressor+BRCA1+and+inhibits+BRCA1+activity&amp;rft.volume=277&amp;rft.issue=10&amp;rft.pages=7849-56&amp;rft.date=2002-03&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M110603200&amp;rft_id=info%3Apmid%2F11751867&amp;rft.aulast=Sum&amp;rft.aufirst=EY&amp;rft.au=Peng%2C+B&amp;rft.au=Yu%2C+X&amp;rft.au=Chen%2C+J&amp;rft.au=Byrne%2C+J&amp;rft.au=Lindeman%2C+GJ&amp;rft.au=Visvader%2C+JE&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M110603200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15205325-185\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15205325_185-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFGilmoreMcCabeQuinnKennedy2004\" class=\"citation journal cs1\">Gilmore PM, McCabe N, Quinn JE, Kennedy RD, Gorski JJ, Andrews HN, McWilliams S, Carty M, Mullan PB, Duprex WP, Liu ET, Johnston PG, Harkin DP (June 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-03-4080\">\"BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3\"</a>. <i>Cancer Res</i>. <b>64</b> (12): 4148\\xe2\\x80\\x9354. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-03-4080\">10.1158/0008-5472.CAN-03-4080</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15205325\">15205325</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=BRCA1+interacts+with+and+is+required+for+paclitaxel-induced+activation+of+mitogen-activated+protein+kinase+kinase+kinase+3&amp;rft.volume=64&amp;rft.issue=12&amp;rft.pages=4148-54&amp;rft.date=2004-06&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-03-4080&amp;rft_id=info%3Apmid%2F15205325&amp;rft.aulast=Gilmore&amp;rft.aufirst=PM&amp;rft.au=McCabe%2C+N&amp;rft.au=Quinn%2C+JE&amp;rft.au=Kennedy%2C+RD&amp;rft.au=Gorski%2C+JJ&amp;rft.au=Andrews%2C+HN&amp;rft.au=McWilliams%2C+S&amp;rft.au=Carty%2C+M&amp;rft.au=Mullan%2C+PB&amp;rft.au=Duprex%2C+WP&amp;rft.au=Liu%2C+ET&amp;rft.au=Johnston%2C+PG&amp;rft.au=Harkin%2C+DP&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1158%252F0008-5472.CAN-03-4080&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11504724-186\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11504724_186-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11504724_186-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11504724_186-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid11504724_186-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid11504724_186-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChibaParvin2001\" class=\"citation journal cs1\">Chiba N, Parvin JD (October 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M105227200\">\"Redistribution of BRCA1 among four different protein complexes following replication blockage\"</a>. <i>J. Biol. Chem</i>. <b>276</b> (42): 38549\\xe2\\x80\\x9354. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M105227200\">10.1074/jbc.M105227200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11504724\">11504724</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Redistribution+of+BRCA1+among+four+different+protein+complexes+following+replication+blockage&amp;rft.volume=276&amp;rft.issue=42&amp;rft.pages=38549-54&amp;rft.date=2001-10&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M105227200&amp;rft_id=info%3Apmid%2F11504724&amp;rft.aulast=Chiba&amp;rft.aufirst=N&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M105227200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12154023-187\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12154023_187-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChibaParvin2002\" class=\"citation journal cs1\">Chiba N, Parvin JD (August 2002). \"The BRCA1 and BARD1 association with the RNA polymerase II holoenzyme\". <i>Cancer Res</i>. <b>62</b> (15): 4222\\xe2\\x80\\x938. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12154023\">12154023</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=The+BRCA1+and+BARD1+association+with+the+RNA+polymerase+II+holoenzyme&amp;rft.volume=62&amp;rft.issue=15&amp;rft.pages=4222-8&amp;rft.date=2002-08&amp;rft_id=info%3Apmid%2F12154023&amp;rft.aulast=Chiba&amp;rft.aufirst=N&amp;rft.au=Parvin%2C+JD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9159119-188\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9159119_188-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9159119_188-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFScullyAndersonChaoWei1997\" class=\"citation journal cs1\">Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD (May 1997). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20825\">\"BRCA1 is a component of the RNA polymerase II holoenzyme\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>94</b> (11): 5605\\xe2\\x80\\x9310. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1997PNAS...94.5605S\">1997PNAS...94.5605S</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.94.11.5605\">10.1073/pnas.94.11.5605</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20825\">20825</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9159119\">9159119</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1+is+a+component+of+the+RNA+polymerase+II+holoenzyme&amp;rft.volume=94&amp;rft.issue=11&amp;rft.pages=5605-10&amp;rft.date=1997-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC20825%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9159119&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.94.11.5605&amp;rft_id=info%3Abibcode%2F1997PNAS...94.5605S&amp;rft.aulast=Scully&amp;rft.aufirst=R&amp;rft.au=Anderson%2C+SF&amp;rft.au=Chao%2C+DM&amp;rft.au=Wei%2C+W&amp;rft.au=Ye%2C+L&amp;rft.au=Young%2C+RA&amp;rft.au=Livingston%2C+DM&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC20825&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10426999-189\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10426999_189-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10426999_189-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid10426999_189-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFZhongChenLiChen1999\" class=\"citation journal cs1\">Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J, Chen PL, Sharp ZD, Lee WH (July 1999). \"Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response\". <i>Science</i>. <b>285</b> (5428): 747\\xe2\\x80\\x9350. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.285.5428.747\">10.1126/science.285.5428.747</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10426999\">10426999</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Association+of+BRCA1+with+the+hRad50-hMre11-p95+complex+and+the+DNA+damage+response&amp;rft.volume=285&amp;rft.issue=5428&amp;rft.pages=747-50&amp;rft.date=1999-07&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.285.5428.747&amp;rft_id=info%3Apmid%2F10426999&amp;rft.aulast=Zhong&amp;rft.aufirst=Q&amp;rft.au=Chen%2C+CF&amp;rft.au=Li%2C+S&amp;rft.au=Chen%2C+Y&amp;rft.au=Wang%2C+CC&amp;rft.au=Xiao%2C+J&amp;rft.au=Chen%2C+PL&amp;rft.au=Sharp%2C+ZD&amp;rft.au=Lee%2C+WH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11353843-190\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11353843_190-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFPaullCortezBowersElledge2001\" class=\"citation journal cs1\">Paull TT, Cortez D, Bowers B, Elledge SJ, Gellert M (May 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33426\">\"Direct DNA binding by Brca1\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>98</b> (11): 6086\\xe2\\x80\\x9391. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.111125998\">10.1073/pnas.111125998</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33426\">33426</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11353843\">11353843</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Direct+DNA+binding+by+Brca1&amp;rft.volume=98&amp;rft.issue=11&amp;rft.pages=6086-91&amp;rft.date=2001-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33426%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11353843&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.111125998&amp;rft.aulast=Paull&amp;rft.aufirst=TT&amp;rft.au=Cortez%2C+D&amp;rft.au=Bowers%2C+B&amp;rft.au=Elledge%2C+SJ&amp;rft.au=Gellert%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33426&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11916966-191\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11916966_191-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11916966_191-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLiLeeAvraham2002\" class=\"citation journal cs1\">Li H, Lee TH, Avraham H (June 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M112231200\">\"A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer\"</a>. <i>J. Biol. Chem</i>. <b>277</b> (23): 20965\\xe2\\x80\\x9373. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M112231200\">10.1074/jbc.M112231200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11916966\">11916966</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=A+novel+tricomplex+of+BRCA1%2C+Nmi%2C+and+c-Myc+inhibits+c-Myc-induced+human+telomerase+reverse+transcriptase+gene+%28hTERT%29+promoter+activity+in+breast+cancer&amp;rft.volume=277&amp;rft.issue=23&amp;rft.pages=20965-73&amp;rft.date=2002-06&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M112231200&amp;rft_id=info%3Apmid%2F11916966&amp;rft.aulast=Li&amp;rft.aufirst=H&amp;rft.au=Lee%2C+TH&amp;rft.au=Avraham%2C+H&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M112231200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14612409-192\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14612409_192-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFXiongFanMengSchramm2003\" class=\"citation journal cs1\">Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM (December 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC262673\">\"BRCA1 inhibition of telomerase activity in cultured cells\"</a>. <i>Mol. Cell. Biol</i>. <b>23</b> (23): 8668\\xe2\\x80\\x9390. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1128%2FMCB.23.23.8668-8690.2003\">10.1128/MCB.23.23.8668-8690.2003</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC262673\">262673</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14612409\">14612409</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell.+Biol.&amp;rft.atitle=BRCA1+inhibition+of+telomerase+activity+in+cultured+cells&amp;rft.volume=23&amp;rft.issue=23&amp;rft.pages=8668-90&amp;rft.date=2003-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC262673%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F14612409&amp;rft_id=info%3Adoi%2F10.1128%2FMCB.23.23.8668-8690.2003&amp;rft.aulast=Xiong&amp;rft.aufirst=J&amp;rft.au=Fan%2C+S&amp;rft.au=Meng%2C+Q&amp;rft.au=Schramm%2C+L&amp;rft.au=Wang%2C+C&amp;rft.au=Bouzahza%2C+B&amp;rft.au=Zhou%2C+J&amp;rft.au=Zafonte%2C+B&amp;rft.au=Goldberg%2C+ID&amp;rft.au=Haddad%2C+BR&amp;rft.au=Pestell%2C+RG&amp;rft.au=Rosen%2C+EM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC262673&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12646176-193\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12646176_193-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFZhouLiu2003\" class=\"citation journal cs1\">Zhou C, Liu J (March 2003). \"Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells\". <i>Biochem. Biophys. Res. Commun</i>. <b>303</b> (1): 130\\xe2\\x80\\x936. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0006-291X%2803%2900318-8\">10.1016/S0006-291X(03)00318-8</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12646176\">12646176</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochem.+Biophys.+Res.+Commun.&amp;rft.atitle=Inhibition+of+human+telomerase+reverse+transcriptase+gene+expression+by+BRCA1+in+human+ovarian+cancer+cells&amp;rft.volume=303&amp;rft.issue=1&amp;rft.pages=130-6&amp;rft.date=2003-03&amp;rft_id=info%3Adoi%2F10.1016%2FS0006-291X%2803%2900318-8&amp;rft_id=info%3Apmid%2F12646176&amp;rft.aulast=Zhou&amp;rft.aufirst=C&amp;rft.au=Liu%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15184379-194\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid15184379_194-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid15184379_194-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSatoHayamiWuNishikawa2004\" class=\"citation journal cs1\">Sato K, Hayami R, Wu W, Nishikawa T, Nishikawa H, Okuda Y, Ogata H, Fukuda M, Ohta T (July 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C400169200\">\"Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase\"</a>. <i>J. Biol. Chem</i>. <b>279</b> (30): 30919\\xe2\\x80\\x9322. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C400169200\">10.1074/jbc.C400169200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15184379\">15184379</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Nucleophosmin%2FB23+is+a+candidate+substrate+for+the+BRCA1-BARD1+ubiquitin+ligase&amp;rft.volume=279&amp;rft.issue=30&amp;rft.pages=30919-22&amp;rft.date=2004-07&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.C400169200&amp;rft_id=info%3Apmid%2F15184379&amp;rft.aulast=Sato&amp;rft.aufirst=K&amp;rft.au=Hayami%2C+R&amp;rft.au=Wu%2C+W&amp;rft.au=Nishikawa%2C+T&amp;rft.au=Nishikawa%2C+H&amp;rft.au=Okuda%2C+Y&amp;rft.au=Ogata%2C+H&amp;rft.au=Fukuda%2C+M&amp;rft.au=Ohta%2C+T&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.C400169200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11085509-195\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11085509_195-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFParkIrvineBuchananKoh2000\" class=\"citation journal cs1\">Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup MR, Press MF, Coetzee GA (November 2000). \"Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor\". <i>Cancer Res</i>. <b>60</b> (21): 5946\\xe2\\x80\\x939. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11085509\">11085509</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Breast+cancer+susceptibility+gene+1+%28BRCAI%29+is+a+coactivator+of+the+androgen+receptor&amp;rft.volume=60&amp;rft.issue=21&amp;rft.pages=5946-9&amp;rft.date=2000-11&amp;rft_id=info%3Apmid%2F11085509&amp;rft.aulast=Park&amp;rft.aufirst=JJ&amp;rft.au=Irvine%2C+RA&amp;rft.au=Buchanan%2C+G&amp;rft.au=Koh%2C+SS&amp;rft.au=Park%2C+JM&amp;rft.au=Tilley%2C+WD&amp;rft.au=Stallcup%2C+MR&amp;rft.au=Press%2C+MF&amp;rft.au=Coetzee%2C+GA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15107825-196\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15107825_196-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFCabartChewMurphy2004\" class=\"citation journal cs1\">Cabart P, Chew HK, Murphy S (July 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1207684\">\"BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II\"</a>. <i>Oncogene</i>. <b>23</b> (31): 5316\\xe2\\x80\\x9329. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1207684\">10.1038/sj.onc.1207684</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15107825\">15107825</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+cooperates+with+NUFIP+and+P-TEFb+to+activate+transcription+by+RNA+polymerase+II&amp;rft.volume=23&amp;rft.issue=31&amp;rft.pages=5316-29&amp;rft.date=2004-07&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1207684&amp;rft_id=info%3Apmid%2F15107825&amp;rft.aulast=Cabart&amp;rft.aufirst=P&amp;rft.au=Chew%2C+HK&amp;rft.au=Murphy%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1207684&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14710355-197\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14710355_197-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFAbramovitchWerner2003\" class=\"citation journal cs1\">Abramovitch S, Werner H (2003). \"Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene\". <i>Horm. Metab. Res</i>. <b>35</b> (11\\xe2\\x80\\x9312): 758\\xe2\\x80\\x9362. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1055%2Fs-2004-814154\">10.1055/s-2004-814154</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14710355\">14710355</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Horm.+Metab.+Res.&amp;rft.atitle=Functional+and+physical+interactions+between+BRCA1+and+p53+in+transcriptional+regulation+of+the+IGF-IR+gene&amp;rft.volume=35&amp;rft.issue=11%E2%80%9312&amp;rft.pages=758-62&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2004-814154&amp;rft_id=info%3Apmid%2F14710355&amp;rft.aulast=Abramovitch&amp;rft.aufirst=S&amp;rft.au=Werner%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9482880-198\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9482880_198-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFOuchiMonteiroAugustAaronson1998\" class=\"citation journal cs1\">Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H (March 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC19327\">\"BRCA1 regulates p53-dependent gene expression\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>95</b> (5): 2302\\xe2\\x80\\x936. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1998PNAS...95.2302O\">1998PNAS...95.2302O</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.95.5.2302\">10.1073/pnas.95.5.2302</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC19327\">19327</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9482880\">9482880</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1+regulates+p53-dependent+gene+expression&amp;rft.volume=95&amp;rft.issue=5&amp;rft.pages=2302-6&amp;rft.date=1998-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC19327%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9482880&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.95.5.2302&amp;rft_id=info%3Abibcode%2F1998PNAS...95.2302O&amp;rft.aulast=Ouchi&amp;rft.aufirst=T&amp;rft.au=Monteiro%2C+AN&amp;rft.au=August%2C+A&amp;rft.au=Aaronson%2C+SA&amp;rft.au=Hanafusa%2C+H&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC19327&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9582019-199\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9582019_199-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFZhangSomasundaramPengTian1998\" class=\"citation journal cs1\">Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber BL, El-Deiry WS (April 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1201932\">\"BRCA1 physically associates with p53 and stimulates its transcriptional activity\"</a>. <i>Oncogene</i>. <b>16</b> (13): 1713\\xe2\\x80\\x9321. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1201932\">10.1038/sj.onc.1201932</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9582019\">9582019</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+physically+associates+with+p53+and+stimulates+its+transcriptional+activity&amp;rft.volume=16&amp;rft.issue=13&amp;rft.pages=1713-21&amp;rft.date=1998-04&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1201932&amp;rft_id=info%3Apmid%2F9582019&amp;rft.aulast=Zhang&amp;rft.aufirst=H&amp;rft.au=Somasundaram%2C+K&amp;rft.au=Peng%2C+Y&amp;rft.au=Tian%2C+H&amp;rft.au=Zhang%2C+H&amp;rft.au=Bi%2C+D&amp;rft.au=Weber%2C+BL&amp;rft.au=El-Deiry%2C+WS&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1201932&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid19369211-200\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19369211_200-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSyHuenChen2009\" class=\"citation journal cs1\">Sy SM, Huen MS, Chen J (April 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678481\">\"PALB2 is an integral component of the BRCA complex required for homologous recombination repair\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>106</b> (17): 7155\\xe2\\x80\\x9360. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2009PNAS..106.7155S\">2009PNAS..106.7155S</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.0811159106\">10.1073/pnas.0811159106</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678481\">2678481</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19369211\">19369211</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=PALB2+is+an+integral+component+of+the+BRCA+complex+required+for+homologous+recombination+repair&amp;rft.volume=106&amp;rft.issue=17&amp;rft.pages=7155-60&amp;rft.date=2009-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2678481%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19369211&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0811159106&amp;rft_id=info%3Abibcode%2F2009PNAS..106.7155S&amp;rft.aulast=Sy&amp;rft.aufirst=SM&amp;rft.au=Huen%2C+MS&amp;rft.au=Chen%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2678481&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14506230-201\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14506230_201-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFKrumMirandaLinLane2003\" class=\"citation journal cs1\">Krum SA, Miranda GA, Lin C, Lane TF (December 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M308418200\">\"BRCA1 associates with processive RNA polymerase II\"</a>. <i>J. Biol. Chem</i>. <b>278</b> (52): 52012\\xe2\\x80\\x9320. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M308418200\">10.1074/jbc.M308418200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14506230\">14506230</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=BRCA1+associates+with+processive+RNA+polymerase+II&amp;rft.volume=278&amp;rft.issue=52&amp;rft.pages=52012-20&amp;rft.date=2003-12&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M308418200&amp;rft_id=info%3Apmid%2F14506230&amp;rft.aulast=Krum&amp;rft.aufirst=SA&amp;rft.au=Miranda%2C+GA&amp;rft.au=Lin%2C+C&amp;rft.au=Lane%2C+TF&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M308418200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12955082-202\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12955082_202-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFKrumWomackLane2003\" class=\"citation journal cs1\">Krum SA, Womack JE, Lane TF (September 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1206515\">\"Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity\"</a>. <i>Oncogene</i>. <b>22</b> (38): 6032\\xe2\\x80\\x9344. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1206515\">10.1038/sj.onc.1206515</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12955082\">12955082</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Bovine+BRCA1+shows+classic+responses+to+genotoxic+stress+but+low+in+vitro+transcriptional+activation+activity&amp;rft.volume=22&amp;rft.issue=38&amp;rft.pages=6032-44&amp;rft.date=2003-09&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1206515&amp;rft_id=info%3Apmid%2F12955082&amp;rft.aulast=Krum&amp;rft.aufirst=SA&amp;rft.au=Womack%2C+JE&amp;rft.au=Lane%2C+TF&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1206515&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12438214-203\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12438214_203-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLiuVirshupWhiteHsu2002\" class=\"citation journal cs1\">Liu Y, Virshup DM, White RL, Hsu LC (November 2002). \"Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha\". <i>Cancer Res</i>. <b>62</b> (22): 6357\\xe2\\x80\\x9361. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12438214\">12438214</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Regulation+of+BRCA1+phosphorylation+by+interaction+with+protein+phosphatase+1alpha&amp;rft.volume=62&amp;rft.issue=22&amp;rft.pages=6357-61&amp;rft.date=2002-11&amp;rft_id=info%3Apmid%2F12438214&amp;rft.aulast=Liu&amp;rft.aufirst=Y&amp;rft.au=Virshup%2C+DM&amp;rft.au=White%2C+RL&amp;rft.au=Hsu%2C+LC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9008167-204\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9008167_204-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFScullyChenPlugXiao1997\" class=\"citation journal cs1\">Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM (January 1997). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2981847-4\">\"Association of BRCA1 with Rad51 in mitotic and meiotic cells\"</a>. <i>Cell</i>. <b>88</b> (2): 265\\xe2\\x80\\x9375. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2981847-4\">10.1016/S0092-8674(00)81847-4</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9008167\">9008167</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=Association+of+BRCA1+with+Rad51+in+mitotic+and+meiotic+cells&amp;rft.volume=88&amp;rft.issue=2&amp;rft.pages=265-75&amp;rft.date=1997-01&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2800%2981847-4&amp;rft_id=info%3Apmid%2F9008167&amp;rft.aulast=Scully&amp;rft.aufirst=R&amp;rft.au=Chen%2C+J&amp;rft.au=Plug%2C+A&amp;rft.au=Xiao%2C+Y&amp;rft.au=Weaver%2C+D&amp;rft.au=Feunteun%2C+J&amp;rft.au=Ashley%2C+T&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252800%252981847-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10220405-205\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10220405_205-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10220405_205-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid10220405_205-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYardenBrody1999\" class=\"citation journal cs1\">Yarden RI, Brody LC (April 1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC21803\">\"BRCA1 interacts with components of the histone deacetylase complex\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>96</b> (9): 4983\\xe2\\x80\\x938. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1999PNAS...96.4983Y\">1999PNAS...96.4983Y</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.96.9.4983\">10.1073/pnas.96.9.4983</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC21803\">21803</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10220405\">10220405</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1+interacts+with+components+of+the+histone+deacetylase+complex&amp;rft.volume=96&amp;rft.issue=9&amp;rft.pages=4983-8&amp;rft.date=1999-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC21803%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10220405&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.96.9.4983&amp;rft_id=info%3Abibcode%2F1999PNAS...96.4983Y&amp;rft.aulast=Yarden&amp;rft.aufirst=RI&amp;rft.au=Brody%2C+LC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC21803&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11394910-206\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11394910_206-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFChenGuanYuLi2001\" class=\"citation journal cs1\">Chen GC, Guan LS, Yu JH, Li GC, Choi Kim HR, Wang ZY (June 2001). \"Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1\". <i>Biochem. Biophys. Res. Commun</i>. <b>284</b> (2): 507\\xe2\\x80\\x9314. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1006%2Fbbrc.2001.5003\">10.1006/bbrc.2001.5003</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11394910\">11394910</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochem.+Biophys.+Res.+Commun.&amp;rft.atitle=Rb-associated+protein+46+%28RbAp46%29+inhibits+transcriptional+transactivation+mediated+by+BRCA1&amp;rft.volume=284&amp;rft.issue=2&amp;rft.pages=507-14&amp;rft.date=2001-06&amp;rft_id=info%3Adoi%2F10.1006%2Fbbrc.2001.5003&amp;rft_id=info%3Apmid%2F11394910&amp;rft.aulast=Chen&amp;rft.aufirst=GC&amp;rft.au=Guan%2C+LS&amp;rft.au=Yu%2C+JH&amp;rft.au=Li%2C+GC&amp;rft.au=Choi+Kim%2C+HR&amp;rft.au=Wang%2C+ZY&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11746496-207\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11746496_207-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11746496_207-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYardenBrody2001\" class=\"citation journal cs1\">Yarden RI, Brody LC (2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://zenodo.org/record/1229223\">\"Identification of proteins that interact with BRCA1 by Far-Western library screening\"</a>. <i>J. Cell. Biochem</i>. <b>83</b> (4): 521\\xe2\\x80\\x9331. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fjcb.1257\">10.1002/jcb.1257</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11746496\">11746496</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:29703139\">29703139</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Cell.+Biochem.&amp;rft.atitle=Identification+of+proteins+that+interact+with+BRCA1+by+Far-Western+library+screening&amp;rft.volume=83&amp;rft.issue=4&amp;rft.pages=521-31&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A29703139%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11746496&amp;rft_id=info%3Adoi%2F10.1002%2Fjcb.1257&amp;rft.aulast=Yarden&amp;rft.aufirst=RI&amp;rft.au=Brody%2C+LC&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1229223&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9738006-208\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9738006_208-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYuWuBowcockAronheim1998\" class=\"citation journal cs1\">Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R (September 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.273.39.25388\">\"The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression\"</a>. <i>J. Biol. Chem</i>. <b>273</b> (39): 25388\\xe2\\x80\\x9392. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.273.39.25388\">10.1074/jbc.273.39.25388</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9738006\">9738006</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=The+C-terminal+%28BRCT%29+domains+of+BRCA1+interact+in+vivo+with+CtIP%2C+a+protein+implicated+in+the+CtBP+pathway+of+transcriptional+repression&amp;rft.volume=273&amp;rft.issue=39&amp;rft.pages=25388-92&amp;rft.date=1998-09&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.273.39.25388&amp;rft_id=info%3Apmid%2F9738006&amp;rft.aulast=Yu&amp;rft.aufirst=X&amp;rft.au=Wu%2C+LC&amp;rft.au=Bowcock%2C+AM&amp;rft.au=Aronheim%2C+A&amp;rft.au=Baer%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.273.39.25388&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10196224-209\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10196224_209-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLiChenSubramanianChinnadurai1999\" class=\"citation journal cs1\">Li S, Chen PL, Subramanian T, Chinnadurai G, Tomlinson G, Osborne CK, Sharp ZD, Lee WH (April 1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.16.11334\">\"Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage\"</a>. <i>J. Biol. Chem</i>. <b>274</b> (16): 11334\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.16.11334\">10.1074/jbc.274.16.11334</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10196224\">10196224</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Binding+of+CtIP+to+the+BRCT+repeats+of+BRCA1+involved+in+the+transcription+regulation+of+p21+is+disrupted+upon+DNA+damage&amp;rft.volume=274&amp;rft.issue=16&amp;rft.pages=11334-8&amp;rft.date=1999-04&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.274.16.11334&amp;rft_id=info%3Apmid%2F10196224&amp;rft.aulast=Li&amp;rft.aufirst=S&amp;rft.au=Chen%2C+PL&amp;rft.au=Subramanian%2C+T&amp;rft.au=Chinnadurai%2C+G&amp;rft.au=Tomlinson%2C+G&amp;rft.au=Osborne%2C+CK&amp;rft.au=Sharp%2C+ZD&amp;rft.au=Lee%2C+WH&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.274.16.11334&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid9811458-210\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9811458_210-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWongOrmondePeroChen1998\" class=\"citation journal cs1\">Wong AK, Ormonde PA, Pero R, Chen Y, Lian L, Salada G, Berry S, Lawrence Q, Dayananth P, Ha P, Tavtigian SV, Teng DH, Bartel PL (November 1998). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202150\">\"Characterization of a carboxy-terminal BRCA1 interacting protein\"</a>. <i>Oncogene</i>. <b>17</b> (18): 2279\\xe2\\x80\\x9385. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202150\">10.1038/sj.onc.1202150</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9811458\">9811458</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Characterization+of+a+carboxy-terminal+BRCA1+interacting+protein&amp;rft.volume=17&amp;rft.issue=18&amp;rft.pages=2279-85&amp;rft.date=1998-11&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1202150&amp;rft_id=info%3Apmid%2F9811458&amp;rft.aulast=Wong&amp;rft.aufirst=AK&amp;rft.au=Ormonde%2C+PA&amp;rft.au=Pero%2C+R&amp;rft.au=Chen%2C+Y&amp;rft.au=Lian%2C+L&amp;rft.au=Salada%2C+G&amp;rft.au=Berry%2C+S&amp;rft.au=Lawrence%2C+Q&amp;rft.au=Dayananth%2C+P&amp;rft.au=Ha%2C+P&amp;rft.au=Tavtigian%2C+SV&amp;rft.au=Teng%2C+DH&amp;rft.au=Bartel%2C+PL&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1202150&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10910365-211\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10910365_211-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFLiTingZhengChen2000\" class=\"citation journal cs1\">Li S, Ting NS, Zheng L, Chen PL, Ziv Y, Shiloh Y, Lee EY, Lee WH (July 2000). \"Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response\". <i>Nature</i>. <b>406</b> (6792): 210\\xe2\\x80\\x935. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000Natur.406..210L\">2000Natur.406..210L</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2F35018134\">10.1038/35018134</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10910365\">10910365</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:3266654\">3266654</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Functional+link+of+BRCA1+and+ataxia+telangiectasia+gene+product+in+DNA+damage+response&amp;rft.volume=406&amp;rft.issue=6792&amp;rft.pages=210-5&amp;rft.date=2000-07&amp;rft_id=info%3Adoi%2F10.1038%2F35018134&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3266654%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10910365&amp;rft_id=info%3Abibcode%2F2000Natur.406..210L&amp;rft.aulast=Li&amp;rft.aufirst=S&amp;rft.au=Ting%2C+NS&amp;rft.au=Zheng%2C+L&amp;rft.au=Chen%2C+PL&amp;rft.au=Ziv%2C+Y&amp;rft.au=Shiloh%2C+Y&amp;rft.au=Lee%2C+EY&amp;rft.au=Lee%2C+WH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11689934-212\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11689934_212-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWu-BaerBaer2001\" class=\"citation journal cs1\">Wu-Baer F, Baer R (November 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2F35102118\">\"Effect of DNA damage on a BRCA1 complex\"</a>. <i>Nature</i>. <b>414</b> (6859): 36. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2F35102118\">10.1038/35102118</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11689934\">11689934</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:4329675\">4329675</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Effect+of+DNA+damage+on+a+BRCA1+complex&amp;rft.volume=414&amp;rft.issue=6859&amp;rft.pages=36&amp;rft.date=2001-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4329675%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11689934&amp;rft_id=info%3Adoi%2F10.1038%2F35102118&amp;rft.aulast=Wu-Baer&amp;rft.aufirst=F&amp;rft.au=Baer%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252F35102118&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10764811-213\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10764811_213-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFYuBaer2000\" class=\"citation journal cs1\">Yu X, Baer R (June 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M909494199\">\"Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor\"</a>. <i>J. Biol. Chem</i>. <b>275</b> (24): 18541\\xe2\\x80\\x939. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M909494199\">10.1074/jbc.M909494199</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10764811\">10764811</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Nuclear+localization+and+cell+cycle-specific+expression+of+CtIP%2C+a+protein+that+associates+with+the+BRCA1+tumor+suppressor&amp;rft.volume=275&amp;rft.issue=24&amp;rft.pages=18541-9&amp;rft.date=2000-06&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M909494199&amp;rft_id=info%3Apmid%2F10764811&amp;rft.aulast=Yu&amp;rft.aufirst=X&amp;rft.au=Baer%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M909494199&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11521194-214\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11521194_214-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11521194_214-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11521194_214-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFFanYuanMaXiong2001\" class=\"citation journal cs1\">Fan S, Yuan R, Ma YX, Xiong J, Meng Q, Erdos M, Zhao JN, Goldberg ID, Pestell RG, Rosen EM (August 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204666\">\"Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding\"</a>. <i>Oncogene</i>. <b>20</b> (35): 4827\\xe2\\x80\\x9341. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204666\">10.1038/sj.onc.1204666</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11521194\">11521194</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Disruption+of+BRCA1+LXCXE+motif+alters+BRCA1+functional+activity+and+regulation+of+RB+family+but+not+RB+protein+binding&amp;rft.volume=20&amp;rft.issue=35&amp;rft.pages=4827-41&amp;rft.date=2001-08&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1204666&amp;rft_id=info%3Apmid%2F11521194&amp;rft.aulast=Fan&amp;rft.aufirst=S&amp;rft.au=Yuan%2C+R&amp;rft.au=Ma%2C+YX&amp;rft.au=Xiong%2C+J&amp;rft.au=Meng%2C+Q&amp;rft.au=Erdos%2C+M&amp;rft.au=Zhao%2C+JN&amp;rft.au=Goldberg%2C+ID&amp;rft.au=Pestell%2C+RG&amp;rft.au=Rosen%2C+EM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1204666&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10518542-215\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10518542_215-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFAprelikovaFangMeissnerCotter1999\" class=\"citation journal cs1\">Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET (October 1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18378\">\"BRCA1-associated growth arrest is RB-dependent\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>96</b> (21): 11866\\xe2\\x80\\x9371. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1999PNAS...9611866A\">1999PNAS...9611866A</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.96.21.11866\">10.1073/pnas.96.21.11866</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18378\">18378</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10518542\">10518542</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1-associated+growth+arrest+is+RB-dependent&amp;rft.volume=96&amp;rft.issue=21&amp;rft.pages=11866-71&amp;rft.date=1999-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC18378%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10518542&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.96.21.11866&amp;rft_id=info%3Abibcode%2F1999PNAS...9611866A&amp;rft.aulast=Aprelikova&amp;rft.aufirst=ON&amp;rft.au=Fang%2C+BS&amp;rft.au=Meissner%2C+EG&amp;rft.au=Cotter%2C+S&amp;rft.au=Campbell%2C+M&amp;rft.au=Kuthiala%2C+A&amp;rft.au=Bessho%2C+M&amp;rft.au=Jensen%2C+RA&amp;rft.au=Liu%2C+ET&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC18378&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10943845-216\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10943845_216-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10943845_216-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBocharWangBeniyaKinev2000\" class=\"citation journal cs1\">Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R (July 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2900030-1\">\"BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer\"</a>. <i>Cell</i>. <b>102</b> (2): 257\\xe2\\x80\\x9365. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2900030-1\">10.1016/S0092-8674(00)00030-1</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10943845\">10943845</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=BRCA1+is+associated+with+a+human+SWI%2FSNF-related+complex%3A+linking+chromatin+remodeling+to+breast+cancer&amp;rft.volume=102&amp;rft.issue=2&amp;rft.pages=257-65&amp;rft.date=2000-07&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2800%2900030-1&amp;rft_id=info%3Apmid%2F10943845&amp;rft.aulast=Bochar&amp;rft.aufirst=DA&amp;rft.au=Wang%2C+L&amp;rft.au=Beniya%2C+H&amp;rft.au=Kinev%2C+A&amp;rft.au=Xue%2C+Y&amp;rft.au=Lane%2C+WS&amp;rft.au=Wang%2C+W&amp;rft.au=Kashanchi%2C+F&amp;rft.au=Shiekhattar%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252800%252900030-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15034933-217\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15034933_217-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHillde_la_SernaVealImbalzano2004\" class=\"citation journal cs1\">Hill DA, de la Serna IL, Veal TM, Imbalzano AN (April 2004). \"BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2\". <i>J. Cell. Biochem</i>. <b>91</b> (5): 987\\xe2\\x80\\x9398. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fjcb.20003\">10.1002/jcb.20003</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15034933\">15034933</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:40668596\">40668596</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Cell.+Biochem.&amp;rft.atitle=BRCA1+interacts+with+dominant+negative+SWI%2FSNF+enzymes+without+affecting+homologous+recombination+or+radiation-induced+gene+activation+of+p21+or+Mdm2&amp;rft.volume=91&amp;rft.issue=5&amp;rft.pages=987-98&amp;rft.date=2004-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A40668596%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15034933&amp;rft_id=info%3Adoi%2F10.1002%2Fjcb.20003&amp;rft.aulast=Hill&amp;rft.aufirst=DA&amp;rft.au=de+la+Serna%2C+IL&amp;rft.au=Veal%2C+TM&amp;rft.au=Imbalzano%2C+AN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10792030-218\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10792030_218-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFOuchiLeeOuchiAaronson2000\" class=\"citation journal cs1\">Ouchi T, Lee SW, Ouchi M, Aaronson SA, Horvath CM (May 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC25807\">\"Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>97</b> (10): 5208\\xe2\\x80\\x9313. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000PNAS...97.5208O\">2000PNAS...97.5208O</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.080469697\">10.1073/pnas.080469697</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC25807\">25807</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10792030\">10792030</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Collaboration+of+signal+transducer+and+activator+of+transcription+1+%28STAT1%29+and+BRCA1+in+differential+regulation+of+IFN-gamma+target+genes&amp;rft.volume=97&amp;rft.issue=10&amp;rft.pages=5208-13&amp;rft.date=2000-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC25807%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10792030&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.080469697&amp;rft_id=info%3Abibcode%2F2000PNAS...97.5208O&amp;rft.aulast=Ouchi&amp;rft.aufirst=T&amp;rft.au=Lee%2C+SW&amp;rft.au=Ouchi%2C+M&amp;rft.au=Aaronson%2C+SA&amp;rft.au=Horvath%2C+CM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC25807&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-isbn978-90-481-3471-7-219\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-isbn978-90-481-3471-7_219-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFSokkaParkkinenPospiechSyvaoja2012\" class=\"citation book cs1\">Sokka M, Parkkinen S, Pospiech H, Syvaoja JE (April 2012). \"Function of TopBP1 in Genome Stability\".  In Nasheuer HP (ed.). <i>Genome Stability and Human Diseases</i>. Springer Dordrecht. pp.&#160;119\\xe2\\x80\\x93141. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1007%2F978-90-481-3471-7_7\">10.1007/978-90-481-3471-7_7</a>. <a href=\"/wiki/ISBN_(identifier)\" class=\"mw-redirect\" title=\"ISBN (identifier)\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-90-481-3471-7\" title=\"Special:BookSources/978-90-481-3471-7\"><bdi>978-90-481-3471-7</bdi></a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Function+of+TopBP1+in+Genome+Stability&amp;rft.btitle=Genome+Stability+and+Human+Diseases&amp;rft.pages=119-141&amp;rft.pub=Springer+Dordrecht&amp;rft.date=2012-04&amp;rft_id=info%3Adoi%2F10.1007%2F978-90-481-3471-7_7&amp;rft.isbn=978-90-481-3471-7&amp;rft.aulast=Sokka&amp;rft.aufirst=M&amp;rft.au=Parkkinen%2C+S&amp;rft.au=Pospiech%2C+H&amp;rft.au=Syvaoja%2C+JE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12732733-220\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12732733_220-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFBrzovicKeeffeNishikawaMiyamoto2003\" class=\"citation journal cs1\">Brzovic PS, Keeffe JR, Nishikawa H, Miyamoto K, Fox D, Fukuda M, Ohta T, Klevit R (May 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC156255\">\"Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>100</b> (10): 5646\\xe2\\x80\\x9351. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2003PNAS..100.5646B\">2003PNAS..100.5646B</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.0836054100\">10.1073/pnas.0836054100</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC156255\">156255</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12732733\">12732733</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Binding+and+recognition+in+the+assembly+of+an+active+BRCA1%2FBARD1+ubiquitin-ligase+complex&amp;rft.volume=100&amp;rft.issue=10&amp;rft.pages=5646-51&amp;rft.date=2003-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC156255%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12732733&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0836054100&amp;rft_id=info%3Abibcode%2F2003PNAS..100.5646B&amp;rft.aulast=Brzovic&amp;rft.aufirst=PS&amp;rft.au=Keeffe%2C+JR&amp;rft.au=Nishikawa%2C+H&amp;rft.au=Miyamoto%2C+K&amp;rft.au=Fox%2C+D&amp;rft.au=Fukuda%2C+M&amp;rft.au=Ohta%2C+T&amp;rft.au=Klevit%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC156255&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14638690-221\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14638690_221-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFNishikawaOokaSatoArima2004\" class=\"citation journal cs1\">Nishikawa H, Ooka S, Sato K, Arima K, Okamoto J, Klevit RE, Fukuda M, Ohta T (February 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M308540200\">\"Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase\"</a>. <i>J. Biol. Chem</i>. <b>279</b> (6): 3916\\xe2\\x80\\x9324. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M308540200\">10.1074/jbc.M308540200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14638690\">14638690</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Mass+spectrometric+and+mutational+analyses+reveal+Lys-6-linked+polyubiquitin+chains+catalyzed+by+BRCA1-BARD1+ubiquitin+ligase&amp;rft.volume=279&amp;rft.issue=6&amp;rft.pages=3916-24&amp;rft.date=2004-02&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M308540200&amp;rft_id=info%3Apmid%2F14638690&amp;rft.aulast=Nishikawa&amp;rft.aufirst=H&amp;rft.au=Ooka%2C+S&amp;rft.au=Sato%2C+K&amp;rft.au=Arima%2C+K&amp;rft.au=Okamoto%2C+J&amp;rft.au=Klevit%2C+RE&amp;rft.au=Fukuda%2C+M&amp;rft.au=Ohta%2C+T&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M308540200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12438698-222\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12438698_222-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFKentsisGordonBorden2002\" class=\"citation journal cs1\">Kentsis A, Gordon RE, Borden KL (November 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137729\">\"Control of biochemical reactions through supramolecular RING domain self-assembly\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>99</b> (24): 15404\\xe2\\x80\\x939. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2002PNAS...9915404K\">2002PNAS...9915404K</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.202608799\">10.1073/pnas.202608799</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137729\">137729</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12438698\">12438698</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Control+of+biochemical+reactions+through+supramolecular+RING+domain+self-assembly&amp;rft.volume=99&amp;rft.issue=24&amp;rft.pages=15404-9&amp;rft.date=2002-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC137729%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12438698&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.202608799&amp;rft_id=info%3Abibcode%2F2002PNAS...9915404K&amp;rft.aulast=Kentsis&amp;rft.aufirst=A&amp;rft.au=Gordon%2C+RE&amp;rft.au=Borden%2C+KL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC137729&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12890688-223\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12890688_223-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFWu-BaerLagrazonYuanBaer2003\" class=\"citation journal cs1\">Wu-Baer F, Lagrazon K, Yuan W, Baer R (September 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C300249200\">\"The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin\"</a>. <i>J. Biol. Chem</i>. <b>278</b> (37): 34743\\xe2\\x80\\x936. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C300249200\">10.1074/jbc.C300249200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12890688\">12890688</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=The+BRCA1%2FBARD1+heterodimer+assembles+polyubiquitin+chains+through+an+unconventional+linkage+involving+lysine+residue+K6+of+ubiquitin&amp;rft.volume=278&amp;rft.issue=37&amp;rft.pages=34743-6&amp;rft.date=2003-09&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.C300249200&amp;rft_id=info%3Apmid%2F12890688&amp;rft.aulast=Wu-Baer&amp;rft.aufirst=F&amp;rft.au=Lagrazon%2C+K&amp;rft.au=Yuan%2C+W&amp;rft.au=Baer%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.C300249200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11278247-224\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11278247_224-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFHashizumeFukudaMaedaNishikawa2001\" class=\"citation journal cs1\">Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T (May 2001). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C000881200\">\"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation\"</a>. <i>J. Biol. Chem</i>. <b>276</b> (18): 14537\\xe2\\x80\\x9340. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C000881200\">10.1074/jbc.C000881200</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11278247\">11278247</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=The+RING+heterodimer+BRCA1-BARD1+is+a+ubiquitin+ligase+inactivated+by+a+breast+cancer-derived+mutation&amp;rft.volume=276&amp;rft.issue=18&amp;rft.pages=14537-40&amp;rft.date=2001-05&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.C000881200&amp;rft_id=info%3Apmid%2F11278247&amp;rft.aulast=Hashizume&amp;rft.aufirst=R&amp;rft.au=Fukuda%2C+M&amp;rft.au=Maeda%2C+I&amp;rft.au=Nishikawa%2C+H&amp;rft.au=Oyake%2C+D&amp;rft.au=Yabuki%2C+Y&amp;rft.au=Ogata%2C+H&amp;rft.au=Ohta%2C+T&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.C000881200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid14502648-225\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14502648_225-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFCableWilsonCalzoneRauscher2003\" class=\"citation journal cs1\">Cable PL, Wilson CA, Calzone FJ, Rauscher FJ, Scully R, Livingston DM, Li L, Blackwell CB, Futreal PA, Afshari CA (October 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://zenodo.org/record/1229285\">\"Novel consensus DNA-binding sequence for BRCA1 protein complexes\"</a>. <i>Mol. Carcinog</i>. <b>38</b> (2): 85\\xe2\\x80\\x9396. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1002%2Fmc.10148\">10.1002/mc.10148</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14502648\">14502648</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:24956554\">24956554</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Carcinog.&amp;rft.atitle=Novel+consensus+DNA-binding+sequence+for+BRCA1+protein+complexes&amp;rft.volume=38&amp;rft.issue=2&amp;rft.pages=85-96&amp;rft.date=2003-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24956554%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14502648&amp;rft_id=info%3Adoi%2F10.1002%2Fmc.10148&amp;rft.aulast=Cable&amp;rft.aufirst=PL&amp;rft.au=Wilson%2C+CA&amp;rft.au=Calzone%2C+FJ&amp;rft.au=Rauscher%2C+FJ&amp;rft.au=Scully%2C+R&amp;rft.au=Livingston%2C+DM&amp;rft.au=Li%2C+L&amp;rft.au=Blackwell%2C+CB&amp;rft.au=Futreal%2C+PA&amp;rft.au=Afshari%2C+CA&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1229285&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid10855792-226\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10855792_226-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFZhangWangKajinoGreene2000\" class=\"citation journal cs1\">Zhang H, Wang Q, Kajino K, Greene MI (May 2000). \"VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells\". <i>DNA Cell Biol</i>. <b>19</b> (5): 253\\xe2\\x80\\x9363. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1089%2F10445490050021168\">10.1089/10445490050021168</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10855792\">10855792</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=DNA+Cell+Biol.&amp;rft.atitle=VCP%2C+a+weak+ATPase+involved+in+multiple+cellular+events%2C+interacts+physically+with+BRCA1+in+the+nucleus+of+living+cells&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=253-63&amp;rft.date=2000-05&amp;rft_id=info%3Adoi%2F10.1089%2F10445490050021168&amp;rft_id=info%3Apmid%2F10855792&amp;rft.aulast=Zhang&amp;rft.aufirst=H&amp;rft.au=Wang%2C+Q&amp;rft.au=Kajino%2C+K&amp;rft.au=Greene%2C+MI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid15065664-227\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15065664_227-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFGanesanSilverDrapkinGreenberg2004\" class=\"citation journal cs1\">Ganesan S, Silver DP, Drapkin R, Greenberg R, Feunteun J, Livingston DM (January 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693294\">\"Association of BRCA1 with the inactive X chromosome and XIST RNA\"</a>. <i>Philos. Trans. R. Soc. Lond. B Biol. Sci</i>. <b>359</b> (1441): 123\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1098%2Frstb.2003.1371\">10.1098/rstb.2003.1371</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693294\">1693294</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15065664\">15065664</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Philos.+Trans.+R.+Soc.+Lond.+B+Biol.+Sci.&amp;rft.atitle=Association+of+BRCA1+with+the+inactive+X+chromosome+and+XIST+RNA&amp;rft.volume=359&amp;rft.issue=1441&amp;rft.pages=123-8&amp;rft.date=2004-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1693294%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15065664&amp;rft_id=info%3Adoi%2F10.1098%2Frstb.2003.1371&amp;rft.aulast=Ganesan&amp;rft.aufirst=S&amp;rft.au=Silver%2C+DP&amp;rft.au=Drapkin%2C+R&amp;rft.au=Greenberg%2C+R&amp;rft.au=Feunteun%2C+J&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1693294&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid12419249-228\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12419249_228-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFGanesanSilverGreenbergAvni2002\" class=\"citation journal cs1\">Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J, Livingston DM (November 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2802%2901052-8\">\"BRCA1 supports XIST RNA concentration on the inactive X chromosome\"</a>. <i>Cell</i>. <b>111</b> (3): 393\\xe2\\x80\\x93405. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2802%2901052-8\">10.1016/S0092-8674(02)01052-8</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12419249\">12419249</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=BRCA1+supports+XIST+RNA+concentration+on+the+inactive+X+chromosome&amp;rft.volume=111&amp;rft.issue=3&amp;rft.pages=393-405&amp;rft.date=2002-11&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2802%2901052-8&amp;rft_id=info%3Apmid%2F12419249&amp;rft.aulast=Ganesan&amp;rft.aufirst=S&amp;rft.au=Silver%2C+DP&amp;rft.au=Greenberg%2C+RA&amp;rft.au=Avni%2C+D&amp;rft.au=Drapkin%2C+R&amp;rft.au=Miron%2C+A&amp;rft.au=Mok%2C+SC&amp;rft.au=Randrianarison%2C+V&amp;rft.au=Brodie%2C+S&amp;rft.au=Salstrom%2C+J&amp;rft.au=Rasmussen%2C+TP&amp;rft.au=Klimke%2C+A&amp;rft.au=Marrese%2C+C&amp;rft.au=Marahrens%2C+Y&amp;rft.au=Deng%2C+CX&amp;rft.au=Feunteun%2C+J&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252802%252901052-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n<li id=\"cite_note-pmid11090615-229\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11090615_229-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1133582631\"/><cite id=\"CITEREFZhengPanLiFlesken-Nikitin2000\" class=\"citation journal cs1\">Zheng L, Pan H, Li S, Flesken-Nikitin A, Chen PL, Boyer TG, Lee WH (October 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2800%2900075-7\">\"Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1\"</a>. <i>Mol. Cell</i>. <b>6</b> (4): 757\\xe2\\x80\\x9368. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2800%2900075-7\">10.1016/S1097-2765(00)00075-7</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11090615\">11090615</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=Sequence-specific+transcriptional+corepressor+function+for+BRCA1+through+a+novel+zinc+finger+protein%2C+ZBRK1&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=757-68&amp;rft.date=2000-10&amp;rft_id=info%3Adoi%2F10.1016%2FS1097-2765%2800%2900075-7&amp;rft_id=info%3Apmid%2F11090615&amp;rft.aulast=Zheng&amp;rft.aufirst=L&amp;rft.au=Pan%2C+H&amp;rft.au=Li%2C+S&amp;rft.au=Flesken-Nikitin%2C+A&amp;rft.au=Chen%2C+PL&amp;rft.au=Boyer%2C+TG&amp;rft.au=Lee%2C+WH&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS1097-2765%252800%252900075-7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\" class=\"Z3988\"></span></span>\\n</li>\\n</ol></div>\\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=22\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\\n<style data-mw-deduplicate=\"TemplateStyles:r1134653256\">.mw-parser-output .side-box{margin:4px 0;box-sizing:border-box;border:1px solid #aaa;font-size:88%;line-height:1.25em;background-color:#f9f9f9;display:flow-root}.mw-parser-output .side-box-abovebelow,.mw-parser-output .side-box-text{padding:0.25em 0.9em}.mw-parser-output .side-box-image{padding:2px 0 2px 0.9em;text-align:center}.mw-parser-output .side-box-imageright{padding:2px 0.9em 2px 0;text-align:center}@media(min-width:500px){.mw-parser-output .side-box-flex{display:flex;align-items:center}.mw-parser-output .side-box-text{flex:1}}@media(min-width:720px){.mw-parser-output .side-box{width:238px}.mw-parser-output .side-box-right{clear:right;float:right;margin-left:1em}.mw-parser-output .side-box-left{margin-right:1em}}</style><div class=\"side-box side-box-right plainlinks sistersitebox\"><style data-mw-deduplicate=\"TemplateStyles:r1126788409\">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style>\\n<div class=\"side-box-flex\">\\n<div class=\"side-box-image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png\" decoding=\"async\" width=\"30\" height=\"40\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x\" data-file-width=\"1024\" data-file-height=\"1376\" /></div>\\n<div class=\"side-box-text plainlist\">Wikimedia Commons has media related to <span style=\"font-weight: bold; font-style: italic;\"><a href=\"https://commons.wikimedia.org/wiki/Category:BRCA1\" class=\"extiw\" title=\"commons:Category:BRCA1\">BRCA1</a></span>.</div></div>\\n</div>\\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://meshb.nlm.nih.gov/record/ui?name=BRCA1+Protein\">BRCA1 Protein</a> at the U.S. National Library of Medicine <a href=\"/wiki/Medical_Subject_Headings\" title=\"Medical Subject Headings\">Medical Subject Headings</a> (MeSH)</li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://meshb.nlm.nih.gov/record/ui?name=Genes%2C+BRCA1\">Genes, BRCA1</a> at the U.S. National Library of Medicine <a href=\"/wiki/Medical_Subject_Headings\" title=\"Medical Subject Headings\">Medical Subject Headings</a> (MeSH)</li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/pdbe/pdbe-kb/proteins/P38398\">PDBe-KB</a> provides an overview of all the structure information available in the PDB for Human BRCA1.</li></ul>\\n<div class=\"navbox-styles\"><style data-mw-deduplicate=\"TemplateStyles:r1129693374\">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:\": \"}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:\" \\xc2\\xb7 \";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:\" (\";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:\")\";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:\" \"counter(listitem)\"\\\\a0 \"}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:\" (\"counter(listitem)\"\\\\a0 \"}</style><style data-mw-deduplicate=\"TemplateStyles:r1061467846\">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div role=\"navigation\" class=\"navbox\" aria-labelledby=\"PDB_gallery\" style=\"padding:3px\"><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\" style=\"background:#e7dcc3\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1129693374\"/><style data-mw-deduplicate=\"TemplateStyles:r1063604349\">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:\"[ \"}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:\" ]\"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class=\"navbar plainlinks hlist navbar-mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:PDB_Gallery\" title=\"Template:PDB Gallery\"><abbr title=\"View this template\" style=\";background:#e7dcc3;background:none transparent;border:none;box-shadow:none;padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:PDB_Gallery\" title=\"Template talk:PDB Gallery\"><abbr title=\"Discuss this template\" style=\";background:#e7dcc3;background:none transparent;border:none;box-shadow:none;padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:PDB_Gallery&amp;action=edit\"><abbr title=\"Edit this template\" style=\";background:#e7dcc3;background:none transparent;border:none;box-shadow:none;padding:0;\">e</abbr></a></li></ul></div><div id=\"PDB_gallery\" style=\"font-size:114%;margin:0 4em\">PDB gallery</div></th></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"><ul class=\"gallery mw-gallery-traditional nochecker\" style=\"line-height:130%\">\\n\\t\\t<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\\n\\t\\t\\t<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a href=\"/wiki/File:PDB_1jm7_EBI.jpg\" class=\"image\" title=\"1jm7: Solution structure of the BRCA1/BARD1 RING-domain heterodimer\"><img alt=\"1jm7: Solution structure of the BRCA1/BARD1 RING-domain heterodimer\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/13/PDB_1jm7_EBI.jpg/180px-PDB_1jm7_EBI.jpg\" decoding=\"async\" width=\"180\" height=\"135\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/13/PDB_1jm7_EBI.jpg/270px-PDB_1jm7_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/13/PDB_1jm7_EBI.jpg/360px-PDB_1jm7_EBI.jpg 2x\" data-file-width=\"800\" data-file-height=\"600\" /></a></div></div>\\n\\t\\t\\t<div class=\"gallerytext\">\\n<p><b>1jm7</b>: Solution structure of the BRCA1/BARD1 RING-domain heterodimer\\n</p>\\n\\t\\t\\t</div>\\n\\t\\t</div></li>\\n\\t\\t<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\\n\\t\\t\\t<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a href=\"/wiki/File:PDB_1jnx_EBI.jpg\" class=\"image\" title=\"1jnx: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\"><img alt=\"1jnx: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f2/PDB_1jnx_EBI.jpg/180px-PDB_1jnx_EBI.jpg\" decoding=\"async\" width=\"180\" height=\"135\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f2/PDB_1jnx_EBI.jpg/270px-PDB_1jnx_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f2/PDB_1jnx_EBI.jpg/360px-PDB_1jnx_EBI.jpg 2x\" data-file-width=\"800\" data-file-height=\"600\" /></a></div></div>\\n\\t\\t\\t<div class=\"gallerytext\">\\n<p><b>1jnx</b>: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\\n</p>\\n\\t\\t\\t</div>\\n\\t\\t</div></li>\\n\\t\\t<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\\n\\t\\t\\t<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a href=\"/wiki/File:PDB_1n5o_EBI.jpg\" class=\"image\" title=\"1n5o: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\"><img alt=\"1n5o: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f7/PDB_1n5o_EBI.jpg/180px-PDB_1n5o_EBI.jpg\" decoding=\"async\" width=\"180\" height=\"135\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f7/PDB_1n5o_EBI.jpg/270px-PDB_1n5o_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f7/PDB_1n5o_EBI.jpg/360px-PDB_1n5o_EBI.jpg 2x\" data-file-width=\"800\" data-file-height=\"600\" /></a></div></div>\\n\\t\\t\\t<div class=\"gallerytext\">\\n<p><b>1n5o</b>: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\\n</p>\\n\\t\\t\\t</div>\\n\\t\\t</div></li>\\n\\t\\t<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\\n\\t\\t\\t<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a href=\"/wiki/File:PDB_1oqa_EBI.jpg\" class=\"image\" title=\"1oqa: Solution structure of the BRCT-c domain from human BRCA1\"><img alt=\"1oqa: Solution structure of the BRCT-c domain from human BRCA1\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/28/PDB_1oqa_EBI.jpg/180px-PDB_1oqa_EBI.jpg\" decoding=\"async\" width=\"180\" height=\"135\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/28/PDB_1oqa_EBI.jpg/270px-PDB_1oqa_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/28/PDB_1oqa_EBI.jpg/360px-PDB_1oqa_EBI.jpg 2x\" data-file-width=\"800\" data-file-height=\"600\" /></a></div></div>\\n\\t\\t\\t<div class=\"gallerytext\">\\n<p><b>1oqa</b>: Solution structure of the BRCT-c domain from human BRCA1\\n</p>\\n\\t\\t\\t</div>\\n\\t\\t</div></li>\\n\\t\\t<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\\n\\t\\t\\t<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a href=\"/wiki/File:PDB_1t15_EBI.jpg\" class=\"image\" title=\"1t15: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\"><img alt=\"1t15: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/PDB_1t15_EBI.jpg/180px-PDB_1t15_EBI.jpg\" decoding=\"async\" width=\"180\" height=\"135\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/PDB_1t15_EBI.jpg/270px-PDB_1t15_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/82/PDB_1t15_EBI.jpg/360px-PDB_1t15_EBI.jpg 2x\" data-file-width=\"800\" data-file-height=\"600\" /></a></div></div>\\n\\t\\t\\t<div class=\"gallerytext\">\\n<p><b>1t15</b>: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\\n</p>\\n\\t\\t\\t</div>\\n\\t\\t</div></li>\\n\\t\\t<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\\n\\t\\t\\t<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a href=\"/wiki/File:PDB_1t29_EBI.jpg\" class=\"image\" title=\"1t29: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\"><img alt=\"1t29: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4b/PDB_1t29_EBI.jpg/180px-PDB_1t29_EBI.jpg\" decoding=\"async\" width=\"180\" height=\"135\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4b/PDB_1t29_EBI.jpg/270px-PDB_1t29_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4b/PDB_1t29_EBI.jpg/360px-PDB_1t29_EBI.jpg 2x\" data-file-width=\"800\" data-file-height=\"600\" /></a></div></div>\\n\\t\\t\\t<div class=\"gallerytext\">\\n<p><b>1t29</b>: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\\n</p>\\n\\t\\t\\t</div>\\n\\t\\t</div></li>\\n\\t\\t<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\\n\\t\\t\\t<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a href=\"/wiki/File:PDB_1t2u_EBI.jpg\" class=\"image\" title=\"1t2u: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\"><img alt=\"1t2u: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/91/PDB_1t2u_EBI.jpg/180px-PDB_1t2u_EBI.jpg\" decoding=\"async\" width=\"180\" height=\"135\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/91/PDB_1t2u_EBI.jpg/270px-PDB_1t2u_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/91/PDB_1t2u_EBI.jpg/360px-PDB_1t2u_EBI.jpg 2x\" data-file-width=\"800\" data-file-height=\"600\" /></a></div></div>\\n\\t\\t\\t<div class=\"gallerytext\">\\n<p><b>1t2u</b>: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\\n</p>\\n\\t\\t\\t</div>\\n\\t\\t</div></li>\\n\\t\\t<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\\n\\t\\t\\t<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a href=\"/wiki/File:PDB_1t2v_EBI.jpg\" class=\"image\" title=\"1t2v: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\"><img alt=\"1t2v: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/55/PDB_1t2v_EBI.jpg/180px-PDB_1t2v_EBI.jpg\" decoding=\"async\" width=\"180\" height=\"135\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/55/PDB_1t2v_EBI.jpg/270px-PDB_1t2v_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/55/PDB_1t2v_EBI.jpg/360px-PDB_1t2v_EBI.jpg 2x\" data-file-width=\"800\" data-file-height=\"600\" /></a></div></div>\\n\\t\\t\\t<div class=\"gallerytext\">\\n<p><b>1t2v</b>: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\\n</p>\\n\\t\\t\\t</div>\\n\\t\\t</div></li>\\n\\t\\t<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\\n\\t\\t\\t<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a href=\"/wiki/File:PDB_1y98_EBI.jpg\" class=\"image\" title=\"1y98: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\"><img alt=\"1y98: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/PDB_1y98_EBI.jpg/180px-PDB_1y98_EBI.jpg\" decoding=\"async\" width=\"180\" height=\"135\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/PDB_1y98_EBI.jpg/270px-PDB_1y98_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bf/PDB_1y98_EBI.jpg/360px-PDB_1y98_EBI.jpg 2x\" data-file-width=\"800\" data-file-height=\"600\" /></a></div></div>\\n\\t\\t\\t<div class=\"gallerytext\">\\n<p><b>1y98</b>: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\\n</p>\\n\\t\\t\\t</div>\\n\\t\\t</div></li>\\n</ul></div></td></tr></tbody></table></div>\\n<div class=\"navbox-styles\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1129693374\"/><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1061467846\"/></div><div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Tumor_suppressor_genes_and_Oncogenes\" style=\"padding:3px\"><table class=\"nowraplinks mw-collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1129693374\"/><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1063604349\"/><div class=\"navbar plainlinks hlist navbar-mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Tumor_suppressor_genes_and_oncogenes\" title=\"Template:Tumor suppressor genes and oncogenes\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Tumor_suppressor_genes_and_oncogenes\" title=\"Template talk:Tumor suppressor genes and oncogenes\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:Tumor_suppressor_genes_and_oncogenes&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\">e</abbr></a></li></ul></div><div id=\"Tumor_suppressor_genes_and_Oncogenes\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Tumor_suppressor_gene\" title=\"Tumor suppressor gene\">Tumor suppressor genes</a> and <a href=\"/wiki/Oncogene\" title=\"Oncogene\">Oncogenes</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Ligand_(biochemistry)\" title=\"Ligand (biochemistry)\">Ligand</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"Growth_factors\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Growth_factor\" title=\"Growth factor\">Growth factors</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"ONCO\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Platelet-derived_growth_factor\" title=\"Platelet-derived growth factor\">c-Sis/PDGF</a></li>\\n<li><a href=\"/wiki/Hepatocyte_growth_factor\" title=\"Hepatocyte growth factor\">HGF</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Receptor_(biochemistry)\" title=\"Receptor (biochemistry)\">Receptor</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Wnt_signaling_pathway\" title=\"Wnt signaling pathway\">Wnt signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"TSP\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/CDH1_(gene)\" class=\"mw-redirect\" title=\"CDH1 (gene)\">CDH1</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Hedgehog_signaling_pathway\" title=\"Hedgehog signaling pathway\">Hedgehog signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"TSP\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/PTCH1\" title=\"PTCH1\">PTCH1</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/TGF_beta_signaling_pathway\" title=\"TGF beta signaling pathway\">TGF beta signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"TSP\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/TGF_beta_receptor_2\" title=\"TGF beta receptor 2\">TGF beta receptor 2</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Receptor_tyrosine_kinase\" title=\"Receptor tyrosine kinase\">Receptor tyrosine kinase</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"ONCO\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/ErbB\" title=\"ErbB\">ErbB</a>/<a href=\"/wiki/Epidermal_growth_factor_receptor\" title=\"Epidermal growth factor receptor\">c-ErbB</a>\\n<ul><li><a href=\"/wiki/HER2/neu\" class=\"mw-redirect\" title=\"HER2/neu\">HER2/neu</a></li>\\n<li><a href=\"/wiki/ERBB3\" title=\"ERBB3\">Her 3</a></li></ul></li>\\n<li><a href=\"/wiki/C-Met\" title=\"C-Met\">c-Met</a></li>\\n<li><a href=\"/wiki/RET_proto-oncogene\" title=\"RET proto-oncogene\">c-Ret</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/JAK-STAT_signaling_pathway\" title=\"JAK-STAT signaling pathway\">JAK-STAT signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"ONCO\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/CD117\" class=\"mw-redirect\" title=\"CD117\">c-Kit</a></li>\\n<li><a href=\"/wiki/CD135\" title=\"CD135\">Flt3</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Intracellular_signaling_peptides_and_proteins\" class=\"mw-redirect\" title=\"Intracellular signaling peptides and proteins\">Intracellular signaling P+Ps</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Wnt_signaling_pathway\" title=\"Wnt signaling pathway\">Wnt signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Beta-catenin\" class=\"mw-redirect\" title=\"Beta-catenin\">Beta-catenin</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Adenomatosis_polyposis_coli\" class=\"mw-redirect\" title=\"Adenomatosis polyposis coli\">APC</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/TGF_beta_signaling_pathway\" title=\"TGF beta signaling pathway\">TGF beta signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"TSP\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Mothers_against_decapentaplegic_homolog_2\" title=\"Mothers against decapentaplegic homolog 2\">SMAD2</a></li>\\n<li><a href=\"/wiki/Mothers_against_decapentaplegic_homolog_4\" title=\"Mothers against decapentaplegic homolog 4\">SMAD4</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Akt/PKB_signaling_pathway\" title=\"Akt/PKB signaling pathway\">Akt/PKB signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/AKT\" class=\"mw-redirect\" title=\"AKT\">c-Akt</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/PTEN_(gene)\" title=\"PTEN (gene)\">PTEN</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Hippo_signaling_pathway\" title=\"Hippo signaling pathway\">Hippo signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"TSP\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Merlin_(protein)\" title=\"Merlin (protein)\">Neurofibromin 2/Merlin</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/MAPK/ERK_pathway\" title=\"MAPK/ERK pathway\">MAPK/ERK pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Ras_(protein)\" class=\"mw-redirect\" title=\"Ras (protein)\">c-Ras</a></li>\\n<li><a href=\"/wiki/HRAS\" title=\"HRAS\">HRAS</a></li>\\n<li><a href=\"/wiki/C-Raf\" title=\"C-Raf\">c-Raf</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Neurofibromin_1\" title=\"Neurofibromin 1\">Neurofibromin 1</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other/unknown</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Proto-oncogene_tyrosine-protein_kinase_Src\" title=\"Proto-oncogene tyrosine-protein kinase Src\">c-Src</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Maspin\" title=\"Maspin\">Maspin</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Cell_nucleus\" title=\"Cell nucleus\">Nucleus</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Cell_cycle\" title=\"Cell cycle\">Cell cycle</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Cyclin-dependent_kinase_4\" title=\"Cyclin-dependent kinase 4\">CDK4</a></li>\\n<li><a href=\"/wiki/Cyclin_D\" title=\"Cyclin D\">Cyclin D</a></li>\\n<li><a href=\"/wiki/Cyclin_E\" title=\"Cyclin E\">Cyclin E</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/P53\" title=\"P53\">p53</a></li>\\n<li><a href=\"/wiki/Retinoblastoma_protein\" title=\"Retinoblastoma protein\">pRb</a></li>\\n<li><a href=\"/wiki/WT1\" class=\"mw-redirect\" title=\"WT1\">WT1</a></li>\\n<li><a href=\"/wiki/P16_(gene)\" class=\"mw-redirect\" title=\"P16 (gene)\">p16</a>/<a href=\"/wiki/P14arf\" title=\"P14arf\">p14arf</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/DNA_repair\" title=\"DNA repair\">DNA repair</a>/<a href=\"/wiki/Fanconi_anemia\" title=\"Fanconi anemia\">Fanconi</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"TSP\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a class=\"mw-selflink selflink\">BRCA1</a></li>\\n<li><a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Ubiquitin_ligase\" title=\"Ubiquitin ligase\">Ubiquitin ligase</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/CBL_(gene)\" title=\"CBL (gene)\">CBL</a></li>\\n<li><a href=\"/wiki/Mdm2\" title=\"Mdm2\">MDM2</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Von_Hippel%E2%80%93Lindau_tumor_suppressor\" title=\"Von Hippel\\xe2\\x80\\x93Lindau tumor suppressor\">VHL</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Transcription_factor\" title=\"Transcription factor\">Transcription factor</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/AP-1_transcription_factor\" title=\"AP-1 transcription factor\">AP-1</a>\\n<ul><li><a href=\"/wiki/C-Fos\" class=\"mw-redirect\" title=\"C-Fos\">c-Fos</a></li>\\n<li><a href=\"/wiki/C-jun\" class=\"mw-redirect\" title=\"C-jun\">c-Jun</a></li></ul></li>\\n<li><a href=\"/wiki/Myc\" title=\"Myc\">c-Myc</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/KLF6\" title=\"KLF6\">KLF6</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Mitochondrion\" title=\"Mitochondrion\">Mitochondrion</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"Apoptosis_inhibitor\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Inhibitor_of_apoptosis\" title=\"Inhibitor of apoptosis\">Apoptosis inhibitor</a></th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/SDHB\" title=\"SDHB\">SDHB</a></li>\\n<li><a href=\"/wiki/SDHD\" title=\"SDHD\">SDHD</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other/ungrouped</th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Bcl-2\" title=\"Bcl-2\">c-Bcl-2</a></li>\\n<li><a href=\"/wiki/Notch_signaling\" class=\"mw-redirect\" title=\"Notch signaling\">Notch</a></li>\\n<li><a href=\"/wiki/Stathmin\" title=\"Stathmin\">Stathmin</a></li></ul>\\n</div></td></tr></tbody></table></div>\\n<div class=\"navbox-styles\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1129693374\"/><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1061467846\"/></div><div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Medicine\" style=\"padding:3px\"><table class=\"nowraplinks hlist mw-collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1129693374\"/><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1063604349\"/><div class=\"navbar plainlinks hlist navbar-mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Medicine\" title=\"Template:Medicine\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Medicine\" title=\"Template talk:Medicine\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:Medicine&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\">e</abbr></a></li></ul></div><div id=\"Medicine\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Medicine\" title=\"Medicine\">Medicine</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Medical_specialty\" title=\"Medical specialty\">Specialties</a><br />and<br /><a href=\"/wiki/Subspecialty\" title=\"Subspecialty\">subspecialties</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Surgery\" title=\"Surgery\">Surgery</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Cardiac_surgery\" title=\"Cardiac surgery\">Cardiac surgery</a></li>\\n<li><a href=\"/wiki/Cardiothoracic_surgery\" title=\"Cardiothoracic surgery\">Cardiothoracic surgery</a></li>\\n<li><a href=\"/wiki/Endocrine_surgery\" title=\"Endocrine surgery\">Endocrine surgery</a></li>\\n<li><a href=\"/wiki/Eye_surgery\" title=\"Eye surgery\">Eye surgery</a></li>\\n<li><a href=\"/wiki/General_surgery\" title=\"General surgery\">General surgery</a>\\n<ul><li><a href=\"/wiki/Colorectal_surgery\" title=\"Colorectal surgery\">Colorectal surgery</a></li>\\n<li><a href=\"/wiki/Digestive_system_surgery\" title=\"Digestive system surgery\">Digestive system surgery</a></li></ul></li>\\n<li><a href=\"/wiki/Neurosurgery\" title=\"Neurosurgery\">Neurosurgery</a></li>\\n<li><a href=\"/wiki/Oral_and_maxillofacial_surgery\" title=\"Oral and maxillofacial surgery\">Oral and maxillofacial surgery</a></li>\\n<li><a href=\"/wiki/Orthopedic_surgery\" title=\"Orthopedic surgery\">Orthopedic surgery</a></li>\\n<li><a href=\"/wiki/Hand_surgery\" title=\"Hand surgery\">Hand surgery</a></li>\\n<li><a href=\"/wiki/Otorhinolaryngology\" title=\"Otorhinolaryngology\">Otolaryngology</a>\\n<ul><li><small>ENT</small></li></ul></li>\\n<li><a href=\"/wiki/Pediatric_surgery\" title=\"Pediatric surgery\">Pediatric surgery</a></li>\\n<li><a href=\"/wiki/Plastic_surgery\" title=\"Plastic surgery\">Plastic surgery</a></li>\\n<li><a href=\"/wiki/Reproductive_surgery\" title=\"Reproductive surgery\">Reproductive surgery</a></li>\\n<li><a href=\"/wiki/Surgical_oncology\" title=\"Surgical oncology\">Surgical oncology</a></li>\\n<li><a href=\"/wiki/Organ_transplantation\" title=\"Organ transplantation\">Transplant surgery</a></li>\\n<li><a href=\"/wiki/Trauma_surgery\" title=\"Trauma surgery\">Trauma surgery</a></li>\\n<li><a href=\"/wiki/Urology\" title=\"Urology\">Urology</a>\\n<ul><li><a href=\"/wiki/Andrology\" title=\"Andrology\">Andrology</a></li></ul></li>\\n<li><a href=\"/wiki/Vascular_surgery\" title=\"Vascular surgery\">Vascular surgery</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Internal_medicine\" title=\"Internal medicine\">Internal<br />medicine</a></th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Allergy\" title=\"Allergy\">Allergy</a>&#160;/&#32;<a href=\"/wiki/Immunology\" title=\"Immunology\">Immunology</a></li>\\n<li><a href=\"/wiki/Angiology\" title=\"Angiology\">Angiology</a></li>\\n<li><a href=\"/wiki/Cardiology\" title=\"Cardiology\">Cardiology</a></li>\\n<li><a href=\"/wiki/Endocrinology\" title=\"Endocrinology\">Endocrinology</a></li>\\n<li><a href=\"/wiki/Gastroenterology\" title=\"Gastroenterology\">Gastroenterology</a>\\n<ul><li><a href=\"/wiki/Hepatology\" title=\"Hepatology\">Hepatology</a></li></ul></li>\\n<li><a href=\"/wiki/Geriatrics\" title=\"Geriatrics\">Geriatrics</a></li>\\n<li><a href=\"/wiki/Hematology\" title=\"Hematology\">Hematology</a></li>\\n<li><a href=\"/wiki/Hospital_medicine\" title=\"Hospital medicine\">Hospital medicine</a></li>\\n<li><a href=\"/wiki/Infectious_diseases_(medical_specialty)\" title=\"Infectious diseases (medical specialty)\">Infectious diseases</a></li>\\n<li><a href=\"/wiki/Nephrology\" title=\"Nephrology\">Nephrology</a></li>\\n<li><a href=\"/wiki/Oncology\" title=\"Oncology\">Oncology</a></li>\\n<li><a href=\"/wiki/Pulmonology\" title=\"Pulmonology\">Pulmonology</a></li>\\n<li><a href=\"/wiki/Rheumatology\" title=\"Rheumatology\">Rheumatology</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Obstetrics_and_gynaecology\" title=\"Obstetrics and gynaecology\">Obstetrics and<br />gynaecology</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Gynaecology\" title=\"Gynaecology\">Gynaecology</a></li>\\n<li><a href=\"/wiki/Gynecologic_oncology\" title=\"Gynecologic oncology\">Gynecologic oncology</a></li>\\n<li><a href=\"/wiki/Maternal%E2%80%93fetal_medicine\" title=\"Maternal\\xe2\\x80\\x93fetal medicine\">Maternal\\xe2\\x80\\x93fetal medicine</a></li>\\n<li><a href=\"/wiki/Obstetrics\" title=\"Obstetrics\">Obstetrics</a></li>\\n<li><a href=\"/wiki/Reproductive_endocrinology_and_infertility\" title=\"Reproductive endocrinology and infertility\">Reproductive endocrinology and infertility</a></li>\\n<li><a href=\"/wiki/Urogynecology\" title=\"Urogynecology\">Urogynecology</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Medical_diagnosis\" title=\"Medical diagnosis\">Diagnostic</a></th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Radiology\" title=\"Radiology\">Radiology</a>\\n<ul><li><a href=\"/wiki/Interventional_radiology\" title=\"Interventional radiology\">Interventional radiology</a></li>\\n<li><a href=\"/wiki/Neuroradiology\" title=\"Neuroradiology\">Neuroradiology</a></li>\\n<li><a href=\"/wiki/Nuclear_medicine\" title=\"Nuclear medicine\">Nuclear medicine</a></li></ul></li>\\n<li><a href=\"/wiki/Pathology\" title=\"Pathology\">Pathology</a>\\n<ul><li><a href=\"/wiki/Anatomical_pathology\" title=\"Anatomical pathology\">Anatomical</a></li>\\n<li><a href=\"/wiki/Clinical_pathology\" title=\"Clinical pathology\">Clinical pathology</a></li>\\n<li><a href=\"/wiki/Clinical_chemistry\" title=\"Clinical chemistry\">Clinical chemistry</a></li>\\n<li><a href=\"/wiki/Cytopathology\" title=\"Cytopathology\">Cytopathology</a></li>\\n<li><a href=\"/wiki/Medical_microbiology\" title=\"Medical microbiology\">Medical microbiology</a></li>\\n<li><a href=\"/wiki/Transfusion_medicine\" title=\"Transfusion medicine\">Transfusion medicine</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Addiction_medicine\" title=\"Addiction medicine\">Addiction medicine</a></li>\\n<li><a href=\"/wiki/Adolescent_medicine\" title=\"Adolescent medicine\">Adolescent medicine</a></li>\\n<li><a href=\"/wiki/Anesthesiology\" title=\"Anesthesiology\">Anesthesiology</a>\\n<ul><li><a href=\"/wiki/Obstetric_anesthesiology\" title=\"Obstetric anesthesiology\">Obstetric anesthesiology</a></li>\\n<li><a href=\"/wiki/Neurosurgical_anesthesia\" title=\"Neurosurgical anesthesia\">Neurosurgical anesthesiology</a></li></ul></li>\\n<li><a href=\"/wiki/Aviation_medicine\" title=\"Aviation medicine\">Aviation medicine</a></li>\\n<li><a href=\"/wiki/Dermatology\" title=\"Dermatology\">Dermatology</a></li>\\n<li><a href=\"/wiki/Disaster_medicine\" title=\"Disaster medicine\">Disaster medicine</a></li>\\n<li><a href=\"/wiki/Diving_medicine\" title=\"Diving medicine\">Diving medicine</a></li>\\n<li><a href=\"/wiki/Emergency_medicine\" title=\"Emergency medicine\">Emergency medicine</a>\\n<ul><li><a href=\"/wiki/Mass_gathering_medicine\" title=\"Mass gathering medicine\">Mass gathering medicine</a></li></ul></li>\\n<li><a href=\"/wiki/Family_medicine\" title=\"Family medicine\">Family medicine</a> / <a href=\"/wiki/General_practice\" title=\"General practice\">General practice</a></li>\\n<li><a href=\"/wiki/Hospital_medicine\" title=\"Hospital medicine\">Hospital medicine</a></li>\\n<li><a href=\"/wiki/Intensive_care_medicine\" title=\"Intensive care medicine\">Intensive care medicine</a></li>\\n<li><a href=\"/wiki/Medical_genetics\" title=\"Medical genetics\">Medical genetics</a></li>\\n<li><a href=\"/wiki/Narcology\" title=\"Narcology\">Narcology</a></li>\\n<li><a href=\"/wiki/Neurology\" title=\"Neurology\">Neurology</a>\\n<ul><li><a href=\"/wiki/Clinical_neurophysiology\" title=\"Clinical neurophysiology\">Clinical neurophysiology</a></li></ul></li>\\n<li><a href=\"/wiki/Occupational_medicine\" title=\"Occupational medicine\">Occupational medicine</a></li>\\n<li><a href=\"/wiki/Ophthalmology\" title=\"Ophthalmology\">Ophthalmology</a></li>\\n<li><a href=\"/wiki/Oral_medicine\" title=\"Oral medicine\">Oral medicine</a></li>\\n<li><a href=\"/wiki/Pain_management\" title=\"Pain management\">Pain management</a></li>\\n<li><a href=\"/wiki/Palliative_care\" title=\"Palliative care\">Palliative care</a></li>\\n<li><a href=\"/wiki/Pediatrics\" title=\"Pediatrics\">Pediatrics</a>\\n<ul><li><a href=\"/wiki/Neonatology\" title=\"Neonatology\">Neonatology</a></li></ul></li>\\n<li><a href=\"/wiki/Phlebologist\" class=\"mw-redirect\" title=\"Phlebologist\">Phlebology</a></li>\\n<li><a href=\"/wiki/Physical_medicine_and_rehabilitation\" title=\"Physical medicine and rehabilitation\">Physical medicine and rehabilitation</a> (PM&amp;R)</li>\\n<li><a href=\"/wiki/Preventive_healthcare\" title=\"Preventive healthcare\">Preventive medicine</a></li>\\n<li><a href=\"/wiki/Prison_healthcare\" title=\"Prison healthcare\">Prison healthcare</a></li>\\n<li><a href=\"/wiki/Psychiatry\" title=\"Psychiatry\">Psychiatry</a>\\n<ul><li><a href=\"/wiki/Addiction_psychiatry\" title=\"Addiction psychiatry\">Addiction psychiatry</a></li></ul></li>\\n<li><a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">Radiation oncology</a></li>\\n<li><a href=\"/wiki/Reproductive_medicine\" title=\"Reproductive medicine\">Reproductive medicine</a></li>\\n<li><a href=\"/wiki/Sexual_medicine\" title=\"Sexual medicine\">Sexual medicine</a>\\n<ul><li><a href=\"/wiki/Venereology\" title=\"Venereology\">Venereology</a></li></ul></li>\\n<li><a href=\"/wiki/Sleep_medicine\" title=\"Sleep medicine\">Sleep medicine</a></li>\\n<li><a href=\"/wiki/Sports_medicine\" title=\"Sports medicine\">Sports medicine</a></li>\\n<li><a href=\"/wiki/Organ_transplantation\" title=\"Organ transplantation\">Transplantation medicine</a></li>\\n<li><a href=\"/wiki/Tropical_medicine\" title=\"Tropical medicine\">Tropical medicine</a>\\n<ul><li><a href=\"/wiki/Travel_medicine\" title=\"Travel medicine\">Travel medicine</a></li></ul></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Medical_education\" title=\"Medical education\">Medical<br />education</a></th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Medical_school\" title=\"Medical school\">Medical school</a></li>\\n<li><a href=\"/wiki/Bachelor_of_Medicine,_Bachelor_of_Surgery\" title=\"Bachelor of Medicine, Bachelor of Surgery\">Bachelor of Medicine, Bachelor of Surgery</a></li>\\n<li><a href=\"/wiki/Bachelor_of_Medical_Sciences\" title=\"Bachelor of Medical Sciences\">Bachelor of Medical Sciences</a></li>\\n<li><a href=\"/wiki/Master_of_Medicine\" title=\"Master of Medicine\">Master of Medicine</a></li>\\n<li><a href=\"/wiki/Master_of_Surgery\" title=\"Master of Surgery\">Master of Surgery</a></li>\\n<li><a href=\"/wiki/Doctor_of_Medicine\" title=\"Doctor of Medicine\">Doctor of Medicine</a></li>\\n<li><a href=\"/wiki/Doctor_of_Osteopathic_Medicine\" title=\"Doctor of Osteopathic Medicine\">Doctor of Osteopathic Medicine</a></li>\\n<li><a href=\"/wiki/MD%E2%80%93PhD\" title=\"MD\\xe2\\x80\\x93PhD\">MD\\xe2\\x80\\x93PhD</a>\\n<ul><li><a href=\"/wiki/Medical_Scientist_Training_Program\" title=\"Medical Scientist Training Program\">Medical Scientist Training Program</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Related topics</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\\n<ul><li><a href=\"/wiki/Alternative_medicine\" title=\"Alternative medicine\">Alternative medicine</a></li>\\n<li><a href=\"/wiki/Allied_health_professions\" title=\"Allied health professions\">Allied health</a>\\n<ul><li><a href=\"/wiki/Dentistry\" title=\"Dentistry\">Dentistry</a></li>\\n<li><a href=\"/wiki/Podiatry\" title=\"Podiatry\">Podiatry</a></li>\\n<li><a href=\"/wiki/Pharmacy\" title=\"Pharmacy\">Pharmacy</a></li>\\n<li><a href=\"/wiki/Physical_therapy\" title=\"Physical therapy\">Physiotherapy</a></li></ul></li>\\n<li><a href=\"/wiki/Molecular_oncology\" title=\"Molecular oncology\">Molecular oncology</a></li>\\n<li><a href=\"/wiki/Nanomedicine\" title=\"Nanomedicine\">Nanomedicine</a></li>\\n<li><a href=\"/wiki/Personalized_medicine\" title=\"Personalized medicine\">Personalized medicine</a></li>\\n<li><a href=\"/wiki/Public_health\" title=\"Public health\">Public health</a></li>\\n<li><a href=\"/wiki/Rural_health\" title=\"Rural health\">Rural health</a></li>\\n<li><a href=\"/wiki/Therapy\" title=\"Therapy\">Therapy</a></li>\\n<li><a href=\"/wiki/Traditional_medicine\" title=\"Traditional medicine\">Traditional medicine</a></li>\\n<li><a href=\"/wiki/Veterinary_medicine\" title=\"Veterinary medicine\">Veterinary medicine</a></li>\\n<li><a href=\"/wiki/Physician\" title=\"Physician\">Physician</a>\\n<ul><li><a href=\"/wiki/Chief_physician\" title=\"Chief physician\">Chief physician</a></li></ul></li>\\n<li><a href=\"/wiki/History_of_medicine\" title=\"History of medicine\">History of medicine</a></li></ul>\\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\\n<ul><li><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/16px-Symbol_category_class.svg.png\" decoding=\"async\" title=\"Category\" width=\"16\" height=\"16\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/23px-Symbol_category_class.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/31px-Symbol_category_class.svg.png 2x\" data-file-width=\"180\" data-file-height=\"185\" /> <a href=\"/wiki/Category:Medicine\" title=\"Category:Medicine\">Category</a></li>\\n<li><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/12px-Commons-logo.svg.png\" decoding=\"async\" title=\"Commons page\" width=\"12\" height=\"16\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/18px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/24px-Commons-logo.svg.png 2x\" data-file-width=\"1024\" data-file-height=\"1376\" /> <a href=\"https://commons.wikimedia.org/wiki/Medicine\" class=\"extiw\" title=\"commons:Medicine\">Commons</a></li>\\n<li><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/37/People_icon.svg/16px-People_icon.svg.png\" decoding=\"async\" title=\"WikiProject\" width=\"16\" height=\"16\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/37/People_icon.svg/24px-People_icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/37/People_icon.svg/32px-People_icon.svg.png 2x\" data-file-width=\"100\" data-file-height=\"100\" /> <a href=\"/wiki/Wikipedia:WikiProject_Medicine\" title=\"Wikipedia:WikiProject Medicine\">Wikiproject</a></li>\\n<li><a href=\"/wiki/File:Symbol_portal_class.svg\" class=\"image\" title=\"Portal\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/e/e2/Symbol_portal_class.svg/16px-Symbol_portal_class.svg.png\" decoding=\"async\" width=\"16\" height=\"16\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/e/e2/Symbol_portal_class.svg/23px-Symbol_portal_class.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/e/e2/Symbol_portal_class.svg/31px-Symbol_portal_class.svg.png 2x\" data-file-width=\"180\" data-file-height=\"185\" /></a> <a href=\"/wiki/Portal:Medicine\" title=\"Portal:Medicine\">Portal</a></li>\\n<li><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/41/Global_thinking.svg/10px-Global_thinking.svg.png\" decoding=\"async\" title=\"Outline\" width=\"10\" height=\"16\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/41/Global_thinking.svg/15px-Global_thinking.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/41/Global_thinking.svg/21px-Global_thinking.svg.png 2x\" data-file-width=\"130\" data-file-height=\"200\" /> <a href=\"/wiki/Outline_of_medicine\" title=\"Outline of medicine\">Outline</a></li></ul>\\n</div></td></tr></tbody></table></div>\\n<!-- \\nNewPP limit report\\nParsed by mw2377\\nCached time: 20230427233751\\nCache expiry: 1814400\\nReduced expiry: false\\nComplications: [vary\\xe2\\x80\\x90revision\\xe2\\x80\\x90sha1, show\\xe2\\x80\\x90toc]\\nCPU time usage: 2.499 seconds\\nReal time usage: 3.162 seconds\\nPreprocessor visited node count: 13321/1000000\\nPost\\xe2\\x80\\x90expand include size: 766038/2097152 bytes\\nTemplate argument size: 8324/2097152 bytes\\nHighest expansion depth: 13/100\\nExpensive parser function count: 105/500\\nUnstrip recursion depth: 1/20\\nUnstrip post\\xe2\\x80\\x90expand size: 813171/5000000 bytes\\nLua time usage: 1.784/10.000 seconds\\nLua memory usage: 14979111/52428800 bytes\\nLua Profile:\\n    MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::getEntity      460 ms       26.7%\\n    ?                                                                300 ms       17.4%\\n    dataWrapper <mw.lua:672>                                         100 ms        5.8%\\n    MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::getLabel       80 ms        4.7%\\n    MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::preprocess       80 ms        4.7%\\n    gsub                                                              80 ms        4.7%\\n    MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::callParserFunction       80 ms        4.7%\\n    MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::match       60 ms        3.5%\\n    recursiveClone <mwInit.lua:41>                                    60 ms        3.5%\\n    MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::find       60 ms        3.5%\\n    [others]                                                         360 ms       20.9%\\nNumber of Wikibase entities loaded: 98/400\\n-->\\n<!--\\nTransclusion expansion time report (%,ms,calls,template)\\n100.00% 2858.201      1 -total\\n 43.58% 1245.612      1 Template:Reflist\\n 40.75% 1164.670      1 Template:Infobox_gene\\n 33.21%  949.161    199 Template:Cite_journal\\n  7.54%  215.479     25 Template:Navbox\\n  3.17%   90.722      1 Template:PDB_Gallery\\n  1.76%   50.270      1 Template:Short_description\\n  1.68%   48.099      5 Template:Citation_needed\\n  1.64%   46.810      1 Template:Tumor_suppressor_genes\\n  1.48%   42.321     11 Template:Cite_web\\n-->\\n\\n<!-- Saved in parser cache with key enwiki:pcache:idhash:412097-0!canonical and timestamp 20230427233748 and revision id 1146808968. Rendering was triggered because: page-view\\n -->\\n</div><!--esi <esi:include src=\"/esitest-fa8a495983347898/content\" /> --><noscript><img src=\"//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1\" alt=\"\" title=\"\" width=\"1\" height=\"1\" style=\"border: none; position: absolute;\" /></noscript>\\n<div class=\"printfooter\" data-nosnippet=\"\">Retrieved from \"<a dir=\"ltr\" href=\"https://en.wikipedia.org/w/index.php?title=BRCA1&amp;oldid=1146808968\">https://en.wikipedia.org/w/index.php?title=BRCA1&amp;oldid=1146808968</a>\"</div></div>\\n\\t\\t\\t\\t\\t<div id=\"catlinks\" class=\"catlinks\" data-mw=\"interface\"><div id=\"mw-normal-catlinks\" class=\"mw-normal-catlinks\"><a href=\"/wiki/Help:Category\" title=\"Help:Category\">Categories</a>: <ul><li><a href=\"/wiki/Category:Genes_on_human_chromosome_17\" title=\"Category:Genes on human chromosome 17\">Genes on human chromosome 17</a></li><li><a href=\"/wiki/Category:Breast_cancer\" title=\"Category:Breast cancer\">Breast cancer</a></li><li><a href=\"/wiki/Category:Tumor_markers\" title=\"Category:Tumor markers\">Tumor markers</a></li><li><a href=\"/wiki/Category:Tumor_suppressor_genes\" title=\"Category:Tumor suppressor genes\">Tumor suppressor genes</a></li></ul></div><div id=\"mw-hidden-catlinks\" class=\"mw-hidden-catlinks mw-hidden-cats-hidden\">Hidden categories: <ul><li><a href=\"/wiki/Category:Webarchive_template_wayback_links\" title=\"Category:Webarchive template wayback links\">Webarchive template wayback links</a></li><li><a href=\"/wiki/Category:CS1_Chinese-language_sources_(zh)\" title=\"Category:CS1 Chinese-language sources (zh)\">CS1 Chinese-language sources (zh)</a></li><li><a href=\"/wiki/Category:Articles_with_short_description\" title=\"Category:Articles with short description\">Articles with short description</a></li><li><a href=\"/wiki/Category:Short_description_is_different_from_Wikidata\" title=\"Category:Short description is different from Wikidata\">Short description is different from Wikidata</a></li><li><a href=\"/wiki/Category:All_articles_with_unsourced_statements\" title=\"Category:All articles with unsourced statements\">All articles with unsourced statements</a></li><li><a href=\"/wiki/Category:Articles_with_unsourced_statements_from_January_2016\" title=\"Category:Articles with unsourced statements from January 2016\">Articles with unsourced statements from January 2016</a></li><li><a href=\"/wiki/Category:Articles_with_unsourced_statements_from_May_2019\" title=\"Category:Articles with unsourced statements from May 2019\">Articles with unsourced statements from May 2019</a></li><li><a href=\"/wiki/Category:Dynamic_lists\" title=\"Category:Dynamic lists\">Dynamic lists</a></li><li><a href=\"/wiki/Category:Commons_category_link_is_on_Wikidata\" title=\"Category:Commons category link is on Wikidata\">Commons category link is on Wikidata</a></li></ul></div></div>\\n\\t\\t\\t\\t</div>\\n\\t\\t\\t</main>\\n\\t\\t\\t\\n\\t\\t</div>\\n\\t\\t<div class=\"mw-footer-container\">\\n\\t\\t\\t\\n<footer id=\"footer\" class=\"mw-footer\" role=\"contentinfo\" >\\n\\t<ul id=\"footer-info\">\\n\\t<li id=\"footer-info-lastmod\"> This page was last edited on 27 March 2023, at 02:22<span class=\"anonymous-show\">&#160;(UTC)</span>.</li>\\n\\t<li id=\"footer-info-copyright\">Text is available under the <a rel=\"license\" href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_the_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License\">Creative Commons Attribution-ShareAlike License 3.0</a><a rel=\"license\" href=\"//creativecommons.org/licenses/by-sa/3.0/\" style=\"display:none;\"></a>;\\nadditional terms may apply.  By using this site, you agree to the <a href=\"//foundation.wikimedia.org/wiki/Terms_of_Use\">Terms of Use</a> and <a href=\"//foundation.wikimedia.org/wiki/Privacy_policy\">Privacy Policy</a>. Wikipedia\\xc2\\xae is a registered trademark of the <a href=\"//www.wikimediafoundation.org/\">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>\\n</ul>\\n\\n\\t<ul id=\"footer-places\">\\n\\t<li id=\"footer-places-privacy\"><a href=\"https://foundation.wikimedia.org/wiki/Privacy_policy\">Privacy policy</a></li>\\n\\t<li id=\"footer-places-about\"><a href=\"/wiki/Wikipedia:About\">About Wikipedia</a></li>\\n\\t<li id=\"footer-places-disclaimers\"><a href=\"/wiki/Wikipedia:General_disclaimer\">Disclaimers</a></li>\\n\\t<li id=\"footer-places-contact\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\">Contact Wikipedia</a></li>\\n\\t<li id=\"footer-places-mobileview\"><a href=\"//en.m.wikipedia.org/w/index.php?title=BRCA1&amp;mobileaction=toggle_view_mobile\" class=\"noprint stopMobileRedirectToggle\">Mobile view</a></li>\\n\\t<li id=\"footer-places-developers\"><a href=\"https://developer.wikimedia.org\">Developers</a></li>\\n\\t<li id=\"footer-places-statslink\"><a href=\"https://stats.wikimedia.org/#/en.wikipedia.org\">Statistics</a></li>\\n\\t<li id=\"footer-places-cookiestatement\"><a href=\"https://foundation.wikimedia.org/wiki/Cookie_statement\">Cookie statement</a></li>\\n</ul>\\n\\n\\t<ul id=\"footer-icons\" class=\"noprint\">\\n\\t<li id=\"footer-copyrightico\"><a href=\"https://wikimediafoundation.org/\"><img src=\"/static/images/footer/wikimedia-button.png\" srcset=\"/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x\" width=\"88\" height=\"31\" alt=\"Wikimedia Foundation\" loading=\"lazy\" /></a></li>\\n\\t<li id=\"footer-poweredbyico\"><a href=\"https://www.mediawiki.org/\"><img src=\"/static/images/footer/poweredby_mediawiki_88x31.png\" alt=\"Powered by MediaWiki\" srcset=\"/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x\" width=\"88\" height=\"31\" loading=\"lazy\"/></a></li>\\n</ul>\\n\\n</footer>\\n\\n\\t\\t</div>\\n\\t</div> \\n</div> \\n<div class=\\'vector-settings\\'>\\n\\t\\n<button\\n\\t\\n\\t\\n\\t\\n\\t\\n\\t\\n\\tclass=\"mw-ui-button mw-ui-icon mw-ui-icon-element vector-limited-width-toggle\">\\n\\t<span>Toggle limited content width</span>\\n\\n</button>\\n\\n</div>\\n<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgHostname\":\"mw2274\",\"wgBackendResponseTime\":137,\"wgPageParseReport\":{\"limitreport\":{\"cputime\":\"2.499\",\"walltime\":\"3.162\",\"ppvisitednodes\":{\"value\":13321,\"limit\":1000000},\"postexpandincludesize\":{\"value\":766038,\"limit\":2097152},\"templateargumentsize\":{\"value\":8324,\"limit\":2097152},\"expansiondepth\":{\"value\":13,\"limit\":100},\"expensivefunctioncount\":{\"value\":105,\"limit\":500},\"unstrip-depth\":{\"value\":1,\"limit\":20},\"unstrip-size\":{\"value\":813171,\"limit\":5000000},\"entityaccesscount\":{\"value\":98,\"limit\":400},\"timingprofile\":[\"100.00% 2858.201      1 -total\",\" 43.58% 1245.612      1 Template:Reflist\",\" 40.75% 1164.670      1 Template:Infobox_gene\",\" 33.21%  949.161    199 Template:Cite_journal\",\"  7.54%  215.479     25 Template:Navbox\",\"  3.17%   90.722      1 Template:PDB_Gallery\",\"  1.76%   50.270      1 Template:Short_description\",\"  1.68%   48.099      5 Template:Citation_needed\",\"  1.64%   46.810      1 Template:Tumor_suppressor_genes\",\"  1.48%   42.321     11 Template:Cite_web\"]},\"scribunto\":{\"limitreport-timeusage\":{\"value\":\"1.784\",\"limit\":\"10.000\"},\"limitreport-memusage\":{\"value\":14979111,\"limit\":52428800},\"limitreport-profile\":[[\"MediaWiki\\\\\\\\Extension\\\\\\\\Scribunto\\\\\\\\Engines\\\\\\\\LuaSandbox\\\\\\\\LuaSandboxCallback::getEntity\",\"460\",\"26.7\"],[\"?\",\"300\",\"17.4\"],[\"dataWrapper \\\\u003Cmw.lua:672\\\\u003E\",\"100\",\"5.8\"],[\"MediaWiki\\\\\\\\Extension\\\\\\\\Scribunto\\\\\\\\Engines\\\\\\\\LuaSandbox\\\\\\\\LuaSandboxCallback::getLabel\",\"80\",\"4.7\"],[\"MediaWiki\\\\\\\\Extension\\\\\\\\Scribunto\\\\\\\\Engines\\\\\\\\LuaSandbox\\\\\\\\LuaSandboxCallback::preprocess\",\"80\",\"4.7\"],[\"gsub\",\"80\",\"4.7\"],[\"MediaWiki\\\\\\\\Extension\\\\\\\\Scribunto\\\\\\\\Engines\\\\\\\\LuaSandbox\\\\\\\\LuaSandboxCallback::callParserFunction\",\"80\",\"4.7\"],[\"MediaWiki\\\\\\\\Extension\\\\\\\\Scribunto\\\\\\\\Engines\\\\\\\\LuaSandbox\\\\\\\\LuaSandboxCallback::match\",\"60\",\"3.5\"],[\"recursiveClone \\\\u003CmwInit.lua:41\\\\u003E\",\"60\",\"3.5\"],[\"MediaWiki\\\\\\\\Extension\\\\\\\\Scribunto\\\\\\\\Engines\\\\\\\\LuaSandbox\\\\\\\\LuaSandboxCallback::find\",\"60\",\"3.5\"],[\"[others]\",\"360\",\"20.9\"]]},\"cachereport\":{\"origin\":\"mw2377\",\"timestamp\":\"20230427233751\",\"ttl\":1814400,\"transientcontent\":false}}});});</script>\\n<script type=\"application/ld+json\">{\"@context\":\"https:\\\\/\\\\/schema.org\",\"@type\":\"Article\",\"name\":\"BRCA1\",\"url\":\"https:\\\\/\\\\/en.wikipedia.org\\\\/wiki\\\\/BRCA1\",\"sameAs\":\"http:\\\\/\\\\/www.wikidata.org\\\\/entity\\\\/Q17487737\",\"mainEntity\":\"http:\\\\/\\\\/www.wikidata.org\\\\/entity\\\\/Q17487737\",\"author\":{\"@type\":\"Organization\",\"name\":\"Contributors to Wikimedia projects\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Wikimedia Foundation, Inc.\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\\/\\\\/www.wikimedia.org\\\\/static\\\\/images\\\\/wmf-hor-googpub.png\"}},\"datePublished\":\"2003-12-23T12:36:26Z\",\"dateModified\":\"2023-03-27T02:22:32Z\",\"image\":\"https:\\\\/\\\\/upload.wikimedia.org\\\\/wikipedia\\\\/commons\\\\/e\\\\/e1\\\\/Protein_BRCA1_PDB_1jm7.png\",\"headline\":\"mammalian protein found in Homo sapiens\"}</script><script type=\"application/ld+json\">{\"@context\":\"https:\\\\/\\\\/schema.org\",\"@type\":\"Article\",\"name\":\"BRCA1\",\"url\":\"https:\\\\/\\\\/en.wikipedia.org\\\\/wiki\\\\/BRCA1\",\"sameAs\":\"http:\\\\/\\\\/www.wikidata.org\\\\/entity\\\\/Q17487737\",\"mainEntity\":\"http:\\\\/\\\\/www.wikidata.org\\\\/entity\\\\/Q17487737\",\"author\":{\"@type\":\"Organization\",\"name\":\"Contributors to Wikimedia projects\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Wikimedia Foundation, Inc.\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\\/\\\\/www.wikimedia.org\\\\/static\\\\/images\\\\/wmf-hor-googpub.png\"}},\"datePublished\":\"2003-12-23T12:36:26Z\",\"dateModified\":\"2023-03-27T02:22:32Z\",\"image\":\"https:\\\\/\\\\/upload.wikimedia.org\\\\/wikipedia\\\\/commons\\\\/e\\\\/e1\\\\/Protein_BRCA1_PDB_1jm7.png\",\"headline\":\"mammalian protein found in Homo sapiens\"}</script>\\n</body>\\n</html>'"
            ]
          },
          "metadata": {},
          "execution_count": 98
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "soup = bs.BeautifulSoup(source,'lxml')"
      ],
      "metadata": {
        "id": "9irqFCKkq2L0"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "soup"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "AtGMOERbrBCB",
        "outputId": "7488cce5-8f19-4f24-fc52-65b7376c2d53"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<!DOCTYPE html>\n",
              "<html class=\"client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-language-alert-in-sidebar-enabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled\" dir=\"ltr\" lang=\"en\">\n",
              "<head>\n",
              "<meta charset=\"utf-8\"/>\n",
              "<title>BRCA1 - Wikipedia</title>\n",
              "<script>document.documentElement.className=\"client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-language-alert-in-sidebar-enabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled\";(function(){var cookie=document.cookie.match(/(?:^|; )enwikimwclientprefs=([^;]+)/);if(cookie){var featureName=cookie[1];document.documentElement.className=document.documentElement.className.replace(featureName+'-enabled',featureName+'-disabled');}}());RLCONF={\"wgBreakFrames\":false,\"wgSeparatorTransformTable\":[\"\",\"\"],\"wgDigitTransformTable\":[\"\",\"\"],\"wgDefaultDateFormat\":\"dmy\",\"wgMonthNames\":[\"\",\"January\",\"February\",\"March\",\"April\",\"May\",\"June\",\"July\",\"August\",\"September\",\"October\",\"November\",\"December\"],\"wgRequestId\":\n",
              "\"267efca1-adbc-4467-8001-9e4890145f94\",\"wgCSPNonce\":false,\"wgCanonicalNamespace\":\"\",\"wgCanonicalSpecialPageName\":false,\"wgNamespaceNumber\":0,\"wgPageName\":\"BRCA1\",\"wgTitle\":\"BRCA1\",\"wgCurRevisionId\":1146808968,\"wgRevisionId\":1146808968,\"wgArticleId\":412097,\"wgIsArticle\":true,\"wgIsRedirect\":false,\"wgAction\":\"view\",\"wgUserName\":null,\"wgUserGroups\":[\"*\"],\"wgCategories\":[\"Webarchive template wayback links\",\"CS1 Chinese-language sources (zh)\",\"Articles with short description\",\"Short description is different from Wikidata\",\"All articles with unsourced statements\",\"Articles with unsourced statements from January 2016\",\"Articles with unsourced statements from May 2019\",\"Dynamic lists\",\"Commons category link is on Wikidata\",\"Genes on human chromosome 17\",\"Breast cancer\",\"Tumor markers\",\"Tumor suppressor genes\"],\"wgPageContentLanguage\":\"en\",\"wgPageContentModel\":\"wikitext\",\"wgRelevantPageName\":\"BRCA1\",\"wgRelevantArticleId\":412097,\"wgIsProbablyEditable\":true,\"wgRelevantPageIsProbablyEditable\":true,\n",
              "\"wgRestrictionEdit\":[],\"wgRestrictionMove\":[],\"wgFlaggedRevsParams\":{\"tags\":{\"status\":{\"levels\":1}}},\"wgVisualEditor\":{\"pageLanguageCode\":\"en\",\"pageLanguageDir\":\"ltr\",\"pageVariantFallbacks\":\"en\"},\"wgMFDisplayWikibaseDescriptions\":{\"search\":true,\"watchlist\":true,\"tagline\":false,\"nearby\":true},\"wgWMESchemaEditAttemptStepOversample\":false,\"wgWMEPageLength\":100000,\"wgNoticeProject\":\"wikipedia\",\"wgMediaViewerOnClick\":true,\"wgMediaViewerEnabledByDefault\":true,\"wgPopupsFlags\":10,\"wgULSCurrentAutonym\":\"English\",\"wgEditSubmitButtonLabelPublish\":true,\"wgCentralAuthMobileDomain\":false,\"wgULSPosition\":\"interlanguage\",\"wgULSisCompactLinksEnabled\":true,\"wgULSisLanguageSelectorEmpty\":false,\"wgWikibaseItemId\":\"Q17487737\",\"GEHomepageSuggestedEditsEnableTopics\":true,\"wgGETopicsMatchModeEnabled\":false,\"wgGEStructuredTaskRejectionReasonTextInputEnabled\":false,\"wgGELevelingUpEnabledForUser\":false};RLSTATE={\"skins.vector.user.styles\":\"ready\",\"ext.globalCssJs.user.styles\":\"ready\",\"site.styles\":\"ready\",\n",
              "\"user.styles\":\"ready\",\"skins.vector.user\":\"ready\",\"ext.globalCssJs.user\":\"ready\",\"user\":\"ready\",\"user.options\":\"loading\",\"ext.cite.styles\":\"ready\",\"mediawiki.page.gallery.styles\":\"ready\",\"mediawiki.ui.button\":\"ready\",\"skins.vector.styles\":\"ready\",\"skins.vector.icons\":\"ready\",\"mediawiki.ui.icon\":\"ready\",\"jquery.makeCollapsible.styles\":\"ready\",\"ext.visualEditor.desktopArticleTarget.noscript\":\"ready\",\"ext.wikimediaBadges\":\"ready\",\"ext.uls.interlanguage\":\"ready\",\"wikibase.client.init\":\"ready\"};RLPAGEMODULES=[\"ext.cite.ux-enhancements\",\"site\",\"mediawiki.page.ready\",\"jquery.makeCollapsible\",\"mediawiki.toc\",\"skins.vector.js\",\"mmv.head\",\"mmv.bootstrap.autostart\",\"ext.visualEditor.desktopArticleTarget.init\",\"ext.visualEditor.targetLoader\",\"ext.eventLogging\",\"ext.wikimediaEvents\",\"ext.navigationTiming\",\"ext.cx.eventlogging.campaigns\",\"ext.centralNotice.geoIP\",\"ext.centralNotice.startUp\",\"ext.gadget.ReferenceTooltips\",\"ext.gadget.charinsert\",\"ext.gadget.extra-toolbar-buttons\",\n",
              "\"ext.gadget.switcher\",\"ext.centralauth.centralautologin\",\"ext.popups\",\"ext.echo.centralauth\",\"ext.uls.compactlinks\",\"ext.uls.interface\",\"ext.cx.uls.quick.actions\",\"wikibase.client.vector-2022\",\"ext.growthExperiments.SuggestedEditSession\"];</script>\n",
              "<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement(\"user.options@12s5i\",function($,jQuery,require,module){mw.user.tokens.set({\"patrolToken\":\"+\\\\\",\"watchToken\":\"+\\\\\",\"csrfToken\":\"+\\\\\"});});});</script>\n",
              "<link href=\"/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cmediawiki.page.gallery.styles%7Cmediawiki.ui.button%2Cicon%7Cskins.vector.icons%2Cstyles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022\" rel=\"stylesheet\"/>\n",
              "<script async=\"\" src=\"/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022\"></script>\n",
              "<meta content=\"\" name=\"ResourceLoaderDynamicStyles\"/>\n",
              "<link href=\"/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022\" rel=\"stylesheet\"/>\n",
              "<meta content=\"MediaWiki 1.41.0-wmf.6\" name=\"generator\"/>\n",
              "<meta content=\"origin\" name=\"referrer\"/>\n",
              "<meta content=\"origin-when-crossorigin\" name=\"referrer\"/>\n",
              "<meta content=\"origin-when-cross-origin\" name=\"referrer\"/>\n",
              "<meta content=\"max-image-preview:standard\" name=\"robots\"/>\n",
              "<meta content=\"telephone=no\" name=\"format-detection\"/>\n",
              "<meta content=\"https://upload.wikimedia.org/wikipedia/commons/e/e1/Protein_BRCA1_PDB_1jm7.png\" property=\"og:image\"/>\n",
              "<meta content=\"1200\" property=\"og:image:width\"/>\n",
              "<meta content=\"813\" property=\"og:image:height\"/>\n",
              "<meta content=\"https://upload.wikimedia.org/wikipedia/commons/e/e1/Protein_BRCA1_PDB_1jm7.png\" property=\"og:image\"/>\n",
              "<meta content=\"800\" property=\"og:image:width\"/>\n",
              "<meta content=\"542\" property=\"og:image:height\"/>\n",
              "<meta content=\"https://upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Protein_BRCA1_PDB_1jm7.png/640px-Protein_BRCA1_PDB_1jm7.png\" property=\"og:image\"/>\n",
              "<meta content=\"640\" property=\"og:image:width\"/>\n",
              "<meta content=\"434\" property=\"og:image:height\"/>\n",
              "<meta content=\"width=1000\" name=\"viewport\"/>\n",
              "<meta content=\"BRCA1 - Wikipedia\" property=\"og:title\"/>\n",
              "<meta content=\"website\" property=\"og:type\"/>\n",
              "<link href=\"//upload.wikimedia.org\" rel=\"preconnect\"/>\n",
              "<link href=\"//en.m.wikipedia.org/wiki/BRCA1\" media=\"only screen and (max-width: 720px)\" rel=\"alternate\"/>\n",
              "<link href=\"/w/index.php?title=BRCA1&amp;action=edit\" rel=\"alternate\" title=\"Edit this page\" type=\"application/x-wiki\"/>\n",
              "<link href=\"/static/apple-touch/wikipedia.png\" rel=\"apple-touch-icon\"/>\n",
              "<link href=\"/static/favicon/wikipedia.ico\" rel=\"icon\"/>\n",
              "<link href=\"/w/opensearch_desc.php\" rel=\"search\" title=\"Wikipedia (en)\" type=\"application/opensearchdescription+xml\"/>\n",
              "<link href=\"//en.wikipedia.org/w/api.php?action=rsd\" rel=\"EditURI\" type=\"application/rsd+xml\"/>\n",
              "<link href=\"https://en.wikipedia.org/wiki/BRCA1\" rel=\"canonical\"/>\n",
              "<link href=\"https://creativecommons.org/licenses/by-sa/3.0/\" rel=\"license\"/>\n",
              "<link href=\"/w/index.php?title=Special:RecentChanges&amp;feed=atom\" rel=\"alternate\" title=\"Wikipedia Atom feed\" type=\"application/atom+xml\"/>\n",
              "<link href=\"//meta.wikimedia.org\" rel=\"dns-prefetch\"/>\n",
              "<link href=\"//login.wikimedia.org\" rel=\"dns-prefetch\"/>\n",
              "</head>\n",
              "<body class=\"skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-BRCA1 rootpage-BRCA1 skin-vector-2022 action-view\"><a class=\"mw-jump-link\" href=\"#bodyContent\">Jump to content</a>\n",
              "<div class=\"vector-header-container\">\n",
              "<header class=\"vector-header mw-header\">\n",
              "<div class=\"vector-header-start\">\n",
              "<nav aria-label=\"Site\" class=\"vector-main-menu-landmark\" role=\"navigation\">\n",
              "<div class=\"vector-menu vector-dropdown vector-menu-dropdown vector-main-menu-dropdown mw-ui-icon-flush-left mw-ui-icon-flush-right\" id=\"vector-main-menu-dropdown\">\n",
              "<input aria-haspopup=\"true\" aria-label=\"Main menu\" class=\"vector-menu-checkbox\" data-event-name=\"ui.dropdown-vector-main-menu-dropdown\" id=\"vector-main-menu-dropdown-checkbox\" role=\"button\" type=\"checkbox\"/>\n",
              "<label aria-hidden=\"true\" class=\"vector-menu-heading mw-ui-button mw-ui-quiet mw-ui-icon-element\" for=\"vector-main-menu-dropdown-checkbox\" id=\"vector-main-menu-dropdown-label\">\n",
              "<span class=\"mw-ui-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu\"></span>\n",
              "<span class=\"vector-menu-heading-label\">Main menu</span>\n",
              "</label>\n",
              "<div class=\"vector-menu-content vector-dropdown-content\">\n",
              "<div class=\"vector-unpinned-container\" id=\"vector-main-menu-unpinned-container\">\n",
              "<div class=\"vector-main-menu vector-pinnable-element\" id=\"vector-main-menu\">\n",
              "<div class=\"vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned\" data-feature-name=\"main-menu-pinned\" data-pinnable-element-id=\"vector-main-menu\" data-pinned-container-id=\"vector-main-menu-pinned-container\" data-unpinned-container-id=\"vector-main-menu-unpinned-container\">\n",
              "<div class=\"vector-pinnable-header-label\">Main menu</div>\n",
              "<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-pin-button\" data-event-name=\"pinnable-header.vector-main-menu.pin\">move to sidebar</button>\n",
              "<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button\" data-event-name=\"pinnable-header.vector-main-menu.unpin\">hide</button>\n",
              "</div>\n",
              "<div class=\"vector-menu mw-portlet mw-portlet-navigation\" id=\"p-navigation\">\n",
              "<div class=\"vector-menu-heading\">\n",
              "\t\tNavigation\n",
              "\t</div>\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"mw-list-item\" id=\"n-mainpage-description\"><a accesskey=\"z\" href=\"/wiki/Main_Page\" title=\"Visit the main page [z]\"><span>Main page</span></a></li><li class=\"mw-list-item\" id=\"n-contents\"><a href=\"/wiki/Wikipedia:Contents\" title=\"Guides to browsing Wikipedia\"><span>Contents</span></a></li><li class=\"mw-list-item\" id=\"n-currentevents\"><a href=\"/wiki/Portal:Current_events\" title=\"Articles related to current events\"><span>Current events</span></a></li><li class=\"mw-list-item\" id=\"n-randompage\"><a accesskey=\"x\" href=\"/wiki/Special:Random\" title=\"Visit a randomly selected article [x]\"><span>Random article</span></a></li><li class=\"mw-list-item\" id=\"n-aboutsite\"><a href=\"/wiki/Wikipedia:About\" title=\"Learn about Wikipedia and how it works\"><span>About Wikipedia</span></a></li><li class=\"mw-list-item\" id=\"n-contactpage\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\" title=\"How to contact Wikipedia\"><span>Contact us</span></a></li><li class=\"mw-list-item\" id=\"n-sitesupport\"><a href=\"https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en\" title=\"Support us by donating to the Wikimedia Foundation\"><span>Donate</span></a></li></ul>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-menu mw-portlet mw-portlet-interaction\" id=\"p-interaction\">\n",
              "<div class=\"vector-menu-heading\">\n",
              "\t\tContribute\n",
              "\t</div>\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"mw-list-item\" id=\"n-help\"><a href=\"/wiki/Help:Contents\" title=\"Guidance on how to use and edit Wikipedia\"><span>Help</span></a></li><li class=\"mw-list-item\" id=\"n-introduction\"><a href=\"/wiki/Help:Introduction\" title=\"Learn how to edit Wikipedia\"><span>Learn to edit</span></a></li><li class=\"mw-list-item\" id=\"n-portal\"><a href=\"/wiki/Wikipedia:Community_portal\" title=\"The hub for editors\"><span>Community portal</span></a></li><li class=\"mw-list-item\" id=\"n-recentchanges\"><a accesskey=\"r\" href=\"/wiki/Special:RecentChanges\" title=\"A list of recent changes to Wikipedia [r]\"><span>Recent changes</span></a></li><li class=\"mw-list-item\" id=\"n-upload\"><a href=\"/wiki/Wikipedia:File_upload_wizard\" title=\"Add images or other media for use on Wikipedia\"><span>Upload file</span></a></li></ul>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-main-menu-action vector-main-menu-action-lang-alert\">\n",
              "<div class=\"vector-main-menu-action-item\">\n",
              "<div class=\"vector-main-menu-action-heading vector-menu-heading\">Languages</div>\n",
              "<div class=\"vector-main-menu-action-content vector-menu-content\">\n",
              "<div class=\"mw-message-box-notice vector-language-sidebar-alert mw-message-box\">Language links are at the top of the page across from the title.</div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</nav>\n",
              "<a class=\"mw-logo\" href=\"/wiki/Main_Page\">\n",
              "<img alt=\"\" aria-hidden=\"true\" class=\"mw-logo-icon\" height=\"50\" src=\"/static/images/icons/wikipedia.png\" width=\"50\"/>\n",
              "<span class=\"mw-logo-container\">\n",
              "<img alt=\"Wikipedia\" class=\"mw-logo-wordmark\" src=\"/static/images/mobile/copyright/wikipedia-wordmark-en.svg\" style=\"width: 7.5em; height: 1.125em;\"/>\n",
              "<img alt=\"The Free Encyclopedia\" class=\"mw-logo-tagline\" height=\"13\" src=\"/static/images/mobile/copyright/wikipedia-tagline-en.svg\" style=\"width: 7.3125em; height: 0.8125em;\" width=\"117\"/>\n",
              "</span>\n",
              "</a>\n",
              "</div>\n",
              "<div class=\"vector-header-end\">\n",
              "<div class=\"vector-search-box-vue vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box\" id=\"p-search\" role=\"search\">\n",
              "<a accesskey=\"f\" class=\"mw-ui-button mw-ui-quiet mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search search-toggle\" href=\"/wiki/Special:Search\" title=\"Search Wikipedia [f]\">\n",
              "<span>Search</span>\n",
              "</a>\n",
              "<div>\n",
              "<form action=\"/w/index.php\" class=\"vector-search-box-form\" id=\"searchform\">\n",
              "<div class=\"vector-search-box-inner\" data-search-loc=\"header-moved\" id=\"simpleSearch\">\n",
              "<input accesskey=\"f\" aria-label=\"Search Wikipedia\" autocapitalize=\"sentences\" class=\"vector-search-box-input\" id=\"searchInput\" name=\"search\" placeholder=\"Search Wikipedia\" title=\"Search Wikipedia [f]\" type=\"search\"/>\n",
              "<input name=\"title\" type=\"hidden\" value=\"Special:Search\"/>\n",
              "<input class=\"searchButton mw-fallbackSearchButton\" id=\"mw-searchButton\" name=\"fulltext\" title=\"Search Wikipedia for this text\" type=\"submit\" value=\"Search\"/>\n",
              "<input class=\"searchButton\" id=\"searchButton\" name=\"go\" title=\"Go to a page with this exact name if it exists\" type=\"submit\" value=\"Go\"/>\n",
              "</div>\n",
              "</form>\n",
              "</div>\n",
              "</div>\n",
              "<nav aria-label=\"Personal tools\" class=\"vector-user-links\" role=\"navigation\">\n",
              "<div class=\"vector-menu mw-portlet mw-portlet-vector-user-menu-overflow\" id=\"p-vector-user-menu-overflow\">\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"user-links-collapsible-item mw-list-item\" id=\"pt-createaccount-2\"><a href=\"/w/index.php?title=Special:CreateAccount&amp;returnto=BRCA1\" title=\"You are encouraged to create an account and log in; however, it is not mandatory\"><span>Create account</span></a></li><li class=\"user-links-collapsible-item mw-list-item\" id=\"pt-login-2\"><a accesskey=\"o\" href=\"/w/index.php?title=Special:UserLogin&amp;returnto=BRCA1\" title=\"You're encouraged to log in; however, it's not mandatory. [o]\"><span>Log in</span></a></li></ul>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-menu vector-dropdown vector-menu-dropdown vector-user-menu mw-ui-icon-flush-right vector-user-menu-logged-out\" id=\"vector-user-links-dropdown\" title=\"Log in and more options\">\n",
              "<input aria-haspopup=\"true\" aria-label=\"Personal tools\" class=\"vector-menu-checkbox\" data-event-name=\"ui.dropdown-vector-user-links-dropdown\" id=\"vector-user-links-dropdown-checkbox\" role=\"button\" type=\"checkbox\"/>\n",
              "<label aria-hidden=\"true\" class=\"vector-menu-heading mw-ui-button mw-ui-quiet mw-ui-icon-element\" for=\"vector-user-links-dropdown-checkbox\" id=\"vector-user-links-dropdown-label\">\n",
              "<span class=\"mw-ui-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis\"></span>\n",
              "<span class=\"vector-menu-heading-label\">Personal tools</span>\n",
              "</label>\n",
              "<div class=\"vector-menu-content vector-dropdown-content\">\n",
              "<div class=\"vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item\" id=\"p-personal\" title=\"User menu\">\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"user-links-collapsible-item mw-list-item\" id=\"pt-createaccount\"><a href=\"/w/index.php?title=Special:CreateAccount&amp;returnto=BRCA1\" title=\"You are encouraged to create an account and log in; however, it is not mandatory\"><span class=\"mw-ui-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd\"></span> <span>Create account</span></a></li><li class=\"user-links-collapsible-item mw-list-item\" id=\"pt-login\"><a accesskey=\"o\" href=\"/w/index.php?title=Special:UserLogin&amp;returnto=BRCA1\" title=\"You're encouraged to log in; however, it's not mandatory. [o]\"><span class=\"mw-ui-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn\"></span> <span>Log in</span></a></li></ul>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-menu mw-portlet mw-portlet-user-menu-anon-editor\" id=\"p-user-menu-anon-editor\">\n",
              "<div class=\"vector-menu-heading\">\n",
              "\t\tPages for logged out editors <a aria-label=\"Learn more about editing\" href=\"/wiki/Help:Introduction\"><span>learn more</span></a>\n",
              "</div>\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"mw-list-item\" id=\"pt-anoncontribs\"><a accesskey=\"y\" href=\"/wiki/Special:MyContributions\" title=\"A list of edits made from this IP address [y]\"><span>Contributions</span></a></li><li class=\"mw-list-item\" id=\"pt-anontalk\"><a accesskey=\"n\" href=\"/wiki/Special:MyTalk\" title=\"Discussion about edits from this IP address [n]\"><span>Talk</span></a></li></ul>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</nav>\n",
              "</div>\n",
              "</header>\n",
              "</div>\n",
              "<div class=\"mw-page-container\">\n",
              "<div class=\"mw-page-container-inner\">\n",
              "<div class=\"vector-main-menu-container\">\n",
              "<div id=\"mw-navigation\">\n",
              "<nav aria-label=\"Site\" class=\"vector-main-menu-landmark\" id=\"mw-panel\" role=\"navigation\">\n",
              "<div class=\"vector-pinned-container\" id=\"vector-main-menu-pinned-container\">\n",
              "</div>\n",
              "</nav>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-sitenotice-container\">\n",
              "<div id=\"siteNotice\"><!-- CentralNotice --></div>\n",
              "</div>\n",
              "<input class=\"vector-menu-checkbox\" id=\"vector-toc-collapsed-checkbox\" type=\"checkbox\"/>\n",
              "<nav aria-label=\"Contents\" class=\"mw-table-of-contents-container vector-toc-landmark vector-sticky-pinned-container\" data-event-name=\"ui.sidebar-toc\" id=\"mw-panel-toc\" role=\"navigation\">\n",
              "<div class=\"vector-pinned-container\" id=\"vector-toc-pinned-container\">\n",
              "<div class=\"vector-toc vector-pinnable-element\" id=\"vector-toc\">\n",
              "<div class=\"vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned\" data-feature-name=\"toc-pinned\" data-pinnable-element-id=\"vector-toc\">\n",
              "<h2 class=\"vector-pinnable-header-label\">Contents</h2>\n",
              "<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-pin-button\" data-event-name=\"pinnable-header.vector-toc.pin\">move to sidebar</button>\n",
              "<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button\" data-event-name=\"pinnable-header.vector-toc.unpin\">hide</button>\n",
              "</div>\n",
              "<ul class=\"vector-toc-contents\" id=\"mw-panel-toc-list\">\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1\" id=\"toc-mw-content-text\">\n",
              "<a class=\"vector-toc-link\" href=\"#\">\n",
              "<div class=\"vector-toc-text\">(Top)</div>\n",
              "</a>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Discovery\">\n",
              "<a class=\"vector-toc-link\" href=\"#Discovery\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">1</span>Discovery</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Discovery-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Gene_location\">\n",
              "<a class=\"vector-toc-link\" href=\"#Gene_location\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">2</span>Gene location</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Gene_location-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Protein_structure\">\n",
              "<a class=\"vector-toc-link\" href=\"#Protein_structure\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">3</span>Protein structure</div>\n",
              "</a>\n",
              "<button aria-controls=\"toc-Protein_structure-sublist\" class=\"mw-ui-icon mw-ui-icon-wikimedia-expand mw-ui-icon-small vector-toc-toggle\">\n",
              "\t\t\t\tToggle Protein structure subsection\n",
              "\t\t\t</button>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Protein_structure-sublist\">\n",
              "<li class=\"vector-toc-list-item vector-toc-level-2\" id=\"toc-Zinc_ring_finger_domain\">\n",
              "<a class=\"vector-toc-link\" href=\"#Zinc_ring_finger_domain\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">3.1</span>Zinc ring finger domain</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Zinc_ring_finger_domain-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-2\" id=\"toc-Serine_cluster_domain\">\n",
              "<a class=\"vector-toc-link\" href=\"#Serine_cluster_domain\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">3.2</span>Serine cluster domain</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Serine_cluster_domain-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-2\" id=\"toc-BRCT_domains\">\n",
              "<a class=\"vector-toc-link\" href=\"#BRCT_domains\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">3.3</span>BRCT domains</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-BRCT_domains-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Function_and_mechanism\">\n",
              "<a class=\"vector-toc-link\" href=\"#Function_and_mechanism\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">4</span>Function and mechanism</div>\n",
              "</a>\n",
              "<button aria-controls=\"toc-Function_and_mechanism-sublist\" class=\"mw-ui-icon mw-ui-icon-wikimedia-expand mw-ui-icon-small vector-toc-toggle\">\n",
              "\t\t\t\tToggle Function and mechanism subsection\n",
              "\t\t\t</button>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Function_and_mechanism-sublist\">\n",
              "<li class=\"vector-toc-list-item vector-toc-level-2\" id=\"toc-Transcription\">\n",
              "<a class=\"vector-toc-link\" href=\"#Transcription\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">4.1</span>Transcription</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Transcription-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Mutations_and_cancer_risk\">\n",
              "<a class=\"vector-toc-link\" href=\"#Mutations_and_cancer_risk\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">5</span>Mutations and cancer risk</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Mutations_and_cancer_risk-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Low_expression_of_BRCA1_in_breast_and_ovarian_cancers\">\n",
              "<a class=\"vector-toc-link\" href=\"#Low_expression_of_BRCA1_in_breast_and_ovarian_cancers\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">6</span>Low expression of <i>BRCA1</i> in breast and ovarian cancers</div>\n",
              "</a>\n",
              "<button aria-controls=\"toc-Low_expression_of_BRCA1_in_breast_and_ovarian_cancers-sublist\" class=\"mw-ui-icon mw-ui-icon-wikimedia-expand mw-ui-icon-small vector-toc-toggle\">\n",
              "\t\t\t\tToggle Low expression of <i>BRCA1</i> in breast and ovarian cancers subsection\n",
              "\t\t\t</button>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Low_expression_of_BRCA1_in_breast_and_ovarian_cancers-sublist\">\n",
              "<li class=\"vector-toc-list-item vector-toc-level-2\" id=\"toc-Mutation_of_BRCA1_in_breast_and_ovarian_cancer\">\n",
              "<a class=\"vector-toc-link\" href=\"#Mutation_of_BRCA1_in_breast_and_ovarian_cancer\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">6.1</span>Mutation of <i>BRCA1</i> in breast and ovarian cancer</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Mutation_of_BRCA1_in_breast_and_ovarian_cancer-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-2\" id=\"toc-BRCA1_promoter_hypermethylation_in_breast_and_ovarian_cancer\">\n",
              "<a class=\"vector-toc-link\" href=\"#BRCA1_promoter_hypermethylation_in_breast_and_ovarian_cancer\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">6.2</span><i>BRCA1</i> promoter hypermethylation in breast and ovarian cancer</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-BRCA1_promoter_hypermethylation_in_breast_and_ovarian_cancer-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-2\" id=\"toc-MicroRNA_repression_of_BRCA1_in_breast_cancers\">\n",
              "<a class=\"vector-toc-link\" href=\"#MicroRNA_repression_of_BRCA1_in_breast_cancers\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">6.3</span>MicroRNA repression of BRCA1 in breast cancers</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-MicroRNA_repression_of_BRCA1_in_breast_cancers-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-2\" id=\"toc-MicroRNA_repression_of_BRCA1_in_ovarian_cancers\">\n",
              "<a class=\"vector-toc-link\" href=\"#MicroRNA_repression_of_BRCA1_in_ovarian_cancers\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">6.4</span>MicroRNA repression of BRCA1 in ovarian cancers</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-MicroRNA_repression_of_BRCA1_in_ovarian_cancers-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-2\" id=\"toc-Deficiency_of_BRCA1_expression_is_likely_tumorigenic\">\n",
              "<a class=\"vector-toc-link\" href=\"#Deficiency_of_BRCA1_expression_is_likely_tumorigenic\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">6.5</span>Deficiency of <i>BRCA1</i> expression is likely tumorigenic</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Deficiency_of_BRCA1_expression_is_likely_tumorigenic-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Germ-line_mutations_and_founder_effect\">\n",
              "<a class=\"vector-toc-link\" href=\"#Germ-line_mutations_and_founder_effect\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">7</span>Germ-line mutations and founder effect</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Germ-line_mutations_and_founder_effect-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Female_fertility\">\n",
              "<a class=\"vector-toc-link\" href=\"#Female_fertility\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">8</span>Female fertility</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Female_fertility-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Cancer_chemotherapy\">\n",
              "<a class=\"vector-toc-link\" href=\"#Cancer_chemotherapy\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">9</span>Cancer chemotherapy</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Cancer_chemotherapy-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Patents,_enforcement,_litigation,_and_controversy\">\n",
              "<a class=\"vector-toc-link\" href=\"#Patents,_enforcement,_litigation,_and_controversy\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">10</span>Patents, enforcement, litigation, and controversy</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Patents,_enforcement,_litigation,_and_controversy-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-Interactions\">\n",
              "<a class=\"vector-toc-link\" href=\"#Interactions\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">11</span>Interactions</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-Interactions-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-References\">\n",
              "<a class=\"vector-toc-link\" href=\"#References\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">12</span>References</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-References-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "<li class=\"vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded\" id=\"toc-External_links\">\n",
              "<a class=\"vector-toc-link\" href=\"#External_links\">\n",
              "<div class=\"vector-toc-text\">\n",
              "<span class=\"vector-toc-numb\">13</span>External links</div>\n",
              "</a>\n",
              "<ul class=\"vector-toc-list\" id=\"toc-External_links-sublist\">\n",
              "</ul>\n",
              "</li>\n",
              "</ul>\n",
              "</div>\n",
              "</div>\n",
              "</nav>\n",
              "<div class=\"mw-content-container\">\n",
              "<main class=\"mw-body\" id=\"content\" role=\"main\">\n",
              "<header class=\"mw-body-header vector-page-titlebar\">\n",
              "<label aria-controls=\"toc-toggle-list\" class=\"mw-ui-button mw-ui-quiet mw-ui-icon mw-ui-icon-flush-left mw-ui-icon-element mw-ui-icon-wikimedia-listBullet\" data-event-name=\"vector.toc-toggle-list\" for=\"vector-toc-collapsed-checkbox\" id=\"vector-toc-collapsed-button\" role=\"button\" tabindex=\"0\" title=\"Table of Contents\">\n",
              "\t\t\t\t\t\tToggle the table of contents\n",
              "\t\t\t\t\t</label>\n",
              "<nav aria-label=\"Contents\" class=\"vector-toc-landmark\" role=\"navigation\">\n",
              "<div class=\"vector-menu vector-dropdown vector-menu-dropdown vector-page-titlebar-toc mw-ui-icon-flush-left\" id=\"vector-page-titlebar-toc\">\n",
              "<input aria-haspopup=\"true\" aria-label=\"Toggle the table of contents\" class=\"vector-menu-checkbox\" data-event-name=\"ui.dropdown-vector-page-titlebar-toc\" id=\"vector-page-titlebar-toc-checkbox\" role=\"button\" type=\"checkbox\"/>\n",
              "<label aria-hidden=\"true\" class=\"vector-menu-heading mw-ui-button mw-ui-quiet mw-ui-icon-element\" for=\"vector-page-titlebar-toc-checkbox\" id=\"vector-page-titlebar-toc-label\">\n",
              "<span class=\"mw-ui-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet\"></span>\n",
              "<span class=\"vector-menu-heading-label\">Toggle the table of contents</span>\n",
              "</label>\n",
              "<div class=\"vector-menu-content vector-dropdown-content\">\n",
              "<div class=\"vector-unpinned-container\" id=\"vector-page-titlebar-toc-unpinned-container\">\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</nav>\n",
              "<h1 class=\"firstHeading mw-first-heading\" id=\"firstHeading\"><span class=\"mw-page-title-main\">BRCA1</span></h1>\n",
              "<div class=\"vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-lang\" id=\"p-lang-btn\">\n",
              "<input aria-haspopup=\"true\" aria-label=\"Go to an article in another language. Available in 23 languages\" class=\"vector-menu-checkbox mw-interlanguage-selector\" data-event-name=\"ui.dropdown-p-lang-btn\" id=\"p-lang-btn-checkbox\" role=\"button\" type=\"checkbox\"/>\n",
              "<label aria-hidden=\"true\" class=\"vector-menu-heading mw-ui-button mw-ui-quiet mw-ui-progressive mw-portlet-lang-heading-23\" for=\"p-lang-btn-checkbox\" id=\"p-lang-btn-label\">\n",
              "<span class=\"mw-ui-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive\"></span>\n",
              "<span class=\"vector-menu-heading-label\">23 languages</span>\n",
              "</label>\n",
              "<div class=\"vector-menu-content vector-dropdown-content\">\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"interlanguage-link interwiki-ar mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://ar.wikipedia.org/wiki/BRCA1\" hreflang=\"ar\" lang=\"ar\" title=\"BRCA1 – Arabic\"><span>العربية</span></a></li><li class=\"interlanguage-link interwiki-bs mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://bs.wikipedia.org/wiki/BRCA1\" hreflang=\"bs\" lang=\"bs\" title=\"BRCA1 – Bosnian\"><span>Bosanski</span></a></li><li class=\"interlanguage-link interwiki-ca mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://ca.wikipedia.org/wiki/BRCA1\" hreflang=\"ca\" lang=\"ca\" title=\"BRCA1 – Catalan\"><span>Català</span></a></li><li class=\"interlanguage-link interwiki-cy mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://cy.wikipedia.org/wiki/BRCA1\" hreflang=\"cy\" lang=\"cy\" title=\"BRCA1 – Welsh\"><span>Cymraeg</span></a></li><li class=\"interlanguage-link interwiki-de mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://de.wikipedia.org/wiki/BRCA1\" hreflang=\"de\" lang=\"de\" title=\"BRCA1 – German\"><span>Deutsch</span></a></li><li class=\"interlanguage-link interwiki-et mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://et.wikipedia.org/wiki/BRCA1\" hreflang=\"et\" lang=\"et\" title=\"BRCA1 – Estonian\"><span>Eesti</span></a></li><li class=\"interlanguage-link interwiki-es mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://es.wikipedia.org/wiki/BRCA1\" hreflang=\"es\" lang=\"es\" title=\"BRCA1 – Spanish\"><span>Español</span></a></li><li class=\"interlanguage-link interwiki-fa mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://fa.wikipedia.org/wiki/BRCA1\" hreflang=\"fa\" lang=\"fa\" title=\"BRCA1 – Persian\"><span>فارسی</span></a></li><li class=\"interlanguage-link interwiki-fr mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://fr.wikipedia.org/wiki/BRCA1\" hreflang=\"fr\" lang=\"fr\" title=\"BRCA1 – French\"><span>Français</span></a></li><li class=\"interlanguage-link interwiki-gl mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://gl.wikipedia.org/wiki/BRCA1\" hreflang=\"gl\" lang=\"gl\" title=\"BRCA1 – Galician\"><span>Galego</span></a></li><li class=\"interlanguage-link interwiki-ko mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://ko.wikipedia.org/wiki/BRCA1\" hreflang=\"ko\" lang=\"ko\" title=\"BRCA1 – Korean\"><span>한국어</span></a></li><li class=\"interlanguage-link interwiki-it mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://it.wikipedia.org/wiki/BRCA1\" hreflang=\"it\" lang=\"it\" title=\"BRCA1 – Italian\"><span>Italiano</span></a></li><li class=\"interlanguage-link interwiki-nl mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://nl.wikipedia.org/wiki/BRCA1\" hreflang=\"nl\" lang=\"nl\" title=\"BRCA1 – Dutch\"><span>Nederlands</span></a></li><li class=\"interlanguage-link interwiki-ja mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://ja.wikipedia.org/wiki/BRCA1\" hreflang=\"ja\" lang=\"ja\" title=\"BRCA1 – Japanese\"><span>日本語</span></a></li><li class=\"interlanguage-link interwiki-pl mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://pl.wikipedia.org/wiki/BRCA1\" hreflang=\"pl\" lang=\"pl\" title=\"BRCA1 – Polish\"><span>Polski</span></a></li><li class=\"interlanguage-link interwiki-pt mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://pt.wikipedia.org/wiki/BRCA1\" hreflang=\"pt\" lang=\"pt\" title=\"BRCA1 – Portuguese\"><span>Português</span></a></li><li class=\"interlanguage-link interwiki-ru mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://ru.wikipedia.org/wiki/BRCA1\" hreflang=\"ru\" lang=\"ru\" title=\"BRCA1 – Russian\"><span>Русский</span></a></li><li class=\"interlanguage-link interwiki-sl mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://sl.wikipedia.org/wiki/BRCA1\" hreflang=\"sl\" lang=\"sl\" title=\"BRCA1 – Slovenian\"><span>Slovenščina</span></a></li><li class=\"interlanguage-link interwiki-fi mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://fi.wikipedia.org/wiki/BRCA1\" hreflang=\"fi\" lang=\"fi\" title=\"BRCA1 – Finnish\"><span>Suomi</span></a></li><li class=\"interlanguage-link interwiki-ta mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://ta.wikipedia.org/wiki/%E0%AE%AA%E0%AE%BF%E0%AE%86%E0%AE%B0%E0%AF%8D%E0%AE%9A%E0%AE%BF%E0%AE%8F1\" hreflang=\"ta\" lang=\"ta\" title=\"பிஆர்சிஏ1 – Tamil\"><span>தமிழ்</span></a></li><li class=\"interlanguage-link interwiki-uk mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://uk.wikipedia.org/wiki/BRCA1\" hreflang=\"uk\" lang=\"uk\" title=\"BRCA1 – Ukrainian\"><span>Українська</span></a></li><li class=\"interlanguage-link interwiki-ur mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://ur.wikipedia.org/wiki/%D8%A8%D8%B1%D8%B3%D8%A7_1\" hreflang=\"ur\" lang=\"ur\" title=\"برسا 1 – Urdu\"><span>اردو</span></a></li><li class=\"interlanguage-link interwiki-zh mw-list-item\"><a class=\"interlanguage-link-target\" href=\"https://zh.wikipedia.org/wiki/BRCA1\" hreflang=\"zh\" lang=\"zh\" title=\"BRCA1 – Chinese\"><span>中文</span></a></li></ul>\n",
              "<div class=\"after-portlet after-portlet-lang\"><span class=\"wb-langlinks-edit wb-langlinks-link\"><a class=\"wbc-editpage\" href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q17487737#sitelinks-wikipedia\" title=\"Edit interlanguage links\">Edit links</a></span></div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</header>\n",
              "<div class=\"vector-page-toolbar\">\n",
              "<div class=\"vector-page-toolbar-container\">\n",
              "<div id=\"left-navigation\">\n",
              "<nav aria-label=\"Namespaces\">\n",
              "<div class=\"vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages\" id=\"p-associated-pages\">\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\">\n",
              "<li class=\"selected vector-tab-noicon mw-list-item\" id=\"ca-nstab-main\"><a accesskey=\"c\" class=\"\" data-mw=\"interface\" href=\"/wiki/BRCA1\" title=\"View the content page [c]\"><span>Article</span></a>\n",
              "</li>\n",
              "<li class=\"vector-tab-noicon mw-list-item\" id=\"ca-talk\"><a accesskey=\"t\" class=\"\" data-mw=\"interface\" href=\"/wiki/Talk:BRCA1\" rel=\"discussion\" title=\"Discuss improvements to the content page [t]\"><span>Talk</span></a>\n",
              "</li>\n",
              "</ul>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-variants emptyPortlet\" id=\"p-variants\">\n",
              "<input aria-haspopup=\"true\" aria-label=\"Change language variant\" class=\"vector-menu-checkbox\" data-event-name=\"ui.dropdown-p-variants\" id=\"p-variants-checkbox\" role=\"button\" type=\"checkbox\"/>\n",
              "<label aria-hidden=\"true\" class=\"vector-menu-heading\" for=\"p-variants-checkbox\" id=\"p-variants-label\">\n",
              "<span class=\"vector-menu-heading-label\">English</span>\n",
              "</label>\n",
              "<div class=\"vector-menu-content vector-dropdown-content\">\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"></ul>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</nav>\n",
              "</div>\n",
              "<div class=\"vector-collapsible\" id=\"right-navigation\">\n",
              "<nav aria-label=\"Views\">\n",
              "<div class=\"vector-menu vector-menu-tabs mw-portlet mw-portlet-views\" id=\"p-views\">\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\">\n",
              "<li class=\"selected vector-tab-noicon mw-list-item\" id=\"ca-view\"><a class=\"\" data-mw=\"interface\" href=\"/wiki/BRCA1\"><span>Read</span></a>\n",
              "</li>\n",
              "<li class=\"vector-tab-noicon mw-list-item\" id=\"ca-edit\"><a accesskey=\"e\" class=\"\" data-mw=\"interface\" href=\"/w/index.php?title=BRCA1&amp;action=edit\" title=\"Edit this page [e]\"><span>Edit</span></a>\n",
              "</li>\n",
              "<li class=\"vector-tab-noicon mw-list-item\" id=\"ca-history\"><a accesskey=\"h\" class=\"\" data-mw=\"interface\" href=\"/w/index.php?title=BRCA1&amp;action=history\" title=\"Past revisions of this page [h]\"><span>View history</span></a>\n",
              "</li>\n",
              "</ul>\n",
              "</div>\n",
              "</div>\n",
              "</nav>\n",
              "<nav aria-label=\"More options\" class=\"vector-page-tools-landmark\">\n",
              "<div class=\"vector-menu vector-dropdown vector-menu-dropdown vector-page-tools-dropdown\" id=\"vector-page-tools-dropdown\">\n",
              "<input aria-haspopup=\"true\" aria-label=\"Tools\" class=\"vector-menu-checkbox\" data-event-name=\"ui.dropdown-vector-page-tools-dropdown\" id=\"vector-page-tools-dropdown-checkbox\" role=\"button\" type=\"checkbox\"/>\n",
              "<label aria-hidden=\"true\" class=\"vector-menu-heading\" for=\"vector-page-tools-dropdown-checkbox\" id=\"vector-page-tools-dropdown-label\">\n",
              "<span class=\"vector-menu-heading-label\">Tools</span>\n",
              "</label>\n",
              "<div class=\"vector-menu-content vector-dropdown-content\">\n",
              "<div class=\"vector-unpinned-container\" id=\"vector-page-tools-unpinned-container\">\n",
              "<div class=\"vector-page-tools vector-pinnable-element\" id=\"vector-page-tools\">\n",
              "<div class=\"vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned\" data-feature-name=\"page-tools-pinned\" data-pinnable-element-id=\"vector-page-tools\" data-pinned-container-id=\"vector-page-tools-pinned-container\" data-unpinned-container-id=\"vector-page-tools-unpinned-container\">\n",
              "<div class=\"vector-pinnable-header-label\">Tools</div>\n",
              "<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-pin-button\" data-event-name=\"pinnable-header.vector-page-tools.pin\">move to sidebar</button>\n",
              "<button class=\"vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button\" data-event-name=\"pinnable-header.vector-page-tools.unpin\">hide</button>\n",
              "</div>\n",
              "<div class=\"vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items\" id=\"p-cactions\" title=\"More options\">\n",
              "<div class=\"vector-menu-heading\">\n",
              "\t\tActions\n",
              "\t</div>\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"selected vector-more-collapsible-item mw-list-item\" id=\"ca-more-view\"><a href=\"/wiki/BRCA1\"><span>Read</span></a></li><li class=\"vector-more-collapsible-item mw-list-item\" id=\"ca-more-edit\"><a href=\"/w/index.php?title=BRCA1&amp;action=edit\"><span>Edit</span></a></li><li class=\"vector-more-collapsible-item mw-list-item\" id=\"ca-more-history\"><a href=\"/w/index.php?title=BRCA1&amp;action=history\"><span>View history</span></a></li></ul>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-menu mw-portlet mw-portlet-tb\" id=\"p-tb\">\n",
              "<div class=\"vector-menu-heading\">\n",
              "\t\tGeneral\n",
              "\t</div>\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"mw-list-item\" id=\"t-whatlinkshere\"><a accesskey=\"j\" href=\"/wiki/Special:WhatLinksHere/BRCA1\" title=\"List of all English Wikipedia pages containing links to this page [j]\"><span>What links here</span></a></li><li class=\"mw-list-item\" id=\"t-recentchangeslinked\"><a accesskey=\"k\" href=\"/wiki/Special:RecentChangesLinked/BRCA1\" rel=\"nofollow\" title=\"Recent changes in pages linked from this page [k]\"><span>Related changes</span></a></li><li class=\"mw-list-item\" id=\"t-upload\"><a accesskey=\"u\" href=\"/wiki/Wikipedia:File_Upload_Wizard\" title=\"Upload files [u]\"><span>Upload file</span></a></li><li class=\"mw-list-item\" id=\"t-specialpages\"><a accesskey=\"q\" href=\"/wiki/Special:SpecialPages\" title=\"A list of all special pages [q]\"><span>Special pages</span></a></li><li class=\"mw-list-item\" id=\"t-permalink\"><a href=\"/w/index.php?title=BRCA1&amp;oldid=1146808968\" title=\"Permanent link to this revision of this page\"><span>Permanent link</span></a></li><li class=\"mw-list-item\" id=\"t-info\"><a href=\"/w/index.php?title=BRCA1&amp;action=info\" title=\"More information about this page\"><span>Page information</span></a></li><li class=\"mw-list-item\" id=\"t-cite\"><a href=\"/w/index.php?title=Special:CiteThisPage&amp;page=BRCA1&amp;id=1146808968&amp;wpFormIdentifier=titleform\" title=\"Information on how to cite this page\"><span>Cite this page</span></a></li><li class=\"mw-list-item\" id=\"t-wikibase\"><a accesskey=\"g\" href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q17487737\" title=\"Structured data on this page hosted by Wikidata [g]\"><span>Wikidata item</span></a></li></ul>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-menu mw-portlet mw-portlet-coll-print_export\" id=\"p-coll-print_export\">\n",
              "<div class=\"vector-menu-heading\">\n",
              "\t\tPrint/export\n",
              "\t</div>\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"mw-list-item\" id=\"coll-download-as-rl\"><a href=\"/w/index.php?title=Special:DownloadAsPdf&amp;page=BRCA1&amp;action=show-download-screen\" title=\"Download this page as a PDF file\"><span>Download as PDF</span></a></li><li class=\"mw-list-item\" id=\"t-print\"><a accesskey=\"p\" href=\"/w/index.php?title=BRCA1&amp;printable=yes\" title=\"Printable version of this page [p]\"><span>Printable version</span></a></li></ul>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-menu mw-portlet mw-portlet-wikibase-otherprojects\" id=\"p-wikibase-otherprojects\">\n",
              "<div class=\"vector-menu-heading\">\n",
              "\t\tIn other projects\n",
              "\t</div>\n",
              "<div class=\"vector-menu-content\">\n",
              "<ul class=\"vector-menu-content-list\"><li class=\"wb-otherproject-link wb-otherproject-commons mw-list-item\"><a href=\"https://commons.wikimedia.org/wiki/Category:BRCA1\" hreflang=\"en\"><span>Wikimedia Commons</span></a></li></ul>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "</nav>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-column-end\">\n",
              "<nav aria-label=\"More options\" class=\"vector-page-tools-landmark vector-sticky-pinned-container\">\n",
              "<div class=\"vector-pinned-container\" id=\"vector-page-tools-pinned-container\">\n",
              "</div>\n",
              "</nav>\n",
              "</div>\n",
              "<div aria-labelledby=\"firstHeading\" class=\"vector-body\" data-mw-ve-target-container=\"\" id=\"bodyContent\">\n",
              "<div class=\"vector-body-before-content\">\n",
              "<div class=\"mw-indicators\">\n",
              "</div>\n",
              "<div class=\"noprint\" id=\"siteSub\">From Wikipedia, the free encyclopedia</div>\n",
              "</div>\n",
              "<div id=\"contentSub\"><div id=\"mw-content-subtitle\"></div></div>\n",
              "<div class=\"mw-body-content mw-content-ltr\" dir=\"ltr\" id=\"mw-content-text\" lang=\"en\"><div class=\"mw-parser-output\"><div class=\"shortdescription nomobile noexcerpt noprint searchaux\" style=\"display:none\">Gene known for its role in breast cancer</div>\n",
              "<table class=\"infobox\" style=\"width:26.4em\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;font-size:125%;font-weight:bold\">BRCA1</th></tr><tr><td colspan=\"4\" style=\"text-align:center\"><a class=\"image\" href=\"/wiki/File:Protein_BRCA1_PDB_1jm7.png\"><img alt=\"Protein BRCA1 PDB 1jm7.png\" data-file-height=\"504\" data-file-width=\"744\" decoding=\"async\" height=\"169\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Protein_BRCA1_PDB_1jm7.png/250px-Protein_BRCA1_PDB_1jm7.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Protein_BRCA1_PDB_1jm7.png/375px-Protein_BRCA1_PDB_1jm7.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Protein_BRCA1_PDB_1jm7.png/500px-Protein_BRCA1_PDB_1jm7.png 2x\" width=\"250\"/></a></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Available structures</th></tr><tr><th rowspan=\"2\" style=\"background-color:#c3fdb8;width:43px\"><a href=\"/wiki/Protein_Data_Bank\" title=\"Protein Data Bank\">PDB</a></th><td colspan=\"2\" style=\"background-color:#eee\">Ortholog search: <span class=\"plainlinks\"><a class=\"external text\" href=\"https://www.ebi.ac.uk/pdbe/searchResults.html?display=both&amp;term=P48754%20or%20P38398\" rel=\"nofollow\">PDBe</a> <a class=\"external text\" href=\"https://www.rcsb.org/search?q=rcsb_polymer_entity_container_identifiers.reference_sequence_identifiers.database_name:UniProt%20AND%20rcsb_polymer_entity_container_identifiers.reference_sequence_identifiers.database_accession:P48754,P38398\" rel=\"nofollow\">RCSB</a> </span></td></tr><tr><td><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr style=\"background-color:#ddd;text-align:center\"><th colspan=\"2\">List of PDB id codes</th></tr><tr><td colspan=\"2\" style=\"background-color:#eee\"><p><span class=\"plainlinks\"><a class=\"external text\" href=\"https://www.rcsb.org/structure/1JM7\" rel=\"nofollow\">1JM7</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/1JNX\" rel=\"nofollow\">1JNX</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/1N5O\" rel=\"nofollow\">1N5O</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/1OQA\" rel=\"nofollow\">1OQA</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/1T15\" rel=\"nofollow\">1T15</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/1T29\" rel=\"nofollow\">1T29</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/1T2U\" rel=\"nofollow\">1T2U</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/1T2V\" rel=\"nofollow\">1T2V</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/1Y98\" rel=\"nofollow\">1Y98</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/2ING\" rel=\"nofollow\">2ING</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/3COJ\" rel=\"nofollow\">3COJ</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/3K0H\" rel=\"nofollow\">3K0H</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/3K0K\" rel=\"nofollow\">3K0K</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/3K15\" rel=\"nofollow\">3K15</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/3PXA\" rel=\"nofollow\">3PXA</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/3PXB\" rel=\"nofollow\">3PXB</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/3PXC\" rel=\"nofollow\">3PXC</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/3PXD\" rel=\"nofollow\">3PXD</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/3PXE\" rel=\"nofollow\">3PXE</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/4IFI\" rel=\"nofollow\">4IFI</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/4IGK\" rel=\"nofollow\">4IGK</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/4JLU\" rel=\"nofollow\">4JLU</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/4OFB\" rel=\"nofollow\">4OFB</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/4U4A\" rel=\"nofollow\">4U4A</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/4Y18\" rel=\"nofollow\">4Y18</a>, <a class=\"external text\" href=\"https://www.rcsb.org/structure/4Y2G\" rel=\"nofollow\">4Y2G</a></span></p></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Identifiers</th></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><span class=\"plainlinks\"><a href=\"/wiki/Gene_nomenclature\" title=\"Gene nomenclature\">Aliases</a></span></th><td colspan=\"3\" style=\"background:#eee\"><span class=\"plainlinks\"><a class=\"external text\" href=\"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/1100\" rel=\"nofollow\">BRCA1</a></span>, breast cancer 1, early onset, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53, FANCS, breast cancer 1, DNA repair associated, BRCA1 DNA repair associated, Genes</td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">External IDs</th><td colspan=\"3\" style=\"background-color:#eee\"><span class=\"plainlinks\"><a class=\"mw-redirect\" href=\"/wiki/Mendelian_Inheritance_in_Man\" title=\"Mendelian Inheritance in Man\">OMIM</a>: <a class=\"external text\" href=\"https://omim.org/entry/113705\" rel=\"nofollow\">113705</a> <a href=\"/wiki/Mouse_Genome_Informatics\" title=\"Mouse Genome Informatics\">MGI</a>: <a class=\"external text\" href=\"http://www.informatics.jax.org/marker/MGI:104537\" rel=\"nofollow\">104537</a> <a href=\"/wiki/HomoloGene\" title=\"HomoloGene\">HomoloGene</a>: <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=homologene&amp;dopt=HomoloGene&amp;list_uids=5276\" rel=\"nofollow\">5276</a> <a href=\"/wiki/GeneCards\" title=\"GeneCards\">GeneCards</a>: <a class=\"external text\" href=\"https://www.genecards.org/cgi-bin/carddisp.pl?gene=BRCA1\" rel=\"nofollow\">BRCA1</a> </span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Gene location (<a href=\"/wiki/Human_genome\" title=\"Human genome\">Human</a>)</th></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><a class=\"image\" href=\"/wiki/File:Ideogram_human_chromosome_17.svg\" title=\"Chromosome 17 (human)\"><img alt=\"Chromosome 17 (human)\" data-file-height=\"189\" data-file-width=\"474\" decoding=\"async\" height=\"120\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/00/Ideogram_human_chromosome_17.svg/300px-Ideogram_human_chromosome_17.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/00/Ideogram_human_chromosome_17.svg/450px-Ideogram_human_chromosome_17.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/00/Ideogram_human_chromosome_17.svg/600px-Ideogram_human_chromosome_17.svg.png 2x\" width=\"300\"/></a></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\" width=\"15%\"><a href=\"/wiki/Chromosome\" title=\"Chromosome\">Chr.</a></th><td colspan=\"3\" style=\"background-color:#eee\" width=\"85%\"><span class=\"plainlinks\"><a class=\"mw-redirect\" href=\"/wiki/Chromosome_17_(human)\" title=\"Chromosome 17 (human)\">Chromosome 17 (human)</a><sup class=\"reference\" id=\"cite_ref-refGRCh38Ensembl_1-0\"><a href=\"#cite_note-refGRCh38Ensembl-1\">[1]</a></sup></span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><div align=\"center\"><div style=\"position: relative; width: 300px;\"><a class=\"image\" href=\"/wiki/File:Human_chromosome_17_ideogram.svg\" title=\"Chromosome 17 (human)\"><img alt=\"Chromosome 17 (human)\" data-file-height=\"216\" data-file-width=\"1125\" decoding=\"async\" height=\"58\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Human_chromosome_17_ideogram.svg/300px-Human_chromosome_17_ideogram.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Human_chromosome_17_ideogram.svg/450px-Human_chromosome_17_ideogram.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Human_chromosome_17_ideogram.svg/600px-Human_chromosome_17_ideogram.svg.png 2x\" width=\"300\"/></a><div style=\"position: absolute; left: 146.89004298083px; top: 2px; padding: 0;\"><a class=\"image\" href=\"/wiki/File:HSR_1996_II_3.5e.svg\" title=\"Genomic location for BRCA1\"><img alt=\"Genomic location for BRCA1\" data-file-height=\"142\" data-file-width=\"142\" decoding=\"async\" height=\"14\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/14px-HSR_1996_II_3.5e.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/21px-HSR_1996_II_3.5e.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/28px-HSR_1996_II_3.5e.svg.png 2x\" width=\"14\"/></a></div><div style=\"position: absolute; left: 152.9px; top: 19px; padding: 0;\"><a class=\"image\" href=\"/wiki/File:Red_rectangle_2x18.png\" title=\"Genomic location for BRCA1\"><img alt=\"Genomic location for BRCA1\" data-file-height=\"18\" data-file-width=\"2\" decoding=\"async\" height=\"18\" src=\"//upload.wikimedia.org/wikipedia/commons/6/6a/Red_rectangle_2x18.png\" width=\"2\"/></a></div></div></div></td></tr><tr><th rowspan=\"2\" scope=\"row\" style=\"background-color:#c3fdb8\" width=\"15%\"><a href=\"/wiki/Locus_(genetics)\" title=\"Locus (genetics)\">Band</a></th><td rowspan=\"2\" style=\"background-color:#eee\" width=\"35%\"><span class=\"plainlinks\">17q21.31</span></td><th scope=\"row\" style=\"background-color:#c3fdb8\">Start</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">43,044,295 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup class=\"reference\" id=\"cite_ref-refGRCh38Ensembl_1-1\"><a href=\"#cite_note-refGRCh38Ensembl-1\">[1]</a></sup></span></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">End</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">43,170,245 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup class=\"reference\" id=\"cite_ref-refGRCh38Ensembl_1-2\"><a href=\"#cite_note-refGRCh38Ensembl-1\">[1]</a></sup></span></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Gene location (<a href=\"/wiki/Laboratory_mouse\" title=\"Laboratory mouse\">Mouse</a>)</th></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><a class=\"image\" href=\"/wiki/File:Ideogram_house_mouse_chromosome_11.svg\" title=\"Chromosome 11 (mouse)\"><img alt=\"Chromosome 11 (mouse)\" data-file-height=\"200\" data-file-width=\"470\" decoding=\"async\" height=\"111\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Ideogram_house_mouse_chromosome_11.svg/260px-Ideogram_house_mouse_chromosome_11.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Ideogram_house_mouse_chromosome_11.svg/390px-Ideogram_house_mouse_chromosome_11.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Ideogram_house_mouse_chromosome_11.svg/520px-Ideogram_house_mouse_chromosome_11.svg.png 2x\" width=\"260\"/></a></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\" width=\"15%\"><a href=\"/wiki/Chromosome\" title=\"Chromosome\">Chr.</a></th><td colspan=\"3\" style=\"background-color:#eee\" width=\"85%\"><span class=\"plainlinks\">Chromosome 11 (mouse)<sup class=\"reference\" id=\"cite_ref-refGRCm38Ensembl_2-0\"><a href=\"#cite_note-refGRCm38Ensembl-2\">[2]</a></sup></span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><div align=\"center\"><div style=\"position: relative; width: 300px;\"><a class=\"image\" href=\"/wiki/File:Ideogram_of_house_mouse_chromosome_11.svg\" title=\"Chromosome 11 (mouse)\"><img alt=\"Chromosome 11 (mouse)\" data-file-height=\"231\" data-file-width=\"1200\" decoding=\"async\" height=\"58\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Ideogram_of_house_mouse_chromosome_11.svg/300px-Ideogram_of_house_mouse_chromosome_11.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Ideogram_of_house_mouse_chromosome_11.svg/450px-Ideogram_of_house_mouse_chromosome_11.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Ideogram_of_house_mouse_chromosome_11.svg/600px-Ideogram_of_house_mouse_chromosome_11.svg.png 2x\" width=\"300\"/></a><div style=\"position: absolute; left: 238.92974423631px; top: 2px; padding: 0;\"><a class=\"image\" href=\"/wiki/File:HSR_1996_II_3.5e.svg\" title=\"Genomic location for BRCA1\"><img alt=\"Genomic location for BRCA1\" data-file-height=\"142\" data-file-width=\"142\" decoding=\"async\" height=\"14\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/14px-HSR_1996_II_3.5e.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/21px-HSR_1996_II_3.5e.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/28px-HSR_1996_II_3.5e.svg.png 2x\" width=\"14\"/></a></div><div style=\"position: absolute; left: 244.9px; top: 19px; padding: 0;\"><a class=\"image\" href=\"/wiki/File:Red_rectangle_2x18.png\" title=\"Genomic location for BRCA1\"><img alt=\"Genomic location for BRCA1\" data-file-height=\"18\" data-file-width=\"2\" decoding=\"async\" height=\"18\" src=\"//upload.wikimedia.org/wikipedia/commons/6/6a/Red_rectangle_2x18.png\" width=\"2\"/></a></div></div></div></td></tr><tr><th rowspan=\"2\" scope=\"row\" style=\"background-color:#c3fdb8\" width=\"15%\"><a href=\"/wiki/Locus_(genetics)\" title=\"Locus (genetics)\">Band</a></th><td rowspan=\"2\" style=\"background-color:#eee\" width=\"35%\"><span class=\"plainlinks\">11 65.18 cM|11 D</span></td><th scope=\"row\" style=\"background-color:#c3fdb8\">Start</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">101,379,590 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup class=\"reference\" id=\"cite_ref-refGRCm38Ensembl_2-1\"><a href=\"#cite_note-refGRCm38Ensembl-2\">[2]</a></sup></span></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">End</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">101,442,781 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup class=\"reference\" id=\"cite_ref-refGRCm38Ensembl_2-2\"><a href=\"#cite_note-refGRCm38Ensembl-2\">[2]</a></sup></span></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\"><a href=\"/wiki/Gene_expression\" title=\"Gene expression\">RNA expression</a> pattern</th></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a class=\"external text\" href=\"https://bgee.org/\" rel=\"nofollow\">Bgee</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th><b><a href=\"/wiki/Human_genome\" title=\"Human genome\">Human</a></b></th><th><b><a href=\"/wiki/Laboratory_mouse\" title=\"Laboratory mouse\">Mouse</a> (ortholog)</b></th></tr><tr><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:center\"><tbody><tr><td colspan=\"1\"><span class=\"plainlinks\" style=\"margin:-3px\"><a class=\"external text\" href=\"https://bgee.org/gene/ENSG00000012048\" rel=\"nofollow\">Top expressed in</a></span></td></tr><tr><td colspan=\"1\"><div class=\"plainlinks\" style=\"margin:-12px 0px -10px 0px\"><ul style=\"line-height:15%;margin:9px\"><li style=\"line-height: 137%;\">ganglionic eminence</li><br/><li style=\"line-height: 137%;\">secondary oocyte</li><br/><li style=\"line-height: 137%;\">bone marrow cells</li><br/><li style=\"line-height: 137%;\">sural nerve</li><br/><li style=\"line-height: 137%;\">cancellous bone</li><br/><li style=\"line-height: 137%;\">stromal cell of endometrium</li><br/><li style=\"line-height: 137%;\">testicle</li><br/><li style=\"line-height: 137%;\">rectum</li><br/><li style=\"line-height: 137%;\">right lobe of thyroid gland</li><br/><li style=\"line-height: 137%;\">appendix</li></ul></div></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:center\"><tbody><tr><td colspan=\"1\"><span class=\"plainlinks\" style=\"margin:-3px\"><a class=\"external text\" href=\"https://bgee.org/gene/ENSMUSG00000017146\" rel=\"nofollow\">Top expressed in</a></span></td></tr><tr><td colspan=\"1\"><div class=\"plainlinks\" style=\"margin:-12px 0px -10px 0px\"><ul style=\"line-height:15%;margin:9px\"><li style=\"line-height: 137%;\">secondary oocyte</li><br/><li style=\"line-height: 137%;\">primitive streak</li><br/><li style=\"line-height: 137%;\">maxillary prominence</li><br/><li style=\"line-height: 137%;\">Paneth cell</li><br/><li style=\"line-height: 137%;\">iris</li><br/><li style=\"line-height: 137%;\">abdominal wall</li><br/><li style=\"line-height: 137%;\">hair follicle</li><br/><li style=\"line-height: 137%;\">ectoderm</li><br/><li style=\"line-height: 137%;\">somite</li><br/><li style=\"line-height: 137%;\">medullary collecting duct</li></ul></div></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><span class=\"plainlinks\"><a class=\"external text\" href=\"https://bgee.org/gene/ENSG00000012048\" rel=\"nofollow\">More reference expression data</a></span></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a class=\"external text\" href=\"http://biogps.org/\" rel=\"nofollow\">BioGPS</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><a class=\"image\" href=\"/wiki/File:PBB_GE_BRCA1_204531_s_at_fs.png\"><img alt=\"PBB GE BRCA1 204531 s at fs.png\" data-file-height=\"530\" data-file-width=\"732\" decoding=\"async\" height=\"181\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/PBB_GE_BRCA1_204531_s_at_fs.png/250px-PBB_GE_BRCA1_204531_s_at_fs.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/PBB_GE_BRCA1_204531_s_at_fs.png/375px-PBB_GE_BRCA1_204531_s_at_fs.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/ad/PBB_GE_BRCA1_204531_s_at_fs.png/500px-PBB_GE_BRCA1_204531_s_at_fs.png 2x\" width=\"250\"/></a><br/><br/><a class=\"image\" href=\"/wiki/File:PBB_GE_BRCA1_211851_x_at_fs.png\"><img alt=\"PBB GE BRCA1 211851 x at fs.png\" data-file-height=\"530\" data-file-width=\"732\" decoding=\"async\" height=\"181\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/PBB_GE_BRCA1_211851_x_at_fs.png/250px-PBB_GE_BRCA1_211851_x_at_fs.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/PBB_GE_BRCA1_211851_x_at_fs.png/375px-PBB_GE_BRCA1_211851_x_at_fs.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0f/PBB_GE_BRCA1_211851_x_at_fs.png/500px-PBB_GE_BRCA1_211851_x_at_fs.png 2x\" width=\"250\"/></a></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><span class=\"plainlinks\"><a class=\"external text\" href=\"http://biogps.org/gene/672/\" rel=\"nofollow\">More reference expression data</a></span></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\"><a class=\"mw-redirect\" href=\"/wiki/Gene_ontology\" title=\"Gene ontology\">Gene ontology</a></th></tr><tr><td style=\"background-color:#c3fdb8;font-weight:bold\">Molecular function</td><td style=\"background-color:#eee\"><div class=\"plainlinks\">\n",
              "<ul><li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0015631\" rel=\"nofollow\">tubulin binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0046872\" rel=\"nofollow\">metal ion binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0019899\" rel=\"nofollow\">enzyme binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0008270\" rel=\"nofollow\">zinc ion binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0003684\" rel=\"nofollow\">damaged DNA binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005515\" rel=\"nofollow\">protein binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0003713\" rel=\"nofollow\">transcription coactivator activity</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0050681\" rel=\"nofollow\">androgen receptor binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0003723\" rel=\"nofollow\">RNA binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0031625\" rel=\"nofollow\">ubiquitin protein ligase binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0004842\" rel=\"nofollow\">ubiquitin-protein transferase activity</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0003677\" rel=\"nofollow\">DNA binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0016740\" rel=\"nofollow\">transferase activity</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0070063\" rel=\"nofollow\">RNA polymerase binding</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0042802\" rel=\"nofollow\">identical protein binding</a></li></ul>\n",
              "</div></td></tr><tr><td style=\"background-color:#c3fdb8;font-weight:bold\">Cellular component</td><td style=\"background-color:#eee\"><div class=\"plainlinks\">\n",
              "<ul><li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0031436\" rel=\"nofollow\">BRCA1-BARD1 complex</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000794\" rel=\"nofollow\">condensed nuclear chromosome</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0070531\" rel=\"nofollow\">BRCA1-A complex</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000151\" rel=\"nofollow\">ubiquitin ligase complex</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005886\" rel=\"nofollow\">plasma membrane</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005654\" rel=\"nofollow\">nucleoplasm</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000793\" rel=\"nofollow\">condensed chromosome</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005737\" rel=\"nofollow\">cytoplasm</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005694\" rel=\"nofollow\">chromosome</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005634\" rel=\"nofollow\">nucleus</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000800\" rel=\"nofollow\">lateral element</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0032991\" rel=\"nofollow\">protein-containing complex</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:1990904\" rel=\"nofollow\">ribonucleoprotein complex</a></li></ul>\n",
              "</div></td></tr><tr><td style=\"background-color:#c3fdb8;font-weight:bold\">Biological process</td><td style=\"background-color:#eee\"><div class=\"plainlinks\">\n",
              "<ul><li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0010212\" rel=\"nofollow\">response to ionizing radiation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0007098\" rel=\"nofollow\">centrosome cycle</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0007059\" rel=\"nofollow\">chromosome segregation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0085020\" rel=\"nofollow\">protein K6-linked ubiquitination</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0008630\" rel=\"nofollow\">intrinsic apoptotic signaling pathway in response to DNA damage</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0007049\" rel=\"nofollow\">cell cycle</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006303\" rel=\"nofollow\">double-strand break repair via nonhomologous end joining</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006915\" rel=\"nofollow\">apoptotic process</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0042981\" rel=\"nofollow\">regulation of apoptotic process</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006349\" rel=\"nofollow\">regulation of gene expression by genetic imprinting</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006355\" rel=\"nofollow\">regulation of transcription, DNA-templated</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045717\" rel=\"nofollow\">negative regulation of fatty acid biosynthetic process</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006351\" rel=\"nofollow\">transcription, DNA-templated</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006359\" rel=\"nofollow\">regulation of transcription by RNA polymerase III</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006633\" rel=\"nofollow\">fatty acid biosynthetic process</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0044030\" rel=\"nofollow\">regulation of DNA methylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0033147\" rel=\"nofollow\">negative regulation of intracellular estrogen receptor signaling pathway</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051865\" rel=\"nofollow\">protein autoubiquitination</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051574\" rel=\"nofollow\">positive regulation of histone H3-K9 methylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006310\" rel=\"nofollow\">DNA recombination</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045766\" rel=\"nofollow\">positive regulation of angiogenesis</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0043627\" rel=\"nofollow\">response to estrogen</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0071681\" rel=\"nofollow\">cellular response to indole-3-methanol</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:1902042\" rel=\"nofollow\">negative regulation of extrinsic apoptotic signaling pathway via death domain receptors</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045892\" rel=\"nofollow\">negative regulation of transcription, DNA-templated</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0031398\" rel=\"nofollow\">positive regulation of protein ubiquitination</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0030521\" rel=\"nofollow\">androgen receptor signaling pathway</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0046600\" rel=\"nofollow\">negative regulation of centriole replication</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006301\" rel=\"nofollow\">postreplication repair</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006629\" rel=\"nofollow\">lipid metabolism</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0071356\" rel=\"nofollow\">cellular response to tumor necrosis factor</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045739\" rel=\"nofollow\">positive regulation of DNA repair</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006631\" rel=\"nofollow\">fatty acid metabolic process</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0010628\" rel=\"nofollow\">positive regulation of gene expression</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051572\" rel=\"nofollow\">negative regulation of histone H3-K4 methylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0042127\" rel=\"nofollow\">regulation of cell population proliferation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:2000378\" rel=\"nofollow\">negative regulation of reactive oxygen species metabolic process</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0010575\" rel=\"nofollow\">positive regulation of vascular endothelial growth factor production</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006978\" rel=\"nofollow\">DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045944\" rel=\"nofollow\">positive regulation of transcription by RNA polymerase II</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0070512\" rel=\"nofollow\">positive regulation of histone H4-K20 methylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000729\" rel=\"nofollow\">DNA double-strand break processing</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0000724\" rel=\"nofollow\">double-strand break repair via homologous recombination</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0035067\" rel=\"nofollow\">negative regulation of histone acetylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0016567\" rel=\"nofollow\">protein ubiquitination</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051571\" rel=\"nofollow\">positive regulation of histone H3-K4 methylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006281\" rel=\"nofollow\">DNA repair</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006302\" rel=\"nofollow\">double-strand break repair</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0035066\" rel=\"nofollow\">positive regulation of histone acetylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0009048\" rel=\"nofollow\">dosage compensation by inactivation of X chromosome</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0051573\" rel=\"nofollow\">negative regulation of histone H3-K9 methylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:2000617\" rel=\"nofollow\">positive regulation of histone H3-K9 acetylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0045893\" rel=\"nofollow\">positive regulation of transcription, DNA-templated</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0043009\" rel=\"nofollow\">chordate embryonic development</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:2000620\" rel=\"nofollow\">positive regulation of histone H4-K16 acetylation</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006974\" rel=\"nofollow\">cellular response to DNA damage stimulus</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0016579\" rel=\"nofollow\">protein deubiquitination</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006260\" rel=\"nofollow\">DNA replication</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0044818\" rel=\"nofollow\">mitotic G2/M transition checkpoint</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006357\" rel=\"nofollow\">regulation of transcription by RNA polymerase II</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0070317\" rel=\"nofollow\">negative regulation of G0 to G1 transition</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006366\" rel=\"nofollow\">transcription by RNA polymerase II</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0007095\" rel=\"nofollow\">mitotic G2 DNA damage checkpoint signaling</a></li>\n",
              "<li><a class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:1901796\" rel=\"nofollow\">regulation of signal transduction by p53 class mediator</a></li></ul>\n",
              "</div></td></tr><tr><td colspan=\"4\" style=\"background-color:#eee;text-align:center\">Sources:<a class=\"external text\" href=\"http://amigo.geneontology.org/\" rel=\"nofollow\">Amigo</a> / <a class=\"external text\" href=\"https://www.ebi.ac.uk/QuickGO/\" rel=\"nofollow\">QuickGO</a></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\"><a class=\"mw-redirect\" href=\"/wiki/Orthologs\" title=\"Orthologs\">Orthologs</a></th></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">Species</th><td><b>Human</b></td><td><b>Mouse</b></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Entrez\" title=\"Entrez\">Entrez</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=retrieve&amp;dopt=default&amp;list_uids=672&amp;rn=1\" rel=\"nofollow\">672</a></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=retrieve&amp;dopt=default&amp;list_uids=12189&amp;rn=1\" rel=\"nofollow\">12189</a></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a class=\"mw-redirect\" href=\"/wiki/Ensembl\" title=\"Ensembl\">Ensembl</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a class=\"external text\" href=\"http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000012048;db=core\" rel=\"nofollow\">ENSG00000012048</a></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a class=\"external text\" href=\"http://www.ensembl.org/Mus_musculus/geneview?gene=ENSMUSG00000017146;db=core\" rel=\"nofollow\">ENSMUSG00000017146</a></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/UniProt\" title=\"UniProt\">UniProt</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a class=\"external text\" href=\"https://www.uniprot.org/uniprot/P38398\" rel=\"nofollow\">P38398</a></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a class=\"external text\" href=\"https://www.uniprot.org/uniprot/P48754\" rel=\"nofollow\">P48754</a></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">RefSeq (mRNA)</th><td><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th class=\"plainlinks\" colspan=\"1\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007294\" rel=\"nofollow\">NM_007294</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007295\" rel=\"nofollow\">NM_007295</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007296\" rel=\"nofollow\">NM_007296</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007297\" rel=\"nofollow\">NM_007297</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007298\" rel=\"nofollow\">NM_007298</a><br/></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007299\" rel=\"nofollow\">NM_007299</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007300\" rel=\"nofollow\">NM_007300</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007301\" rel=\"nofollow\">NM_007301</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007302\" rel=\"nofollow\">NM_007302</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007303\" rel=\"nofollow\">NM_007303</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007305\" rel=\"nofollow\">NM_007305</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_007306\" rel=\"nofollow\">NM_007306</a></span></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th class=\"plainlinks\" colspan=\"1\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_009764\" rel=\"nofollow\">NM_009764</a></span></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">RefSeq (protein)</th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th class=\"plainlinks\" colspan=\"1\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009225\" rel=\"nofollow\">NP_009225</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009228\" rel=\"nofollow\">NP_009228</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009229\" rel=\"nofollow\">NP_009229</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009230\" rel=\"nofollow\">NP_009230</a><br/><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009231\" rel=\"nofollow\">NP_009231</a></span></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th class=\"plainlinks\" colspan=\"1\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_033894\" rel=\"nofollow\">NP_033894</a></span></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">Location (UCSC)</th><td><span class=\"plainlinks\"><a class=\"external text\" href=\"https://genome.ucsc.edu/cgi-bin/hgTracks?org=Human&amp;db=hg38&amp;position=chr17:43044295-43170245\" rel=\"nofollow\">Chr 17: 43.04 – 43.17 Mb</a></span></td><td><span class=\"plainlinks\"><a class=\"external text\" href=\"https://genome.ucsc.edu/cgi-bin/hgTracks?org=Mouse&amp;db=mm0&amp;position=chr11:101379590-101442781\" rel=\"nofollow\">Chr 11: 101.38 – 101.44 Mb</a></span></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/PubMed\" title=\"PubMed\">PubMed</a> search</th><td><span class=\"plainlinks\"><sup class=\"reference\" id=\"cite_ref-3\"><a href=\"#cite_note-3\">[3]</a></sup></span></td><td><span class=\"plainlinks\"><sup class=\"reference\" id=\"cite_ref-4\"><a href=\"#cite_note-4\">[4]</a></sup></span></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;font-size:x-small;background-color:#eee\"><a href=\"/wiki/Wikidata\" title=\"Wikidata\">Wikidata</a></td></tr><tr><td colspan=\"4\" style=\"text-align:center;font-size:x-small;background-color:#eee\"><table style=\"padding:0;border:none;margin:0;width:100%;text-align:center\"><tbody><tr><td colspan=\"2\" style=\"background-color:#eee;text-align:center;font-size:x-small\"><a class=\"extiw\" href=\"https://www.wikidata.org/wiki/Q227339\" title=\"d:Q227339\">View/Edit Human</a></td><td colspan=\"2\" style=\"background-color:#eee;text-align:center;font-size:x-small\"><a class=\"extiw\" href=\"https://www.wikidata.org/wiki/Q14862219\" title=\"d:Q14862219\">View/Edit Mouse</a></td></tr></tbody></table></td></tr></tbody></table>\n",
              "<p><b>Breast cancer type 1 susceptibility protein</b> is a <a href=\"/wiki/Protein\" title=\"Protein\">protein</a> that in humans is encoded by the <i><b>BRCA1</b></i>  (<span class=\"rt-commentedText nowrap\"><span class=\"IPA nopopups noexcerpt\" lang=\"en-fonipa\"><a href=\"/wiki/Help:IPA/English\" title=\"Help:IPA/English\">/<span style=\"border-bottom:1px dotted\"><span title=\"/ˌ/: secondary stress follows\">ˌ</span><span title=\"'b' in 'buy'\">b</span><span title=\"'r' in 'rye'\">r</span><span title=\"/æ/: 'a' in 'bad'\">æ</span><span title=\"'k' in 'kind'\">k</span><span title=\"/ə/: 'a' in 'about'\">ə</span><span title=\"/ˈ/: primary stress follows\">ˈ</span><span title=\"'w' in 'wind'\">w</span><span title=\"/ʌ/: 'u' in 'cut'\">ʌ</span><span title=\"'n' in 'nigh'\">n</span></span>/</a></span></span>) <a href=\"/wiki/Gene\" title=\"Gene\">gene</a>.<sup class=\"reference\" id=\"cite_ref-5\"><a href=\"#cite_note-5\">[5]</a></sup> <a class=\"mw-redirect\" href=\"/wiki/Ortholog\" title=\"Ortholog\">Orthologs</a> are common in other <a href=\"/wiki/Vertebrate\" title=\"Vertebrate\">vertebrate</a> species, whereas <a href=\"/wiki/Invertebrate\" title=\"Invertebrate\">invertebrate</a> genomes may encode a more distantly related gene.<sup class=\"reference\" id=\"cite_ref-Ensembl_6-0\"><a href=\"#cite_note-Ensembl-6\">[6]</a></sup> <i>BRCA1</i> is a human <a href=\"/wiki/Tumor_suppressor_gene\" title=\"Tumor suppressor gene\">tumor suppressor gene</a><sup class=\"reference\" id=\"cite_ref-pmid10193517_7-0\"><a href=\"#cite_note-pmid10193517-7\">[7]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid15546503_8-0\"><a href=\"#cite_note-pmid15546503-8\">[8]</a></sup> (also known as a <a href=\"/wiki/Caretaker_gene\" title=\"Caretaker gene\">caretaker gene</a>) and is responsible for repairing DNA.<sup class=\"reference\" id=\"cite_ref-CAP_9-0\"><a href=\"#cite_note-CAP-9\">[9]</a></sup>\n",
              "</p><p><i>BRCA1</i> and <i><a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a></i> are unrelated proteins,<sup class=\"reference\" id=\"cite_ref-Irminger-Finger_2016_10-0\"><a href=\"#cite_note-Irminger-Finger_2016-10\">[10]</a></sup> but both are normally expressed in the cells of <a href=\"/wiki/Breast\" title=\"Breast\">breast</a> and other tissue, where they help repair damaged <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a>, or destroy cells if DNA cannot be repaired. They are involved in the repair of <a href=\"/wiki/Chromosome\" title=\"Chromosome\">chromosomal</a> damage with an important role in the error-free <a href=\"/wiki/DNA_repair\" title=\"DNA repair\">repair</a> of DNA double-strand breaks.<sup class=\"reference\" id=\"cite_ref-Friedenson2007_11-0\"><a href=\"#cite_note-Friedenson2007-11\">[11]</a></sup><sup class=\"reference\" id=\"cite_ref-scivee.tv_12-0\"><a href=\"#cite_note-scivee.tv-12\">[12]</a></sup> If <i>BRCA1</i> or <i>BRCA2</i> itself is damaged by a <a href=\"/wiki/BRCA_mutation\" title=\"BRCA mutation\">BRCA mutation</a>, damaged DNA is not repaired properly, and this increases the risk for <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a>.<sup class=\"reference\" id=\"cite_ref-urlBreast_and_Ovarian_Cancer_Genetic_Screening_13-0\"><a href=\"#cite_note-urlBreast_and_Ovarian_Cancer_Genetic_Screening-13\">[13]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid17683622_14-0\"><a href=\"#cite_note-pmid17683622-14\">[14]</a></sup> <i>BRCA1</i> and <i>BRCA2</i> have been described as \"breast cancer susceptibility genes\" and \"breast cancer susceptibility proteins\".  The predominant allele has a normal, tumor suppressive function whereas high <a href=\"/wiki/Penetrance\" title=\"Penetrance\">penetrance</a> mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer.<sup class=\"reference\" id=\"cite_ref-O'Donovan_2010_15-0\"><a href=\"#cite_note-O'Donovan_2010-15\">[15]</a></sup>\n",
              "</p><p><i>BRCA1</i> combines with other tumor suppressors, DNA damage sensors and signal transducers to form a large multi-subunit protein complex known as the <i>BRCA1</i>-associated genome surveillance complex (BASC).<sup class=\"reference\" id=\"cite_ref-pmid10783165_16-0\"><a href=\"#cite_note-pmid10783165-16\">[16]</a></sup> The <i>BRCA1</i> protein associates with <a href=\"/wiki/RNA_polymerase_II\" title=\"RNA polymerase II\">RNA polymerase II</a>, and through the <a href=\"/wiki/C-terminus\" title=\"C-terminus\">C-terminal</a> domain, also interacts with <a href=\"/wiki/Histone_deacetylase\" title=\"Histone deacetylase\">histone deacetylase</a> complexes. Thus, this protein plays a role in transcription, and <a href=\"/wiki/DNA_repair\" title=\"DNA repair\">DNA repair</a> of double-strand DNA breaks<sup class=\"reference\" id=\"cite_ref-pmid17683622_14-1\"><a href=\"#cite_note-pmid17683622-14\">[14]</a></sup> <a href=\"/wiki/Ubiquitin\" title=\"Ubiquitin\">ubiquitination</a>, <a href=\"/wiki/Transcriptional_regulation\" title=\"Transcriptional regulation\">transcriptional regulation</a> as well as other functions.<sup class=\"reference\" id=\"cite_ref-Starita2003_17-0\"><a href=\"#cite_note-Starita2003-17\">[17]</a></sup>\n",
              "</p><p>Methods to test for the likelihood of a patient with mutations in <i>BRCA1</i> and <i><a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a></i> developing cancer were covered by <a href=\"/wiki/Biological_patent\" title=\"Biological patent\">patents</a> owned or controlled by <a href=\"/wiki/Myriad_Genetics\" title=\"Myriad Genetics\">Myriad Genetics</a>.<sup class=\"reference\" id=\"cite_ref-US_5747282_18-0\"><a href=\"#cite_note-US_5747282-18\">[18]</a></sup><sup class=\"reference\" id=\"cite_ref-US_5837492_19-0\"><a href=\"#cite_note-US_5837492-19\">[19]</a></sup>  Myriad's business model of offering the diagnostic test exclusively led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012;<sup class=\"reference\" id=\"cite_ref-MyriadInvestorPage_20-0\"><a href=\"#cite_note-MyriadInvestorPage-20\">[20]</a></sup> it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs, which in turn led to the landmark <i><a class=\"mw-redirect\" href=\"/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics\" title=\"Association for Molecular Pathology v. Myriad Genetics\">Association for Molecular Pathology v. Myriad Genetics</a></i> lawsuit.<sup class=\"reference\" id=\"cite_ref-SchwartzNYTimes_21-0\"><a href=\"#cite_note-SchwartzNYTimes-21\">[21]</a></sup>\n",
              "</p>\n",
              "<meta property=\"mw:PageProp/toc\"/>\n",
              "<h2><span class=\"mw-headline\" id=\"Discovery\">Discovery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=1\" title=\"Edit section: Discovery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<p>The first evidence for the existence of a gene encoding a DNA repair enzyme involved in breast cancer susceptibility was provided by <a href=\"/wiki/Mary-Claire_King\" title=\"Mary-Claire King\">Mary-Claire King</a>'s laboratory at <a href=\"/wiki/University_of_California,_Berkeley\" title=\"University of California, Berkeley\">UC Berkeley</a> in 1990.<sup class=\"reference\" id=\"cite_ref-pmid2270482_22-0\"><a href=\"#cite_note-pmid2270482-22\">[22]</a></sup>  Four years later, after an international race to find it,<sup class=\"reference\" id=\"cite_ref-23\"><a href=\"#cite_note-23\">[23]</a></sup> the gene was cloned in 1994 by scientists at University of Utah, National Institute of Environmental Health Sciences (NIEHS) and <a href=\"/wiki/Myriad_Genetics\" title=\"Myriad Genetics\">Myriad Genetics</a>.<sup class=\"reference\" id=\"cite_ref-US_5747282_18-1\"><a href=\"#cite_note-US_5747282-18\">[18]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid7545954_24-0\"><a href=\"#cite_note-pmid7545954-24\">[24]</a></sup>\n",
              "</p>\n",
              "<h2><span class=\"mw-headline\" id=\"Gene_location\">Gene location</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=2\" title=\"Edit section: Gene location\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<p>The human <i>BRCA1</i> gene is located on the long (q) arm of <a class=\"mw-redirect\" href=\"/wiki/Chromosome_17_(human)\" title=\"Chromosome 17 (human)\">chromosome 17</a> at region 2 band 1, from <a href=\"/wiki/Base_pair\" title=\"Base pair\">base pair</a> 41,196,312 to base pair 41,277,500 (Build GRCh37/hg19) <a class=\"external text\" href=\"http://genome.ucsc.edu/cgi-bin/hgTracks?db=hg19&amp;singleSearch=knownCanonical&amp;position=BRCA1\" rel=\"nofollow\">(map)</a>.<sup class=\"reference\" id=\"cite_ref-25\"><a href=\"#cite_note-25\">[25]</a></sup> <i>BRCA1</i> <a class=\"mw-redirect\" href=\"/wiki/Orthologs\" title=\"Orthologs\">orthologs</a> have been identified in most <a href=\"/wiki/Vertebrate\" title=\"Vertebrate\">vertebrates</a> for which complete genome data are available.<sup class=\"reference\" id=\"cite_ref-Ensembl_6-1\"><a href=\"#cite_note-Ensembl-6\">[6]</a></sup>\n",
              "</p>\n",
              "<h2><span class=\"mw-headline\" id=\"Protein_structure\">Protein structure</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=3\" title=\"Edit section: Protein structure\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<p>The BRCA1 <a href=\"/wiki/Protein\" title=\"Protein\">protein</a> contains the following domains:<sup class=\"reference\" id=\"cite_ref-pmid9553742_26-0\"><a href=\"#cite_note-pmid9553742-26\">[26]</a></sup>\n",
              "</p>\n",
              "<ul><li>Zinc finger, C3HC4 type (<a href=\"/wiki/RING_finger_domain\" title=\"RING finger domain\">RING finger</a>)</li>\n",
              "<li>BRCA1 C Terminus (<a href=\"/wiki/BRCT_domain\" title=\"BRCT domain\">BRCT</a>) domain</li></ul>\n",
              "<p>This protein also contains <a class=\"mw-redirect\" href=\"/wiki/Nuclear_localization_signal\" title=\"Nuclear localization signal\">nuclear localization signals</a> and <a href=\"/wiki/Nuclear_export_signal\" title=\"Nuclear export signal\">nuclear export signal</a> motifs.<sup class=\"reference\" id=\"cite_ref-pmid16108063_27-0\"><a href=\"#cite_note-pmid16108063-27\">[27]</a></sup>\n",
              "</p><p>The human <a class=\"mw-redirect\" href=\"/wiki/BRCA1_protein\" title=\"BRCA1 protein\">BRCA1 protein</a> consists of four major protein domains; the <a href=\"/wiki/RING_finger_domain\" title=\"RING finger domain\">Znf C3HC4- RING domain</a>, the BRCA1 serine domain and two <a href=\"/wiki/BRCT_domain\" title=\"BRCT domain\">BRCT</a> domains. These domains encode approximately 27% of BRCA1 protein. There are six known isoforms of BRCA1,<sup class=\"reference\" id=\"cite_ref-28\"><a href=\"#cite_note-28\">[28]</a></sup> with isoforms 1 and 2 comprising 1863 amino acids each.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">[<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (January 2016)\">citation needed</span></a></i>]</sup>\n",
              "</p><p>BRCA1 is unrelated to <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a>, i.e. they are not <a href=\"/wiki/Sequence_homology\" title=\"Sequence homology\">homologs</a> or <a class=\"mw-redirect\" href=\"/wiki/Paralogy\" title=\"Paralogy\">paralogs</a>.<sup class=\"reference\" id=\"cite_ref-Irminger-Finger_2016_10-1\"><a href=\"#cite_note-Irminger-Finger_2016-10\">[10]</a></sup>\n",
              "</p>\n",
              "<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:442px;\"><a class=\"image\" href=\"/wiki/File:BRCA1partB.png\"><img alt=\"text\" class=\"thumbimage\" data-file-height=\"223\" data-file-width=\"555\" decoding=\"async\" height=\"177\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/27/BRCA1partB.png/440px-BRCA1partB.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/2/27/BRCA1partB.png 1.5x\" width=\"440\"/></a> <div class=\"thumbcaption\"><div class=\"magnify\"><a class=\"internal\" href=\"/wiki/File:BRCA1partB.png\" title=\"Enlarge\"></a></div>Domain map of BRCA1; RING, serine containing domain (SCD), and BRCT domains are indicated. Horizontal black lines indicate protein-binding domains for the listed partners. Red circles mark phosphorylation sites.<sup class=\"reference\" id=\"cite_ref-pmid22737296_29-0\"><a href=\"#cite_note-pmid22737296-29\">[29]</a></sup></div></div></div>\n",
              "<h3><span class=\"mw-headline\" id=\"Zinc_ring_finger_domain\">Zinc ring finger domain</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=4\" title=\"Edit section: Zinc ring finger domain\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n",
              "<p>The <a href=\"/wiki/RING_finger_domain\" title=\"RING finger domain\">RING motif</a>, a <a class=\"mw-redirect\" href=\"/wiki/Zn_finger\" title=\"Zn finger\">Zn finger</a> found in eukaryotic peptides, is 40–60 amino acids long and consists of eight conserved metal-binding residues, two quartets of <a href=\"/wiki/Cysteine\" title=\"Cysteine\">cysteine</a> or <a href=\"/wiki/Histidine\" title=\"Histidine\">histidine</a> residues that coordinate two zinc atoms.<sup class=\"reference\" id=\"cite_ref-pmid11573085_30-0\"><a href=\"#cite_note-pmid11573085-30\">[30]</a></sup>  This motif contains a short anti-parallel <a class=\"mw-redirect\" href=\"/wiki/Beta-sheet\" title=\"Beta-sheet\">beta-sheet</a>, two zinc-binding loops and a central <a href=\"/wiki/Alpha_helix\" title=\"Alpha helix\">alpha helix</a> in a small domain.  This RING domain interacts with associated proteins, including <a href=\"/wiki/BARD1\" title=\"BARD1\">BARD1</a>, which also contains a RING motif, to form a heterodimer. The BRCA1 RING motif is flanked by alpha helices formed by residues 8–22 and 81–96 of the BRCA1 protein. It interacts with a homologous region in BARD1 also consisting of a RING finger flanked by two <a class=\"mw-redirect\" href=\"/wiki/Alpha-helices\" title=\"Alpha-helices\">alpha-helices</a> formed from residues 36–48 and 101–116. These four helices combine to form a <a class=\"mw-redirect\" href=\"/wiki/Heterodimerization\" title=\"Heterodimerization\">heterodimerization</a> interface and stabilize the BRCA1-BARD1 heterodimer complex. Additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression.<sup class=\"reference\" id=\"cite_ref-pmid11573085_30-1\"><a href=\"#cite_note-pmid11573085-30\">[30]</a></sup>\n",
              "</p><p>The ring domain is an important element of <a href=\"/wiki/Ubiquitin_ligase#Individual_E3_ubiquitin_ligases\" title=\"Ubiquitin ligase\">ubiquitin E3 ligases</a>, which catalyze protein ubiquitination. <a href=\"/wiki/Ubiquitin\" title=\"Ubiquitin\">Ubiquitin</a> is a small regulatory protein found in all tissues that direct proteins to compartments within the cell. BRCA1 polypeptides, in particular, Lys-48-linked polyubiquitin chains are dispersed throughout the resting cell nucleus, but at the start of <a href=\"/wiki/DNA_replication\" title=\"DNA replication\">DNA replication</a>, they gather in restrained groups that also contain <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a> and BARD1. BARD1 is thought to be involved in the recognition and binding of protein targets for ubiquitination.<sup class=\"reference\" id=\"cite_ref-pmid11573079_31-0\"><a href=\"#cite_note-pmid11573079-31\">[31]</a></sup> It attaches to proteins and labels them for destruction. Ubiquitination occurs via the BRCA1 fusion protein and is abolished by zinc <a href=\"/wiki/Chelation\" title=\"Chelation\">chelation</a>.<sup class=\"reference\" id=\"cite_ref-pmid11573085_30-2\"><a href=\"#cite_note-pmid11573085-30\">[30]</a></sup> The enzyme activity of the fusion protein is dependent on the proper folding of the ring domain.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">[<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (January 2016)\">citation needed</span></a></i>]</sup>\n",
              "</p>\n",
              "<h3><span class=\"mw-headline\" id=\"Serine_cluster_domain\">Serine cluster domain</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=5\" title=\"Edit section: Serine cluster domain\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n",
              "<p>BRCA1 serine cluster domain (SCD) spans amino acids 1280–1524. A portion of the domain is located in exons 11–13. High rates of mutation occur in exons 11–13. Reported phosphorylation sites of BRCA1 are concentrated in the SCD, where they are phosphorylated by <a class=\"mw-redirect\" href=\"/wiki/Ataxia_telangiectasia_mutated\" title=\"Ataxia telangiectasia mutated\">ATM/ATR kinases</a> both <a href=\"/wiki/In_vitro\" title=\"In vitro\">in vitro</a> and <a href=\"/wiki/In_vivo\" title=\"In vivo\">in vivo</a>. ATM/ATR are kinases activated by <a class=\"mw-redirect\" href=\"/wiki/DNA_damage\" title=\"DNA damage\">DNA damage</a>. Mutation of serine residues may affect localization of BRCA1 to sites of DNA damage and DNA damage response function.<sup class=\"reference\" id=\"cite_ref-pmid22737296_29-1\"><a href=\"#cite_note-pmid22737296-29\">[29]</a></sup>\n",
              "</p>\n",
              "<h3><span class=\"mw-headline\" id=\"BRCT_domains\">BRCT domains</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=6\" title=\"Edit section: BRCT domains\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n",
              "<p>The dual repeat <a href=\"/wiki/BRCT_domain\" title=\"BRCT domain\">BRCT domain</a> of the BRCA1 protein is an elongated structure approximately 70 Å long and 30–35 Å wide.<sup class=\"reference\" id=\"cite_ref-Williams_2001_32-0\"><a href=\"#cite_note-Williams_2001-32\">[32]</a></sup> The 85–95 amino acid domains in BRCT can be found as single modules or as multiple tandem repeats containing two domains.<sup class=\"reference\" id=\"cite_ref-pmid10946236_33-0\"><a href=\"#cite_note-pmid10946236-33\">[33]</a></sup> Both of these possibilities can occur in a single protein in a variety of different conformations.<sup class=\"reference\" id=\"cite_ref-Williams_2001_32-1\"><a href=\"#cite_note-Williams_2001-32\">[32]</a></sup> The C-terminal BRCT region of the BRCA1 protein is essential for repair of DNA, transcription regulation and tumor suppressor function.<sup class=\"reference\" id=\"cite_ref-pmid11877378_34-0\"><a href=\"#cite_note-pmid11877378-34\">[34]</a></sup> In BRCA1 the dual <a href=\"/wiki/Tandem_repeat\" title=\"Tandem repeat\">tandem repeat</a> BRCT domains are arranged in a head-to-tail-fashion in the three-dimensional structure, burying 1600 Å of hydrophobic, solvent-accessible surface area in the interface. These all contribute to the tightly packed knob-in-hole structure that comprises the interface. These homologous domains interact to control cellular responses to <a class=\"mw-redirect\" href=\"/wiki/DNA_damage\" title=\"DNA damage\">DNA damage</a>. A <a href=\"/wiki/Missense_mutation\" title=\"Missense mutation\">missense mutation</a> at the interface of these two proteins can perturb the <a href=\"/wiki/Cell_cycle\" title=\"Cell cycle\">cell cycle</a>, resulting a greater risk of developing cancer.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">[<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (May 2019)\">citation needed</span></a></i>]</sup>\n",
              "</p>\n",
              "<h2><span class=\"mw-headline\" id=\"Function_and_mechanism\">Function and mechanism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=7\" title=\"Edit section: Function and mechanism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<p>BRCA1 is part of a complex that repairs <a class=\"mw-redirect\" href=\"/wiki/Double-strand_breaks\" title=\"Double-strand breaks\">double-strand breaks</a> in DNA. The strands of the DNA double helix are continuously breaking as they become damaged. Sometimes only one strand is broken, sometimes both strands are broken simultaneously. DNA cross-linking agents are an important source of chromosome/DNA damage. Double-strand breaks occur as intermediates after the crosslinks are removed, and indeed, biallelic mutations in <i>BRCA1</i> have been identified to be responsible for <a href=\"/wiki/Fanconi_anemia\" title=\"Fanconi anemia\">Fanconi Anemia</a>, Complementation Group S (FA-S),<sup class=\"reference\" id=\"cite_ref-Sawyer_2014_35-0\"><a href=\"#cite_note-Sawyer_2014-35\">[35]</a></sup> a genetic disease associated with hypersensitivity to DNA crosslinking agents. BRCA1 is part of a protein complex that repairs DNA when both strands are broken. When this happens, it is difficult for the repair mechanism to \"know\" how to replace the correct DNA sequence, and there are multiple ways to attempt the repair. The double-strand repair mechanism in which BRCA1 participates is <a href=\"/wiki/Homology_directed_repair\" title=\"Homology directed repair\">homology-directed repair</a>, where the repair proteins copy the identical sequence from the intact <a class=\"mw-redirect\" href=\"/wiki/Sister_chromatid\" title=\"Sister chromatid\">sister chromatid</a>.<sup class=\"reference\" id=\"cite_ref-36\"><a href=\"#cite_note-36\">[36]</a></sup> FA-S is almost always a lethal condition in utero; only a handful cases of biallelic BRCA1 mutations have been reported in literature despite the high carrier frequencies in the Ashkenazim, and none since 2013.<sup class=\"reference\" id=\"cite_ref-Domchek_2013_37-0\"><a href=\"#cite_note-Domchek_2013-37\">[37]</a></sup>\n",
              "</p><p>In the nucleus of many types of normal cells, the BRCA1 protein interacts with <a href=\"/wiki/RAD51\" title=\"RAD51\">RAD51</a> during repair of DNA double-strand breaks.<sup class=\"reference\" id=\"cite_ref-pmid17052168_38-0\"><a href=\"#cite_note-pmid17052168-38\">[38]</a></sup> These breaks can be caused by natural radiation or other exposures, but also occur when <a href=\"/wiki/Chromosome\" title=\"Chromosome\">chromosomes</a> exchange genetic material (homologous recombination, e.g., \"crossing over\" during meiosis). The <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a> protein, which has a function similar to that of BRCA1, also interacts with the RAD51 protein. By influencing DNA damage repair, these three proteins play a role in maintaining the stability of the human genome.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">[<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (January 2016)\">citation needed</span></a></i>]</sup>\n",
              "</p><p>BRCA1 is also involved in another type of DNA repair, termed <a href=\"/wiki/DNA_mismatch_repair\" title=\"DNA mismatch repair\">mismatch repair</a>.  BRCA1 interacts with the DNA mismatch repair protein <a href=\"/wiki/MSH2\" title=\"MSH2\">MSH2</a>.<sup class=\"reference\" id=\"cite_ref-pmid11498787_39-0\"><a href=\"#cite_note-pmid11498787-39\">[39]</a></sup>  MSH2, <a href=\"/wiki/MSH6\" title=\"MSH6\">MSH6</a>, <a href=\"/wiki/Poly_(ADP-ribose)_polymerase\" title=\"Poly (ADP-ribose) polymerase\">PARP</a> and some other proteins involved in single-strand repair are reported to be elevated in BRCA1-deficient mammary tumors.<sup class=\"reference\" id=\"cite_ref-pmid22366898_40-0\"><a href=\"#cite_note-pmid22366898-40\">[40]</a></sup>\n",
              "</p><p>A protein called <a href=\"/wiki/Valosin-containing_protein\" title=\"Valosin-containing protein\">valosin-containing protein</a> (VCP, also known as p97) plays a role to recruit BRCA1 to the damaged DNA sites.  After ionizing radiation, VCP is recruited to DNA lesions and cooperates with the ubiquitin ligase RNF8 to orchestrate assembly of signaling complexes for efficient DSB repair.<sup class=\"reference\" id=\"cite_ref-pmid22020440_41-0\"><a href=\"#cite_note-pmid22020440-41\">[41]</a></sup>  BRCA1 interacts with VCP.<sup class=\"reference\" id=\"cite_ref-42\"><a href=\"#cite_note-42\">[42]</a></sup> BRCA1 also interacts with <a href=\"/wiki/Myc\" title=\"Myc\">c-Myc</a>, and other proteins that are critical to maintain genome stability.<sup class=\"reference\" id=\"cite_ref-pmid9788437_43-0\"><a href=\"#cite_note-pmid9788437-43\">[43]</a></sup>\n",
              "</p><p>BRCA1 directly binds to DNA, with higher affinity for branched DNA structures. This ability to bind to DNA contributes to its ability to inhibit the nuclease activity of the <a class=\"mw-redirect\" href=\"/wiki/Mre11-Rad50-Nbs1\" title=\"Mre11-Rad50-Nbs1\">MRN</a> complex as well as the nuclease activity of Mre11 alone.<sup class=\"reference\" id=\"cite_ref-Paull2001_44-0\"><a href=\"#cite_note-Paull2001-44\">[44]</a></sup> This may explain a role for BRCA1 to promote lower fidelity DNA repair by <a href=\"/wiki/Non-homologous_end_joining\" title=\"Non-homologous end joining\">non-homologous end joining</a> (NHEJ).<sup class=\"reference\" id=\"cite_ref-Durant2005_45-0\"><a href=\"#cite_note-Durant2005-45\">[45]</a></sup> BRCA1 also colocalizes with γ-H2AX (histone H2AX phosphorylated on serine-139) in DNA double-strand break repair foci, indicating it may play a role in recruiting repair factors.<sup class=\"reference\" id=\"cite_ref-Starita2003_17-1\"><a href=\"#cite_note-Starita2003-17\">[17]</a></sup><sup class=\"reference\" id=\"cite_ref-Ye2001_46-0\"><a href=\"#cite_note-Ye2001-46\">[46]</a></sup>\n",
              "</p><p><a href=\"/wiki/Formaldehyde\" title=\"Formaldehyde\">Formaldehyde</a> and <a href=\"/wiki/Acetaldehyde\" title=\"Acetaldehyde\">acetaldehyde</a> are common environmental sources of DNA cross links that often require repairs mediated by BRCA1 containing pathways.<sup class=\"reference\" id=\"cite_ref-Ridpath_2007_47-0\"><a href=\"#cite_note-Ridpath_2007-47\">[47]</a></sup>\n",
              "</p><p>This DNA repair function is essential; mice with loss-of-function mutations in both BRCA1 alleles are not viable, and as of 2015 only two adults were known to have loss-of-function mutations in both alleles (leading to FA-S); both had congenital or developmental issues, and both had cancer. One was presumed to have survived to adulthood because one of the BRCA1 mutations was <a class=\"mw-redirect\" href=\"/wiki/Hypomorphic\" title=\"Hypomorphic\">hypomorphic</a>.<sup class=\"reference\" id=\"cite_ref-48\"><a href=\"#cite_note-48\">[48]</a></sup>\n",
              "</p>\n",
              "<h3><span class=\"mw-headline\" id=\"Transcription\">Transcription</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=8\" title=\"Edit section: Transcription\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n",
              "<p>BRCA1 was shown to co-purify with the human RNA Polymerase II holoenzyme in HeLa extracts, implying it is a component of the holoenzyme.<sup class=\"reference\" id=\"cite_ref-Scully1997_49-0\"><a href=\"#cite_note-Scully1997-49\">[49]</a></sup> Later research, however, contradicted this assumption, instead showing that the predominant complex including BRCA1 in HeLa cells is a 2 megadalton complex containing SWI/SNF.<sup class=\"reference\" id=\"cite_ref-Bochar2000_50-0\"><a href=\"#cite_note-Bochar2000-50\">[50]</a></sup> SWI/SNF is a chromatin remodeling complex. Artificial tethering of BRCA1 to chromatin was shown to decondense heterochromatin, though the SWI/SNF interacting domain was not necessary for this role.<sup class=\"reference\" id=\"cite_ref-Ye2001_46-1\"><a href=\"#cite_note-Ye2001-46\">[46]</a></sup> BRCA1 interacts with the NELF-B (<a href=\"/wiki/Cofactor_of_BRCA1\" title=\"Cofactor of BRCA1\">COBRA1</a>) subunit of the <a href=\"/wiki/Negative_elongation_factor\" title=\"Negative elongation factor\">NELF</a> complex.<sup class=\"reference\" id=\"cite_ref-Ye2001_46-2\"><a href=\"#cite_note-Ye2001-46\">[46]</a></sup>\n",
              "</p>\n",
              "<h2><span class=\"mw-headline\" id=\"Mutations_and_cancer_risk\">Mutations and cancer risk</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=9\" title=\"Edit section: Mutations and cancer risk\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:312px;\"><a class=\"image\" href=\"/wiki/File:BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg\"><img class=\"thumbimage\" data-file-height=\"3705\" data-file-width=\"5945\" decoding=\"async\" height=\"193\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/19/BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg/310px-BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/19/BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg/465px-BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/19/BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg/620px-BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg 2x\" width=\"310\"/></a> <div class=\"thumbcaption\"><div class=\"magnify\"><a class=\"internal\" href=\"/wiki/File:BRCA1_and_BRCA2_mutations_and_absolute_cancer_risk.jpg\" title=\"Enlarge\"></a></div>Absolute risk of cancers in BRCA1 or <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a> mutation.<sup class=\"reference\" id=\"cite_ref-Petrucelli_2016_51-0\"><a href=\"#cite_note-Petrucelli_2016-51\">[51]</a></sup></div></div></div>\n",
              "<style data-mw-deduplicate=\"TemplateStyles:r1033289096\">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div class=\"hatnote navigation-not-searchable\" role=\"note\">Further information: <a href=\"/wiki/BRCA_mutation\" title=\"BRCA mutation\">BRCA mutation</a></div>\n",
              "<p>Certain variations of the <i>BRCA1</i> gene lead to an increased risk for <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a> as part of a <a href=\"/wiki/Hereditary_breast%E2%80%93ovarian_cancer_syndrome\" title=\"Hereditary breast–ovarian cancer syndrome\">hereditary breast–ovarian cancer syndrome</a>. Researchers have identified hundreds of <a href=\"/wiki/Mutation\" title=\"Mutation\">mutations</a> in the <i>BRCA1</i> gene, many of which are associated with an increased risk of cancer. Females with an abnormal BRCA1 or BRCA2 gene have up to an 80% risk of developing breast cancer by age 90; increased risk of developing ovarian cancer is about 55% for females with BRCA1 mutations and about 25% for females with BRCA2 mutations.<sup class=\"reference\" id=\"cite_ref-urlGenetics_52-0\"><a href=\"#cite_note-urlGenetics-52\">[52]</a></sup>\n",
              "</p><p>These mutations can be changes in one or a small number of DNA <a href=\"/wiki/Base_pair\" title=\"Base pair\">base pairs</a> (the building-blocks of DNA), and can be identified with PCR and DNA sequencing.<sup class=\"reference\" id=\"cite_ref-53\"><a href=\"#cite_note-53\">[53]</a></sup>\n",
              "</p><p>In some cases, large segments of DNA are rearranged. Those large segments, also called large rearrangements, can be a deletion or a duplication of one or several exons in the gene. Classical methods for mutation detection (sequencing) are unable to reveal these types of mutation.<sup class=\"reference\" id=\"cite_ref-pmid15832305_54-0\"><a href=\"#cite_note-pmid15832305-54\">[54]</a></sup> Other methods have been proposed: traditional <a class=\"mw-redirect\" href=\"/wiki/Quantitative_PCR\" title=\"Quantitative PCR\">quantitative PCR</a>,<sup class=\"reference\" id=\"cite_ref-pmid14984472_55-0\"><a href=\"#cite_note-pmid14984472-55\">[55]</a></sup> <a href=\"/wiki/Multiplex_ligation-dependent_probe_amplification\" title=\"Multiplex ligation-dependent probe amplification\">multiplex ligation-dependent probe amplification</a> (MLPA),<sup class=\"reference\" id=\"cite_ref-pmid12670888_56-0\"><a href=\"#cite_note-pmid12670888-56\">[56]</a></sup> and Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF).<sup class=\"reference\" id=\"cite_ref-pmid12203994_57-0\"><a href=\"#cite_note-pmid12203994-57\">[57]</a></sup> Newer methods have also been recently proposed: heteroduplex analysis (HDA) by multi-capillary electrophoresis or also dedicated oligonucleotides array based on <a href=\"/wiki/Comparative_genomic_hybridization\" title=\"Comparative genomic hybridization\">comparative genomic hybridization</a> (array-CGH).<sup class=\"reference\" id=\"cite_ref-pmid17718857_58-0\"><a href=\"#cite_note-pmid17718857-58\">[58]</a></sup>\n",
              "</p><p>Some results suggest that <a href=\"/wiki/Methylation\" title=\"Methylation\">hypermethylation</a> of the BRCA1 <a class=\"mw-redirect\" href=\"/wiki/Promoter_(biology)\" title=\"Promoter (biology)\">promoter</a>, which has been reported in some cancers, could be considered as an inactivating mechanism for BRCA1 expression.<sup class=\"reference\" id=\"cite_ref-pmid18567944_59-0\"><a href=\"#cite_note-pmid18567944-59\">[59]</a></sup>\n",
              "</p><p>A mutated <i>BRCA1</i> gene usually makes a <a href=\"/wiki/Protein\" title=\"Protein\">protein</a> that does not function properly. Researchers believe that the defective BRCA1 protein is unable to help fix DNA damage leading to mutations in other genes. These mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor. Thus, BRCA1 inactivating mutations lead to a predisposition for cancer.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">[<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (January 2016)\">citation needed</span></a></i>]</sup>\n",
              "</p><p>BRCA1 mRNA <a href=\"/wiki/Three_prime_untranslated_region\" title=\"Three prime untranslated region\">3' UTR</a> can be bound by an <a class=\"mw-redirect\" href=\"/wiki/MiRNA\" title=\"MiRNA\">miRNA</a>, <a href=\"/wiki/Mir-17_microRNA_precursor_family\" title=\"Mir-17 microRNA precursor family\">Mir-17 microRNA</a>. It has been suggested that variations in this miRNA along with <a href=\"/wiki/Mir-30_microRNA_precursor\" title=\"Mir-30 microRNA precursor\">Mir-30 microRNA</a> could confer susceptibility to breast cancer.<sup class=\"reference\" id=\"cite_ref-60\"><a href=\"#cite_note-60\">[60]</a></sup>\n",
              "</p><p>In addition to breast cancer, mutations in the <i>BRCA1</i> gene also increase the risk of <a href=\"/wiki/Ovarian_cancer\" title=\"Ovarian cancer\">ovarian</a> and <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate cancers</a>. Moreover, precancerous lesions (<a href=\"/wiki/Dysplasia\" title=\"Dysplasia\">dysplasia</a>) within the <a href=\"/wiki/Fallopian_tube\" title=\"Fallopian tube\">Fallopian tube</a> have been linked to <i>BRCA1</i> gene mutations. Pathogenic mutations anywhere in a model pathway containing BRCA1 and BRCA2 greatly increase risks for a subset of leukemias and lymphomas.<sup class=\"reference\" id=\"cite_ref-pmid17683622_14-2\"><a href=\"#cite_note-pmid17683622-14\">[14]</a></sup>\n",
              "</p><p>Women who have inherited a defective BRCA1 or BRCA2 gene are at a greatly elevated risk to develop breast and ovarian cancer. Their risk of developing breast and/or ovarian cancer is so high, and so specific to those cancers, that many mutation carriers choose to have <a href=\"/wiki/Prophylactic_surgery\" title=\"Prophylactic surgery\">prophylactic surgery</a>. There has been much conjecture to explain such apparently striking tissue specificity. Major determinants of where BRCA1/2 hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation or the carcinogen. The target tissue may have receptors for the pathogen, may become selectively exposed to an inflammatory process or to a carcinogen. An innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets. This theory also fits data for several tumor suppressors beyond BRCA1 or BRCA2. A major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery.<sup class=\"reference\" id=\"cite_ref-Levin2012_61-0\"><a href=\"#cite_note-Levin2012-61\">[61]</a></sup>\n",
              "</p><p>As aforementioned, biallelic and homozygous inheritance of the BRCA1 gene leads to FA-S, which is almost always an embryonically lethal condition.\n",
              "</p>\n",
              "<h2><span class=\"mw-headline\" id=\"Low_expression_of_BRCA1_in_breast_and_ovarian_cancers\">Low expression of <i>BRCA1</i> in breast and ovarian cancers</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=10\" title=\"Edit section: Low expression of BRCA1 in breast and ovarian cancers\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<p>BRCA1 expression is reduced or undetectable in the majority of high grade, ductal breast cancers.<sup class=\"reference\" id=\"cite_ref-pmid9988281_62-0\"><a href=\"#cite_note-pmid9988281-62\">[62]</a></sup>  It has long been noted that loss of BRCA1 activity, either by germ-line mutations or by down-regulation of gene expression, leads to tumor formation in specific target tissues.  In particular, decreased BRCA1 expression contributes to both sporadic and inherited breast tumor progression.<sup class=\"reference\" id=\"cite_ref-pmid12559046_63-0\"><a href=\"#cite_note-pmid12559046-63\">[63]</a></sup>  Reduced expression of BRCA1 is tumorigenic because it plays an important role in the repair of DNA damages, especially double-strand breaks, by the potentially error-free pathway of homologous recombination.<sup class=\"reference\" id=\"cite_ref-Jacinto_64-0\"><a href=\"#cite_note-Jacinto-64\">[64]</a></sup>  Since cells that lack the BRCA1 protein tend to repair DNA damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer.<sup class=\"reference\" id=\"cite_ref-Jacinto_64-1\"><a href=\"#cite_note-Jacinto-64\">[64]</a></sup>\n",
              "</p><p>Similarly, BRCA1 expression is low in the majority (55%) of sporadic <a href=\"/wiki/Ovarian_cancer#Epithelial_carcinoma\" title=\"Ovarian cancer\">epithelial ovarian cancers (EOCs)</a> where EOCs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers.<sup class=\"reference\" id=\"cite_ref-Sun_65-0\"><a href=\"#cite_note-Sun-65\">[65]</a></sup>  In <a href=\"/wiki/Ovarian_cancer#Serous_carcinoma\" title=\"Ovarian cancer\">serous ovarian carcinomas</a>, a sub-category constituting about 2/3 of EOCs, low BRCA1 expression occurs in more than 50% of cases.<sup class=\"reference\" id=\"cite_ref-pmid22790015_66-0\"><a href=\"#cite_note-pmid22790015-66\">[66]</a></sup>  Bowtell<sup class=\"reference\" id=\"cite_ref-pmid20944665_67-0\"><a href=\"#cite_note-pmid20944665-67\">[67]</a></sup> reviewed the literature indicating that deficient homologous recombination repair caused by BRCA1 deficiency is tumorigenic.  In particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy.  Especially noted was that BRCA1 deficiency could be the cause of tumorigenesis whether due to BRCA1 mutation or any other event that causes a deficiency of BRCA1 expression.\n",
              "</p>\n",
              "<h3><span class=\"mw-headline\" id=\"Mutation_of_BRCA1_in_breast_and_ovarian_cancer\">Mutation of <i>BRCA1</i> in breast and ovarian cancer</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=11\" title=\"Edit section: Mutation of BRCA1 in breast and ovarian cancer\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n",
              "<p>Only about 3%–8% of all women with breast cancer carry a mutation in BRCA1 or BRCA2.<sup class=\"reference\" id=\"cite_ref-pmid9653432_68-0\"><a href=\"#cite_note-pmid9653432-68\">[68]</a></sup>  Similarly, <i>BRCA1</i> mutations are only seen in about 18% of ovarian cancers (13% germline mutations and 5% somatic mutations).<sup class=\"reference\" id=\"cite_ref-pmid24240112_69-0\"><a href=\"#cite_note-pmid24240112-69\">[69]</a></sup>\n",
              "</p><p>Thus, while BRCA1 expression is low in the majority of these cancers, <i>BRCA1</i> mutation is not a major cause of reduced expression. Certain latent viruses, which are frequently detected in breast cancer tumors, can decrease the expression of the BRCA1 gene and cause the development of breast tumors.<sup class=\"reference\" id=\"cite_ref-pmid30579323_70-0\"><a href=\"#cite_note-pmid30579323-70\">[70]</a></sup>\n",
              "</p>\n",
              "<h3><span class=\"mw-headline\" id=\"BRCA1_promoter_hypermethylation_in_breast_and_ovarian_cancer\"><i>BRCA1</i> promoter hypermethylation in breast and ovarian cancer</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=12\" title=\"Edit section: BRCA1 promoter hypermethylation in breast and ovarian cancer\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n",
              "<p><i>BRCA1</i> <a href=\"/wiki/DNA_methylation\" title=\"DNA methylation\">promoter hypermethylation</a> was present in only 13% of unselected primary breast carcinomas.<sup class=\"reference\" id=\"cite_ref-pmid10749912_71-0\"><a href=\"#cite_note-pmid10749912-71\">[71]</a></sup>  Similarly, <i>BRCA1</i> promoter hypermethylation was present in only 5% to 15% of EOC cases.<sup class=\"reference\" id=\"cite_ref-Sun_65-1\"><a href=\"#cite_note-Sun-65\">[65]</a></sup>\n",
              "</p><p>Thus, while BRCA1 expression is low in these cancers, <i>BRCA1</i> promoter methylation is only a minor cause of reduced expression.\n",
              "</p>\n",
              "<h3><span class=\"mw-headline\" id=\"MicroRNA_repression_of_BRCA1_in_breast_cancers\">MicroRNA repression of BRCA1 in breast cancers</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=13\" title=\"Edit section: MicroRNA repression of BRCA1 in breast cancers\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n",
              "<p>There are a number of specific <a href=\"/wiki/MicroRNA#DNA_repair_and_cancer\" title=\"MicroRNA\">microRNAs</a>, when overexpressed, that directly reduce expression of specific DNA repair proteins (see <a href=\"/wiki/MicroRNA#DNA_repair_and_cancer\" title=\"MicroRNA\">MicroRNA section DNA repair and cancer</a>)  In the case of breast cancer, microRNA-182 (miR-182) specifically targets BRCA1.<sup class=\"reference\" id=\"cite_ref-Moskwa_72-0\"><a href=\"#cite_note-Moskwa-72\">[72]</a></sup>  Breast cancers can be <a href=\"/wiki/Breast_cancer_classification\" title=\"Breast cancer classification\">classified</a> based on receptor status or histology, with <a href=\"/wiki/Triple-negative_breast_cancer\" title=\"Triple-negative breast cancer\">triple-negative breast cancer</a> (15%–25% of breast cancers), <a href=\"/wiki/Breast_cancer#HER2_and_cancer\" title=\"Breast cancer\">HER2+</a> (15%–30% of breast cancers), <a href=\"/wiki/Estrogen_receptor#Cancer\" title=\"Estrogen receptor\">ER+</a>/<a href=\"/wiki/Progesterone_receptor\" title=\"Progesterone receptor\">PR+</a> (about 70% of breast cancers), and <a href=\"/wiki/Invasive_lobular_carcinoma\" title=\"Invasive lobular carcinoma\">Invasive lobular carcinoma</a> (about 5%–10% of invasive breast cancer).  All four types of breast cancer were found to have an average of about 100-fold increase in miR-182, compared to normal breast tissue.<sup class=\"reference\" id=\"cite_ref-pmid23249749_73-0\"><a href=\"#cite_note-pmid23249749-73\">[73]</a></sup>  In breast cancer cell lines, there is an inverse correlation of BRCA1 protein levels with miR-182 expression.<sup class=\"reference\" id=\"cite_ref-Moskwa_72-1\"><a href=\"#cite_note-Moskwa-72\">[72]</a></sup> Thus it appears that much of the reduction or absence of BRCA1 in high grade ductal breast cancers may be due to over-expressed miR-182.\n",
              "</p><p>In addition to miR-182, a pair of almost identical microRNAs, miR-146a and miR-146b-5p, also repress BRCA1 expression.  These two microRNAs are over-expressed in triple-negative tumors and their over-expression results in BRCA1 inactivation.<sup class=\"reference\" id=\"cite_ref-pmid21472990_74-0\"><a href=\"#cite_note-pmid21472990-74\">[74]</a></sup>  Thus, miR-146a and/or miR-146b-5p may also contribute to reduced expression of BRCA1 in these triple-negative breast cancers.\n",
              "</p>\n",
              "<h3><span class=\"mw-headline\" id=\"MicroRNA_repression_of_BRCA1_in_ovarian_cancers\">MicroRNA repression of BRCA1 in ovarian cancers</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=14\" title=\"Edit section: MicroRNA repression of BRCA1 in ovarian cancers\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n",
              "<p>In both <a href=\"/wiki/Ovarian_cancer#Pathophysiology\" title=\"Ovarian cancer\">serous tubal intraepithelial carcinoma</a> (the precursor lesion to <a href=\"/wiki/Ovarian_cancer#Pathophysiology\" title=\"Ovarian cancer\">high grade serous ovarian carcinoma (HG-SOC)</a>), and in HG-SOC itself, miR-182 is overexpressed in about 70% of cases.<sup class=\"reference\" id=\"cite_ref-Liu_75-0\"><a href=\"#cite_note-Liu-75\">[75]</a></sup>  In cells with over-expressed miR-182, BRCA1 remained low, even after exposure to ionizing radiation (which normally raises BRCA1 expression).<sup class=\"reference\" id=\"cite_ref-Liu_75-1\"><a href=\"#cite_note-Liu-75\">[75]</a></sup>  Thus much of the reduced or absent BRCA1 in HG-SOC may be due to over-expressed miR-182.\n",
              "</p><p>Another microRNA known to reduce expression of BRCA1 in ovarian cancer cells is miR-9.<sup class=\"reference\" id=\"cite_ref-Sun_65-2\"><a href=\"#cite_note-Sun-65\">[65]</a></sup>  Among 58 tumors from patients with stage IIIC or stage IV serous ovarian cancers (HG-SOG), an inverse correlation was found between expressions of miR-9 and BRCA1,<sup class=\"reference\" id=\"cite_ref-Sun_65-3\"><a href=\"#cite_note-Sun-65\">[65]</a></sup> so that increased miR-9 may also contribute to reduced expression of BRCA1 in these ovarian cancers.\n",
              "</p>\n",
              "<h3><span class=\"mw-headline\" id=\"Deficiency_of_BRCA1_expression_is_likely_tumorigenic\">Deficiency of <i>BRCA1</i> expression is likely tumorigenic</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=15\" title=\"Edit section: Deficiency of BRCA1 expression is likely tumorigenic\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n",
              "<p>DNA damage appears to be the primary underlying cause of cancer,<sup class=\"reference\" id=\"cite_ref-pmid18403632_76-0\"><a href=\"#cite_note-pmid18403632-76\">[76]</a></sup> and deficiencies in DNA repair appears to underlie many forms of cancer.<sup class=\"reference\" id=\"cite_ref-pmid18082599_77-0\"><a href=\"#cite_note-pmid18082599-77\">[77]</a></sup>  If DNA repair is deficient, DNA damage tends to accumulate. Such excess DNA damage may increase <a class=\"mw-redirect\" href=\"/wiki/Mutational\" title=\"Mutational\">mutational</a> errors during <a href=\"/wiki/DNA_replication\" title=\"DNA replication\">DNA replication</a> due to error-prone <a href=\"/wiki/DNA_repair#Translesion_synthesis\" title=\"DNA repair\">translesion synthesis</a>. Excess DNA damage may also increase <a href=\"/wiki/Epigenetics\" title=\"Epigenetics\">epigenetic</a> alterations due to errors during DNA repair.<sup class=\"reference\" id=\"cite_ref-Hagan_78-0\"><a href=\"#cite_note-Hagan-78\">[78]</a></sup><sup class=\"reference\" id=\"cite_ref-Cuozzo_79-0\"><a href=\"#cite_note-Cuozzo-79\">[79]</a></sup> Such mutations and epigenetic alterations may give rise to <a href=\"/wiki/Cancer\" title=\"Cancer\">cancer</a>.  The frequent microRNA-induced deficiency of <i>BRCA1</i> in breast and ovarian cancers likely contribute to the progression of those cancers.\n",
              "</p>\n",
              "<h2><span class=\"mw-headline\" id=\"Germ-line_mutations_and_founder_effect\">Germ-line mutations and founder effect</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=16\" title=\"Edit section: Germ-line mutations and founder effect\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<p>All germ-line BRCA1 mutations identified to date have been inherited, suggesting the possibility of a large \"founder\" effect in which a certain mutation is common to a well-defined population group and can, in theory, be traced back to a common ancestor. Given the complexity of mutation screening for BRCA1, these common mutations may simplify the methods required for mutation screening in certain populations. Analysis of mutations that occur with high frequency also permits the study of their clinical expression.<sup class=\"reference\" id=\"cite_ref-Lacroix2005_80-0\"><a href=\"#cite_note-Lacroix2005-80\">[80]</a></sup> Examples of manifestations of a founder effect are seen among <a href=\"/wiki/Ashkenazi_Jews\" title=\"Ashkenazi Jews\">Ashkenazi Jews</a>. Three mutations in BRCA1 have been reported to account for the majority of Ashkenazi Jewish patients with inherited BRCA1-related breast and/or ovarian cancer: 185delAG, 188del11 and 5382insC in the BRCA1 gene.<sup class=\"reference\" id=\"cite_ref-Struewing1995_81-0\"><a href=\"#cite_note-Struewing1995-81\">[81]</a></sup><sup class=\"reference\" id=\"cite_ref-Tonin1995_82-0\"><a href=\"#cite_note-Tonin1995-82\">[82]</a></sup> In fact, it has been shown that if a Jewish woman does not carry a BRCA1 185delAG, BRCA1 5382insC founder mutation, it is highly unlikely that a different BRCA1 mutation will be found.<sup class=\"reference\" id=\"cite_ref-Narod2004_83-0\"><a href=\"#cite_note-Narod2004-83\">[83]</a></sup> Additional examples of founder mutations in BRCA1 are given in Table 1 (mainly derived from<sup class=\"reference\" id=\"cite_ref-Lacroix2005_80-1\"><a href=\"#cite_note-Lacroix2005-80\">[80]</a></sup>).\n",
              "</p>\n",
              "<link href=\"mw-data:TemplateStyles:r1033289096\" rel=\"mw-deduplicated-inline-style\"/><div class=\"hatnote navigation-not-searchable plainlinks\" role=\"note\">This is a <a href=\"/wiki/Wikipedia:WikiProject_Lists#Dynamic_lists\" title=\"Wikipedia:WikiProject Lists\">dynamic list</a> and may never be able to satisfy particular standards for completeness. You can help by <a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=BRCA1&amp;action=edit\">adding missing items</a> with <a href=\"/wiki/Wikipedia:Reliable_sources\" title=\"Wikipedia:Reliable sources\">reliable sources</a>.</div>\n",
              "<table class=\"wikitable\">\n",
              "<tbody><tr>\n",
              "<th>Population or subgroup</th>\n",
              "<th>BRCA1 mutation(s)<sup class=\"reference\" id=\"cite_ref-denDunnen2000_84-0\"><a href=\"#cite_note-denDunnen2000-84\">[84]</a></sup></th>\n",
              "<th>Reference(s)\n",
              "</th></tr>\n",
              "<tr>\n",
              "<td>African-Americans</td>\n",
              "<td>943ins10, M1775R</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Neuhausen2000_85-0\"><a href=\"#cite_note-Neuhausen2000-85\">[85]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Afrikaners</td>\n",
              "<td>E881X, 1374delC</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Reeves2004_86-0\"><a href=\"#cite_note-Reeves2004-86\">[86]</a></sup><sup class=\"reference\" id=\"cite_ref-Francies2015_87-0\"><a href=\"#cite_note-Francies2015-87\">[87]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Ashkenazi Jewish</td>\n",
              "<td>185delAG, 188del11, 5382insC</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Struewing1995_81-1\"><a href=\"#cite_note-Struewing1995-81\">[81]</a></sup><sup class=\"reference\" id=\"cite_ref-Tonin1995_82-1\"><a href=\"#cite_note-Tonin1995-82\">[82]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Austrians</td>\n",
              "<td>2795delA, C61G, 5382insC, Q1806stop</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Wagner1998_88-0\"><a href=\"#cite_note-Wagner1998-88\">[88]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Belgians</td>\n",
              "<td>2804delAA, IVS5+3A&gt;G</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Peelen1997_89-0\"><a href=\"#cite_note-Peelen1997-89\">[89]</a></sup><sup class=\"reference\" id=\"cite_ref-Claes1999_90-0\"><a href=\"#cite_note-Claes1999-90\">[90]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Dutch</td>\n",
              "<td>Exon 2 deletion, exon 13 deletion, 2804delAA</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Peelen1997_89-1\"><a href=\"#cite_note-Peelen1997-89\">[89]</a></sup><sup class=\"reference\" id=\"cite_ref-PetrijBosch_91-0\"><a href=\"#cite_note-PetrijBosch-91\">[91]</a></sup><sup class=\"reference\" id=\"cite_ref-Verhoog_92-0\"><a href=\"#cite_note-Verhoog-92\">[92]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Finns</td>\n",
              "<td>3745delT, IVS11-2A&gt;G</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Huusko_93-0\"><a href=\"#cite_note-Huusko-93\">[93]</a></sup><sup class=\"reference\" id=\"cite_ref-Paakkonen_94-0\"><a href=\"#cite_note-Paakkonen-94\">[94]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>French</td>\n",
              "<td>3600del11, G1710X</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Muller_95-0\"><a href=\"#cite_note-Muller-95\">[95]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>French Canadians</td>\n",
              "<td>C4446T</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Tonin1999_96-0\"><a href=\"#cite_note-Tonin1999-96\">[96]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Germans</td>\n",
              "<td>5382insC, 4184del4</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Backe1999_97-0\"><a href=\"#cite_note-Backe1999-97\">[97]</a></sup><sup class=\"reference\" id=\"cite_ref-urlBrca1_98-0\"><a href=\"#cite_note-urlBrca1-98\">[98]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Greeks</td>\n",
              "<td>5382insC</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Ladopoulou2002_99-0\"><a href=\"#cite_note-Ladopoulou2002-99\">[99]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Hungarians</td>\n",
              "<td>300T&gt;G, 5382insC, 185delAG</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-VanDerLooij2000_100-0\"><a href=\"#cite_note-VanDerLooij2000-100\">[100]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Italians</td>\n",
              "<td>5083del19</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Baudi2001_101-0\"><a href=\"#cite_note-Baudi2001-101\">[101]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Japanese</td>\n",
              "<td>L63X, Q934X</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Sekine2001_102-0\"><a href=\"#cite_note-Sekine2001-102\">[102]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Native North Americans</td>\n",
              "<td>1510insG, 1506A&gt;G</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Liede2002b_103-0\"><a href=\"#cite_note-Liede2002b-103\">[103]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Northern Irish</td>\n",
              "<td>2800delAA</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-TSNI2003_104-0\"><a href=\"#cite_note-TSNI2003-104\">[104]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Norwegians</td>\n",
              "<td>816delGT, 1135insA, 1675delA, 3347delAG</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Borg1999_105-0\"><a href=\"#cite_note-Borg1999-105\">[105]</a></sup><sup class=\"reference\" id=\"cite_ref-Heimdal2003_106-0\"><a href=\"#cite_note-Heimdal2003-106\">[106]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Pakistanis</td>\n",
              "<td>2080insA, 3889delAG, 4184del4, 4284delAG, IVS14-1A&gt;G</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Liede2002_107-0\"><a href=\"#cite_note-Liede2002-107\">[107]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Poles</td>\n",
              "<td>300T&gt;G, 5382insC, C61G, 4153delA</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Gorski2000_108-0\"><a href=\"#cite_note-Gorski2000-108\">[108]</a></sup><sup class=\"reference\" id=\"cite_ref-Perkowska2003_109-0\"><a href=\"#cite_note-Perkowska2003-109\">[109]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Russians</td>\n",
              "<td>5382insC, 4153delA</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Gayther1997_110-0\"><a href=\"#cite_note-Gayther1997-110\">[110]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Scots</td>\n",
              "<td>2800delAA</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-TSNI2003_104-1\"><a href=\"#cite_note-TSNI2003-104\">[104]</a></sup><sup class=\"reference\" id=\"cite_ref-Liede2000_111-0\"><a href=\"#cite_note-Liede2000-111\">[111]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Spaniards</td>\n",
              "<td>R71G</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Vega2001_112-0\"><a href=\"#cite_note-Vega2001-112\">[112]</a></sup><sup class=\"reference\" id=\"cite_ref-Campos2003_113-0\"><a href=\"#cite_note-Campos2003-113\">[113]</a></sup>\n",
              "</td></tr>\n",
              "<tr>\n",
              "<td>Swedes</td>\n",
              "<td>Q563X, 3171ins5, 1201del11, 2594delC</td>\n",
              "<td><sup class=\"reference\" id=\"cite_ref-Neuhausen2000_85-1\"><a href=\"#cite_note-Neuhausen2000-85\">[85]</a></sup><sup class=\"reference\" id=\"cite_ref-Bergman2001_114-0\"><a href=\"#cite_note-Bergman2001-114\">[114]</a></sup>\n",
              "</td></tr></tbody></table>\n",
              "<h2><span class=\"mw-headline\" id=\"Female_fertility\">Female fertility</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=17\" title=\"Edit section: Female fertility\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<p>As women age, reproductive performance declines, leading to menopause. This decline is tied to a reduction in the number of ovarian follicles. Although about 1 million oocytes are present at birth in the human ovary, only about 500 (about 0.05%) of these ovulate. The decline in ovarian reserve appears to occur at a constantly increasing rate with age,<sup class=\"reference\" id=\"cite_ref-pmid18192670_115-0\"><a href=\"#cite_note-pmid18192670-115\">[115]</a></sup> and leads to nearly complete exhaustion of the reserve by about age 52. As ovarian reserve and fertility decline with age, there is also a parallel increase in pregnancy failure and meiotic errors, resulting in chromosomally abnormal conceptions.<sup class=\"reference\" id=\"cite_ref-116\"><a href=\"#cite_note-116\">[116]</a></sup>\n",
              "</p><p>Women with a germ-line <i>BRCA1</i> mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women.<sup class=\"reference\" id=\"cite_ref-pmid19996028_117-0\"><a href=\"#cite_note-pmid19996028-117\">[117]</a></sup> Furthermore, women with an inherited <i>BRCA1</i> mutation undergo menopause prematurely.<sup class=\"reference\" id=\"cite_ref-pmid16773440_118-0\"><a href=\"#cite_note-pmid16773440-118\">[118]</a></sup>  Since BRCA1 is a key DNA repair protein, these findings suggest that naturally occurring DNA damages in oocytes are repaired less efficiently in women with a <i>BRCA1</i> defect, and that this repair inefficiency leads to early reproductive failure.<sup class=\"reference\" id=\"cite_ref-pmid19996028_117-1\"><a href=\"#cite_note-pmid19996028-117\">[117]</a></sup>\n",
              "</p><p>As noted above, the BRCA1 protein plays a key role in homologous recombinational repair.  This is the only known cellular process that can accurately repair DNA double-strand breaks. DNA double-strand breaks accumulate with age in humans and mice in primordial follicles.<sup class=\"reference\" id=\"cite_ref-Titus_119-0\"><a href=\"#cite_note-Titus-119\">[119]</a></sup>  Primordial follicles contain oocytes that are at an intermediate (prophase I) stage of meiosis.  Meiosis is the general process in eukaryotic organisms by which germ cells are formed, and it is likely an adaptation for removing DNA damages, especially double-strand breaks, from germ line DNA.<sup class=\"reference\" id=\"cite_ref-120\"><a href=\"#cite_note-120\">[120]</a></sup> (Also see article <a href=\"/wiki/Meiosis\" title=\"Meiosis\">Meiosis</a>).  Homologous recombinational repair employing BRCA1 is especially promoted during meiosis.  It was found that expression of four key genes necessary for homologous recombinational repair of DNA double-strand breaks (<i>BRCA1, MRE11, RAD51</i> and <i>ATM</i>) decline with age in the oocytes of humans and mice,<sup class=\"reference\" id=\"cite_ref-Titus_119-1\"><a href=\"#cite_note-Titus-119\">[119]</a></sup> leading to the hypothesis that DNA double-strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging.\n",
              "</p>\n",
              "<h2><span class=\"mw-headline\" id=\"Cancer_chemotherapy\">Cancer chemotherapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=18\" title=\"Edit section: Cancer chemotherapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<p>Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide.  At diagnosis, almost 70% of persons with NSCLC have locally advanced or metastatic disease.  Persons with NSCLC are often treated with therapeutic platinum compounds (e.g. cisplatin, carboplatin or oxaliplatin) that cause inter-strand cross-links in DNA.  Among individuals with NSCLC, low expression of <i>BRCA1</i> in the primary tumor correlated with improved survival after platinum-containing chemotherapy.<sup class=\"reference\" id=\"cite_ref-Taron_121-0\"><a href=\"#cite_note-Taron-121\">[121]</a></sup><sup class=\"reference\" id=\"cite_ref-Papadaki_122-0\"><a href=\"#cite_note-Papadaki-122\">[122]</a></sup>  This correlation implies that low BRCA1 in cancer, and the consequent low level of DNA repair, causes vulnerability of cancer to treatment by the DNA cross-linking agents.  High BRCA1 may protect cancer cells by acting in a pathway that removes the damages in DNA introduced by the platinum drugs.  Thus the level of <i>BRCA1</i> expression is a potentially important tool for tailoring chemotherapy in lung cancer management.<sup class=\"reference\" id=\"cite_ref-Taron_121-1\"><a href=\"#cite_note-Taron-121\">[121]</a></sup><sup class=\"reference\" id=\"cite_ref-Papadaki_122-1\"><a href=\"#cite_note-Papadaki-122\">[122]</a></sup>\n",
              "</p><p>Level of <i>BRCA1</i> expression is also relevant to ovarian cancer treatment.  Patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their <i>BRCA1</i> expression was low compared to patients with higher <i>BRCA1</i> expression (46 compared to 33 months).<sup class=\"reference\" id=\"cite_ref-pmid19035454_123-0\"><a href=\"#cite_note-pmid19035454-123\">[123]</a></sup>\n",
              "</p>\n",
              "<h2><span id=\"Patents.2C_enforcement.2C_litigation.2C_and_controversy\"></span><span class=\"mw-headline\" id=\"Patents,_enforcement,_litigation,_and_controversy\">Patents, enforcement, litigation, and controversy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=19\" title=\"Edit section: Patents, enforcement, litigation, and controversy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<link href=\"mw-data:TemplateStyles:r1033289096\" rel=\"mw-deduplicated-inline-style\"/><div class=\"hatnote navigation-not-searchable\" role=\"note\">Main article: <a class=\"mw-redirect\" href=\"/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics\" title=\"Association for Molecular Pathology v. Myriad Genetics\">Association for Molecular Pathology v. Myriad Genetics</a></div>\n",
              "<p>A patent application for the isolated BRCA1 gene and cancer promoting mutations discussed above, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the University of Utah, National Institute of Environmental Health Sciences (NIEHS) and <a href=\"/wiki/Myriad_Genetics\" title=\"Myriad Genetics\">Myriad Genetics</a> in 1994;<sup class=\"reference\" id=\"cite_ref-US_5747282_18-2\"><a href=\"#cite_note-US_5747282-18\">[18]</a></sup> over the next year, Myriad, (in collaboration with investigators at Endo Recherche, Inc., HSC Research &amp; Development Limited Partnership, and University of Pennsylvania), isolated and sequenced the <a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a> gene and identified key mutations, and the first BRCA2 patent was filed in the U.S. by Myriad and other institutions in 1995.<sup class=\"reference\" id=\"cite_ref-US_5837492_19-1\"><a href=\"#cite_note-US_5837492-19\">[19]</a></sup>  Myriad is the exclusive licensee of these <a href=\"/wiki/Biological_patent\" title=\"Biological patent\">patents</a> and has enforced them in the US against clinical diagnostic labs.<sup class=\"reference\" id=\"cite_ref-SchwartzNYTimes_21-1\"><a href=\"#cite_note-SchwartzNYTimes-21\">[21]</a></sup>  This business model led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012;<sup class=\"reference\" id=\"cite_ref-MyriadInvestorPage_20-1\"><a href=\"#cite_note-MyriadInvestorPage-20\">[20]</a></sup> it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs, which in turn led to the landmark <i><a class=\"mw-redirect\" href=\"/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics\" title=\"Association for Molecular Pathology v. Myriad Genetics\">Association for Molecular Pathology v. Myriad Genetics</a></i> lawsuit.<sup class=\"reference\" id=\"cite_ref-SchwartzNYTimes_21-2\"><a href=\"#cite_note-SchwartzNYTimes-21\">[21]</a></sup><sup class=\"reference\" id=\"cite_ref-url_BRCA1_patent_legal_battle_124-0\"><a href=\"#cite_note-url_BRCA1_patent_legal_battle-124\">[124]</a></sup>  The patents began to expire in 2014.\n",
              "</p><p>According to an article published in the journal, <i>Genetic Medicine</i>, in 2010, \"The patent story outside the United States is more complicated.... For example, patents have been obtained but the patents are being ignored by provincial health systems in Canada. In Australia and the UK, Myriad's licensee permitted use by health systems but announced a change of plans in August 2008. Only a single mutation has been patented in Myriad's lone European-wide patent, although some patents remain under review of an opposition proceeding. In effect, the United States is the only jurisdiction where Myriad's strong patent position has conferred sole-provider status.\"<sup class=\"reference\" id=\"cite_ref-125\"><a href=\"#cite_note-125\">[125]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12509391_126-0\"><a href=\"#cite_note-pmid12509391-126\">[126]</a></sup>  Peter Meldrum, CEO of Myriad Genetics, has acknowledged that Myriad has \"other competitive advantages that may make such [patent] enforcement unnecessary\" in Europe.<sup class=\"reference\" id=\"cite_ref-127\"><a href=\"#cite_note-127\">[127]</a></sup>\n",
              "</p><p>As with any gene, finding variation in BRCA1 is not hard. The real value comes from understanding what the clinical consequences of any particular variant are. Myriad has a large, proprietary database of such genotype-phenotype correlations. In response, parallel open-source databases are being developed.\n",
              "</p><p>Legal decisions surrounding the BRCA1 and BRCA2 patents will affect the field of genetic testing in general.<sup class=\"reference\" id=\"cite_ref-urlGenetics_and_Patenting_128-0\"><a href=\"#cite_note-urlGenetics_and_Patenting-128\">[128]</a></sup>  A June 2013 article, in  <i>Association for Molecular Pathology v. Myriad Genetics</i> (No. 12-398), quoted the <a href=\"/wiki/Supreme_Court_of_the_United_States\" title=\"Supreme Court of the United States\">US Supreme Court</a>'s unanimous ruling that, \"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating Myriad's patents on the BRCA1 and BRCA2 genes. However, the Court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection.<sup class=\"reference\" id=\"cite_ref-129\"><a href=\"#cite_note-129\">[129]</a></sup>  The <a href=\"/wiki/Federal_Court_of_Australia\" title=\"Federal Court of Australia\">Federal Court of Australia</a> came to the opposite conclusion, upholding the validity of an Australian Myriad Genetics patent over the BRCA1 gene in February 2013.<sup class=\"reference\" id=\"cite_ref-130\"><a href=\"#cite_note-130\">[130]</a></sup>  The Federal Court also rejected an appeal in September 2014.<sup class=\"reference\" id=\"cite_ref-131\"><a href=\"#cite_note-131\">[131]</a></sup> Yvonne D'Arcy won her case against US-based biotech company Myriad Genetics in the <a href=\"/wiki/High_Court_of_Australia\" title=\"High Court of Australia\">High Court of Australia</a>. In their unanimous decision on October 7, 2015, the \"high court found that an isolated nucleic acid, coding for a BRCA1 protein, with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a 'patentable invention.'\"<sup class=\"reference\" id=\"cite_ref-theguardian_2015_oct_07_132-0\"><a href=\"#cite_note-theguardian_2015_oct_07-132\">[132]</a></sup>\n",
              "</p>\n",
              "<h2><span class=\"mw-headline\" id=\"Interactions\">Interactions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=20\" title=\"Edit section: Interactions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<p>BRCA1 has been shown to <a href=\"/wiki/Protein%E2%80%93protein_interaction\" title=\"Protein–protein interaction\">interact</a> with the following proteins:\n",
              "</p>\n",
              "<style data-mw-deduplicate=\"TemplateStyles:r1147244281\">.mw-parser-output .div-col{margin-top:0.3em;column-width:30em}.mw-parser-output .div-col-small{font-size:90%}.mw-parser-output .div-col-rules{column-rule:1px solid #aaa}.mw-parser-output .div-col dl,.mw-parser-output .div-col ol,.mw-parser-output .div-col ul{margin-top:0}.mw-parser-output .div-col li,.mw-parser-output .div-col dd{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style><div class=\"div-col\" style=\"column-width: 20em;\">\n",
              "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Abl_gene\" title=\"Abl gene\">ABL1</a><sup class=\"reference\" id=\"cite_ref-pmid12024016_133-0\"><a href=\"#cite_note-pmid12024016-133\">[133]</a></sup></li>\n",
              "<li><a href=\"/wiki/AKT1\" title=\"AKT1\">AKT1</a><sup class=\"reference\" id=\"cite_ref-pmid10542266_134-0\"><a href=\"#cite_note-pmid10542266-134\">[134]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid19074868_135-0\"><a href=\"#cite_note-pmid19074868-135\">[135]</a></sup></li>\n",
              "<li><a href=\"/wiki/Androgen_receptor\" title=\"Androgen receptor\">AR</a><sup class=\"reference\" id=\"cite_ref-pmid11016951_136-0\"><a href=\"#cite_note-pmid11016951-136\">[136]</a></sup></li>\n",
              "<li><a href=\"/wiki/Ataxia_telangiectasia_and_Rad3_related\" title=\"Ataxia telangiectasia and Rad3 related\">ATR</a><sup class=\"reference\" id=\"cite_ref-pmid10608806_137-0\"><a href=\"#cite_note-pmid10608806-137\">[137]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11114888_138-0\"><a href=\"#cite_note-pmid11114888-138\">[138]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11016625_139-0\"><a href=\"#cite_note-pmid11016625-139\">[139]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11278964_140-0\"><a href=\"#cite_note-pmid11278964-140\">[140]</a></sup></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/Ataxia_telangiectasia_mutated\" title=\"Ataxia telangiectasia mutated\">ATM</a><sup class=\"reference\" id=\"cite_ref-pmid10783165_16-1\"><a href=\"#cite_note-pmid10783165-16\">[16]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10608806_137-1\"><a href=\"#cite_note-pmid10608806-137\">[137]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11114888_138-1\"><a href=\"#cite_note-pmid11114888-138\">[138]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11016625_139-1\"><a href=\"#cite_note-pmid11016625-139\">[139]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11278964_140-1\"><a href=\"#cite_note-pmid11278964-140\">[140]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10866324_141-0\"><a href=\"#cite_note-pmid10866324-141\">[141]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10550055_142-0\"><a href=\"#cite_note-pmid10550055-142\">[142]</a></sup></li>\n",
              "<li><a href=\"/wiki/ATF1\" title=\"ATF1\">ATF1</a><sup class=\"reference\" id=\"cite_ref-pmid10945975_143-0\"><a href=\"#cite_note-pmid10945975-143\">[143]</a></sup></li>\n",
              "<li><a href=\"/wiki/BACH1\" title=\"BACH1\">BACH1</a><sup class=\"reference\" id=\"cite_ref-pmid11301010_144-0\"><a href=\"#cite_note-pmid11301010-144\">[144]</a></sup></li>\n",
              "<li><a href=\"/wiki/BARD1\" title=\"BARD1\">BARD1</a><sup class=\"reference\" id=\"cite_ref-pmid11573085_30-3\"><a href=\"#cite_note-pmid11573085-30\">[30]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11498787_39-1\"><a href=\"#cite_note-pmid11498787-39\">[39]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9788437_43-1\"><a href=\"#cite_note-pmid9788437-43\">[43]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11301010_144-1\"><a href=\"#cite_note-pmid11301010-144\">[144]</a></sup></li>\n",
              "<li><a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a><sup class=\"reference\" id=\"cite_ref-pmid14636569_145-0\"><a href=\"#cite_note-pmid14636569-145\">[145]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9774970_146-0\"><a href=\"#cite_note-pmid9774970-146\">[146]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14499622_147-0\"><a href=\"#cite_note-pmid14499622-147\">[147]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11477095_148-0\"><a href=\"#cite_note-pmid11477095-148\">[148]</a></sup></li>\n",
              "<li><a href=\"/wiki/BRCC3\" title=\"BRCC3\">BRCC3</a><sup class=\"reference\" id=\"cite_ref-pmid14636569_145-1\"><a href=\"#cite_note-pmid14636569-145\">[145]</a></sup></li>\n",
              "<li><a href=\"/wiki/BRE_(gene)\" title=\"BRE (gene)\">BRE</a><sup class=\"reference\" id=\"cite_ref-pmid14636569_145-2\"><a href=\"#cite_note-pmid14636569-145\">[145]</a></sup></li>\n",
              "<li><a href=\"/wiki/BRIP1\" title=\"BRIP1\">BRIP1</a><sup class=\"reference\" id=\"cite_ref-pmid11877378_34-1\"><a href=\"#cite_note-pmid11877378-34\">[34]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14578343_149-0\"><a href=\"#cite_note-pmid14578343-149\">[149]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid15208681_150-0\"><a href=\"#cite_note-pmid15208681-150\">[150]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid15242590_151-0\"><a href=\"#cite_note-pmid15242590-151\">[151]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14576433_152-0\"><a href=\"#cite_note-pmid14576433-152\">[152]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid15133502_153-0\"><a href=\"#cite_note-pmid15133502-153\">[153]</a></sup></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/C-jun\" title=\"C-jun\">C-jun</a><sup class=\"reference\" id=\"cite_ref-pmid12080089_154-0\"><a href=\"#cite_note-pmid12080089-154\">[154]</a></sup></li>\n",
              "<li><a href=\"/wiki/CHEK2\" title=\"CHEK2\">CHEK2</a><sup class=\"reference\" id=\"cite_ref-pmid10724175_155-0\"><a href=\"#cite_note-pmid10724175-155\">[155]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid18804494_156-0\"><a href=\"#cite_note-pmid18804494-156\">[156]</a></sup></li>\n",
              "<li><a href=\"/wiki/CLSPN\" title=\"CLSPN\">CLSPN</a><sup class=\"reference\" id=\"cite_ref-pmid15096610_157-0\"><a href=\"#cite_note-pmid15096610-157\">[157]</a></sup></li>\n",
              "<li><a href=\"/wiki/Cofactor_of_BRCA1\" title=\"Cofactor of BRCA1\">COBRA1</a><sup class=\"reference\" id=\"cite_ref-pmid11739404_158-0\"><a href=\"#cite_note-pmid11739404-158\">[158]</a></sup></li>\n",
              "<li><a href=\"/wiki/CREB-binding_protein\" title=\"CREB-binding protein\">CREBBP</a><sup class=\"reference\" id=\"cite_ref-pmid12700228_159-0\"><a href=\"#cite_note-pmid12700228-159\">[159]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10655477_160-0\"><a href=\"#cite_note-pmid10655477-160\">[160]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9926942_161-0\"><a href=\"#cite_note-pmid9926942-161\">[161]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11782371_162-0\"><a href=\"#cite_note-pmid11782371-162\">[162]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9443979_163-0\"><a href=\"#cite_note-pmid9443979-163\">[163]</a></sup></li>\n",
              "<li><a href=\"/wiki/CSNK2B\" title=\"CSNK2B\">CSNK2B</a><sup class=\"reference\" id=\"cite_ref-pmid10403822_164-0\"><a href=\"#cite_note-pmid10403822-164\">[164]</a></sup></li>\n",
              "<li><a href=\"/wiki/CSTF2\" title=\"CSTF2\">CSTF2</a><sup class=\"reference\" id=\"cite_ref-pmid11257228_165-0\"><a href=\"#cite_note-pmid11257228-165\">[165]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10477523_166-0\"><a href=\"#cite_note-pmid10477523-166\">[166]</a></sup></li>\n",
              "<li><a href=\"/wiki/Cyclin-dependent_kinase_2\" title=\"Cyclin-dependent kinase 2\">CDK2</a><sup class=\"reference\" id=\"cite_ref-pmid9244350_167-0\"><a href=\"#cite_note-pmid9244350-167\">[167]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid8764100_168-0\"><a href=\"#cite_note-pmid8764100-168\">[168]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10373534_169-0\"><a href=\"#cite_note-pmid10373534-169\">[169]</a></sup></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/DHX9\" title=\"DHX9\">DHX9</a><sup class=\"reference\" id=\"cite_ref-pmid12592385_170-0\"><a href=\"#cite_note-pmid12592385-170\">[170]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9662397_171-0\"><a href=\"#cite_note-pmid9662397-171\">[171]</a></sup></li>\n",
              "<li><a href=\"/wiki/ELK4\" title=\"ELK4\">ELK4</a><sup class=\"reference\" id=\"cite_ref-pmid11313879_172-0\"><a href=\"#cite_note-pmid11313879-172\">[172]</a></sup></li>\n",
              "<li><a href=\"/wiki/EP300\" title=\"EP300\">EP300</a><sup class=\"reference\" id=\"cite_ref-pmid10655477_160-1\"><a href=\"#cite_note-pmid10655477-160\">[160]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11782371_162-1\"><a href=\"#cite_note-pmid11782371-162\">[162]</a></sup></li>\n",
              "<li><a href=\"/wiki/Estrogen_receptor_alpha\" title=\"Estrogen receptor alpha\">ESR1</a><sup class=\"reference\" id=\"cite_ref-pmid11782371_162-2\"><a href=\"#cite_note-pmid11782371-162\">[162]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11493692_173-0\"><a href=\"#cite_note-pmid11493692-173\">[173]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11244506_174-0\"><a href=\"#cite_note-pmid11244506-174\">[174]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12400015_175-0\"><a href=\"#cite_note-pmid12400015-175\">[175]</a></sup></li>\n",
              "<li><a href=\"/wiki/FANCA\" title=\"FANCA\">FANCA</a><sup class=\"reference\" id=\"cite_ref-pmid12354784_176-0\"><a href=\"#cite_note-pmid12354784-176\">[176]</a></sup></li>\n",
              "<li><a href=\"/wiki/FANCD2\" title=\"FANCD2\">FANCD2</a><sup class=\"reference\" id=\"cite_ref-pmid12887909_177-0\"><a href=\"#cite_note-pmid12887909-177\">[177]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14499622_147-1\"><a href=\"#cite_note-pmid14499622-147\">[147]</a></sup></li>\n",
              "<li><a href=\"/wiki/FHL2\" title=\"FHL2\">FHL2</a><sup class=\"reference\" id=\"cite_ref-pmid14550570_178-0\"><a href=\"#cite_note-pmid14550570-178\">[178]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14986435_179-0\"><a href=\"#cite_note-pmid14986435-179\">[179]</a></sup></li>\n",
              "<li><a href=\"/wiki/H2AFX\" title=\"H2AFX\">H2AFX</a><sup class=\"reference\" id=\"cite_ref-pmid12485996_180-0\"><a href=\"#cite_note-pmid12485996-180\">[180]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11927591_181-0\"><a href=\"#cite_note-pmid11927591-181\">[181]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10959836_182-0\"><a href=\"#cite_note-pmid10959836-182\">[182]</a></sup></li>\n",
              "<li><a href=\"/wiki/JUNB\" title=\"JUNB\">JUNB</a><sup class=\"reference\" id=\"cite_ref-pmid12080089_154-1\"><a href=\"#cite_note-pmid12080089-154\">[154]</a></sup></li>\n",
              "<li><a href=\"/wiki/JunD\" title=\"JunD\">JunD</a><sup class=\"reference\" id=\"cite_ref-pmid12080089_154-2\"><a href=\"#cite_note-pmid12080089-154\">[154]</a></sup></li>\n",
              "<li><a href=\"/wiki/LMO4\" title=\"LMO4\">LMO4</a><sup class=\"reference\" id=\"cite_ref-pmid12925972_183-0\"><a href=\"#cite_note-pmid12925972-183\">[183]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11751867_184-0\"><a href=\"#cite_note-pmid11751867-184\">[184]</a></sup></li>\n",
              "<li><a href=\"/wiki/MAP3K3\" title=\"MAP3K3\">MAP3K3</a><sup class=\"reference\" id=\"cite_ref-pmid15205325_185-0\"><a href=\"#cite_note-pmid15205325-185\">[185]</a></sup></li>\n",
              "<li><a href=\"/wiki/MED1\" title=\"MED1\">MED1</a><sup class=\"reference\" id=\"cite_ref-pmid15208681_150-1\"><a href=\"#cite_note-pmid15208681-150\">[150]</a></sup></li>\n",
              "<li><a href=\"/wiki/MED17\" title=\"MED17\">MED17</a><sup class=\"reference\" id=\"cite_ref-pmid11504724_186-0\"><a href=\"#cite_note-pmid11504724-186\">[186]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid15208681_150-2\"><a href=\"#cite_note-pmid15208681-150\">[150]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12154023_187-0\"><a href=\"#cite_note-pmid12154023-187\">[187]</a></sup></li>\n",
              "<li><a href=\"/wiki/MED21\" title=\"MED21\">MED21</a><sup class=\"reference\" id=\"cite_ref-pmid9159119_188-0\"><a href=\"#cite_note-pmid9159119-188\">[188]</a></sup></li>\n",
              "<li><a href=\"/wiki/MED24\" title=\"MED24\">MED24</a><sup class=\"reference\" id=\"cite_ref-pmid15208681_150-3\"><a href=\"#cite_note-pmid15208681-150\">[150]</a></sup></li>\n",
              "<li><a href=\"/wiki/MRE11A\" title=\"MRE11A\">MRE11A</a><sup class=\"reference\" id=\"cite_ref-pmid10783165_16-2\"><a href=\"#cite_note-pmid10783165-16\">[16]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11504724_186-1\"><a href=\"#cite_note-pmid11504724-186\">[186]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10426999_189-0\"><a href=\"#cite_note-pmid10426999-189\">[189]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11353843_190-0\"><a href=\"#cite_note-pmid11353843-190\">[190]</a></sup></li>\n",
              "<li><a href=\"/wiki/MSH2\" title=\"MSH2\">MSH2</a><sup class=\"reference\" id=\"cite_ref-pmid10783165_16-3\"><a href=\"#cite_note-pmid10783165-16\">[16]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11498787_39-2\"><a href=\"#cite_note-pmid11498787-39\">[39]</a></sup></li>\n",
              "<li><a href=\"/wiki/MSH3\" title=\"MSH3\">MSH3</a><sup class=\"reference\" id=\"cite_ref-pmid11498787_39-3\"><a href=\"#cite_note-pmid11498787-39\">[39]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14578343_149-1\"><a href=\"#cite_note-pmid14578343-149\">[149]</a></sup></li>\n",
              "<li><a href=\"/wiki/MSH6\" title=\"MSH6\">MSH6</a><sup class=\"reference\" id=\"cite_ref-pmid10783165_16-4\"><a href=\"#cite_note-pmid10783165-16\">[16]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11498787_39-4\"><a href=\"#cite_note-pmid11498787-39\">[39]</a></sup></li>\n",
              "<li><a href=\"/wiki/Myc\" title=\"Myc\">Myc</a><sup class=\"reference\" id=\"cite_ref-pmid9788437_43-2\"><a href=\"#cite_note-pmid9788437-43\">[43]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11916966_191-0\"><a href=\"#cite_note-pmid11916966-191\">[191]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14612409_192-0\"><a href=\"#cite_note-pmid14612409-192\">[192]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12646176_193-0\"><a href=\"#cite_note-pmid12646176-193\">[193]</a></sup></li>\n",
              "<li><a href=\"/wiki/Nibrin\" title=\"Nibrin\">NBN</a><sup class=\"reference\" id=\"cite_ref-pmid10783165_16-5\"><a href=\"#cite_note-pmid10783165-16\">[16]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11504724_186-2\"><a href=\"#cite_note-pmid11504724-186\">[186]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10426999_189-1\"><a href=\"#cite_note-pmid10426999-189\">[189]</a></sup></li>\n",
              "<li><a href=\"/wiki/N-myc-interactor\" title=\"N-myc-interactor\">NMI</a><sup class=\"reference\" id=\"cite_ref-pmid11916966_191-1\"><a href=\"#cite_note-pmid11916966-191\">[191]</a></sup></li>\n",
              "<li><a href=\"/wiki/NPM1\" title=\"NPM1\">NPM1</a><sup class=\"reference\" id=\"cite_ref-pmid15184379_194-0\"><a href=\"#cite_note-pmid15184379-194\">[194]</a></sup></li>\n",
              "<li><a href=\"/wiki/Nuclear_receptor_coactivator_2\" title=\"Nuclear receptor coactivator 2\">NCOA2</a><sup class=\"reference\" id=\"cite_ref-pmid14578343_149-2\"><a href=\"#cite_note-pmid14578343-149\">[149]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11085509_195-0\"><a href=\"#cite_note-pmid11085509-195\">[195]</a></sup></li>\n",
              "<li><a href=\"/wiki/NUFIP1\" title=\"NUFIP1\">NUFIP1</a><sup class=\"reference\" id=\"cite_ref-pmid15107825_196-0\"><a href=\"#cite_note-pmid15107825-196\">[196]</a></sup></li>\n",
              "<li><a href=\"/wiki/P53\" title=\"P53\">P53</a><sup class=\"reference\" id=\"cite_ref-pmid14636569_145-3\"><a href=\"#cite_note-pmid14636569-145\">[145]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9926942_161-1\"><a href=\"#cite_note-pmid9926942-161\">[161]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14710355_197-0\"><a href=\"#cite_note-pmid14710355-197\">[197]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9482880_198-0\"><a href=\"#cite_note-pmid9482880-198\">[198]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9582019_199-0\"><a href=\"#cite_note-pmid9582019-199\">[199]</a></sup></li>\n",
              "<li><a href=\"/wiki/PALB2\" title=\"PALB2\">PALB2</a><sup class=\"reference\" id=\"cite_ref-pmid19369211_200-0\"><a href=\"#cite_note-pmid19369211-200\">[200]</a></sup></li>\n",
              "<li><a href=\"/wiki/POLR2A\" title=\"POLR2A\">POLR2A</a><sup class=\"reference\" id=\"cite_ref-pmid11504724_186-3\"><a href=\"#cite_note-pmid11504724-186\">[186]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9159119_188-1\"><a href=\"#cite_note-pmid9159119-188\">[188]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14506230_201-0\"><a href=\"#cite_note-pmid14506230-201\">[201]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12955082_202-0\"><a href=\"#cite_note-pmid12955082-202\">[202]</a></sup></li>\n",
              "<li><a href=\"/wiki/PPP1CA\" title=\"PPP1CA\">PPP1CA</a><sup class=\"reference\" id=\"cite_ref-pmid12438214_203-0\"><a href=\"#cite_note-pmid12438214-203\">[203]</a></sup></li>\n",
              "<li><a href=\"/wiki/Rad50\" title=\"Rad50\">Rad50</a><sup class=\"reference\" id=\"cite_ref-pmid10783165_16-6\"><a href=\"#cite_note-pmid10783165-16\">[16]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11504724_186-4\"><a href=\"#cite_note-pmid11504724-186\">[186]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10426999_189-2\"><a href=\"#cite_note-pmid10426999-189\">[189]</a></sup></li>\n",
              "<li><a href=\"/wiki/RAD51\" title=\"RAD51\">RAD51</a><sup class=\"reference\" id=\"cite_ref-pmid11498787_39-5\"><a href=\"#cite_note-pmid11498787-39\">[39]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14636569_145-4\"><a href=\"#cite_note-pmid14636569-145\">[145]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9774970_146-1\"><a href=\"#cite_note-pmid9774970-146\">[146]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9008167_204-0\"><a href=\"#cite_note-pmid9008167-204\">[204]</a></sup></li>\n",
              "<li><a href=\"/wiki/RBBP4\" title=\"RBBP4\">RBBP4</a><sup class=\"reference\" id=\"cite_ref-pmid10220405_205-0\"><a href=\"#cite_note-pmid10220405-205\">[205]</a></sup></li>\n",
              "<li><a href=\"/wiki/RBBP7\" title=\"RBBP7\">RBBP7</a><sup class=\"reference\" id=\"cite_ref-pmid10220405_205-1\"><a href=\"#cite_note-pmid10220405-205\">[205]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11394910_206-0\"><a href=\"#cite_note-pmid11394910-206\">[206]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11746496_207-0\"><a href=\"#cite_note-pmid11746496-207\">[207]</a></sup></li>\n",
              "<li><a href=\"/wiki/RBBP8\" title=\"RBBP8\">RBBP8</a><sup class=\"reference\" id=\"cite_ref-pmid9738006_208-0\"><a href=\"#cite_note-pmid9738006-208\">[208]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14578343_149-3\"><a href=\"#cite_note-pmid14578343-149\">[149]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10196224_209-0\"><a href=\"#cite_note-pmid10196224-209\">[209]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid9811458_210-0\"><a href=\"#cite_note-pmid9811458-210\">[210]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10910365_211-0\"><a href=\"#cite_note-pmid10910365-211\">[211]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11689934_212-0\"><a href=\"#cite_note-pmid11689934-212\">[212]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10764811_213-0\"><a href=\"#cite_note-pmid10764811-213\">[213]</a></sup></li>\n",
              "<li><a href=\"/wiki/RELA\" title=\"RELA\">RELA</a><sup class=\"reference\" id=\"cite_ref-pmid12700228_159-1\"><a href=\"#cite_note-pmid12700228-159\">[159]</a></sup></li>\n",
              "<li><a href=\"/wiki/Retinoblastoma_protein\" title=\"Retinoblastoma protein\">RB1</a><sup class=\"reference\" id=\"cite_ref-pmid10220405_205-2\"><a href=\"#cite_note-pmid10220405-205\">[205]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11521194_214-0\"><a href=\"#cite_note-pmid11521194-214\">[214]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid10518542_215-0\"><a href=\"#cite_note-pmid10518542-215\">[215]</a></sup></li>\n",
              "<li><a href=\"/wiki/Retinoblastoma-like_protein_1\" title=\"Retinoblastoma-like protein 1\">RBL1</a><sup class=\"reference\" id=\"cite_ref-pmid11521194_214-1\"><a href=\"#cite_note-pmid11521194-214\">[214]</a></sup></li>\n",
              "<li><a href=\"/wiki/Retinoblastoma-like_protein_2\" title=\"Retinoblastoma-like protein 2\">RBL2</a><sup class=\"reference\" id=\"cite_ref-pmid11521194_214-2\"><a href=\"#cite_note-pmid11521194-214\">[214]</a></sup></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/RPL31\" title=\"RPL31\">RPL31</a><sup class=\"reference\" id=\"cite_ref-pmid11746496_207-1\"><a href=\"#cite_note-pmid11746496-207\">[207]</a></sup></li>\n",
              "<li><a href=\"/wiki/SMARCA4\" title=\"SMARCA4\">SMARCA4</a><sup class=\"reference\" id=\"cite_ref-pmid10943845_216-0\"><a href=\"#cite_note-pmid10943845-216\">[216]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid15034933_217-0\"><a href=\"#cite_note-pmid15034933-217\">[217]</a></sup></li>\n",
              "<li><a href=\"/wiki/SMARCB1\" title=\"SMARCB1\">SMARCB1</a><sup class=\"reference\" id=\"cite_ref-pmid10943845_216-1\"><a href=\"#cite_note-pmid10943845-216\">[216]</a></sup></li>\n",
              "<li><a href=\"/wiki/STAT1\" title=\"STAT1\">STAT1</a><sup class=\"reference\" id=\"cite_ref-pmid10792030_218-0\"><a href=\"#cite_note-pmid10792030-218\">[218]</a></sup></li>\n",
              "<li><a href=\"/wiki/TOPBP1\" title=\"TOPBP1\">TOPBP1</a><sup class=\"reference\" id=\"cite_ref-isbn978-90-481-3471-7_219-0\"><a href=\"#cite_note-isbn978-90-481-3471-7-219\">[219]</a></sup></li>\n",
              "<li><a href=\"/wiki/UBE2D1\" title=\"UBE2D1\">UBE2D1</a><sup class=\"reference\" id=\"cite_ref-pmid12485996_180-1\"><a href=\"#cite_note-pmid12485996-180\">[180]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12732733_220-0\"><a href=\"#cite_note-pmid12732733-220\">[220]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14638690_221-0\"><a href=\"#cite_note-pmid14638690-221\">[221]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12438698_222-0\"><a href=\"#cite_note-pmid12438698-222\">[222]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11927591_181-1\"><a href=\"#cite_note-pmid11927591-181\">[181]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid14636569_145-5\"><a href=\"#cite_note-pmid14636569-145\">[145]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid15184379_194-1\"><a href=\"#cite_note-pmid15184379-194\">[194]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12887909_177-1\"><a href=\"#cite_note-pmid12887909-177\">[177]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12890688_223-0\"><a href=\"#cite_note-pmid12890688-223\">[223]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid11278247_224-0\"><a href=\"#cite_note-pmid11278247-224\">[224]</a></sup></li>\n",
              "<li><a href=\"/wiki/USF2\" title=\"USF2\">USF2</a><sup class=\"reference\" id=\"cite_ref-pmid14502648_225-0\"><a href=\"#cite_note-pmid14502648-225\">[225]</a></sup></li>\n",
              "<li><a href=\"/wiki/Valosin-containing_protein\" title=\"Valosin-containing protein\">VCP</a><sup class=\"reference\" id=\"cite_ref-pmid10855792_226-0\"><a href=\"#cite_note-pmid10855792-226\">[226]</a></sup></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/XIST_(gene)\" title=\"XIST (gene)\">XIST</a><sup class=\"reference\" id=\"cite_ref-pmid15065664_227-0\"><a href=\"#cite_note-pmid15065664-227\">[227]</a></sup><sup class=\"reference\" id=\"cite_ref-pmid12419249_228-0\"><a href=\"#cite_note-pmid12419249-228\">[228]</a></sup></li>\n",
              "<li><a href=\"/wiki/ZNF350\" title=\"ZNF350\">ZNF350</a><sup class=\"reference\" id=\"cite_ref-pmid11090615_229-0\"><a href=\"#cite_note-pmid11090615-229\">[229]</a></sup></li></ul>\n",
              "</div>\n",
              "<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=21\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<style data-mw-deduplicate=\"TemplateStyles:r1011085734\">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class=\"reflist reflist-columns references-column-width\" style=\"column-width: 30em;\">\n",
              "<ol class=\"references\">\n",
              "<li id=\"cite_note-refGRCh38Ensembl-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-refGRCh38Ensembl_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-refGRCh38Ensembl_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-refGRCh38Ensembl_1-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a class=\"external text\" href=\"http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000012048\" rel=\"nofollow\">GRCh38: Ensembl release 89: ENSG00000012048</a> - <a href=\"/wiki/Ensembl_genome_database_project\" title=\"Ensembl genome database project\">Ensembl</a>, May 2017</span>\n",
              "</li>\n",
              "<li id=\"cite_note-refGRCm38Ensembl-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-refGRCm38Ensembl_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-refGRCm38Ensembl_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-refGRCm38Ensembl_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a class=\"external text\" href=\"http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000017146\" rel=\"nofollow\">GRCm38: Ensembl release 89: ENSMUSG00000017146</a> - <a href=\"/wiki/Ensembl_genome_database_project\" title=\"Ensembl genome database project\">Ensembl</a>, May 2017</span>\n",
              "</li>\n",
              "<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><style data-mw-deduplicate=\"TemplateStyles:r1133582631\">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:\"\\\"\"\"\\\"\"\"'\"\"'\"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url(\"//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url(\"//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url(\"//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url(\"//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg\")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=Link&amp;LinkName=gene_pubmed&amp;from_uid=672\" rel=\"nofollow\">\"Human PubMed Reference:\"</a>. <i>National Center for Biotechnology Information, U.S. National Library of Medicine</i>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Center+for+Biotechnology+Information%2C+U.S.+National+Library+of+Medicine&amp;rft.atitle=Human+PubMed+Reference%3A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3Fdb%3Dgene%26cmd%3DLink%26LinkName%3Dgene_pubmed%26from_uid%3D672&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=Link&amp;LinkName=gene_pubmed&amp;from_uid=12189\" rel=\"nofollow\">\"Mouse PubMed Reference:\"</a>. <i>National Center for Biotechnology Information, U.S. National Library of Medicine</i>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Center+for+Biotechnology+Information%2C+U.S.+National+Library+of+Medicine&amp;rft.atitle=Mouse+PubMed+Reference%3A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3Fdb%3Dgene%26cmd%3DLink%26LinkName%3Dgene_pubmed%26from_uid%3D12189&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\" id=\"CITEREFHamel2007\">Hamel PJ (2007-05-29). <a class=\"external text\" href=\"http://www.healthcentral.com/breast-cancer/c/78/9925/brca1-brca2\" rel=\"nofollow\">\"BRCA1 and BRCA2: No Longer the Only Troublesome Genes Out There\"</a>. HealthCentral<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-07-02</span></span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BRCA1+and+BRCA2%3A+No+Longer+the+Only+Troublesome+Genes+Out+There&amp;rft.pub=HealthCentral&amp;rft.date=2007-05-29&amp;rft.aulast=Hamel&amp;rft.aufirst=PJ&amp;rft_id=http%3A%2F%2Fwww.healthcentral.com%2Fbreast-cancer%2Fc%2F78%2F9925%2Fbrca1-brca2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Ensembl-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ensembl_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ensembl_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.ensembl.org/Multi/GeneTree/Image?gt=ENSGT00440000034289\" rel=\"nofollow\">\"BRCA1 gene tree\"</a>. Ensembl.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BRCA1+gene+tree&amp;rft.pub=Ensembl&amp;rft_id=http%3A%2F%2Fwww.ensembl.org%2FMulti%2FGeneTree%2FImage%3Fgt%3DENSGT00440000034289&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10193517-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10193517_7-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFDuncanReevesCooke1998\">Duncan JA, Reeves JR, Cooke TG (October 1998). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC395646\" rel=\"nofollow\">\"BRCA1 and BRCA2 proteins: roles in health and disease\"</a>. <i>Molecular Pathology</i>. <b>51</b> (5): 237–47. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1136%2Fmp.51.5.237\" rel=\"nofollow\">10.1136/mp.51.5.237</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC395646\" rel=\"nofollow\">395646</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10193517\" rel=\"nofollow\">10193517</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Pathology&amp;rft.atitle=BRCA1+and+BRCA2+proteins%3A+roles+in+health+and+disease&amp;rft.volume=51&amp;rft.issue=5&amp;rft.pages=237-47&amp;rft.date=1998-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC395646%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10193517&amp;rft_id=info%3Adoi%2F10.1136%2Fmp.51.5.237&amp;rft.aulast=Duncan&amp;rft.aufirst=JA&amp;rft.au=Reeves%2C+JR&amp;rft.au=Cooke%2C+TG&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC395646&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15546503-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15546503_8-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYoshidaMiki2004\">Yoshida K, Miki Y (November 2004). <a class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1349-7006.2004.tb02195.x\" rel=\"nofollow\">\"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage\"</a>. <i>Cancer Science</i>. <b>95</b> (11): 866–71. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1349-7006.2004.tb02195.x\" rel=\"nofollow\">10.1111/j.1349-7006.2004.tb02195.x</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15546503\" rel=\"nofollow\">15546503</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:24297965\" rel=\"nofollow\">24297965</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Science&amp;rft.atitle=Role+of+BRCA1+and+BRCA2+as+regulators+of+DNA+repair%2C+transcription%2C+and+cell+cycle+in+response+to+DNA+damage&amp;rft.volume=95&amp;rft.issue=11&amp;rft.pages=866-71&amp;rft.date=2004-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24297965%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15546503&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1349-7006.2004.tb02195.x&amp;rft.aulast=Yoshida&amp;rft.aufirst=K&amp;rft.au=Miki%2C+Y&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fj.1349-7006.2004.tb02195.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-CAP-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-CAP_9-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\" id=\"CITEREFCheck2006\">Check W (2006-09-01). <a class=\"external text\" href=\"http://www.cap.org/apps/cap.portal?_nfpb=true&amp;cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&amp;_windowLabel=cntvwrPtlt&amp;cntvwrPtlt{actionForm.contentReference}=cap_today%2Ffeature_stories%2F0906BRCA.html&amp;_state=maximized&amp;_pageLabel=cntvwr\" rel=\"nofollow\">\"BRCA: What we know now\"</a>. College of American Pathologists<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-08-23</span></span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BRCA%3A+What+we+know+now&amp;rft.pub=College+of+American+Pathologists&amp;rft.date=2006-09-01&amp;rft.aulast=Check&amp;rft.aufirst=W&amp;rft_id=http%3A%2F%2Fwww.cap.org%2Fapps%2Fcap.portal%3F_nfpb%3Dtrue%26cntvwrPtlt_actionOverride%3D%252Fportlets%252FcontentViewer%252Fshow%26_windowLabel%3DcntvwrPtlt%26cntvwrPtlt%7BactionForm.contentReference%7D%3Dcap_today%252Ffeature_stories%252F0906BRCA.html%26_state%3Dmaximized%26_pageLabel%3Dcntvwr&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Irminger-Finger_2016-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Irminger-Finger_2016_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Irminger-Finger_2016_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFIrminger-FingerRatajskaPilyugin2016\">Irminger-Finger I, Ratajska M, Pilyugin M (2016). <a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.biocel.2015.12.008\" rel=\"nofollow\">\"New concepts on BARD1: Regulator of BRCA pathways and beyond\"</a>. <i>The International Journal of Biochemistry &amp; Cell Biology</i>. <b>72</b>: 1–17. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.biocel.2015.12.008\" rel=\"nofollow\">10.1016/j.biocel.2015.12.008</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/26738429\" rel=\"nofollow\">26738429</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+International+Journal+of+Biochemistry+%26+Cell+Biology&amp;rft.atitle=New+concepts+on+BARD1%3A+Regulator+of+BRCA+pathways+and+beyond&amp;rft.volume=72&amp;rft.pages=1-17&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.1016%2Fj.biocel.2015.12.008&amp;rft_id=info%3Apmid%2F26738429&amp;rft.aulast=Irminger-Finger&amp;rft.aufirst=I&amp;rft.au=Ratajska%2C+M&amp;rft.au=Pilyugin%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.biocel.2015.12.008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Friedenson2007-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Friedenson2007_11-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFFriedenson2007\">Friedenson B (August 2007). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959234\" rel=\"nofollow\">\"The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers\"</a>. <i>BMC Cancer</i>. <b>7</b>: 152–162. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1186%2F1471-2407-7-152\" rel=\"nofollow\">10.1186/1471-2407-7-152</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959234\" rel=\"nofollow\">1959234</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17683622\" rel=\"nofollow\">17683622</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Cancer&amp;rft.atitle=The+BRCA1%2F2+pathway+prevents+hematologic+cancers+in+addition+to+breast+and+ovarian+cancers&amp;rft.volume=7&amp;rft.pages=152-162&amp;rft.date=2007-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1959234%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17683622&amp;rft_id=info%3Adoi%2F10.1186%2F1471-2407-7-152&amp;rft.aulast=Friedenson&amp;rft.aufirst=B&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1959234&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-scivee.tv-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-scivee.tv_12-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\" id=\"CITEREFFriedenson2008\">Friedenson B (2008-06-08). <a class=\"external text\" href=\"http://www.scivee.tv/node/6090\" rel=\"nofollow\">\"Breast cancer genes protect against some leukemias and lymphomas\"</a> <span class=\"cs1-format\">(video)</span>. SciVee.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Breast+cancer+genes+protect+against+some+leukemias+and+lymphomas&amp;rft.pub=SciVee&amp;rft.date=2008-06-08&amp;rft.aulast=Friedenson&amp;rft.aufirst=B&amp;rft_id=http%3A%2F%2Fwww.scivee.tv%2Fnode%2F6090&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-urlBreast_and_Ovarian_Cancer_Genetic_Screening-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlBreast_and_Ovarian_Cancer_Genetic_Screening_13-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.pamf.org/health/guidelines/geneticscreening.html\" rel=\"nofollow\">\"Breast and Ovarian Cancer Genetic Screening\"</a>. Palo Alto Medical Foundation. <a class=\"external text\" href=\"https://web.archive.org/web/20081004080235/http://www.pamf.org/health/guidelines/geneticscreening.html\" rel=\"nofollow\">Archived</a> from the original on 4 October 2008<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-10-11</span></span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Breast+and+Ovarian+Cancer+Genetic+Screening&amp;rft.pub=Palo+Alto+Medical+Foundation&amp;rft_id=http%3A%2F%2Fwww.pamf.org%2Fhealth%2Fguidelines%2Fgeneticscreening.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid17683622-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid17683622_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid17683622_14-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid17683622_14-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFFriedenson2007\">Friedenson B (2007). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959234\" rel=\"nofollow\">\"The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers\"</a>. <i>BMC Cancer</i>. <b>7</b>: 152. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1186%2F1471-2407-7-152\" rel=\"nofollow\">10.1186/1471-2407-7-152</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959234\" rel=\"nofollow\">1959234</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17683622\" rel=\"nofollow\">17683622</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Cancer&amp;rft.atitle=The+BRCA1%2F2+pathway+prevents+hematologic+cancers+in+addition+to+breast+and+ovarian+cancers&amp;rft.volume=7&amp;rft.pages=152&amp;rft.date=2007&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1959234%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17683622&amp;rft_id=info%3Adoi%2F10.1186%2F1471-2407-7-152&amp;rft.aulast=Friedenson&amp;rft.aufirst=B&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1959234&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-O'Donovan_2010-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-O'Donovan_2010_15-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFO'DonovanLivingston2010\">O'Donovan PJ, Livingston DM (April 2010). <a class=\"external text\" href=\"https://doi.org/10.1093%2Fcarcin%2Fbgq069\" rel=\"nofollow\">\"BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair\"</a>. <i>Carcinogenesis</i>. <b>31</b> (6): 961–7. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1093%2Fcarcin%2Fbgq069\" rel=\"nofollow\">10.1093/carcin/bgq069</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/20400477\" rel=\"nofollow\">20400477</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Carcinogenesis&amp;rft.atitle=BRCA1+and+BRCA2%3A+breast%2Fovarian+cancer+susceptibility+gene+products+and+participants+in+DNA+double-strand+break+repair&amp;rft.volume=31&amp;rft.issue=6&amp;rft.pages=961-7&amp;rft.date=2010-04&amp;rft_id=info%3Adoi%2F10.1093%2Fcarcin%2Fbgq069&amp;rft_id=info%3Apmid%2F20400477&amp;rft.aulast=O%27Donovan&amp;rft.aufirst=PJ&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fcarcin%252Fbgq069&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10783165-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10783165_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-pmid10783165_16-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWangCortezYazdiNeff2000\">Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J (April 2000). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC316544\" rel=\"nofollow\">\"BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures\"</a>. <i>Genes Dev</i>. <b>14</b> (8): 927–39. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1101%2Fgad.14.8.927\" rel=\"nofollow\">10.1101/gad.14.8.927</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC316544\" rel=\"nofollow\">316544</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10783165\" rel=\"nofollow\">10783165</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes+Dev.&amp;rft.atitle=BASC%2C+a+super+complex+of+BRCA1-associated+proteins+involved+in+the+recognition+and+repair+of+aberrant+DNA+structures&amp;rft.volume=14&amp;rft.issue=8&amp;rft.pages=927-39&amp;rft.date=2000-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC316544%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10783165&amp;rft_id=info%3Adoi%2F10.1101%2Fgad.14.8.927&amp;rft.aulast=Wang&amp;rft.aufirst=Y&amp;rft.au=Cortez%2C+D&amp;rft.au=Yazdi%2C+P&amp;rft.au=Neff%2C+N&amp;rft.au=Elledge%2C+SJ&amp;rft.au=Qin%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC316544&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Starita2003-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Starita2003_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Starita2003_17-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFStaritaParvin2003\">Starita LM, Parvin JD (2003). \"The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair\". <i>Current Opinion in Cell Biology</i>. <b>15</b> (3): 345–350. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS0955-0674%2803%2900042-5\" rel=\"nofollow\">10.1016/S0955-0674(03)00042-5</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12787778\" rel=\"nofollow\">12787778</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Cell+Biology&amp;rft.atitle=The+multiple+nuclear+functions+of+BRCA1%3A+transcription%2C+ubiquitination+and+DNA+repair&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=345-350&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1016%2FS0955-0674%2803%2900042-5&amp;rft_id=info%3Apmid%2F12787778&amp;rft.aulast=Starita&amp;rft.aufirst=LM&amp;rft.au=Parvin%2C+JD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-US_5747282-18\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-US_5747282_18-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-US_5747282_18-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-US_5747282_18-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><style data-mw-deduplicate=\"TemplateStyles:r1041539562\">.mw-parser-output .citation{word-wrap:break-word}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}</style><span class=\"citation patent\" id=\"CITEREFSkolnick_HS,_Goldgar_DE,_Miki_Y,_Swenson_J,_Kamb_A,_Harshman_KD,_Shattuck-Eidens_DM,_Tavtigian_SV,_Wiseman_RW,_Futreal_PA1998\"><a class=\"external text\" href=\"https://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=US5747282\" rel=\"nofollow\">US patent 5747282</a>, Skolnick HS, Goldgar DE, Miki Y, Swenson J, Kamb A, Harshman KD, Shattuck-Eidens DM, Tavtigian SV, Wiseman RW, Futreal PA, \"7Q-linked breast and ovarian cancer susceptibility gene\", issued 1998-05-05,  assigned to Myriad Genetics, Inc., The United States of America as represented by the Secretary of Health and Human Services, and University of Utah Research Foundation</span><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&amp;rft.number=5747282&amp;rft.cc=US&amp;rft.title=7Q-linked+breast+and+ovarian+cancer+susceptibility+gene&amp;rft.inventor=Skolnick+HS%2C+Goldgar+DE%2C+Miki+Y%2C+Swenson+J%2C+Kamb+A%2C+Harshman+KD%2C+Shattuck-Eidens+DM%2C+Tavtigian+SV%2C+Wiseman+RW%2C+Futreal+PA&amp;rft.assignee=Myriad+Genetics%2C+Inc.%2C+The+United+States+of+America+as+represented+by+the+Secretary+of+Health+and+Human+Services%2C&amp;rft.date=1998-05-05&amp;rft.appldate=1995-06-07\"><span style=\"display: none;\"> </span></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-US_5837492-19\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-US_5837492_19-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-US_5837492_19-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1041539562\" rel=\"mw-deduplicated-inline-style\"/><span class=\"citation patent\" id=\"CITEREFTavtigian_SV,_Kamb_A,_Simard_J,_Couch_F,_Rommens_JM,_Weber_BL1998\"><a class=\"external text\" href=\"https://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=US5837492\" rel=\"nofollow\">US patent 5837492</a>, Tavtigian SV, Kamb A, Simard J, Couch F, Rommens JM, Weber BL, \"Chromosome 13-linked breast cancer susceptibility gene\", issued 1998-11-17,  assigned to Myriad Genetics, Inc., Endo Recherche, Inc., HSC Research &amp; Development Limited Partnership, Trustees of the University of Pennsylvania</span><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&amp;rft.number=5837492&amp;rft.cc=US&amp;rft.title=Chromosome+13-linked+breast+cancer+susceptibility+gene&amp;rft.inventor=Tavtigian+SV%2C+Kamb+A%2C+Simard+J%2C+Couch+F%2C+Rommens+JM%2C+Weber+BL&amp;rft.assignee=Myriad+Genetics%2C+Inc.%2C+Endo+Recherche%2C+Inc.%2C+HSC+Research+%26+Development+Limited+Partnership%2C+Trustees+of+the+University+of+Pennsylvania&amp;rft.date=1998-11-17&amp;rft.appldate=1996-04-29\"><span style=\"display: none;\"> </span></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-MyriadInvestorPage-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-MyriadInvestorPage_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-MyriadInvestorPage_20-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a class=\"external text\" href=\"https://investor.myriad.com/index.cfm\" rel=\"nofollow\">Myriad Investor Page—see \"Myriad at a glance\"</a> <a class=\"external text\" href=\"https://web.archive.org/web/20121018224334/http://investor.myriad.com/index.cfm\" rel=\"nofollow\">Archived</a> 2012-10-18 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a> accessed October 2012</span>\n",
              "</li>\n",
              "<li id=\"cite_note-SchwartzNYTimes-21\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SchwartzNYTimes_21-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SchwartzNYTimes_21-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-SchwartzNYTimes_21-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\" id=\"CITEREFSchwartz2009\">Schwartz J (2009-05-12). <a class=\"external text\" href=\"https://www.nytimes.com/2009/05/13/health/13patent.html\" rel=\"nofollow\">\"Cancer Patients Challenge the Patenting of a Gene\"</a>. <i>The New York Times</i>. Health.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Cancer+Patients+Challenge+the+Patenting+of+a+Gene&amp;rft.date=2009-05-12&amp;rft.aulast=Schwartz&amp;rft.aufirst=J&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F05%2F13%2Fhealth%2F13patent.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid2270482-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid2270482_22-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHallLeeNewmanMorrow1990\">Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (December 1990). \"Linkage of early-onset familial breast cancer to chromosome 17q21\". <i>Science</i>. <b>250</b> (4988): 1684–9. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1990Sci...250.1684H\" rel=\"nofollow\">1990Sci...250.1684H</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.2270482\" rel=\"nofollow\">10.1126/science.2270482</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/2270482\" rel=\"nofollow\">2270482</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Linkage+of+early-onset+familial+breast+cancer+to+chromosome+17q21&amp;rft.volume=250&amp;rft.issue=4988&amp;rft.pages=1684-9&amp;rft.date=1990-12&amp;rft_id=info%3Apmid%2F2270482&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.2270482&amp;rft_id=info%3Abibcode%2F1990Sci...250.1684H&amp;rft.aulast=Hall&amp;rft.aufirst=JM&amp;rft.au=Lee%2C+MK&amp;rft.au=Newman%2C+B&amp;rft.au=Morrow%2C+JE&amp;rft.au=Anderson%2C+LA&amp;rft.au=Huey%2C+B&amp;rft.au=King%2C+MC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><a class=\"external text\" href=\"http://scienceblog.cancerresearchuk.org/2012/02/28/high-impact-science-tracking-down-the-brca-genes-part-1/\" rel=\"nofollow\">High-Impact Science: Tracking down the BRCA genes (Part 1)</a> – Cancer Research UK science blog, 2012</span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid7545954-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid7545954_24-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFMikiSwensenShattuck-EidensFutreal1994\">Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W (October 1994). <a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.7545954\" rel=\"nofollow\">\"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1\"</a>. <i>Science</i>. <b>266</b> (5182): 66–71. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1994Sci...266...66M\" rel=\"nofollow\">1994Sci...266...66M</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.7545954\" rel=\"nofollow\">10.1126/science.7545954</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/7545954\" rel=\"nofollow\">7545954</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=A+strong+candidate+for+the+breast+and+ovarian+cancer+susceptibility+gene+BRCA1&amp;rft.volume=266&amp;rft.issue=5182&amp;rft.pages=66-71&amp;rft.date=1994-10&amp;rft_id=info%3Apmid%2F7545954&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.7545954&amp;rft_id=info%3Abibcode%2F1994Sci...266...66M&amp;rft.aulast=Miki&amp;rft.aufirst=Y&amp;rft.au=Swensen%2C+J&amp;rft.au=Shattuck-Eidens%2C+D&amp;rft.au=Futreal%2C+PA&amp;rft.au=Harshman%2C+K&amp;rft.au=Tavtigian%2C+S&amp;rft.au=Liu%2C+Q&amp;rft.au=Cochran%2C+C&amp;rft.au=Bennett%2C+LM&amp;rft.au=Ding%2C+W&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1126%252Fscience.7545954&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\">National Center for Biotechnology Information, U.S. National Library of Medicine  <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/gene/672\" rel=\"nofollow\">EntrezGene reference information for BRCA1 breast cancer 1, early onset (Homo sapiens)</a></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9553742-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9553742_26-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPaterson1998\">Paterson JW (February 1998). <a class=\"external text\" href=\"https://doi.org/10.1155%2F1998%2F298530\" rel=\"nofollow\">\"BRCA1: a review of structure and putative functions\"</a>. <i>Dis. Markers</i>. <b>13</b> (4): 261–74. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1155%2F1998%2F298530\" rel=\"nofollow\">10.1155/1998/298530</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9553742\" rel=\"nofollow\">9553742</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Dis.+Markers&amp;rft.atitle=BRCA1%3A+a+review+of+structure+and+putative+functions&amp;rft.volume=13&amp;rft.issue=4&amp;rft.pages=261-74&amp;rft.date=1998-02&amp;rft_id=info%3Adoi%2F10.1155%2F1998%2F298530&amp;rft_id=info%3Apmid%2F9553742&amp;rft.aulast=Paterson&amp;rft.aufirst=JW&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1155%252F1998%252F298530&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid16108063-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16108063_27-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHenderson2005\">Henderson BR (September 2005). \"Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking\". <i>BioEssays</i>. <b>27</b> (9): 884–93. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1002%2Fbies.20277\" rel=\"nofollow\">10.1002/bies.20277</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/16108063\" rel=\"nofollow\">16108063</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:10138907\" rel=\"nofollow\">10138907</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioEssays&amp;rft.atitle=Regulation+of+BRCA1%2C+BRCA2+and+BARD1+intracellular+trafficking&amp;rft.volume=27&amp;rft.issue=9&amp;rft.pages=884-93&amp;rft.date=2005-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A10138907%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16108063&amp;rft_id=info%3Adoi%2F10.1002%2Fbies.20277&amp;rft.aulast=Henderson&amp;rft.aufirst=BR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><span class=\"plain links\">Universal protein resource accession number <a class=\"external text\" href=\"https://www.uniprot.org/uniprot/P38398\" rel=\"nofollow\">P38398</a> for \"Breast cancer type 1 susceptibility protein\" at <a href=\"/wiki/UniProt\" title=\"UniProt\">UniProt</a>.</span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid22737296-29\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid22737296_29-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid22737296_29-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFClarkRodriguezSnyderHankins2012\">Clark SL, Rodriguez AM, Snyder RR, Hankins GD, Boehning D (April 2012). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380633\" rel=\"nofollow\">\"Structure-Function Of The Tumor Suppressor BRCA1\"</a>. <i>Comput Struct Biotechnol J</i>. <b>1</b> (1): e201204005. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.5936%2Fcsbj.201204005\" rel=\"nofollow\">10.5936/csbj.201204005</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380633\" rel=\"nofollow\">3380633</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22737296\" rel=\"nofollow\">22737296</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Comput+Struct+Biotechnol+J&amp;rft.atitle=Structure-Function+Of+The+Tumor+Suppressor+BRCA1&amp;rft.volume=1&amp;rft.issue=1&amp;rft.pages=e201204005&amp;rft.date=2012-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3380633%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22737296&amp;rft_id=info%3Adoi%2F10.5936%2Fcsbj.201204005&amp;rft.aulast=Clark&amp;rft.aufirst=SL&amp;rft.au=Rodriguez%2C+AM&amp;rft.au=Snyder%2C+RR&amp;rft.au=Hankins%2C+GD&amp;rft.au=Boehning%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3380633&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11573085-30\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11573085_30-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11573085_30-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11573085_30-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid11573085_30-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBrzovicRajagopalHoytKing2001\">Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE (October 2001). \"Structure of a BRCA1-BARD1 heterodimeric RING-RING complex\". <i>Nature Structural &amp; Molecular Biology</i>. <b>8</b> (10): 833–7. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fnsb1001-833\" rel=\"nofollow\">10.1038/nsb1001-833</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11573085\" rel=\"nofollow\">11573085</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:37617901\" rel=\"nofollow\">37617901</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.atitle=Structure+of+a+BRCA1-BARD1+heterodimeric+RING-RING+complex&amp;rft.volume=8&amp;rft.issue=10&amp;rft.pages=833-7&amp;rft.date=2001-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A37617901%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11573085&amp;rft_id=info%3Adoi%2F10.1038%2Fnsb1001-833&amp;rft.aulast=Brzovic&amp;rft.aufirst=PS&amp;rft.au=Rajagopal%2C+P&amp;rft.au=Hoyt%2C+DW&amp;rft.au=King%2C+MC&amp;rft.au=Klevit%2C+RE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11573079-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11573079_31-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBaer2001\">Baer R (October 2001). \"With the ends in sight: images from the BRCA1 tumor suppressor\". <i>Nature Structural &amp; Molecular Biology</i>. <b>8</b> (10): 822–4. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fnsb1001-822\" rel=\"nofollow\">10.1038/nsb1001-822</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11573079\" rel=\"nofollow\">11573079</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:20552445\" rel=\"nofollow\">20552445</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.atitle=With+the+ends+in+sight%3A+images+from+the+BRCA1+tumor+suppressor&amp;rft.volume=8&amp;rft.issue=10&amp;rft.pages=822-4&amp;rft.date=2001-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20552445%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11573079&amp;rft_id=info%3Adoi%2F10.1038%2Fnsb1001-822&amp;rft.aulast=Baer&amp;rft.aufirst=R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Williams_2001-32\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Williams_2001_32-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Williams_2001_32-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWilliamsGreenGlover2001\">Williams RS, Green R, Glover JN (October 2001). \"Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1\". <i>Nature Structural &amp; Molecular Biology</i>. <b>8</b> (10): 838–42. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fnsb1001-838\" rel=\"nofollow\">10.1038/nsb1001-838</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11573086\" rel=\"nofollow\">11573086</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:19275284\" rel=\"nofollow\">19275284</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.atitle=Crystal+structure+of+the+BRCT+repeat+region+from+the+breast+cancer-associated+protein+BRCA1&amp;rft.volume=8&amp;rft.issue=10&amp;rft.pages=838-42&amp;rft.date=2001-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19275284%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11573086&amp;rft_id=info%3Adoi%2F10.1038%2Fnsb1001-838&amp;rft.aulast=Williams&amp;rft.aufirst=RS&amp;rft.au=Green%2C+R&amp;rft.au=Glover%2C+JN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10946236-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10946236_33-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHuytonBatesZhangSternberg2000\">Huyton T, Bates PA, Zhang X, Sternberg MJ, Freemont PS (August 2000). \"The BRCA1 C-terminal domain: structure and function\". <i>Mutat. Res</i>. <b>460</b> (3–4): 319–32. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS0921-8777%2800%2900034-3\" rel=\"nofollow\">10.1016/S0921-8777(00)00034-3</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10946236\" rel=\"nofollow\">10946236</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mutat.+Res.&amp;rft.atitle=The+BRCA1+C-terminal+domain%3A+structure+and+function&amp;rft.volume=460&amp;rft.issue=3%E2%80%934&amp;rft.pages=319-32&amp;rft.date=2000-08&amp;rft_id=info%3Adoi%2F10.1016%2FS0921-8777%2800%2900034-3&amp;rft_id=info%3Apmid%2F10946236&amp;rft.aulast=Huyton&amp;rft.aufirst=T&amp;rft.au=Bates%2C+PA&amp;rft.au=Zhang%2C+X&amp;rft.au=Sternberg%2C+MJ&amp;rft.au=Freemont%2C+PS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11877378-34\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11877378_34-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11877378_34-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFJooJeffreyCantorFinnin2002\">Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP (March 2002). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155350\" rel=\"nofollow\">\"Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure\"</a>. <i>Genes Dev</i>. <b>16</b> (5): 583–93. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1101%2Fgad.959202\" rel=\"nofollow\">10.1101/gad.959202</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155350\" rel=\"nofollow\">155350</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11877378\" rel=\"nofollow\">11877378</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes+Dev.&amp;rft.atitle=Structure+of+the+53BP1+BRCT+region+bound+to+p53+and+its+comparison+to+the+Brca1+BRCT+structure&amp;rft.volume=16&amp;rft.issue=5&amp;rft.pages=583-93&amp;rft.date=2002-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC155350%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11877378&amp;rft_id=info%3Adoi%2F10.1101%2Fgad.959202&amp;rft.aulast=Joo&amp;rft.aufirst=WS&amp;rft.au=Jeffrey%2C+PD&amp;rft.au=Cantor%2C+SB&amp;rft.au=Finnin%2C+MS&amp;rft.au=Livingston%2C+DM&amp;rft.au=Pavletich%2C+NP&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC155350&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Sawyer_2014-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Sawyer_2014_35-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFSawyerTianKahkonenSchwartzentruber2014\">Sawyer SL, Tian L, Kahkonen M, Schwartzentruber J, Kircher M, Majewski J, Dyment DA, Innes AM, Boycott KM, Moreau LA, Moilanen JS, Greenberg RA (2014). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320660\" rel=\"nofollow\">\"Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype\"</a>. <i>Cancer Discov</i>. <b>5</b> (2): 135–42. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1158%2F2159-8290.CD-14-1156\" rel=\"nofollow\">10.1158/2159-8290.CD-14-1156</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320660\" rel=\"nofollow\">4320660</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/25472942\" rel=\"nofollow\">25472942</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Discov&amp;rft.atitle=Biallelic+Mutations+in+BRCA1+Cause+a+New+Fanconi+Anemia+Subtype&amp;rft.volume=5&amp;rft.issue=2&amp;rft.pages=135-42&amp;rft.date=2014&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4320660%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25472942&amp;rft_id=info%3Adoi%2F10.1158%2F2159-8290.CD-14-1156&amp;rft.aulast=Sawyer&amp;rft.aufirst=SL&amp;rft.au=Tian%2C+L&amp;rft.au=Kahkonen%2C+M&amp;rft.au=Schwartzentruber%2C+J&amp;rft.au=Kircher%2C+M&amp;rft.au=Majewski%2C+J&amp;rft.au=Dyment%2C+DA&amp;rft.au=Innes%2C+AM&amp;rft.au=Boycott%2C+KM&amp;rft.au=Moreau%2C+LA&amp;rft.au=Moilanen%2C+JS&amp;rft.au=Greenberg%2C+RA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4320660&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://web.archive.org/web/20180212073520/http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/D/DNArepair.html#DSBs\" rel=\"nofollow\">\"Kimball's Biologh Pages\"</a>. Archived from <a class=\"external text\" href=\"http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/D/DNArepair.html#DSBs\" rel=\"nofollow\">the original</a> on 2018-02-12<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-02-25</span></span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Kimball%27s+Biologh+Pages&amp;rft_id=http%3A%2F%2Fusers.rcn.com%2Fjkimball.ma.ultranet%2FBiologyPages%2FD%2FDNArepair.html%23DSBs&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Domchek_2013-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Domchek_2013_37-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFDomchekTangStopferLilli2013\">Domchek SM, Tang J, Stopfer J, Lilli DR, Hamel N, Tischkowitz M,  et al. (April 2013). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625496\" rel=\"nofollow\">\"Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer\"</a>. <i>Cancer Discovery</i>. <b>3</b> (4): 399–405. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1158%2F2159-8290.CD-12-0421\" rel=\"nofollow\">10.1158/2159-8290.CD-12-0421</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625496\" rel=\"nofollow\">3625496</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/23269703\" rel=\"nofollow\">23269703</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Discovery&amp;rft.atitle=Biallelic+deleterious+BRCA1+mutations+in+a+woman+with+early-onset+ovarian+cancer&amp;rft.volume=3&amp;rft.issue=4&amp;rft.pages=399-405&amp;rft.date=2013-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3625496%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23269703&amp;rft_id=info%3Adoi%2F10.1158%2F2159-8290.CD-12-0421&amp;rft.aulast=Domchek&amp;rft.aufirst=SM&amp;rft.au=Tang%2C+J&amp;rft.au=Stopfer%2C+J&amp;rft.au=Lilli%2C+DR&amp;rft.au=Hamel%2C+N&amp;rft.au=Tischkowitz%2C+M&amp;rft.au=Monteiro%2C+AN&amp;rft.au=Messick%2C+TE&amp;rft.au=Powers%2C+J&amp;rft.au=Yonker%2C+A&amp;rft.au=Couch%2C+FJ&amp;rft.au=Goldgar%2C+DE&amp;rft.au=Davidson%2C+HR&amp;rft.au=Nathanson%2C+KL&amp;rft.au=Foulkes%2C+WD&amp;rft.au=Greenberg%2C+RA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3625496&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid17052168-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17052168_38-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBoulton2006\">Boulton SJ (November 2006). \"Cellular functions of the BRCA tumour-suppressor proteins\". <i>Biochem. Soc. Trans</i>. <b>34</b> (Pt 5): 633–45. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1042%2FBST0340633\" rel=\"nofollow\">10.1042/BST0340633</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17052168\" rel=\"nofollow\">17052168</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochem.+Soc.+Trans.&amp;rft.atitle=Cellular+functions+of+the+BRCA+tumour-suppressor+proteins&amp;rft.volume=34&amp;rft.issue=Pt+5&amp;rft.pages=633-45&amp;rft.date=2006-11&amp;rft_id=info%3Adoi%2F10.1042%2FBST0340633&amp;rft_id=info%3Apmid%2F17052168&amp;rft.aulast=Boulton&amp;rft.aufirst=SJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11498787-39\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11498787_39-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid11498787_39-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWangZhangGuerretteChen2001\">Wang Q, Zhang H, Guerrette S, Chen J, Mazurek A, Wilson T, Slupianek A, Skorski T, Fishel R, Greene MI (August 2001). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204625\" rel=\"nofollow\">\"Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1\"</a>. <i>Oncogene</i>. <b>20</b> (34): 4640–9. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204625\" rel=\"nofollow\">10.1038/sj.onc.1204625</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11498787\" rel=\"nofollow\">11498787</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Adenosine+nucleotide+modulates+the+physical+interaction+between+hMSH2+and+BRCA1&amp;rft.volume=20&amp;rft.issue=34&amp;rft.pages=4640-9&amp;rft.date=2001-08&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1204625&amp;rft_id=info%3Apmid%2F11498787&amp;rft.aulast=Wang&amp;rft.aufirst=Q&amp;rft.au=Zhang%2C+H&amp;rft.au=Guerrette%2C+S&amp;rft.au=Chen%2C+J&amp;rft.au=Mazurek%2C+A&amp;rft.au=Wilson%2C+T&amp;rft.au=Slupianek%2C+A&amp;rft.au=Skorski%2C+T&amp;rft.au=Fishel%2C+R&amp;rft.au=Greene%2C+MI&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1204625&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid22366898-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22366898_40-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWarmoesJaspersPhamPiersma2012\">Warmoes M, Jaspers JE, Pham TV, Piersma SR, Oudgenoeg G, Massink MP, Waisfisz Q, Rottenberg S, Boven E, Jonkers J, Jimenez CR (July 2012). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394939\" rel=\"nofollow\">\"Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer\"</a>. <i>Mol. Cell. Proteomics</i>. <b>11</b> (7): M111.013334-1-M111.013334-19. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1074%2Fmcp.M111.013334\" rel=\"nofollow\">10.1074/mcp.M111.013334</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394939\" rel=\"nofollow\">3394939</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22366898\" rel=\"nofollow\">22366898</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell.+Proteomics&amp;rft.atitle=Proteomics+of+mouse+BRCA1-deficient+mammary+tumors+identifies+DNA+repair+proteins+with+potential+diagnostic+and+prognostic+value+in+human+breast+cancer&amp;rft.volume=11&amp;rft.issue=7&amp;rft.pages=M111.013334-1-M111.013334-19&amp;rft.date=2012-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3394939%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22366898&amp;rft_id=info%3Adoi%2F10.1074%2Fmcp.M111.013334&amp;rft.aulast=Warmoes&amp;rft.aufirst=M&amp;rft.au=Jaspers%2C+JE&amp;rft.au=Pham%2C+TV&amp;rft.au=Piersma%2C+SR&amp;rft.au=Oudgenoeg%2C+G&amp;rft.au=Massink%2C+MP&amp;rft.au=Waisfisz%2C+Q&amp;rft.au=Rottenberg%2C+S&amp;rft.au=Boven%2C+E&amp;rft.au=Jonkers%2C+J&amp;rft.au=Jimenez%2C+CR&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3394939&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid22020440-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22020440_41-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFMeerangRitzPaliwalGarajova2011\">Meerang M, Ritz D, Paliwal S, Garajova Z, Bosshard M, Mailand N, Janscak P, Hübscher U, Meyer H, Ramadan K (November 2011). \"The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks\". <i>Nat. Cell Biol</i>. <b>13</b> (11): 1376–82. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fncb2367\" rel=\"nofollow\">10.1038/ncb2367</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22020440\" rel=\"nofollow\">22020440</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:22109822\" rel=\"nofollow\">22109822</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Cell+Biol.&amp;rft.atitle=The+ubiquitin-selective+segregase+VCP%2Fp97+orchestrates+the+response+to+DNA+double-strand+breaks&amp;rft.volume=13&amp;rft.issue=11&amp;rft.pages=1376-82&amp;rft.date=2011-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22109822%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22020440&amp;rft_id=info%3Adoi%2F10.1038%2Fncb2367&amp;rft.aulast=Meerang&amp;rft.aufirst=M&amp;rft.au=Ritz%2C+D&amp;rft.au=Paliwal%2C+S&amp;rft.au=Garajova%2C+Z&amp;rft.au=Bosshard%2C+M&amp;rft.au=Mailand%2C+N&amp;rft.au=Janscak%2C+P&amp;rft.au=H%C3%BCbscher%2C+U&amp;rft.au=Meyer%2C+H&amp;rft.au=Ramadan%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFZhangWangKajinoGreene2000\">Zhang H, Wang Q, Kajino K, Greene MI (2000). \"VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells\". <i>DNA Cell Biol</i>. <b>19</b> (5): 253–263. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1089%2F10445490050021168\" rel=\"nofollow\">10.1089/10445490050021168</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10855792\" rel=\"nofollow\">10855792</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=DNA+Cell+Biol&amp;rft.atitle=VCP%2C+a+weak+ATPase+involved+in+multiple+cellular+events%2C+interacts+physically+with+BRCA1+in+the+nucleus+of+living+cells&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=253-263&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1089%2F10445490050021168&amp;rft_id=info%3Apmid%2F10855792&amp;rft.aulast=Zhang&amp;rft.aufirst=H&amp;rft.au=Wang%2C+Q&amp;rft.au=Kajino%2C+K&amp;rft.au=Greene%2C+MI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9788437-43\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9788437_43-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9788437_43-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid9788437_43-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWangZhangKajinoGreene1998\">Wang Q, Zhang H, Kajino K, Greene MI (October 1998). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202403\" rel=\"nofollow\">\"BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells\"</a>. <i>Oncogene</i>. <b>17</b> (15): 1939–48. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202403\" rel=\"nofollow\">10.1038/sj.onc.1202403</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9788437\" rel=\"nofollow\">9788437</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+binds+c-Myc+and+inhibits+its+transcriptional+and+transforming+activity+in+cells&amp;rft.volume=17&amp;rft.issue=15&amp;rft.pages=1939-48&amp;rft.date=1998-10&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1202403&amp;rft_id=info%3Apmid%2F9788437&amp;rft.aulast=Wang&amp;rft.aufirst=Q&amp;rft.au=Zhang%2C+H&amp;rft.au=Kajino%2C+K&amp;rft.au=Greene%2C+MI&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1202403&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Paull2001-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Paull2001_44-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPaullCortezBowersElledge2001\">Paull TT, Cortez D, Bowers B, Elledge SJ, Gellert M (2001). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33426\" rel=\"nofollow\">\"Direct DNA binding by Brca1\"</a>. <i>Proceedings of the National Academy of Sciences</i>. <b>98</b> (11): 6086–6091. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.111125998\" rel=\"nofollow\">10.1073/pnas.111125998</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33426\" rel=\"nofollow\">33426</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11353843\" rel=\"nofollow\">11353843</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.atitle=Direct+DNA+binding+by+Brca1&amp;rft.volume=98&amp;rft.issue=11&amp;rft.pages=6086-6091&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33426%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11353843&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.111125998&amp;rft.aulast=Paull&amp;rft.aufirst=TT&amp;rft.au=Cortez%2C+D&amp;rft.au=Bowers%2C+B&amp;rft.au=Elledge%2C+SJ&amp;rft.au=Gellert%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33426&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Durant2005-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Durant2005_45-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFDurantNickoloff2005\">Durant ST, Nickoloff JA (2005). <a class=\"external text\" href=\"https://doi.org/10.4161%2Fcc.4.9.2027\" rel=\"nofollow\">\"Good timing in the cell cycle for precise DNA repair by BRCA1\"</a>. <i>Cell Cycle</i>. <b>4</b> (9): 1216–22. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.4161%2Fcc.4.9.2027\" rel=\"nofollow\">10.4161/cc.4.9.2027</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/16103751\" rel=\"nofollow\">16103751</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Cycle&amp;rft.atitle=Good+timing+in+the+cell+cycle+for+precise+DNA+repair+by+BRCA1&amp;rft.volume=4&amp;rft.issue=9&amp;rft.pages=1216-22&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.4161%2Fcc.4.9.2027&amp;rft_id=info%3Apmid%2F16103751&amp;rft.aulast=Durant&amp;rft.aufirst=ST&amp;rft.au=Nickoloff%2C+JA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.4161%252Fcc.4.9.2027&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Ye2001-46\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ye2001_46-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ye2001_46-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Ye2001_46-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYeHuZhongNye2001\">Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R (2001). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150890\" rel=\"nofollow\">\"BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations\"</a>. <i>The Journal of Cell Biology</i>. <b>155</b> (6): 911–922. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1083%2Fjcb.200108049\" rel=\"nofollow\">10.1083/jcb.200108049</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150890\" rel=\"nofollow\">2150890</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11739404\" rel=\"nofollow\">11739404</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Cell+Biology&amp;rft.atitle=BRCA1-induced+large-scale+chromatin+unfolding+and+allele-specific+effects+of+cancer-predisposing+mutations&amp;rft.volume=155&amp;rft.issue=6&amp;rft.pages=911-922&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2150890%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11739404&amp;rft_id=info%3Adoi%2F10.1083%2Fjcb.200108049&amp;rft.aulast=Ye&amp;rft.aufirst=Q&amp;rft.au=Hu%2C+YF&amp;rft.au=Zhong%2C+H&amp;rft.au=Nye%2C+AC&amp;rft.au=Belmont%2C+AS&amp;rft.au=Li%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2150890&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Ridpath_2007-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ridpath_2007_47-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFRidpathNakamuraTanoLuke2007\">Ridpath JR, Nakamura A, Tano K, Luke AM, Sonoda E, Arakawa H, Buerstedde JM, Gillespie DA, Sale JE, Yamazoe M, Bishop DK, Takata M, Takeda S, Watanabe M, Swenberg JA, Nakamura J (December 2007). <a class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-07-3028\" rel=\"nofollow\">\"Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde\"</a>. <i>Cancer Res</i>. <b>67</b> (23): 11117–22. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-07-3028\" rel=\"nofollow\">10.1158/0008-5472.CAN-07-3028</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18056434\" rel=\"nofollow\">18056434</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Cells+deficient+in+the+FANC%2FBRCA+pathway+are+hypersensitive+to+plasma+levels+of+formaldehyde&amp;rft.volume=67&amp;rft.issue=23&amp;rft.pages=11117-22&amp;rft.date=2007-12&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-07-3028&amp;rft_id=info%3Apmid%2F18056434&amp;rft.aulast=Ridpath&amp;rft.aufirst=JR&amp;rft.au=Nakamura%2C+A&amp;rft.au=Tano%2C+K&amp;rft.au=Luke%2C+AM&amp;rft.au=Sonoda%2C+E&amp;rft.au=Arakawa%2C+H&amp;rft.au=Buerstedde%2C+JM&amp;rft.au=Gillespie%2C+DA&amp;rft.au=Sale%2C+JE&amp;rft.au=Yamazoe%2C+M&amp;rft.au=Bishop%2C+DK&amp;rft.au=Takata%2C+M&amp;rft.au=Takeda%2C+S&amp;rft.au=Watanabe%2C+M&amp;rft.au=Swenberg%2C+JA&amp;rft.au=Nakamura%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1158%252F0008-5472.CAN-07-3028&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPrakashZhangFengJasin2015\">Prakash R, Zhang Y, Feng W, Jasin M (April 2015). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382744\" rel=\"nofollow\">\"Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins\"</a>. <i>Cold Spring Harbor Perspectives in Biology</i>. <b>7</b> (4): a016600. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1101%2Fcshperspect.a016600\" rel=\"nofollow\">10.1101/cshperspect.a016600</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382744\" rel=\"nofollow\">4382744</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/25833843\" rel=\"nofollow\">25833843</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cold+Spring+Harbor+Perspectives+in+Biology&amp;rft.atitle=Homologous+recombination+and+human+health%3A+the+roles+of+BRCA1%2C+BRCA2%2C+and+associated+proteins&amp;rft.volume=7&amp;rft.issue=4&amp;rft.pages=a016600&amp;rft.date=2015-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4382744%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25833843&amp;rft_id=info%3Adoi%2F10.1101%2Fcshperspect.a016600&amp;rft.aulast=Prakash&amp;rft.aufirst=R&amp;rft.au=Zhang%2C+Y&amp;rft.au=Feng%2C+W&amp;rft.au=Jasin%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4382744&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Scully1997-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Scully1997_49-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFScullyAndersonChaoWei1997\">Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD (1997). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20825\" rel=\"nofollow\">\"BRCA1 is a component of the RNA polymerase II holoenzyme\"</a>. <i>Proceedings of the National Academy of Sciences</i>. <b>94</b> (11): 5605–10. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1997PNAS...94.5605S\" rel=\"nofollow\">1997PNAS...94.5605S</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.94.11.5605\" rel=\"nofollow\">10.1073/pnas.94.11.5605</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20825\" rel=\"nofollow\">20825</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9159119\" rel=\"nofollow\">9159119</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.atitle=BRCA1+is+a+component+of+the+RNA+polymerase+II+holoenzyme&amp;rft.volume=94&amp;rft.issue=11&amp;rft.pages=5605-10&amp;rft.date=1997&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC20825%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9159119&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.94.11.5605&amp;rft_id=info%3Abibcode%2F1997PNAS...94.5605S&amp;rft.aulast=Scully&amp;rft.aufirst=R&amp;rft.au=Anderson%2C+SF&amp;rft.au=Chao%2C+DM&amp;rft.au=Wei%2C+W&amp;rft.au=Ye%2C+L&amp;rft.au=Young%2C+RA&amp;rft.au=Livingston%2C+DM&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC20825&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Bochar2000-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bochar2000_50-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBocharWangBeniyaKinev2000\">Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R (2000). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2900030-1\" rel=\"nofollow\">\"BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer\"</a>. <i>Cell</i>. <b>102</b> (2): 257–265. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2900030-1\" rel=\"nofollow\">10.1016/S0092-8674(00)00030-1</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10943845\" rel=\"nofollow\">10943845</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=BRCA1+Is+Associated+with+a+Human+SWI%2FSNF-Related+Complex+Linking+Chromatin+Remodeling+to+Breast+Cancer&amp;rft.volume=102&amp;rft.issue=2&amp;rft.pages=257-265&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2800%2900030-1&amp;rft_id=info%3Apmid%2F10943845&amp;rft.aulast=Bochar&amp;rft.aufirst=DA&amp;rft.au=Wang%2C+L&amp;rft.au=Beniya%2C+H&amp;rft.au=Kinev%2C+A&amp;rft.au=Xue%2C+Y&amp;rft.au=Lane%2C+WS&amp;rft.au=Wang%2C+W&amp;rft.au=Kashanchi%2C+F&amp;rft.au=Shiekhattar%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252800%252900030-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Petrucelli_2016-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Petrucelli_2016_51-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation book cs1\" id=\"CITEREFPetrucelliDalyPal2016\">Petrucelli N, Daly MB, Pal T (December 2016) [September 1998]. <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK1247/\" rel=\"nofollow\">\"BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer\"</a>.  In Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Mirzaa G, Amemiya A (eds.). <i>GeneReviews</i>. University of Washington, Seattle. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/20301425\" rel=\"nofollow\">20301425</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=BRCA1-+and+BRCA2-Associated+Hereditary+Breast+and+Ovarian+Cancer&amp;rft.btitle=GeneReviews&amp;rft.pub=University+of+Washington%2C+Seattle&amp;rft.date=2016-12&amp;rft_id=info%3Apmid%2F20301425&amp;rft.aulast=Petrucelli&amp;rft.aufirst=N&amp;rft.au=Daly%2C+MB&amp;rft.au=Pal%2C+T&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1247%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-urlGenetics-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlGenetics_52-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.breastcancer.org/risk/factors/genetics\" rel=\"nofollow\">\"Genetics\"</a>. Breastcancer.org. 2012-09-17.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Genetics&amp;rft.pub=Breastcancer.org&amp;rft.date=2012-09-17&amp;rft_id=http%3A%2F%2Fwww.breastcancer.org%2Frisk%2Ffactors%2Fgenetics&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFElstrodtHollestelleNagelGorin2006\">Elstrodt, Fons; Hollestelle, Antoinette; Nagel, Jord H.A.; Gorin, Michael; Wasielewski, Marijke; van den Ouweland, Ans; Merajver, Sofia D.; Ethier, Stephen P.; Schutte, Mieke (2006-01-01). <a class=\"external text\" href=\"https://aacrjournals.org/cancerres/article/66/1/41/525599/BRCA1-Mutation-Analysis-of-41-Human-Breast-Cancer\" rel=\"nofollow\">\"BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants\"</a>. <i>Cancer Research</i>. <b>66</b> (1): 41–45. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-05-2853\" rel=\"nofollow\">10.1158/0008-5472.CAN-05-2853</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"https://www.worldcat.org/issn/0008-5472\" rel=\"nofollow\">0008-5472</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=BRCA1+Mutation+Analysis+of+41+Human+Breast+Cancer+Cell+Lines+Reveals+Three+New+Deleterious+Mutants&amp;rft.volume=66&amp;rft.issue=1&amp;rft.pages=41-45&amp;rft.date=2006-01-01&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-05-2853&amp;rft.issn=0008-5472&amp;rft.aulast=Elstrodt&amp;rft.aufirst=Fons&amp;rft.au=Hollestelle%2C+Antoinette&amp;rft.au=Nagel%2C+Jord+H.A.&amp;rft.au=Gorin%2C+Michael&amp;rft.au=Wasielewski%2C+Marijke&amp;rft.au=van+den+Ouweland%2C+Ans&amp;rft.au=Merajver%2C+Sofia+D.&amp;rft.au=Ethier%2C+Stephen+P.&amp;rft.au=Schutte%2C+Mieke&amp;rft_id=https%3A%2F%2Faacrjournals.org%2Fcancerres%2Farticle%2F66%2F1%2F41%2F525599%2FBRCA1-Mutation-Analysis-of-41-Human-Breast-Cancer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15832305-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15832305_54-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFMazoyer2005\">Mazoyer S (May 2005). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.20169\" rel=\"nofollow\">\"Genomic rearrangements in the BRCA1 and BRCA2 genes\"</a>. <i>Hum. Mutat</i>. <b>25</b> (5): 415–22. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.20169\" rel=\"nofollow\">10.1002/humu.20169</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15832305\" rel=\"nofollow\">15832305</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:32023181\" rel=\"nofollow\">32023181</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=Genomic+rearrangements+in+the+BRCA1+and+BRCA2+genes&amp;rft.volume=25&amp;rft.issue=5&amp;rft.pages=415-22&amp;rft.date=2005-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32023181%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15832305&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.20169&amp;rft.aulast=Mazoyer&amp;rft.aufirst=S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.20169&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14984472-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14984472_55-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBarroisBiècheMazoyerChampème2004\">Barrois M, Bièche I, Mazoyer S, Champème MH, Bressac-de Paillerets B, Lidereau R (February 2004). \"Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families\". <i>Clin. Genet</i>. <b>65</b> (2): 131–6. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1111%2Fj.0009-9163.2004.00200.x\" rel=\"nofollow\">10.1111/j.0009-9163.2004.00200.x</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14984472\" rel=\"nofollow\">14984472</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:11583160\" rel=\"nofollow\">11583160</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Genet.&amp;rft.atitle=Real-time+PCR-based+gene+dosage+assay+for+detecting+BRCA1+rearrangements+in+breast-ovarian+cancer+families&amp;rft.volume=65&amp;rft.issue=2&amp;rft.pages=131-6&amp;rft.date=2004-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A11583160%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14984472&amp;rft_id=info%3Adoi%2F10.1111%2Fj.0009-9163.2004.00200.x&amp;rft.aulast=Barrois&amp;rft.aufirst=M&amp;rft.au=Bi%C3%A8che%2C+I&amp;rft.au=Mazoyer%2C+S&amp;rft.au=Champ%C3%A8me%2C+MH&amp;rft.au=Bressac-de+Paillerets%2C+B&amp;rft.au=Lidereau%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12670888-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12670888_56-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHogervorstNederlofGilleMcElgunn2003\">Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van't Veer LJ, Pals G (April 2003). \"Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method\". <i>Cancer Res</i>. <b>63</b> (7): 1449–53. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12670888\" rel=\"nofollow\">12670888</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Large+genomic+deletions+and+duplications+in+the+BRCA1+gene+identified+by+a+novel+quantitative+method&amp;rft.volume=63&amp;rft.issue=7&amp;rft.pages=1449-53&amp;rft.date=2003-04&amp;rft_id=info%3Apmid%2F12670888&amp;rft.aulast=Hogervorst&amp;rft.aufirst=FB&amp;rft.au=Nederlof%2C+PM&amp;rft.au=Gille%2C+JJ&amp;rft.au=McElgunn%2C+CJ&amp;rft.au=Grippeling%2C+M&amp;rft.au=Pruntel%2C+R&amp;rft.au=Regnerus%2C+R&amp;rft.au=van+Welsem%2C+T&amp;rft.au=van+Spaendonk%2C+R&amp;rft.au=Menko%2C+FH&amp;rft.au=Kluijt%2C+I&amp;rft.au=Dommering%2C+C&amp;rft.au=Verhoef%2C+S&amp;rft.au=Schouten%2C+JP&amp;rft.au=van%27t+Veer%2C+LJ&amp;rft.au=Pals%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12203994-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12203994_57-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFCasilliDi_RoccoGadTournier2002\">Casilli F, Di Rocco ZC, Gad S, Tournier I, Stoppa-Lyonnet D, Frebourg T, Tosi M (September 2002). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.10108\" rel=\"nofollow\">\"Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments\"</a>. <i>Hum. Mutat</i>. <b>20</b> (3): 218–26. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.10108\" rel=\"nofollow\">10.1002/humu.10108</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12203994\" rel=\"nofollow\">12203994</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:24737909\" rel=\"nofollow\">24737909</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=Rapid+detection+of+novel+BRCA1+rearrangements+in+high-risk+breast-ovarian+cancer+families+using+multiplex+PCR+of+short+fluorescent+fragments&amp;rft.volume=20&amp;rft.issue=3&amp;rft.pages=218-26&amp;rft.date=2002-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24737909%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12203994&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.10108&amp;rft.aulast=Casilli&amp;rft.aufirst=F&amp;rft.au=Di+Rocco%2C+ZC&amp;rft.au=Gad%2C+S&amp;rft.au=Tournier%2C+I&amp;rft.au=Stoppa-Lyonnet%2C+D&amp;rft.au=Frebourg%2C+T&amp;rft.au=Tosi%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.10108&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid17718857-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17718857_58-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFRouleauLefolTozluAndrieu2007\">Rouleau E, Lefol C, Tozlu S, Andrieu C, Guy C, Copigny F, Nogues C, Bieche I, Lidereau R (September 2007). \"High-resolution oligonucleotide array-CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1\". <i>Clin. Genet</i>. <b>72</b> (3): 199–207. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1399-0004.2007.00849.x\" rel=\"nofollow\">10.1111/j.1399-0004.2007.00849.x</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17718857\" rel=\"nofollow\">17718857</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:2393567\" rel=\"nofollow\">2393567</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Genet.&amp;rft.atitle=High-resolution+oligonucleotide+array-CGH+applied+to+the+detection+and+characterization+of+large+rearrangements+in+the+hereditary+breast+cancer+gene+BRCA1&amp;rft.volume=72&amp;rft.issue=3&amp;rft.pages=199-207&amp;rft.date=2007-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2393567%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17718857&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1399-0004.2007.00849.x&amp;rft.aulast=Rouleau&amp;rft.aufirst=E&amp;rft.au=Lefol%2C+C&amp;rft.au=Tozlu%2C+S&amp;rft.au=Andrieu%2C+C&amp;rft.au=Guy%2C+C&amp;rft.au=Copigny%2C+F&amp;rft.au=Nogues%2C+C&amp;rft.au=Bieche%2C+I&amp;rft.au=Lidereau%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid18567944-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18567944_59-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFTapiaSmalleyKohenMuñoz2008\">Tapia T, Smalley SV, Kohen P, Muñoz A, Solis LM, Corvalan A, Faundez P, Devoto L, Camus M, Alvarez M, Carvallo P (2008). \"Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors\". <i>Epigenetics</i>. <b>3</b> (3): 157–63. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.4161%2Fepi.3.3.6387\" rel=\"nofollow\">10.4161/epi.3.3.6387</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18567944\" rel=\"nofollow\">18567944</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:35616414\" rel=\"nofollow\">35616414</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Epigenetics&amp;rft.atitle=Promoter+hypermethylation+of+BRCA1+correlates+with+absence+of+expression+in+hereditary+breast+cancer+tumors&amp;rft.volume=3&amp;rft.issue=3&amp;rft.pages=157-63&amp;rft.date=2008&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A35616414%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18567944&amp;rft_id=info%3Adoi%2F10.4161%2Fepi.3.3.6387&amp;rft.aulast=Tapia&amp;rft.aufirst=T&amp;rft.au=Smalley%2C+SV&amp;rft.au=Kohen%2C+P&amp;rft.au=Mu%C3%B1oz%2C+A&amp;rft.au=Solis%2C+LM&amp;rft.au=Corvalan%2C+A&amp;rft.au=Faundez%2C+P&amp;rft.au=Devoto%2C+L&amp;rft.au=Camus%2C+M&amp;rft.au=Alvarez%2C+M&amp;rft.au=Carvallo%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-60\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFShenAmbrosoneZhao2009\">Shen J, Ambrosone CB, Zhao H (March 2009). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.24008\" rel=\"nofollow\">\"Novel genetic variants in microRNA genes and familial breast cancer\"</a>. <i>Int. J. Cancer</i>. <b>124</b> (5): 1178–82. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.24008\" rel=\"nofollow\">10.1002/ijc.24008</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19048628\" rel=\"nofollow\">19048628</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.atitle=Novel+genetic+variants+in+microRNA+genes+and+familial+breast+cancer&amp;rft.volume=124&amp;rft.issue=5&amp;rft.pages=1178-82&amp;rft.date=2009-03&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.24008&amp;rft_id=info%3Apmid%2F19048628&amp;rft.aulast=Shen&amp;rft.aufirst=J&amp;rft.au=Ambrosone%2C+CB&amp;rft.au=Zhao%2C+H&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fijc.24008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Levin2012-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Levin2012_61-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLevinLechFriedenson2012\">Levin B, Lech D, Friedenson B (2012). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521784\" rel=\"nofollow\">\"Evidence that BRCA1- or BRCA2-associated cancers are not inevitable\"</a>. <i>Mol Med</i>. <b>18</b> (9): 1327–37. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.2119%2Fmolmed.2012.00280\" rel=\"nofollow\">10.2119/molmed.2012.00280</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521784\" rel=\"nofollow\">3521784</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22972572\" rel=\"nofollow\">22972572</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol+Med&amp;rft.atitle=Evidence+that+BRCA1-+or+BRCA2-associated+cancers+are+not+inevitable&amp;rft.volume=18&amp;rft.issue=9&amp;rft.pages=1327-37&amp;rft.date=2012&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3521784%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22972572&amp;rft_id=info%3Adoi%2F10.2119%2Fmolmed.2012.00280&amp;rft.aulast=Levin&amp;rft.aufirst=B&amp;rft.au=Lech%2C+D&amp;rft.au=Friedenson%2C+B&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3521784&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9988281-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9988281_62-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWilsonRamosVillaseñorAnders1999\">Wilson CA, Ramos L, Villaseñor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ (1999). \"Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas\". <i>Nat. Genet</i>. <b>21</b> (2): 236–40. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2F6029\" rel=\"nofollow\">10.1038/6029</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9988281\" rel=\"nofollow\">9988281</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:7988460\" rel=\"nofollow\">7988460</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Genet.&amp;rft.atitle=Localization+of+human+BRCA1+and+its+loss+in+high-grade%2C+non-inherited+breast+carcinomas&amp;rft.volume=21&amp;rft.issue=2&amp;rft.pages=236-40&amp;rft.date=1999&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7988460%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9988281&amp;rft_id=info%3Adoi%2F10.1038%2F6029&amp;rft.aulast=Wilson&amp;rft.aufirst=CA&amp;rft.au=Ramos%2C+L&amp;rft.au=Villase%C3%B1or%2C+MR&amp;rft.au=Anders%2C+KH&amp;rft.au=Press%2C+MF&amp;rft.au=Clarke%2C+K&amp;rft.au=Karlan%2C+B&amp;rft.au=Chen%2C+JJ&amp;rft.au=Scully%2C+R&amp;rft.au=Livingston%2C+D&amp;rft.au=Zuch%2C+RH&amp;rft.au=Kanter%2C+MH&amp;rft.au=Cohen%2C+S&amp;rft.au=Calzone%2C+FJ&amp;rft.au=Slamon%2C+DJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12559046-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12559046_63-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFMuellerRoskelley2003\">Mueller CR, Roskelley CD (2003). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154136\" rel=\"nofollow\">\"Regulation of BRCA1 expression and its relationship to sporadic breast cancer\"</a>. <i>Breast Cancer Res</i>. <b>5</b> (1): 45–52. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1186%2Fbcr557\" rel=\"nofollow\">10.1186/bcr557</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154136\" rel=\"nofollow\">154136</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12559046\" rel=\"nofollow\">12559046</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Breast+Cancer+Res.&amp;rft.atitle=Regulation+of+BRCA1+expression+and+its+relationship+to+sporadic+breast+cancer&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=45-52&amp;rft.date=2003&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC154136%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12559046&amp;rft_id=info%3Adoi%2F10.1186%2Fbcr557&amp;rft.aulast=Mueller&amp;rft.aufirst=CR&amp;rft.au=Roskelley%2C+CD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC154136&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Jacinto-64\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Jacinto_64-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Jacinto_64-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFJacintoEsteller2007\">Jacinto FV, Esteller M (2007). <a class=\"external text\" href=\"https://doi.org/10.1093%2Fmutage%2Fgem009\" rel=\"nofollow\">\"Mutator pathways unleashed by epigenetic silencing in human cancer\"</a>. <i>Mutagenesis</i>. <b>22</b> (4): 247–53. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1093%2Fmutage%2Fgem009\" rel=\"nofollow\">10.1093/mutage/gem009</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17412712\" rel=\"nofollow\">17412712</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mutagenesis&amp;rft.atitle=Mutator+pathways+unleashed+by+epigenetic+silencing+in+human+cancer&amp;rft.volume=22&amp;rft.issue=4&amp;rft.pages=247-53&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1093%2Fmutage%2Fgem009&amp;rft_id=info%3Apmid%2F17412712&amp;rft.aulast=Jacinto&amp;rft.aufirst=FV&amp;rft.au=Esteller%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fmutage%252Fgem009&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Sun-65\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sun_65-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sun_65-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Sun_65-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Sun_65-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFSunLiYangZhou2013\">Sun C, Li N, Yang Z, Zhou B, He Y, Weng D, Fang Y, Wu P, Chen P, Yang X, Ma D, Zhou J, Chen G (2013). <a class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2Fdjt302\" rel=\"nofollow\">\"miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition\"</a>. <i>J. Natl. Cancer Inst</i>. <b>105</b> (22): 1750–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2Fdjt302\" rel=\"nofollow\">10.1093/jnci/djt302</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/24168967\" rel=\"nofollow\">24168967</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.atitle=miR-9+regulation+of+BRCA1+and+ovarian+cancer+sensitivity+to+cisplatin+and+PARP+inhibition&amp;rft.volume=105&amp;rft.issue=22&amp;rft.pages=1750-8&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjt302&amp;rft_id=info%3Apmid%2F24168967&amp;rft.aulast=Sun&amp;rft.aufirst=C&amp;rft.au=Li%2C+N&amp;rft.au=Yang%2C+Z&amp;rft.au=Zhou%2C+B&amp;rft.au=He%2C+Y&amp;rft.au=Weng%2C+D&amp;rft.au=Fang%2C+Y&amp;rft.au=Wu%2C+P&amp;rft.au=Chen%2C+P&amp;rft.au=Yang%2C+X&amp;rft.au=Ma%2C+D&amp;rft.au=Zhou%2C+J&amp;rft.au=Chen%2C+G&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fjnci%252Fdjt302&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid22790015-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22790015_66-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFMcMillenAponteLiuHelenowski2012\">McMillen BD, Aponte MM, Liu Z, Helenowski IB, Scholtens DM, Buttin BM, Wei JJ (2012). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fmodpathol.2012.118\" rel=\"nofollow\">\"Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma\"</a>. <i>Mod. Pathol</i>. <b>25</b> (12): 1644–53. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fmodpathol.2012.118\" rel=\"nofollow\">10.1038/modpathol.2012.118</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22790015\" rel=\"nofollow\">22790015</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mod.+Pathol.&amp;rft.atitle=Expression+analysis+of+MIR182+and+its+associated+target+genes+in+advanced+ovarian+carcinoma&amp;rft.volume=25&amp;rft.issue=12&amp;rft.pages=1644-53&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1038%2Fmodpathol.2012.118&amp;rft_id=info%3Apmid%2F22790015&amp;rft.aulast=McMillen&amp;rft.aufirst=BD&amp;rft.au=Aponte%2C+MM&amp;rft.au=Liu%2C+Z&amp;rft.au=Helenowski%2C+IB&amp;rft.au=Scholtens%2C+DM&amp;rft.au=Buttin%2C+BM&amp;rft.au=Wei%2C+JJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fmodpathol.2012.118&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid20944665-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid20944665_67-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBowtell2010\">Bowtell DD (2010). \"The genesis and evolution of high-grade serous ovarian cancer\". <i>Nat. Rev. Cancer</i>. <b>10</b> (11): 803–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fnrc2946\" rel=\"nofollow\">10.1038/nrc2946</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/20944665\" rel=\"nofollow\">20944665</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:22688947\" rel=\"nofollow\">22688947</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Rev.+Cancer&amp;rft.atitle=The+genesis+and+evolution+of+high-grade+serous+ovarian+cancer&amp;rft.volume=10&amp;rft.issue=11&amp;rft.pages=803-8&amp;rft.date=2010&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22688947%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20944665&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc2946&amp;rft.aulast=Bowtell&amp;rft.aufirst=DD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9653432-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9653432_68-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBrodyBiesecker1998\">Brody LC, Biesecker BB (1998). \"Breast cancer susceptibility genes. BRCA1 and BRCA2\". <i>Medicine (Baltimore)</i>. <b>77</b> (3): 208–26. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1097%2F00005792-199805000-00006\" rel=\"nofollow\">10.1097/00005792-199805000-00006</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9653432\" rel=\"nofollow\">9653432</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medicine+%28Baltimore%29&amp;rft.atitle=Breast+cancer+susceptibility+genes.+BRCA1+and+BRCA2&amp;rft.volume=77&amp;rft.issue=3&amp;rft.pages=208-26&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1097%2F00005792-199805000-00006&amp;rft_id=info%3Apmid%2F9653432&amp;rft.aulast=Brody&amp;rft.aufirst=LC&amp;rft.au=Biesecker%2C+BB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid24240112-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid24240112_69-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPenningtonWalshHarrellLee2014\">Pennington KP, Walsh T, Harrell MI, Lee MK, Pennil CC, Rendi MH, Thornton A, Norquist BM, Casadei S, Nord AS, Agnew KJ, Pritchard CC, Scroggins S, Garcia RL, King MC, Swisher EM (2014). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944197\" rel=\"nofollow\">\"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas\"</a>. <i>Clin. Cancer Res</i>. <b>20</b> (3): 764–75. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1158%2F1078-0432.CCR-13-2287\" rel=\"nofollow\">10.1158/1078-0432.CCR-13-2287</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944197\" rel=\"nofollow\">3944197</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/24240112\" rel=\"nofollow\">24240112</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Cancer+Res.&amp;rft.atitle=Germline+and+somatic+mutations+in+homologous+recombination+genes+predict+platinum+response+and+survival+in+ovarian%2C+fallopian+tube%2C+and+peritoneal+carcinomas&amp;rft.volume=20&amp;rft.issue=3&amp;rft.pages=764-75&amp;rft.date=2014&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3944197%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24240112&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-13-2287&amp;rft.aulast=Pennington&amp;rft.aufirst=KP&amp;rft.au=Walsh%2C+T&amp;rft.au=Harrell%2C+MI&amp;rft.au=Lee%2C+MK&amp;rft.au=Pennil%2C+CC&amp;rft.au=Rendi%2C+MH&amp;rft.au=Thornton%2C+A&amp;rft.au=Norquist%2C+BM&amp;rft.au=Casadei%2C+S&amp;rft.au=Nord%2C+AS&amp;rft.au=Agnew%2C+KJ&amp;rft.au=Pritchard%2C+CC&amp;rft.au=Scroggins%2C+S&amp;rft.au=Garcia%2C+RL&amp;rft.au=King%2C+MC&amp;rft.au=Swisher%2C+EM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3944197&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid30579323-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid30579323_70-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPolanskySchwab2019\">Polansky H, Schwab H (August 2019). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716096\" rel=\"nofollow\">\"How latent viruses cause breast cancer: An explanation based on the microcompetition model\"</a>. <i>Bosnian Journal of Basic Medical Sciences</i>. <b>19</b> (3): 221–226. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.17305%2Fbjbms.2018.3950\" rel=\"nofollow\">10.17305/bjbms.2018.3950</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716096\" rel=\"nofollow\">6716096</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/30579323\" rel=\"nofollow\">30579323</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bosnian+Journal+of+Basic+Medical+Sciences&amp;rft.atitle=How+latent+viruses+cause+breast+cancer%3A+An+explanation+based+on+the+microcompetition+model&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=221-226&amp;rft.date=2019-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6716096%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30579323&amp;rft_id=info%3Adoi%2F10.17305%2Fbjbms.2018.3950&amp;rft.aulast=Polansky&amp;rft.aufirst=H&amp;rft.au=Schwab%2C+H&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6716096&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10749912-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10749912_71-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFEstellerSilvaDominguezBonilla2000\">Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, <a href=\"/wiki/Stephen_B._Baylin\" title=\"Stephen B. Baylin\">Baylin SB</a>, <a href=\"/wiki/James_G._Herman\" title=\"James G. Herman\">Herman JG</a> (2000). <a class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2F92.7.564\" rel=\"nofollow\">\"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors\"</a>. <i>J. Natl. Cancer Inst</i>. <b>92</b> (7): 564–9. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2F92.7.564\" rel=\"nofollow\">10.1093/jnci/92.7.564</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10749912\" rel=\"nofollow\">10749912</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.atitle=Promoter+hypermethylation+and+BRCA1+inactivation+in+sporadic+breast+and+ovarian+tumors&amp;rft.volume=92&amp;rft.issue=7&amp;rft.pages=564-9&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2F92.7.564&amp;rft_id=info%3Apmid%2F10749912&amp;rft.aulast=Esteller&amp;rft.aufirst=M&amp;rft.au=Silva%2C+JM&amp;rft.au=Dominguez%2C+G&amp;rft.au=Bonilla%2C+F&amp;rft.au=Matias-Guiu%2C+X&amp;rft.au=Lerma%2C+E&amp;rft.au=Bussaglia%2C+E&amp;rft.au=Prat%2C+J&amp;rft.au=Harkes%2C+IC&amp;rft.au=Repasky%2C+EA&amp;rft.au=Gabrielson%2C+E&amp;rft.au=Schutte%2C+M&amp;rft.au=Baylin%2C+SB&amp;rft.au=Herman%2C+JG&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fjnci%252F92.7.564&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Moskwa-72\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Moskwa_72-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Moskwa_72-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFMoskwaBuffaPanPanchakshari2011\">Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, Muschel RJ, Beech J, Kulshrestha R, Abdelmohsen K, Weinstock DM, Gorospe M, Harris AL, Helleday T, Chowdhury D (2011). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249932\" rel=\"nofollow\">\"miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors\"</a>. <i>Mol. Cell</i>. <b>41</b> (2): 210–20. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.molcel.2010.12.005\" rel=\"nofollow\">10.1016/j.molcel.2010.12.005</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249932\" rel=\"nofollow\">3249932</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/21195000\" rel=\"nofollow\">21195000</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=miR-182-mediated+downregulation+of+BRCA1+impacts+DNA+repair+and+sensitivity+to+PARP+inhibitors&amp;rft.volume=41&amp;rft.issue=2&amp;rft.pages=210-20&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3249932%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21195000&amp;rft_id=info%3Adoi%2F10.1016%2Fj.molcel.2010.12.005&amp;rft.aulast=Moskwa&amp;rft.aufirst=P&amp;rft.au=Buffa%2C+FM&amp;rft.au=Pan%2C+Y&amp;rft.au=Panchakshari%2C+R&amp;rft.au=Gottipati%2C+P&amp;rft.au=Muschel%2C+RJ&amp;rft.au=Beech%2C+J&amp;rft.au=Kulshrestha%2C+R&amp;rft.au=Abdelmohsen%2C+K&amp;rft.au=Weinstock%2C+DM&amp;rft.au=Gorospe%2C+M&amp;rft.au=Harris%2C+AL&amp;rft.au=Helleday%2C+T&amp;rft.au=Chowdhury%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3249932&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid23249749-73\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23249749_73-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFKrishnanSteptoeMartinWani2013\">Krishnan K, Steptoe AL, Martin HC, Wani S, Nones K, Waddell N, Mariasegaram M, Simpson PT, Lakhani SR, Gabrielli B, Vlassov A, Cloonan N, Grimmond SM (2013). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543090\" rel=\"nofollow\">\"MicroRNA-182-5p targets a network of genes involved in DNA repair\"</a>. <i>RNA</i>. <b>19</b> (2): 230–42. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1261%2Frna.034926.112\" rel=\"nofollow\">10.1261/rna.034926.112</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543090\" rel=\"nofollow\">3543090</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/23249749\" rel=\"nofollow\">23249749</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=RNA&amp;rft.atitle=MicroRNA-182-5p+targets+a+network+of+genes+involved+in+DNA+repair&amp;rft.volume=19&amp;rft.issue=2&amp;rft.pages=230-42&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3543090%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23249749&amp;rft_id=info%3Adoi%2F10.1261%2Frna.034926.112&amp;rft.aulast=Krishnan&amp;rft.aufirst=K&amp;rft.au=Steptoe%2C+AL&amp;rft.au=Martin%2C+HC&amp;rft.au=Wani%2C+S&amp;rft.au=Nones%2C+K&amp;rft.au=Waddell%2C+N&amp;rft.au=Mariasegaram%2C+M&amp;rft.au=Simpson%2C+PT&amp;rft.au=Lakhani%2C+SR&amp;rft.au=Gabrielli%2C+B&amp;rft.au=Vlassov%2C+A&amp;rft.au=Cloonan%2C+N&amp;rft.au=Grimmond%2C+SM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3543090&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid21472990-74\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21472990_74-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFGarciaBuissonBertrandRimokh2011\">Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS, Lidereau R, Mikaélian I, Mazoyer S (2011). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377076\" rel=\"nofollow\">\"Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers\"</a>. <i>EMBO Mol Med</i>. <b>3</b> (5): 279–90. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1002%2Femmm.201100136\" rel=\"nofollow\">10.1002/emmm.201100136</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377076\" rel=\"nofollow\">3377076</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/21472990\" rel=\"nofollow\">21472990</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EMBO+Mol+Med&amp;rft.atitle=Down-regulation+of+BRCA1+expression+by+miR-146a+and+miR-146b-5p+in+triple+negative+sporadic+breast+cancers&amp;rft.volume=3&amp;rft.issue=5&amp;rft.pages=279-90&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3377076%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21472990&amp;rft_id=info%3Adoi%2F10.1002%2Femmm.201100136&amp;rft.aulast=Garcia&amp;rft.aufirst=AI&amp;rft.au=Buisson%2C+M&amp;rft.au=Bertrand%2C+P&amp;rft.au=Rimokh%2C+R&amp;rft.au=Rouleau%2C+E&amp;rft.au=Lopez%2C+BS&amp;rft.au=Lidereau%2C+R&amp;rft.au=Mika%C3%A9lian%2C+I&amp;rft.au=Mazoyer%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3377076&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Liu-75\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Liu_75-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Liu_75-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLiuLiuSeguraShao2012\">Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, Hernando E, Wei JJ (2012). \"MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma\". <i>J. Pathol</i>. <b>228</b> (2): 204–15. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1002%2Fpath.4000\" rel=\"nofollow\">10.1002/path.4000</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22322863\" rel=\"nofollow\">22322863</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:206325689\" rel=\"nofollow\">206325689</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Pathol.&amp;rft.atitle=MiR-182+overexpression+in+tumourigenesis+of+high-grade+serous+ovarian+carcinoma&amp;rft.volume=228&amp;rft.issue=2&amp;rft.pages=204-15&amp;rft.date=2012&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A206325689%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22322863&amp;rft_id=info%3Adoi%2F10.1002%2Fpath.4000&amp;rft.aulast=Liu&amp;rft.aufirst=Z&amp;rft.au=Liu%2C+J&amp;rft.au=Segura%2C+MF&amp;rft.au=Shao%2C+C&amp;rft.au=Lee%2C+P&amp;rft.au=Gong%2C+Y&amp;rft.au=Hernando%2C+E&amp;rft.au=Wei%2C+JJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid18403632-76\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18403632_76-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFKastan2008\">Kastan MB (2008). <a class=\"external text\" href=\"https://doi.org/10.1158%2F1541-7786.MCR-08-0020\" rel=\"nofollow\">\"DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture\"</a>. <i>Mol. Cancer Res</i>. <b>6</b> (4): 517–24. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1158%2F1541-7786.MCR-08-0020\" rel=\"nofollow\">10.1158/1541-7786.MCR-08-0020</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18403632\" rel=\"nofollow\">18403632</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cancer+Res.&amp;rft.atitle=DNA+damage+responses%3A+mechanisms+and+roles+in+human+disease%3A+2007+G.H.A.+Clowes+Memorial+Award+Lecture&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=517-24&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1158%2F1541-7786.MCR-08-0020&amp;rft_id=info%3Apmid%2F18403632&amp;rft.aulast=Kastan&amp;rft.aufirst=MB&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1158%252F1541-7786.MCR-08-0020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid18082599-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18082599_77-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHarperElledge2007\">Harper JW, Elledge SJ (2007). <a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.molcel.2007.11.015\" rel=\"nofollow\">\"The DNA damage response: ten years after\"</a>. <i>Mol. Cell</i>. <b>28</b> (5): 739–45. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.molcel.2007.11.015\" rel=\"nofollow\">10.1016/j.molcel.2007.11.015</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18082599\" rel=\"nofollow\">18082599</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=The+DNA+damage+response%3A+ten+years+after&amp;rft.volume=28&amp;rft.issue=5&amp;rft.pages=739-45&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1016%2Fj.molcel.2007.11.015&amp;rft_id=info%3Apmid%2F18082599&amp;rft.aulast=Harper&amp;rft.aufirst=JW&amp;rft.au=Elledge%2C+SJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.molcel.2007.11.015&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Hagan-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Hagan_78-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFO'HaganMohammadBaylin2008\">O'Hagan HM, Mohammad HP, Baylin SB (2008). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723\" rel=\"nofollow\">\"Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island\"</a>. <i>PLOS Genetics</i>. <b>4</b> (8): e1000155. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1371%2Fjournal.pgen.1000155\" rel=\"nofollow\">10.1371/journal.pgen.1000155</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723\" rel=\"nofollow\">2491723</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18704159\" rel=\"nofollow\">18704159</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+Genetics&amp;rft.atitle=Double+strand+breaks+can+initiate+gene+silencing+and+SIRT1-dependent+onset+of+DNA+methylation+in+an+exogenous+promoter+CpG+island&amp;rft.volume=4&amp;rft.issue=8&amp;rft.pages=e1000155&amp;rft.date=2008&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2491723%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18704159&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pgen.1000155&amp;rft.aulast=O%27Hagan&amp;rft.aufirst=HM&amp;rft.au=Mohammad%2C+HP&amp;rft.au=Baylin%2C+SB&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2491723&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Cuozzo-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Cuozzo_79-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFCuozzoPorcelliniAngrisanoMorano2007\">Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV (Jul 2007). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100\" rel=\"nofollow\">\"DNA damage, homology-directed repair, and DNA methylation\"</a>. <i>PLOS Genetics</i>. <b>3</b> (7): e110. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1371%2Fjournal.pgen.0030110\" rel=\"nofollow\">10.1371/journal.pgen.0030110</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100\" rel=\"nofollow\">1913100</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/17616978\" rel=\"nofollow\">17616978</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+Genetics&amp;rft.atitle=DNA+damage%2C+homology-directed+repair%2C+and+DNA+methylation&amp;rft.volume=3&amp;rft.issue=7&amp;rft.pages=e110&amp;rft.date=2007-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1913100%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17616978&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pgen.0030110&amp;rft.aulast=Cuozzo&amp;rft.aufirst=C&amp;rft.au=Porcellini%2C+A&amp;rft.au=Angrisano%2C+T&amp;rft.au=Morano%2C+A&amp;rft.au=Lee%2C+B&amp;rft.au=Di+Pardo%2C+A&amp;rft.au=Messina%2C+S&amp;rft.au=Iuliano%2C+R&amp;rft.au=Fusco%2C+A&amp;rft.au=Santillo%2C+MR&amp;rft.au=Muller%2C+MT&amp;rft.au=Chiariotti%2C+L&amp;rft.au=Gottesman%2C+ME&amp;rft.au=Avvedimento%2C+EV&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1913100&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Lacroix2005-80\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Lacroix2005_80-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Lacroix2005_80-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLacroixLeclercq2005\">Lacroix M, Leclercq G (2005). \"The \"portrait\" of hereditary breast cancer\". <i>Breast Cancer Research and Treatment</i>. <b>89</b> (3): 297–304. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1007%2Fs10549-004-2172-4\" rel=\"nofollow\">10.1007/s10549-004-2172-4</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15754129\" rel=\"nofollow\">15754129</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:23327569\" rel=\"nofollow\">23327569</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Breast+Cancer+Research+and+Treatment&amp;rft.atitle=The+%22portrait%22+of+hereditary+breast+cancer&amp;rft.volume=89&amp;rft.issue=3&amp;rft.pages=297-304&amp;rft.date=2005&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23327569%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15754129&amp;rft_id=info%3Adoi%2F10.1007%2Fs10549-004-2172-4&amp;rft.aulast=Lacroix&amp;rft.aufirst=M&amp;rft.au=Leclercq%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Struewing1995-81\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Struewing1995_81-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Struewing1995_81-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFStruewingAbeliovichPeretzAvishai1995\">Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (October 1995). \"The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals\". <i>Nat. Genet</i>. <b>11</b> (2): 198–200. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fng1095-198\" rel=\"nofollow\">10.1038/ng1095-198</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/7550349\" rel=\"nofollow\">7550349</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:21387351\" rel=\"nofollow\">21387351</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Genet.&amp;rft.atitle=The+carrier+frequency+of+the+BRCA1+185delAG+mutation+is+approximately+1+percent+in+Ashkenazi+Jewish+individuals&amp;rft.volume=11&amp;rft.issue=2&amp;rft.pages=198-200&amp;rft.date=1995-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21387351%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F7550349&amp;rft_id=info%3Adoi%2F10.1038%2Fng1095-198&amp;rft.aulast=Struewing&amp;rft.aufirst=JP&amp;rft.au=Abeliovich%2C+D&amp;rft.au=Peretz%2C+T&amp;rft.au=Avishai%2C+N&amp;rft.au=Kaback%2C+MM&amp;rft.au=Collins%2C+FS&amp;rft.au=Brody%2C+LC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Tonin1995-82\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Tonin1995_82-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Tonin1995_82-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFToninSerovaLenoirLynch1995\">Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, Narod S (1995). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801236\" rel=\"nofollow\">\"BRCA1 mutations in Ashkenazi Jewish women\"</a>. <i>American Journal of Human Genetics</i>. <b>57</b> (1): 189. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801236\" rel=\"nofollow\">1801236</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/7611288\" rel=\"nofollow\">7611288</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=BRCA1+mutations+in+Ashkenazi+Jewish+women&amp;rft.volume=57&amp;rft.issue=1&amp;rft.pages=189&amp;rft.date=1995&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1801236%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F7611288&amp;rft.aulast=Tonin&amp;rft.aufirst=P&amp;rft.au=Serova%2C+O&amp;rft.au=Lenoir%2C+G&amp;rft.au=Lynch%2C+H&amp;rft.au=Durocher%2C+F&amp;rft.au=Simard%2C+J&amp;rft.au=Morgan%2C+K&amp;rft.au=Narod%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1801236&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Narod2004-83\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Narod2004_83-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFNarodFoulkes2004\">Narod SA, Foulkes WD (2004). \"BRCA1 and BRCA2: 1994 and beyond\". <i>Nature Reviews Cancer</i>. <b>4</b> (9): 665–676. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fnrc1431\" rel=\"nofollow\">10.1038/nrc1431</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15343273\" rel=\"nofollow\">15343273</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:30686068\" rel=\"nofollow\">30686068</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.atitle=BRCA1+and+BRCA2%3A+1994+and+beyond&amp;rft.volume=4&amp;rft.issue=9&amp;rft.pages=665-676&amp;rft.date=2004&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A30686068%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15343273&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc1431&amp;rft.aulast=Narod&amp;rft.aufirst=SA&amp;rft.au=Foulkes%2C+WD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-denDunnen2000-84\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-denDunnen2000_84-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFden_DunnenAntonarakis2000\">den Dunnen JT, Antonarakis SE (2000). <a class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291098-1004%28200001%2915%3A1%3C7%3A%3AAID-HUMU4%3E3.0.CO%3B2-N\" rel=\"nofollow\">\"Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion\"</a>. <i>Human Mutation</i>. <b>15</b> (1): 7–12. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291098-1004%28200001%2915%3A1%3C7%3A%3AAID-HUMU4%3E3.0.CO%3B2-N\" rel=\"nofollow\">10.1002/(SICI)1098-1004(200001)15:1&lt;7::AID-HUMU4&gt;3.0.CO;2-N</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10612815\" rel=\"nofollow\">10612815</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Mutation&amp;rft.atitle=Mutation+nomenclature+extensions+and+suggestions+to+describe+complex+mutations%3A+a+discussion&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=7-12&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291098-1004%28200001%2915%3A1%3C7%3A%3AAID-HUMU4%3E3.0.CO%3B2-N&amp;rft_id=info%3Apmid%2F10612815&amp;rft.aulast=den+Dunnen&amp;rft.aufirst=JT&amp;rft.au=Antonarakis%2C+SE&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252F%2528SICI%25291098-1004%2528200001%252915%253A1%253C7%253A%253AAID-HUMU4%253E3.0.CO%253B2-N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Neuhausen2000-85\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Neuhausen2000_85-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Neuhausen2000_85-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFNeuhausen2000\">Neuhausen SL (2000). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139426\" rel=\"nofollow\">\"Founder populations and their uses for breast cancer genetics\"</a>. <i>Cancer Research</i>. <b>2</b> (2): 77–81. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1186%2Fbcr36\" rel=\"nofollow\">10.1186/bcr36</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139426\" rel=\"nofollow\">139426</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11250694\" rel=\"nofollow\">11250694</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Founder+populations+and+their+uses+for+breast+cancer+genetics&amp;rft.volume=2&amp;rft.issue=2&amp;rft.pages=77-81&amp;rft.date=2000&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC139426%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11250694&amp;rft_id=info%3Adoi%2F10.1186%2Fbcr36&amp;rft.aulast=Neuhausen&amp;rft.aufirst=SL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC139426&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Reeves2004-86\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Reeves2004_86-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFReevesYawitchvan_der_Merwevan_den_Berg2004\">Reeves MD, Yawitch TM, van der Merwe NC, van den Berg HJ, Dreyer G, van Rensburg EJ (July 2004). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.20186\" rel=\"nofollow\">\"BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families\"</a>. <i>Int. J. Cancer</i>. <b>110</b> (5): 677–82. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.20186\" rel=\"nofollow\">10.1002/ijc.20186</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15146556\" rel=\"nofollow\">15146556</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:22970255\" rel=\"nofollow\">22970255</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.atitle=BRCA1+mutations+in+South+African+breast+and%2For+ovarian+cancer+families%3A+evidence+of+a+novel+founder+mutation+in+Afrikaner+families&amp;rft.volume=110&amp;rft.issue=5&amp;rft.pages=677-82&amp;rft.date=2004-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22970255%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15146556&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.20186&amp;rft.aulast=Reeves&amp;rft.aufirst=MD&amp;rft.au=Yawitch%2C+TM&amp;rft.au=van+der+Merwe%2C+NC&amp;rft.au=van+den+Berg%2C+HJ&amp;rft.au=Dreyer%2C+G&amp;rft.au=van+Rensburg%2C+EJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fijc.20186&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Francies2015-87\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Francies2015_87-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFFranciesWainsteinDe_LeeneerCairns2015\">Francies FZ, Wainstein T, De Leeneer K, Cairns A, Murdoch M, Nietz S, Cubasch H, Poppe B, Van Maerken T, Crombez B, Coene I, Kerr R, Slabbert JP, Vral A, Krause A, Baeyens A (Nov 2015). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647511\" rel=\"nofollow\">\"BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer\"</a>. <i>BMC Cancer</i>. <b>15</b>: 912. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1186%2Fs12885-015-1913-6\" rel=\"nofollow\">10.1186/s12885-015-1913-6</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647511\" rel=\"nofollow\">4647511</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/26577449\" rel=\"nofollow\">26577449</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Cancer&amp;rft.atitle=BRCA1%2C+BRCA2+and+PALB2+mutations+and+CHEK2+c.1100delC+in+different+South+African+ethnic+groups+diagnosed+with+premenopausal+and%2For+triple+negative+breast+cancer&amp;rft.volume=15&amp;rft.pages=912&amp;rft.date=2015-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4647511%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26577449&amp;rft_id=info%3Adoi%2F10.1186%2Fs12885-015-1913-6&amp;rft.aulast=Francies&amp;rft.aufirst=FZ&amp;rft.au=Wainstein%2C+T&amp;rft.au=De+Leeneer%2C+K&amp;rft.au=Cairns%2C+A&amp;rft.au=Murdoch%2C+M&amp;rft.au=Nietz%2C+S&amp;rft.au=Cubasch%2C+H&amp;rft.au=Poppe%2C+B&amp;rft.au=Van+Maerken%2C+T&amp;rft.au=Crombez%2C+B&amp;rft.au=Coene%2C+I&amp;rft.au=Kerr%2C+R&amp;rft.au=Slabbert%2C+JP&amp;rft.au=Vral%2C+A&amp;rft.au=Krause%2C+A&amp;rft.au=Baeyens%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4647511&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Wagner1998-88\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Wagner1998_88-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWagnerMöslingerMuhrLangbauer1998\">Wagner TM, Möslinger RA, Muhr D, Langbauer G, Hirtenlehner K, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Ropp E, Kubista E, Amirimani B, Helbich T, Becherer A, Scheiner O, Breiteneder H, Borg A, Devilee P, Oefner P, Zielinski C (1998). <a class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291097-0215%2819980729%2977%3A3%3C354%3A%3AAID-IJC8%3E3.0.CO%3B2-N\" rel=\"nofollow\">\"BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics\"</a>. <i>International Journal of Cancer</i>. <b>77</b> (3): 354–360. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291097-0215%2819980729%2977%3A3%3C354%3A%3AAID-IJC8%3E3.0.CO%3B2-N\" rel=\"nofollow\">10.1002/(SICI)1097-0215(19980729)77:3&lt;354::AID-IJC8&gt;3.0.CO;2-N</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9663595\" rel=\"nofollow\">9663595</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Cancer&amp;rft.atitle=BRCA1-related+breast+cancer+in+Austrian+breast+and+ovarian+cancer+families%3A+specific+BRCA1+mutations+and+pathological+characteristics&amp;rft.volume=77&amp;rft.issue=3&amp;rft.pages=354-360&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-0215%2819980729%2977%3A3%3C354%3A%3AAID-IJC8%3E3.0.CO%3B2-N&amp;rft_id=info%3Apmid%2F9663595&amp;rft.aulast=Wagner&amp;rft.aufirst=TM&amp;rft.au=M%C3%B6slinger%2C+RA&amp;rft.au=Muhr%2C+D&amp;rft.au=Langbauer%2C+G&amp;rft.au=Hirtenlehner%2C+K&amp;rft.au=Concin%2C+H&amp;rft.au=Doeller%2C+W&amp;rft.au=Haid%2C+A&amp;rft.au=Lang%2C+AH&amp;rft.au=Mayer%2C+P&amp;rft.au=Ropp%2C+E&amp;rft.au=Kubista%2C+E&amp;rft.au=Amirimani%2C+B&amp;rft.au=Helbich%2C+T&amp;rft.au=Becherer%2C+A&amp;rft.au=Scheiner%2C+O&amp;rft.au=Breiteneder%2C+H&amp;rft.au=Borg%2C+A&amp;rft.au=Devilee%2C+P&amp;rft.au=Oefner%2C+P&amp;rft.au=Zielinski%2C+C&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252F%2528SICI%25291097-0215%252819980729%252977%253A3%253C354%253A%253AAID-IJC8%253E3.0.CO%253B2-N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Peelen1997-89\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Peelen1997_89-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Peelen1997_89-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPeelenvan_VlietPetrij-BoschMieremet1997\">Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AM, Hogervorst F, Brohet R, Ligtenberg MJ, Teugels E, van der Luijt R, van der Hout AH, Gille JJ, Pals G, Jedema I, Olmer R, van Leeuwen I, Newman B, Plandsoen M, van der Est M, Brink G, Hageman S, Arts PJ, Bakker MM, Devilee P (1997). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712432\" rel=\"nofollow\">\"A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families\"</a>. <i>American Journal of Human Genetics</i>. <b>60</b> (5): 1041–1049. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712432\" rel=\"nofollow\">1712432</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9150151\" rel=\"nofollow\">9150151</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=A+high+proportion+of+novel+mutations+in+BRCA1+with+strong+founder+effects+among+Dutch+and+Belgian+hereditary+breast+and+ovarian+cancer+families&amp;rft.volume=60&amp;rft.issue=5&amp;rft.pages=1041-1049&amp;rft.date=1997&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1712432%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9150151&amp;rft.aulast=Peelen&amp;rft.aufirst=T&amp;rft.au=van+Vliet%2C+M&amp;rft.au=Petrij-Bosch%2C+A&amp;rft.au=Mieremet%2C+R&amp;rft.au=Szabo%2C+C&amp;rft.au=van+den+Ouweland%2C+AM&amp;rft.au=Hogervorst%2C+F&amp;rft.au=Brohet%2C+R&amp;rft.au=Ligtenberg%2C+MJ&amp;rft.au=Teugels%2C+E&amp;rft.au=van+der+Luijt%2C+R&amp;rft.au=van+der+Hout%2C+AH&amp;rft.au=Gille%2C+JJ&amp;rft.au=Pals%2C+G&amp;rft.au=Jedema%2C+I&amp;rft.au=Olmer%2C+R&amp;rft.au=van+Leeuwen%2C+I&amp;rft.au=Newman%2C+B&amp;rft.au=Plandsoen%2C+M&amp;rft.au=van+der+Est%2C+M&amp;rft.au=Brink%2C+G&amp;rft.au=Hageman%2C+S&amp;rft.au=Arts%2C+PJ&amp;rft.au=Bakker%2C+MM&amp;rft.au=Devilee%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1712432&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Claes1999-90\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Claes1999_90-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFClaesMachackovaDe_VosPoppe1999\">Claes K, Machackova E, De Vos M, Poppe B, De Paepe A, Messiaen L (1999). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851655\" rel=\"nofollow\">\"Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A &gt; G\"</a>. <i>Disease Markers</i>. <b>15</b> (1–3): 69–73. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1155%2F1999%2F241046\" rel=\"nofollow\">10.1155/1999/241046</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851655\" rel=\"nofollow\">3851655</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10595255\" rel=\"nofollow\">10595255</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Disease+Markers&amp;rft.atitle=Mutation+analysis+of+the+BRCA1+and+BRCA2+genes+in+the+Belgian+patient+population+and+identification+of+a+Belgian+founder+mutation+BRCA1+IVS5+%2B+3A+%3E+G&amp;rft.volume=15&amp;rft.issue=1%E2%80%933&amp;rft.pages=69-73&amp;rft.date=1999&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3851655%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10595255&amp;rft_id=info%3Adoi%2F10.1155%2F1999%2F241046&amp;rft.aulast=Claes&amp;rft.aufirst=K&amp;rft.au=Machackova%2C+E&amp;rft.au=De+Vos%2C+M&amp;rft.au=Poppe%2C+B&amp;rft.au=De+Paepe%2C+A&amp;rft.au=Messiaen%2C+L&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3851655&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-PetrijBosch-91\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PetrijBosch_91-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPetrij-BoschPeelenvan_Vlietvan_Eijk1997\">Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drüsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van 't Veer LJ, Bakker E, van Ommen GJ, Devilee P (1997). <a class=\"external text\" href=\"https://repub.eur.nl/pub/54808/ng1197-341.pdf\" rel=\"nofollow\">\"BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Nature Genetics</i>. <b>17</b> (3): 341–345. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fng1197-341\" rel=\"nofollow\">10.1038/ng1197-341</a>. <a class=\"mw-redirect\" href=\"/wiki/Hdl_(identifier)\" title=\"Hdl (identifier)\">hdl</a>:<a class=\"external text\" href=\"https://hdl.handle.net/1765%2F54808\" rel=\"nofollow\">1765/54808</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9354803\" rel=\"nofollow\">9354803</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:13028232\" rel=\"nofollow\">13028232</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Genetics&amp;rft.atitle=BRCA1+genomic+deletions+are+major+founder+mutations+in+Dutch+breast+cancer+patients&amp;rft.volume=17&amp;rft.issue=3&amp;rft.pages=341-345&amp;rft.date=1997&amp;rft_id=info%3Ahdl%2F1765%2F54808&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13028232%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9354803&amp;rft_id=info%3Adoi%2F10.1038%2Fng1197-341&amp;rft.aulast=Petrij-Bosch&amp;rft.aufirst=A&amp;rft.au=Peelen%2C+T&amp;rft.au=van+Vliet%2C+M&amp;rft.au=van+Eijk%2C+R&amp;rft.au=Olmer%2C+R&amp;rft.au=Dr%C3%BCsedau%2C+M&amp;rft.au=Hogervorst%2C+FB&amp;rft.au=Hageman%2C+S&amp;rft.au=Arts%2C+PJ&amp;rft.au=Ligtenberg%2C+MJ&amp;rft.au=Meijers-Heijboer%2C+H&amp;rft.au=Klijn%2C+JG&amp;rft.au=Vasen%2C+HF&amp;rft.au=Cornelisse%2C+CJ&amp;rft.au=van+%27t+Veer%2C+LJ&amp;rft.au=Bakker%2C+E&amp;rft.au=van+Ommen%2C+GJ&amp;rft.au=Devilee%2C+P&amp;rft_id=https%3A%2F%2Frepub.eur.nl%2Fpub%2F54808%2Fng1197-341.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Verhoog-92\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Verhoog_92-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFVerhoogvan_den_OuwelandBernsvan_Veghel-Plandsoen2001\">Verhoog LC, van den Ouweland AM, Berns E, van Veghel-Plandsoen MM, van Staveren IL, Wagner A, Bartels CC, Tilanus-Linthorst MM, Devilee P, Seynaeve C, Halley DJ, Niermeijer MF, Klijn JG, Meijers-Heijboer H (2001). \"Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families\". <i>European Journal of Cancer</i>. <b>37</b> (16): 2082–2090. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS0959-8049%2801%2900244-1\" rel=\"nofollow\">10.1016/S0959-8049(01)00244-1</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11597388\" rel=\"nofollow\">11597388</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Cancer&amp;rft.atitle=Large+regional+differences+in+the+frequency+of+distinct+BRCA1%2FBRCA2+mutations+in+517+Dutch+breast+and%2For+ovarian+cancer+families&amp;rft.volume=37&amp;rft.issue=16&amp;rft.pages=2082-2090&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1016%2FS0959-8049%2801%2900244-1&amp;rft_id=info%3Apmid%2F11597388&amp;rft.aulast=Verhoog&amp;rft.aufirst=LC&amp;rft.au=van+den+Ouweland%2C+AM&amp;rft.au=Berns%2C+E&amp;rft.au=van+Veghel-Plandsoen%2C+MM&amp;rft.au=van+Staveren%2C+IL&amp;rft.au=Wagner%2C+A&amp;rft.au=Bartels%2C+CC&amp;rft.au=Tilanus-Linthorst%2C+MM&amp;rft.au=Devilee%2C+P&amp;rft.au=Seynaeve%2C+C&amp;rft.au=Halley%2C+DJ&amp;rft.au=Niermeijer%2C+MF&amp;rft.au=Klijn%2C+JG&amp;rft.au=Meijers-Heijboer%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Huusko-93\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Huusko_93-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHuuskoPääkkönenLaunonenPöyhönen1998\">Huusko P, Pääkkönen K, Launonen V, Pöyhönen M, Blanco G, Kauppila A, Puistola U, Kiviniemi H, Kujala M, Leisti J, Winqvist R (1998). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377159\" rel=\"nofollow\">\"Evidence of founder mutations in Finnish BRCA1 and BRCA2 families\"</a>. <i>American Journal of Human Genetics</i>. <b>62</b> (6): 1544–1548. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1086%2F301880\" rel=\"nofollow\">10.1086/301880</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377159\" rel=\"nofollow\">1377159</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9585608\" rel=\"nofollow\">9585608</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=Evidence+of+founder+mutations+in+Finnish+BRCA1+and+BRCA2+families&amp;rft.volume=62&amp;rft.issue=6&amp;rft.pages=1544-1548&amp;rft.date=1998&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1377159%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9585608&amp;rft_id=info%3Adoi%2F10.1086%2F301880&amp;rft.aulast=Huusko&amp;rft.aufirst=P&amp;rft.au=P%C3%A4%C3%A4kk%C3%B6nen%2C+K&amp;rft.au=Launonen%2C+V&amp;rft.au=P%C3%B6yh%C3%B6nen%2C+M&amp;rft.au=Blanco%2C+G&amp;rft.au=Kauppila%2C+A&amp;rft.au=Puistola%2C+U&amp;rft.au=Kiviniemi%2C+H&amp;rft.au=Kujala%2C+M&amp;rft.au=Leisti%2C+J&amp;rft.au=Winqvist%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1377159&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Paakkonen-94\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Paakkonen_94-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPääkkönenSauramoSarantausVahteristo2001\">Pääkkönen K, Sauramo S, Sarantaus L, Vahteristo P, Hartikainen A, Vehmanen P, Ignatius J, Ollikainen V, Kääriäinen H, Vauramo E, Nevanlinna H, Krahe R, Holli K, Kere J (2001). \"Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population\". <i>Genetic Epidemiology</i>. <b>20</b> (2): 239–246. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1002%2F1098-2272%28200102%2920%3A2%3C239%3A%3AAID-GEPI6%3E3.0.CO%3B2-Y\" rel=\"nofollow\">10.1002/1098-2272(200102)20:2&lt;239::AID-GEPI6&gt;3.0.CO;2-Y</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11180449\" rel=\"nofollow\">11180449</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:41804152\" rel=\"nofollow\">41804152</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+Epidemiology&amp;rft.atitle=Involvement+of+BRCA1+and+BRCA2+in+breast+cancer+in+a+western+Finnish+sub-population&amp;rft.volume=20&amp;rft.issue=2&amp;rft.pages=239-246&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A41804152%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11180449&amp;rft_id=info%3Adoi%2F10.1002%2F1098-2272%28200102%2920%3A2%3C239%3A%3AAID-GEPI6%3E3.0.CO%3B2-Y&amp;rft.aulast=P%C3%A4%C3%A4kk%C3%B6nen&amp;rft.aufirst=K&amp;rft.au=Sauramo%2C+S&amp;rft.au=Sarantaus%2C+L&amp;rft.au=Vahteristo%2C+P&amp;rft.au=Hartikainen%2C+A&amp;rft.au=Vehmanen%2C+P&amp;rft.au=Ignatius%2C+J&amp;rft.au=Ollikainen%2C+V&amp;rft.au=K%C3%A4%C3%A4ri%C3%A4inen%2C+H&amp;rft.au=Vauramo%2C+E&amp;rft.au=Nevanlinna%2C+H&amp;rft.au=Krahe%2C+R&amp;rft.au=Holli%2C+K&amp;rft.au=Kere%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Muller-95\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Muller_95-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFMullerBonaiti-PelliéAbecassisStoppa-Lyonnet2004\">Muller D, Bonaiti-Pellié C, Abecassis J, Stoppa-Lyonnet D, Fricker JP (2004). \"BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect\". <i>Familial Cancer</i>. <b>3</b> (1): 15–20. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1023%2FB%3AFAME.0000026819.44213.df\" rel=\"nofollow\">10.1023/B:FAME.0000026819.44213.df</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15131401\" rel=\"nofollow\">15131401</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:24615109\" rel=\"nofollow\">24615109</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Familial+Cancer&amp;rft.atitle=BRCA1+testing+in+breast+and%2For+ovarian+cancer+families+from+northeastern+France+identifies+two+common+mutations+with+a+founder+effect&amp;rft.volume=3&amp;rft.issue=1&amp;rft.pages=15-20&amp;rft.date=2004&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24615109%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15131401&amp;rft_id=info%3Adoi%2F10.1023%2FB%3AFAME.0000026819.44213.df&amp;rft.aulast=Muller&amp;rft.aufirst=D&amp;rft.au=Bonaiti-Pelli%C3%A9%2C+C&amp;rft.au=Abecassis%2C+J&amp;rft.au=Stoppa-Lyonnet%2C+D&amp;rft.au=Fricker%2C+JP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Tonin1999-96\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Tonin1999_96-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFToninMes-MassonNarodGhadirian1999\">Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P, Provencher D (1999). \"Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history\". <i>Clinical Genetics</i>. <b>55</b> (5): 318–324. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1034%2Fj.1399-0004.1999.550504.x\" rel=\"nofollow\">10.1034/j.1399-0004.1999.550504.x</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10422801\" rel=\"nofollow\">10422801</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:23931343\" rel=\"nofollow\">23931343</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Genetics&amp;rft.atitle=Founder+BRCA1+and+BRCA2+mutations+in+French+Canadian+ovarian+cancer+cases+unselected+for+family+history&amp;rft.volume=55&amp;rft.issue=5&amp;rft.pages=318-324&amp;rft.date=1999&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23931343%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10422801&amp;rft_id=info%3Adoi%2F10.1034%2Fj.1399-0004.1999.550504.x&amp;rft.aulast=Tonin&amp;rft.aufirst=PN&amp;rft.au=Mes-Masson%2C+AM&amp;rft.au=Narod%2C+SA&amp;rft.au=Ghadirian%2C+P&amp;rft.au=Provencher%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Backe1999-97\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Backe1999_97-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBackeHofferbertSkawranDörk1999\">Backe J, Hofferbert S, Skawran B, Dörk T, Stuhrmann M, Karstens JH, Untch M, Meindl A, Burgemeister R, Chang-Claude J, Weber BH (1999). \"Frequency of BRCA1 mutation 5382insC in German breast cancer patients\". <i>Gynecologic Oncology</i>. <b>72</b> (3): 402–406. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1006%2Fgyno.1998.5270\" rel=\"nofollow\">10.1006/gyno.1998.5270</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10053113\" rel=\"nofollow\">10053113</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gynecologic+Oncology&amp;rft.atitle=Frequency+of+BRCA1+mutation+5382insC+in+German+breast+cancer+patients&amp;rft.volume=72&amp;rft.issue=3&amp;rft.pages=402-406&amp;rft.date=1999&amp;rft_id=info%3Adoi%2F10.1006%2Fgyno.1998.5270&amp;rft_id=info%3Apmid%2F10053113&amp;rft.aulast=Backe&amp;rft.aufirst=J&amp;rft.au=Hofferbert%2C+S&amp;rft.au=Skawran%2C+B&amp;rft.au=D%C3%B6rk%2C+T&amp;rft.au=Stuhrmann%2C+M&amp;rft.au=Karstens%2C+JH&amp;rft.au=Untch%2C+M&amp;rft.au=Meindl%2C+A&amp;rft.au=Burgemeister%2C+R&amp;rft.au=Chang-Claude%2C+J&amp;rft.au=Weber%2C+BH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-urlBrca1-98\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlBrca1_98-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://mutview.dmb.med.keio.ac.jp/MutationView/jsp/mutview/html/brca1.html\" rel=\"nofollow\">\"Mutation data of the BRCA1 gene\"</a>. <i>KMDB/MutationView (Keio Mutation Databases)</i>. Keio University.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=KMDB%2FMutationView+%28Keio+Mutation+Databases%29&amp;rft.atitle=Mutation+data+of+the+BRCA1+gene&amp;rft_id=http%3A%2F%2Fmutview.dmb.med.keio.ac.jp%2FMutationView%2Fjsp%2Fmutview%2Fhtml%2Fbrca1.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Ladopoulou2002-99\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ladopoulou2002_99-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLadopoulouKroupisKonstantopoulouIoannidou-Mouzaka2002\">Ladopoulou A, Kroupis C, Konstantopoulou I, Ioannidou-Mouzaka L, Schofield AC, Pantazidis A, Armaou S, Tsiagas I, Lianidou E, Efstathiou E, Tsionou C, Panopoulos C, Mihalatos M, Nasioulas G, Skarlos D, Haites NE, Fountzilas G, Pandis N, Yannoukakos D (2002). \"Germ line BRCA1 and BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed\". <i>Cancer Letters</i>. <b>185</b> (1): 61–70. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS0304-3835%2801%2900845-X\" rel=\"nofollow\">10.1016/S0304-3835(01)00845-X</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12142080\" rel=\"nofollow\">12142080</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Letters&amp;rft.atitle=Germ+line+BRCA1+and+BRCA2+mutations+in+Greek+breast%2Fovarian+cancer+families%3A+5382insC+is+the+most+frequent+mutation+observed&amp;rft.volume=185&amp;rft.issue=1&amp;rft.pages=61-70&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1016%2FS0304-3835%2801%2900845-X&amp;rft_id=info%3Apmid%2F12142080&amp;rft.aulast=Ladopoulou&amp;rft.aufirst=A&amp;rft.au=Kroupis%2C+C&amp;rft.au=Konstantopoulou%2C+I&amp;rft.au=Ioannidou-Mouzaka%2C+L&amp;rft.au=Schofield%2C+AC&amp;rft.au=Pantazidis%2C+A&amp;rft.au=Armaou%2C+S&amp;rft.au=Tsiagas%2C+I&amp;rft.au=Lianidou%2C+E&amp;rft.au=Efstathiou%2C+E&amp;rft.au=Tsionou%2C+C&amp;rft.au=Panopoulos%2C+C&amp;rft.au=Mihalatos%2C+M&amp;rft.au=Nasioulas%2C+G&amp;rft.au=Skarlos%2C+D&amp;rft.au=Haites%2C+NE&amp;rft.au=Fountzilas%2C+G&amp;rft.au=Pandis%2C+N&amp;rft.au=Yannoukakos%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-VanDerLooij2000-100\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-VanDerLooij2000_100-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFVan_Der_LooijSzaboBesznyakLiszka2000\">Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E (2000). \"Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary\". <i>International Journal of Cancer</i>. <b>86</b> (5): 737–740. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1002%2F%28SICI%291097-0215%2820000601%2986%3A5%3C737%3A%3AAID-IJC21%3E3.0.CO%3B2-1\" rel=\"nofollow\">10.1002/(SICI)1097-0215(20000601)86:5&lt;737::AID-IJC21&gt;3.0.CO;2-1</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10797299\" rel=\"nofollow\">10797299</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:25394976\" rel=\"nofollow\">25394976</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Cancer&amp;rft.atitle=Prevalence+of+founder+BRCA1+and+BRCA2+mutations+among+breast+and+ovarian+cancer+patients+in+Hungary&amp;rft.volume=86&amp;rft.issue=5&amp;rft.pages=737-740&amp;rft.date=2000&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25394976%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10797299&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-0215%2820000601%2986%3A5%3C737%3A%3AAID-IJC21%3E3.0.CO%3B2-1&amp;rft.aulast=Van+Der+Looij&amp;rft.aufirst=M&amp;rft.au=Szabo%2C+C&amp;rft.au=Besznyak%2C+I&amp;rft.au=Liszka%2C+G&amp;rft.au=Csokay%2C+B&amp;rft.au=Pulay%2C+T&amp;rft.au=Toth%2C+J&amp;rft.au=Devilee%2C+P&amp;rft.au=King%2C+MC&amp;rft.au=Olah%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Baudi2001-101\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Baudi2001_101-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBaudiQuaresimaGrandinettiCuda2001\">Baudi F, Quaresima B, Grandinetti C, Cuda G, Faniello C, Tassone P, Barbieri V, Bisegna R, Ricevuto E, Conforti S, Viel A, Marchetti P, Ficorella C, Radice P, Costanzo F, Venuta S (2001). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.1167\" rel=\"nofollow\">\"Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer\"</a>. <i>Human Mutation</i>. <b>18</b> (2): 163–164. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.1167\" rel=\"nofollow\">10.1002/humu.1167</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11462242\" rel=\"nofollow\">11462242</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:2995\" rel=\"nofollow\">2995</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Mutation&amp;rft.atitle=Evidence+of+a+founder+mutation+of+BRCA1+in+a+highly+homogeneous+population+from+southern+Italy+with+breast%2Fovarian+cancer&amp;rft.volume=18&amp;rft.issue=2&amp;rft.pages=163-164&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2995%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11462242&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.1167&amp;rft.aulast=Baudi&amp;rft.aufirst=F&amp;rft.au=Quaresima%2C+B&amp;rft.au=Grandinetti%2C+C&amp;rft.au=Cuda%2C+G&amp;rft.au=Faniello%2C+C&amp;rft.au=Tassone%2C+P&amp;rft.au=Barbieri%2C+V&amp;rft.au=Bisegna%2C+R&amp;rft.au=Ricevuto%2C+E&amp;rft.au=Conforti%2C+S&amp;rft.au=Viel%2C+A&amp;rft.au=Marchetti%2C+P&amp;rft.au=Ficorella%2C+C&amp;rft.au=Radice%2C+P&amp;rft.au=Costanzo%2C+F&amp;rft.au=Venuta%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.1167&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Sekine2001-102\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Sekine2001_102-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFSekineNagataTsujiHirai2001\">Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesaki N, Satoh S, Enomoto T, Motoyama S, Tanaka K (2001). \"Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population\". <i>Clinical Cancer Research</i>. <b>7</b> (10): 3144–3150. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11595708\" rel=\"nofollow\">11595708</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=Mutational+analysis+of+BRCA1+and+BRCA2+and+clinicopathologic+analysis+of+ovarian+cancer+in+82+ovarian+cancer+families%3A+two+common+founder+mutations+of+BRCA1+in+Japanese+population&amp;rft.volume=7&amp;rft.issue=10&amp;rft.pages=3144-3150&amp;rft.date=2001&amp;rft_id=info%3Apmid%2F11595708&amp;rft.aulast=Sekine&amp;rft.aufirst=M&amp;rft.au=Nagata%2C+H&amp;rft.au=Tsuji%2C+S&amp;rft.au=Hirai%2C+Y&amp;rft.au=Fujimoto%2C+S&amp;rft.au=Hatae%2C+M&amp;rft.au=Kobayashi%2C+I&amp;rft.au=Fujii%2C+T&amp;rft.au=Nagata%2C+I&amp;rft.au=Ushijima%2C+K&amp;rft.au=Obata%2C+K&amp;rft.au=Suzuki%2C+M&amp;rft.au=Yoshinaga%2C+M&amp;rft.au=Umesaki%2C+N&amp;rft.au=Satoh%2C+S&amp;rft.au=Enomoto%2C+T&amp;rft.au=Motoyama%2C+S&amp;rft.au=Tanaka%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Liede2002b-103\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Liede2002b_103-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLiedeJackHegeleNarod2002\">Liede A, Jack E, Hegele RA, Narod SA (2002). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9027\" rel=\"nofollow\">\"A BRCA1 mutation in Native North American families\"</a>. <i>Human Mutation</i>. <b>19</b> (4): 460. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9027\" rel=\"nofollow\">10.1002/humu.9027</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11933205\" rel=\"nofollow\">11933205</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:37710898\" rel=\"nofollow\">37710898</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Mutation&amp;rft.atitle=A+BRCA1+mutation+in+Native+North+American+families&amp;rft.volume=19&amp;rft.issue=4&amp;rft.pages=460&amp;rft.date=2002&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A37710898%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11933205&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.9027&amp;rft.aulast=Liede&amp;rft.aufirst=A&amp;rft.au=Jack%2C+E&amp;rft.au=Hegele%2C+RA&amp;rft.au=Narod%2C+SA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.9027&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-TSNI2003-104\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-TSNI2003_104-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-TSNI2003_104-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFThe_Scottish/Northern_Irish_BRCA1/BRCA2_Consortium2003\">The Scottish/Northern Irish BRCA1/BRCA2 Consortium (2003). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747571\" rel=\"nofollow\">\"BRCA1 and BRCA2 mutations in Scotland and Northern Ireland\"</a>. <i>British Journal of Cancer</i>. <b>88</b> (8): 1256–1262. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.bjc.6600840\" rel=\"nofollow\">10.1038/sj.bjc.6600840</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747571\" rel=\"nofollow\">2747571</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12698193\" rel=\"nofollow\">12698193</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Cancer&amp;rft.atitle=BRCA1+and+BRCA2+mutations+in+Scotland+and+Northern+Ireland&amp;rft.volume=88&amp;rft.issue=8&amp;rft.pages=1256-1262&amp;rft.date=2003&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2747571%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12698193&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bjc.6600840&amp;rft.au=The+Scottish%2FNorthern+Irish+BRCA1%2FBRCA2+Consortium&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2747571&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Borg1999-105\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Borg1999_105-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBorgDørumHeimdalMaehle1999\">Borg A, Dørum A, Heimdal K, Maehle L, Hovig E, Møller P (1999). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851406\" rel=\"nofollow\">\"BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations\"</a>. <i>Disease Markers</i>. <b>15</b> (1–3): 79–84. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1155%2F1999%2F278269\" rel=\"nofollow\">10.1155/1999/278269</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851406\" rel=\"nofollow\">3851406</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10595257\" rel=\"nofollow\">10595257</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Disease+Markers&amp;rft.atitle=BRCA1+1675delA+and+1135insA+account+for+one+third+of+Norwegian+familial+breast-ovarian+cancer+and+are+associated+with+later+disease+onset+than+less+frequent+mutations&amp;rft.volume=15&amp;rft.issue=1%E2%80%933&amp;rft.pages=79-84&amp;rft.date=1999&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3851406%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10595257&amp;rft_id=info%3Adoi%2F10.1155%2F1999%2F278269&amp;rft.aulast=Borg&amp;rft.aufirst=A&amp;rft.au=D%C3%B8rum%2C+A&amp;rft.au=Heimdal%2C+K&amp;rft.au=Maehle%2C+L&amp;rft.au=Hovig%2C+E&amp;rft.au=M%C3%B8ller%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3851406&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Heimdal2003-106\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Heimdal2003_106-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHeimdalMaehleApoldPedersen2003\">Heimdal K, Maehle L, Apold J, Pedersen JC, Møller P (2003). \"The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer\". <i>European Journal of Cancer</i>. <b>39</b> (15): 2205–2213. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS0959-8049%2803%2900548-3\" rel=\"nofollow\">10.1016/S0959-8049(03)00548-3</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14522380\" rel=\"nofollow\">14522380</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Cancer&amp;rft.atitle=The+Norwegian+founder+mutations+in+BRCA1%3A+high+penetrance+confirmed+in+an+incident+cancer+series+and+differences+observed+in+the+risk+of+ovarian+cancer&amp;rft.volume=39&amp;rft.issue=15&amp;rft.pages=2205-2213&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1016%2FS0959-8049%2803%2900548-3&amp;rft_id=info%3Apmid%2F14522380&amp;rft.aulast=Heimdal&amp;rft.aufirst=K&amp;rft.au=Maehle%2C+L&amp;rft.au=Apold%2C+J&amp;rft.au=Pedersen%2C+JC&amp;rft.au=M%C3%B8ller%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Liede2002-107\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Liede2002_107-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLiedeMalikAzizRios_Pd_Pde2002\">Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA (2002). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC379195\" rel=\"nofollow\">\"Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan\"</a>. <i>American Journal of Human Genetics</i>. <b>71</b> (3): 595–606. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1086%2F342506\" rel=\"nofollow\">10.1086/342506</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC379195\" rel=\"nofollow\">379195</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12181777\" rel=\"nofollow\">12181777</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=Contribution+of+BRCA1+and+BRCA2+Mutations+to+Breast+and+Ovarian+Cancer+in+Pakistan&amp;rft.volume=71&amp;rft.issue=3&amp;rft.pages=595-606&amp;rft.date=2002&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC379195%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12181777&amp;rft_id=info%3Adoi%2F10.1086%2F342506&amp;rft.aulast=Liede&amp;rft.aufirst=A&amp;rft.au=Malik%2C+IA&amp;rft.au=Aziz%2C+Z&amp;rft.au=Rios+Pd+Pde%2C+L&amp;rft.au=Kwan%2C+E&amp;rft.au=Narod%2C+SA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC379195&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Gorski2000-108\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Gorski2000_108-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFGórskiByrskiHuzarskiJakubowska2000\">Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzańska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubiński J (2000). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1378051\" rel=\"nofollow\">\"Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer\"</a>. <i>American Journal of Human Genetics</i>. <b>66</b> (6): 1963–1968. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1086%2F302922\" rel=\"nofollow\">10.1086/302922</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1378051\" rel=\"nofollow\">1378051</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10788334\" rel=\"nofollow\">10788334</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.atitle=Founder+mutations+in+the+BRCA1+gene+in+Polish+families+with+breast-ovarian+cancer&amp;rft.volume=66&amp;rft.issue=6&amp;rft.pages=1963-1968&amp;rft.date=2000&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1378051%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10788334&amp;rft_id=info%3Adoi%2F10.1086%2F302922&amp;rft.aulast=G%C3%B3rski&amp;rft.aufirst=B&amp;rft.au=Byrski%2C+T&amp;rft.au=Huzarski%2C+T&amp;rft.au=Jakubowska%2C+A&amp;rft.au=Menkiszak%2C+J&amp;rft.au=Gronwald%2C+J&amp;rft.au=Pluza%C5%84ska%2C+A&amp;rft.au=Bebenek%2C+M&amp;rft.au=Fischer-Maliszewska%2C+L&amp;rft.au=Grzybowska%2C+E&amp;rft.au=Narod%2C+SA&amp;rft.au=Lubi%C5%84ski%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1378051&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Perkowska2003-109\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Perkowska2003_109-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPerkowskaBroZekWysockaHaraldsson2003\">Perkowska M, BroZek I, Wysocka B, Haraldsson K, Sandberg T, Johansson U, Sellberg G, Borg A, Limon J (May 2003). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9139\" rel=\"nofollow\">\"BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland\"</a>. <i>Hum. Mutat</i>. <b>21</b> (5): 553–4. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9139\" rel=\"nofollow\">10.1002/humu.9139</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12673801\" rel=\"nofollow\">12673801</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:7001156\" rel=\"nofollow\">7001156</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=BRCA1+and+BRCA2+mutation+analysis+in+breast-ovarian+cancer+families+from+northeastern+Poland&amp;rft.volume=21&amp;rft.issue=5&amp;rft.pages=553-4&amp;rft.date=2003-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7001156%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12673801&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.9139&amp;rft.aulast=Perkowska&amp;rft.aufirst=M&amp;rft.au=BroZek%2C+I&amp;rft.au=Wysocka%2C+B&amp;rft.au=Haraldsson%2C+K&amp;rft.au=Sandberg%2C+T&amp;rft.au=Johansson%2C+U&amp;rft.au=Sellberg%2C+G&amp;rft.au=Borg%2C+A&amp;rft.au=Limon%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.9139&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Gayther1997-110\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Gayther1997_110-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFGaytherHarringtonRussellKharkevich1997\">Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BA (May 1997). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712436\" rel=\"nofollow\">\"Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia\"</a>. <i>Am. J. Hum. Genet</i>. <b>60</b> (5): 1239–42. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712436\" rel=\"nofollow\">1712436</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9150173\" rel=\"nofollow\">9150173</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Hum.+Genet.&amp;rft.atitle=Frequently+occurring+germ-line+mutations+of+the+BRCA1+gene+in+ovarian+cancer+families+from+Russia&amp;rft.volume=60&amp;rft.issue=5&amp;rft.pages=1239-42&amp;rft.date=1997-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1712436%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9150173&amp;rft.aulast=Gayther&amp;rft.aufirst=SA&amp;rft.au=Harrington%2C+P&amp;rft.au=Russell%2C+P&amp;rft.au=Kharkevich%2C+G&amp;rft.au=Garkavtseva%2C+RF&amp;rft.au=Ponder%2C+BA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1712436&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Liede2000-111\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Liede2000_111-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLiedeCohenBlackDavidson2000\">Liede A, Cohen B, Black DM, Davidson RH, Renwick A, Hoodfar E, Olopade OI, Micek M, Anderson V, De Mey R, Fordyce A, Warner E, Dann JL, King MC, Weber B, Narod SA, Steel CM (February 2000). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363321\" rel=\"nofollow\">\"Evidence of a founder BRCA1 mutation in Scotland\"</a>. <i>Br. J. Cancer</i>. <b>82</b> (3): 705–11. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1054%2Fbjoc.1999.0984\" rel=\"nofollow\">10.1054/bjoc.1999.0984</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363321\" rel=\"nofollow\">2363321</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10682686\" rel=\"nofollow\">10682686</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br.+J.+Cancer&amp;rft.atitle=Evidence+of+a+founder+BRCA1+mutation+in+Scotland&amp;rft.volume=82&amp;rft.issue=3&amp;rft.pages=705-11&amp;rft.date=2000-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2363321%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10682686&amp;rft_id=info%3Adoi%2F10.1054%2Fbjoc.1999.0984&amp;rft.aulast=Liede&amp;rft.aufirst=A&amp;rft.au=Cohen%2C+B&amp;rft.au=Black%2C+DM&amp;rft.au=Davidson%2C+RH&amp;rft.au=Renwick%2C+A&amp;rft.au=Hoodfar%2C+E&amp;rft.au=Olopade%2C+OI&amp;rft.au=Micek%2C+M&amp;rft.au=Anderson%2C+V&amp;rft.au=De+Mey%2C+R&amp;rft.au=Fordyce%2C+A&amp;rft.au=Warner%2C+E&amp;rft.au=Dann%2C+JL&amp;rft.au=King%2C+MC&amp;rft.au=Weber%2C+B&amp;rft.au=Narod%2C+SA&amp;rft.au=Steel%2C+CM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2363321&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Vega2001-112\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Vega2001_112-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFVegaCamposBressac-De-PailleretsBond2001\">Vega A, Campos B, Bressac-De-Paillerets B, Bond PM, Janin N, Douglas FS, Domènech M, Baena M, Pericay C, Alonso C, Carracedo A, Baiget M, Diez O (June 2001). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.1136\" rel=\"nofollow\">\"The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript\"</a>. <i>Hum. Mutat</i>. <b>17</b> (6): 520–1. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.1136\" rel=\"nofollow\">10.1002/humu.1136</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11385711\" rel=\"nofollow\">11385711</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:39462456\" rel=\"nofollow\">39462456</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=The+R71G+BRCA1+is+a+founder+Spanish+mutation+and+leads+to+aberrant+splicing+of+the+transcript&amp;rft.volume=17&amp;rft.issue=6&amp;rft.pages=520-1&amp;rft.date=2001-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39462456%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11385711&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.1136&amp;rft.aulast=Vega&amp;rft.aufirst=A&amp;rft.au=Campos%2C+B&amp;rft.au=Bressac-De-Paillerets%2C+B&amp;rft.au=Bond%2C+PM&amp;rft.au=Janin%2C+N&amp;rft.au=Douglas%2C+FS&amp;rft.au=Dom%C3%A8nech%2C+M&amp;rft.au=Baena%2C+M&amp;rft.au=Pericay%2C+C&amp;rft.au=Alonso%2C+C&amp;rft.au=Carracedo%2C+A&amp;rft.au=Baiget%2C+M&amp;rft.au=Diez%2C+O&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.1136&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Campos2003-113\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Campos2003_113-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFCamposDíezOdefreyDomènech2003\">Campos B, Díez O, Odefrey F, Domènech M, Moncoutier V, Martínez-Ferrandis JI, Osorio A, Balmaña J, Barroso A, Armengod ME, Benítez J, Alonso C, Stoppa-Lyonnet D, Goldgar D, Baiget M (April 2003). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9133\" rel=\"nofollow\">\"Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain\"</a>. <i>Hum. Mutat</i>. <b>21</b> (4): 452. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fhumu.9133\" rel=\"nofollow\">10.1002/humu.9133</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12655574\" rel=\"nofollow\">12655574</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:34333797\" rel=\"nofollow\">34333797</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mutat.&amp;rft.atitle=Haplotype+analysis+of+the+BRCA2+9254delATCAT+recurrent+mutation+in+breast%2Fovarian+cancer+families+from+Spain&amp;rft.volume=21&amp;rft.issue=4&amp;rft.pages=452&amp;rft.date=2003-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34333797%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12655574&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.9133&amp;rft.aulast=Campos&amp;rft.aufirst=B&amp;rft.au=D%C3%ADez%2C+O&amp;rft.au=Odefrey%2C+F&amp;rft.au=Dom%C3%A8nech%2C+M&amp;rft.au=Moncoutier%2C+V&amp;rft.au=Mart%C3%ADnez-Ferrandis%2C+JI&amp;rft.au=Osorio%2C+A&amp;rft.au=Balma%C3%B1a%2C+J&amp;rft.au=Barroso%2C+A&amp;rft.au=Armengod%2C+ME&amp;rft.au=Ben%C3%ADtez%2C+J&amp;rft.au=Alonso%2C+C&amp;rft.au=Stoppa-Lyonnet%2C+D&amp;rft.au=Goldgar%2C+D&amp;rft.au=Baiget%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhumu.9133&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Bergman2001-114\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bergman2001_114-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBergmanEinbeigiOlofssonTaib2001\">Bergman A, Einbeigi Z, Olofsson U, Taib Z, Wallgren A, Karlsson P, Wahlström J, Martinsson T, Nordling M (October 2001). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.ejhg.5200704\" rel=\"nofollow\">\"The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation\"</a>. <i>Eur. J. Hum. Genet</i>. <b>9</b> (10): 787–93. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.ejhg.5200704\" rel=\"nofollow\">10.1038/sj.ejhg.5200704</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11781691\" rel=\"nofollow\">11781691</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Eur.+J.+Hum.+Genet.&amp;rft.atitle=The+western+Swedish+BRCA1+founder+mutation+3171ins5%3B+a+3.7+cM+conserved+haplotype+of+today+is+a+reminiscence+of+a+1500-year-old+mutation&amp;rft.volume=9&amp;rft.issue=10&amp;rft.pages=787-93&amp;rft.date=2001-10&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.ejhg.5200704&amp;rft_id=info%3Apmid%2F11781691&amp;rft.aulast=Bergman&amp;rft.aufirst=A&amp;rft.au=Einbeigi%2C+Z&amp;rft.au=Olofsson%2C+U&amp;rft.au=Taib%2C+Z&amp;rft.au=Wallgren%2C+A&amp;rft.au=Karlsson%2C+P&amp;rft.au=Wahlstr%C3%B6m%2C+J&amp;rft.au=Martinsson%2C+T&amp;rft.au=Nordling%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.ejhg.5200704&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid18192670-115\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18192670_115-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHansenKnowltonThyerCharleston2008\">Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA (March 2008). <a class=\"external text\" href=\"https://doi.org/10.1093%2Fhumrep%2Fdem408\" rel=\"nofollow\">\"A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause\"</a>. <i>Hum. Reprod</i>. <b>23</b> (3): 699–708. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1093%2Fhumrep%2Fdem408\" rel=\"nofollow\">10.1093/humrep/dem408</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18192670\" rel=\"nofollow\">18192670</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Reprod.&amp;rft.atitle=A+new+model+of+reproductive+aging%3A+the+decline+in+ovarian+non-growing+follicle+number+from+birth+to+menopause&amp;rft.volume=23&amp;rft.issue=3&amp;rft.pages=699-708&amp;rft.date=2008-03&amp;rft_id=info%3Adoi%2F10.1093%2Fhumrep%2Fdem408&amp;rft_id=info%3Apmid%2F18192670&amp;rft.aulast=Hansen&amp;rft.aufirst=KR&amp;rft.au=Knowlton%2C+NS&amp;rft.au=Thyer%2C+AC&amp;rft.au=Charleston%2C+JS&amp;rft.au=Soules%2C+MR&amp;rft.au=Klein%2C+NA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fhumrep%252Fdem408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-116\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-116\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHassoldHunt2009\">Hassold T, Hunt P (December 2009). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894811\" rel=\"nofollow\">\"Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew\"</a>. <i>Current Opinion in Pediatrics</i>. <b>21</b> (6): 703–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1097%2FMOP.0b013e328332c6ab\" rel=\"nofollow\">10.1097/MOP.0b013e328332c6ab</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894811\" rel=\"nofollow\">2894811</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19881348\" rel=\"nofollow\">19881348</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Pediatrics&amp;rft.atitle=Maternal+age+and+chromosomally+abnormal+pregnancies%3A+what+we+know+and+what+we+wish+we+knew&amp;rft.volume=21&amp;rft.issue=6&amp;rft.pages=703-8&amp;rft.date=2009-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2894811%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19881348&amp;rft_id=info%3Adoi%2F10.1097%2FMOP.0b013e328332c6ab&amp;rft.aulast=Hassold&amp;rft.aufirst=T&amp;rft.au=Hunt%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2894811&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid19996028-117\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid19996028_117-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid19996028_117-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFOktayKimBaradBabayev2010\">Oktay K, Kim JY, Barad D, Babayev SN (January 2010). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040011\" rel=\"nofollow\">\"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks\"</a>. <i>J. Clin. Oncol</i>. <b>28</b> (2): 240–4. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1200%2FJCO.2009.24.2057\" rel=\"nofollow\">10.1200/JCO.2009.24.2057</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040011\" rel=\"nofollow\">3040011</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19996028\" rel=\"nofollow\">19996028</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.atitle=Association+of+BRCA1+mutations+with+occult+primary+ovarian+insufficiency%3A+a+possible+explanation+for+the+link+between+infertility+and+breast%2Fovarian+cancer+risks&amp;rft.volume=28&amp;rft.issue=2&amp;rft.pages=240-4&amp;rft.date=2010-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3040011%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19996028&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2009.24.2057&amp;rft.aulast=Oktay&amp;rft.aufirst=K&amp;rft.au=Kim%2C+JY&amp;rft.au=Barad%2C+D&amp;rft.au=Babayev%2C+SN&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3040011&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid16773440-118\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16773440_118-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFRzepka-GórskaTarnowskiChudecka-GłazGórski2006\">Rzepka-Górska I, Tarnowski B, Chudecka-Głaz A, Górski B, Zielińska D, Tołoczko-Grabarek A (November 2006). \"Premature menopause in patients with BRCA1 gene mutation\". <i>Breast Cancer Res. Treat</i>. <b>100</b> (1): 59–63. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1007%2Fs10549-006-9220-1\" rel=\"nofollow\">10.1007/s10549-006-9220-1</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/16773440\" rel=\"nofollow\">16773440</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:19572648\" rel=\"nofollow\">19572648</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Breast+Cancer+Res.+Treat.&amp;rft.atitle=Premature+menopause+in+patients+with+BRCA1+gene+mutation&amp;rft.volume=100&amp;rft.issue=1&amp;rft.pages=59-63&amp;rft.date=2006-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19572648%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16773440&amp;rft_id=info%3Adoi%2F10.1007%2Fs10549-006-9220-1&amp;rft.aulast=Rzepka-G%C3%B3rska&amp;rft.aufirst=I&amp;rft.au=Tarnowski%2C+B&amp;rft.au=Chudecka-G%C5%82az%2C+A&amp;rft.au=G%C3%B3rski%2C+B&amp;rft.au=Zieli%C5%84ska%2C+D&amp;rft.au=To%C5%82oczko-Grabarek%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Titus-119\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Titus_119-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Titus_119-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFTitusLiStobezkiAkula2013\">Titus S, Li F, Stobezki R, Akula K, Unsal E, Jeong K, Dickler M, Robson M, Moy F, Goswami S, Oktay K (February 2013). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130338\" rel=\"nofollow\">\"Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans\"</a>. <i>Sci Transl Med</i>. <b>5</b> (172): 172ra21. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1126%2Fscitranslmed.3004925\" rel=\"nofollow\">10.1126/scitranslmed.3004925</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130338\" rel=\"nofollow\">5130338</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/23408054\" rel=\"nofollow\">23408054</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sci+Transl+Med&amp;rft.atitle=Impairment+of+BRCA1-related+DNA+double-strand+break+repair+leads+to+ovarian+aging+in+mice+and+humans&amp;rft.volume=5&amp;rft.issue=172&amp;rft.pages=172ra21&amp;rft.date=2013-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5130338%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23408054&amp;rft_id=info%3Adoi%2F10.1126%2Fscitranslmed.3004925&amp;rft.aulast=Titus&amp;rft.aufirst=S&amp;rft.au=Li%2C+F&amp;rft.au=Stobezki%2C+R&amp;rft.au=Akula%2C+K&amp;rft.au=Unsal%2C+E&amp;rft.au=Jeong%2C+K&amp;rft.au=Dickler%2C+M&amp;rft.au=Robson%2C+M&amp;rft.au=Moy%2C+F&amp;rft.au=Goswami%2C+S&amp;rft.au=Oktay%2C+K&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5130338&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-120\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-120\">^</a></b></span> <span class=\"reference-text\">Bernstein H; Hopf FA; Michod RE (1987). The Molecular Basis of the Evolution of Sex. Adv. Genet. Advances in Genetics. Vol. 24. pp. 323–70. doi:10.1016/S0065-2660(08)60012-7. ISBN 9780120176243. PMID 3324702</span>\n",
              "</li>\n",
              "<li id=\"cite_note-Taron-121\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Taron_121-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Taron_121-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFTaronRosellFelipMendez2004\">Taron M, Rosell R, Felip E, Mendez P, Souglakos J, Ronco MS, Queralt C, Majo J, Sanchez JM, Sanchez JJ, Maestre J (October 2004). <a class=\"external text\" href=\"https://doi.org/10.1093%2Fhmg%2Fddh260\" rel=\"nofollow\">\"BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer\"</a>. <i>Hum. Mol. Genet</i>. <b>13</b> (20): 2443–9. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1093%2Fhmg%2Fddh260\" rel=\"nofollow\">10.1093/hmg/ddh260</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15317748\" rel=\"nofollow\">15317748</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mol.+Genet.&amp;rft.atitle=BRCA1+mRNA+expression+levels+as+an+indicator+of+chemoresistance+in+lung+cancer&amp;rft.volume=13&amp;rft.issue=20&amp;rft.pages=2443-9&amp;rft.date=2004-10&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2Fddh260&amp;rft_id=info%3Apmid%2F15317748&amp;rft.aulast=Taron&amp;rft.aufirst=M&amp;rft.au=Rosell%2C+R&amp;rft.au=Felip%2C+E&amp;rft.au=Mendez%2C+P&amp;rft.au=Souglakos%2C+J&amp;rft.au=Ronco%2C+MS&amp;rft.au=Queralt%2C+C&amp;rft.au=Majo%2C+J&amp;rft.au=Sanchez%2C+JM&amp;rft.au=Sanchez%2C+JJ&amp;rft.au=Maestre%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fhmg%252Fddh260&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-Papadaki-122\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Papadaki_122-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Papadaki_122-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPapadakiSfakianakiIoannidisLagoudaki2012\">Papadaki C, Sfakianaki M, Ioannidis G, Lagoudaki E, Trypaki M, Tryfonidis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J (April 2012). <a class=\"external text\" href=\"https://doi.org/10.1097%2FJTO.0b013e318244bdd4\" rel=\"nofollow\">\"ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer\"</a>. <i>J Thorac Oncol</i>. <b>7</b> (4): 663–71. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1097%2FJTO.0b013e318244bdd4\" rel=\"nofollow\">10.1097/JTO.0b013e318244bdd4</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/22425915\" rel=\"nofollow\">22425915</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Thorac+Oncol&amp;rft.atitle=ERCC1+and+BRAC1+mRNA+expression+levels+in+the+primary+tumor+could+predict+the+effectiveness+of+the+second-line+cisplatin-based+chemotherapy+in+pretreated+patients+with+metastatic+non-small+cell+lung+cancer&amp;rft.volume=7&amp;rft.issue=4&amp;rft.pages=663-71&amp;rft.date=2012-04&amp;rft_id=info%3Adoi%2F10.1097%2FJTO.0b013e318244bdd4&amp;rft_id=info%3Apmid%2F22425915&amp;rft.aulast=Papadaki&amp;rft.aufirst=C&amp;rft.au=Sfakianaki%2C+M&amp;rft.au=Ioannidis%2C+G&amp;rft.au=Lagoudaki%2C+E&amp;rft.au=Trypaki%2C+M&amp;rft.au=Tryfonidis%2C+K&amp;rft.au=Mavroudis%2C+D&amp;rft.au=Stathopoulos%2C+E&amp;rft.au=Georgoulias%2C+V&amp;rft.au=Souglakos%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1097%252FJTO.0b013e318244bdd4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid19035454-123\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19035454_123-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWeberpalsGarbuioO'BrienClark-Knowles2009\">Weberpals J, Garbuio K, O'Brien A, Clark-Knowles K, Doucette S, Antoniouk O, Goss G, Dimitroulakos J (February 2009). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.23987\" rel=\"nofollow\">\"The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer\"</a>. <i>Int. J. Cancer</i>. <b>124</b> (4): 806–15. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.23987\" rel=\"nofollow\">10.1002/ijc.23987</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19035454\" rel=\"nofollow\">19035454</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:13357407\" rel=\"nofollow\">13357407</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.atitle=The+DNA+repair+proteins+BRCA1+and+ERCC1+as+predictive+markers+in+sporadic+ovarian+cancer&amp;rft.volume=124&amp;rft.issue=4&amp;rft.pages=806-15&amp;rft.date=2009-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13357407%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19035454&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.23987&amp;rft.aulast=Weberpals&amp;rft.aufirst=J&amp;rft.au=Garbuio%2C+K&amp;rft.au=O%27Brien%2C+A&amp;rft.au=Clark-Knowles%2C+K&amp;rft.au=Doucette%2C+S&amp;rft.au=Antoniouk%2C+O&amp;rft.au=Goss%2C+G&amp;rft.au=Dimitroulakos%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fijc.23987&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-url_BRCA1_patent_legal_battle-124\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-url_BRCA1_patent_legal_battle_124-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation news cs1\"><a class=\"external text\" href=\"http://edition.cnn.com/2009/HEALTH/05/12/us.genes.lawsuit/index.html\" rel=\"nofollow\">\"ACLU sues over patents on breast cancer genes\"</a>. CNN. <a class=\"external text\" href=\"https://web.archive.org/web/20090515095043/http://edition.cnn.com/2009/HEALTH/05/12/us.genes.lawsuit/index.html\" rel=\"nofollow\">Archived</a> from the original on 15 May 2009<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-05-14</span></span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=ACLU+sues+over+patents+on+breast+cancer+genes&amp;rft_id=http%3A%2F%2Fedition.cnn.com%2F2009%2FHEALTH%2F05%2F12%2Fus.genes.lawsuit%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-125\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-125\">^</a></b></span> <span class=\"reference-text\">Robert Cook-Deegan, MD et al (2010) <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047448/\" rel=\"nofollow\">Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Inherited Susceptibility to Cancer: Comparing Breast and Ovarian Cancers to Colon Cancers: Patents and Licensing for Breast, Ovarian and Colon Cancer Testing</a> Genet Med.12(4 Suppl): S15–S38.</span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12509391-126\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12509391_126-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBenowitz2003\">Benowitz S (January 2003). \"European groups oppose Myriad's latest patent on BRCA1\". <i>J. Natl. Cancer Inst</i>. <b>95</b> (1): 8–9. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1093%2Fjnci%2F95.1.8\" rel=\"nofollow\">10.1093/jnci/95.1.8</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12509391\" rel=\"nofollow\">12509391</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.atitle=European+groups+oppose+Myriad%27s+latest+patent+on+BRCA1&amp;rft.volume=95&amp;rft.issue=1&amp;rft.pages=8-9&amp;rft.date=2003-01&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2F95.1.8&amp;rft_id=info%3Apmid%2F12509391&amp;rft.aulast=Benowitz&amp;rft.aufirst=S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-127\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-127\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\" id=\"CITEREFConleyVorhousCook-Deegan2011\">Conley J, Vorhous D, Cook-Deegan J (2011-03-01). <a class=\"external text\" href=\"http://www.genomicslawreport.com/index.php/2011/03/01/how-will-myriad-respond-to-the-next-generation-of-brca-testing/\" rel=\"nofollow\">\"How Will Myriad Respond to the Next Generation of BRCA Testing?\"</a>. Robinson, Bradshaw, and Hinson<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-12-09</span></span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=How+Will+Myriad+Respond+to+the+Next+Generation+of+BRCA+Testing%3F&amp;rft.pub=Robinson%2C+Bradshaw%2C+and+Hinson&amp;rft.date=2011-03-01&amp;rft.aulast=Conley&amp;rft.aufirst=J&amp;rft.au=Vorhous%2C+D&amp;rft.au=Cook-Deegan%2C+J&amp;rft_id=http%3A%2F%2Fwww.genomicslawreport.com%2Findex.php%2F2011%2F03%2F01%2Fhow-will-myriad-respond-to-the-next-generation-of-brca-testing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-urlGenetics_and_Patenting-128\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlGenetics_and_Patenting_128-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.ornl.gov/sci/techresources/Human_Genome/elsi/patents.shtml\" rel=\"nofollow\">\"Genetics and Patenting\"</a>. <i>Human Genome Project Information</i>. U.S. Department of Energy Genome Programs. 2010-07-07.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Human+Genome+Project+Information&amp;rft.atitle=Genetics+and+Patenting&amp;rft.date=2010-07-07&amp;rft_id=http%3A%2F%2Fwww.ornl.gov%2Fsci%2Ftechresources%2FHuman_Genome%2Felsi%2Fpatents.shtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-129\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-129\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation news cs1\" id=\"CITEREFLiptak2013\">Liptak A (June 13, 2013). <a class=\"external text\" href=\"https://www.nytimes.com/2013/06/14/us/supreme-court-rules-human-genes-may-not-be-patented.html\" rel=\"nofollow\">\"Supreme Court Rules Human Genes May Not Be Patented\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 13,</span> 2013</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Supreme+Court+Rules+Human+Genes+May+Not+Be+Patented&amp;rft.date=2013-06-13&amp;rft.aulast=Liptak&amp;rft.aufirst=Adam&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2013%2F06%2F14%2Fus%2Fsupreme-court-rules-human-genes-may-not-be-patented.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-130\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-130\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation news cs1\" id=\"CITEREFCorderoy2013\">Corderoy A (February 15, 2013). <a class=\"external text\" href=\"http://www.smh.com.au/national/health/landmark-patent-ruling-over-breast-cancer-gene-brca1-20130215-2egsq.html\" rel=\"nofollow\">\"Landmark patent ruling over breast cancer gene BRCA1\"</a>. <i><a class=\"mw-redirect\" href=\"/wiki/Sydney_Morning_Herald\" title=\"Sydney Morning Herald\">Sydney Morning Herald</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 14,</span> 2013</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sydney+Morning+Herald&amp;rft.atitle=Landmark+patent+ruling+over+breast+cancer+gene+BRCA1&amp;rft.date=2013-02-15&amp;rft.aulast=Corderoy&amp;rft.aufirst=Amy&amp;rft_id=http%3A%2F%2Fwww.smh.com.au%2Fnational%2Fhealth%2Flandmark-patent-ruling-over-breast-cancer-gene-brca1-20130215-2egsq.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-131\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-131\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation news cs1\"><a class=\"external text\" href=\"https://www.theguardian.com/world/2014/sep/05/court-rules-breast-cancer-gene-brca1-patented-australia\" rel=\"nofollow\">\"Australian federal court rules isolated genetic material can be patented\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i>. 5 September 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 September</span> 2014</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Australian+federal+court+rules+isolated+genetic+material+can+be+patented&amp;rft.date=2014-09-05&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fworld%2F2014%2Fsep%2F05%2Fcourt-rules-breast-cancer-gene-brca1-patented-australia&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-theguardian_2015_oct_07-132\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-theguardian_2015_oct_07_132-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation news cs1\"><a class=\"external text\" href=\"https://www.theguardian.com/society/2015/oct/07/patient-wins-high-court-challenge-against-companys-cancer-gene-patent\" rel=\"nofollow\">\"Patient wins high court challenge against company's cancer gene patent\"</a>. <i>The Guardian</i>. 7 October 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 October</span> 2015</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Patient+wins+high+court+challenge+against+company%27s+cancer+gene+patent&amp;rft.date=2015-10-07&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fsociety%2F2015%2Foct%2F07%2Fpatient-wins-high-court-challenge-against-companys-cancer-gene-patent&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12024016-133\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12024016_133-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFForayMarotRandrianarisonVenezia2002\">Foray N, Marot D, Randrianarison V, Venezia ND, Picard D, Perricaudet M, Favaudon V, Jeggo P (June 2002). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC133860\" rel=\"nofollow\">\"Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation\"</a>. <i>Mol. Cell. Biol</i>. <b>22</b> (12): 4020–32. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1128%2FMCB.22.12.4020-4032.2002\" rel=\"nofollow\">10.1128/MCB.22.12.4020-4032.2002</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC133860\" rel=\"nofollow\">133860</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12024016\" rel=\"nofollow\">12024016</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell.+Biol.&amp;rft.atitle=Constitutive+association+of+BRCA1+and+c-Abl+and+its+ATM-dependent+disruption+after+irradiation&amp;rft.volume=22&amp;rft.issue=12&amp;rft.pages=4020-32&amp;rft.date=2002-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC133860%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12024016&amp;rft_id=info%3Adoi%2F10.1128%2FMCB.22.12.4020-4032.2002&amp;rft.aulast=Foray&amp;rft.aufirst=N&amp;rft.au=Marot%2C+D&amp;rft.au=Randrianarison%2C+V&amp;rft.au=Venezia%2C+ND&amp;rft.au=Picard%2C+D&amp;rft.au=Perricaudet%2C+M&amp;rft.au=Favaudon%2C+V&amp;rft.au=Jeggo%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC133860&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10542266-134\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10542266_134-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFAltiokBattAltiokPapautsky1999\">Altiok S, Batt D, Altiok N, Papautsky A, Downward J, Roberts TM, Avraham H (November 1999). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.45.32274\" rel=\"nofollow\">\"Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells\"</a>. <i>J. Biol. Chem</i>. <b>274</b> (45): 32274–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.45.32274\" rel=\"nofollow\">10.1074/jbc.274.45.32274</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10542266\" rel=\"nofollow\">10542266</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Heregulin+induces+phosphorylation+of+BRCA1+through+phosphatidylinositol+3-Kinase%2FAKT+in+breast+cancer+cells&amp;rft.volume=274&amp;rft.issue=45&amp;rft.pages=32274-8&amp;rft.date=1999-11&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.274.45.32274&amp;rft_id=info%3Apmid%2F10542266&amp;rft.aulast=Altiok&amp;rft.aufirst=S&amp;rft.au=Batt%2C+D&amp;rft.au=Altiok%2C+N&amp;rft.au=Papautsky%2C+A&amp;rft.au=Downward%2C+J&amp;rft.au=Roberts%2C+TM&amp;rft.au=Avraham%2C+H&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.274.45.32274&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid19074868-135\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19074868_135-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFXiangOhashiHuangPandita2008\">Xiang T, Ohashi A, Huang Y, Pandita TK, Ludwig T, Powell SN, Yang Q (December 2008). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605656\" rel=\"nofollow\">\"Negative Regulation of AKT Activation by BRCA1\"</a>. <i>Cancer Res</i>. <b>68</b> (24): 10040–4. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-08-3009\" rel=\"nofollow\">10.1158/0008-5472.CAN-08-3009</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605656\" rel=\"nofollow\">2605656</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19074868\" rel=\"nofollow\">19074868</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Negative+Regulation+of+AKT+Activation+by+BRCA1&amp;rft.volume=68&amp;rft.issue=24&amp;rft.pages=10040-4&amp;rft.date=2008-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2605656%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19074868&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-08-3009&amp;rft.aulast=Xiang&amp;rft.aufirst=T&amp;rft.au=Ohashi%2C+A&amp;rft.au=Huang%2C+Y&amp;rft.au=Pandita%2C+TK&amp;rft.au=Ludwig%2C+T&amp;rft.au=Powell%2C+SN&amp;rft.au=Yang%2C+Q&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2605656&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11016951-136\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11016951_136-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYehHuRahmanLin2000\">Yeh S, Hu YC, Rahman M, Lin HK, Hsu CL, Ting HJ, Kang HY, Chang C (October 2000). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17187\" rel=\"nofollow\">\"Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>97</b> (21): 11256–61. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000PNAS...9711256Y\" rel=\"nofollow\">2000PNAS...9711256Y</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.190353897\" rel=\"nofollow\">10.1073/pnas.190353897</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17187\" rel=\"nofollow\">17187</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11016951\" rel=\"nofollow\">11016951</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Increase+of+androgen-induced+cell+death+and+androgen+receptor+transactivation+by+BRCA1+in+prostate+cancer+cells&amp;rft.volume=97&amp;rft.issue=21&amp;rft.pages=11256-61&amp;rft.date=2000-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC17187%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11016951&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.190353897&amp;rft_id=info%3Abibcode%2F2000PNAS...9711256Y&amp;rft.aulast=Yeh&amp;rft.aufirst=S&amp;rft.au=Hu%2C+YC&amp;rft.au=Rahman%2C+M&amp;rft.au=Lin%2C+HK&amp;rft.au=Hsu%2C+CL&amp;rft.au=Ting%2C+HJ&amp;rft.au=Kang%2C+HY&amp;rft.au=Chang%2C+C&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC17187&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10608806-137\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10608806_137-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10608806_137-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFKimLimCanmanKastan1999\">Kim ST, Lim DS, Canman CE, Kastan MB (December 1999). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.53.37538\" rel=\"nofollow\">\"Substrate specificities and identification of putative substrates of ATM kinase family members\"</a>. <i>J. Biol. Chem</i>. <b>274</b> (53): 37538–43. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.53.37538\" rel=\"nofollow\">10.1074/jbc.274.53.37538</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10608806\" rel=\"nofollow\">10608806</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Substrate+specificities+and+identification+of+putative+substrates+of+ATM+kinase+family+members&amp;rft.volume=274&amp;rft.issue=53&amp;rft.pages=37538-43&amp;rft.date=1999-12&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.274.53.37538&amp;rft_id=info%3Apmid%2F10608806&amp;rft.aulast=Kim&amp;rft.aufirst=ST&amp;rft.au=Lim%2C+DS&amp;rft.au=Canman%2C+CE&amp;rft.au=Kastan%2C+MB&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.274.53.37538&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11114888-138\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11114888_138-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11114888_138-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFTibbettsCortezBrumbaughScully2000\">Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, Abraham RT (December 2000). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317107\" rel=\"nofollow\">\"Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress\"</a>. <i>Genes Dev</i>. <b>14</b> (23): 2989–3002. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1101%2Fgad.851000\" rel=\"nofollow\">10.1101/gad.851000</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317107\" rel=\"nofollow\">317107</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11114888\" rel=\"nofollow\">11114888</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes+Dev.&amp;rft.atitle=Functional+interactions+between+BRCA1+and+the+checkpoint+kinase+ATR+during+genotoxic+stress&amp;rft.volume=14&amp;rft.issue=23&amp;rft.pages=2989-3002&amp;rft.date=2000-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC317107%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11114888&amp;rft_id=info%3Adoi%2F10.1101%2Fgad.851000&amp;rft.aulast=Tibbetts&amp;rft.aufirst=RS&amp;rft.au=Cortez%2C+D&amp;rft.au=Brumbaugh%2C+KM&amp;rft.au=Scully%2C+R&amp;rft.au=Livingston%2C+D&amp;rft.au=Elledge%2C+SJ&amp;rft.au=Abraham%2C+RT&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC317107&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11016625-139\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11016625_139-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11016625_139-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChen2000\">Chen J (September 2000). \"Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage\". <i>Cancer Res</i>. <b>60</b> (18): 5037–9. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11016625\" rel=\"nofollow\">11016625</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Ataxia+telangiectasia-related+protein+is+involved+in+the+phosphorylation+of+BRCA1+following+deoxyribonucleic+acid+damage&amp;rft.volume=60&amp;rft.issue=18&amp;rft.pages=5037-9&amp;rft.date=2000-09&amp;rft_id=info%3Apmid%2F11016625&amp;rft.aulast=Chen&amp;rft.aufirst=J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11278964-140\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11278964_140-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11278964_140-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFGateiZhouHobsonScott2001\">Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK (May 2001). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M011681200\" rel=\"nofollow\">\"Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies\"</a>. <i>J. Biol. Chem</i>. <b>276</b> (20): 17276–80. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M011681200\" rel=\"nofollow\">10.1074/jbc.M011681200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11278964\" rel=\"nofollow\">11278964</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Ataxia+telangiectasia+mutated+%28ATM%29+kinase+and+ATM+and+Rad3+related+kinase+mediate+phosphorylation+of+Brca1+at+distinct+and+overlapping+sites.+In+vivo+assessment+using+phospho-specific+antibodies&amp;rft.volume=276&amp;rft.issue=20&amp;rft.pages=17276-80&amp;rft.date=2001-05&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M011681200&amp;rft_id=info%3Apmid%2F11278964&amp;rft.aulast=Gatei&amp;rft.aufirst=M&amp;rft.au=Zhou%2C+BB&amp;rft.au=Hobson%2C+K&amp;rft.au=Scott%2C+S&amp;rft.au=Young%2C+D&amp;rft.au=Khanna%2C+KK&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M011681200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10866324-141\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10866324_141-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFGateiScottFilippovitchSoronika2000\">Gatei M, Scott SP, Filippovitch I, Soronika N, Lavin MF, Weber B, Khanna KK (June 2000). \"Role for ATM in DNA damage-induced phosphorylation of BRCA1\". <i>Cancer Res</i>. <b>60</b> (12): 3299–304. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10866324\" rel=\"nofollow\">10866324</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Role+for+ATM+in+DNA+damage-induced+phosphorylation+of+BRCA1&amp;rft.volume=60&amp;rft.issue=12&amp;rft.pages=3299-304&amp;rft.date=2000-06&amp;rft_id=info%3Apmid%2F10866324&amp;rft.aulast=Gatei&amp;rft.aufirst=M&amp;rft.au=Scott%2C+SP&amp;rft.au=Filippovitch%2C+I&amp;rft.au=Soronika%2C+N&amp;rft.au=Lavin%2C+MF&amp;rft.au=Weber%2C+B&amp;rft.au=Khanna%2C+KK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10550055-142\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10550055_142-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFCortezWangQinElledge1999\">Cortez D, Wang Y, Qin J, Elledge SJ (November 1999). \"Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks\". <i>Science</i>. <b>286</b> (5442): 1162–6. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.286.5442.1162\" rel=\"nofollow\">10.1126/science.286.5442.1162</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10550055\" rel=\"nofollow\">10550055</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Requirement+of+ATM-dependent+phosphorylation+of+brca1+in+the+DNA+damage+response+to+double-strand+breaks&amp;rft.volume=286&amp;rft.issue=5442&amp;rft.pages=1162-6&amp;rft.date=1999-11&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.286.5442.1162&amp;rft_id=info%3Apmid%2F10550055&amp;rft.aulast=Cortez&amp;rft.aufirst=D&amp;rft.au=Wang%2C+Y&amp;rft.au=Qin%2C+J&amp;rft.au=Elledge%2C+SJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10945975-143\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10945975_143-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHouvrasBenezraZhangManfredi2000\">Houvras Y, Benezra M, Zhang H, Manfredi JJ, Weber BL, Licht JD (November 2000). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M002539200\" rel=\"nofollow\">\"BRCA1 physically and functionally interacts with ATF1\"</a>. <i>J. Biol. Chem</i>. <b>275</b> (46): 36230–7. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M002539200\" rel=\"nofollow\">10.1074/jbc.M002539200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10945975\" rel=\"nofollow\">10945975</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=BRCA1+physically+and+functionally+interacts+with+ATF1&amp;rft.volume=275&amp;rft.issue=46&amp;rft.pages=36230-7&amp;rft.date=2000-11&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M002539200&amp;rft_id=info%3Apmid%2F10945975&amp;rft.aulast=Houvras&amp;rft.aufirst=Y&amp;rft.au=Benezra%2C+M&amp;rft.au=Zhang%2C+H&amp;rft.au=Manfredi%2C+JJ&amp;rft.au=Weber%2C+BL&amp;rft.au=Licht%2C+JD&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M002539200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11301010-144\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11301010_144-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11301010_144-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFCantorBellGanesanKass2001\">Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, Livingston DM (April 2001). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2801%2900304-X\" rel=\"nofollow\">\"BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function\"</a>. <i>Cell</i>. <b>105</b> (1): 149–60. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2801%2900304-X\" rel=\"nofollow\">10.1016/S0092-8674(01)00304-X</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11301010\" rel=\"nofollow\">11301010</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=BACH1%2C+a+novel+helicase-like+protein%2C+interacts+directly+with+BRCA1+and+contributes+to+its+DNA+repair+function&amp;rft.volume=105&amp;rft.issue=1&amp;rft.pages=149-60&amp;rft.date=2001-04&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2801%2900304-X&amp;rft_id=info%3Apmid%2F11301010&amp;rft.aulast=Cantor&amp;rft.aufirst=SB&amp;rft.au=Bell%2C+DW&amp;rft.au=Ganesan%2C+S&amp;rft.au=Kass%2C+EM&amp;rft.au=Drapkin%2C+R&amp;rft.au=Grossman%2C+S&amp;rft.au=Wahrer%2C+DC&amp;rft.au=Sgroi%2C+DC&amp;rft.au=Lane%2C+WS&amp;rft.au=Haber%2C+DA&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252801%252900304-X&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14636569-145\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid14636569_145-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid14636569_145-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFDongHakimiChenKumaraswamy2003\">Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, Shiekhattar R (November 2003). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2803%2900424-6\" rel=\"nofollow\">\"Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair\"</a>. <i>Mol. Cell</i>. <b>12</b> (5): 1087–99. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2803%2900424-6\" rel=\"nofollow\">10.1016/S1097-2765(03)00424-6</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14636569\" rel=\"nofollow\">14636569</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=Regulation+of+BRCC%2C+a+holoenzyme+complex+containing+BRCA1+and+BRCA2%2C+by+a+signalosome-like+subunit+and+its+role+in+DNA+repair&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=1087-99&amp;rft.date=2003-11&amp;rft_id=info%3Adoi%2F10.1016%2FS1097-2765%2803%2900424-6&amp;rft_id=info%3Apmid%2F14636569&amp;rft.aulast=Dong&amp;rft.aufirst=Y&amp;rft.au=Hakimi%2C+MA&amp;rft.au=Chen%2C+X&amp;rft.au=Kumaraswamy%2C+E&amp;rft.au=Cooch%2C+NS&amp;rft.au=Godwin%2C+AK&amp;rft.au=Shiekhattar%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS1097-2765%252803%252900424-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9774970-146\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9774970_146-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9774970_146-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChenSilverWalpitaCantor1998\">Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R (September 1998). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2800%2980276-2\" rel=\"nofollow\">\"Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells\"</a>. <i>Mol. Cell</i>. <b>2</b> (3): 317–28. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2800%2980276-2\" rel=\"nofollow\">10.1016/S1097-2765(00)80276-2</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9774970\" rel=\"nofollow\">9774970</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=Stable+interaction+between+the+products+of+the+BRCA1+and+BRCA2+tumor+suppressor+genes+in+mitotic+and+meiotic+cells&amp;rft.volume=2&amp;rft.issue=3&amp;rft.pages=317-28&amp;rft.date=1998-09&amp;rft_id=info%3Adoi%2F10.1016%2FS1097-2765%2800%2980276-2&amp;rft_id=info%3Apmid%2F9774970&amp;rft.aulast=Chen&amp;rft.aufirst=J&amp;rft.au=Silver%2C+DP&amp;rft.au=Walpita%2C+D&amp;rft.au=Cantor%2C+SB&amp;rft.au=Gazdar%2C+AF&amp;rft.au=Tomlinson%2C+G&amp;rft.au=Couch%2C+FJ&amp;rft.au=Weber%2C+BL&amp;rft.au=Ashley%2C+T&amp;rft.au=Livingston%2C+DM&amp;rft.au=Scully%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS1097-2765%252800%252980276-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14499622-147\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid14499622_147-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid14499622_147-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFReuterMedhurstWaisfiszZhi2003\">Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, Gross HJ, Joenje H, Hoatlin ME, Mathew CG, Huber PA (October 2003). \"Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport\". <i>Exp. Cell Res</i>. <b>289</b> (2): 211–21. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS0014-4827%2803%2900261-1\" rel=\"nofollow\">10.1016/S0014-4827(03)00261-1</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14499622\" rel=\"nofollow\">14499622</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Exp.+Cell+Res.&amp;rft.atitle=Yeast+two-hybrid+screens+imply+involvement+of+Fanconi+anemia+proteins+in+transcription+regulation%2C+cell+signaling%2C+oxidative+metabolism%2C+and+cellular+transport&amp;rft.volume=289&amp;rft.issue=2&amp;rft.pages=211-21&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1016%2FS0014-4827%2803%2900261-1&amp;rft_id=info%3Apmid%2F14499622&amp;rft.aulast=Reuter&amp;rft.aufirst=TY&amp;rft.au=Medhurst%2C+AL&amp;rft.au=Waisfisz%2C+Q&amp;rft.au=Zhi%2C+Y&amp;rft.au=Herterich%2C+S&amp;rft.au=Hoehn%2C+H&amp;rft.au=Gross%2C+HJ&amp;rft.au=Joenje%2C+H&amp;rft.au=Hoatlin%2C+ME&amp;rft.au=Mathew%2C+CG&amp;rft.au=Huber%2C+PA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11477095-148\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11477095_148-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFSarkisianMasterHuberHa2001\">Sarkisian CJ, Master SR, Huber LJ, Ha SI, Chodosh LA (October 2001). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M106281200\" rel=\"nofollow\">\"Analysis of murine Brca2 reveals conservation of protein–protein interactions but differences in nuclear localization signals\"</a>. <i>J. Biol. Chem</i>. <b>276</b> (40): 37640–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M106281200\" rel=\"nofollow\">10.1074/jbc.M106281200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11477095\" rel=\"nofollow\">11477095</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Analysis+of+murine+Brca2+reveals+conservation+of+protein%E2%80%93protein+interactions+but+differences+in+nuclear+localization+signals&amp;rft.volume=276&amp;rft.issue=40&amp;rft.pages=37640-8&amp;rft.date=2001-10&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M106281200&amp;rft_id=info%3Apmid%2F11477095&amp;rft.aulast=Sarkisian&amp;rft.aufirst=CJ&amp;rft.au=Master%2C+SR&amp;rft.au=Huber%2C+LJ&amp;rft.au=Ha%2C+SI&amp;rft.au=Chodosh%2C+LA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M106281200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14578343-149\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid14578343_149-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid14578343_149-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid14578343_149-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid14578343_149-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFRodriguezYuChenSongyang2003\">Rodriguez M, Yu X, Chen J, Songyang Z (December 2003). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C300407200\" rel=\"nofollow\">\"Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains\"</a>. <i>J. Biol. Chem</i>. <b>278</b> (52): 52914–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C300407200\" rel=\"nofollow\">10.1074/jbc.C300407200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14578343\" rel=\"nofollow\">14578343</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Phosphopeptide+binding+specificities+of+BRCA1+COOH-terminal+%28BRCT%29+domains&amp;rft.volume=278&amp;rft.issue=52&amp;rft.pages=52914-8&amp;rft.date=2003-12&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.C300407200&amp;rft_id=info%3Apmid%2F14578343&amp;rft.aulast=Rodriguez&amp;rft.aufirst=M&amp;rft.au=Yu%2C+X&amp;rft.au=Chen%2C+J&amp;rft.au=Songyang%2C+Z&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.C300407200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15208681-150\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid15208681_150-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid15208681_150-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid15208681_150-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid15208681_150-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWadaOishiTakadaYanagisawa2004\">Wada O, Oishi H, Takada I, Yanagisawa J, Yano T, Kato S (August 2004). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1207786\" rel=\"nofollow\">\"BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220\"</a>. <i>Oncogene</i>. <b>23</b> (35): 6000–5. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1207786\" rel=\"nofollow\">10.1038/sj.onc.1207786</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15208681\" rel=\"nofollow\">15208681</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+function+mediates+a+TRAP%2FDRIP+complex+through+direct+interaction+with+TRAP220&amp;rft.volume=23&amp;rft.issue=35&amp;rft.pages=6000-5&amp;rft.date=2004-08&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1207786&amp;rft_id=info%3Apmid%2F15208681&amp;rft.aulast=Wada&amp;rft.aufirst=O&amp;rft.au=Oishi%2C+H&amp;rft.au=Takada%2C+I&amp;rft.au=Yanagisawa%2C+J&amp;rft.au=Yano%2C+T&amp;rft.au=Kato%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1207786&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15242590-151\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15242590_151-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBotuyanNominéYuJuranic2004\">Botuyan MV, Nominé Y, Yu X, Juranic N, Macura S, Chen J, Mer G (July 2004). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652423\" rel=\"nofollow\">\"Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains\"</a>. <i>Structure</i>. <b>12</b> (7): 1137–46. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.str.2004.06.002\" rel=\"nofollow\">10.1016/j.str.2004.06.002</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652423\" rel=\"nofollow\">3652423</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15242590\" rel=\"nofollow\">15242590</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Structure&amp;rft.atitle=Structural+basis+of+BACH1+phosphopeptide+recognition+by+BRCA1+tandem+BRCT+domains&amp;rft.volume=12&amp;rft.issue=7&amp;rft.pages=1137-46&amp;rft.date=2004-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3652423%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15242590&amp;rft_id=info%3Adoi%2F10.1016%2Fj.str.2004.06.002&amp;rft.aulast=Botuyan&amp;rft.aufirst=MV&amp;rft.au=Nomin%C3%A9%2C+Y&amp;rft.au=Yu%2C+X&amp;rft.au=Juranic%2C+N&amp;rft.au=Macura%2C+S&amp;rft.au=Chen%2C+J&amp;rft.au=Mer%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3652423&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14576433-152\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14576433_152-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYuChiniHeMer2003\">Yu X, Chini CC, He M, Mer G, Chen J (October 2003). \"The BRCT domain is a phospho-protein binding domain\". <i>Science</i>. <b>302</b> (5645): 639–42. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2003Sci...302..639Y\" rel=\"nofollow\">2003Sci...302..639Y</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.1088753\" rel=\"nofollow\">10.1126/science.1088753</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14576433\" rel=\"nofollow\">14576433</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:29407635\" rel=\"nofollow\">29407635</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=The+BRCT+domain+is+a+phospho-protein+binding+domain&amp;rft.volume=302&amp;rft.issue=5645&amp;rft.pages=639-42&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1088753&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A29407635%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14576433&amp;rft_id=info%3Abibcode%2F2003Sci...302..639Y&amp;rft.aulast=Yu&amp;rft.aufirst=X&amp;rft.au=Chini%2C+CC&amp;rft.au=He%2C+M&amp;rft.au=Mer%2C+G&amp;rft.au=Chen%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15133502-153\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15133502_153-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFClappertonMankeLoweryHo2004\">Clapperton JA, Manke IA, Lowery DM, Ho T, Haire LF, Yaffe MB, Smerdon SJ (June 2004). \"Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer\". <i>Nature Structural &amp; Molecular Biology</i>. <b>11</b> (6): 512–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fnsmb775\" rel=\"nofollow\">10.1038/nsmb775</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15133502\" rel=\"nofollow\">15133502</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:7354915\" rel=\"nofollow\">7354915</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.atitle=Structure+and+mechanism+of+BRCA1+BRCT+domain+recognition+of+phosphorylated+BACH1+with+implications+for+cancer&amp;rft.volume=11&amp;rft.issue=6&amp;rft.pages=512-8&amp;rft.date=2004-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7354915%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15133502&amp;rft_id=info%3Adoi%2F10.1038%2Fnsmb775&amp;rft.aulast=Clapperton&amp;rft.aufirst=JA&amp;rft.au=Manke%2C+IA&amp;rft.au=Lowery%2C+DM&amp;rft.au=Ho%2C+T&amp;rft.au=Haire%2C+LF&amp;rft.au=Yaffe%2C+MB&amp;rft.au=Smerdon%2C+SJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12080089-154\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12080089_154-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12080089_154-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid12080089_154-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHuLi2002\">Hu YF, Li R (June 2002). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC186344\" rel=\"nofollow\">\"JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction\"</a>. <i>Genes Dev</i>. <b>16</b> (12): 1509–17. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1101%2Fgad.995502\" rel=\"nofollow\">10.1101/gad.995502</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC186344\" rel=\"nofollow\">186344</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12080089\" rel=\"nofollow\">12080089</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes+Dev.&amp;rft.atitle=JunB+potentiates+function+of+BRCA1+activation+domain+1+%28AD1%29+through+a+coiled-coil-mediated+interaction&amp;rft.volume=16&amp;rft.issue=12&amp;rft.pages=1509-17&amp;rft.date=2002-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC186344%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12080089&amp;rft_id=info%3Adoi%2F10.1101%2Fgad.995502&amp;rft.aulast=Hu&amp;rft.aufirst=YF&amp;rft.au=Li%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC186344&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10724175-155\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10724175_155-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLeeCollinsBrownLee2000\">Lee JS, Collins KM, Brown AL, Lee CH, Chung JH (March 2000). \"hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response\". <i>Nature</i>. <b>404</b> (6774): 201–4. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000Natur.404..201L\" rel=\"nofollow\">2000Natur.404..201L</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2F35004614\" rel=\"nofollow\">10.1038/35004614</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10724175\" rel=\"nofollow\">10724175</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:4345911\" rel=\"nofollow\">4345911</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=hCds1-mediated+phosphorylation+of+BRCA1+regulates+the+DNA+damage+response&amp;rft.volume=404&amp;rft.issue=6774&amp;rft.pages=201-4&amp;rft.date=2000-03&amp;rft_id=info%3Adoi%2F10.1038%2F35004614&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4345911%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10724175&amp;rft_id=info%3Abibcode%2F2000Natur.404..201L&amp;rft.aulast=Lee&amp;rft.aufirst=JS&amp;rft.au=Collins%2C+KM&amp;rft.au=Brown%2C+AL&amp;rft.au=Lee%2C+CH&amp;rft.au=Chung%2C+JH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid18804494-156\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18804494_156-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChabalier-TasteRaccaDozierLarminat2008\">Chabalier-Taste C, Racca C, Dozier C, Larminat F (December 2008). <a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.bbamcr.2008.08.006\" rel=\"nofollow\">\"BRCA1 is regulated by Chk2 in response to spindle damage\"</a>. <i>Biochim. Biophys. Acta</i>. <b>1783</b> (12): 2223–33. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.bbamcr.2008.08.006\" rel=\"nofollow\">10.1016/j.bbamcr.2008.08.006</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/18804494\" rel=\"nofollow\">18804494</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochim.+Biophys.+Acta&amp;rft.atitle=BRCA1+is+regulated+by+Chk2+in+response+to+spindle+damage&amp;rft.volume=1783&amp;rft.issue=12&amp;rft.pages=2223-33&amp;rft.date=2008-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbamcr.2008.08.006&amp;rft_id=info%3Apmid%2F18804494&amp;rft.aulast=Chabalier-Taste&amp;rft.aufirst=C&amp;rft.au=Racca%2C+C&amp;rft.au=Dozier%2C+C&amp;rft.au=Larminat%2C+F&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.bbamcr.2008.08.006&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15096610-157\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15096610_157-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLinLiStewartElledge2004\">Lin SY, Li K, Stewart GS, Elledge SJ (April 2004). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC404071\" rel=\"nofollow\">\"Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>101</b> (17): 6484–9. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2004PNAS..101.6484L\" rel=\"nofollow\">2004PNAS..101.6484L</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.0401847101\" rel=\"nofollow\">10.1073/pnas.0401847101</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC404071\" rel=\"nofollow\">404071</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15096610\" rel=\"nofollow\">15096610</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Human+Claspin+works+with+BRCA1+to+both+positively+and+negatively+regulate+cell+proliferation&amp;rft.volume=101&amp;rft.issue=17&amp;rft.pages=6484-9&amp;rft.date=2004-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC404071%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15096610&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0401847101&amp;rft_id=info%3Abibcode%2F2004PNAS..101.6484L&amp;rft.aulast=Lin&amp;rft.aufirst=SY&amp;rft.au=Li%2C+K&amp;rft.au=Stewart%2C+GS&amp;rft.au=Elledge%2C+SJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC404071&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11739404-158\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11739404_158-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYeHuZhongNye2001\">Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R (December 2001). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150890\" rel=\"nofollow\">\"BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations\"</a>. <i>J. Cell Biol</i>. <b>155</b> (6): 911–21. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1083%2Fjcb.200108049\" rel=\"nofollow\">10.1083/jcb.200108049</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150890\" rel=\"nofollow\">2150890</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11739404\" rel=\"nofollow\">11739404</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Cell+Biol.&amp;rft.atitle=BRCA1-induced+large-scale+chromatin+unfolding+and+allele-specific+effects+of+cancer-predisposing+mutations&amp;rft.volume=155&amp;rft.issue=6&amp;rft.pages=911-21&amp;rft.date=2001-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2150890%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11739404&amp;rft_id=info%3Adoi%2F10.1083%2Fjcb.200108049&amp;rft.aulast=Ye&amp;rft.aufirst=Q&amp;rft.au=Hu%2C+YF&amp;rft.au=Zhong%2C+H&amp;rft.au=Nye%2C+AC&amp;rft.au=Belmont%2C+AS&amp;rft.au=Li%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2150890&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12700228-159\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12700228_159-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12700228_159-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBenezraChevallierMorrisonMacLachlan2003\">Benezra M, Chevallier N, Morrison DJ, MacLachlan TK, El-Deiry WS, Licht JD (July 2003). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M303076200\" rel=\"nofollow\">\"BRCA1 augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunit\"</a>. <i>J. Biol. Chem</i>. <b>278</b> (29): 26333–41. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M303076200\" rel=\"nofollow\">10.1074/jbc.M303076200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12700228\" rel=\"nofollow\">12700228</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=BRCA1+augments+transcription+by+the+NF-kappaB+transcription+factor+by+binding+to+the+Rel+domain+of+the+p65%2FRelA+subunit&amp;rft.volume=278&amp;rft.issue=29&amp;rft.pages=26333-41&amp;rft.date=2003-07&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M303076200&amp;rft_id=info%3Apmid%2F12700228&amp;rft.aulast=Benezra&amp;rft.aufirst=M&amp;rft.au=Chevallier%2C+N&amp;rft.au=Morrison%2C+DJ&amp;rft.au=MacLachlan%2C+TK&amp;rft.au=El-Deiry%2C+WS&amp;rft.au=Licht%2C+JD&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M303076200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10655477-160\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10655477_160-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10655477_160-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPaoJanknechtRuffnerHunter2000\">Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM (February 2000). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15508\" rel=\"nofollow\">\"CBP/p300 interact with and function as transcriptional coactivators of BRCA1\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>97</b> (3): 1020–5. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000PNAS...97.1020P\" rel=\"nofollow\">2000PNAS...97.1020P</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.97.3.1020\" rel=\"nofollow\">10.1073/pnas.97.3.1020</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15508\" rel=\"nofollow\">15508</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10655477\" rel=\"nofollow\">10655477</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=CBP%2Fp300+interact+with+and+function+as+transcriptional+coactivators+of+BRCA1&amp;rft.volume=97&amp;rft.issue=3&amp;rft.pages=1020-5&amp;rft.date=2000-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC15508%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10655477&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.97.3.1020&amp;rft_id=info%3Abibcode%2F2000PNAS...97.1020P&amp;rft.aulast=Pao&amp;rft.aufirst=GM&amp;rft.au=Janknecht%2C+R&amp;rft.au=Ruffner%2C+H&amp;rft.au=Hunter%2C+T&amp;rft.au=Verma%2C+IM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC15508&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9926942-161\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9926942_161-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9926942_161-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChaiCuiShaoShyam1999\">Chai YL, Cui J, Shao N, Shyam E, Reddy P, Rao VN (January 1999). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202323\" rel=\"nofollow\">\"The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter\"</a>. <i>Oncogene</i>. <b>18</b> (1): 263–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202323\" rel=\"nofollow\">10.1038/sj.onc.1202323</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9926942\" rel=\"nofollow\">9926942</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=The+second+BRCT+domain+of+BRCA1+proteins+interacts+with+p53+and+stimulates+transcription+from+the+p21WAF1%2FCIP1+promoter&amp;rft.volume=18&amp;rft.issue=1&amp;rft.pages=263-8&amp;rft.date=1999-01&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1202323&amp;rft_id=info%3Apmid%2F9926942&amp;rft.aulast=Chai&amp;rft.aufirst=YL&amp;rft.au=Cui%2C+J&amp;rft.au=Shao%2C+N&amp;rft.au=Shyam%2C+E&amp;rft.au=Reddy%2C+P&amp;rft.au=Rao%2C+VN&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1202323&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11782371-162\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11782371_162-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11782371_162-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11782371_162-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFFanMaWangYuan2002\">Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM (January 2002). \"p300 Modulates the BRCA1 inhibition of estrogen receptor activity\". <i>Cancer Res</i>. <b>62</b> (1): 141–51. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11782371\" rel=\"nofollow\">11782371</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=p300+Modulates+the+BRCA1+inhibition+of+estrogen+receptor+activity&amp;rft.volume=62&amp;rft.issue=1&amp;rft.pages=141-51&amp;rft.date=2002-01&amp;rft_id=info%3Apmid%2F11782371&amp;rft.aulast=Fan&amp;rft.aufirst=S&amp;rft.au=Ma%2C+YX&amp;rft.au=Wang%2C+C&amp;rft.au=Yuan%2C+RQ&amp;rft.au=Meng%2C+Q&amp;rft.au=Wang%2C+JA&amp;rft.au=Erdos%2C+M&amp;rft.au=Goldberg%2C+ID&amp;rft.au=Webb%2C+P&amp;rft.au=Kushner%2C+PJ&amp;rft.au=Pestell%2C+RG&amp;rft.au=Rosen%2C+EM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9443979-163\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9443979_163-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFNeishAndersonSchlegelWei1998\">Neish AS, Anderson SF, Schlegel BP, Wei W, Parvin JD (February 1998). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC147327\" rel=\"nofollow\">\"Factors associated with the mammalian RNA polymerase II holoenzyme\"</a>. <i>Nucleic Acids Res</i>. <b>26</b> (3): 847–53. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1093%2Fnar%2F26.3.847\" rel=\"nofollow\">10.1093/nar/26.3.847</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC147327\" rel=\"nofollow\">147327</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9443979\" rel=\"nofollow\">9443979</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nucleic+Acids+Res.&amp;rft.atitle=Factors+associated+with+the+mammalian+RNA+polymerase+II+holoenzyme&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=847-53&amp;rft.date=1998-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC147327%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9443979&amp;rft_id=info%3Adoi%2F10.1093%2Fnar%2F26.3.847&amp;rft.aulast=Neish&amp;rft.aufirst=AS&amp;rft.au=Anderson%2C+SF&amp;rft.au=Schlegel%2C+BP&amp;rft.au=Wei%2C+W&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC147327&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10403822-164\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10403822_164-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFO'BrienLemkeCockeRao1999\">O'Brien KA, Lemke SJ, Cocke KS, Rao RN, Beckmann RP (July 1999). \"Casein kinase 2 binds to and phosphorylates BRCA1\". <i>Biochem. Biophys. Res. Commun</i>. <b>260</b> (3): 658–64. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1006%2Fbbrc.1999.0892\" rel=\"nofollow\">10.1006/bbrc.1999.0892</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10403822\" rel=\"nofollow\">10403822</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochem.+Biophys.+Res.+Commun.&amp;rft.atitle=Casein+kinase+2+binds+to+and+phosphorylates+BRCA1&amp;rft.volume=260&amp;rft.issue=3&amp;rft.pages=658-64&amp;rft.date=1999-07&amp;rft_id=info%3Adoi%2F10.1006%2Fbbrc.1999.0892&amp;rft_id=info%3Apmid%2F10403822&amp;rft.aulast=O%27Brien&amp;rft.aufirst=KA&amp;rft.au=Lemke%2C+SJ&amp;rft.au=Cocke%2C+KS&amp;rft.au=Rao%2C+RN&amp;rft.au=Beckmann%2C+RP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11257228-165\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11257228_165-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFKleimanManley2001\">Kleiman FE, Manley JL (March 2001). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2801%2900270-7\" rel=\"nofollow\">\"The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression\"</a>. <i>Cell</i>. <b>104</b> (5): 743–53. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2801%2900270-7\" rel=\"nofollow\">10.1016/S0092-8674(01)00270-7</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11257228\" rel=\"nofollow\">11257228</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=The+BARD1-CstF-50+interaction+links+mRNA+3%27+end+formation+to+DNA+damage+and+tumor+suppression&amp;rft.volume=104&amp;rft.issue=5&amp;rft.pages=743-53&amp;rft.date=2001-03&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2801%2900270-7&amp;rft_id=info%3Apmid%2F11257228&amp;rft.aulast=Kleiman&amp;rft.aufirst=FE&amp;rft.au=Manley%2C+JL&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252801%252900270-7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10477523-166\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10477523_166-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFKleimanManley1999\">Kleiman FE, Manley JL (September 1999). \"Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50\". <i>Science</i>. <b>285</b> (5433): 1576–9. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.285.5433.1576\" rel=\"nofollow\">10.1126/science.285.5433.1576</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10477523\" rel=\"nofollow\">10477523</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Functional+interaction+of+BRCA1-associated+BARD1+with+polyadenylation+factor+CstF-50&amp;rft.volume=285&amp;rft.issue=5433&amp;rft.pages=1576-9&amp;rft.date=1999-09&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.285.5433.1576&amp;rft_id=info%3Apmid%2F10477523&amp;rft.aulast=Kleiman&amp;rft.aufirst=FE&amp;rft.au=Manley%2C+JL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9244350-167\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9244350_167-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWangShaoDingCui1997\">Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN (Jul 1997). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1201252\" rel=\"nofollow\">\"BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases\"</a>. <i>Oncogene</i>. <b>15</b> (2): 143–57. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1201252\" rel=\"nofollow\">10.1038/sj.onc.1201252</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9244350\" rel=\"nofollow\">9244350</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+proteins+are+transported+to+the+nucleus+in+the+absence+of+serum+and+splice+variants+BRCA1a%2C+BRCA1b+are+tyrosine+phosphoproteins+that+associate+with+E2F%2C+cyclins+and+cyclin+dependent+kinases&amp;rft.volume=15&amp;rft.issue=2&amp;rft.pages=143-57&amp;rft.date=1997-07&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1201252&amp;rft_id=info%3Apmid%2F9244350&amp;rft.aulast=Wang&amp;rft.aufirst=H&amp;rft.au=Shao%2C+N&amp;rft.au=Ding%2C+QM&amp;rft.au=Cui%2C+J&amp;rft.au=Reddy%2C+ES&amp;rft.au=Rao%2C+VN&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1201252&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid8764100-168\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid8764100_168-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChenFarmerChenJones1996\">Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH (July 1996). \"BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner\". <i>Cancer Res</i>. <b>56</b> (14): 3168–72. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/8764100\" rel=\"nofollow\">8764100</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=BRCA1+is+a+220-kDa+nuclear+phosphoprotein+that+is+expressed+and+phosphorylated+in+a+cell+cycle-dependent+manner&amp;rft.volume=56&amp;rft.issue=14&amp;rft.pages=3168-72&amp;rft.date=1996-07&amp;rft_id=info%3Apmid%2F8764100&amp;rft.aulast=Chen&amp;rft.aufirst=Y&amp;rft.au=Farmer%2C+AA&amp;rft.au=Chen%2C+CF&amp;rft.au=Jones%2C+DC&amp;rft.au=Chen%2C+PL&amp;rft.au=Lee%2C+WH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10373534-169\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10373534_169-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFRuffnerJiangCraigHunter1999\">Ruffner H, Jiang W, Craig AG, Hunter T, Verma IM (July 1999). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC84283\" rel=\"nofollow\">\"BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site\"</a>. <i>Mol. Cell. Biol</i>. <b>19</b> (7): 4843–54. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1128%2FMCB.19.7.4843\" rel=\"nofollow\">10.1128/MCB.19.7.4843</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC84283\" rel=\"nofollow\">84283</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10373534\" rel=\"nofollow\">10373534</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell.+Biol.&amp;rft.atitle=BRCA1+is+phosphorylated+at+serine+1497+in+vivo+at+a+cyclin-dependent+kinase+2+phosphorylation+site&amp;rft.volume=19&amp;rft.issue=7&amp;rft.pages=4843-54&amp;rft.date=1999-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC84283%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10373534&amp;rft_id=info%3Adoi%2F10.1128%2FMCB.19.7.4843&amp;rft.aulast=Ruffner&amp;rft.aufirst=H&amp;rft.au=Jiang%2C+W&amp;rft.au=Craig%2C+AG&amp;rft.au=Hunter%2C+T&amp;rft.au=Verma%2C+IM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC84283&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12592385-170\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12592385_170-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFSchlegelStaritaParvin2003\">Schlegel BP, Starita LM, Parvin JD (February 2003). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1206195\" rel=\"nofollow\">\"Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells\"</a>. <i>Oncogene</i>. <b>22</b> (7): 983–91. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1206195\" rel=\"nofollow\">10.1038/sj.onc.1206195</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12592385\" rel=\"nofollow\">12592385</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Overexpression+of+a+protein+fragment+of+RNA+helicase+A+causes+inhibition+of+endogenous+BRCA1+function+and+defects+in+ploidy+and+cytokinesis+in+mammary+epithelial+cells&amp;rft.volume=22&amp;rft.issue=7&amp;rft.pages=983-91&amp;rft.date=2003-02&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1206195&amp;rft_id=info%3Apmid%2F12592385&amp;rft.aulast=Schlegel&amp;rft.aufirst=BP&amp;rft.au=Starita%2C+LM&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1206195&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9662397-171\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9662397_171-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFAndersonSchlegelNakajimaWolpin1998\">Anderson SF, Schlegel BP, Nakajima T, Wolpin ES, Parvin JD (July 1998). \"BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A\". <i>Nat. Genet</i>. <b>19</b> (3): 254–6. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2F930\" rel=\"nofollow\">10.1038/930</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9662397\" rel=\"nofollow\">9662397</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:10953768\" rel=\"nofollow\">10953768</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Genet.&amp;rft.atitle=BRCA1+protein+is+linked+to+the+RNA+polymerase+II+holoenzyme+complex+via+RNA+helicase+A&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=254-6&amp;rft.date=1998-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A10953768%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9662397&amp;rft_id=info%3Adoi%2F10.1038%2F930&amp;rft.aulast=Anderson&amp;rft.aufirst=SF&amp;rft.au=Schlegel%2C+BP&amp;rft.au=Nakajima%2C+T&amp;rft.au=Wolpin%2C+ES&amp;rft.au=Parvin%2C+JD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11313879-172\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11313879_172-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChaiChipitsynaCuiLiao2001\">Chai Y, Chipitsyna G, Cui J, Liao B, Liu S, Aysola K, Yezdani M, Reddy ES, Rao VN (March 2001). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204256\" rel=\"nofollow\">\"c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells\"</a>. <i>Oncogene</i>. <b>20</b> (11): 1357–67. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204256\" rel=\"nofollow\">10.1038/sj.onc.1204256</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11313879\" rel=\"nofollow\">11313879</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=c-Fos+oncogene+regulator+Elk-1+interacts+with+BRCA1+splice+variants+BRCA1a%2F1b+and+enhances+BRCA1a%2F1b-mediated+growth+suppression+in+breast+cancer+cells&amp;rft.volume=20&amp;rft.issue=11&amp;rft.pages=1357-67&amp;rft.date=2001-03&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1204256&amp;rft_id=info%3Apmid%2F11313879&amp;rft.aulast=Chai&amp;rft.aufirst=Y&amp;rft.au=Chipitsyna%2C+G&amp;rft.au=Cui%2C+J&amp;rft.au=Liao%2C+B&amp;rft.au=Liu%2C+S&amp;rft.au=Aysola%2C+K&amp;rft.au=Yezdani%2C+M&amp;rft.au=Reddy%2C+ES&amp;rft.au=Rao%2C+VN&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1204256&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11493692-173\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11493692_173-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFZhengAnnabAfshariLee2001\">Zheng L, Annab LA, Afshari CA, Lee WH, Boyer TG (August 2001). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55496\" rel=\"nofollow\">\"BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>98</b> (17): 9587–92. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2001PNAS...98.9587Z\" rel=\"nofollow\">2001PNAS...98.9587Z</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.171174298\" rel=\"nofollow\">10.1073/pnas.171174298</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55496\" rel=\"nofollow\">55496</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11493692\" rel=\"nofollow\">11493692</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1+mediates+ligand-independent+transcriptional+repression+of+the+estrogen+receptor&amp;rft.volume=98&amp;rft.issue=17&amp;rft.pages=9587-92&amp;rft.date=2001-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC55496%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11493692&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.171174298&amp;rft_id=info%3Abibcode%2F2001PNAS...98.9587Z&amp;rft.aulast=Zheng&amp;rft.aufirst=L&amp;rft.au=Annab%2C+LA&amp;rft.au=Afshari%2C+CA&amp;rft.au=Lee%2C+WH&amp;rft.au=Boyer%2C+TG&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC55496&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11244506-174\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11244506_174-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFFanMaWangYuan2001\">Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM (January 2001). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204073\" rel=\"nofollow\">\"Role of direct interaction in BRCA1 inhibition of estrogen receptor activity\"</a>. <i>Oncogene</i>. <b>20</b> (1): 77–87. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204073\" rel=\"nofollow\">10.1038/sj.onc.1204073</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11244506\" rel=\"nofollow\">11244506</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Role+of+direct+interaction+in+BRCA1+inhibition+of+estrogen+receptor+activity&amp;rft.volume=20&amp;rft.issue=1&amp;rft.pages=77-87&amp;rft.date=2001-01&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1204073&amp;rft_id=info%3Apmid%2F11244506&amp;rft.aulast=Fan&amp;rft.aufirst=S&amp;rft.au=Ma%2C+YX&amp;rft.au=Wang%2C+C&amp;rft.au=Yuan%2C+RQ&amp;rft.au=Meng%2C+Q&amp;rft.au=Wang%2C+JA&amp;rft.au=Erdos%2C+M&amp;rft.au=Goldberg%2C+ID&amp;rft.au=Webb%2C+P&amp;rft.au=Kushner%2C+PJ&amp;rft.au=Pestell%2C+RG&amp;rft.au=Rosen%2C+EM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1204073&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12400015-175\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12400015_175-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFKawaiLiChunAvraham2002\">Kawai H, Li H, Chun P, Avraham S, Avraham HK (October 2002). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1205971\" rel=\"nofollow\">\"Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells\"</a>. <i>Oncogene</i>. <b>21</b> (50): 7730–9. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1205971\" rel=\"nofollow\">10.1038/sj.onc.1205971</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12400015\" rel=\"nofollow\">12400015</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Direct+interaction+between+BRCA1+and+the+estrogen+receptor+regulates+vascular+endothelial+growth+factor+%28VEGF%29+transcription+and+secretion+in+breast+cancer+cells&amp;rft.volume=21&amp;rft.issue=50&amp;rft.pages=7730-9&amp;rft.date=2002-10&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1205971&amp;rft_id=info%3Apmid%2F12400015&amp;rft.aulast=Kawai&amp;rft.aufirst=H&amp;rft.au=Li%2C+H&amp;rft.au=Chun%2C+P&amp;rft.au=Avraham%2C+S&amp;rft.au=Avraham%2C+HK&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1205971&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12354784-176\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12354784_176-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFFoliasMatkovicBruunReid2002\">Folias A, Matkovic M, Bruun D, Reid S, Hejna J, Grompe M, D'Andrea A, Moses R (October 2002). <a class=\"external text\" href=\"https://doi.org/10.1093%2Fhmg%2F11.21.2591\" rel=\"nofollow\">\"BRCA1 interacts directly with the Fanconi anemia protein FANCA\"</a>. <i>Hum. Mol. Genet</i>. <b>11</b> (21): 2591–7. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1093%2Fhmg%2F11.21.2591\" rel=\"nofollow\">10.1093/hmg/11.21.2591</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12354784\" rel=\"nofollow\">12354784</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum.+Mol.+Genet.&amp;rft.atitle=BRCA1+interacts+directly+with+the+Fanconi+anemia+protein+FANCA&amp;rft.volume=11&amp;rft.issue=21&amp;rft.pages=2591-7&amp;rft.date=2002-10&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2F11.21.2591&amp;rft_id=info%3Apmid%2F12354784&amp;rft.aulast=Folias&amp;rft.aufirst=A&amp;rft.au=Matkovic%2C+M&amp;rft.au=Bruun%2C+D&amp;rft.au=Reid%2C+S&amp;rft.au=Hejna%2C+J&amp;rft.au=Grompe%2C+M&amp;rft.au=D%27Andrea%2C+A&amp;rft.au=Moses%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fhmg%252F11.21.2591&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12887909-177\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12887909_177-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12887909_177-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFVandenbergGergelyOngPace2003\">Vandenberg CJ, Gergely F, Ong CY, Pace P, Mallery DL, Hiom K, Patel KJ (July 2003). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2803%2900281-8\" rel=\"nofollow\">\"BRCA1-independent ubiquitination of FANCD2\"</a>. <i>Mol. Cell</i>. <b>12</b> (1): 247–54. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2803%2900281-8\" rel=\"nofollow\">10.1016/S1097-2765(03)00281-8</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12887909\" rel=\"nofollow\">12887909</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=BRCA1-independent+ubiquitination+of+FANCD2&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=247-54&amp;rft.date=2003-07&amp;rft_id=info%3Adoi%2F10.1016%2FS1097-2765%2803%2900281-8&amp;rft_id=info%3Apmid%2F12887909&amp;rft.aulast=Vandenberg&amp;rft.aufirst=CJ&amp;rft.au=Gergely%2C+F&amp;rft.au=Ong%2C+CY&amp;rft.au=Pace%2C+P&amp;rft.au=Mallery%2C+DL&amp;rft.au=Hiom%2C+K&amp;rft.au=Patel%2C+KJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS1097-2765%252803%252900281-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14550570-178\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14550570_178-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYanZhuZhongLu2003\">Yan J, Zhu J, Zhong H, Lu Q, Huang C, Ye Q (October 2003). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS0014-5793%2803%2900978-5\" rel=\"nofollow\">\"BRCA1 interacts with FHL2 and enhances FHL2 transactivation function\"</a>. <i>FEBS Lett</i>. <b>553</b> (1–2): 183–9. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0014-5793%2803%2900978-5\" rel=\"nofollow\">10.1016/S0014-5793(03)00978-5</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14550570\" rel=\"nofollow\">14550570</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:31566004\" rel=\"nofollow\">31566004</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FEBS+Lett.&amp;rft.atitle=BRCA1+interacts+with+FHL2+and+enhances+FHL2+transactivation+function&amp;rft.volume=553&amp;rft.issue=1%E2%80%932&amp;rft.pages=183-9&amp;rft.date=2003-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31566004%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14550570&amp;rft_id=info%3Adoi%2F10.1016%2FS0014-5793%2803%2900978-5&amp;rft.aulast=Yan&amp;rft.aufirst=J&amp;rft.au=Zhu%2C+J&amp;rft.au=Zhong%2C+H&amp;rft.au=Lu%2C+Q&amp;rft.au=Huang%2C+C&amp;rft.au=Ye%2C+Q&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0014-5793%252803%252900978-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14986435-179\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14986435_179-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1 cs1-prop-foreign-lang-source\" id=\"CITEREFYanYeZhuZhong2003\">Yan JH, Ye QN, Zhu JH, Zhong HJ, Zheng HY, Huang CF (December 2003). \"[Isolation and characterization of a BRCA1-interacting protein]\". <i>Yi Chuan Xue Bao</i> (in Chinese). <b>30</b> (12): 1161–6. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14986435\" rel=\"nofollow\">14986435</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Yi+Chuan+Xue+Bao&amp;rft.atitle=%5BIsolation+and+characterization+of+a+BRCA1-interacting+protein%5D&amp;rft.volume=30&amp;rft.issue=12&amp;rft.pages=1161-6&amp;rft.date=2003-12&amp;rft_id=info%3Apmid%2F14986435&amp;rft.aulast=Yan&amp;rft.aufirst=JH&amp;rft.au=Ye%2C+QN&amp;rft.au=Zhu%2C+JH&amp;rft.au=Zhong%2C+HJ&amp;rft.au=Zheng%2C+HY&amp;rft.au=Huang%2C+CF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12485996-180\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12485996_180-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12485996_180-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFMalleryVandenbergHiom2002\">Mallery DL, Vandenberg CJ, Hiom K (December 2002). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139111\" rel=\"nofollow\">\"Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains\"</a>. <i>EMBO J</i>. <b>21</b> (24): 6755–62. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1093%2Femboj%2Fcdf691\" rel=\"nofollow\">10.1093/emboj/cdf691</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139111\" rel=\"nofollow\">139111</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12485996\" rel=\"nofollow\">12485996</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EMBO+J.&amp;rft.atitle=Activation+of+the+E3+ligase+function+of+the+BRCA1%2FBARD1+complex+by+polyubiquitin+chains&amp;rft.volume=21&amp;rft.issue=24&amp;rft.pages=6755-62&amp;rft.date=2002-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC139111%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12485996&amp;rft_id=info%3Adoi%2F10.1093%2Femboj%2Fcdf691&amp;rft.aulast=Mallery&amp;rft.aufirst=DL&amp;rft.au=Vandenberg%2C+CJ&amp;rft.au=Hiom%2C+K&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC139111&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11927591-181\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11927591_181-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11927591_181-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChenKleimanManleyOuchi2002\">Chen A, Kleiman FE, Manley JL, Ouchi T, Pan ZQ (June 2002). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M201252200\" rel=\"nofollow\">\"Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase\"</a>. <i>J. Biol. Chem</i>. <b>277</b> (24): 22085–92. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M201252200\" rel=\"nofollow\">10.1074/jbc.M201252200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11927591\" rel=\"nofollow\">11927591</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Autoubiquitination+of+the+BRCA1%2ABARD1+RING+ubiquitin+ligase&amp;rft.volume=277&amp;rft.issue=24&amp;rft.pages=22085-92&amp;rft.date=2002-06&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M201252200&amp;rft_id=info%3Apmid%2F11927591&amp;rft.aulast=Chen&amp;rft.aufirst=A&amp;rft.au=Kleiman%2C+FE&amp;rft.au=Manley%2C+JL&amp;rft.au=Ouchi%2C+T&amp;rft.au=Pan%2C+ZQ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M201252200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10959836-182\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10959836_182-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPaullRogakouYamazakiKirchgessner2000\">Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM (2000). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS0960-9822%2800%2900610-2\" rel=\"nofollow\">\"A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage\"</a>. <i>Curr. Biol</i>. <b>10</b> (15): 886–95. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0960-9822%2800%2900610-2\" rel=\"nofollow\">10.1016/S0960-9822(00)00610-2</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10959836\" rel=\"nofollow\">10959836</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Curr.+Biol.&amp;rft.atitle=A+critical+role+for+histone+H2AX+in+recruitment+of+repair+factors+to+nuclear+foci+after+DNA+damage&amp;rft.volume=10&amp;rft.issue=15&amp;rft.pages=886-95&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1016%2FS0960-9822%2800%2900610-2&amp;rft_id=info%3Apmid%2F10959836&amp;rft.aulast=Paull&amp;rft.aufirst=TT&amp;rft.au=Rogakou%2C+EP&amp;rft.au=Yamazaki%2C+V&amp;rft.au=Kirchgessner%2C+CU&amp;rft.au=Gellert%2C+M&amp;rft.au=Bonner%2C+WM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0960-9822%252800%252900610-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12925972-183\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12925972_183-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFSutherlandVisvaderChoongSum2003\">Sutherland KD, Visvader JE, Choong DY, Sum EY, Lindeman GJ, Campbell IG (October 2003). <a class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.11343\" rel=\"nofollow\">\"Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas\"</a>. <i>Int. J. Cancer</i>. <b>107</b> (1): 155–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1002%2Fijc.11343\" rel=\"nofollow\">10.1002/ijc.11343</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12925972\" rel=\"nofollow\">12925972</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:20908722\" rel=\"nofollow\">20908722</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.atitle=Mutational+analysis+of+the+LMO4+gene%2C+encoding+a+BRCA1-interacting+protein%2C+in+breast+carcinomas&amp;rft.volume=107&amp;rft.issue=1&amp;rft.pages=155-8&amp;rft.date=2003-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20908722%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12925972&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.11343&amp;rft.aulast=Sutherland&amp;rft.aufirst=KD&amp;rft.au=Visvader%2C+JE&amp;rft.au=Choong%2C+DY&amp;rft.au=Sum%2C+EY&amp;rft.au=Lindeman%2C+GJ&amp;rft.au=Campbell%2C+IG&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fijc.11343&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11751867-184\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11751867_184-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFSumPengYuChen2002\">Sum EY, Peng B, Yu X, Chen J, Byrne J, Lindeman GJ, Visvader JE (March 2002). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M110603200\" rel=\"nofollow\">\"The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity\"</a>. <i>J. Biol. Chem</i>. <b>277</b> (10): 7849–56. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M110603200\" rel=\"nofollow\">10.1074/jbc.M110603200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11751867\" rel=\"nofollow\">11751867</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=The+LIM+domain+protein+LMO4+interacts+with+the+cofactor+CtIP+and+the+tumor+suppressor+BRCA1+and+inhibits+BRCA1+activity&amp;rft.volume=277&amp;rft.issue=10&amp;rft.pages=7849-56&amp;rft.date=2002-03&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M110603200&amp;rft_id=info%3Apmid%2F11751867&amp;rft.aulast=Sum&amp;rft.aufirst=EY&amp;rft.au=Peng%2C+B&amp;rft.au=Yu%2C+X&amp;rft.au=Chen%2C+J&amp;rft.au=Byrne%2C+J&amp;rft.au=Lindeman%2C+GJ&amp;rft.au=Visvader%2C+JE&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M110603200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15205325-185\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15205325_185-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFGilmoreMcCabeQuinnKennedy2004\">Gilmore PM, McCabe N, Quinn JE, Kennedy RD, Gorski JJ, Andrews HN, McWilliams S, Carty M, Mullan PB, Duprex WP, Liu ET, Johnston PG, Harkin DP (June 2004). <a class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-03-4080\" rel=\"nofollow\">\"BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3\"</a>. <i>Cancer Res</i>. <b>64</b> (12): 4148–54. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1158%2F0008-5472.CAN-03-4080\" rel=\"nofollow\">10.1158/0008-5472.CAN-03-4080</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15205325\" rel=\"nofollow\">15205325</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=BRCA1+interacts+with+and+is+required+for+paclitaxel-induced+activation+of+mitogen-activated+protein+kinase+kinase+kinase+3&amp;rft.volume=64&amp;rft.issue=12&amp;rft.pages=4148-54&amp;rft.date=2004-06&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-03-4080&amp;rft_id=info%3Apmid%2F15205325&amp;rft.aulast=Gilmore&amp;rft.aufirst=PM&amp;rft.au=McCabe%2C+N&amp;rft.au=Quinn%2C+JE&amp;rft.au=Kennedy%2C+RD&amp;rft.au=Gorski%2C+JJ&amp;rft.au=Andrews%2C+HN&amp;rft.au=McWilliams%2C+S&amp;rft.au=Carty%2C+M&amp;rft.au=Mullan%2C+PB&amp;rft.au=Duprex%2C+WP&amp;rft.au=Liu%2C+ET&amp;rft.au=Johnston%2C+PG&amp;rft.au=Harkin%2C+DP&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1158%252F0008-5472.CAN-03-4080&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11504724-186\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11504724_186-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11504724_186-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11504724_186-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid11504724_186-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid11504724_186-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChibaParvin2001\">Chiba N, Parvin JD (October 2001). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M105227200\" rel=\"nofollow\">\"Redistribution of BRCA1 among four different protein complexes following replication blockage\"</a>. <i>J. Biol. Chem</i>. <b>276</b> (42): 38549–54. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M105227200\" rel=\"nofollow\">10.1074/jbc.M105227200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11504724\" rel=\"nofollow\">11504724</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Redistribution+of+BRCA1+among+four+different+protein+complexes+following+replication+blockage&amp;rft.volume=276&amp;rft.issue=42&amp;rft.pages=38549-54&amp;rft.date=2001-10&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M105227200&amp;rft_id=info%3Apmid%2F11504724&amp;rft.aulast=Chiba&amp;rft.aufirst=N&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M105227200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12154023-187\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12154023_187-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChibaParvin2002\">Chiba N, Parvin JD (August 2002). \"The BRCA1 and BARD1 association with the RNA polymerase II holoenzyme\". <i>Cancer Res</i>. <b>62</b> (15): 4222–8. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12154023\" rel=\"nofollow\">12154023</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=The+BRCA1+and+BARD1+association+with+the+RNA+polymerase+II+holoenzyme&amp;rft.volume=62&amp;rft.issue=15&amp;rft.pages=4222-8&amp;rft.date=2002-08&amp;rft_id=info%3Apmid%2F12154023&amp;rft.aulast=Chiba&amp;rft.aufirst=N&amp;rft.au=Parvin%2C+JD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9159119-188\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9159119_188-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9159119_188-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFScullyAndersonChaoWei1997\">Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD (May 1997). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20825\" rel=\"nofollow\">\"BRCA1 is a component of the RNA polymerase II holoenzyme\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>94</b> (11): 5605–10. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1997PNAS...94.5605S\" rel=\"nofollow\">1997PNAS...94.5605S</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.94.11.5605\" rel=\"nofollow\">10.1073/pnas.94.11.5605</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20825\" rel=\"nofollow\">20825</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9159119\" rel=\"nofollow\">9159119</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1+is+a+component+of+the+RNA+polymerase+II+holoenzyme&amp;rft.volume=94&amp;rft.issue=11&amp;rft.pages=5605-10&amp;rft.date=1997-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC20825%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9159119&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.94.11.5605&amp;rft_id=info%3Abibcode%2F1997PNAS...94.5605S&amp;rft.aulast=Scully&amp;rft.aufirst=R&amp;rft.au=Anderson%2C+SF&amp;rft.au=Chao%2C+DM&amp;rft.au=Wei%2C+W&amp;rft.au=Ye%2C+L&amp;rft.au=Young%2C+RA&amp;rft.au=Livingston%2C+DM&amp;rft.au=Parvin%2C+JD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC20825&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10426999-189\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10426999_189-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10426999_189-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid10426999_189-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFZhongChenLiChen1999\">Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J, Chen PL, Sharp ZD, Lee WH (July 1999). \"Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response\". <i>Science</i>. <b>285</b> (5428): 747–50. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.285.5428.747\" rel=\"nofollow\">10.1126/science.285.5428.747</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10426999\" rel=\"nofollow\">10426999</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Association+of+BRCA1+with+the+hRad50-hMre11-p95+complex+and+the+DNA+damage+response&amp;rft.volume=285&amp;rft.issue=5428&amp;rft.pages=747-50&amp;rft.date=1999-07&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.285.5428.747&amp;rft_id=info%3Apmid%2F10426999&amp;rft.aulast=Zhong&amp;rft.aufirst=Q&amp;rft.au=Chen%2C+CF&amp;rft.au=Li%2C+S&amp;rft.au=Chen%2C+Y&amp;rft.au=Wang%2C+CC&amp;rft.au=Xiao%2C+J&amp;rft.au=Chen%2C+PL&amp;rft.au=Sharp%2C+ZD&amp;rft.au=Lee%2C+WH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11353843-190\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11353843_190-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFPaullCortezBowersElledge2001\">Paull TT, Cortez D, Bowers B, Elledge SJ, Gellert M (May 2001). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33426\" rel=\"nofollow\">\"Direct DNA binding by Brca1\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>98</b> (11): 6086–91. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.111125998\" rel=\"nofollow\">10.1073/pnas.111125998</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33426\" rel=\"nofollow\">33426</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11353843\" rel=\"nofollow\">11353843</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Direct+DNA+binding+by+Brca1&amp;rft.volume=98&amp;rft.issue=11&amp;rft.pages=6086-91&amp;rft.date=2001-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33426%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11353843&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.111125998&amp;rft.aulast=Paull&amp;rft.aufirst=TT&amp;rft.au=Cortez%2C+D&amp;rft.au=Bowers%2C+B&amp;rft.au=Elledge%2C+SJ&amp;rft.au=Gellert%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33426&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11916966-191\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11916966_191-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11916966_191-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLiLeeAvraham2002\">Li H, Lee TH, Avraham H (June 2002). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M112231200\" rel=\"nofollow\">\"A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer\"</a>. <i>J. Biol. Chem</i>. <b>277</b> (23): 20965–73. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M112231200\" rel=\"nofollow\">10.1074/jbc.M112231200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11916966\" rel=\"nofollow\">11916966</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=A+novel+tricomplex+of+BRCA1%2C+Nmi%2C+and+c-Myc+inhibits+c-Myc-induced+human+telomerase+reverse+transcriptase+gene+%28hTERT%29+promoter+activity+in+breast+cancer&amp;rft.volume=277&amp;rft.issue=23&amp;rft.pages=20965-73&amp;rft.date=2002-06&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M112231200&amp;rft_id=info%3Apmid%2F11916966&amp;rft.aulast=Li&amp;rft.aufirst=H&amp;rft.au=Lee%2C+TH&amp;rft.au=Avraham%2C+H&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M112231200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14612409-192\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14612409_192-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFXiongFanMengSchramm2003\">Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM (December 2003). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC262673\" rel=\"nofollow\">\"BRCA1 inhibition of telomerase activity in cultured cells\"</a>. <i>Mol. Cell. Biol</i>. <b>23</b> (23): 8668–90. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1128%2FMCB.23.23.8668-8690.2003\" rel=\"nofollow\">10.1128/MCB.23.23.8668-8690.2003</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC262673\" rel=\"nofollow\">262673</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14612409\" rel=\"nofollow\">14612409</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell.+Biol.&amp;rft.atitle=BRCA1+inhibition+of+telomerase+activity+in+cultured+cells&amp;rft.volume=23&amp;rft.issue=23&amp;rft.pages=8668-90&amp;rft.date=2003-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC262673%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F14612409&amp;rft_id=info%3Adoi%2F10.1128%2FMCB.23.23.8668-8690.2003&amp;rft.aulast=Xiong&amp;rft.aufirst=J&amp;rft.au=Fan%2C+S&amp;rft.au=Meng%2C+Q&amp;rft.au=Schramm%2C+L&amp;rft.au=Wang%2C+C&amp;rft.au=Bouzahza%2C+B&amp;rft.au=Zhou%2C+J&amp;rft.au=Zafonte%2C+B&amp;rft.au=Goldberg%2C+ID&amp;rft.au=Haddad%2C+BR&amp;rft.au=Pestell%2C+RG&amp;rft.au=Rosen%2C+EM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC262673&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12646176-193\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12646176_193-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFZhouLiu2003\">Zhou C, Liu J (March 2003). \"Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells\". <i>Biochem. Biophys. Res. Commun</i>. <b>303</b> (1): 130–6. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS0006-291X%2803%2900318-8\" rel=\"nofollow\">10.1016/S0006-291X(03)00318-8</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12646176\" rel=\"nofollow\">12646176</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochem.+Biophys.+Res.+Commun.&amp;rft.atitle=Inhibition+of+human+telomerase+reverse+transcriptase+gene+expression+by+BRCA1+in+human+ovarian+cancer+cells&amp;rft.volume=303&amp;rft.issue=1&amp;rft.pages=130-6&amp;rft.date=2003-03&amp;rft_id=info%3Adoi%2F10.1016%2FS0006-291X%2803%2900318-8&amp;rft_id=info%3Apmid%2F12646176&amp;rft.aulast=Zhou&amp;rft.aufirst=C&amp;rft.au=Liu%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15184379-194\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid15184379_194-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid15184379_194-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFSatoHayamiWuNishikawa2004\">Sato K, Hayami R, Wu W, Nishikawa T, Nishikawa H, Okuda Y, Ogata H, Fukuda M, Ohta T (July 2004). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C400169200\" rel=\"nofollow\">\"Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase\"</a>. <i>J. Biol. Chem</i>. <b>279</b> (30): 30919–22. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C400169200\" rel=\"nofollow\">10.1074/jbc.C400169200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15184379\" rel=\"nofollow\">15184379</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Nucleophosmin%2FB23+is+a+candidate+substrate+for+the+BRCA1-BARD1+ubiquitin+ligase&amp;rft.volume=279&amp;rft.issue=30&amp;rft.pages=30919-22&amp;rft.date=2004-07&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.C400169200&amp;rft_id=info%3Apmid%2F15184379&amp;rft.aulast=Sato&amp;rft.aufirst=K&amp;rft.au=Hayami%2C+R&amp;rft.au=Wu%2C+W&amp;rft.au=Nishikawa%2C+T&amp;rft.au=Nishikawa%2C+H&amp;rft.au=Okuda%2C+Y&amp;rft.au=Ogata%2C+H&amp;rft.au=Fukuda%2C+M&amp;rft.au=Ohta%2C+T&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.C400169200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11085509-195\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11085509_195-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFParkIrvineBuchananKoh2000\">Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup MR, Press MF, Coetzee GA (November 2000). \"Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor\". <i>Cancer Res</i>. <b>60</b> (21): 5946–9. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11085509\" rel=\"nofollow\">11085509</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Breast+cancer+susceptibility+gene+1+%28BRCAI%29+is+a+coactivator+of+the+androgen+receptor&amp;rft.volume=60&amp;rft.issue=21&amp;rft.pages=5946-9&amp;rft.date=2000-11&amp;rft_id=info%3Apmid%2F11085509&amp;rft.aulast=Park&amp;rft.aufirst=JJ&amp;rft.au=Irvine%2C+RA&amp;rft.au=Buchanan%2C+G&amp;rft.au=Koh%2C+SS&amp;rft.au=Park%2C+JM&amp;rft.au=Tilley%2C+WD&amp;rft.au=Stallcup%2C+MR&amp;rft.au=Press%2C+MF&amp;rft.au=Coetzee%2C+GA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15107825-196\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15107825_196-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFCabartChewMurphy2004\">Cabart P, Chew HK, Murphy S (July 2004). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1207684\" rel=\"nofollow\">\"BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II\"</a>. <i>Oncogene</i>. <b>23</b> (31): 5316–29. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1207684\" rel=\"nofollow\">10.1038/sj.onc.1207684</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15107825\" rel=\"nofollow\">15107825</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+cooperates+with+NUFIP+and+P-TEFb+to+activate+transcription+by+RNA+polymerase+II&amp;rft.volume=23&amp;rft.issue=31&amp;rft.pages=5316-29&amp;rft.date=2004-07&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1207684&amp;rft_id=info%3Apmid%2F15107825&amp;rft.aulast=Cabart&amp;rft.aufirst=P&amp;rft.au=Chew%2C+HK&amp;rft.au=Murphy%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1207684&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14710355-197\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14710355_197-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFAbramovitchWerner2003\">Abramovitch S, Werner H (2003). \"Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene\". <i>Horm. Metab. Res</i>. <b>35</b> (11–12): 758–62. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1055%2Fs-2004-814154\" rel=\"nofollow\">10.1055/s-2004-814154</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14710355\" rel=\"nofollow\">14710355</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Horm.+Metab.+Res.&amp;rft.atitle=Functional+and+physical+interactions+between+BRCA1+and+p53+in+transcriptional+regulation+of+the+IGF-IR+gene&amp;rft.volume=35&amp;rft.issue=11%E2%80%9312&amp;rft.pages=758-62&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2004-814154&amp;rft_id=info%3Apmid%2F14710355&amp;rft.aulast=Abramovitch&amp;rft.aufirst=S&amp;rft.au=Werner%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9482880-198\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9482880_198-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFOuchiMonteiroAugustAaronson1998\">Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H (March 1998). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC19327\" rel=\"nofollow\">\"BRCA1 regulates p53-dependent gene expression\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>95</b> (5): 2302–6. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1998PNAS...95.2302O\" rel=\"nofollow\">1998PNAS...95.2302O</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.95.5.2302\" rel=\"nofollow\">10.1073/pnas.95.5.2302</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC19327\" rel=\"nofollow\">19327</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9482880\" rel=\"nofollow\">9482880</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1+regulates+p53-dependent+gene+expression&amp;rft.volume=95&amp;rft.issue=5&amp;rft.pages=2302-6&amp;rft.date=1998-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC19327%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9482880&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.95.5.2302&amp;rft_id=info%3Abibcode%2F1998PNAS...95.2302O&amp;rft.aulast=Ouchi&amp;rft.aufirst=T&amp;rft.au=Monteiro%2C+AN&amp;rft.au=August%2C+A&amp;rft.au=Aaronson%2C+SA&amp;rft.au=Hanafusa%2C+H&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC19327&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9582019-199\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9582019_199-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFZhangSomasundaramPengTian1998\">Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber BL, El-Deiry WS (April 1998). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1201932\" rel=\"nofollow\">\"BRCA1 physically associates with p53 and stimulates its transcriptional activity\"</a>. <i>Oncogene</i>. <b>16</b> (13): 1713–21. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1201932\" rel=\"nofollow\">10.1038/sj.onc.1201932</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9582019\" rel=\"nofollow\">9582019</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=BRCA1+physically+associates+with+p53+and+stimulates+its+transcriptional+activity&amp;rft.volume=16&amp;rft.issue=13&amp;rft.pages=1713-21&amp;rft.date=1998-04&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1201932&amp;rft_id=info%3Apmid%2F9582019&amp;rft.aulast=Zhang&amp;rft.aufirst=H&amp;rft.au=Somasundaram%2C+K&amp;rft.au=Peng%2C+Y&amp;rft.au=Tian%2C+H&amp;rft.au=Zhang%2C+H&amp;rft.au=Bi%2C+D&amp;rft.au=Weber%2C+BL&amp;rft.au=El-Deiry%2C+WS&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1201932&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid19369211-200\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19369211_200-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFSyHuenChen2009\">Sy SM, Huen MS, Chen J (April 2009). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678481\" rel=\"nofollow\">\"PALB2 is an integral component of the BRCA complex required for homologous recombination repair\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>106</b> (17): 7155–60. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2009PNAS..106.7155S\" rel=\"nofollow\">2009PNAS..106.7155S</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.0811159106\" rel=\"nofollow\">10.1073/pnas.0811159106</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678481\" rel=\"nofollow\">2678481</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/19369211\" rel=\"nofollow\">19369211</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=PALB2+is+an+integral+component+of+the+BRCA+complex+required+for+homologous+recombination+repair&amp;rft.volume=106&amp;rft.issue=17&amp;rft.pages=7155-60&amp;rft.date=2009-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2678481%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19369211&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0811159106&amp;rft_id=info%3Abibcode%2F2009PNAS..106.7155S&amp;rft.aulast=Sy&amp;rft.aufirst=SM&amp;rft.au=Huen%2C+MS&amp;rft.au=Chen%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2678481&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14506230-201\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14506230_201-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFKrumMirandaLinLane2003\">Krum SA, Miranda GA, Lin C, Lane TF (December 2003). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M308418200\" rel=\"nofollow\">\"BRCA1 associates with processive RNA polymerase II\"</a>. <i>J. Biol. Chem</i>. <b>278</b> (52): 52012–20. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M308418200\" rel=\"nofollow\">10.1074/jbc.M308418200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14506230\" rel=\"nofollow\">14506230</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=BRCA1+associates+with+processive+RNA+polymerase+II&amp;rft.volume=278&amp;rft.issue=52&amp;rft.pages=52012-20&amp;rft.date=2003-12&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M308418200&amp;rft_id=info%3Apmid%2F14506230&amp;rft.aulast=Krum&amp;rft.aufirst=SA&amp;rft.au=Miranda%2C+GA&amp;rft.au=Lin%2C+C&amp;rft.au=Lane%2C+TF&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M308418200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12955082-202\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12955082_202-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFKrumWomackLane2003\">Krum SA, Womack JE, Lane TF (September 2003). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1206515\" rel=\"nofollow\">\"Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity\"</a>. <i>Oncogene</i>. <b>22</b> (38): 6032–44. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1206515\" rel=\"nofollow\">10.1038/sj.onc.1206515</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12955082\" rel=\"nofollow\">12955082</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Bovine+BRCA1+shows+classic+responses+to+genotoxic+stress+but+low+in+vitro+transcriptional+activation+activity&amp;rft.volume=22&amp;rft.issue=38&amp;rft.pages=6032-44&amp;rft.date=2003-09&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1206515&amp;rft_id=info%3Apmid%2F12955082&amp;rft.aulast=Krum&amp;rft.aufirst=SA&amp;rft.au=Womack%2C+JE&amp;rft.au=Lane%2C+TF&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1206515&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12438214-203\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12438214_203-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLiuVirshupWhiteHsu2002\">Liu Y, Virshup DM, White RL, Hsu LC (November 2002). \"Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha\". <i>Cancer Res</i>. <b>62</b> (22): 6357–61. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12438214\" rel=\"nofollow\">12438214</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Regulation+of+BRCA1+phosphorylation+by+interaction+with+protein+phosphatase+1alpha&amp;rft.volume=62&amp;rft.issue=22&amp;rft.pages=6357-61&amp;rft.date=2002-11&amp;rft_id=info%3Apmid%2F12438214&amp;rft.aulast=Liu&amp;rft.aufirst=Y&amp;rft.au=Virshup%2C+DM&amp;rft.au=White%2C+RL&amp;rft.au=Hsu%2C+LC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9008167-204\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9008167_204-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFScullyChenPlugXiao1997\">Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM (January 1997). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2981847-4\" rel=\"nofollow\">\"Association of BRCA1 with Rad51 in mitotic and meiotic cells\"</a>. <i>Cell</i>. <b>88</b> (2): 265–75. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2981847-4\" rel=\"nofollow\">10.1016/S0092-8674(00)81847-4</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9008167\" rel=\"nofollow\">9008167</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=Association+of+BRCA1+with+Rad51+in+mitotic+and+meiotic+cells&amp;rft.volume=88&amp;rft.issue=2&amp;rft.pages=265-75&amp;rft.date=1997-01&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2800%2981847-4&amp;rft_id=info%3Apmid%2F9008167&amp;rft.aulast=Scully&amp;rft.aufirst=R&amp;rft.au=Chen%2C+J&amp;rft.au=Plug%2C+A&amp;rft.au=Xiao%2C+Y&amp;rft.au=Weaver%2C+D&amp;rft.au=Feunteun%2C+J&amp;rft.au=Ashley%2C+T&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252800%252981847-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10220405-205\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10220405_205-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10220405_205-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid10220405_205-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYardenBrody1999\">Yarden RI, Brody LC (April 1999). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC21803\" rel=\"nofollow\">\"BRCA1 interacts with components of the histone deacetylase complex\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>96</b> (9): 4983–8. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1999PNAS...96.4983Y\" rel=\"nofollow\">1999PNAS...96.4983Y</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.96.9.4983\" rel=\"nofollow\">10.1073/pnas.96.9.4983</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC21803\" rel=\"nofollow\">21803</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10220405\" rel=\"nofollow\">10220405</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1+interacts+with+components+of+the+histone+deacetylase+complex&amp;rft.volume=96&amp;rft.issue=9&amp;rft.pages=4983-8&amp;rft.date=1999-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC21803%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10220405&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.96.9.4983&amp;rft_id=info%3Abibcode%2F1999PNAS...96.4983Y&amp;rft.aulast=Yarden&amp;rft.aufirst=RI&amp;rft.au=Brody%2C+LC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC21803&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11394910-206\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11394910_206-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFChenGuanYuLi2001\">Chen GC, Guan LS, Yu JH, Li GC, Choi Kim HR, Wang ZY (June 2001). \"Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1\". <i>Biochem. Biophys. Res. Commun</i>. <b>284</b> (2): 507–14. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1006%2Fbbrc.2001.5003\" rel=\"nofollow\">10.1006/bbrc.2001.5003</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11394910\" rel=\"nofollow\">11394910</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochem.+Biophys.+Res.+Commun.&amp;rft.atitle=Rb-associated+protein+46+%28RbAp46%29+inhibits+transcriptional+transactivation+mediated+by+BRCA1&amp;rft.volume=284&amp;rft.issue=2&amp;rft.pages=507-14&amp;rft.date=2001-06&amp;rft_id=info%3Adoi%2F10.1006%2Fbbrc.2001.5003&amp;rft_id=info%3Apmid%2F11394910&amp;rft.aulast=Chen&amp;rft.aufirst=GC&amp;rft.au=Guan%2C+LS&amp;rft.au=Yu%2C+JH&amp;rft.au=Li%2C+GC&amp;rft.au=Choi+Kim%2C+HR&amp;rft.au=Wang%2C+ZY&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11746496-207\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11746496_207-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11746496_207-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYardenBrody2001\">Yarden RI, Brody LC (2001). <a class=\"external text\" href=\"https://zenodo.org/record/1229223\" rel=\"nofollow\">\"Identification of proteins that interact with BRCA1 by Far-Western library screening\"</a>. <i>J. Cell. Biochem</i>. <b>83</b> (4): 521–31. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1002%2Fjcb.1257\" rel=\"nofollow\">10.1002/jcb.1257</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11746496\" rel=\"nofollow\">11746496</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:29703139\" rel=\"nofollow\">29703139</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Cell.+Biochem.&amp;rft.atitle=Identification+of+proteins+that+interact+with+BRCA1+by+Far-Western+library+screening&amp;rft.volume=83&amp;rft.issue=4&amp;rft.pages=521-31&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A29703139%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11746496&amp;rft_id=info%3Adoi%2F10.1002%2Fjcb.1257&amp;rft.aulast=Yarden&amp;rft.aufirst=RI&amp;rft.au=Brody%2C+LC&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1229223&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9738006-208\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9738006_208-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYuWuBowcockAronheim1998\">Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R (September 1998). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.273.39.25388\" rel=\"nofollow\">\"The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression\"</a>. <i>J. Biol. Chem</i>. <b>273</b> (39): 25388–92. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.273.39.25388\" rel=\"nofollow\">10.1074/jbc.273.39.25388</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9738006\" rel=\"nofollow\">9738006</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=The+C-terminal+%28BRCT%29+domains+of+BRCA1+interact+in+vivo+with+CtIP%2C+a+protein+implicated+in+the+CtBP+pathway+of+transcriptional+repression&amp;rft.volume=273&amp;rft.issue=39&amp;rft.pages=25388-92&amp;rft.date=1998-09&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.273.39.25388&amp;rft_id=info%3Apmid%2F9738006&amp;rft.aulast=Yu&amp;rft.aufirst=X&amp;rft.au=Wu%2C+LC&amp;rft.au=Bowcock%2C+AM&amp;rft.au=Aronheim%2C+A&amp;rft.au=Baer%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.273.39.25388&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10196224-209\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10196224_209-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLiChenSubramanianChinnadurai1999\">Li S, Chen PL, Subramanian T, Chinnadurai G, Tomlinson G, Osborne CK, Sharp ZD, Lee WH (April 1999). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.16.11334\" rel=\"nofollow\">\"Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage\"</a>. <i>J. Biol. Chem</i>. <b>274</b> (16): 11334–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.274.16.11334\" rel=\"nofollow\">10.1074/jbc.274.16.11334</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10196224\" rel=\"nofollow\">10196224</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Binding+of+CtIP+to+the+BRCT+repeats+of+BRCA1+involved+in+the+transcription+regulation+of+p21+is+disrupted+upon+DNA+damage&amp;rft.volume=274&amp;rft.issue=16&amp;rft.pages=11334-8&amp;rft.date=1999-04&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.274.16.11334&amp;rft_id=info%3Apmid%2F10196224&amp;rft.aulast=Li&amp;rft.aufirst=S&amp;rft.au=Chen%2C+PL&amp;rft.au=Subramanian%2C+T&amp;rft.au=Chinnadurai%2C+G&amp;rft.au=Tomlinson%2C+G&amp;rft.au=Osborne%2C+CK&amp;rft.au=Sharp%2C+ZD&amp;rft.au=Lee%2C+WH&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.274.16.11334&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid9811458-210\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9811458_210-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWongOrmondePeroChen1998\">Wong AK, Ormonde PA, Pero R, Chen Y, Lian L, Salada G, Berry S, Lawrence Q, Dayananth P, Ha P, Tavtigian SV, Teng DH, Bartel PL (November 1998). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202150\" rel=\"nofollow\">\"Characterization of a carboxy-terminal BRCA1 interacting protein\"</a>. <i>Oncogene</i>. <b>17</b> (18): 2279–85. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1202150\" rel=\"nofollow\">10.1038/sj.onc.1202150</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/9811458\" rel=\"nofollow\">9811458</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Characterization+of+a+carboxy-terminal+BRCA1+interacting+protein&amp;rft.volume=17&amp;rft.issue=18&amp;rft.pages=2279-85&amp;rft.date=1998-11&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1202150&amp;rft_id=info%3Apmid%2F9811458&amp;rft.aulast=Wong&amp;rft.aufirst=AK&amp;rft.au=Ormonde%2C+PA&amp;rft.au=Pero%2C+R&amp;rft.au=Chen%2C+Y&amp;rft.au=Lian%2C+L&amp;rft.au=Salada%2C+G&amp;rft.au=Berry%2C+S&amp;rft.au=Lawrence%2C+Q&amp;rft.au=Dayananth%2C+P&amp;rft.au=Ha%2C+P&amp;rft.au=Tavtigian%2C+SV&amp;rft.au=Teng%2C+DH&amp;rft.au=Bartel%2C+PL&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1202150&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10910365-211\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10910365_211-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFLiTingZhengChen2000\">Li S, Ting NS, Zheng L, Chen PL, Ziv Y, Shiloh Y, Lee EY, Lee WH (July 2000). \"Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response\". <i>Nature</i>. <b>406</b> (6792): 210–5. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000Natur.406..210L\" rel=\"nofollow\">2000Natur.406..210L</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2F35018134\" rel=\"nofollow\">10.1038/35018134</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10910365\" rel=\"nofollow\">10910365</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:3266654\" rel=\"nofollow\">3266654</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Functional+link+of+BRCA1+and+ataxia+telangiectasia+gene+product+in+DNA+damage+response&amp;rft.volume=406&amp;rft.issue=6792&amp;rft.pages=210-5&amp;rft.date=2000-07&amp;rft_id=info%3Adoi%2F10.1038%2F35018134&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3266654%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10910365&amp;rft_id=info%3Abibcode%2F2000Natur.406..210L&amp;rft.aulast=Li&amp;rft.aufirst=S&amp;rft.au=Ting%2C+NS&amp;rft.au=Zheng%2C+L&amp;rft.au=Chen%2C+PL&amp;rft.au=Ziv%2C+Y&amp;rft.au=Shiloh%2C+Y&amp;rft.au=Lee%2C+EY&amp;rft.au=Lee%2C+WH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11689934-212\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11689934_212-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWu-BaerBaer2001\">Wu-Baer F, Baer R (November 2001). <a class=\"external text\" href=\"https://doi.org/10.1038%2F35102118\" rel=\"nofollow\">\"Effect of DNA damage on a BRCA1 complex\"</a>. <i>Nature</i>. <b>414</b> (6859): 36. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2F35102118\" rel=\"nofollow\">10.1038/35102118</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11689934\" rel=\"nofollow\">11689934</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:4329675\" rel=\"nofollow\">4329675</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Effect+of+DNA+damage+on+a+BRCA1+complex&amp;rft.volume=414&amp;rft.issue=6859&amp;rft.pages=36&amp;rft.date=2001-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4329675%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11689934&amp;rft_id=info%3Adoi%2F10.1038%2F35102118&amp;rft.aulast=Wu-Baer&amp;rft.aufirst=F&amp;rft.au=Baer%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252F35102118&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10764811-213\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10764811_213-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFYuBaer2000\">Yu X, Baer R (June 2000). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M909494199\" rel=\"nofollow\">\"Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor\"</a>. <i>J. Biol. Chem</i>. <b>275</b> (24): 18541–9. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M909494199\" rel=\"nofollow\">10.1074/jbc.M909494199</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10764811\" rel=\"nofollow\">10764811</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Nuclear+localization+and+cell+cycle-specific+expression+of+CtIP%2C+a+protein+that+associates+with+the+BRCA1+tumor+suppressor&amp;rft.volume=275&amp;rft.issue=24&amp;rft.pages=18541-9&amp;rft.date=2000-06&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M909494199&amp;rft_id=info%3Apmid%2F10764811&amp;rft.aulast=Yu&amp;rft.aufirst=X&amp;rft.au=Baer%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M909494199&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11521194-214\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11521194_214-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11521194_214-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11521194_214-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFFanYuanMaXiong2001\">Fan S, Yuan R, Ma YX, Xiong J, Meng Q, Erdos M, Zhao JN, Goldberg ID, Pestell RG, Rosen EM (August 2001). <a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204666\" rel=\"nofollow\">\"Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding\"</a>. <i>Oncogene</i>. <b>20</b> (35): 4827–41. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fsj.onc.1204666\" rel=\"nofollow\">10.1038/sj.onc.1204666</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11521194\" rel=\"nofollow\">11521194</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Disruption+of+BRCA1+LXCXE+motif+alters+BRCA1+functional+activity+and+regulation+of+RB+family+but+not+RB+protein+binding&amp;rft.volume=20&amp;rft.issue=35&amp;rft.pages=4827-41&amp;rft.date=2001-08&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1204666&amp;rft_id=info%3Apmid%2F11521194&amp;rft.aulast=Fan&amp;rft.aufirst=S&amp;rft.au=Yuan%2C+R&amp;rft.au=Ma%2C+YX&amp;rft.au=Xiong%2C+J&amp;rft.au=Meng%2C+Q&amp;rft.au=Erdos%2C+M&amp;rft.au=Zhao%2C+JN&amp;rft.au=Goldberg%2C+ID&amp;rft.au=Pestell%2C+RG&amp;rft.au=Rosen%2C+EM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.onc.1204666&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10518542-215\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10518542_215-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFAprelikovaFangMeissnerCotter1999\">Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET (October 1999). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18378\" rel=\"nofollow\">\"BRCA1-associated growth arrest is RB-dependent\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>96</b> (21): 11866–71. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/1999PNAS...9611866A\" rel=\"nofollow\">1999PNAS...9611866A</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.96.21.11866\" rel=\"nofollow\">10.1073/pnas.96.21.11866</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18378\" rel=\"nofollow\">18378</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10518542\" rel=\"nofollow\">10518542</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BRCA1-associated+growth+arrest+is+RB-dependent&amp;rft.volume=96&amp;rft.issue=21&amp;rft.pages=11866-71&amp;rft.date=1999-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC18378%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10518542&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.96.21.11866&amp;rft_id=info%3Abibcode%2F1999PNAS...9611866A&amp;rft.aulast=Aprelikova&amp;rft.aufirst=ON&amp;rft.au=Fang%2C+BS&amp;rft.au=Meissner%2C+EG&amp;rft.au=Cotter%2C+S&amp;rft.au=Campbell%2C+M&amp;rft.au=Kuthiala%2C+A&amp;rft.au=Bessho%2C+M&amp;rft.au=Jensen%2C+RA&amp;rft.au=Liu%2C+ET&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC18378&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10943845-216\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10943845_216-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10943845_216-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBocharWangBeniyaKinev2000\">Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R (July 2000). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2900030-1\" rel=\"nofollow\">\"BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer\"</a>. <i>Cell</i>. <b>102</b> (2): 257–65. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2800%2900030-1\" rel=\"nofollow\">10.1016/S0092-8674(00)00030-1</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10943845\" rel=\"nofollow\">10943845</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=BRCA1+is+associated+with+a+human+SWI%2FSNF-related+complex%3A+linking+chromatin+remodeling+to+breast+cancer&amp;rft.volume=102&amp;rft.issue=2&amp;rft.pages=257-65&amp;rft.date=2000-07&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2800%2900030-1&amp;rft_id=info%3Apmid%2F10943845&amp;rft.aulast=Bochar&amp;rft.aufirst=DA&amp;rft.au=Wang%2C+L&amp;rft.au=Beniya%2C+H&amp;rft.au=Kinev%2C+A&amp;rft.au=Xue%2C+Y&amp;rft.au=Lane%2C+WS&amp;rft.au=Wang%2C+W&amp;rft.au=Kashanchi%2C+F&amp;rft.au=Shiekhattar%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252800%252900030-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15034933-217\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15034933_217-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHillde_la_SernaVealImbalzano2004\">Hill DA, de la Serna IL, Veal TM, Imbalzano AN (April 2004). \"BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2\". <i>J. Cell. Biochem</i>. <b>91</b> (5): 987–98. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1002%2Fjcb.20003\" rel=\"nofollow\">10.1002/jcb.20003</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15034933\" rel=\"nofollow\">15034933</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:40668596\" rel=\"nofollow\">40668596</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Cell.+Biochem.&amp;rft.atitle=BRCA1+interacts+with+dominant+negative+SWI%2FSNF+enzymes+without+affecting+homologous+recombination+or+radiation-induced+gene+activation+of+p21+or+Mdm2&amp;rft.volume=91&amp;rft.issue=5&amp;rft.pages=987-98&amp;rft.date=2004-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A40668596%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15034933&amp;rft_id=info%3Adoi%2F10.1002%2Fjcb.20003&amp;rft.aulast=Hill&amp;rft.aufirst=DA&amp;rft.au=de+la+Serna%2C+IL&amp;rft.au=Veal%2C+TM&amp;rft.au=Imbalzano%2C+AN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10792030-218\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10792030_218-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFOuchiLeeOuchiAaronson2000\">Ouchi T, Lee SW, Ouchi M, Aaronson SA, Horvath CM (May 2000). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC25807\" rel=\"nofollow\">\"Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>97</b> (10): 5208–13. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2000PNAS...97.5208O\" rel=\"nofollow\">2000PNAS...97.5208O</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.080469697\" rel=\"nofollow\">10.1073/pnas.080469697</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC25807\" rel=\"nofollow\">25807</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10792030\" rel=\"nofollow\">10792030</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Collaboration+of+signal+transducer+and+activator+of+transcription+1+%28STAT1%29+and+BRCA1+in+differential+regulation+of+IFN-gamma+target+genes&amp;rft.volume=97&amp;rft.issue=10&amp;rft.pages=5208-13&amp;rft.date=2000-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC25807%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F10792030&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.080469697&amp;rft_id=info%3Abibcode%2F2000PNAS...97.5208O&amp;rft.aulast=Ouchi&amp;rft.aufirst=T&amp;rft.au=Lee%2C+SW&amp;rft.au=Ouchi%2C+M&amp;rft.au=Aaronson%2C+SA&amp;rft.au=Horvath%2C+CM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC25807&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-isbn978-90-481-3471-7-219\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-isbn978-90-481-3471-7_219-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation book cs1\" id=\"CITEREFSokkaParkkinenPospiechSyvaoja2012\">Sokka M, Parkkinen S, Pospiech H, Syvaoja JE (April 2012). \"Function of TopBP1 in Genome Stability\".  In Nasheuer HP (ed.). <i>Genome Stability and Human Diseases</i>. Springer Dordrecht. pp. 119–141. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1007%2F978-90-481-3471-7_7\" rel=\"nofollow\">10.1007/978-90-481-3471-7_7</a>. <a class=\"mw-redirect\" href=\"/wiki/ISBN_(identifier)\" title=\"ISBN (identifier)\">ISBN</a> <a href=\"/wiki/Special:BookSources/978-90-481-3471-7\" title=\"Special:BookSources/978-90-481-3471-7\"><bdi>978-90-481-3471-7</bdi></a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Function+of+TopBP1+in+Genome+Stability&amp;rft.btitle=Genome+Stability+and+Human+Diseases&amp;rft.pages=119-141&amp;rft.pub=Springer+Dordrecht&amp;rft.date=2012-04&amp;rft_id=info%3Adoi%2F10.1007%2F978-90-481-3471-7_7&amp;rft.isbn=978-90-481-3471-7&amp;rft.aulast=Sokka&amp;rft.aufirst=M&amp;rft.au=Parkkinen%2C+S&amp;rft.au=Pospiech%2C+H&amp;rft.au=Syvaoja%2C+JE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12732733-220\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12732733_220-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFBrzovicKeeffeNishikawaMiyamoto2003\">Brzovic PS, Keeffe JR, Nishikawa H, Miyamoto K, Fox D, Fukuda M, Ohta T, Klevit R (May 2003). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC156255\" rel=\"nofollow\">\"Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>100</b> (10): 5646–51. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2003PNAS..100.5646B\" rel=\"nofollow\">2003PNAS..100.5646B</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.0836054100\" rel=\"nofollow\">10.1073/pnas.0836054100</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC156255\" rel=\"nofollow\">156255</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12732733\" rel=\"nofollow\">12732733</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Binding+and+recognition+in+the+assembly+of+an+active+BRCA1%2FBARD1+ubiquitin-ligase+complex&amp;rft.volume=100&amp;rft.issue=10&amp;rft.pages=5646-51&amp;rft.date=2003-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC156255%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12732733&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0836054100&amp;rft_id=info%3Abibcode%2F2003PNAS..100.5646B&amp;rft.aulast=Brzovic&amp;rft.aufirst=PS&amp;rft.au=Keeffe%2C+JR&amp;rft.au=Nishikawa%2C+H&amp;rft.au=Miyamoto%2C+K&amp;rft.au=Fox%2C+D&amp;rft.au=Fukuda%2C+M&amp;rft.au=Ohta%2C+T&amp;rft.au=Klevit%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC156255&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14638690-221\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14638690_221-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFNishikawaOokaSatoArima2004\">Nishikawa H, Ooka S, Sato K, Arima K, Okamoto J, Klevit RE, Fukuda M, Ohta T (February 2004). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M308540200\" rel=\"nofollow\">\"Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase\"</a>. <i>J. Biol. Chem</i>. <b>279</b> (6): 3916–24. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.M308540200\" rel=\"nofollow\">10.1074/jbc.M308540200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14638690\" rel=\"nofollow\">14638690</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Mass+spectrometric+and+mutational+analyses+reveal+Lys-6-linked+polyubiquitin+chains+catalyzed+by+BRCA1-BARD1+ubiquitin+ligase&amp;rft.volume=279&amp;rft.issue=6&amp;rft.pages=3916-24&amp;rft.date=2004-02&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M308540200&amp;rft_id=info%3Apmid%2F14638690&amp;rft.aulast=Nishikawa&amp;rft.aufirst=H&amp;rft.au=Ooka%2C+S&amp;rft.au=Sato%2C+K&amp;rft.au=Arima%2C+K&amp;rft.au=Okamoto%2C+J&amp;rft.au=Klevit%2C+RE&amp;rft.au=Fukuda%2C+M&amp;rft.au=Ohta%2C+T&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.M308540200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12438698-222\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12438698_222-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFKentsisGordonBorden2002\">Kentsis A, Gordon RE, Borden KL (November 2002). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137729\" rel=\"nofollow\">\"Control of biochemical reactions through supramolecular RING domain self-assembly\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>99</b> (24): 15404–9. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2002PNAS...9915404K\" rel=\"nofollow\">2002PNAS...9915404K</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.202608799\" rel=\"nofollow\">10.1073/pnas.202608799</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137729\" rel=\"nofollow\">137729</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12438698\" rel=\"nofollow\">12438698</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Control+of+biochemical+reactions+through+supramolecular+RING+domain+self-assembly&amp;rft.volume=99&amp;rft.issue=24&amp;rft.pages=15404-9&amp;rft.date=2002-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC137729%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12438698&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.202608799&amp;rft_id=info%3Abibcode%2F2002PNAS...9915404K&amp;rft.aulast=Kentsis&amp;rft.aufirst=A&amp;rft.au=Gordon%2C+RE&amp;rft.au=Borden%2C+KL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC137729&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12890688-223\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12890688_223-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFWu-BaerLagrazonYuanBaer2003\">Wu-Baer F, Lagrazon K, Yuan W, Baer R (September 2003). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C300249200\" rel=\"nofollow\">\"The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin\"</a>. <i>J. Biol. Chem</i>. <b>278</b> (37): 34743–6. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C300249200\" rel=\"nofollow\">10.1074/jbc.C300249200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12890688\" rel=\"nofollow\">12890688</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=The+BRCA1%2FBARD1+heterodimer+assembles+polyubiquitin+chains+through+an+unconventional+linkage+involving+lysine+residue+K6+of+ubiquitin&amp;rft.volume=278&amp;rft.issue=37&amp;rft.pages=34743-6&amp;rft.date=2003-09&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.C300249200&amp;rft_id=info%3Apmid%2F12890688&amp;rft.aulast=Wu-Baer&amp;rft.aufirst=F&amp;rft.au=Lagrazon%2C+K&amp;rft.au=Yuan%2C+W&amp;rft.au=Baer%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.C300249200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11278247-224\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11278247_224-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFHashizumeFukudaMaedaNishikawa2001\">Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T (May 2001). <a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C000881200\" rel=\"nofollow\">\"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation\"</a>. <i>J. Biol. Chem</i>. <b>276</b> (18): 14537–40. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1074%2Fjbc.C000881200\" rel=\"nofollow\">10.1074/jbc.C000881200</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11278247\" rel=\"nofollow\">11278247</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=The+RING+heterodimer+BRCA1-BARD1+is+a+ubiquitin+ligase+inactivated+by+a+breast+cancer-derived+mutation&amp;rft.volume=276&amp;rft.issue=18&amp;rft.pages=14537-40&amp;rft.date=2001-05&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.C000881200&amp;rft_id=info%3Apmid%2F11278247&amp;rft.aulast=Hashizume&amp;rft.aufirst=R&amp;rft.au=Fukuda%2C+M&amp;rft.au=Maeda%2C+I&amp;rft.au=Nishikawa%2C+H&amp;rft.au=Oyake%2C+D&amp;rft.au=Yabuki%2C+Y&amp;rft.au=Ogata%2C+H&amp;rft.au=Ohta%2C+T&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1074%252Fjbc.C000881200&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid14502648-225\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14502648_225-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFCableWilsonCalzoneRauscher2003\">Cable PL, Wilson CA, Calzone FJ, Rauscher FJ, Scully R, Livingston DM, Li L, Blackwell CB, Futreal PA, Afshari CA (October 2003). <a class=\"external text\" href=\"https://zenodo.org/record/1229285\" rel=\"nofollow\">\"Novel consensus DNA-binding sequence for BRCA1 protein complexes\"</a>. <i>Mol. Carcinog</i>. <b>38</b> (2): 85–96. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1002%2Fmc.10148\" rel=\"nofollow\">10.1002/mc.10148</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/14502648\" rel=\"nofollow\">14502648</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:24956554\" rel=\"nofollow\">24956554</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Carcinog.&amp;rft.atitle=Novel+consensus+DNA-binding+sequence+for+BRCA1+protein+complexes&amp;rft.volume=38&amp;rft.issue=2&amp;rft.pages=85-96&amp;rft.date=2003-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24956554%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14502648&amp;rft_id=info%3Adoi%2F10.1002%2Fmc.10148&amp;rft.aulast=Cable&amp;rft.aufirst=PL&amp;rft.au=Wilson%2C+CA&amp;rft.au=Calzone%2C+FJ&amp;rft.au=Rauscher%2C+FJ&amp;rft.au=Scully%2C+R&amp;rft.au=Livingston%2C+DM&amp;rft.au=Li%2C+L&amp;rft.au=Blackwell%2C+CB&amp;rft.au=Futreal%2C+PA&amp;rft.au=Afshari%2C+CA&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1229285&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid10855792-226\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10855792_226-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFZhangWangKajinoGreene2000\">Zhang H, Wang Q, Kajino K, Greene MI (May 2000). \"VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells\". <i>DNA Cell Biol</i>. <b>19</b> (5): 253–63. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1089%2F10445490050021168\" rel=\"nofollow\">10.1089/10445490050021168</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/10855792\" rel=\"nofollow\">10855792</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=DNA+Cell+Biol.&amp;rft.atitle=VCP%2C+a+weak+ATPase+involved+in+multiple+cellular+events%2C+interacts+physically+with+BRCA1+in+the+nucleus+of+living+cells&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=253-63&amp;rft.date=2000-05&amp;rft_id=info%3Adoi%2F10.1089%2F10445490050021168&amp;rft_id=info%3Apmid%2F10855792&amp;rft.aulast=Zhang&amp;rft.aufirst=H&amp;rft.au=Wang%2C+Q&amp;rft.au=Kajino%2C+K&amp;rft.au=Greene%2C+MI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid15065664-227\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15065664_227-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFGanesanSilverDrapkinGreenberg2004\">Ganesan S, Silver DP, Drapkin R, Greenberg R, Feunteun J, Livingston DM (January 2004). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693294\" rel=\"nofollow\">\"Association of BRCA1 with the inactive X chromosome and XIST RNA\"</a>. <i>Philos. Trans. R. Soc. Lond. B Biol. Sci</i>. <b>359</b> (1441): 123–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1098%2Frstb.2003.1371\" rel=\"nofollow\">10.1098/rstb.2003.1371</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693294\" rel=\"nofollow\">1693294</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/15065664\" rel=\"nofollow\">15065664</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Philos.+Trans.+R.+Soc.+Lond.+B+Biol.+Sci.&amp;rft.atitle=Association+of+BRCA1+with+the+inactive+X+chromosome+and+XIST+RNA&amp;rft.volume=359&amp;rft.issue=1441&amp;rft.pages=123-8&amp;rft.date=2004-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1693294%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15065664&amp;rft_id=info%3Adoi%2F10.1098%2Frstb.2003.1371&amp;rft.aulast=Ganesan&amp;rft.aufirst=S&amp;rft.au=Silver%2C+DP&amp;rft.au=Drapkin%2C+R&amp;rft.au=Greenberg%2C+R&amp;rft.au=Feunteun%2C+J&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1693294&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid12419249-228\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12419249_228-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFGanesanSilverGreenbergAvni2002\">Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J, Livingston DM (November 2002). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2802%2901052-8\" rel=\"nofollow\">\"BRCA1 supports XIST RNA concentration on the inactive X chromosome\"</a>. <i>Cell</i>. <b>111</b> (3): 393–405. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0092-8674%2802%2901052-8\" rel=\"nofollow\">10.1016/S0092-8674(02)01052-8</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/12419249\" rel=\"nofollow\">12419249</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=BRCA1+supports+XIST+RNA+concentration+on+the+inactive+X+chromosome&amp;rft.volume=111&amp;rft.issue=3&amp;rft.pages=393-405&amp;rft.date=2002-11&amp;rft_id=info%3Adoi%2F10.1016%2FS0092-8674%2802%2901052-8&amp;rft_id=info%3Apmid%2F12419249&amp;rft.aulast=Ganesan&amp;rft.aufirst=S&amp;rft.au=Silver%2C+DP&amp;rft.au=Greenberg%2C+RA&amp;rft.au=Avni%2C+D&amp;rft.au=Drapkin%2C+R&amp;rft.au=Miron%2C+A&amp;rft.au=Mok%2C+SC&amp;rft.au=Randrianarison%2C+V&amp;rft.au=Brodie%2C+S&amp;rft.au=Salstrom%2C+J&amp;rft.au=Rasmussen%2C+TP&amp;rft.au=Klimke%2C+A&amp;rft.au=Marrese%2C+C&amp;rft.au=Marahrens%2C+Y&amp;rft.au=Deng%2C+CX&amp;rft.au=Feunteun%2C+J&amp;rft.au=Livingston%2C+DM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0092-8674%252802%252901052-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "<li id=\"cite_note-pmid11090615-229\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11090615_229-0\">^</a></b></span> <span class=\"reference-text\"><link href=\"mw-data:TemplateStyles:r1133582631\" rel=\"mw-deduplicated-inline-style\"/><cite class=\"citation journal cs1\" id=\"CITEREFZhengPanLiFlesken-Nikitin2000\">Zheng L, Pan H, Li S, Flesken-Nikitin A, Chen PL, Boyer TG, Lee WH (October 2000). <a class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2800%2900075-7\" rel=\"nofollow\">\"Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1\"</a>. <i>Mol. Cell</i>. <b>6</b> (4): 757–68. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS1097-2765%2800%2900075-7\" rel=\"nofollow\">10.1016/S1097-2765(00)00075-7</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"https://pubmed.ncbi.nlm.nih.gov/11090615\" rel=\"nofollow\">11090615</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol.+Cell&amp;rft.atitle=Sequence-specific+transcriptional+corepressor+function+for+BRCA1+through+a+novel+zinc+finger+protein%2C+ZBRK1&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=757-68&amp;rft.date=2000-10&amp;rft_id=info%3Adoi%2F10.1016%2FS1097-2765%2800%2900075-7&amp;rft_id=info%3Apmid%2F11090615&amp;rft.aulast=Zheng&amp;rft.aufirst=L&amp;rft.au=Pan%2C+H&amp;rft.au=Li%2C+S&amp;rft.au=Flesken-Nikitin%2C+A&amp;rft.au=Chen%2C+PL&amp;rft.au=Boyer%2C+TG&amp;rft.au=Lee%2C+WH&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS1097-2765%252800%252900075-7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABRCA1\"></span></span>\n",
              "</li>\n",
              "</ol></div>\n",
              "<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BRCA1&amp;action=edit&amp;section=22\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n",
              "<style data-mw-deduplicate=\"TemplateStyles:r1134653256\">.mw-parser-output .side-box{margin:4px 0;box-sizing:border-box;border:1px solid #aaa;font-size:88%;line-height:1.25em;background-color:#f9f9f9;display:flow-root}.mw-parser-output .side-box-abovebelow,.mw-parser-output .side-box-text{padding:0.25em 0.9em}.mw-parser-output .side-box-image{padding:2px 0 2px 0.9em;text-align:center}.mw-parser-output .side-box-imageright{padding:2px 0.9em 2px 0;text-align:center}@media(min-width:500px){.mw-parser-output .side-box-flex{display:flex;align-items:center}.mw-parser-output .side-box-text{flex:1}}@media(min-width:720px){.mw-parser-output .side-box{width:238px}.mw-parser-output .side-box-right{clear:right;float:right;margin-left:1em}.mw-parser-output .side-box-left{margin-right:1em}}</style><div class=\"side-box side-box-right plainlinks sistersitebox\"><style data-mw-deduplicate=\"TemplateStyles:r1126788409\">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style>\n",
              "<div class=\"side-box-flex\">\n",
              "<div class=\"side-box-image\"><img alt=\"\" class=\"noviewer\" data-file-height=\"1376\" data-file-width=\"1024\" decoding=\"async\" height=\"40\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x\" width=\"30\"/></div>\n",
              "<div class=\"side-box-text plainlist\">Wikimedia Commons has media related to <span style=\"font-weight: bold; font-style: italic;\"><a class=\"extiw\" href=\"https://commons.wikimedia.org/wiki/Category:BRCA1\" title=\"commons:Category:BRCA1\">BRCA1</a></span>.</div></div>\n",
              "</div>\n",
              "<ul><li><a class=\"external text\" href=\"https://meshb.nlm.nih.gov/record/ui?name=BRCA1+Protein\" rel=\"nofollow\">BRCA1 Protein</a> at the U.S. National Library of Medicine <a href=\"/wiki/Medical_Subject_Headings\" title=\"Medical Subject Headings\">Medical Subject Headings</a> (MeSH)</li>\n",
              "<li><a class=\"external text\" href=\"https://meshb.nlm.nih.gov/record/ui?name=Genes%2C+BRCA1\" rel=\"nofollow\">Genes, BRCA1</a> at the U.S. National Library of Medicine <a href=\"/wiki/Medical_Subject_Headings\" title=\"Medical Subject Headings\">Medical Subject Headings</a> (MeSH)</li>\n",
              "<li><a class=\"external text\" href=\"https://www.ebi.ac.uk/pdbe/pdbe-kb/proteins/P38398\" rel=\"nofollow\">PDBe-KB</a> provides an overview of all the structure information available in the PDB for Human BRCA1.</li></ul>\n",
              "<div class=\"navbox-styles\"><style data-mw-deduplicate=\"TemplateStyles:r1129693374\">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:\": \"}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:\" · \";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:\" (\";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:\")\";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:\" \"counter(listitem)\"\\a0 \"}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:\" (\"counter(listitem)\"\\a0 \"}</style><style data-mw-deduplicate=\"TemplateStyles:r1061467846\">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div aria-labelledby=\"PDB_gallery\" class=\"navbox\" role=\"navigation\" style=\"padding:3px\"><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\" style=\"background:#e7dcc3\"><link href=\"mw-data:TemplateStyles:r1129693374\" rel=\"mw-deduplicated-inline-style\"/><style data-mw-deduplicate=\"TemplateStyles:r1063604349\">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:\"[ \"}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:\" ]\"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class=\"navbar plainlinks hlist navbar-mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:PDB_Gallery\" title=\"Template:PDB Gallery\"><abbr style=\";background:#e7dcc3;background:none transparent;border:none;box-shadow:none;padding:0;\" title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:PDB_Gallery\" title=\"Template talk:PDB Gallery\"><abbr style=\";background:#e7dcc3;background:none transparent;border:none;box-shadow:none;padding:0;\" title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:PDB_Gallery&amp;action=edit\"><abbr style=\";background:#e7dcc3;background:none transparent;border:none;box-shadow:none;padding:0;\" title=\"Edit this template\">e</abbr></a></li></ul></div><div id=\"PDB_gallery\" style=\"font-size:114%;margin:0 4em\">PDB gallery</div></th></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"><ul class=\"gallery mw-gallery-traditional nochecker\" style=\"line-height:130%\">\n",
              "<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\n",
              "<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a class=\"image\" href=\"/wiki/File:PDB_1jm7_EBI.jpg\" title=\"1jm7: Solution structure of the BRCA1/BARD1 RING-domain heterodimer\"><img alt=\"1jm7: Solution structure of the BRCA1/BARD1 RING-domain heterodimer\" data-file-height=\"600\" data-file-width=\"800\" decoding=\"async\" height=\"135\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/13/PDB_1jm7_EBI.jpg/180px-PDB_1jm7_EBI.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/13/PDB_1jm7_EBI.jpg/270px-PDB_1jm7_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/13/PDB_1jm7_EBI.jpg/360px-PDB_1jm7_EBI.jpg 2x\" width=\"180\"/></a></div></div>\n",
              "<div class=\"gallerytext\">\n",
              "<p><b>1jm7</b>: Solution structure of the BRCA1/BARD1 RING-domain heterodimer\n",
              "</p>\n",
              "</div>\n",
              "</div></li>\n",
              "<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\n",
              "<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a class=\"image\" href=\"/wiki/File:PDB_1jnx_EBI.jpg\" title=\"1jnx: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\"><img alt=\"1jnx: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\" data-file-height=\"600\" data-file-width=\"800\" decoding=\"async\" height=\"135\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f2/PDB_1jnx_EBI.jpg/180px-PDB_1jnx_EBI.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f2/PDB_1jnx_EBI.jpg/270px-PDB_1jnx_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f2/PDB_1jnx_EBI.jpg/360px-PDB_1jnx_EBI.jpg 2x\" width=\"180\"/></a></div></div>\n",
              "<div class=\"gallerytext\">\n",
              "<p><b>1jnx</b>: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\n",
              "</p>\n",
              "</div>\n",
              "</div></li>\n",
              "<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\n",
              "<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a class=\"image\" href=\"/wiki/File:PDB_1n5o_EBI.jpg\" title=\"1n5o: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\"><img alt=\"1n5o: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\" data-file-height=\"600\" data-file-width=\"800\" decoding=\"async\" height=\"135\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f7/PDB_1n5o_EBI.jpg/180px-PDB_1n5o_EBI.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f7/PDB_1n5o_EBI.jpg/270px-PDB_1n5o_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f7/PDB_1n5o_EBI.jpg/360px-PDB_1n5o_EBI.jpg 2x\" width=\"180\"/></a></div></div>\n",
              "<div class=\"gallerytext\">\n",
              "<p><b>1n5o</b>: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\n",
              "</p>\n",
              "</div>\n",
              "</div></li>\n",
              "<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\n",
              "<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a class=\"image\" href=\"/wiki/File:PDB_1oqa_EBI.jpg\" title=\"1oqa: Solution structure of the BRCT-c domain from human BRCA1\"><img alt=\"1oqa: Solution structure of the BRCT-c domain from human BRCA1\" data-file-height=\"600\" data-file-width=\"800\" decoding=\"async\" height=\"135\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/28/PDB_1oqa_EBI.jpg/180px-PDB_1oqa_EBI.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/28/PDB_1oqa_EBI.jpg/270px-PDB_1oqa_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/28/PDB_1oqa_EBI.jpg/360px-PDB_1oqa_EBI.jpg 2x\" width=\"180\"/></a></div></div>\n",
              "<div class=\"gallerytext\">\n",
              "<p><b>1oqa</b>: Solution structure of the BRCT-c domain from human BRCA1\n",
              "</p>\n",
              "</div>\n",
              "</div></li>\n",
              "<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\n",
              "<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a class=\"image\" href=\"/wiki/File:PDB_1t15_EBI.jpg\" title=\"1t15: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\"><img alt=\"1t15: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\" data-file-height=\"600\" data-file-width=\"800\" decoding=\"async\" height=\"135\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/PDB_1t15_EBI.jpg/180px-PDB_1t15_EBI.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/PDB_1t15_EBI.jpg/270px-PDB_1t15_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/82/PDB_1t15_EBI.jpg/360px-PDB_1t15_EBI.jpg 2x\" width=\"180\"/></a></div></div>\n",
              "<div class=\"gallerytext\">\n",
              "<p><b>1t15</b>: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\n",
              "</p>\n",
              "</div>\n",
              "</div></li>\n",
              "<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\n",
              "<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a class=\"image\" href=\"/wiki/File:PDB_1t29_EBI.jpg\" title=\"1t29: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\"><img alt=\"1t29: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\" data-file-height=\"600\" data-file-width=\"800\" decoding=\"async\" height=\"135\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4b/PDB_1t29_EBI.jpg/180px-PDB_1t29_EBI.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4b/PDB_1t29_EBI.jpg/270px-PDB_1t29_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4b/PDB_1t29_EBI.jpg/360px-PDB_1t29_EBI.jpg 2x\" width=\"180\"/></a></div></div>\n",
              "<div class=\"gallerytext\">\n",
              "<p><b>1t29</b>: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\n",
              "</p>\n",
              "</div>\n",
              "</div></li>\n",
              "<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\n",
              "<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a class=\"image\" href=\"/wiki/File:PDB_1t2u_EBI.jpg\" title=\"1t2u: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\"><img alt=\"1t2u: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\" data-file-height=\"600\" data-file-width=\"800\" decoding=\"async\" height=\"135\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/91/PDB_1t2u_EBI.jpg/180px-PDB_1t2u_EBI.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/91/PDB_1t2u_EBI.jpg/270px-PDB_1t2u_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/91/PDB_1t2u_EBI.jpg/360px-PDB_1t2u_EBI.jpg 2x\" width=\"180\"/></a></div></div>\n",
              "<div class=\"gallerytext\">\n",
              "<p><b>1t2u</b>: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\n",
              "</p>\n",
              "</div>\n",
              "</div></li>\n",
              "<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\n",
              "<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a class=\"image\" href=\"/wiki/File:PDB_1t2v_EBI.jpg\" title=\"1t2v: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\"><img alt=\"1t2v: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\" data-file-height=\"600\" data-file-width=\"800\" decoding=\"async\" height=\"135\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/55/PDB_1t2v_EBI.jpg/180px-PDB_1t2v_EBI.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/55/PDB_1t2v_EBI.jpg/270px-PDB_1t2v_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/55/PDB_1t2v_EBI.jpg/360px-PDB_1t2v_EBI.jpg 2x\" width=\"180\"/></a></div></div>\n",
              "<div class=\"gallerytext\">\n",
              "<p><b>1t2v</b>: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\n",
              "</p>\n",
              "</div>\n",
              "</div></li>\n",
              "<li class=\"gallerybox\" style=\"width: 215px\"><div style=\"width: 215px\">\n",
              "<div class=\"thumb\" style=\"width: 210px;\"><div style=\"margin:37.5px auto;\"><a class=\"image\" href=\"/wiki/File:PDB_1y98_EBI.jpg\" title=\"1y98: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\"><img alt=\"1y98: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\" data-file-height=\"600\" data-file-width=\"800\" decoding=\"async\" height=\"135\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/PDB_1y98_EBI.jpg/180px-PDB_1y98_EBI.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/bf/PDB_1y98_EBI.jpg/270px-PDB_1y98_EBI.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bf/PDB_1y98_EBI.jpg/360px-PDB_1y98_EBI.jpg 2x\" width=\"180\"/></a></div></div>\n",
              "<div class=\"gallerytext\">\n",
              "<p><b>1y98</b>: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\n",
              "</p>\n",
              "</div>\n",
              "</div></li>\n",
              "</ul></div></td></tr></tbody></table></div>\n",
              "<div class=\"navbox-styles\"><link href=\"mw-data:TemplateStyles:r1129693374\" rel=\"mw-deduplicated-inline-style\"/><link href=\"mw-data:TemplateStyles:r1061467846\" rel=\"mw-deduplicated-inline-style\"/></div><div aria-labelledby=\"Tumor_suppressor_genes_and_Oncogenes\" class=\"navbox\" role=\"navigation\" style=\"padding:3px\"><table class=\"nowraplinks mw-collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><link href=\"mw-data:TemplateStyles:r1129693374\" rel=\"mw-deduplicated-inline-style\"/><link href=\"mw-data:TemplateStyles:r1063604349\" rel=\"mw-deduplicated-inline-style\"/><div class=\"navbar plainlinks hlist navbar-mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Tumor_suppressor_genes_and_oncogenes\" title=\"Template:Tumor suppressor genes and oncogenes\"><abbr style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\" title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Tumor_suppressor_genes_and_oncogenes\" title=\"Template talk:Tumor suppressor genes and oncogenes\"><abbr style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\" title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:Tumor_suppressor_genes_and_oncogenes&amp;action=edit\"><abbr style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\" title=\"Edit this template\">e</abbr></a></li></ul></div><div id=\"Tumor_suppressor_genes_and_Oncogenes\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Tumor_suppressor_gene\" title=\"Tumor suppressor gene\">Tumor suppressor genes</a> and <a href=\"/wiki/Oncogene\" title=\"Oncogene\">Oncogenes</a></div></th></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Ligand_(biochemistry)\" title=\"Ligand (biochemistry)\">Ligand</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"Growth_factors\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Growth_factor\" title=\"Growth factor\">Growth factors</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"ONCO\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Platelet-derived_growth_factor\" title=\"Platelet-derived growth factor\">c-Sis/PDGF</a></li>\n",
              "<li><a href=\"/wiki/Hepatocyte_growth_factor\" title=\"Hepatocyte growth factor\">HGF</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Receptor_(biochemistry)\" title=\"Receptor (biochemistry)\">Receptor</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Wnt_signaling_pathway\" title=\"Wnt signaling pathway\">Wnt signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"TSP\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a class=\"mw-redirect\" href=\"/wiki/CDH1_(gene)\" title=\"CDH1 (gene)\">CDH1</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Hedgehog_signaling_pathway\" title=\"Hedgehog signaling pathway\">Hedgehog signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"TSP\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/PTCH1\" title=\"PTCH1\">PTCH1</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/TGF_beta_signaling_pathway\" title=\"TGF beta signaling pathway\">TGF beta signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"TSP\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/TGF_beta_receptor_2\" title=\"TGF beta receptor 2\">TGF beta receptor 2</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Receptor_tyrosine_kinase\" title=\"Receptor tyrosine kinase\">Receptor tyrosine kinase</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"ONCO\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/ErbB\" title=\"ErbB\">ErbB</a>/<a href=\"/wiki/Epidermal_growth_factor_receptor\" title=\"Epidermal growth factor receptor\">c-ErbB</a>\n",
              "<ul><li><a class=\"mw-redirect\" href=\"/wiki/HER2/neu\" title=\"HER2/neu\">HER2/neu</a></li>\n",
              "<li><a href=\"/wiki/ERBB3\" title=\"ERBB3\">Her 3</a></li></ul></li>\n",
              "<li><a href=\"/wiki/C-Met\" title=\"C-Met\">c-Met</a></li>\n",
              "<li><a href=\"/wiki/RET_proto-oncogene\" title=\"RET proto-oncogene\">c-Ret</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/JAK-STAT_signaling_pathway\" title=\"JAK-STAT signaling pathway\">JAK-STAT signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"ONCO\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a class=\"mw-redirect\" href=\"/wiki/CD117\" title=\"CD117\">c-Kit</a></li>\n",
              "<li><a href=\"/wiki/CD135\" title=\"CD135\">Flt3</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a class=\"mw-redirect\" href=\"/wiki/Intracellular_signaling_peptides_and_proteins\" title=\"Intracellular signaling peptides and proteins\">Intracellular signaling P+Ps</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Wnt_signaling_pathway\" title=\"Wnt signaling pathway\">Wnt signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Beta-catenin\" title=\"Beta-catenin\">Beta-catenin</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Adenomatosis_polyposis_coli\" title=\"Adenomatosis polyposis coli\">APC</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/TGF_beta_signaling_pathway\" title=\"TGF beta signaling pathway\">TGF beta signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"TSP\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Mothers_against_decapentaplegic_homolog_2\" title=\"Mothers against decapentaplegic homolog 2\">SMAD2</a></li>\n",
              "<li><a href=\"/wiki/Mothers_against_decapentaplegic_homolog_4\" title=\"Mothers against decapentaplegic homolog 4\">SMAD4</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Akt/PKB_signaling_pathway\" title=\"Akt/PKB signaling pathway\">Akt/PKB signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a class=\"mw-redirect\" href=\"/wiki/AKT\" title=\"AKT\">c-Akt</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/PTEN_(gene)\" title=\"PTEN (gene)\">PTEN</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Hippo_signaling_pathway\" title=\"Hippo signaling pathway\">Hippo signaling pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"TSP\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Merlin_(protein)\" title=\"Merlin (protein)\">Neurofibromin 2/Merlin</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/MAPK/ERK_pathway\" title=\"MAPK/ERK pathway\">MAPK/ERK pathway</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Ras_(protein)\" title=\"Ras (protein)\">c-Ras</a></li>\n",
              "<li><a href=\"/wiki/HRAS\" title=\"HRAS\">HRAS</a></li>\n",
              "<li><a href=\"/wiki/C-Raf\" title=\"C-Raf\">c-Raf</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Neurofibromin_1\" title=\"Neurofibromin 1\">Neurofibromin 1</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Other/unknown</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Proto-oncogene_tyrosine-protein_kinase_Src\" title=\"Proto-oncogene tyrosine-protein kinase Src\">c-Src</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Maspin\" title=\"Maspin\">Maspin</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Cell_nucleus\" title=\"Cell nucleus\">Nucleus</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Cell_cycle\" title=\"Cell cycle\">Cell cycle</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Cyclin-dependent_kinase_4\" title=\"Cyclin-dependent kinase 4\">CDK4</a></li>\n",
              "<li><a href=\"/wiki/Cyclin_D\" title=\"Cyclin D\">Cyclin D</a></li>\n",
              "<li><a href=\"/wiki/Cyclin_E\" title=\"Cyclin E\">Cyclin E</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/P53\" title=\"P53\">p53</a></li>\n",
              "<li><a href=\"/wiki/Retinoblastoma_protein\" title=\"Retinoblastoma protein\">pRb</a></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/WT1\" title=\"WT1\">WT1</a></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/P16_(gene)\" title=\"P16 (gene)\">p16</a>/<a href=\"/wiki/P14arf\" title=\"P14arf\">p14arf</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/DNA_repair\" title=\"DNA repair\">DNA repair</a>/<a href=\"/wiki/Fanconi_anemia\" title=\"Fanconi anemia\">Fanconi</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"TSP\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a class=\"mw-selflink selflink\">BRCA1</a></li>\n",
              "<li><a href=\"/wiki/BRCA2\" title=\"BRCA2\">BRCA2</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Ubiquitin_ligase\" title=\"Ubiquitin ligase\">Ubiquitin ligase</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/CBL_(gene)\" title=\"CBL (gene)\">CBL</a></li>\n",
              "<li><a href=\"/wiki/Mdm2\" title=\"Mdm2\">MDM2</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Von_Hippel%E2%80%93Lindau_tumor_suppressor\" title=\"Von Hippel–Lindau tumor suppressor\">VHL</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Transcription_factor\" title=\"Transcription factor\">Transcription factor</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">ONCO</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/AP-1_transcription_factor\" title=\"AP-1 transcription factor\">AP-1</a>\n",
              "<ul><li><a class=\"mw-redirect\" href=\"/wiki/C-Fos\" title=\"C-Fos\">c-Fos</a></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/C-jun\" title=\"C-jun\">c-Jun</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Myc\" title=\"Myc\">c-Myc</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">TSP</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/KLF6\" title=\"KLF6\">KLF6</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Mitochondrion\" title=\"Mitochondrion\">Mitochondrion</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"Apoptosis_inhibitor\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Inhibitor_of_apoptosis\" title=\"Inhibitor of apoptosis\">Apoptosis inhibitor</a></th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/SDHB\" title=\"SDHB\">SDHB</a></li>\n",
              "<li><a href=\"/wiki/SDHD\" title=\"SDHD\">SDHD</a></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Other/ungrouped</th><td class=\"navbox-list-with-group navbox-list navbox-odd hlist\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Bcl-2\" title=\"Bcl-2\">c-Bcl-2</a></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/Notch_signaling\" title=\"Notch signaling\">Notch</a></li>\n",
              "<li><a href=\"/wiki/Stathmin\" title=\"Stathmin\">Stathmin</a></li></ul>\n",
              "</div></td></tr></tbody></table></div>\n",
              "<div class=\"navbox-styles\"><link href=\"mw-data:TemplateStyles:r1129693374\" rel=\"mw-deduplicated-inline-style\"/><link href=\"mw-data:TemplateStyles:r1061467846\" rel=\"mw-deduplicated-inline-style\"/></div><div aria-labelledby=\"Medicine\" class=\"navbox\" role=\"navigation\" style=\"padding:3px\"><table class=\"nowraplinks hlist mw-collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><link href=\"mw-data:TemplateStyles:r1129693374\" rel=\"mw-deduplicated-inline-style\"/><link href=\"mw-data:TemplateStyles:r1063604349\" rel=\"mw-deduplicated-inline-style\"/><div class=\"navbar plainlinks hlist navbar-mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Medicine\" title=\"Template:Medicine\"><abbr style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\" title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Medicine\" title=\"Template talk:Medicine\"><abbr style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\" title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:Medicine&amp;action=edit\"><abbr style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\" title=\"Edit this template\">e</abbr></a></li></ul></div><div id=\"Medicine\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Medicine\" title=\"Medicine\">Medicine</a></div></th></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Medical_specialty\" title=\"Medical specialty\">Specialties</a><br/>and<br/><a href=\"/wiki/Subspecialty\" title=\"Subspecialty\">subspecialties</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Surgery\" title=\"Surgery\">Surgery</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Cardiac_surgery\" title=\"Cardiac surgery\">Cardiac surgery</a></li>\n",
              "<li><a href=\"/wiki/Cardiothoracic_surgery\" title=\"Cardiothoracic surgery\">Cardiothoracic surgery</a></li>\n",
              "<li><a href=\"/wiki/Endocrine_surgery\" title=\"Endocrine surgery\">Endocrine surgery</a></li>\n",
              "<li><a href=\"/wiki/Eye_surgery\" title=\"Eye surgery\">Eye surgery</a></li>\n",
              "<li><a href=\"/wiki/General_surgery\" title=\"General surgery\">General surgery</a>\n",
              "<ul><li><a href=\"/wiki/Colorectal_surgery\" title=\"Colorectal surgery\">Colorectal surgery</a></li>\n",
              "<li><a href=\"/wiki/Digestive_system_surgery\" title=\"Digestive system surgery\">Digestive system surgery</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Neurosurgery\" title=\"Neurosurgery\">Neurosurgery</a></li>\n",
              "<li><a href=\"/wiki/Oral_and_maxillofacial_surgery\" title=\"Oral and maxillofacial surgery\">Oral and maxillofacial surgery</a></li>\n",
              "<li><a href=\"/wiki/Orthopedic_surgery\" title=\"Orthopedic surgery\">Orthopedic surgery</a></li>\n",
              "<li><a href=\"/wiki/Hand_surgery\" title=\"Hand surgery\">Hand surgery</a></li>\n",
              "<li><a href=\"/wiki/Otorhinolaryngology\" title=\"Otorhinolaryngology\">Otolaryngology</a>\n",
              "<ul><li><small>ENT</small></li></ul></li>\n",
              "<li><a href=\"/wiki/Pediatric_surgery\" title=\"Pediatric surgery\">Pediatric surgery</a></li>\n",
              "<li><a href=\"/wiki/Plastic_surgery\" title=\"Plastic surgery\">Plastic surgery</a></li>\n",
              "<li><a href=\"/wiki/Reproductive_surgery\" title=\"Reproductive surgery\">Reproductive surgery</a></li>\n",
              "<li><a href=\"/wiki/Surgical_oncology\" title=\"Surgical oncology\">Surgical oncology</a></li>\n",
              "<li><a href=\"/wiki/Organ_transplantation\" title=\"Organ transplantation\">Transplant surgery</a></li>\n",
              "<li><a href=\"/wiki/Trauma_surgery\" title=\"Trauma surgery\">Trauma surgery</a></li>\n",
              "<li><a href=\"/wiki/Urology\" title=\"Urology\">Urology</a>\n",
              "<ul><li><a href=\"/wiki/Andrology\" title=\"Andrology\">Andrology</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Vascular_surgery\" title=\"Vascular surgery\">Vascular surgery</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Internal_medicine\" title=\"Internal medicine\">Internal<br/>medicine</a></th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Allergy\" title=\"Allergy\">Allergy</a> / <a href=\"/wiki/Immunology\" title=\"Immunology\">Immunology</a></li>\n",
              "<li><a href=\"/wiki/Angiology\" title=\"Angiology\">Angiology</a></li>\n",
              "<li><a href=\"/wiki/Cardiology\" title=\"Cardiology\">Cardiology</a></li>\n",
              "<li><a href=\"/wiki/Endocrinology\" title=\"Endocrinology\">Endocrinology</a></li>\n",
              "<li><a href=\"/wiki/Gastroenterology\" title=\"Gastroenterology\">Gastroenterology</a>\n",
              "<ul><li><a href=\"/wiki/Hepatology\" title=\"Hepatology\">Hepatology</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Geriatrics\" title=\"Geriatrics\">Geriatrics</a></li>\n",
              "<li><a href=\"/wiki/Hematology\" title=\"Hematology\">Hematology</a></li>\n",
              "<li><a href=\"/wiki/Hospital_medicine\" title=\"Hospital medicine\">Hospital medicine</a></li>\n",
              "<li><a href=\"/wiki/Infectious_diseases_(medical_specialty)\" title=\"Infectious diseases (medical specialty)\">Infectious diseases</a></li>\n",
              "<li><a href=\"/wiki/Nephrology\" title=\"Nephrology\">Nephrology</a></li>\n",
              "<li><a href=\"/wiki/Oncology\" title=\"Oncology\">Oncology</a></li>\n",
              "<li><a href=\"/wiki/Pulmonology\" title=\"Pulmonology\">Pulmonology</a></li>\n",
              "<li><a href=\"/wiki/Rheumatology\" title=\"Rheumatology\">Rheumatology</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Obstetrics_and_gynaecology\" title=\"Obstetrics and gynaecology\">Obstetrics and<br/>gynaecology</a></th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Gynaecology\" title=\"Gynaecology\">Gynaecology</a></li>\n",
              "<li><a href=\"/wiki/Gynecologic_oncology\" title=\"Gynecologic oncology\">Gynecologic oncology</a></li>\n",
              "<li><a href=\"/wiki/Maternal%E2%80%93fetal_medicine\" title=\"Maternal–fetal medicine\">Maternal–fetal medicine</a></li>\n",
              "<li><a href=\"/wiki/Obstetrics\" title=\"Obstetrics\">Obstetrics</a></li>\n",
              "<li><a href=\"/wiki/Reproductive_endocrinology_and_infertility\" title=\"Reproductive endocrinology and infertility\">Reproductive endocrinology and infertility</a></li>\n",
              "<li><a href=\"/wiki/Urogynecology\" title=\"Urogynecology\">Urogynecology</a></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Medical_diagnosis\" title=\"Medical diagnosis\">Diagnostic</a></th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Radiology\" title=\"Radiology\">Radiology</a>\n",
              "<ul><li><a href=\"/wiki/Interventional_radiology\" title=\"Interventional radiology\">Interventional radiology</a></li>\n",
              "<li><a href=\"/wiki/Neuroradiology\" title=\"Neuroradiology\">Neuroradiology</a></li>\n",
              "<li><a href=\"/wiki/Nuclear_medicine\" title=\"Nuclear medicine\">Nuclear medicine</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Pathology\" title=\"Pathology\">Pathology</a>\n",
              "<ul><li><a href=\"/wiki/Anatomical_pathology\" title=\"Anatomical pathology\">Anatomical</a></li>\n",
              "<li><a href=\"/wiki/Clinical_pathology\" title=\"Clinical pathology\">Clinical pathology</a></li>\n",
              "<li><a href=\"/wiki/Clinical_chemistry\" title=\"Clinical chemistry\">Clinical chemistry</a></li>\n",
              "<li><a href=\"/wiki/Cytopathology\" title=\"Cytopathology\">Cytopathology</a></li>\n",
              "<li><a href=\"/wiki/Medical_microbiology\" title=\"Medical microbiology\">Medical microbiology</a></li>\n",
              "<li><a href=\"/wiki/Transfusion_medicine\" title=\"Transfusion medicine\">Transfusion medicine</a></li></ul></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Other</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Addiction_medicine\" title=\"Addiction medicine\">Addiction medicine</a></li>\n",
              "<li><a href=\"/wiki/Adolescent_medicine\" title=\"Adolescent medicine\">Adolescent medicine</a></li>\n",
              "<li><a href=\"/wiki/Anesthesiology\" title=\"Anesthesiology\">Anesthesiology</a>\n",
              "<ul><li><a href=\"/wiki/Obstetric_anesthesiology\" title=\"Obstetric anesthesiology\">Obstetric anesthesiology</a></li>\n",
              "<li><a href=\"/wiki/Neurosurgical_anesthesia\" title=\"Neurosurgical anesthesia\">Neurosurgical anesthesiology</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Aviation_medicine\" title=\"Aviation medicine\">Aviation medicine</a></li>\n",
              "<li><a href=\"/wiki/Dermatology\" title=\"Dermatology\">Dermatology</a></li>\n",
              "<li><a href=\"/wiki/Disaster_medicine\" title=\"Disaster medicine\">Disaster medicine</a></li>\n",
              "<li><a href=\"/wiki/Diving_medicine\" title=\"Diving medicine\">Diving medicine</a></li>\n",
              "<li><a href=\"/wiki/Emergency_medicine\" title=\"Emergency medicine\">Emergency medicine</a>\n",
              "<ul><li><a href=\"/wiki/Mass_gathering_medicine\" title=\"Mass gathering medicine\">Mass gathering medicine</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Family_medicine\" title=\"Family medicine\">Family medicine</a> / <a href=\"/wiki/General_practice\" title=\"General practice\">General practice</a></li>\n",
              "<li><a href=\"/wiki/Hospital_medicine\" title=\"Hospital medicine\">Hospital medicine</a></li>\n",
              "<li><a href=\"/wiki/Intensive_care_medicine\" title=\"Intensive care medicine\">Intensive care medicine</a></li>\n",
              "<li><a href=\"/wiki/Medical_genetics\" title=\"Medical genetics\">Medical genetics</a></li>\n",
              "<li><a href=\"/wiki/Narcology\" title=\"Narcology\">Narcology</a></li>\n",
              "<li><a href=\"/wiki/Neurology\" title=\"Neurology\">Neurology</a>\n",
              "<ul><li><a href=\"/wiki/Clinical_neurophysiology\" title=\"Clinical neurophysiology\">Clinical neurophysiology</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Occupational_medicine\" title=\"Occupational medicine\">Occupational medicine</a></li>\n",
              "<li><a href=\"/wiki/Ophthalmology\" title=\"Ophthalmology\">Ophthalmology</a></li>\n",
              "<li><a href=\"/wiki/Oral_medicine\" title=\"Oral medicine\">Oral medicine</a></li>\n",
              "<li><a href=\"/wiki/Pain_management\" title=\"Pain management\">Pain management</a></li>\n",
              "<li><a href=\"/wiki/Palliative_care\" title=\"Palliative care\">Palliative care</a></li>\n",
              "<li><a href=\"/wiki/Pediatrics\" title=\"Pediatrics\">Pediatrics</a>\n",
              "<ul><li><a href=\"/wiki/Neonatology\" title=\"Neonatology\">Neonatology</a></li></ul></li>\n",
              "<li><a class=\"mw-redirect\" href=\"/wiki/Phlebologist\" title=\"Phlebologist\">Phlebology</a></li>\n",
              "<li><a href=\"/wiki/Physical_medicine_and_rehabilitation\" title=\"Physical medicine and rehabilitation\">Physical medicine and rehabilitation</a> (PM&amp;R)</li>\n",
              "<li><a href=\"/wiki/Preventive_healthcare\" title=\"Preventive healthcare\">Preventive medicine</a></li>\n",
              "<li><a href=\"/wiki/Prison_healthcare\" title=\"Prison healthcare\">Prison healthcare</a></li>\n",
              "<li><a href=\"/wiki/Psychiatry\" title=\"Psychiatry\">Psychiatry</a>\n",
              "<ul><li><a href=\"/wiki/Addiction_psychiatry\" title=\"Addiction psychiatry\">Addiction psychiatry</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">Radiation oncology</a></li>\n",
              "<li><a href=\"/wiki/Reproductive_medicine\" title=\"Reproductive medicine\">Reproductive medicine</a></li>\n",
              "<li><a href=\"/wiki/Sexual_medicine\" title=\"Sexual medicine\">Sexual medicine</a>\n",
              "<ul><li><a href=\"/wiki/Venereology\" title=\"Venereology\">Venereology</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Sleep_medicine\" title=\"Sleep medicine\">Sleep medicine</a></li>\n",
              "<li><a href=\"/wiki/Sports_medicine\" title=\"Sports medicine\">Sports medicine</a></li>\n",
              "<li><a href=\"/wiki/Organ_transplantation\" title=\"Organ transplantation\">Transplantation medicine</a></li>\n",
              "<li><a href=\"/wiki/Tropical_medicine\" title=\"Tropical medicine\">Tropical medicine</a>\n",
              "<ul><li><a href=\"/wiki/Travel_medicine\" title=\"Travel medicine\">Travel medicine</a></li></ul></li></ul>\n",
              "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Medical_education\" title=\"Medical education\">Medical<br/>education</a></th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Medical_school\" title=\"Medical school\">Medical school</a></li>\n",
              "<li><a href=\"/wiki/Bachelor_of_Medicine,_Bachelor_of_Surgery\" title=\"Bachelor of Medicine, Bachelor of Surgery\">Bachelor of Medicine, Bachelor of Surgery</a></li>\n",
              "<li><a href=\"/wiki/Bachelor_of_Medical_Sciences\" title=\"Bachelor of Medical Sciences\">Bachelor of Medical Sciences</a></li>\n",
              "<li><a href=\"/wiki/Master_of_Medicine\" title=\"Master of Medicine\">Master of Medicine</a></li>\n",
              "<li><a href=\"/wiki/Master_of_Surgery\" title=\"Master of Surgery\">Master of Surgery</a></li>\n",
              "<li><a href=\"/wiki/Doctor_of_Medicine\" title=\"Doctor of Medicine\">Doctor of Medicine</a></li>\n",
              "<li><a href=\"/wiki/Doctor_of_Osteopathic_Medicine\" title=\"Doctor of Osteopathic Medicine\">Doctor of Osteopathic Medicine</a></li>\n",
              "<li><a href=\"/wiki/MD%E2%80%93PhD\" title=\"MD–PhD\">MD–PhD</a>\n",
              "<ul><li><a href=\"/wiki/Medical_Scientist_Training_Program\" title=\"Medical Scientist Training Program\">Medical Scientist Training Program</a></li></ul></li></ul>\n",
              "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Related topics</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n",
              "<ul><li><a href=\"/wiki/Alternative_medicine\" title=\"Alternative medicine\">Alternative medicine</a></li>\n",
              "<li><a href=\"/wiki/Allied_health_professions\" title=\"Allied health professions\">Allied health</a>\n",
              "<ul><li><a href=\"/wiki/Dentistry\" title=\"Dentistry\">Dentistry</a></li>\n",
              "<li><a href=\"/wiki/Podiatry\" title=\"Podiatry\">Podiatry</a></li>\n",
              "<li><a href=\"/wiki/Pharmacy\" title=\"Pharmacy\">Pharmacy</a></li>\n",
              "<li><a href=\"/wiki/Physical_therapy\" title=\"Physical therapy\">Physiotherapy</a></li></ul></li>\n",
              "<li><a href=\"/wiki/Molecular_oncology\" title=\"Molecular oncology\">Molecular oncology</a></li>\n",
              "<li><a href=\"/wiki/Nanomedicine\" title=\"Nanomedicine\">Nanomedicine</a></li>\n",
              "<li><a href=\"/wiki/Personalized_medicine\" title=\"Personalized medicine\">Personalized medicine</a></li>\n",
              "<li><a href=\"/wiki/Public_health\" title=\"Public health\">Public health</a></li>\n",
              "<li><a href=\"/wiki/Rural_health\" title=\"Rural health\">Rural health</a></li>\n",
              "<li><a href=\"/wiki/Therapy\" title=\"Therapy\">Therapy</a></li>\n",
              "<li><a href=\"/wiki/Traditional_medicine\" title=\"Traditional medicine\">Traditional medicine</a></li>\n",
              "<li><a href=\"/wiki/Veterinary_medicine\" title=\"Veterinary medicine\">Veterinary medicine</a></li>\n",
              "<li><a href=\"/wiki/Physician\" title=\"Physician\">Physician</a>\n",
              "<ul><li><a href=\"/wiki/Chief_physician\" title=\"Chief physician\">Chief physician</a></li></ul></li>\n",
              "<li><a href=\"/wiki/History_of_medicine\" title=\"History of medicine\">History of medicine</a></li></ul>\n",
              "</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\n",
              "<ul><li><img alt=\"\" class=\"noviewer\" data-file-height=\"185\" data-file-width=\"180\" decoding=\"async\" height=\"16\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/16px-Symbol_category_class.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/23px-Symbol_category_class.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/31px-Symbol_category_class.svg.png 2x\" title=\"Category\" width=\"16\"/> <a href=\"/wiki/Category:Medicine\" title=\"Category:Medicine\">Category</a></li>\n",
              "<li><img alt=\"\" class=\"noviewer\" data-file-height=\"1376\" data-file-width=\"1024\" decoding=\"async\" height=\"16\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/12px-Commons-logo.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/18px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/24px-Commons-logo.svg.png 2x\" title=\"Commons page\" width=\"12\"/> <a class=\"extiw\" href=\"https://commons.wikimedia.org/wiki/Medicine\" title=\"commons:Medicine\">Commons</a></li>\n",
              "<li><img alt=\"\" class=\"noviewer\" data-file-height=\"100\" data-file-width=\"100\" decoding=\"async\" height=\"16\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/37/People_icon.svg/16px-People_icon.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/37/People_icon.svg/24px-People_icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/37/People_icon.svg/32px-People_icon.svg.png 2x\" title=\"WikiProject\" width=\"16\"/> <a href=\"/wiki/Wikipedia:WikiProject_Medicine\" title=\"Wikipedia:WikiProject Medicine\">Wikiproject</a></li>\n",
              "<li><a class=\"image\" href=\"/wiki/File:Symbol_portal_class.svg\" title=\"Portal\"><img alt=\"\" class=\"noviewer\" data-file-height=\"185\" data-file-width=\"180\" decoding=\"async\" height=\"16\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/e/e2/Symbol_portal_class.svg/16px-Symbol_portal_class.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/e/e2/Symbol_portal_class.svg/23px-Symbol_portal_class.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/e/e2/Symbol_portal_class.svg/31px-Symbol_portal_class.svg.png 2x\" width=\"16\"/></a> <a href=\"/wiki/Portal:Medicine\" title=\"Portal:Medicine\">Portal</a></li>\n",
              "<li><img alt=\"\" class=\"noviewer\" data-file-height=\"200\" data-file-width=\"130\" decoding=\"async\" height=\"16\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/41/Global_thinking.svg/10px-Global_thinking.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/41/Global_thinking.svg/15px-Global_thinking.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/41/Global_thinking.svg/21px-Global_thinking.svg.png 2x\" title=\"Outline\" width=\"10\"/> <a href=\"/wiki/Outline_of_medicine\" title=\"Outline of medicine\">Outline</a></li></ul>\n",
              "</div></td></tr></tbody></table></div>\n",
              "<!-- \n",
              "NewPP limit report\n",
              "Parsed by mw2377\n",
              "Cached time: 20230427233751\n",
              "Cache expiry: 1814400\n",
              "Reduced expiry: false\n",
              "Complications: [vary‐revision‐sha1, show‐toc]\n",
              "CPU time usage: 2.499 seconds\n",
              "Real time usage: 3.162 seconds\n",
              "Preprocessor visited node count: 13321/1000000\n",
              "Post‐expand include size: 766038/2097152 bytes\n",
              "Template argument size: 8324/2097152 bytes\n",
              "Highest expansion depth: 13/100\n",
              "Expensive parser function count: 105/500\n",
              "Unstrip recursion depth: 1/20\n",
              "Unstrip post‐expand size: 813171/5000000 bytes\n",
              "Lua time usage: 1.784/10.000 seconds\n",
              "Lua memory usage: 14979111/52428800 bytes\n",
              "Lua Profile:\n",
              "    MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::getEntity      460 ms       26.7%\n",
              "    ?                                                                300 ms       17.4%\n",
              "    dataWrapper <mw.lua:672>                                         100 ms        5.8%\n",
              "    MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::getLabel       80 ms        4.7%\n",
              "    MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::preprocess       80 ms        4.7%\n",
              "    gsub                                                              80 ms        4.7%\n",
              "    MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::callParserFunction       80 ms        4.7%\n",
              "    MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::match       60 ms        3.5%\n",
              "    recursiveClone <mwInit.lua:41>                                    60 ms        3.5%\n",
              "    MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::find       60 ms        3.5%\n",
              "    [others]                                                         360 ms       20.9%\n",
              "Number of Wikibase entities loaded: 98/400\n",
              "-->\n",
              "<!--\n",
              "Transclusion expansion time report (%,ms,calls,template)\n",
              "100.00% 2858.201      1 -total\n",
              " 43.58% 1245.612      1 Template:Reflist\n",
              " 40.75% 1164.670      1 Template:Infobox_gene\n",
              " 33.21%  949.161    199 Template:Cite_journal\n",
              "  7.54%  215.479     25 Template:Navbox\n",
              "  3.17%   90.722      1 Template:PDB_Gallery\n",
              "  1.76%   50.270      1 Template:Short_description\n",
              "  1.68%   48.099      5 Template:Citation_needed\n",
              "  1.64%   46.810      1 Template:Tumor_suppressor_genes\n",
              "  1.48%   42.321     11 Template:Cite_web\n",
              "-->\n",
              "<!-- Saved in parser cache with key enwiki:pcache:idhash:412097-0!canonical and timestamp 20230427233748 and revision id 1146808968. Rendering was triggered because: page-view\n",
              " -->\n",
              "</div><!--esi <esi:include src=\"/esitest-fa8a495983347898/content\" /> --><noscript><img alt=\"\" height=\"1\" src=\"//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1\" style=\"border: none; position: absolute;\" title=\"\" width=\"1\"/></noscript>\n",
              "<div class=\"printfooter\" data-nosnippet=\"\">Retrieved from \"<a dir=\"ltr\" href=\"https://en.wikipedia.org/w/index.php?title=BRCA1&amp;oldid=1146808968\">https://en.wikipedia.org/w/index.php?title=BRCA1&amp;oldid=1146808968</a>\"</div></div>\n",
              "<div class=\"catlinks\" data-mw=\"interface\" id=\"catlinks\"><div class=\"mw-normal-catlinks\" id=\"mw-normal-catlinks\"><a href=\"/wiki/Help:Category\" title=\"Help:Category\">Categories</a>: <ul><li><a href=\"/wiki/Category:Genes_on_human_chromosome_17\" title=\"Category:Genes on human chromosome 17\">Genes on human chromosome 17</a></li><li><a href=\"/wiki/Category:Breast_cancer\" title=\"Category:Breast cancer\">Breast cancer</a></li><li><a href=\"/wiki/Category:Tumor_markers\" title=\"Category:Tumor markers\">Tumor markers</a></li><li><a href=\"/wiki/Category:Tumor_suppressor_genes\" title=\"Category:Tumor suppressor genes\">Tumor suppressor genes</a></li></ul></div><div class=\"mw-hidden-catlinks mw-hidden-cats-hidden\" id=\"mw-hidden-catlinks\">Hidden categories: <ul><li><a href=\"/wiki/Category:Webarchive_template_wayback_links\" title=\"Category:Webarchive template wayback links\">Webarchive template wayback links</a></li><li><a href=\"/wiki/Category:CS1_Chinese-language_sources_(zh)\" title=\"Category:CS1 Chinese-language sources (zh)\">CS1 Chinese-language sources (zh)</a></li><li><a href=\"/wiki/Category:Articles_with_short_description\" title=\"Category:Articles with short description\">Articles with short description</a></li><li><a href=\"/wiki/Category:Short_description_is_different_from_Wikidata\" title=\"Category:Short description is different from Wikidata\">Short description is different from Wikidata</a></li><li><a href=\"/wiki/Category:All_articles_with_unsourced_statements\" title=\"Category:All articles with unsourced statements\">All articles with unsourced statements</a></li><li><a href=\"/wiki/Category:Articles_with_unsourced_statements_from_January_2016\" title=\"Category:Articles with unsourced statements from January 2016\">Articles with unsourced statements from January 2016</a></li><li><a href=\"/wiki/Category:Articles_with_unsourced_statements_from_May_2019\" title=\"Category:Articles with unsourced statements from May 2019\">Articles with unsourced statements from May 2019</a></li><li><a href=\"/wiki/Category:Dynamic_lists\" title=\"Category:Dynamic lists\">Dynamic lists</a></li><li><a href=\"/wiki/Category:Commons_category_link_is_on_Wikidata\" title=\"Category:Commons category link is on Wikidata\">Commons category link is on Wikidata</a></li></ul></div></div>\n",
              "</div>\n",
              "</main>\n",
              "</div>\n",
              "<div class=\"mw-footer-container\">\n",
              "<footer class=\"mw-footer\" id=\"footer\" role=\"contentinfo\">\n",
              "<ul id=\"footer-info\">\n",
              "<li id=\"footer-info-lastmod\"> This page was last edited on 27 March 2023, at 02:22<span class=\"anonymous-show\"> (UTC)</span>.</li>\n",
              "<li id=\"footer-info-copyright\">Text is available under the <a href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_the_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License\" rel=\"license\">Creative Commons Attribution-ShareAlike License 3.0</a><a href=\"//creativecommons.org/licenses/by-sa/3.0/\" rel=\"license\" style=\"display:none;\"></a>;\n",
              "additional terms may apply.  By using this site, you agree to the <a href=\"//foundation.wikimedia.org/wiki/Terms_of_Use\">Terms of Use</a> and <a href=\"//foundation.wikimedia.org/wiki/Privacy_policy\">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href=\"//www.wikimediafoundation.org/\">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>\n",
              "</ul>\n",
              "<ul id=\"footer-places\">\n",
              "<li id=\"footer-places-privacy\"><a href=\"https://foundation.wikimedia.org/wiki/Privacy_policy\">Privacy policy</a></li>\n",
              "<li id=\"footer-places-about\"><a href=\"/wiki/Wikipedia:About\">About Wikipedia</a></li>\n",
              "<li id=\"footer-places-disclaimers\"><a href=\"/wiki/Wikipedia:General_disclaimer\">Disclaimers</a></li>\n",
              "<li id=\"footer-places-contact\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\">Contact Wikipedia</a></li>\n",
              "<li id=\"footer-places-mobileview\"><a class=\"noprint stopMobileRedirectToggle\" href=\"//en.m.wikipedia.org/w/index.php?title=BRCA1&amp;mobileaction=toggle_view_mobile\">Mobile view</a></li>\n",
              "<li id=\"footer-places-developers\"><a href=\"https://developer.wikimedia.org\">Developers</a></li>\n",
              "<li id=\"footer-places-statslink\"><a href=\"https://stats.wikimedia.org/#/en.wikipedia.org\">Statistics</a></li>\n",
              "<li id=\"footer-places-cookiestatement\"><a href=\"https://foundation.wikimedia.org/wiki/Cookie_statement\">Cookie statement</a></li>\n",
              "</ul>\n",
              "<ul class=\"noprint\" id=\"footer-icons\">\n",
              "<li id=\"footer-copyrightico\"><a href=\"https://wikimediafoundation.org/\"><img alt=\"Wikimedia Foundation\" height=\"31\" loading=\"lazy\" src=\"/static/images/footer/wikimedia-button.png\" srcset=\"/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x\" width=\"88\"/></a></li>\n",
              "<li id=\"footer-poweredbyico\"><a href=\"https://www.mediawiki.org/\"><img alt=\"Powered by MediaWiki\" height=\"31\" loading=\"lazy\" src=\"/static/images/footer/poweredby_mediawiki_88x31.png\" srcset=\"/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x\" width=\"88\"/></a></li>\n",
              "</ul>\n",
              "</footer>\n",
              "</div>\n",
              "</div>\n",
              "</div>\n",
              "<div class=\"vector-settings\">\n",
              "<button class=\"mw-ui-button mw-ui-icon mw-ui-icon-element vector-limited-width-toggle\">\n",
              "<span>Toggle limited content width</span>\n",
              "</button>\n",
              "</div>\n",
              "<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgHostname\":\"mw2274\",\"wgBackendResponseTime\":137,\"wgPageParseReport\":{\"limitreport\":{\"cputime\":\"2.499\",\"walltime\":\"3.162\",\"ppvisitednodes\":{\"value\":13321,\"limit\":1000000},\"postexpandincludesize\":{\"value\":766038,\"limit\":2097152},\"templateargumentsize\":{\"value\":8324,\"limit\":2097152},\"expansiondepth\":{\"value\":13,\"limit\":100},\"expensivefunctioncount\":{\"value\":105,\"limit\":500},\"unstrip-depth\":{\"value\":1,\"limit\":20},\"unstrip-size\":{\"value\":813171,\"limit\":5000000},\"entityaccesscount\":{\"value\":98,\"limit\":400},\"timingprofile\":[\"100.00% 2858.201      1 -total\",\" 43.58% 1245.612      1 Template:Reflist\",\" 40.75% 1164.670      1 Template:Infobox_gene\",\" 33.21%  949.161    199 Template:Cite_journal\",\"  7.54%  215.479     25 Template:Navbox\",\"  3.17%   90.722      1 Template:PDB_Gallery\",\"  1.76%   50.270      1 Template:Short_description\",\"  1.68%   48.099      5 Template:Citation_needed\",\"  1.64%   46.810      1 Template:Tumor_suppressor_genes\",\"  1.48%   42.321     11 Template:Cite_web\"]},\"scribunto\":{\"limitreport-timeusage\":{\"value\":\"1.784\",\"limit\":\"10.000\"},\"limitreport-memusage\":{\"value\":14979111,\"limit\":52428800},\"limitreport-profile\":[[\"MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::getEntity\",\"460\",\"26.7\"],[\"?\",\"300\",\"17.4\"],[\"dataWrapper \\u003Cmw.lua:672\\u003E\",\"100\",\"5.8\"],[\"MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::getLabel\",\"80\",\"4.7\"],[\"MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::preprocess\",\"80\",\"4.7\"],[\"gsub\",\"80\",\"4.7\"],[\"MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::callParserFunction\",\"80\",\"4.7\"],[\"MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::match\",\"60\",\"3.5\"],[\"recursiveClone \\u003CmwInit.lua:41\\u003E\",\"60\",\"3.5\"],[\"MediaWiki\\\\Extension\\\\Scribunto\\\\Engines\\\\LuaSandbox\\\\LuaSandboxCallback::find\",\"60\",\"3.5\"],[\"[others]\",\"360\",\"20.9\"]]},\"cachereport\":{\"origin\":\"mw2377\",\"timestamp\":\"20230427233751\",\"ttl\":1814400,\"transientcontent\":false}}});});</script>\n",
              "<script type=\"application/ld+json\">{\"@context\":\"https:\\/\\/schema.org\",\"@type\":\"Article\",\"name\":\"BRCA1\",\"url\":\"https:\\/\\/en.wikipedia.org\\/wiki\\/BRCA1\",\"sameAs\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q17487737\",\"mainEntity\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q17487737\",\"author\":{\"@type\":\"Organization\",\"name\":\"Contributors to Wikimedia projects\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Wikimedia Foundation, Inc.\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\/\\/www.wikimedia.org\\/static\\/images\\/wmf-hor-googpub.png\"}},\"datePublished\":\"2003-12-23T12:36:26Z\",\"dateModified\":\"2023-03-27T02:22:32Z\",\"image\":\"https:\\/\\/upload.wikimedia.org\\/wikipedia\\/commons\\/e\\/e1\\/Protein_BRCA1_PDB_1jm7.png\",\"headline\":\"mammalian protein found in Homo sapiens\"}</script><script type=\"application/ld+json\">{\"@context\":\"https:\\/\\/schema.org\",\"@type\":\"Article\",\"name\":\"BRCA1\",\"url\":\"https:\\/\\/en.wikipedia.org\\/wiki\\/BRCA1\",\"sameAs\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q17487737\",\"mainEntity\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q17487737\",\"author\":{\"@type\":\"Organization\",\"name\":\"Contributors to Wikimedia projects\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Wikimedia Foundation, Inc.\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\/\\/www.wikimedia.org\\/static\\/images\\/wmf-hor-googpub.png\"}},\"datePublished\":\"2003-12-23T12:36:26Z\",\"dateModified\":\"2023-03-27T02:22:32Z\",\"image\":\"https:\\/\\/upload.wikimedia.org\\/wikipedia\\/commons\\/e\\/e1\\/Protein_BRCA1_PDB_1jm7.png\",\"headline\":\"mammalian protein found in Homo sapiens\"}</script>\n",
              "</body>\n",
              "</html>"
            ]
          },
          "metadata": {},
          "execution_count": 100
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "text = \"\"\n",
        "for paragraph in soup.find_all('p'):\n",
        "    text += paragraph.text"
      ],
      "metadata": {
        "id": "EKMgHdc2rB9Q"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "text"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 139
        },
        "id": "6Yc0Dyw0rOtU",
        "outputId": "2d405033-21cb-4e9f-8818-37bace6d58e7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'1JM7, 1JNX, 1N5O, 1OQA, 1T15, 1T29, 1T2U, 1T2V, 1Y98, 2ING, 3COJ, 3K0H, 3K0K, 3K15, 3PXA, 3PXB, 3PXC, 3PXD, 3PXE, 4IFI, 4IGK, 4JLU, 4OFB, 4U4A, 4Y18, 4Y2G67212189ENSG00000012048ENSMUSG00000017146P38398P48754NM_007299NM_007300NM_007301NM_007302NM_007303NM_007305NM_007306NM_009764NP_009225NP_009228NP_009229NP_009230NP_009231NP_033894Breast cancer type 1 susceptibility protein is a protein that in humans is encoded by the BRCA1  (/ˌbrækəˈwʌn/) gene.[5] Orthologs are common in other vertebrate species, whereas invertebrate genomes may encode a more distantly related gene.[6] BRCA1 is a human tumor suppressor gene[7][8] (also known as a caretaker gene) and is responsible for repairing DNA.[9]\\nBRCA1 and BRCA2 are unrelated proteins,[10] but both are normally expressed in the cells of breast and other tissue, where they help repair damaged DNA, or destroy cells if DNA cannot be repaired. They are involved in the repair of chromosomal damage with an important role in the error-free repair of DNA double-strand breaks.[11][12] If BRCA1 or BRCA2 itself is damaged by a BRCA mutation, damaged DNA is not repaired properly, and this increases the risk for breast cancer.[13][14] BRCA1 and BRCA2 have been described as \"breast cancer susceptibility genes\" and \"breast cancer susceptibility proteins\".  The predominant allele has a normal, tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer.[15]\\nBRCA1 combines with other tumor suppressors, DNA damage sensors and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC).[16] The BRCA1 protein associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. Thus, this protein plays a role in transcription, and DNA repair of double-strand DNA breaks[14] ubiquitination, transcriptional regulation as well as other functions.[17]\\nMethods to test for the likelihood of a patient with mutations in BRCA1 and BRCA2 developing cancer were covered by patents owned or controlled by Myriad Genetics.[18][19]  Myriad\\'s business model of offering the diagnostic test exclusively led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012;[20] it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs, which in turn led to the landmark Association for Molecular Pathology v. Myriad Genetics lawsuit.[21]\\nThe first evidence for the existence of a gene encoding a DNA repair enzyme involved in breast cancer susceptibility was provided by Mary-Claire King\\'s laboratory at UC Berkeley in 1990.[22]  Four years later, after an international race to find it,[23] the gene was cloned in 1994 by scientists at University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics.[18][24]\\nThe human BRCA1 gene is located on the long (q) arm of chromosome 17 at region 2 band 1, from base pair 41,196,312 to base pair 41,277,500 (Build GRCh37/hg19) (map).[25] BRCA1 orthologs have been identified in most vertebrates for which complete genome data are available.[6]\\nThe BRCA1 protein contains the following domains:[26]\\nThis protein also contains nuclear localization signals and nuclear export signal motifs.[27]\\nThe human BRCA1 protein consists of four major protein domains; the Znf C3HC4- RING domain, the BRCA1 serine domain and two BRCT domains. These domains encode approximately 27% of BRCA1 protein. There are six known isoforms of BRCA1,[28] with isoforms 1 and 2 comprising 1863 amino acids each.[citation needed]\\nBRCA1 is unrelated to BRCA2, i.e. they are not homologs or paralogs.[10]\\nThe RING motif, a Zn finger found in eukaryotic peptides, is 40–60 amino acids long and consists of eight conserved metal-binding residues, two quartets of cysteine or histidine residues that coordinate two zinc atoms.[30]  This motif contains a short anti-parallel beta-sheet, two zinc-binding loops and a central alpha helix in a small domain.  This RING domain interacts with associated proteins, including BARD1, which also contains a RING motif, to form a heterodimer. The BRCA1 RING motif is flanked by alpha helices formed by residues 8–22 and 81–96 of the BRCA1 protein. It interacts with a homologous region in BARD1 also consisting of a RING finger flanked by two alpha-helices formed from residues 36–48 and 101–116. These four helices combine to form a heterodimerization interface and stabilize the BRCA1-BARD1 heterodimer complex. Additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression.[30]\\nThe ring domain is an important element of ubiquitin E3 ligases, which catalyze protein ubiquitination. Ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell. BRCA1 polypeptides, in particular, Lys-48-linked polyubiquitin chains are dispersed throughout the resting cell nucleus, but at the start of DNA replication, they gather in restrained groups that also contain BRCA2 and BARD1. BARD1 is thought to be involved in the recognition and binding of protein targets for ubiquitination.[31] It attaches to proteins and labels them for destruction. Ubiquitination occurs via the BRCA1 fusion protein and is abolished by zinc chelation.[30] The enzyme activity of the fusion protein is dependent on the proper folding of the ring domain.[citation needed]\\nBRCA1 serine cluster domain (SCD) spans amino acids 1280–1524. A portion of the domain is located in exons 11–13. High rates of mutation occur in exons 11–13. Reported phosphorylation sites of BRCA1 are concentrated in the SCD, where they are phosphorylated by ATM/ATR kinases both in vitro and in vivo. ATM/ATR are kinases activated by DNA damage. Mutation of serine residues may affect localization of BRCA1 to sites of DNA damage and DNA damage response function.[29]\\nThe dual repeat BRCT domain of the BRCA1 protein is an elongated structure approximately 70 Å long and 30–35 Å wide.[32] The 85–95 amino acid domains in BRCT can be found as single modules or as multiple tandem repeats containing two domains.[33] Both of these possibilities can occur in a single protein in a variety of different conformations.[32] The C-terminal BRCT region of the BRCA1 protein is essential for repair of DNA, transcription regulation and tumor suppressor function.[34] In BRCA1 the dual tandem repeat BRCT domains are arranged in a head-to-tail-fashion in the three-dimensional structure, burying 1600 Å of hydrophobic, solvent-accessible surface area in the interface. These all contribute to the tightly packed knob-in-hole structure that comprises the interface. These homologous domains interact to control cellular responses to DNA damage. A missense mutation at the interface of these two proteins can perturb the cell cycle, resulting a greater risk of developing cancer.[citation needed]\\nBRCA1 is part of a complex that repairs double-strand breaks in DNA. The strands of the DNA double helix are continuously breaking as they become damaged. Sometimes only one strand is broken, sometimes both strands are broken simultaneously. DNA cross-linking agents are an important source of chromosome/DNA damage. Double-strand breaks occur as intermediates after the crosslinks are removed, and indeed, biallelic mutations in BRCA1 have been identified to be responsible for Fanconi Anemia, Complementation Group S (FA-S),[35] a genetic disease associated with hypersensitivity to DNA crosslinking agents. BRCA1 is part of a protein complex that repairs DNA when both strands are broken. When this happens, it is difficult for the repair mechanism to \"know\" how to replace the correct DNA sequence, and there are multiple ways to attempt the repair. The double-strand repair mechanism in which BRCA1 participates is homology-directed repair, where the repair proteins copy the identical sequence from the intact sister chromatid.[36] FA-S is almost always a lethal condition in utero; only a handful cases of biallelic BRCA1 mutations have been reported in literature despite the high carrier frequencies in the Ashkenazim, and none since 2013.[37]\\nIn the nucleus of many types of normal cells, the BRCA1 protein interacts with RAD51 during repair of DNA double-strand breaks.[38] These breaks can be caused by natural radiation or other exposures, but also occur when chromosomes exchange genetic material (homologous recombination, e.g., \"crossing over\" during meiosis). The BRCA2 protein, which has a function similar to that of BRCA1, also interacts with the RAD51 protein. By influencing DNA damage repair, these three proteins play a role in maintaining the stability of the human genome.[citation needed]\\nBRCA1 is also involved in another type of DNA repair, termed mismatch repair.  BRCA1 interacts with the DNA mismatch repair protein MSH2.[39]  MSH2, MSH6, PARP and some other proteins involved in single-strand repair are reported to be elevated in BRCA1-deficient mammary tumors.[40]\\nA protein called valosin-containing protein (VCP, also known as p97) plays a role to recruit BRCA1 to the damaged DNA sites.  After ionizing radiation, VCP is recruited to DNA lesions and cooperates with the ubiquitin ligase RNF8 to orchestrate assembly of signaling complexes for efficient DSB repair.[41]  BRCA1 interacts with VCP.[42] BRCA1 also interacts with c-Myc, and other proteins that are critical to maintain genome stability.[43]\\nBRCA1 directly binds to DNA, with higher affinity for branched DNA structures. This ability to bind to DNA contributes to its ability to inhibit the nuclease activity of the MRN complex as well as the nuclease activity of Mre11 alone.[44] This may explain a role for BRCA1 to promote lower fidelity DNA repair by non-homologous end joining (NHEJ).[45] BRCA1 also colocalizes with γ-H2AX (histone H2AX phosphorylated on serine-139) in DNA double-strand break repair foci, indicating it may play a role in recruiting repair factors.[17][46]\\nFormaldehyde and acetaldehyde are common environmental sources of DNA cross links that often require repairs mediated by BRCA1 containing pathways.[47]\\nThis DNA repair function is essential; mice with loss-of-function mutations in both BRCA1 alleles are not viable, and as of 2015 only two adults were known to have loss-of-function mutations in both alleles (leading to FA-S); both had congenital or developmental issues, and both had cancer. One was presumed to have survived to adulthood because one of the BRCA1 mutations was hypomorphic.[48]\\nBRCA1 was shown to co-purify with the human RNA Polymerase II holoenzyme in HeLa extracts, implying it is a component of the holoenzyme.[49] Later research, however, contradicted this assumption, instead showing that the predominant complex including BRCA1 in HeLa cells is a 2 megadalton complex containing SWI/SNF.[50] SWI/SNF is a chromatin remodeling complex. Artificial tethering of BRCA1 to chromatin was shown to decondense heterochromatin, though the SWI/SNF interacting domain was not necessary for this role.[46] BRCA1 interacts with the NELF-B (COBRA1) subunit of the NELF complex.[46]\\nCertain variations of the BRCA1 gene lead to an increased risk for breast cancer as part of a hereditary breast–ovarian cancer syndrome. Researchers have identified hundreds of mutations in the BRCA1 gene, many of which are associated with an increased risk of cancer. Females with an abnormal BRCA1 or BRCA2 gene have up to an 80% risk of developing breast cancer by age 90; increased risk of developing ovarian cancer is about 55% for females with BRCA1 mutations and about 25% for females with BRCA2 mutations.[52]\\nThese mutations can be changes in one or a small number of DNA base pairs (the building-blocks of DNA), and can be identified with PCR and DNA sequencing.[53]\\nIn some cases, large segments of DNA are rearranged. Those large segments, also called large rearrangements, can be a deletion or a duplication of one or several exons in the gene. Classical methods for mutation detection (sequencing) are unable to reveal these types of mutation.[54] Other methods have been proposed: traditional quantitative PCR,[55] multiplex ligation-dependent probe amplification (MLPA),[56] and Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF).[57] Newer methods have also been recently proposed: heteroduplex analysis (HDA) by multi-capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization (array-CGH).[58]\\nSome results suggest that hypermethylation of the BRCA1 promoter, which has been reported in some cancers, could be considered as an inactivating mechanism for BRCA1 expression.[59]\\nA mutated BRCA1 gene usually makes a protein that does not function properly. Researchers believe that the defective BRCA1 protein is unable to help fix DNA damage leading to mutations in other genes. These mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor. Thus, BRCA1 inactivating mutations lead to a predisposition for cancer.[citation needed]\\nBRCA1 mRNA 3\\' UTR can be bound by an miRNA, Mir-17 microRNA. It has been suggested that variations in this miRNA along with Mir-30 microRNA could confer susceptibility to breast cancer.[60]\\nIn addition to breast cancer, mutations in the BRCA1 gene also increase the risk of ovarian and prostate cancers. Moreover, precancerous lesions (dysplasia) within the Fallopian tube have been linked to BRCA1 gene mutations. Pathogenic mutations anywhere in a model pathway containing BRCA1 and BRCA2 greatly increase risks for a subset of leukemias and lymphomas.[14]\\nWomen who have inherited a defective BRCA1 or BRCA2 gene are at a greatly elevated risk to develop breast and ovarian cancer. Their risk of developing breast and/or ovarian cancer is so high, and so specific to those cancers, that many mutation carriers choose to have prophylactic surgery. There has been much conjecture to explain such apparently striking tissue specificity. Major determinants of where BRCA1/2 hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation or the carcinogen. The target tissue may have receptors for the pathogen, may become selectively exposed to an inflammatory process or to a carcinogen. An innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets. This theory also fits data for several tumor suppressors beyond BRCA1 or BRCA2. A major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery.[61]\\nAs aforementioned, biallelic and homozygous inheritance of the BRCA1 gene leads to FA-S, which is almost always an embryonically lethal condition.\\nBRCA1 expression is reduced or undetectable in the majority of high grade, ductal breast cancers.[62]  It has long been noted that loss of BRCA1 activity, either by germ-line mutations or by down-regulation of gene expression, leads to tumor formation in specific target tissues.  In particular, decreased BRCA1 expression contributes to both sporadic and inherited breast tumor progression.[63]  Reduced expression of BRCA1 is tumorigenic because it plays an important role in the repair of DNA damages, especially double-strand breaks, by the potentially error-free pathway of homologous recombination.[64]  Since cells that lack the BRCA1 protein tend to repair DNA damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer.[64]\\nSimilarly, BRCA1 expression is low in the majority (55%) of sporadic epithelial ovarian cancers (EOCs) where EOCs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers.[65]  In serous ovarian carcinomas, a sub-category constituting about 2/3 of EOCs, low BRCA1 expression occurs in more than 50% of cases.[66]  Bowtell[67] reviewed the literature indicating that deficient homologous recombination repair caused by BRCA1 deficiency is tumorigenic.  In particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy.  Especially noted was that BRCA1 deficiency could be the cause of tumorigenesis whether due to BRCA1 mutation or any other event that causes a deficiency of BRCA1 expression.\\nOnly about 3%–8% of all women with breast cancer carry a mutation in BRCA1 or BRCA2.[68]  Similarly, BRCA1 mutations are only seen in about 18% of ovarian cancers (13% germline mutations and 5% somatic mutations).[69]\\nThus, while BRCA1 expression is low in the majority of these cancers, BRCA1 mutation is not a major cause of reduced expression. Certain latent viruses, which are frequently detected in breast cancer tumors, can decrease the expression of the BRCA1 gene and cause the development of breast tumors.[70]\\nBRCA1 promoter hypermethylation was present in only 13% of unselected primary breast carcinomas.[71]  Similarly, BRCA1 promoter hypermethylation was present in only 5% to 15% of EOC cases.[65]\\nThus, while BRCA1 expression is low in these cancers, BRCA1 promoter methylation is only a minor cause of reduced expression.\\nThere are a number of specific microRNAs, when overexpressed, that directly reduce expression of specific DNA repair proteins (see MicroRNA section DNA repair and cancer)  In the case of breast cancer, microRNA-182 (miR-182) specifically targets BRCA1.[72]  Breast cancers can be classified based on receptor status or histology, with triple-negative breast cancer (15%–25% of breast cancers), HER2+ (15%–30% of breast cancers), ER+/PR+ (about 70% of breast cancers), and Invasive lobular carcinoma (about 5%–10% of invasive breast cancer).  All four types of breast cancer were found to have an average of about 100-fold increase in miR-182, compared to normal breast tissue.[73]  In breast cancer cell lines, there is an inverse correlation of BRCA1 protein levels with miR-182 expression.[72] Thus it appears that much of the reduction or absence of BRCA1 in high grade ductal breast cancers may be due to over-expressed miR-182.\\nIn addition to miR-182, a pair of almost identical microRNAs, miR-146a and miR-146b-5p, also repress BRCA1 expression.  These two microRNAs are over-expressed in triple-negative tumors and their over-expression results in BRCA1 inactivation.[74]  Thus, miR-146a and/or miR-146b-5p may also contribute to reduced expression of BRCA1 in these triple-negative breast cancers.\\nIn both serous tubal intraepithelial carcinoma (the precursor lesion to high grade serous ovarian carcinoma (HG-SOC)), and in HG-SOC itself, miR-182 is overexpressed in about 70% of cases.[75]  In cells with over-expressed miR-182, BRCA1 remained low, even after exposure to ionizing radiation (which normally raises BRCA1 expression).[75]  Thus much of the reduced or absent BRCA1 in HG-SOC may be due to over-expressed miR-182.\\nAnother microRNA known to reduce expression of BRCA1 in ovarian cancer cells is miR-9.[65]  Among 58 tumors from patients with stage IIIC or stage IV serous ovarian cancers (HG-SOG), an inverse correlation was found between expressions of miR-9 and BRCA1,[65] so that increased miR-9 may also contribute to reduced expression of BRCA1 in these ovarian cancers.\\nDNA damage appears to be the primary underlying cause of cancer,[76] and deficiencies in DNA repair appears to underlie many forms of cancer.[77]  If DNA repair is deficient, DNA damage tends to accumulate. Such excess DNA damage may increase mutational errors during DNA replication due to error-prone translesion synthesis. Excess DNA damage may also increase epigenetic alterations due to errors during DNA repair.[78][79] Such mutations and epigenetic alterations may give rise to cancer.  The frequent microRNA-induced deficiency of BRCA1 in breast and ovarian cancers likely contribute to the progression of those cancers.\\nAll germ-line BRCA1 mutations identified to date have been inherited, suggesting the possibility of a large \"founder\" effect in which a certain mutation is common to a well-defined population group and can, in theory, be traced back to a common ancestor. Given the complexity of mutation screening for BRCA1, these common mutations may simplify the methods required for mutation screening in certain populations. Analysis of mutations that occur with high frequency also permits the study of their clinical expression.[80] Examples of manifestations of a founder effect are seen among Ashkenazi Jews. Three mutations in BRCA1 have been reported to account for the majority of Ashkenazi Jewish patients with inherited BRCA1-related breast and/or ovarian cancer: 185delAG, 188del11 and 5382insC in the BRCA1 gene.[81][82] In fact, it has been shown that if a Jewish woman does not carry a BRCA1 185delAG, BRCA1 5382insC founder mutation, it is highly unlikely that a different BRCA1 mutation will be found.[83] Additional examples of founder mutations in BRCA1 are given in Table 1 (mainly derived from[80]).\\nAs women age, reproductive performance declines, leading to menopause. This decline is tied to a reduction in the number of ovarian follicles. Although about 1 million oocytes are present at birth in the human ovary, only about 500 (about 0.05%) of these ovulate. The decline in ovarian reserve appears to occur at a constantly increasing rate with age,[115] and leads to nearly complete exhaustion of the reserve by about age 52. As ovarian reserve and fertility decline with age, there is also a parallel increase in pregnancy failure and meiotic errors, resulting in chromosomally abnormal conceptions.[116]\\nWomen with a germ-line BRCA1 mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women.[117] Furthermore, women with an inherited BRCA1 mutation undergo menopause prematurely.[118]  Since BRCA1 is a key DNA repair protein, these findings suggest that naturally occurring DNA damages in oocytes are repaired less efficiently in women with a BRCA1 defect, and that this repair inefficiency leads to early reproductive failure.[117]\\nAs noted above, the BRCA1 protein plays a key role in homologous recombinational repair.  This is the only known cellular process that can accurately repair DNA double-strand breaks. DNA double-strand breaks accumulate with age in humans and mice in primordial follicles.[119]  Primordial follicles contain oocytes that are at an intermediate (prophase I) stage of meiosis.  Meiosis is the general process in eukaryotic organisms by which germ cells are formed, and it is likely an adaptation for removing DNA damages, especially double-strand breaks, from germ line DNA.[120] (Also see article Meiosis).  Homologous recombinational repair employing BRCA1 is especially promoted during meiosis.  It was found that expression of four key genes necessary for homologous recombinational repair of DNA double-strand breaks (BRCA1, MRE11, RAD51 and ATM) decline with age in the oocytes of humans and mice,[119] leading to the hypothesis that DNA double-strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging.\\nNon-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide.  At diagnosis, almost 70% of persons with NSCLC have locally advanced or metastatic disease.  Persons with NSCLC are often treated with therapeutic platinum compounds (e.g. cisplatin, carboplatin or oxaliplatin) that cause inter-strand cross-links in DNA.  Among individuals with NSCLC, low expression of BRCA1 in the primary tumor correlated with improved survival after platinum-containing chemotherapy.[121][122]  This correlation implies that low BRCA1 in cancer, and the consequent low level of DNA repair, causes vulnerability of cancer to treatment by the DNA cross-linking agents.  High BRCA1 may protect cancer cells by acting in a pathway that removes the damages in DNA introduced by the platinum drugs.  Thus the level of BRCA1 expression is a potentially important tool for tailoring chemotherapy in lung cancer management.[121][122]\\nLevel of BRCA1 expression is also relevant to ovarian cancer treatment.  Patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their BRCA1 expression was low compared to patients with higher BRCA1 expression (46 compared to 33 months).[123]\\nA patent application for the isolated BRCA1 gene and cancer promoting mutations discussed above, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics in 1994;[18] over the next year, Myriad, (in collaboration with investigators at Endo Recherche, Inc., HSC Research & Development Limited Partnership, and University of Pennsylvania), isolated and sequenced the BRCA2 gene and identified key mutations, and the first BRCA2 patent was filed in the U.S. by Myriad and other institutions in 1995.[19]  Myriad is the exclusive licensee of these patents and has enforced them in the US against clinical diagnostic labs.[21]  This business model led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012;[20] it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs, which in turn led to the landmark Association for Molecular Pathology v. Myriad Genetics lawsuit.[21][124]  The patents began to expire in 2014.\\nAccording to an article published in the journal, Genetic Medicine, in 2010, \"The patent story outside the United States is more complicated.... For example, patents have been obtained but the patents are being ignored by provincial health systems in Canada. In Australia and the UK, Myriad\\'s licensee permitted use by health systems but announced a change of plans in August 2008. Only a single mutation has been patented in Myriad\\'s lone European-wide patent, although some patents remain under review of an opposition proceeding. In effect, the United States is the only jurisdiction where Myriad\\'s strong patent position has conferred sole-provider status.\"[125][126]  Peter Meldrum, CEO of Myriad Genetics, has acknowledged that Myriad has \"other competitive advantages that may make such [patent] enforcement unnecessary\" in Europe.[127]\\nAs with any gene, finding variation in BRCA1 is not hard. The real value comes from understanding what the clinical consequences of any particular variant are. Myriad has a large, proprietary database of such genotype-phenotype correlations. In response, parallel open-source databases are being developed.\\nLegal decisions surrounding the BRCA1 and BRCA2 patents will affect the field of genetic testing in general.[128]  A June 2013 article, in  Association for Molecular Pathology v. Myriad Genetics (No. 12-398), quoted the US Supreme Court\\'s unanimous ruling that, \"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating Myriad\\'s patents on the BRCA1 and BRCA2 genes. However, the Court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection.[129]  The Federal Court of Australia came to the opposite conclusion, upholding the validity of an Australian Myriad Genetics patent over the BRCA1 gene in February 2013.[130]  The Federal Court also rejected an appeal in September 2014.[131] Yvonne D\\'Arcy won her case against US-based biotech company Myriad Genetics in the High Court of Australia. In their unanimous decision on October 7, 2015, the \"high court found that an isolated nucleic acid, coding for a BRCA1 protein, with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a \\'patentable invention.\\'\"[132]\\nBRCA1 has been shown to interact with the following proteins:\\n1jm7: Solution structure of the BRCA1/BARD1 RING-domain heterodimer\\n1jnx: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\\n1n5o: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\\n1oqa: Solution structure of the BRCT-c domain from human BRCA1\\n1t15: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\\n1t29: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\\n1t2u: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\\n1t2v: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\\n1y98: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\\n'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 102
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import re"
      ],
      "metadata": {
        "id": "3cb7a89CrP-C"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "text = re.sub(r'\\[[0-9]*\\]', ' ',text)"
      ],
      "metadata": {
        "id": "VEjilLxLrT2B"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "text = re.sub(r'\\s+',' ',text)"
      ],
      "metadata": {
        "id": "PEyoQBXXrVar"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "text"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 139
        },
        "id": "13HifQ44rWwf",
        "outputId": "574ab604-45df-42d0-fb52-17f6d9dbb7ce"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'1JM7, 1JNX, 1N5O, 1OQA, 1T15, 1T29, 1T2U, 1T2V, 1Y98, 2ING, 3COJ, 3K0H, 3K0K, 3K15, 3PXA, 3PXB, 3PXC, 3PXD, 3PXE, 4IFI, 4IGK, 4JLU, 4OFB, 4U4A, 4Y18, 4Y2G67212189ENSG00000012048ENSMUSG00000017146P38398P48754NM_007299NM_007300NM_007301NM_007302NM_007303NM_007305NM_007306NM_009764NP_009225NP_009228NP_009229NP_009230NP_009231NP_033894Breast cancer type 1 susceptibility protein is a protein that in humans is encoded by the BRCA1 (/ˌbrækəˈwʌn/) gene. Orthologs are common in other vertebrate species, whereas invertebrate genomes may encode a more distantly related gene. BRCA1 is a human tumor suppressor gene (also known as a caretaker gene) and is responsible for repairing DNA. BRCA1 and BRCA2 are unrelated proteins, but both are normally expressed in the cells of breast and other tissue, where they help repair damaged DNA, or destroy cells if DNA cannot be repaired. They are involved in the repair of chromosomal damage with an important role in the error-free repair of DNA double-strand breaks. If BRCA1 or BRCA2 itself is damaged by a BRCA mutation, damaged DNA is not repaired properly, and this increases the risk for breast cancer. BRCA1 and BRCA2 have been described as \"breast cancer susceptibility genes\" and \"breast cancer susceptibility proteins\". The predominant allele has a normal, tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer. BRCA1 combines with other tumor suppressors, DNA damage sensors and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). The BRCA1 protein associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. Thus, this protein plays a role in transcription, and DNA repair of double-strand DNA breaks ubiquitination, transcriptional regulation as well as other functions. Methods to test for the likelihood of a patient with mutations in BRCA1 and BRCA2 developing cancer were covered by patents owned or controlled by Myriad Genetics. Myriad\\'s business model of offering the diagnostic test exclusively led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012; it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs, which in turn led to the landmark Association for Molecular Pathology v. Myriad Genetics lawsuit. The first evidence for the existence of a gene encoding a DNA repair enzyme involved in breast cancer susceptibility was provided by Mary-Claire King\\'s laboratory at UC Berkeley in 1990. Four years later, after an international race to find it, the gene was cloned in 1994 by scientists at University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics. The human BRCA1 gene is located on the long (q) arm of chromosome 17 at region 2 band 1, from base pair 41,196,312 to base pair 41,277,500 (Build GRCh37/hg19) (map). BRCA1 orthologs have been identified in most vertebrates for which complete genome data are available. The BRCA1 protein contains the following domains: This protein also contains nuclear localization signals and nuclear export signal motifs. The human BRCA1 protein consists of four major protein domains; the Znf C3HC4- RING domain, the BRCA1 serine domain and two BRCT domains. These domains encode approximately 27% of BRCA1 protein. There are six known isoforms of BRCA1, with isoforms 1 and 2 comprising 1863 amino acids each.[citation needed] BRCA1 is unrelated to BRCA2, i.e. they are not homologs or paralogs. The RING motif, a Zn finger found in eukaryotic peptides, is 40–60 amino acids long and consists of eight conserved metal-binding residues, two quartets of cysteine or histidine residues that coordinate two zinc atoms. This motif contains a short anti-parallel beta-sheet, two zinc-binding loops and a central alpha helix in a small domain. This RING domain interacts with associated proteins, including BARD1, which also contains a RING motif, to form a heterodimer. The BRCA1 RING motif is flanked by alpha helices formed by residues 8–22 and 81–96 of the BRCA1 protein. It interacts with a homologous region in BARD1 also consisting of a RING finger flanked by two alpha-helices formed from residues 36–48 and 101–116. These four helices combine to form a heterodimerization interface and stabilize the BRCA1-BARD1 heterodimer complex. Additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. The ring domain is an important element of ubiquitin E3 ligases, which catalyze protein ubiquitination. Ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell. BRCA1 polypeptides, in particular, Lys-48-linked polyubiquitin chains are dispersed throughout the resting cell nucleus, but at the start of DNA replication, they gather in restrained groups that also contain BRCA2 and BARD1. BARD1 is thought to be involved in the recognition and binding of protein targets for ubiquitination. It attaches to proteins and labels them for destruction. Ubiquitination occurs via the BRCA1 fusion protein and is abolished by zinc chelation. The enzyme activity of the fusion protein is dependent on the proper folding of the ring domain.[citation needed] BRCA1 serine cluster domain (SCD) spans amino acids 1280–1524. A portion of the domain is located in exons 11–13. High rates of mutation occur in exons 11–13. Reported phosphorylation sites of BRCA1 are concentrated in the SCD, where they are phosphorylated by ATM/ATR kinases both in vitro and in vivo. ATM/ATR are kinases activated by DNA damage. Mutation of serine residues may affect localization of BRCA1 to sites of DNA damage and DNA damage response function. The dual repeat BRCT domain of the BRCA1 protein is an elongated structure approximately 70 Å long and 30–35 Å wide. The 85–95 amino acid domains in BRCT can be found as single modules or as multiple tandem repeats containing two domains. Both of these possibilities can occur in a single protein in a variety of different conformations. The C-terminal BRCT region of the BRCA1 protein is essential for repair of DNA, transcription regulation and tumor suppressor function. In BRCA1 the dual tandem repeat BRCT domains are arranged in a head-to-tail-fashion in the three-dimensional structure, burying 1600 Å of hydrophobic, solvent-accessible surface area in the interface. These all contribute to the tightly packed knob-in-hole structure that comprises the interface. These homologous domains interact to control cellular responses to DNA damage. A missense mutation at the interface of these two proteins can perturb the cell cycle, resulting a greater risk of developing cancer.[citation needed] BRCA1 is part of a complex that repairs double-strand breaks in DNA. The strands of the DNA double helix are continuously breaking as they become damaged. Sometimes only one strand is broken, sometimes both strands are broken simultaneously. DNA cross-linking agents are an important source of chromosome/DNA damage. Double-strand breaks occur as intermediates after the crosslinks are removed, and indeed, biallelic mutations in BRCA1 have been identified to be responsible for Fanconi Anemia, Complementation Group S (FA-S), a genetic disease associated with hypersensitivity to DNA crosslinking agents. BRCA1 is part of a protein complex that repairs DNA when both strands are broken. When this happens, it is difficult for the repair mechanism to \"know\" how to replace the correct DNA sequence, and there are multiple ways to attempt the repair. The double-strand repair mechanism in which BRCA1 participates is homology-directed repair, where the repair proteins copy the identical sequence from the intact sister chromatid. FA-S is almost always a lethal condition in utero; only a handful cases of biallelic BRCA1 mutations have been reported in literature despite the high carrier frequencies in the Ashkenazim, and none since 2013. In the nucleus of many types of normal cells, the BRCA1 protein interacts with RAD51 during repair of DNA double-strand breaks. These breaks can be caused by natural radiation or other exposures, but also occur when chromosomes exchange genetic material (homologous recombination, e.g., \"crossing over\" during meiosis). The BRCA2 protein, which has a function similar to that of BRCA1, also interacts with the RAD51 protein. By influencing DNA damage repair, these three proteins play a role in maintaining the stability of the human genome.[citation needed] BRCA1 is also involved in another type of DNA repair, termed mismatch repair. BRCA1 interacts with the DNA mismatch repair protein MSH2. MSH2, MSH6, PARP and some other proteins involved in single-strand repair are reported to be elevated in BRCA1-deficient mammary tumors. A protein called valosin-containing protein (VCP, also known as p97) plays a role to recruit BRCA1 to the damaged DNA sites. After ionizing radiation, VCP is recruited to DNA lesions and cooperates with the ubiquitin ligase RNF8 to orchestrate assembly of signaling complexes for efficient DSB repair. BRCA1 interacts with VCP. BRCA1 also interacts with c-Myc, and other proteins that are critical to maintain genome stability. BRCA1 directly binds to DNA, with higher affinity for branched DNA structures. This ability to bind to DNA contributes to its ability to inhibit the nuclease activity of the MRN complex as well as the nuclease activity of Mre11 alone. This may explain a role for BRCA1 to promote lower fidelity DNA repair by non-homologous end joining (NHEJ). BRCA1 also colocalizes with γ-H2AX (histone H2AX phosphorylated on serine-139) in DNA double-strand break repair foci, indicating it may play a role in recruiting repair factors. Formaldehyde and acetaldehyde are common environmental sources of DNA cross links that often require repairs mediated by BRCA1 containing pathways. This DNA repair function is essential; mice with loss-of-function mutations in both BRCA1 alleles are not viable, and as of 2015 only two adults were known to have loss-of-function mutations in both alleles (leading to FA-S); both had congenital or developmental issues, and both had cancer. One was presumed to have survived to adulthood because one of the BRCA1 mutations was hypomorphic. BRCA1 was shown to co-purify with the human RNA Polymerase II holoenzyme in HeLa extracts, implying it is a component of the holoenzyme. Later research, however, contradicted this assumption, instead showing that the predominant complex including BRCA1 in HeLa cells is a 2 megadalton complex containing SWI/SNF. SWI/SNF is a chromatin remodeling complex. Artificial tethering of BRCA1 to chromatin was shown to decondense heterochromatin, though the SWI/SNF interacting domain was not necessary for this role. BRCA1 interacts with the NELF-B (COBRA1) subunit of the NELF complex. Certain variations of the BRCA1 gene lead to an increased risk for breast cancer as part of a hereditary breast–ovarian cancer syndrome. Researchers have identified hundreds of mutations in the BRCA1 gene, many of which are associated with an increased risk of cancer. Females with an abnormal BRCA1 or BRCA2 gene have up to an 80% risk of developing breast cancer by age 90; increased risk of developing ovarian cancer is about 55% for females with BRCA1 mutations and about 25% for females with BRCA2 mutations. These mutations can be changes in one or a small number of DNA base pairs (the building-blocks of DNA), and can be identified with PCR and DNA sequencing. In some cases, large segments of DNA are rearranged. Those large segments, also called large rearrangements, can be a deletion or a duplication of one or several exons in the gene. Classical methods for mutation detection (sequencing) are unable to reveal these types of mutation. Other methods have been proposed: traditional quantitative PCR, multiplex ligation-dependent probe amplification (MLPA), and Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF). Newer methods have also been recently proposed: heteroduplex analysis (HDA) by multi-capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization (array-CGH). Some results suggest that hypermethylation of the BRCA1 promoter, which has been reported in some cancers, could be considered as an inactivating mechanism for BRCA1 expression. A mutated BRCA1 gene usually makes a protein that does not function properly. Researchers believe that the defective BRCA1 protein is unable to help fix DNA damage leading to mutations in other genes. These mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor. Thus, BRCA1 inactivating mutations lead to a predisposition for cancer.[citation needed] BRCA1 mRNA 3\\' UTR can be bound by an miRNA, Mir-17 microRNA. It has been suggested that variations in this miRNA along with Mir-30 microRNA could confer susceptibility to breast cancer. In addition to breast cancer, mutations in the BRCA1 gene also increase the risk of ovarian and prostate cancers. Moreover, precancerous lesions (dysplasia) within the Fallopian tube have been linked to BRCA1 gene mutations. Pathogenic mutations anywhere in a model pathway containing BRCA1 and BRCA2 greatly increase risks for a subset of leukemias and lymphomas. Women who have inherited a defective BRCA1 or BRCA2 gene are at a greatly elevated risk to develop breast and ovarian cancer. Their risk of developing breast and/or ovarian cancer is so high, and so specific to those cancers, that many mutation carriers choose to have prophylactic surgery. There has been much conjecture to explain such apparently striking tissue specificity. Major determinants of where BRCA1/2 hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation or the carcinogen. The target tissue may have receptors for the pathogen, may become selectively exposed to an inflammatory process or to a carcinogen. An innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets. This theory also fits data for several tumor suppressors beyond BRCA1 or BRCA2. A major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery. As aforementioned, biallelic and homozygous inheritance of the BRCA1 gene leads to FA-S, which is almost always an embryonically lethal condition. BRCA1 expression is reduced or undetectable in the majority of high grade, ductal breast cancers. It has long been noted that loss of BRCA1 activity, either by germ-line mutations or by down-regulation of gene expression, leads to tumor formation in specific target tissues. In particular, decreased BRCA1 expression contributes to both sporadic and inherited breast tumor progression. Reduced expression of BRCA1 is tumorigenic because it plays an important role in the repair of DNA damages, especially double-strand breaks, by the potentially error-free pathway of homologous recombination. Since cells that lack the BRCA1 protein tend to repair DNA damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer. Similarly, BRCA1 expression is low in the majority (55%) of sporadic epithelial ovarian cancers (EOCs) where EOCs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers. In serous ovarian carcinomas, a sub-category constituting about 2/3 of EOCs, low BRCA1 expression occurs in more than 50% of cases. Bowtell reviewed the literature indicating that deficient homologous recombination repair caused by BRCA1 deficiency is tumorigenic. In particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy. Especially noted was that BRCA1 deficiency could be the cause of tumorigenesis whether due to BRCA1 mutation or any other event that causes a deficiency of BRCA1 expression. Only about 3%–8% of all women with breast cancer carry a mutation in BRCA1 or BRCA2. Similarly, BRCA1 mutations are only seen in about 18% of ovarian cancers (13% germline mutations and 5% somatic mutations). Thus, while BRCA1 expression is low in the majority of these cancers, BRCA1 mutation is not a major cause of reduced expression. Certain latent viruses, which are frequently detected in breast cancer tumors, can decrease the expression of the BRCA1 gene and cause the development of breast tumors. BRCA1 promoter hypermethylation was present in only 13% of unselected primary breast carcinomas. Similarly, BRCA1 promoter hypermethylation was present in only 5% to 15% of EOC cases. Thus, while BRCA1 expression is low in these cancers, BRCA1 promoter methylation is only a minor cause of reduced expression. There are a number of specific microRNAs, when overexpressed, that directly reduce expression of specific DNA repair proteins (see MicroRNA section DNA repair and cancer) In the case of breast cancer, microRNA-182 (miR-182) specifically targets BRCA1. Breast cancers can be classified based on receptor status or histology, with triple-negative breast cancer (15%–25% of breast cancers), HER2+ (15%–30% of breast cancers), ER+/PR+ (about 70% of breast cancers), and Invasive lobular carcinoma (about 5%–10% of invasive breast cancer). All four types of breast cancer were found to have an average of about 100-fold increase in miR-182, compared to normal breast tissue. In breast cancer cell lines, there is an inverse correlation of BRCA1 protein levels with miR-182 expression. Thus it appears that much of the reduction or absence of BRCA1 in high grade ductal breast cancers may be due to over-expressed miR-182. In addition to miR-182, a pair of almost identical microRNAs, miR-146a and miR-146b-5p, also repress BRCA1 expression. These two microRNAs are over-expressed in triple-negative tumors and their over-expression results in BRCA1 inactivation. Thus, miR-146a and/or miR-146b-5p may also contribute to reduced expression of BRCA1 in these triple-negative breast cancers. In both serous tubal intraepithelial carcinoma (the precursor lesion to high grade serous ovarian carcinoma (HG-SOC)), and in HG-SOC itself, miR-182 is overexpressed in about 70% of cases. In cells with over-expressed miR-182, BRCA1 remained low, even after exposure to ionizing radiation (which normally raises BRCA1 expression). Thus much of the reduced or absent BRCA1 in HG-SOC may be due to over-expressed miR-182. Another microRNA known to reduce expression of BRCA1 in ovarian cancer cells is miR-9. Among 58 tumors from patients with stage IIIC or stage IV serous ovarian cancers (HG-SOG), an inverse correlation was found between expressions of miR-9 and BRCA1, so that increased miR-9 may also contribute to reduced expression of BRCA1 in these ovarian cancers. DNA damage appears to be the primary underlying cause of cancer, and deficiencies in DNA repair appears to underlie many forms of cancer. If DNA repair is deficient, DNA damage tends to accumulate. Such excess DNA damage may increase mutational errors during DNA replication due to error-prone translesion synthesis. Excess DNA damage may also increase epigenetic alterations due to errors during DNA repair. Such mutations and epigenetic alterations may give rise to cancer. The frequent microRNA-induced deficiency of BRCA1 in breast and ovarian cancers likely contribute to the progression of those cancers. All germ-line BRCA1 mutations identified to date have been inherited, suggesting the possibility of a large \"founder\" effect in which a certain mutation is common to a well-defined population group and can, in theory, be traced back to a common ancestor. Given the complexity of mutation screening for BRCA1, these common mutations may simplify the methods required for mutation screening in certain populations. Analysis of mutations that occur with high frequency also permits the study of their clinical expression. Examples of manifestations of a founder effect are seen among Ashkenazi Jews. Three mutations in BRCA1 have been reported to account for the majority of Ashkenazi Jewish patients with inherited BRCA1-related breast and/or ovarian cancer: 185delAG, 188del11 and 5382insC in the BRCA1 gene. In fact, it has been shown that if a Jewish woman does not carry a BRCA1 185delAG, BRCA1 5382insC founder mutation, it is highly unlikely that a different BRCA1 mutation will be found. Additional examples of founder mutations in BRCA1 are given in Table 1 (mainly derived from ). As women age, reproductive performance declines, leading to menopause. This decline is tied to a reduction in the number of ovarian follicles. Although about 1 million oocytes are present at birth in the human ovary, only about 500 (about 0.05%) of these ovulate. The decline in ovarian reserve appears to occur at a constantly increasing rate with age, and leads to nearly complete exhaustion of the reserve by about age 52. As ovarian reserve and fertility decline with age, there is also a parallel increase in pregnancy failure and meiotic errors, resulting in chromosomally abnormal conceptions. Women with a germ-line BRCA1 mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women. Furthermore, women with an inherited BRCA1 mutation undergo menopause prematurely. Since BRCA1 is a key DNA repair protein, these findings suggest that naturally occurring DNA damages in oocytes are repaired less efficiently in women with a BRCA1 defect, and that this repair inefficiency leads to early reproductive failure. As noted above, the BRCA1 protein plays a key role in homologous recombinational repair. This is the only known cellular process that can accurately repair DNA double-strand breaks. DNA double-strand breaks accumulate with age in humans and mice in primordial follicles. Primordial follicles contain oocytes that are at an intermediate (prophase I) stage of meiosis. Meiosis is the general process in eukaryotic organisms by which germ cells are formed, and it is likely an adaptation for removing DNA damages, especially double-strand breaks, from germ line DNA. (Also see article Meiosis). Homologous recombinational repair employing BRCA1 is especially promoted during meiosis. It was found that expression of four key genes necessary for homologous recombinational repair of DNA double-strand breaks (BRCA1, MRE11, RAD51 and ATM) decline with age in the oocytes of humans and mice, leading to the hypothesis that DNA double-strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging. Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. At diagnosis, almost 70% of persons with NSCLC have locally advanced or metastatic disease. Persons with NSCLC are often treated with therapeutic platinum compounds (e.g. cisplatin, carboplatin or oxaliplatin) that cause inter-strand cross-links in DNA. Among individuals with NSCLC, low expression of BRCA1 in the primary tumor correlated with improved survival after platinum-containing chemotherapy. This correlation implies that low BRCA1 in cancer, and the consequent low level of DNA repair, causes vulnerability of cancer to treatment by the DNA cross-linking agents. High BRCA1 may protect cancer cells by acting in a pathway that removes the damages in DNA introduced by the platinum drugs. Thus the level of BRCA1 expression is a potentially important tool for tailoring chemotherapy in lung cancer management. Level of BRCA1 expression is also relevant to ovarian cancer treatment. Patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their BRCA1 expression was low compared to patients with higher BRCA1 expression (46 compared to 33 months). A patent application for the isolated BRCA1 gene and cancer promoting mutations discussed above, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics in 1994; over the next year, Myriad, (in collaboration with investigators at Endo Recherche, Inc., HSC Research & Development Limited Partnership, and University of Pennsylvania), isolated and sequenced the BRCA2 gene and identified key mutations, and the first BRCA2 patent was filed in the U.S. by Myriad and other institutions in 1995. Myriad is the exclusive licensee of these patents and has enforced them in the US against clinical diagnostic labs. This business model led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012; it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs, which in turn led to the landmark Association for Molecular Pathology v. Myriad Genetics lawsuit. The patents began to expire in 2014. According to an article published in the journal, Genetic Medicine, in 2010, \"The patent story outside the United States is more complicated.... For example, patents have been obtained but the patents are being ignored by provincial health systems in Canada. In Australia and the UK, Myriad\\'s licensee permitted use by health systems but announced a change of plans in August 2008. Only a single mutation has been patented in Myriad\\'s lone European-wide patent, although some patents remain under review of an opposition proceeding. In effect, the United States is the only jurisdiction where Myriad\\'s strong patent position has conferred sole-provider status.\" Peter Meldrum, CEO of Myriad Genetics, has acknowledged that Myriad has \"other competitive advantages that may make such [patent] enforcement unnecessary\" in Europe. As with any gene, finding variation in BRCA1 is not hard. The real value comes from understanding what the clinical consequences of any particular variant are. Myriad has a large, proprietary database of such genotype-phenotype correlations. In response, parallel open-source databases are being developed. Legal decisions surrounding the BRCA1 and BRCA2 patents will affect the field of genetic testing in general. A June 2013 article, in Association for Molecular Pathology v. Myriad Genetics (No. 12-398), quoted the US Supreme Court\\'s unanimous ruling that, \"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating Myriad\\'s patents on the BRCA1 and BRCA2 genes. However, the Court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection. The Federal Court of Australia came to the opposite conclusion, upholding the validity of an Australian Myriad Genetics patent over the BRCA1 gene in February 2013. The Federal Court also rejected an appeal in September 2014. Yvonne D\\'Arcy won her case against US-based biotech company Myriad Genetics in the High Court of Australia. In their unanimous decision on October 7, 2015, the \"high court found that an isolated nucleic acid, coding for a BRCA1 protein, with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a \\'patentable invention.\\'\" BRCA1 has been shown to interact with the following proteins: 1jm7: Solution structure of the BRCA1/BARD1 RING-domain heterodimer 1jnx: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1 1n5o: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation 1oqa: Solution structure of the BRCT-c domain from human BRCA1 1t15: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase 1t29: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide 1t2u: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F 1t2v: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide 1y98: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide. '"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 106
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "clean_text = text.lower()"
      ],
      "metadata": {
        "id": "f5oSfgALrXfh"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "clean_text"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 139
        },
        "id": "pMnRHwkRrePp",
        "outputId": "08b9c703-95ee-4836-a605-f2adef82c898"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'1jm7, 1jnx, 1n5o, 1oqa, 1t15, 1t29, 1t2u, 1t2v, 1y98, 2ing, 3coj, 3k0h, 3k0k, 3k15, 3pxa, 3pxb, 3pxc, 3pxd, 3pxe, 4ifi, 4igk, 4jlu, 4ofb, 4u4a, 4y18, 4y2g67212189ensg00000012048ensmusg00000017146p38398p48754nm_007299nm_007300nm_007301nm_007302nm_007303nm_007305nm_007306nm_009764np_009225np_009228np_009229np_009230np_009231np_033894breast cancer type 1 susceptibility protein is a protein that in humans is encoded by the brca1 (/ˌbrækəˈwʌn/) gene. orthologs are common in other vertebrate species, whereas invertebrate genomes may encode a more distantly related gene. brca1 is a human tumor suppressor gene (also known as a caretaker gene) and is responsible for repairing dna. brca1 and brca2 are unrelated proteins, but both are normally expressed in the cells of breast and other tissue, where they help repair damaged dna, or destroy cells if dna cannot be repaired. they are involved in the repair of chromosomal damage with an important role in the error-free repair of dna double-strand breaks. if brca1 or brca2 itself is damaged by a brca mutation, damaged dna is not repaired properly, and this increases the risk for breast cancer. brca1 and brca2 have been described as \"breast cancer susceptibility genes\" and \"breast cancer susceptibility proteins\". the predominant allele has a normal, tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer. brca1 combines with other tumor suppressors, dna damage sensors and signal transducers to form a large multi-subunit protein complex known as the brca1-associated genome surveillance complex (basc). the brca1 protein associates with rna polymerase ii, and through the c-terminal domain, also interacts with histone deacetylase complexes. thus, this protein plays a role in transcription, and dna repair of double-strand dna breaks ubiquitination, transcriptional regulation as well as other functions. methods to test for the likelihood of a patient with mutations in brca1 and brca2 developing cancer were covered by patents owned or controlled by myriad genetics. myriad\\'s business model of offering the diagnostic test exclusively led from myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500m in annual revenue in 2012; it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs, which in turn led to the landmark association for molecular pathology v. myriad genetics lawsuit. the first evidence for the existence of a gene encoding a dna repair enzyme involved in breast cancer susceptibility was provided by mary-claire king\\'s laboratory at uc berkeley in 1990. four years later, after an international race to find it, the gene was cloned in 1994 by scientists at university of utah, national institute of environmental health sciences (niehs) and myriad genetics. the human brca1 gene is located on the long (q) arm of chromosome 17 at region 2 band 1, from base pair 41,196,312 to base pair 41,277,500 (build grch37/hg19) (map). brca1 orthologs have been identified in most vertebrates for which complete genome data are available. the brca1 protein contains the following domains: this protein also contains nuclear localization signals and nuclear export signal motifs. the human brca1 protein consists of four major protein domains; the znf c3hc4- ring domain, the brca1 serine domain and two brct domains. these domains encode approximately 27% of brca1 protein. there are six known isoforms of brca1, with isoforms 1 and 2 comprising 1863 amino acids each.[citation needed] brca1 is unrelated to brca2, i.e. they are not homologs or paralogs. the ring motif, a zn finger found in eukaryotic peptides, is 40–60 amino acids long and consists of eight conserved metal-binding residues, two quartets of cysteine or histidine residues that coordinate two zinc atoms. this motif contains a short anti-parallel beta-sheet, two zinc-binding loops and a central alpha helix in a small domain. this ring domain interacts with associated proteins, including bard1, which also contains a ring motif, to form a heterodimer. the brca1 ring motif is flanked by alpha helices formed by residues 8–22 and 81–96 of the brca1 protein. it interacts with a homologous region in bard1 also consisting of a ring finger flanked by two alpha-helices formed from residues 36–48 and 101–116. these four helices combine to form a heterodimerization interface and stabilize the brca1-bard1 heterodimer complex. additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions. the bard1/brca1 interaction is disrupted by tumorigenic amino acid substitutions in brca1, implying that the formation of a stable complex between these proteins may be an essential aspect of brca1 tumor suppression. the ring domain is an important element of ubiquitin e3 ligases, which catalyze protein ubiquitination. ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell. brca1 polypeptides, in particular, lys-48-linked polyubiquitin chains are dispersed throughout the resting cell nucleus, but at the start of dna replication, they gather in restrained groups that also contain brca2 and bard1. bard1 is thought to be involved in the recognition and binding of protein targets for ubiquitination. it attaches to proteins and labels them for destruction. ubiquitination occurs via the brca1 fusion protein and is abolished by zinc chelation. the enzyme activity of the fusion protein is dependent on the proper folding of the ring domain.[citation needed] brca1 serine cluster domain (scd) spans amino acids 1280–1524. a portion of the domain is located in exons 11–13. high rates of mutation occur in exons 11–13. reported phosphorylation sites of brca1 are concentrated in the scd, where they are phosphorylated by atm/atr kinases both in vitro and in vivo. atm/atr are kinases activated by dna damage. mutation of serine residues may affect localization of brca1 to sites of dna damage and dna damage response function. the dual repeat brct domain of the brca1 protein is an elongated structure approximately 70 å long and 30–35 å wide. the 85–95 amino acid domains in brct can be found as single modules or as multiple tandem repeats containing two domains. both of these possibilities can occur in a single protein in a variety of different conformations. the c-terminal brct region of the brca1 protein is essential for repair of dna, transcription regulation and tumor suppressor function. in brca1 the dual tandem repeat brct domains are arranged in a head-to-tail-fashion in the three-dimensional structure, burying 1600 å of hydrophobic, solvent-accessible surface area in the interface. these all contribute to the tightly packed knob-in-hole structure that comprises the interface. these homologous domains interact to control cellular responses to dna damage. a missense mutation at the interface of these two proteins can perturb the cell cycle, resulting a greater risk of developing cancer.[citation needed] brca1 is part of a complex that repairs double-strand breaks in dna. the strands of the dna double helix are continuously breaking as they become damaged. sometimes only one strand is broken, sometimes both strands are broken simultaneously. dna cross-linking agents are an important source of chromosome/dna damage. double-strand breaks occur as intermediates after the crosslinks are removed, and indeed, biallelic mutations in brca1 have been identified to be responsible for fanconi anemia, complementation group s (fa-s), a genetic disease associated with hypersensitivity to dna crosslinking agents. brca1 is part of a protein complex that repairs dna when both strands are broken. when this happens, it is difficult for the repair mechanism to \"know\" how to replace the correct dna sequence, and there are multiple ways to attempt the repair. the double-strand repair mechanism in which brca1 participates is homology-directed repair, where the repair proteins copy the identical sequence from the intact sister chromatid. fa-s is almost always a lethal condition in utero; only a handful cases of biallelic brca1 mutations have been reported in literature despite the high carrier frequencies in the ashkenazim, and none since 2013. in the nucleus of many types of normal cells, the brca1 protein interacts with rad51 during repair of dna double-strand breaks. these breaks can be caused by natural radiation or other exposures, but also occur when chromosomes exchange genetic material (homologous recombination, e.g., \"crossing over\" during meiosis). the brca2 protein, which has a function similar to that of brca1, also interacts with the rad51 protein. by influencing dna damage repair, these three proteins play a role in maintaining the stability of the human genome.[citation needed] brca1 is also involved in another type of dna repair, termed mismatch repair. brca1 interacts with the dna mismatch repair protein msh2. msh2, msh6, parp and some other proteins involved in single-strand repair are reported to be elevated in brca1-deficient mammary tumors. a protein called valosin-containing protein (vcp, also known as p97) plays a role to recruit brca1 to the damaged dna sites. after ionizing radiation, vcp is recruited to dna lesions and cooperates with the ubiquitin ligase rnf8 to orchestrate assembly of signaling complexes for efficient dsb repair. brca1 interacts with vcp. brca1 also interacts with c-myc, and other proteins that are critical to maintain genome stability. brca1 directly binds to dna, with higher affinity for branched dna structures. this ability to bind to dna contributes to its ability to inhibit the nuclease activity of the mrn complex as well as the nuclease activity of mre11 alone. this may explain a role for brca1 to promote lower fidelity dna repair by non-homologous end joining (nhej). brca1 also colocalizes with γ-h2ax (histone h2ax phosphorylated on serine-139) in dna double-strand break repair foci, indicating it may play a role in recruiting repair factors. formaldehyde and acetaldehyde are common environmental sources of dna cross links that often require repairs mediated by brca1 containing pathways. this dna repair function is essential; mice with loss-of-function mutations in both brca1 alleles are not viable, and as of 2015 only two adults were known to have loss-of-function mutations in both alleles (leading to fa-s); both had congenital or developmental issues, and both had cancer. one was presumed to have survived to adulthood because one of the brca1 mutations was hypomorphic. brca1 was shown to co-purify with the human rna polymerase ii holoenzyme in hela extracts, implying it is a component of the holoenzyme. later research, however, contradicted this assumption, instead showing that the predominant complex including brca1 in hela cells is a 2 megadalton complex containing swi/snf. swi/snf is a chromatin remodeling complex. artificial tethering of brca1 to chromatin was shown to decondense heterochromatin, though the swi/snf interacting domain was not necessary for this role. brca1 interacts with the nelf-b (cobra1) subunit of the nelf complex. certain variations of the brca1 gene lead to an increased risk for breast cancer as part of a hereditary breast–ovarian cancer syndrome. researchers have identified hundreds of mutations in the brca1 gene, many of which are associated with an increased risk of cancer. females with an abnormal brca1 or brca2 gene have up to an 80% risk of developing breast cancer by age 90; increased risk of developing ovarian cancer is about 55% for females with brca1 mutations and about 25% for females with brca2 mutations. these mutations can be changes in one or a small number of dna base pairs (the building-blocks of dna), and can be identified with pcr and dna sequencing. in some cases, large segments of dna are rearranged. those large segments, also called large rearrangements, can be a deletion or a duplication of one or several exons in the gene. classical methods for mutation detection (sequencing) are unable to reveal these types of mutation. other methods have been proposed: traditional quantitative pcr, multiplex ligation-dependent probe amplification (mlpa), and quantitative multiplex pcr of short fluorescent fragments (qmpsf). newer methods have also been recently proposed: heteroduplex analysis (hda) by multi-capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization (array-cgh). some results suggest that hypermethylation of the brca1 promoter, which has been reported in some cancers, could be considered as an inactivating mechanism for brca1 expression. a mutated brca1 gene usually makes a protein that does not function properly. researchers believe that the defective brca1 protein is unable to help fix dna damage leading to mutations in other genes. these mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor. thus, brca1 inactivating mutations lead to a predisposition for cancer.[citation needed] brca1 mrna 3\\' utr can be bound by an mirna, mir-17 microrna. it has been suggested that variations in this mirna along with mir-30 microrna could confer susceptibility to breast cancer. in addition to breast cancer, mutations in the brca1 gene also increase the risk of ovarian and prostate cancers. moreover, precancerous lesions (dysplasia) within the fallopian tube have been linked to brca1 gene mutations. pathogenic mutations anywhere in a model pathway containing brca1 and brca2 greatly increase risks for a subset of leukemias and lymphomas. women who have inherited a defective brca1 or brca2 gene are at a greatly elevated risk to develop breast and ovarian cancer. their risk of developing breast and/or ovarian cancer is so high, and so specific to those cancers, that many mutation carriers choose to have prophylactic surgery. there has been much conjecture to explain such apparently striking tissue specificity. major determinants of where brca1/2 hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation or the carcinogen. the target tissue may have receptors for the pathogen, may become selectively exposed to an inflammatory process or to a carcinogen. an innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets. this theory also fits data for several tumor suppressors beyond brca1 or brca2. a major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery. as aforementioned, biallelic and homozygous inheritance of the brca1 gene leads to fa-s, which is almost always an embryonically lethal condition. brca1 expression is reduced or undetectable in the majority of high grade, ductal breast cancers. it has long been noted that loss of brca1 activity, either by germ-line mutations or by down-regulation of gene expression, leads to tumor formation in specific target tissues. in particular, decreased brca1 expression contributes to both sporadic and inherited breast tumor progression. reduced expression of brca1 is tumorigenic because it plays an important role in the repair of dna damages, especially double-strand breaks, by the potentially error-free pathway of homologous recombination. since cells that lack the brca1 protein tend to repair dna damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer. similarly, brca1 expression is low in the majority (55%) of sporadic epithelial ovarian cancers (eocs) where eocs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers. in serous ovarian carcinomas, a sub-category constituting about 2/3 of eocs, low brca1 expression occurs in more than 50% of cases. bowtell reviewed the literature indicating that deficient homologous recombination repair caused by brca1 deficiency is tumorigenic. in particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy. especially noted was that brca1 deficiency could be the cause of tumorigenesis whether due to brca1 mutation or any other event that causes a deficiency of brca1 expression. only about 3%–8% of all women with breast cancer carry a mutation in brca1 or brca2. similarly, brca1 mutations are only seen in about 18% of ovarian cancers (13% germline mutations and 5% somatic mutations). thus, while brca1 expression is low in the majority of these cancers, brca1 mutation is not a major cause of reduced expression. certain latent viruses, which are frequently detected in breast cancer tumors, can decrease the expression of the brca1 gene and cause the development of breast tumors. brca1 promoter hypermethylation was present in only 13% of unselected primary breast carcinomas. similarly, brca1 promoter hypermethylation was present in only 5% to 15% of eoc cases. thus, while brca1 expression is low in these cancers, brca1 promoter methylation is only a minor cause of reduced expression. there are a number of specific micrornas, when overexpressed, that directly reduce expression of specific dna repair proteins (see microrna section dna repair and cancer) in the case of breast cancer, microrna-182 (mir-182) specifically targets brca1. breast cancers can be classified based on receptor status or histology, with triple-negative breast cancer (15%–25% of breast cancers), her2+ (15%–30% of breast cancers), er+/pr+ (about 70% of breast cancers), and invasive lobular carcinoma (about 5%–10% of invasive breast cancer). all four types of breast cancer were found to have an average of about 100-fold increase in mir-182, compared to normal breast tissue. in breast cancer cell lines, there is an inverse correlation of brca1 protein levels with mir-182 expression. thus it appears that much of the reduction or absence of brca1 in high grade ductal breast cancers may be due to over-expressed mir-182. in addition to mir-182, a pair of almost identical micrornas, mir-146a and mir-146b-5p, also repress brca1 expression. these two micrornas are over-expressed in triple-negative tumors and their over-expression results in brca1 inactivation. thus, mir-146a and/or mir-146b-5p may also contribute to reduced expression of brca1 in these triple-negative breast cancers. in both serous tubal intraepithelial carcinoma (the precursor lesion to high grade serous ovarian carcinoma (hg-soc)), and in hg-soc itself, mir-182 is overexpressed in about 70% of cases. in cells with over-expressed mir-182, brca1 remained low, even after exposure to ionizing radiation (which normally raises brca1 expression). thus much of the reduced or absent brca1 in hg-soc may be due to over-expressed mir-182. another microrna known to reduce expression of brca1 in ovarian cancer cells is mir-9. among 58 tumors from patients with stage iiic or stage iv serous ovarian cancers (hg-sog), an inverse correlation was found between expressions of mir-9 and brca1, so that increased mir-9 may also contribute to reduced expression of brca1 in these ovarian cancers. dna damage appears to be the primary underlying cause of cancer, and deficiencies in dna repair appears to underlie many forms of cancer. if dna repair is deficient, dna damage tends to accumulate. such excess dna damage may increase mutational errors during dna replication due to error-prone translesion synthesis. excess dna damage may also increase epigenetic alterations due to errors during dna repair. such mutations and epigenetic alterations may give rise to cancer. the frequent microrna-induced deficiency of brca1 in breast and ovarian cancers likely contribute to the progression of those cancers. all germ-line brca1 mutations identified to date have been inherited, suggesting the possibility of a large \"founder\" effect in which a certain mutation is common to a well-defined population group and can, in theory, be traced back to a common ancestor. given the complexity of mutation screening for brca1, these common mutations may simplify the methods required for mutation screening in certain populations. analysis of mutations that occur with high frequency also permits the study of their clinical expression. examples of manifestations of a founder effect are seen among ashkenazi jews. three mutations in brca1 have been reported to account for the majority of ashkenazi jewish patients with inherited brca1-related breast and/or ovarian cancer: 185delag, 188del11 and 5382insc in the brca1 gene. in fact, it has been shown that if a jewish woman does not carry a brca1 185delag, brca1 5382insc founder mutation, it is highly unlikely that a different brca1 mutation will be found. additional examples of founder mutations in brca1 are given in table 1 (mainly derived from ). as women age, reproductive performance declines, leading to menopause. this decline is tied to a reduction in the number of ovarian follicles. although about 1 million oocytes are present at birth in the human ovary, only about 500 (about 0.05%) of these ovulate. the decline in ovarian reserve appears to occur at a constantly increasing rate with age, and leads to nearly complete exhaustion of the reserve by about age 52. as ovarian reserve and fertility decline with age, there is also a parallel increase in pregnancy failure and meiotic errors, resulting in chromosomally abnormal conceptions. women with a germ-line brca1 mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women. furthermore, women with an inherited brca1 mutation undergo menopause prematurely. since brca1 is a key dna repair protein, these findings suggest that naturally occurring dna damages in oocytes are repaired less efficiently in women with a brca1 defect, and that this repair inefficiency leads to early reproductive failure. as noted above, the brca1 protein plays a key role in homologous recombinational repair. this is the only known cellular process that can accurately repair dna double-strand breaks. dna double-strand breaks accumulate with age in humans and mice in primordial follicles. primordial follicles contain oocytes that are at an intermediate (prophase i) stage of meiosis. meiosis is the general process in eukaryotic organisms by which germ cells are formed, and it is likely an adaptation for removing dna damages, especially double-strand breaks, from germ line dna. (also see article meiosis). homologous recombinational repair employing brca1 is especially promoted during meiosis. it was found that expression of four key genes necessary for homologous recombinational repair of dna double-strand breaks (brca1, mre11, rad51 and atm) decline with age in the oocytes of humans and mice, leading to the hypothesis that dna double-strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging. non-small cell lung cancer (nsclc) is the leading cause of cancer deaths worldwide. at diagnosis, almost 70% of persons with nsclc have locally advanced or metastatic disease. persons with nsclc are often treated with therapeutic platinum compounds (e.g. cisplatin, carboplatin or oxaliplatin) that cause inter-strand cross-links in dna. among individuals with nsclc, low expression of brca1 in the primary tumor correlated with improved survival after platinum-containing chemotherapy. this correlation implies that low brca1 in cancer, and the consequent low level of dna repair, causes vulnerability of cancer to treatment by the dna cross-linking agents. high brca1 may protect cancer cells by acting in a pathway that removes the damages in dna introduced by the platinum drugs. thus the level of brca1 expression is a potentially important tool for tailoring chemotherapy in lung cancer management. level of brca1 expression is also relevant to ovarian cancer treatment. patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their brca1 expression was low compared to patients with higher brca1 expression (46 compared to 33 months). a patent application for the isolated brca1 gene and cancer promoting mutations discussed above, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the university of utah, national institute of environmental health sciences (niehs) and myriad genetics in 1994; over the next year, myriad, (in collaboration with investigators at endo recherche, inc., hsc research & development limited partnership, and university of pennsylvania), isolated and sequenced the brca2 gene and identified key mutations, and the first brca2 patent was filed in the u.s. by myriad and other institutions in 1995. myriad is the exclusive licensee of these patents and has enforced them in the us against clinical diagnostic labs. this business model led from myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500m in annual revenue in 2012; it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs, which in turn led to the landmark association for molecular pathology v. myriad genetics lawsuit. the patents began to expire in 2014. according to an article published in the journal, genetic medicine, in 2010, \"the patent story outside the united states is more complicated.... for example, patents have been obtained but the patents are being ignored by provincial health systems in canada. in australia and the uk, myriad\\'s licensee permitted use by health systems but announced a change of plans in august 2008. only a single mutation has been patented in myriad\\'s lone european-wide patent, although some patents remain under review of an opposition proceeding. in effect, the united states is the only jurisdiction where myriad\\'s strong patent position has conferred sole-provider status.\" peter meldrum, ceo of myriad genetics, has acknowledged that myriad has \"other competitive advantages that may make such [patent] enforcement unnecessary\" in europe. as with any gene, finding variation in brca1 is not hard. the real value comes from understanding what the clinical consequences of any particular variant are. myriad has a large, proprietary database of such genotype-phenotype correlations. in response, parallel open-source databases are being developed. legal decisions surrounding the brca1 and brca2 patents will affect the field of genetic testing in general. a june 2013 article, in association for molecular pathology v. myriad genetics (no. 12-398), quoted the us supreme court\\'s unanimous ruling that, \"a naturally occurring dna segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating myriad\\'s patents on the brca1 and brca2 genes. however, the court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection. the federal court of australia came to the opposite conclusion, upholding the validity of an australian myriad genetics patent over the brca1 gene in february 2013. the federal court also rejected an appeal in september 2014. yvonne d\\'arcy won her case against us-based biotech company myriad genetics in the high court of australia. in their unanimous decision on october 7, 2015, the \"high court found that an isolated nucleic acid, coding for a brca1 protein, with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a \\'patentable invention.\\'\" brca1 has been shown to interact with the following proteins: 1jm7: solution structure of the brca1/bard1 ring-domain heterodimer 1jnx: crystal structure of the brct repeat region from the breast cancer associated protein, brca1 1n5o: structural consequences of a cancer-causing brca1-brct missense mutation 1oqa: solution structure of the brct-c domain from human brca1 1t15: crystal structure of the brca1 brct domains in complex with the phosphorylated interacting region from bach1 helicase 1t29: crystal structure of the brca1 brct repeats bound to a phosphorylated bach1 peptide 1t2u: structural basis of phosphopeptide recognition by the brct domain of brca1: structure of brca1 missense variant v1809f 1t2v: structural basis of phospho-peptide recognition by the brct domain of brca1, structure with phosphopeptide 1y98: structure of the brct repeats of brca1 bound to a ctip phosphopeptide. '"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 108
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "clean_text = re.sub(r'\\W',' ',clean_text)"
      ],
      "metadata": {
        "id": "wo9UzFnNrfGB"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "clean_text"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 139
        },
        "id": "_Gpfh83ariAb",
        "outputId": "b78dc1d0-68a8-4c3f-9313-b02d3d7f8f1d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'1jm7  1jnx  1n5o  1oqa  1t15  1t29  1t2u  1t2v  1y98  2ing  3coj  3k0h  3k0k  3k15  3pxa  3pxb  3pxc  3pxd  3pxe  4ifi  4igk  4jlu  4ofb  4u4a  4y18  4y2g67212189ensg00000012048ensmusg00000017146p38398p48754nm_007299nm_007300nm_007301nm_007302nm_007303nm_007305nm_007306nm_009764np_009225np_009228np_009229np_009230np_009231np_033894breast cancer type 1 susceptibility protein is a protein that in humans is encoded by the brca1   ˌbrækəˈwʌn   gene  orthologs are common in other vertebrate species  whereas invertebrate genomes may encode a more distantly related gene  brca1 is a human tumor suppressor gene  also known as a caretaker gene  and is responsible for repairing dna  brca1 and brca2 are unrelated proteins  but both are normally expressed in the cells of breast and other tissue  where they help repair damaged dna  or destroy cells if dna cannot be repaired  they are involved in the repair of chromosomal damage with an important role in the error free repair of dna double strand breaks  if brca1 or brca2 itself is damaged by a brca mutation  damaged dna is not repaired properly  and this increases the risk for breast cancer  brca1 and brca2 have been described as  breast cancer susceptibility genes  and  breast cancer susceptibility proteins   the predominant allele has a normal  tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer  brca1 combines with other tumor suppressors  dna damage sensors and signal transducers to form a large multi subunit protein complex known as the brca1 associated genome surveillance complex  basc   the brca1 protein associates with rna polymerase ii  and through the c terminal domain  also interacts with histone deacetylase complexes  thus  this protein plays a role in transcription  and dna repair of double strand dna breaks ubiquitination  transcriptional regulation as well as other functions  methods to test for the likelihood of a patient with mutations in brca1 and brca2 developing cancer were covered by patents owned or controlled by myriad genetics  myriad s business model of offering the diagnostic test exclusively led from myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about  500m in annual revenue in 2012  it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs  which in turn led to the landmark association for molecular pathology v  myriad genetics lawsuit  the first evidence for the existence of a gene encoding a dna repair enzyme involved in breast cancer susceptibility was provided by mary claire king s laboratory at uc berkeley in 1990  four years later  after an international race to find it  the gene was cloned in 1994 by scientists at university of utah  national institute of environmental health sciences  niehs  and myriad genetics  the human brca1 gene is located on the long  q  arm of chromosome 17 at region 2 band 1  from base pair 41 196 312 to base pair 41 277 500  build grch37 hg19   map   brca1 orthologs have been identified in most vertebrates for which complete genome data are available  the brca1 protein contains the following domains  this protein also contains nuclear localization signals and nuclear export signal motifs  the human brca1 protein consists of four major protein domains  the znf c3hc4  ring domain  the brca1 serine domain and two brct domains  these domains encode approximately 27  of brca1 protein  there are six known isoforms of brca1  with isoforms 1 and 2 comprising 1863 amino acids each  citation needed  brca1 is unrelated to brca2  i e  they are not homologs or paralogs  the ring motif  a zn finger found in eukaryotic peptides  is 40 60 amino acids long and consists of eight conserved metal binding residues  two quartets of cysteine or histidine residues that coordinate two zinc atoms  this motif contains a short anti parallel beta sheet  two zinc binding loops and a central alpha helix in a small domain  this ring domain interacts with associated proteins  including bard1  which also contains a ring motif  to form a heterodimer  the brca1 ring motif is flanked by alpha helices formed by residues 8 22 and 81 96 of the brca1 protein  it interacts with a homologous region in bard1 also consisting of a ring finger flanked by two alpha helices formed from residues 36 48 and 101 116  these four helices combine to form a heterodimerization interface and stabilize the brca1 bard1 heterodimer complex  additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions  the bard1 brca1 interaction is disrupted by tumorigenic amino acid substitutions in brca1  implying that the formation of a stable complex between these proteins may be an essential aspect of brca1 tumor suppression  the ring domain is an important element of ubiquitin e3 ligases  which catalyze protein ubiquitination  ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell  brca1 polypeptides  in particular  lys 48 linked polyubiquitin chains are dispersed throughout the resting cell nucleus  but at the start of dna replication  they gather in restrained groups that also contain brca2 and bard1  bard1 is thought to be involved in the recognition and binding of protein targets for ubiquitination  it attaches to proteins and labels them for destruction  ubiquitination occurs via the brca1 fusion protein and is abolished by zinc chelation  the enzyme activity of the fusion protein is dependent on the proper folding of the ring domain  citation needed  brca1 serine cluster domain  scd  spans amino acids 1280 1524  a portion of the domain is located in exons 11 13  high rates of mutation occur in exons 11 13  reported phosphorylation sites of brca1 are concentrated in the scd  where they are phosphorylated by atm atr kinases both in vitro and in vivo  atm atr are kinases activated by dna damage  mutation of serine residues may affect localization of brca1 to sites of dna damage and dna damage response function  the dual repeat brct domain of the brca1 protein is an elongated structure approximately 70 å long and 30 35 å wide  the 85 95 amino acid domains in brct can be found as single modules or as multiple tandem repeats containing two domains  both of these possibilities can occur in a single protein in a variety of different conformations  the c terminal brct region of the brca1 protein is essential for repair of dna  transcription regulation and tumor suppressor function  in brca1 the dual tandem repeat brct domains are arranged in a head to tail fashion in the three dimensional structure  burying 1600 å of hydrophobic  solvent accessible surface area in the interface  these all contribute to the tightly packed knob in hole structure that comprises the interface  these homologous domains interact to control cellular responses to dna damage  a missense mutation at the interface of these two proteins can perturb the cell cycle  resulting a greater risk of developing cancer  citation needed  brca1 is part of a complex that repairs double strand breaks in dna  the strands of the dna double helix are continuously breaking as they become damaged  sometimes only one strand is broken  sometimes both strands are broken simultaneously  dna cross linking agents are an important source of chromosome dna damage  double strand breaks occur as intermediates after the crosslinks are removed  and indeed  biallelic mutations in brca1 have been identified to be responsible for fanconi anemia  complementation group s  fa s   a genetic disease associated with hypersensitivity to dna crosslinking agents  brca1 is part of a protein complex that repairs dna when both strands are broken  when this happens  it is difficult for the repair mechanism to  know  how to replace the correct dna sequence  and there are multiple ways to attempt the repair  the double strand repair mechanism in which brca1 participates is homology directed repair  where the repair proteins copy the identical sequence from the intact sister chromatid  fa s is almost always a lethal condition in utero  only a handful cases of biallelic brca1 mutations have been reported in literature despite the high carrier frequencies in the ashkenazim  and none since 2013  in the nucleus of many types of normal cells  the brca1 protein interacts with rad51 during repair of dna double strand breaks  these breaks can be caused by natural radiation or other exposures  but also occur when chromosomes exchange genetic material  homologous recombination  e g    crossing over  during meiosis   the brca2 protein  which has a function similar to that of brca1  also interacts with the rad51 protein  by influencing dna damage repair  these three proteins play a role in maintaining the stability of the human genome  citation needed  brca1 is also involved in another type of dna repair  termed mismatch repair  brca1 interacts with the dna mismatch repair protein msh2  msh2  msh6  parp and some other proteins involved in single strand repair are reported to be elevated in brca1 deficient mammary tumors  a protein called valosin containing protein  vcp  also known as p97  plays a role to recruit brca1 to the damaged dna sites  after ionizing radiation  vcp is recruited to dna lesions and cooperates with the ubiquitin ligase rnf8 to orchestrate assembly of signaling complexes for efficient dsb repair  brca1 interacts with vcp  brca1 also interacts with c myc  and other proteins that are critical to maintain genome stability  brca1 directly binds to dna  with higher affinity for branched dna structures  this ability to bind to dna contributes to its ability to inhibit the nuclease activity of the mrn complex as well as the nuclease activity of mre11 alone  this may explain a role for brca1 to promote lower fidelity dna repair by non homologous end joining  nhej   brca1 also colocalizes with γ h2ax  histone h2ax phosphorylated on serine 139  in dna double strand break repair foci  indicating it may play a role in recruiting repair factors  formaldehyde and acetaldehyde are common environmental sources of dna cross links that often require repairs mediated by brca1 containing pathways  this dna repair function is essential  mice with loss of function mutations in both brca1 alleles are not viable  and as of 2015 only two adults were known to have loss of function mutations in both alleles  leading to fa s   both had congenital or developmental issues  and both had cancer  one was presumed to have survived to adulthood because one of the brca1 mutations was hypomorphic  brca1 was shown to co purify with the human rna polymerase ii holoenzyme in hela extracts  implying it is a component of the holoenzyme  later research  however  contradicted this assumption  instead showing that the predominant complex including brca1 in hela cells is a 2 megadalton complex containing swi snf  swi snf is a chromatin remodeling complex  artificial tethering of brca1 to chromatin was shown to decondense heterochromatin  though the swi snf interacting domain was not necessary for this role  brca1 interacts with the nelf b  cobra1  subunit of the nelf complex  certain variations of the brca1 gene lead to an increased risk for breast cancer as part of a hereditary breast ovarian cancer syndrome  researchers have identified hundreds of mutations in the brca1 gene  many of which are associated with an increased risk of cancer  females with an abnormal brca1 or brca2 gene have up to an 80  risk of developing breast cancer by age 90  increased risk of developing ovarian cancer is about 55  for females with brca1 mutations and about 25  for females with brca2 mutations  these mutations can be changes in one or a small number of dna base pairs  the building blocks of dna   and can be identified with pcr and dna sequencing  in some cases  large segments of dna are rearranged  those large segments  also called large rearrangements  can be a deletion or a duplication of one or several exons in the gene  classical methods for mutation detection  sequencing  are unable to reveal these types of mutation  other methods have been proposed  traditional quantitative pcr  multiplex ligation dependent probe amplification  mlpa   and quantitative multiplex pcr of short fluorescent fragments  qmpsf   newer methods have also been recently proposed  heteroduplex analysis  hda  by multi capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization  array cgh   some results suggest that hypermethylation of the brca1 promoter  which has been reported in some cancers  could be considered as an inactivating mechanism for brca1 expression  a mutated brca1 gene usually makes a protein that does not function properly  researchers believe that the defective brca1 protein is unable to help fix dna damage leading to mutations in other genes  these mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor  thus  brca1 inactivating mutations lead to a predisposition for cancer  citation needed  brca1 mrna 3  utr can be bound by an mirna  mir 17 microrna  it has been suggested that variations in this mirna along with mir 30 microrna could confer susceptibility to breast cancer  in addition to breast cancer  mutations in the brca1 gene also increase the risk of ovarian and prostate cancers  moreover  precancerous lesions  dysplasia  within the fallopian tube have been linked to brca1 gene mutations  pathogenic mutations anywhere in a model pathway containing brca1 and brca2 greatly increase risks for a subset of leukemias and lymphomas  women who have inherited a defective brca1 or brca2 gene are at a greatly elevated risk to develop breast and ovarian cancer  their risk of developing breast and or ovarian cancer is so high  and so specific to those cancers  that many mutation carriers choose to have prophylactic surgery  there has been much conjecture to explain such apparently striking tissue specificity  major determinants of where brca1 2 hereditary cancers occur are related to tissue specificity of the cancer pathogen  the agent that causes chronic inflammation or the carcinogen  the target tissue may have receptors for the pathogen  may become selectively exposed to an inflammatory process or to a carcinogen  an innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets  this theory also fits data for several tumor suppressors beyond brca1 or brca2  a major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery  as aforementioned  biallelic and homozygous inheritance of the brca1 gene leads to fa s  which is almost always an embryonically lethal condition  brca1 expression is reduced or undetectable in the majority of high grade  ductal breast cancers  it has long been noted that loss of brca1 activity  either by germ line mutations or by down regulation of gene expression  leads to tumor formation in specific target tissues  in particular  decreased brca1 expression contributes to both sporadic and inherited breast tumor progression  reduced expression of brca1 is tumorigenic because it plays an important role in the repair of dna damages  especially double strand breaks  by the potentially error free pathway of homologous recombination  since cells that lack the brca1 protein tend to repair dna damages by alternative more error prone mechanisms  the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer  similarly  brca1 expression is low in the majority  55   of sporadic epithelial ovarian cancers  eocs  where eocs are the most common type of ovarian cancer  representing approximately 90  of ovarian cancers  in serous ovarian carcinomas  a sub category constituting about 2 3 of eocs  low brca1 expression occurs in more than 50  of cases  bowtell reviewed the literature indicating that deficient homologous recombination repair caused by brca1 deficiency is tumorigenic  in particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high grade serous ovarian cancer and dictate its response to therapy  especially noted was that brca1 deficiency could be the cause of tumorigenesis whether due to brca1 mutation or any other event that causes a deficiency of brca1 expression  only about 3  8  of all women with breast cancer carry a mutation in brca1 or brca2  similarly  brca1 mutations are only seen in about 18  of ovarian cancers  13  germline mutations and 5  somatic mutations   thus  while brca1 expression is low in the majority of these cancers  brca1 mutation is not a major cause of reduced expression  certain latent viruses  which are frequently detected in breast cancer tumors  can decrease the expression of the brca1 gene and cause the development of breast tumors  brca1 promoter hypermethylation was present in only 13  of unselected primary breast carcinomas  similarly  brca1 promoter hypermethylation was present in only 5  to 15  of eoc cases  thus  while brca1 expression is low in these cancers  brca1 promoter methylation is only a minor cause of reduced expression  there are a number of specific micrornas  when overexpressed  that directly reduce expression of specific dna repair proteins  see microrna section dna repair and cancer  in the case of breast cancer  microrna 182  mir 182  specifically targets brca1  breast cancers can be classified based on receptor status or histology  with triple negative breast cancer  15  25  of breast cancers   her2   15  30  of breast cancers   er  pr   about 70  of breast cancers   and invasive lobular carcinoma  about 5  10  of invasive breast cancer   all four types of breast cancer were found to have an average of about 100 fold increase in mir 182  compared to normal breast tissue  in breast cancer cell lines  there is an inverse correlation of brca1 protein levels with mir 182 expression  thus it appears that much of the reduction or absence of brca1 in high grade ductal breast cancers may be due to over expressed mir 182  in addition to mir 182  a pair of almost identical micrornas  mir 146a and mir 146b 5p  also repress brca1 expression  these two micrornas are over expressed in triple negative tumors and their over expression results in brca1 inactivation  thus  mir 146a and or mir 146b 5p may also contribute to reduced expression of brca1 in these triple negative breast cancers  in both serous tubal intraepithelial carcinoma  the precursor lesion to high grade serous ovarian carcinoma  hg soc    and in hg soc itself  mir 182 is overexpressed in about 70  of cases  in cells with over expressed mir 182  brca1 remained low  even after exposure to ionizing radiation  which normally raises brca1 expression   thus much of the reduced or absent brca1 in hg soc may be due to over expressed mir 182  another microrna known to reduce expression of brca1 in ovarian cancer cells is mir 9  among 58 tumors from patients with stage iiic or stage iv serous ovarian cancers  hg sog   an inverse correlation was found between expressions of mir 9 and brca1  so that increased mir 9 may also contribute to reduced expression of brca1 in these ovarian cancers  dna damage appears to be the primary underlying cause of cancer  and deficiencies in dna repair appears to underlie many forms of cancer  if dna repair is deficient  dna damage tends to accumulate  such excess dna damage may increase mutational errors during dna replication due to error prone translesion synthesis  excess dna damage may also increase epigenetic alterations due to errors during dna repair  such mutations and epigenetic alterations may give rise to cancer  the frequent microrna induced deficiency of brca1 in breast and ovarian cancers likely contribute to the progression of those cancers  all germ line brca1 mutations identified to date have been inherited  suggesting the possibility of a large  founder  effect in which a certain mutation is common to a well defined population group and can  in theory  be traced back to a common ancestor  given the complexity of mutation screening for brca1  these common mutations may simplify the methods required for mutation screening in certain populations  analysis of mutations that occur with high frequency also permits the study of their clinical expression  examples of manifestations of a founder effect are seen among ashkenazi jews  three mutations in brca1 have been reported to account for the majority of ashkenazi jewish patients with inherited brca1 related breast and or ovarian cancer  185delag  188del11 and 5382insc in the brca1 gene  in fact  it has been shown that if a jewish woman does not carry a brca1 185delag  brca1 5382insc founder mutation  it is highly unlikely that a different brca1 mutation will be found  additional examples of founder mutations in brca1 are given in table 1  mainly derived from    as women age  reproductive performance declines  leading to menopause  this decline is tied to a reduction in the number of ovarian follicles  although about 1 million oocytes are present at birth in the human ovary  only about 500  about 0 05   of these ovulate  the decline in ovarian reserve appears to occur at a constantly increasing rate with age  and leads to nearly complete exhaustion of the reserve by about age 52  as ovarian reserve and fertility decline with age  there is also a parallel increase in pregnancy failure and meiotic errors  resulting in chromosomally abnormal conceptions  women with a germ line brca1 mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women  furthermore  women with an inherited brca1 mutation undergo menopause prematurely  since brca1 is a key dna repair protein  these findings suggest that naturally occurring dna damages in oocytes are repaired less efficiently in women with a brca1 defect  and that this repair inefficiency leads to early reproductive failure  as noted above  the brca1 protein plays a key role in homologous recombinational repair  this is the only known cellular process that can accurately repair dna double strand breaks  dna double strand breaks accumulate with age in humans and mice in primordial follicles  primordial follicles contain oocytes that are at an intermediate  prophase i  stage of meiosis  meiosis is the general process in eukaryotic organisms by which germ cells are formed  and it is likely an adaptation for removing dna damages  especially double strand breaks  from germ line dna   also see article meiosis   homologous recombinational repair employing brca1 is especially promoted during meiosis  it was found that expression of four key genes necessary for homologous recombinational repair of dna double strand breaks  brca1  mre11  rad51 and atm  decline with age in the oocytes of humans and mice  leading to the hypothesis that dna double strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging  non small cell lung cancer  nsclc  is the leading cause of cancer deaths worldwide  at diagnosis  almost 70  of persons with nsclc have locally advanced or metastatic disease  persons with nsclc are often treated with therapeutic platinum compounds  e g  cisplatin  carboplatin or oxaliplatin  that cause inter strand cross links in dna  among individuals with nsclc  low expression of brca1 in the primary tumor correlated with improved survival after platinum containing chemotherapy  this correlation implies that low brca1 in cancer  and the consequent low level of dna repair  causes vulnerability of cancer to treatment by the dna cross linking agents  high brca1 may protect cancer cells by acting in a pathway that removes the damages in dna introduced by the platinum drugs  thus the level of brca1 expression is a potentially important tool for tailoring chemotherapy in lung cancer management  level of brca1 expression is also relevant to ovarian cancer treatment  patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their brca1 expression was low compared to patients with higher brca1 expression  46 compared to 33 months   a patent application for the isolated brca1 gene and cancer promoting mutations discussed above  as well as methods to diagnose the likelihood of getting breast cancer  was filed by the university of utah  national institute of environmental health sciences  niehs  and myriad genetics in 1994  over the next year  myriad   in collaboration with investigators at endo recherche  inc   hsc research   development limited partnership  and university of pennsylvania   isolated and sequenced the brca2 gene and identified key mutations  and the first brca2 patent was filed in the u s  by myriad and other institutions in 1995  myriad is the exclusive licensee of these patents and has enforced them in the us against clinical diagnostic labs  this business model led from myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about  500m in annual revenue in 2012  it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs  which in turn led to the landmark association for molecular pathology v  myriad genetics lawsuit  the patents began to expire in 2014  according to an article published in the journal  genetic medicine  in 2010   the patent story outside the united states is more complicated     for example  patents have been obtained but the patents are being ignored by provincial health systems in canada  in australia and the uk  myriad s licensee permitted use by health systems but announced a change of plans in august 2008  only a single mutation has been patented in myriad s lone european wide patent  although some patents remain under review of an opposition proceeding  in effect  the united states is the only jurisdiction where myriad s strong patent position has conferred sole provider status   peter meldrum  ceo of myriad genetics  has acknowledged that myriad has  other competitive advantages that may make such  patent  enforcement unnecessary  in europe  as with any gene  finding variation in brca1 is not hard  the real value comes from understanding what the clinical consequences of any particular variant are  myriad has a large  proprietary database of such genotype phenotype correlations  in response  parallel open source databases are being developed  legal decisions surrounding the brca1 and brca2 patents will affect the field of genetic testing in general  a june 2013 article  in association for molecular pathology v  myriad genetics  no  12 398   quoted the us supreme court s unanimous ruling that   a naturally occurring dna segment is a product of nature and not patent eligible merely because it has been isolated   invalidating myriad s patents on the brca1 and brca2 genes  however  the court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection  the federal court of australia came to the opposite conclusion  upholding the validity of an australian myriad genetics patent over the brca1 gene in february 2013  the federal court also rejected an appeal in september 2014  yvonne d arcy won her case against us based biotech company myriad genetics in the high court of australia  in their unanimous decision on october 7  2015  the  high court found that an isolated nucleic acid  coding for a brca1 protein  with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a  patentable invention    brca1 has been shown to interact with the following proteins  1jm7  solution structure of the brca1 bard1 ring domain heterodimer 1jnx  crystal structure of the brct repeat region from the breast cancer associated protein  brca1 1n5o  structural consequences of a cancer causing brca1 brct missense mutation 1oqa  solution structure of the brct c domain from human brca1 1t15  crystal structure of the brca1 brct domains in complex with the phosphorylated interacting region from bach1 helicase 1t29  crystal structure of the brca1 brct repeats bound to a phosphorylated bach1 peptide 1t2u  structural basis of phosphopeptide recognition by the brct domain of brca1  structure of brca1 missense variant v1809f 1t2v  structural basis of phospho peptide recognition by the brct domain of brca1  structure with phosphopeptide 1y98  structure of the brct repeats of brca1 bound to a ctip phosphopeptide  '"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 110
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "clean_text = re.sub(r'\\d',' ',clean_text)"
      ],
      "metadata": {
        "id": "iN_SpEw6rjHW"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "clean_text"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 139
        },
        "id": "ObSwTO2urllb",
        "outputId": "07ed7bb8-49c7-4d19-91ab-5be901871849"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "' jm    jnx   n o   oqa   t     t     t u   t v   y     ing   coj   k h   k k   k     pxa   pxb   pxc   pxd   pxe   ifi   igk   jlu   ofb   u a   y     y g        ensg           ensmusg           p     p     nm_      nm_      nm_      nm_      nm_      nm_      nm_      nm_      np_      np_      np_      np_      np_      np_      breast cancer type   susceptibility protein is a protein that in humans is encoded by the brca    ˌbrækəˈwʌn   gene  orthologs are common in other vertebrate species  whereas invertebrate genomes may encode a more distantly related gene  brca  is a human tumor suppressor gene  also known as a caretaker gene  and is responsible for repairing dna  brca  and brca  are unrelated proteins  but both are normally expressed in the cells of breast and other tissue  where they help repair damaged dna  or destroy cells if dna cannot be repaired  they are involved in the repair of chromosomal damage with an important role in the error free repair of dna double strand breaks  if brca  or brca  itself is damaged by a brca mutation  damaged dna is not repaired properly  and this increases the risk for breast cancer  brca  and brca  have been described as  breast cancer susceptibility genes  and  breast cancer susceptibility proteins   the predominant allele has a normal  tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer  brca  combines with other tumor suppressors  dna damage sensors and signal transducers to form a large multi subunit protein complex known as the brca  associated genome surveillance complex  basc   the brca  protein associates with rna polymerase ii  and through the c terminal domain  also interacts with histone deacetylase complexes  thus  this protein plays a role in transcription  and dna repair of double strand dna breaks ubiquitination  transcriptional regulation as well as other functions  methods to test for the likelihood of a patient with mutations in brca  and brca  developing cancer were covered by patents owned or controlled by myriad genetics  myriad s business model of offering the diagnostic test exclusively led from myriad being a startup in      to being a publicly traded company with      employees and about     m in annual revenue in       it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs  which in turn led to the landmark association for molecular pathology v  myriad genetics lawsuit  the first evidence for the existence of a gene encoding a dna repair enzyme involved in breast cancer susceptibility was provided by mary claire king s laboratory at uc berkeley in       four years later  after an international race to find it  the gene was cloned in      by scientists at university of utah  national institute of environmental health sciences  niehs  and myriad genetics  the human brca  gene is located on the long  q  arm of chromosome    at region   band    from base pair            to base pair             build grch   hg     map   brca  orthologs have been identified in most vertebrates for which complete genome data are available  the brca  protein contains the following domains  this protein also contains nuclear localization signals and nuclear export signal motifs  the human brca  protein consists of four major protein domains  the znf c hc   ring domain  the brca  serine domain and two brct domains  these domains encode approximately     of brca  protein  there are six known isoforms of brca   with isoforms   and   comprising      amino acids each  citation needed  brca  is unrelated to brca   i e  they are not homologs or paralogs  the ring motif  a zn finger found in eukaryotic peptides  is       amino acids long and consists of eight conserved metal binding residues  two quartets of cysteine or histidine residues that coordinate two zinc atoms  this motif contains a short anti parallel beta sheet  two zinc binding loops and a central alpha helix in a small domain  this ring domain interacts with associated proteins  including bard   which also contains a ring motif  to form a heterodimer  the brca  ring motif is flanked by alpha helices formed by residues      and       of the brca  protein  it interacts with a homologous region in bard  also consisting of a ring finger flanked by two alpha helices formed from residues       and          these four helices combine to form a heterodimerization interface and stabilize the brca  bard  heterodimer complex  additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions  the bard  brca  interaction is disrupted by tumorigenic amino acid substitutions in brca   implying that the formation of a stable complex between these proteins may be an essential aspect of brca  tumor suppression  the ring domain is an important element of ubiquitin e  ligases  which catalyze protein ubiquitination  ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell  brca  polypeptides  in particular  lys    linked polyubiquitin chains are dispersed throughout the resting cell nucleus  but at the start of dna replication  they gather in restrained groups that also contain brca  and bard   bard  is thought to be involved in the recognition and binding of protein targets for ubiquitination  it attaches to proteins and labels them for destruction  ubiquitination occurs via the brca  fusion protein and is abolished by zinc chelation  the enzyme activity of the fusion protein is dependent on the proper folding of the ring domain  citation needed  brca  serine cluster domain  scd  spans amino acids            a portion of the domain is located in exons        high rates of mutation occur in exons        reported phosphorylation sites of brca  are concentrated in the scd  where they are phosphorylated by atm atr kinases both in vitro and in vivo  atm atr are kinases activated by dna damage  mutation of serine residues may affect localization of brca  to sites of dna damage and dna damage response function  the dual repeat brct domain of the brca  protein is an elongated structure approximately    å long and       å wide  the       amino acid domains in brct can be found as single modules or as multiple tandem repeats containing two domains  both of these possibilities can occur in a single protein in a variety of different conformations  the c terminal brct region of the brca  protein is essential for repair of dna  transcription regulation and tumor suppressor function  in brca  the dual tandem repeat brct domains are arranged in a head to tail fashion in the three dimensional structure  burying      å of hydrophobic  solvent accessible surface area in the interface  these all contribute to the tightly packed knob in hole structure that comprises the interface  these homologous domains interact to control cellular responses to dna damage  a missense mutation at the interface of these two proteins can perturb the cell cycle  resulting a greater risk of developing cancer  citation needed  brca  is part of a complex that repairs double strand breaks in dna  the strands of the dna double helix are continuously breaking as they become damaged  sometimes only one strand is broken  sometimes both strands are broken simultaneously  dna cross linking agents are an important source of chromosome dna damage  double strand breaks occur as intermediates after the crosslinks are removed  and indeed  biallelic mutations in brca  have been identified to be responsible for fanconi anemia  complementation group s  fa s   a genetic disease associated with hypersensitivity to dna crosslinking agents  brca  is part of a protein complex that repairs dna when both strands are broken  when this happens  it is difficult for the repair mechanism to  know  how to replace the correct dna sequence  and there are multiple ways to attempt the repair  the double strand repair mechanism in which brca  participates is homology directed repair  where the repair proteins copy the identical sequence from the intact sister chromatid  fa s is almost always a lethal condition in utero  only a handful cases of biallelic brca  mutations have been reported in literature despite the high carrier frequencies in the ashkenazim  and none since       in the nucleus of many types of normal cells  the brca  protein interacts with rad   during repair of dna double strand breaks  these breaks can be caused by natural radiation or other exposures  but also occur when chromosomes exchange genetic material  homologous recombination  e g    crossing over  during meiosis   the brca  protein  which has a function similar to that of brca   also interacts with the rad   protein  by influencing dna damage repair  these three proteins play a role in maintaining the stability of the human genome  citation needed  brca  is also involved in another type of dna repair  termed mismatch repair  brca  interacts with the dna mismatch repair protein msh   msh   msh   parp and some other proteins involved in single strand repair are reported to be elevated in brca  deficient mammary tumors  a protein called valosin containing protein  vcp  also known as p    plays a role to recruit brca  to the damaged dna sites  after ionizing radiation  vcp is recruited to dna lesions and cooperates with the ubiquitin ligase rnf  to orchestrate assembly of signaling complexes for efficient dsb repair  brca  interacts with vcp  brca  also interacts with c myc  and other proteins that are critical to maintain genome stability  brca  directly binds to dna  with higher affinity for branched dna structures  this ability to bind to dna contributes to its ability to inhibit the nuclease activity of the mrn complex as well as the nuclease activity of mre   alone  this may explain a role for brca  to promote lower fidelity dna repair by non homologous end joining  nhej   brca  also colocalizes with γ h ax  histone h ax phosphorylated on serine      in dna double strand break repair foci  indicating it may play a role in recruiting repair factors  formaldehyde and acetaldehyde are common environmental sources of dna cross links that often require repairs mediated by brca  containing pathways  this dna repair function is essential  mice with loss of function mutations in both brca  alleles are not viable  and as of      only two adults were known to have loss of function mutations in both alleles  leading to fa s   both had congenital or developmental issues  and both had cancer  one was presumed to have survived to adulthood because one of the brca  mutations was hypomorphic  brca  was shown to co purify with the human rna polymerase ii holoenzyme in hela extracts  implying it is a component of the holoenzyme  later research  however  contradicted this assumption  instead showing that the predominant complex including brca  in hela cells is a   megadalton complex containing swi snf  swi snf is a chromatin remodeling complex  artificial tethering of brca  to chromatin was shown to decondense heterochromatin  though the swi snf interacting domain was not necessary for this role  brca  interacts with the nelf b  cobra   subunit of the nelf complex  certain variations of the brca  gene lead to an increased risk for breast cancer as part of a hereditary breast ovarian cancer syndrome  researchers have identified hundreds of mutations in the brca  gene  many of which are associated with an increased risk of cancer  females with an abnormal brca  or brca  gene have up to an     risk of developing breast cancer by age     increased risk of developing ovarian cancer is about     for females with brca  mutations and about     for females with brca  mutations  these mutations can be changes in one or a small number of dna base pairs  the building blocks of dna   and can be identified with pcr and dna sequencing  in some cases  large segments of dna are rearranged  those large segments  also called large rearrangements  can be a deletion or a duplication of one or several exons in the gene  classical methods for mutation detection  sequencing  are unable to reveal these types of mutation  other methods have been proposed  traditional quantitative pcr  multiplex ligation dependent probe amplification  mlpa   and quantitative multiplex pcr of short fluorescent fragments  qmpsf   newer methods have also been recently proposed  heteroduplex analysis  hda  by multi capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization  array cgh   some results suggest that hypermethylation of the brca  promoter  which has been reported in some cancers  could be considered as an inactivating mechanism for brca  expression  a mutated brca  gene usually makes a protein that does not function properly  researchers believe that the defective brca  protein is unable to help fix dna damage leading to mutations in other genes  these mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor  thus  brca  inactivating mutations lead to a predisposition for cancer  citation needed  brca  mrna    utr can be bound by an mirna  mir    microrna  it has been suggested that variations in this mirna along with mir    microrna could confer susceptibility to breast cancer  in addition to breast cancer  mutations in the brca  gene also increase the risk of ovarian and prostate cancers  moreover  precancerous lesions  dysplasia  within the fallopian tube have been linked to brca  gene mutations  pathogenic mutations anywhere in a model pathway containing brca  and brca  greatly increase risks for a subset of leukemias and lymphomas  women who have inherited a defective brca  or brca  gene are at a greatly elevated risk to develop breast and ovarian cancer  their risk of developing breast and or ovarian cancer is so high  and so specific to those cancers  that many mutation carriers choose to have prophylactic surgery  there has been much conjecture to explain such apparently striking tissue specificity  major determinants of where brca    hereditary cancers occur are related to tissue specificity of the cancer pathogen  the agent that causes chronic inflammation or the carcinogen  the target tissue may have receptors for the pathogen  may become selectively exposed to an inflammatory process or to a carcinogen  an innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets  this theory also fits data for several tumor suppressors beyond brca  or brca   a major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery  as aforementioned  biallelic and homozygous inheritance of the brca  gene leads to fa s  which is almost always an embryonically lethal condition  brca  expression is reduced or undetectable in the majority of high grade  ductal breast cancers  it has long been noted that loss of brca  activity  either by germ line mutations or by down regulation of gene expression  leads to tumor formation in specific target tissues  in particular  decreased brca  expression contributes to both sporadic and inherited breast tumor progression  reduced expression of brca  is tumorigenic because it plays an important role in the repair of dna damages  especially double strand breaks  by the potentially error free pathway of homologous recombination  since cells that lack the brca  protein tend to repair dna damages by alternative more error prone mechanisms  the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer  similarly  brca  expression is low in the majority       of sporadic epithelial ovarian cancers  eocs  where eocs are the most common type of ovarian cancer  representing approximately     of ovarian cancers  in serous ovarian carcinomas  a sub category constituting about     of eocs  low brca  expression occurs in more than     of cases  bowtell reviewed the literature indicating that deficient homologous recombination repair caused by brca  deficiency is tumorigenic  in particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high grade serous ovarian cancer and dictate its response to therapy  especially noted was that brca  deficiency could be the cause of tumorigenesis whether due to brca  mutation or any other event that causes a deficiency of brca  expression  only about       of all women with breast cancer carry a mutation in brca  or brca   similarly  brca  mutations are only seen in about     of ovarian cancers      germline mutations and    somatic mutations   thus  while brca  expression is low in the majority of these cancers  brca  mutation is not a major cause of reduced expression  certain latent viruses  which are frequently detected in breast cancer tumors  can decrease the expression of the brca  gene and cause the development of breast tumors  brca  promoter hypermethylation was present in only     of unselected primary breast carcinomas  similarly  brca  promoter hypermethylation was present in only    to     of eoc cases  thus  while brca  expression is low in these cancers  brca  promoter methylation is only a minor cause of reduced expression  there are a number of specific micrornas  when overexpressed  that directly reduce expression of specific dna repair proteins  see microrna section dna repair and cancer  in the case of breast cancer  microrna      mir      specifically targets brca   breast cancers can be classified based on receptor status or histology  with triple negative breast cancer          of breast cancers   her            of breast cancers   er  pr   about     of breast cancers   and invasive lobular carcinoma  about        of invasive breast cancer   all four types of breast cancer were found to have an average of about     fold increase in mir      compared to normal breast tissue  in breast cancer cell lines  there is an inverse correlation of brca  protein levels with mir     expression  thus it appears that much of the reduction or absence of brca  in high grade ductal breast cancers may be due to over expressed mir      in addition to mir      a pair of almost identical micrornas  mir    a and mir    b  p  also repress brca  expression  these two micrornas are over expressed in triple negative tumors and their over expression results in brca  inactivation  thus  mir    a and or mir    b  p may also contribute to reduced expression of brca  in these triple negative breast cancers  in both serous tubal intraepithelial carcinoma  the precursor lesion to high grade serous ovarian carcinoma  hg soc    and in hg soc itself  mir     is overexpressed in about     of cases  in cells with over expressed mir      brca  remained low  even after exposure to ionizing radiation  which normally raises brca  expression   thus much of the reduced or absent brca  in hg soc may be due to over expressed mir      another microrna known to reduce expression of brca  in ovarian cancer cells is mir    among    tumors from patients with stage iiic or stage iv serous ovarian cancers  hg sog   an inverse correlation was found between expressions of mir   and brca   so that increased mir   may also contribute to reduced expression of brca  in these ovarian cancers  dna damage appears to be the primary underlying cause of cancer  and deficiencies in dna repair appears to underlie many forms of cancer  if dna repair is deficient  dna damage tends to accumulate  such excess dna damage may increase mutational errors during dna replication due to error prone translesion synthesis  excess dna damage may also increase epigenetic alterations due to errors during dna repair  such mutations and epigenetic alterations may give rise to cancer  the frequent microrna induced deficiency of brca  in breast and ovarian cancers likely contribute to the progression of those cancers  all germ line brca  mutations identified to date have been inherited  suggesting the possibility of a large  founder  effect in which a certain mutation is common to a well defined population group and can  in theory  be traced back to a common ancestor  given the complexity of mutation screening for brca   these common mutations may simplify the methods required for mutation screening in certain populations  analysis of mutations that occur with high frequency also permits the study of their clinical expression  examples of manifestations of a founder effect are seen among ashkenazi jews  three mutations in brca  have been reported to account for the majority of ashkenazi jewish patients with inherited brca  related breast and or ovarian cancer     delag     del   and     insc in the brca  gene  in fact  it has been shown that if a jewish woman does not carry a brca     delag  brca      insc founder mutation  it is highly unlikely that a different brca  mutation will be found  additional examples of founder mutations in brca  are given in table    mainly derived from    as women age  reproductive performance declines  leading to menopause  this decline is tied to a reduction in the number of ovarian follicles  although about   million oocytes are present at birth in the human ovary  only about      about        of these ovulate  the decline in ovarian reserve appears to occur at a constantly increasing rate with age  and leads to nearly complete exhaustion of the reserve by about age     as ovarian reserve and fertility decline with age  there is also a parallel increase in pregnancy failure and meiotic errors  resulting in chromosomally abnormal conceptions  women with a germ line brca  mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women  furthermore  women with an inherited brca  mutation undergo menopause prematurely  since brca  is a key dna repair protein  these findings suggest that naturally occurring dna damages in oocytes are repaired less efficiently in women with a brca  defect  and that this repair inefficiency leads to early reproductive failure  as noted above  the brca  protein plays a key role in homologous recombinational repair  this is the only known cellular process that can accurately repair dna double strand breaks  dna double strand breaks accumulate with age in humans and mice in primordial follicles  primordial follicles contain oocytes that are at an intermediate  prophase i  stage of meiosis  meiosis is the general process in eukaryotic organisms by which germ cells are formed  and it is likely an adaptation for removing dna damages  especially double strand breaks  from germ line dna   also see article meiosis   homologous recombinational repair employing brca  is especially promoted during meiosis  it was found that expression of four key genes necessary for homologous recombinational repair of dna double strand breaks  brca   mre    rad   and atm  decline with age in the oocytes of humans and mice  leading to the hypothesis that dna double strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging  non small cell lung cancer  nsclc  is the leading cause of cancer deaths worldwide  at diagnosis  almost     of persons with nsclc have locally advanced or metastatic disease  persons with nsclc are often treated with therapeutic platinum compounds  e g  cisplatin  carboplatin or oxaliplatin  that cause inter strand cross links in dna  among individuals with nsclc  low expression of brca  in the primary tumor correlated with improved survival after platinum containing chemotherapy  this correlation implies that low brca  in cancer  and the consequent low level of dna repair  causes vulnerability of cancer to treatment by the dna cross linking agents  high brca  may protect cancer cells by acting in a pathway that removes the damages in dna introduced by the platinum drugs  thus the level of brca  expression is a potentially important tool for tailoring chemotherapy in lung cancer management  level of brca  expression is also relevant to ovarian cancer treatment  patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their brca  expression was low compared to patients with higher brca  expression     compared to    months   a patent application for the isolated brca  gene and cancer promoting mutations discussed above  as well as methods to diagnose the likelihood of getting breast cancer  was filed by the university of utah  national institute of environmental health sciences  niehs  and myriad genetics in       over the next year  myriad   in collaboration with investigators at endo recherche  inc   hsc research   development limited partnership  and university of pennsylvania   isolated and sequenced the brca  gene and identified key mutations  and the first brca  patent was filed in the u s  by myriad and other institutions in       myriad is the exclusive licensee of these patents and has enforced them in the us against clinical diagnostic labs  this business model led from myriad being a startup in      to being a publicly traded company with      employees and about     m in annual revenue in       it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs  which in turn led to the landmark association for molecular pathology v  myriad genetics lawsuit  the patents began to expire in       according to an article published in the journal  genetic medicine  in        the patent story outside the united states is more complicated     for example  patents have been obtained but the patents are being ignored by provincial health systems in canada  in australia and the uk  myriad s licensee permitted use by health systems but announced a change of plans in august       only a single mutation has been patented in myriad s lone european wide patent  although some patents remain under review of an opposition proceeding  in effect  the united states is the only jurisdiction where myriad s strong patent position has conferred sole provider status   peter meldrum  ceo of myriad genetics  has acknowledged that myriad has  other competitive advantages that may make such  patent  enforcement unnecessary  in europe  as with any gene  finding variation in brca  is not hard  the real value comes from understanding what the clinical consequences of any particular variant are  myriad has a large  proprietary database of such genotype phenotype correlations  in response  parallel open source databases are being developed  legal decisions surrounding the brca  and brca  patents will affect the field of genetic testing in general  a june      article  in association for molecular pathology v  myriad genetics  no           quoted the us supreme court s unanimous ruling that   a naturally occurring dna segment is a product of nature and not patent eligible merely because it has been isolated   invalidating myriad s patents on the brca  and brca  genes  however  the court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection  the federal court of australia came to the opposite conclusion  upholding the validity of an australian myriad genetics patent over the brca  gene in february       the federal court also rejected an appeal in september       yvonne d arcy won her case against us based biotech company myriad genetics in the high court of australia  in their unanimous decision on october          the  high court found that an isolated nucleic acid  coding for a brca  protein  with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a  patentable invention    brca  has been shown to interact with the following proteins   jm   solution structure of the brca  bard  ring domain heterodimer  jnx  crystal structure of the brct repeat region from the breast cancer associated protein  brca   n o  structural consequences of a cancer causing brca  brct missense mutation  oqa  solution structure of the brct c domain from human brca   t    crystal structure of the brca  brct domains in complex with the phosphorylated interacting region from bach  helicase  t    crystal structure of the brca  brct repeats bound to a phosphorylated bach  peptide  t u  structural basis of phosphopeptide recognition by the brct domain of brca   structure of brca  missense variant v    f  t v  structural basis of phospho peptide recognition by the brct domain of brca   structure with phosphopeptide  y    structure of the brct repeats of brca  bound to a ctip phosphopeptide  '"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 112
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "clean_text = re.sub(r'^\\s+|\\s+$','',clean_text)"
      ],
      "metadata": {
        "id": "luhsrpqwrmfr"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "clean_text"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 139
        },
        "id": "v3lc12mErpiL",
        "outputId": "596371b7-a1e5-482a-daa5-31e791d18012"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'jm    jnx   n o   oqa   t     t     t u   t v   y     ing   coj   k h   k k   k     pxa   pxb   pxc   pxd   pxe   ifi   igk   jlu   ofb   u a   y     y g        ensg           ensmusg           p     p     nm_      nm_      nm_      nm_      nm_      nm_      nm_      nm_      np_      np_      np_      np_      np_      np_      breast cancer type   susceptibility protein is a protein that in humans is encoded by the brca    ˌbrækəˈwʌn   gene  orthologs are common in other vertebrate species  whereas invertebrate genomes may encode a more distantly related gene  brca  is a human tumor suppressor gene  also known as a caretaker gene  and is responsible for repairing dna  brca  and brca  are unrelated proteins  but both are normally expressed in the cells of breast and other tissue  where they help repair damaged dna  or destroy cells if dna cannot be repaired  they are involved in the repair of chromosomal damage with an important role in the error free repair of dna double strand breaks  if brca  or brca  itself is damaged by a brca mutation  damaged dna is not repaired properly  and this increases the risk for breast cancer  brca  and brca  have been described as  breast cancer susceptibility genes  and  breast cancer susceptibility proteins   the predominant allele has a normal  tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer  brca  combines with other tumor suppressors  dna damage sensors and signal transducers to form a large multi subunit protein complex known as the brca  associated genome surveillance complex  basc   the brca  protein associates with rna polymerase ii  and through the c terminal domain  also interacts with histone deacetylase complexes  thus  this protein plays a role in transcription  and dna repair of double strand dna breaks ubiquitination  transcriptional regulation as well as other functions  methods to test for the likelihood of a patient with mutations in brca  and brca  developing cancer were covered by patents owned or controlled by myriad genetics  myriad s business model of offering the diagnostic test exclusively led from myriad being a startup in      to being a publicly traded company with      employees and about     m in annual revenue in       it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs  which in turn led to the landmark association for molecular pathology v  myriad genetics lawsuit  the first evidence for the existence of a gene encoding a dna repair enzyme involved in breast cancer susceptibility was provided by mary claire king s laboratory at uc berkeley in       four years later  after an international race to find it  the gene was cloned in      by scientists at university of utah  national institute of environmental health sciences  niehs  and myriad genetics  the human brca  gene is located on the long  q  arm of chromosome    at region   band    from base pair            to base pair             build grch   hg     map   brca  orthologs have been identified in most vertebrates for which complete genome data are available  the brca  protein contains the following domains  this protein also contains nuclear localization signals and nuclear export signal motifs  the human brca  protein consists of four major protein domains  the znf c hc   ring domain  the brca  serine domain and two brct domains  these domains encode approximately     of brca  protein  there are six known isoforms of brca   with isoforms   and   comprising      amino acids each  citation needed  brca  is unrelated to brca   i e  they are not homologs or paralogs  the ring motif  a zn finger found in eukaryotic peptides  is       amino acids long and consists of eight conserved metal binding residues  two quartets of cysteine or histidine residues that coordinate two zinc atoms  this motif contains a short anti parallel beta sheet  two zinc binding loops and a central alpha helix in a small domain  this ring domain interacts with associated proteins  including bard   which also contains a ring motif  to form a heterodimer  the brca  ring motif is flanked by alpha helices formed by residues      and       of the brca  protein  it interacts with a homologous region in bard  also consisting of a ring finger flanked by two alpha helices formed from residues       and          these four helices combine to form a heterodimerization interface and stabilize the brca  bard  heterodimer complex  additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions  the bard  brca  interaction is disrupted by tumorigenic amino acid substitutions in brca   implying that the formation of a stable complex between these proteins may be an essential aspect of brca  tumor suppression  the ring domain is an important element of ubiquitin e  ligases  which catalyze protein ubiquitination  ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell  brca  polypeptides  in particular  lys    linked polyubiquitin chains are dispersed throughout the resting cell nucleus  but at the start of dna replication  they gather in restrained groups that also contain brca  and bard   bard  is thought to be involved in the recognition and binding of protein targets for ubiquitination  it attaches to proteins and labels them for destruction  ubiquitination occurs via the brca  fusion protein and is abolished by zinc chelation  the enzyme activity of the fusion protein is dependent on the proper folding of the ring domain  citation needed  brca  serine cluster domain  scd  spans amino acids            a portion of the domain is located in exons        high rates of mutation occur in exons        reported phosphorylation sites of brca  are concentrated in the scd  where they are phosphorylated by atm atr kinases both in vitro and in vivo  atm atr are kinases activated by dna damage  mutation of serine residues may affect localization of brca  to sites of dna damage and dna damage response function  the dual repeat brct domain of the brca  protein is an elongated structure approximately    å long and       å wide  the       amino acid domains in brct can be found as single modules or as multiple tandem repeats containing two domains  both of these possibilities can occur in a single protein in a variety of different conformations  the c terminal brct region of the brca  protein is essential for repair of dna  transcription regulation and tumor suppressor function  in brca  the dual tandem repeat brct domains are arranged in a head to tail fashion in the three dimensional structure  burying      å of hydrophobic  solvent accessible surface area in the interface  these all contribute to the tightly packed knob in hole structure that comprises the interface  these homologous domains interact to control cellular responses to dna damage  a missense mutation at the interface of these two proteins can perturb the cell cycle  resulting a greater risk of developing cancer  citation needed  brca  is part of a complex that repairs double strand breaks in dna  the strands of the dna double helix are continuously breaking as they become damaged  sometimes only one strand is broken  sometimes both strands are broken simultaneously  dna cross linking agents are an important source of chromosome dna damage  double strand breaks occur as intermediates after the crosslinks are removed  and indeed  biallelic mutations in brca  have been identified to be responsible for fanconi anemia  complementation group s  fa s   a genetic disease associated with hypersensitivity to dna crosslinking agents  brca  is part of a protein complex that repairs dna when both strands are broken  when this happens  it is difficult for the repair mechanism to  know  how to replace the correct dna sequence  and there are multiple ways to attempt the repair  the double strand repair mechanism in which brca  participates is homology directed repair  where the repair proteins copy the identical sequence from the intact sister chromatid  fa s is almost always a lethal condition in utero  only a handful cases of biallelic brca  mutations have been reported in literature despite the high carrier frequencies in the ashkenazim  and none since       in the nucleus of many types of normal cells  the brca  protein interacts with rad   during repair of dna double strand breaks  these breaks can be caused by natural radiation or other exposures  but also occur when chromosomes exchange genetic material  homologous recombination  e g    crossing over  during meiosis   the brca  protein  which has a function similar to that of brca   also interacts with the rad   protein  by influencing dna damage repair  these three proteins play a role in maintaining the stability of the human genome  citation needed  brca  is also involved in another type of dna repair  termed mismatch repair  brca  interacts with the dna mismatch repair protein msh   msh   msh   parp and some other proteins involved in single strand repair are reported to be elevated in brca  deficient mammary tumors  a protein called valosin containing protein  vcp  also known as p    plays a role to recruit brca  to the damaged dna sites  after ionizing radiation  vcp is recruited to dna lesions and cooperates with the ubiquitin ligase rnf  to orchestrate assembly of signaling complexes for efficient dsb repair  brca  interacts with vcp  brca  also interacts with c myc  and other proteins that are critical to maintain genome stability  brca  directly binds to dna  with higher affinity for branched dna structures  this ability to bind to dna contributes to its ability to inhibit the nuclease activity of the mrn complex as well as the nuclease activity of mre   alone  this may explain a role for brca  to promote lower fidelity dna repair by non homologous end joining  nhej   brca  also colocalizes with γ h ax  histone h ax phosphorylated on serine      in dna double strand break repair foci  indicating it may play a role in recruiting repair factors  formaldehyde and acetaldehyde are common environmental sources of dna cross links that often require repairs mediated by brca  containing pathways  this dna repair function is essential  mice with loss of function mutations in both brca  alleles are not viable  and as of      only two adults were known to have loss of function mutations in both alleles  leading to fa s   both had congenital or developmental issues  and both had cancer  one was presumed to have survived to adulthood because one of the brca  mutations was hypomorphic  brca  was shown to co purify with the human rna polymerase ii holoenzyme in hela extracts  implying it is a component of the holoenzyme  later research  however  contradicted this assumption  instead showing that the predominant complex including brca  in hela cells is a   megadalton complex containing swi snf  swi snf is a chromatin remodeling complex  artificial tethering of brca  to chromatin was shown to decondense heterochromatin  though the swi snf interacting domain was not necessary for this role  brca  interacts with the nelf b  cobra   subunit of the nelf complex  certain variations of the brca  gene lead to an increased risk for breast cancer as part of a hereditary breast ovarian cancer syndrome  researchers have identified hundreds of mutations in the brca  gene  many of which are associated with an increased risk of cancer  females with an abnormal brca  or brca  gene have up to an     risk of developing breast cancer by age     increased risk of developing ovarian cancer is about     for females with brca  mutations and about     for females with brca  mutations  these mutations can be changes in one or a small number of dna base pairs  the building blocks of dna   and can be identified with pcr and dna sequencing  in some cases  large segments of dna are rearranged  those large segments  also called large rearrangements  can be a deletion or a duplication of one or several exons in the gene  classical methods for mutation detection  sequencing  are unable to reveal these types of mutation  other methods have been proposed  traditional quantitative pcr  multiplex ligation dependent probe amplification  mlpa   and quantitative multiplex pcr of short fluorescent fragments  qmpsf   newer methods have also been recently proposed  heteroduplex analysis  hda  by multi capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization  array cgh   some results suggest that hypermethylation of the brca  promoter  which has been reported in some cancers  could be considered as an inactivating mechanism for brca  expression  a mutated brca  gene usually makes a protein that does not function properly  researchers believe that the defective brca  protein is unable to help fix dna damage leading to mutations in other genes  these mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor  thus  brca  inactivating mutations lead to a predisposition for cancer  citation needed  brca  mrna    utr can be bound by an mirna  mir    microrna  it has been suggested that variations in this mirna along with mir    microrna could confer susceptibility to breast cancer  in addition to breast cancer  mutations in the brca  gene also increase the risk of ovarian and prostate cancers  moreover  precancerous lesions  dysplasia  within the fallopian tube have been linked to brca  gene mutations  pathogenic mutations anywhere in a model pathway containing brca  and brca  greatly increase risks for a subset of leukemias and lymphomas  women who have inherited a defective brca  or brca  gene are at a greatly elevated risk to develop breast and ovarian cancer  their risk of developing breast and or ovarian cancer is so high  and so specific to those cancers  that many mutation carriers choose to have prophylactic surgery  there has been much conjecture to explain such apparently striking tissue specificity  major determinants of where brca    hereditary cancers occur are related to tissue specificity of the cancer pathogen  the agent that causes chronic inflammation or the carcinogen  the target tissue may have receptors for the pathogen  may become selectively exposed to an inflammatory process or to a carcinogen  an innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets  this theory also fits data for several tumor suppressors beyond brca  or brca   a major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery  as aforementioned  biallelic and homozygous inheritance of the brca  gene leads to fa s  which is almost always an embryonically lethal condition  brca  expression is reduced or undetectable in the majority of high grade  ductal breast cancers  it has long been noted that loss of brca  activity  either by germ line mutations or by down regulation of gene expression  leads to tumor formation in specific target tissues  in particular  decreased brca  expression contributes to both sporadic and inherited breast tumor progression  reduced expression of brca  is tumorigenic because it plays an important role in the repair of dna damages  especially double strand breaks  by the potentially error free pathway of homologous recombination  since cells that lack the brca  protein tend to repair dna damages by alternative more error prone mechanisms  the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer  similarly  brca  expression is low in the majority       of sporadic epithelial ovarian cancers  eocs  where eocs are the most common type of ovarian cancer  representing approximately     of ovarian cancers  in serous ovarian carcinomas  a sub category constituting about     of eocs  low brca  expression occurs in more than     of cases  bowtell reviewed the literature indicating that deficient homologous recombination repair caused by brca  deficiency is tumorigenic  in particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high grade serous ovarian cancer and dictate its response to therapy  especially noted was that brca  deficiency could be the cause of tumorigenesis whether due to brca  mutation or any other event that causes a deficiency of brca  expression  only about       of all women with breast cancer carry a mutation in brca  or brca   similarly  brca  mutations are only seen in about     of ovarian cancers      germline mutations and    somatic mutations   thus  while brca  expression is low in the majority of these cancers  brca  mutation is not a major cause of reduced expression  certain latent viruses  which are frequently detected in breast cancer tumors  can decrease the expression of the brca  gene and cause the development of breast tumors  brca  promoter hypermethylation was present in only     of unselected primary breast carcinomas  similarly  brca  promoter hypermethylation was present in only    to     of eoc cases  thus  while brca  expression is low in these cancers  brca  promoter methylation is only a minor cause of reduced expression  there are a number of specific micrornas  when overexpressed  that directly reduce expression of specific dna repair proteins  see microrna section dna repair and cancer  in the case of breast cancer  microrna      mir      specifically targets brca   breast cancers can be classified based on receptor status or histology  with triple negative breast cancer          of breast cancers   her            of breast cancers   er  pr   about     of breast cancers   and invasive lobular carcinoma  about        of invasive breast cancer   all four types of breast cancer were found to have an average of about     fold increase in mir      compared to normal breast tissue  in breast cancer cell lines  there is an inverse correlation of brca  protein levels with mir     expression  thus it appears that much of the reduction or absence of brca  in high grade ductal breast cancers may be due to over expressed mir      in addition to mir      a pair of almost identical micrornas  mir    a and mir    b  p  also repress brca  expression  these two micrornas are over expressed in triple negative tumors and their over expression results in brca  inactivation  thus  mir    a and or mir    b  p may also contribute to reduced expression of brca  in these triple negative breast cancers  in both serous tubal intraepithelial carcinoma  the precursor lesion to high grade serous ovarian carcinoma  hg soc    and in hg soc itself  mir     is overexpressed in about     of cases  in cells with over expressed mir      brca  remained low  even after exposure to ionizing radiation  which normally raises brca  expression   thus much of the reduced or absent brca  in hg soc may be due to over expressed mir      another microrna known to reduce expression of brca  in ovarian cancer cells is mir    among    tumors from patients with stage iiic or stage iv serous ovarian cancers  hg sog   an inverse correlation was found between expressions of mir   and brca   so that increased mir   may also contribute to reduced expression of brca  in these ovarian cancers  dna damage appears to be the primary underlying cause of cancer  and deficiencies in dna repair appears to underlie many forms of cancer  if dna repair is deficient  dna damage tends to accumulate  such excess dna damage may increase mutational errors during dna replication due to error prone translesion synthesis  excess dna damage may also increase epigenetic alterations due to errors during dna repair  such mutations and epigenetic alterations may give rise to cancer  the frequent microrna induced deficiency of brca  in breast and ovarian cancers likely contribute to the progression of those cancers  all germ line brca  mutations identified to date have been inherited  suggesting the possibility of a large  founder  effect in which a certain mutation is common to a well defined population group and can  in theory  be traced back to a common ancestor  given the complexity of mutation screening for brca   these common mutations may simplify the methods required for mutation screening in certain populations  analysis of mutations that occur with high frequency also permits the study of their clinical expression  examples of manifestations of a founder effect are seen among ashkenazi jews  three mutations in brca  have been reported to account for the majority of ashkenazi jewish patients with inherited brca  related breast and or ovarian cancer     delag     del   and     insc in the brca  gene  in fact  it has been shown that if a jewish woman does not carry a brca     delag  brca      insc founder mutation  it is highly unlikely that a different brca  mutation will be found  additional examples of founder mutations in brca  are given in table    mainly derived from    as women age  reproductive performance declines  leading to menopause  this decline is tied to a reduction in the number of ovarian follicles  although about   million oocytes are present at birth in the human ovary  only about      about        of these ovulate  the decline in ovarian reserve appears to occur at a constantly increasing rate with age  and leads to nearly complete exhaustion of the reserve by about age     as ovarian reserve and fertility decline with age  there is also a parallel increase in pregnancy failure and meiotic errors  resulting in chromosomally abnormal conceptions  women with a germ line brca  mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women  furthermore  women with an inherited brca  mutation undergo menopause prematurely  since brca  is a key dna repair protein  these findings suggest that naturally occurring dna damages in oocytes are repaired less efficiently in women with a brca  defect  and that this repair inefficiency leads to early reproductive failure  as noted above  the brca  protein plays a key role in homologous recombinational repair  this is the only known cellular process that can accurately repair dna double strand breaks  dna double strand breaks accumulate with age in humans and mice in primordial follicles  primordial follicles contain oocytes that are at an intermediate  prophase i  stage of meiosis  meiosis is the general process in eukaryotic organisms by which germ cells are formed  and it is likely an adaptation for removing dna damages  especially double strand breaks  from germ line dna   also see article meiosis   homologous recombinational repair employing brca  is especially promoted during meiosis  it was found that expression of four key genes necessary for homologous recombinational repair of dna double strand breaks  brca   mre    rad   and atm  decline with age in the oocytes of humans and mice  leading to the hypothesis that dna double strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging  non small cell lung cancer  nsclc  is the leading cause of cancer deaths worldwide  at diagnosis  almost     of persons with nsclc have locally advanced or metastatic disease  persons with nsclc are often treated with therapeutic platinum compounds  e g  cisplatin  carboplatin or oxaliplatin  that cause inter strand cross links in dna  among individuals with nsclc  low expression of brca  in the primary tumor correlated with improved survival after platinum containing chemotherapy  this correlation implies that low brca  in cancer  and the consequent low level of dna repair  causes vulnerability of cancer to treatment by the dna cross linking agents  high brca  may protect cancer cells by acting in a pathway that removes the damages in dna introduced by the platinum drugs  thus the level of brca  expression is a potentially important tool for tailoring chemotherapy in lung cancer management  level of brca  expression is also relevant to ovarian cancer treatment  patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their brca  expression was low compared to patients with higher brca  expression     compared to    months   a patent application for the isolated brca  gene and cancer promoting mutations discussed above  as well as methods to diagnose the likelihood of getting breast cancer  was filed by the university of utah  national institute of environmental health sciences  niehs  and myriad genetics in       over the next year  myriad   in collaboration with investigators at endo recherche  inc   hsc research   development limited partnership  and university of pennsylvania   isolated and sequenced the brca  gene and identified key mutations  and the first brca  patent was filed in the u s  by myriad and other institutions in       myriad is the exclusive licensee of these patents and has enforced them in the us against clinical diagnostic labs  this business model led from myriad being a startup in      to being a publicly traded company with      employees and about     m in annual revenue in       it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs  which in turn led to the landmark association for molecular pathology v  myriad genetics lawsuit  the patents began to expire in       according to an article published in the journal  genetic medicine  in        the patent story outside the united states is more complicated     for example  patents have been obtained but the patents are being ignored by provincial health systems in canada  in australia and the uk  myriad s licensee permitted use by health systems but announced a change of plans in august       only a single mutation has been patented in myriad s lone european wide patent  although some patents remain under review of an opposition proceeding  in effect  the united states is the only jurisdiction where myriad s strong patent position has conferred sole provider status   peter meldrum  ceo of myriad genetics  has acknowledged that myriad has  other competitive advantages that may make such  patent  enforcement unnecessary  in europe  as with any gene  finding variation in brca  is not hard  the real value comes from understanding what the clinical consequences of any particular variant are  myriad has a large  proprietary database of such genotype phenotype correlations  in response  parallel open source databases are being developed  legal decisions surrounding the brca  and brca  patents will affect the field of genetic testing in general  a june      article  in association for molecular pathology v  myriad genetics  no           quoted the us supreme court s unanimous ruling that   a naturally occurring dna segment is a product of nature and not patent eligible merely because it has been isolated   invalidating myriad s patents on the brca  and brca  genes  however  the court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection  the federal court of australia came to the opposite conclusion  upholding the validity of an australian myriad genetics patent over the brca  gene in february       the federal court also rejected an appeal in september       yvonne d arcy won her case against us based biotech company myriad genetics in the high court of australia  in their unanimous decision on october          the  high court found that an isolated nucleic acid  coding for a brca  protein  with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a  patentable invention    brca  has been shown to interact with the following proteins   jm   solution structure of the brca  bard  ring domain heterodimer  jnx  crystal structure of the brct repeat region from the breast cancer associated protein  brca   n o  structural consequences of a cancer causing brca  brct missense mutation  oqa  solution structure of the brct c domain from human brca   t    crystal structure of the brca  brct domains in complex with the phosphorylated interacting region from bach  helicase  t    crystal structure of the brca  brct repeats bound to a phosphorylated bach  peptide  t u  structural basis of phosphopeptide recognition by the brct domain of brca   structure of brca  missense variant v    f  t v  structural basis of phospho peptide recognition by the brct domain of brca   structure with phosphopeptide  y    structure of the brct repeats of brca  bound to a ctip phosphopeptide'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 114
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import nltk"
      ],
      "metadata": {
        "id": "ikqF_reGrqhm"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "nltk.download('punkt')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "bvQXvfjVrsZL",
        "outputId": "71990dfa-ae6c-42f1-842b-a7057a2d3aba"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Package punkt is already up-to-date!\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "metadata": {},
          "execution_count": 116
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "sentences = nltk.sent_tokenize(text)"
      ],
      "metadata": {
        "id": "nWcDSS_XrtOW"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "sentences"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "fA3MDmvJsCoB",
        "outputId": "100c6f7a-3e01-4cc8-ad52-ec137145d786"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['1JM7, 1JNX, 1N5O, 1OQA, 1T15, 1T29, 1T2U, 1T2V, 1Y98, 2ING, 3COJ, 3K0H, 3K0K, 3K15, 3PXA, 3PXB, 3PXC, 3PXD, 3PXE, 4IFI, 4IGK, 4JLU, 4OFB, 4U4A, 4Y18, 4Y2G67212189ENSG00000012048ENSMUSG00000017146P38398P48754NM_007299NM_007300NM_007301NM_007302NM_007303NM_007305NM_007306NM_009764NP_009225NP_009228NP_009229NP_009230NP_009231NP_033894Breast cancer type 1 susceptibility protein is a protein that in humans is encoded by the BRCA1 (/ˌbrækəˈwʌn/) gene.',\n",
              " 'Orthologs are common in other vertebrate species, whereas invertebrate genomes may encode a more distantly related gene.',\n",
              " 'BRCA1 is a human tumor suppressor gene (also known as a caretaker gene) and is responsible for repairing DNA.',\n",
              " 'BRCA1 and BRCA2 are unrelated proteins, but both are normally expressed in the cells of breast and other tissue, where they help repair damaged DNA, or destroy cells if DNA cannot be repaired.',\n",
              " 'They are involved in the repair of chromosomal damage with an important role in the error-free repair of DNA double-strand breaks.',\n",
              " 'If BRCA1 or BRCA2 itself is damaged by a BRCA mutation, damaged DNA is not repaired properly, and this increases the risk for breast cancer.',\n",
              " 'BRCA1 and BRCA2 have been described as \"breast cancer susceptibility genes\" and \"breast cancer susceptibility proteins\".',\n",
              " 'The predominant allele has a normal, tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer.',\n",
              " 'BRCA1 combines with other tumor suppressors, DNA damage sensors and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC).',\n",
              " 'The BRCA1 protein associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes.',\n",
              " 'Thus, this protein plays a role in transcription, and DNA repair of double-strand DNA breaks ubiquitination, transcriptional regulation as well as other functions.',\n",
              " 'Methods to test for the likelihood of a patient with mutations in BRCA1 and BRCA2 developing cancer were covered by patents owned or controlled by Myriad Genetics.',\n",
              " \"Myriad's business model of offering the diagnostic test exclusively led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012; it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs, which in turn led to the landmark Association for Molecular Pathology v. Myriad Genetics lawsuit.\",\n",
              " \"The first evidence for the existence of a gene encoding a DNA repair enzyme involved in breast cancer susceptibility was provided by Mary-Claire King's laboratory at UC Berkeley in 1990.\",\n",
              " 'Four years later, after an international race to find it, the gene was cloned in 1994 by scientists at University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics.',\n",
              " 'The human BRCA1 gene is located on the long (q) arm of chromosome 17 at region 2 band 1, from base pair 41,196,312 to base pair 41,277,500 (Build GRCh37/hg19) (map).',\n",
              " 'BRCA1 orthologs have been identified in most vertebrates for which complete genome data are available.',\n",
              " 'The BRCA1 protein contains the following domains: This protein also contains nuclear localization signals and nuclear export signal motifs.',\n",
              " 'The human BRCA1 protein consists of four major protein domains; the Znf C3HC4- RING domain, the BRCA1 serine domain and two BRCT domains.',\n",
              " 'These domains encode approximately 27% of BRCA1 protein.',\n",
              " 'There are six known isoforms of BRCA1, with isoforms 1 and 2 comprising 1863 amino acids each.',\n",
              " '[citation needed] BRCA1 is unrelated to BRCA2, i.e.',\n",
              " 'they are not homologs or paralogs.',\n",
              " 'The RING motif, a Zn finger found in eukaryotic peptides, is 40–60 amino acids long and consists of eight conserved metal-binding residues, two quartets of cysteine or histidine residues that coordinate two zinc atoms.',\n",
              " 'This motif contains a short anti-parallel beta-sheet, two zinc-binding loops and a central alpha helix in a small domain.',\n",
              " 'This RING domain interacts with associated proteins, including BARD1, which also contains a RING motif, to form a heterodimer.',\n",
              " 'The BRCA1 RING motif is flanked by alpha helices formed by residues 8–22 and 81–96 of the BRCA1 protein.',\n",
              " 'It interacts with a homologous region in BARD1 also consisting of a RING finger flanked by two alpha-helices formed from residues 36–48 and 101–116.',\n",
              " 'These four helices combine to form a heterodimerization interface and stabilize the BRCA1-BARD1 heterodimer complex.',\n",
              " 'Additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions.',\n",
              " 'The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression.',\n",
              " 'The ring domain is an important element of ubiquitin E3 ligases, which catalyze protein ubiquitination.',\n",
              " 'Ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell.',\n",
              " 'BRCA1 polypeptides, in particular, Lys-48-linked polyubiquitin chains are dispersed throughout the resting cell nucleus, but at the start of DNA replication, they gather in restrained groups that also contain BRCA2 and BARD1.',\n",
              " 'BARD1 is thought to be involved in the recognition and binding of protein targets for ubiquitination.',\n",
              " 'It attaches to proteins and labels them for destruction.',\n",
              " 'Ubiquitination occurs via the BRCA1 fusion protein and is abolished by zinc chelation.',\n",
              " 'The enzyme activity of the fusion protein is dependent on the proper folding of the ring domain.',\n",
              " '[citation needed] BRCA1 serine cluster domain (SCD) spans amino acids 1280–1524.',\n",
              " 'A portion of the domain is located in exons 11–13.',\n",
              " 'High rates of mutation occur in exons 11–13.',\n",
              " 'Reported phosphorylation sites of BRCA1 are concentrated in the SCD, where they are phosphorylated by ATM/ATR kinases both in vitro and in vivo.',\n",
              " 'ATM/ATR are kinases activated by DNA damage.',\n",
              " 'Mutation of serine residues may affect localization of BRCA1 to sites of DNA damage and DNA damage response function.',\n",
              " 'The dual repeat BRCT domain of the BRCA1 protein is an elongated structure approximately 70 Å long and 30–35 Å wide.',\n",
              " 'The 85–95 amino acid domains in BRCT can be found as single modules or as multiple tandem repeats containing two domains.',\n",
              " 'Both of these possibilities can occur in a single protein in a variety of different conformations.',\n",
              " 'The C-terminal BRCT region of the BRCA1 protein is essential for repair of DNA, transcription regulation and tumor suppressor function.',\n",
              " 'In BRCA1 the dual tandem repeat BRCT domains are arranged in a head-to-tail-fashion in the three-dimensional structure, burying 1600 Å of hydrophobic, solvent-accessible surface area in the interface.',\n",
              " 'These all contribute to the tightly packed knob-in-hole structure that comprises the interface.',\n",
              " 'These homologous domains interact to control cellular responses to DNA damage.',\n",
              " 'A missense mutation at the interface of these two proteins can perturb the cell cycle, resulting a greater risk of developing cancer.',\n",
              " '[citation needed] BRCA1 is part of a complex that repairs double-strand breaks in DNA.',\n",
              " 'The strands of the DNA double helix are continuously breaking as they become damaged.',\n",
              " 'Sometimes only one strand is broken, sometimes both strands are broken simultaneously.',\n",
              " 'DNA cross-linking agents are an important source of chromosome/DNA damage.',\n",
              " 'Double-strand breaks occur as intermediates after the crosslinks are removed, and indeed, biallelic mutations in BRCA1 have been identified to be responsible for Fanconi Anemia, Complementation Group S (FA-S), a genetic disease associated with hypersensitivity to DNA crosslinking agents.',\n",
              " 'BRCA1 is part of a protein complex that repairs DNA when both strands are broken.',\n",
              " 'When this happens, it is difficult for the repair mechanism to \"know\" how to replace the correct DNA sequence, and there are multiple ways to attempt the repair.',\n",
              " 'The double-strand repair mechanism in which BRCA1 participates is homology-directed repair, where the repair proteins copy the identical sequence from the intact sister chromatid.',\n",
              " 'FA-S is almost always a lethal condition in utero; only a handful cases of biallelic BRCA1 mutations have been reported in literature despite the high carrier frequencies in the Ashkenazim, and none since 2013.',\n",
              " 'In the nucleus of many types of normal cells, the BRCA1 protein interacts with RAD51 during repair of DNA double-strand breaks.',\n",
              " 'These breaks can be caused by natural radiation or other exposures, but also occur when chromosomes exchange genetic material (homologous recombination, e.g., \"crossing over\" during meiosis).',\n",
              " 'The BRCA2 protein, which has a function similar to that of BRCA1, also interacts with the RAD51 protein.',\n",
              " 'By influencing DNA damage repair, these three proteins play a role in maintaining the stability of the human genome.',\n",
              " '[citation needed] BRCA1 is also involved in another type of DNA repair, termed mismatch repair.',\n",
              " 'BRCA1 interacts with the DNA mismatch repair protein MSH2.',\n",
              " 'MSH2, MSH6, PARP and some other proteins involved in single-strand repair are reported to be elevated in BRCA1-deficient mammary tumors.',\n",
              " 'A protein called valosin-containing protein (VCP, also known as p97) plays a role to recruit BRCA1 to the damaged DNA sites.',\n",
              " 'After ionizing radiation, VCP is recruited to DNA lesions and cooperates with the ubiquitin ligase RNF8 to orchestrate assembly of signaling complexes for efficient DSB repair.',\n",
              " 'BRCA1 interacts with VCP.',\n",
              " 'BRCA1 also interacts with c-Myc, and other proteins that are critical to maintain genome stability.',\n",
              " 'BRCA1 directly binds to DNA, with higher affinity for branched DNA structures.',\n",
              " 'This ability to bind to DNA contributes to its ability to inhibit the nuclease activity of the MRN complex as well as the nuclease activity of Mre11 alone.',\n",
              " 'This may explain a role for BRCA1 to promote lower fidelity DNA repair by non-homologous end joining (NHEJ).',\n",
              " 'BRCA1 also colocalizes with γ-H2AX (histone H2AX phosphorylated on serine-139) in DNA double-strand break repair foci, indicating it may play a role in recruiting repair factors.',\n",
              " 'Formaldehyde and acetaldehyde are common environmental sources of DNA cross links that often require repairs mediated by BRCA1 containing pathways.',\n",
              " 'This DNA repair function is essential; mice with loss-of-function mutations in both BRCA1 alleles are not viable, and as of 2015 only two adults were known to have loss-of-function mutations in both alleles (leading to FA-S); both had congenital or developmental issues, and both had cancer.',\n",
              " 'One was presumed to have survived to adulthood because one of the BRCA1 mutations was hypomorphic.',\n",
              " 'BRCA1 was shown to co-purify with the human RNA Polymerase II holoenzyme in HeLa extracts, implying it is a component of the holoenzyme.',\n",
              " 'Later research, however, contradicted this assumption, instead showing that the predominant complex including BRCA1 in HeLa cells is a 2 megadalton complex containing SWI/SNF.',\n",
              " 'SWI/SNF is a chromatin remodeling complex.',\n",
              " 'Artificial tethering of BRCA1 to chromatin was shown to decondense heterochromatin, though the SWI/SNF interacting domain was not necessary for this role.',\n",
              " 'BRCA1 interacts with the NELF-B (COBRA1) subunit of the NELF complex.',\n",
              " 'Certain variations of the BRCA1 gene lead to an increased risk for breast cancer as part of a hereditary breast–ovarian cancer syndrome.',\n",
              " 'Researchers have identified hundreds of mutations in the BRCA1 gene, many of which are associated with an increased risk of cancer.',\n",
              " 'Females with an abnormal BRCA1 or BRCA2 gene have up to an 80% risk of developing breast cancer by age 90; increased risk of developing ovarian cancer is about 55% for females with BRCA1 mutations and about 25% for females with BRCA2 mutations.',\n",
              " 'These mutations can be changes in one or a small number of DNA base pairs (the building-blocks of DNA), and can be identified with PCR and DNA sequencing.',\n",
              " 'In some cases, large segments of DNA are rearranged.',\n",
              " 'Those large segments, also called large rearrangements, can be a deletion or a duplication of one or several exons in the gene.',\n",
              " 'Classical methods for mutation detection (sequencing) are unable to reveal these types of mutation.',\n",
              " 'Other methods have been proposed: traditional quantitative PCR, multiplex ligation-dependent probe amplification (MLPA), and Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF).',\n",
              " 'Newer methods have also been recently proposed: heteroduplex analysis (HDA) by multi-capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization (array-CGH).',\n",
              " 'Some results suggest that hypermethylation of the BRCA1 promoter, which has been reported in some cancers, could be considered as an inactivating mechanism for BRCA1 expression.',\n",
              " 'A mutated BRCA1 gene usually makes a protein that does not function properly.',\n",
              " 'Researchers believe that the defective BRCA1 protein is unable to help fix DNA damage leading to mutations in other genes.',\n",
              " 'These mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor.',\n",
              " 'Thus, BRCA1 inactivating mutations lead to a predisposition for cancer.',\n",
              " \"[citation needed] BRCA1 mRNA 3' UTR can be bound by an miRNA, Mir-17 microRNA.\",\n",
              " 'It has been suggested that variations in this miRNA along with Mir-30 microRNA could confer susceptibility to breast cancer.',\n",
              " 'In addition to breast cancer, mutations in the BRCA1 gene also increase the risk of ovarian and prostate cancers.',\n",
              " 'Moreover, precancerous lesions (dysplasia) within the Fallopian tube have been linked to BRCA1 gene mutations.',\n",
              " 'Pathogenic mutations anywhere in a model pathway containing BRCA1 and BRCA2 greatly increase risks for a subset of leukemias and lymphomas.',\n",
              " 'Women who have inherited a defective BRCA1 or BRCA2 gene are at a greatly elevated risk to develop breast and ovarian cancer.',\n",
              " 'Their risk of developing breast and/or ovarian cancer is so high, and so specific to those cancers, that many mutation carriers choose to have prophylactic surgery.',\n",
              " 'There has been much conjecture to explain such apparently striking tissue specificity.',\n",
              " 'Major determinants of where BRCA1/2 hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation or the carcinogen.',\n",
              " 'The target tissue may have receptors for the pathogen, may become selectively exposed to an inflammatory process or to a carcinogen.',\n",
              " 'An innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets.',\n",
              " 'This theory also fits data for several tumor suppressors beyond BRCA1 or BRCA2.',\n",
              " 'A major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery.',\n",
              " 'As aforementioned, biallelic and homozygous inheritance of the BRCA1 gene leads to FA-S, which is almost always an embryonically lethal condition.',\n",
              " 'BRCA1 expression is reduced or undetectable in the majority of high grade, ductal breast cancers.',\n",
              " 'It has long been noted that loss of BRCA1 activity, either by germ-line mutations or by down-regulation of gene expression, leads to tumor formation in specific target tissues.',\n",
              " 'In particular, decreased BRCA1 expression contributes to both sporadic and inherited breast tumor progression.',\n",
              " 'Reduced expression of BRCA1 is tumorigenic because it plays an important role in the repair of DNA damages, especially double-strand breaks, by the potentially error-free pathway of homologous recombination.',\n",
              " 'Since cells that lack the BRCA1 protein tend to repair DNA damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer.',\n",
              " 'Similarly, BRCA1 expression is low in the majority (55%) of sporadic epithelial ovarian cancers (EOCs) where EOCs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers.',\n",
              " 'In serous ovarian carcinomas, a sub-category constituting about 2/3 of EOCs, low BRCA1 expression occurs in more than 50% of cases.',\n",
              " 'Bowtell reviewed the literature indicating that deficient homologous recombination repair caused by BRCA1 deficiency is tumorigenic.',\n",
              " 'In particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy.',\n",
              " 'Especially noted was that BRCA1 deficiency could be the cause of tumorigenesis whether due to BRCA1 mutation or any other event that causes a deficiency of BRCA1 expression.',\n",
              " 'Only about 3%–8% of all women with breast cancer carry a mutation in BRCA1 or BRCA2.',\n",
              " 'Similarly, BRCA1 mutations are only seen in about 18% of ovarian cancers (13% germline mutations and 5% somatic mutations).',\n",
              " 'Thus, while BRCA1 expression is low in the majority of these cancers, BRCA1 mutation is not a major cause of reduced expression.',\n",
              " 'Certain latent viruses, which are frequently detected in breast cancer tumors, can decrease the expression of the BRCA1 gene and cause the development of breast tumors.',\n",
              " 'BRCA1 promoter hypermethylation was present in only 13% of unselected primary breast carcinomas.',\n",
              " 'Similarly, BRCA1 promoter hypermethylation was present in only 5% to 15% of EOC cases.',\n",
              " 'Thus, while BRCA1 expression is low in these cancers, BRCA1 promoter methylation is only a minor cause of reduced expression.',\n",
              " 'There are a number of specific microRNAs, when overexpressed, that directly reduce expression of specific DNA repair proteins (see MicroRNA section DNA repair and cancer) In the case of breast cancer, microRNA-182 (miR-182) specifically targets BRCA1.',\n",
              " 'Breast cancers can be classified based on receptor status or histology, with triple-negative breast cancer (15%–25% of breast cancers), HER2+ (15%–30% of breast cancers), ER+/PR+ (about 70% of breast cancers), and Invasive lobular carcinoma (about 5%–10% of invasive breast cancer).',\n",
              " 'All four types of breast cancer were found to have an average of about 100-fold increase in miR-182, compared to normal breast tissue.',\n",
              " 'In breast cancer cell lines, there is an inverse correlation of BRCA1 protein levels with miR-182 expression.',\n",
              " 'Thus it appears that much of the reduction or absence of BRCA1 in high grade ductal breast cancers may be due to over-expressed miR-182.',\n",
              " 'In addition to miR-182, a pair of almost identical microRNAs, miR-146a and miR-146b-5p, also repress BRCA1 expression.',\n",
              " 'These two microRNAs are over-expressed in triple-negative tumors and their over-expression results in BRCA1 inactivation.',\n",
              " 'Thus, miR-146a and/or miR-146b-5p may also contribute to reduced expression of BRCA1 in these triple-negative breast cancers.',\n",
              " 'In both serous tubal intraepithelial carcinoma (the precursor lesion to high grade serous ovarian carcinoma (HG-SOC)), and in HG-SOC itself, miR-182 is overexpressed in about 70% of cases.',\n",
              " 'In cells with over-expressed miR-182, BRCA1 remained low, even after exposure to ionizing radiation (which normally raises BRCA1 expression).',\n",
              " 'Thus much of the reduced or absent BRCA1 in HG-SOC may be due to over-expressed miR-182.',\n",
              " 'Another microRNA known to reduce expression of BRCA1 in ovarian cancer cells is miR-9.',\n",
              " 'Among 58 tumors from patients with stage IIIC or stage IV serous ovarian cancers (HG-SOG), an inverse correlation was found between expressions of miR-9 and BRCA1, so that increased miR-9 may also contribute to reduced expression of BRCA1 in these ovarian cancers.',\n",
              " 'DNA damage appears to be the primary underlying cause of cancer, and deficiencies in DNA repair appears to underlie many forms of cancer.',\n",
              " 'If DNA repair is deficient, DNA damage tends to accumulate.',\n",
              " 'Such excess DNA damage may increase mutational errors during DNA replication due to error-prone translesion synthesis.',\n",
              " 'Excess DNA damage may also increase epigenetic alterations due to errors during DNA repair.',\n",
              " 'Such mutations and epigenetic alterations may give rise to cancer.',\n",
              " 'The frequent microRNA-induced deficiency of BRCA1 in breast and ovarian cancers likely contribute to the progression of those cancers.',\n",
              " 'All germ-line BRCA1 mutations identified to date have been inherited, suggesting the possibility of a large \"founder\" effect in which a certain mutation is common to a well-defined population group and can, in theory, be traced back to a common ancestor.',\n",
              " 'Given the complexity of mutation screening for BRCA1, these common mutations may simplify the methods required for mutation screening in certain populations.',\n",
              " 'Analysis of mutations that occur with high frequency also permits the study of their clinical expression.',\n",
              " 'Examples of manifestations of a founder effect are seen among Ashkenazi Jews.',\n",
              " 'Three mutations in BRCA1 have been reported to account for the majority of Ashkenazi Jewish patients with inherited BRCA1-related breast and/or ovarian cancer: 185delAG, 188del11 and 5382insC in the BRCA1 gene.',\n",
              " 'In fact, it has been shown that if a Jewish woman does not carry a BRCA1 185delAG, BRCA1 5382insC founder mutation, it is highly unlikely that a different BRCA1 mutation will be found.',\n",
              " 'Additional examples of founder mutations in BRCA1 are given in Table 1 (mainly derived from ).',\n",
              " 'As women age, reproductive performance declines, leading to menopause.',\n",
              " 'This decline is tied to a reduction in the number of ovarian follicles.',\n",
              " 'Although about 1 million oocytes are present at birth in the human ovary, only about 500 (about 0.05%) of these ovulate.',\n",
              " 'The decline in ovarian reserve appears to occur at a constantly increasing rate with age, and leads to nearly complete exhaustion of the reserve by about age 52.',\n",
              " 'As ovarian reserve and fertility decline with age, there is also a parallel increase in pregnancy failure and meiotic errors, resulting in chromosomally abnormal conceptions.',\n",
              " 'Women with a germ-line BRCA1 mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women.',\n",
              " 'Furthermore, women with an inherited BRCA1 mutation undergo menopause prematurely.',\n",
              " 'Since BRCA1 is a key DNA repair protein, these findings suggest that naturally occurring DNA damages in oocytes are repaired less efficiently in women with a BRCA1 defect, and that this repair inefficiency leads to early reproductive failure.',\n",
              " 'As noted above, the BRCA1 protein plays a key role in homologous recombinational repair.',\n",
              " 'This is the only known cellular process that can accurately repair DNA double-strand breaks.',\n",
              " 'DNA double-strand breaks accumulate with age in humans and mice in primordial follicles.',\n",
              " 'Primordial follicles contain oocytes that are at an intermediate (prophase I) stage of meiosis.',\n",
              " 'Meiosis is the general process in eukaryotic organisms by which germ cells are formed, and it is likely an adaptation for removing DNA damages, especially double-strand breaks, from germ line DNA.',\n",
              " '(Also see article Meiosis).',\n",
              " 'Homologous recombinational repair employing BRCA1 is especially promoted during meiosis.',\n",
              " 'It was found that expression of four key genes necessary for homologous recombinational repair of DNA double-strand breaks (BRCA1, MRE11, RAD51 and ATM) decline with age in the oocytes of humans and mice, leading to the hypothesis that DNA double-strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging.',\n",
              " 'Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide.',\n",
              " 'At diagnosis, almost 70% of persons with NSCLC have locally advanced or metastatic disease.',\n",
              " 'Persons with NSCLC are often treated with therapeutic platinum compounds (e.g.',\n",
              " 'cisplatin, carboplatin or oxaliplatin) that cause inter-strand cross-links in DNA.',\n",
              " 'Among individuals with NSCLC, low expression of BRCA1 in the primary tumor correlated with improved survival after platinum-containing chemotherapy.',\n",
              " 'This correlation implies that low BRCA1 in cancer, and the consequent low level of DNA repair, causes vulnerability of cancer to treatment by the DNA cross-linking agents.',\n",
              " 'High BRCA1 may protect cancer cells by acting in a pathway that removes the damages in DNA introduced by the platinum drugs.',\n",
              " 'Thus the level of BRCA1 expression is a potentially important tool for tailoring chemotherapy in lung cancer management.',\n",
              " 'Level of BRCA1 expression is also relevant to ovarian cancer treatment.',\n",
              " 'Patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their BRCA1 expression was low compared to patients with higher BRCA1 expression (46 compared to 33 months).',\n",
              " 'A patent application for the isolated BRCA1 gene and cancer promoting mutations discussed above, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics in 1994; over the next year, Myriad, (in collaboration with investigators at Endo Recherche, Inc., HSC Research & Development Limited Partnership, and University of Pennsylvania), isolated and sequenced the BRCA2 gene and identified key mutations, and the first BRCA2 patent was filed in the U.S. by Myriad and other institutions in 1995.',\n",
              " 'Myriad is the exclusive licensee of these patents and has enforced them in the US against clinical diagnostic labs.',\n",
              " 'This business model led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012; it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs, which in turn led to the landmark Association for Molecular Pathology v. Myriad Genetics lawsuit.',\n",
              " 'The patents began to expire in 2014.',\n",
              " 'According to an article published in the journal, Genetic Medicine, in 2010, \"The patent story outside the United States is more complicated.... For example, patents have been obtained but the patents are being ignored by provincial health systems in Canada.',\n",
              " \"In Australia and the UK, Myriad's licensee permitted use by health systems but announced a change of plans in August 2008.\",\n",
              " \"Only a single mutation has been patented in Myriad's lone European-wide patent, although some patents remain under review of an opposition proceeding.\",\n",
              " 'In effect, the United States is the only jurisdiction where Myriad\\'s strong patent position has conferred sole-provider status.\"',\n",
              " 'Peter Meldrum, CEO of Myriad Genetics, has acknowledged that Myriad has \"other competitive advantages that may make such [patent] enforcement unnecessary\" in Europe.',\n",
              " 'As with any gene, finding variation in BRCA1 is not hard.',\n",
              " 'The real value comes from understanding what the clinical consequences of any particular variant are.',\n",
              " 'Myriad has a large, proprietary database of such genotype-phenotype correlations.',\n",
              " 'In response, parallel open-source databases are being developed.',\n",
              " 'Legal decisions surrounding the BRCA1 and BRCA2 patents will affect the field of genetic testing in general.',\n",
              " 'A June 2013 article, in Association for Molecular Pathology v. Myriad Genetics (No.',\n",
              " '12-398), quoted the US Supreme Court\\'s unanimous ruling that, \"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating Myriad\\'s patents on the BRCA1 and BRCA2 genes.',\n",
              " 'However, the Court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection.',\n",
              " 'The Federal Court of Australia came to the opposite conclusion, upholding the validity of an Australian Myriad Genetics patent over the BRCA1 gene in February 2013.',\n",
              " 'The Federal Court also rejected an appeal in September 2014.',\n",
              " \"Yvonne D'Arcy won her case against US-based biotech company Myriad Genetics in the High Court of Australia.\",\n",
              " 'In their unanimous decision on October 7, 2015, the \"high court found that an isolated nucleic acid, coding for a BRCA1 protein, with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a \\'patentable invention.\\'\"',\n",
              " 'BRCA1 has been shown to interact with the following proteins: 1jm7: Solution structure of the BRCA1/BARD1 RING-domain heterodimer 1jnx: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1 1n5o: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation 1oqa: Solution structure of the BRCT-c domain from human BRCA1 1t15: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase 1t29: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide 1t2u: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F 1t2v: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide 1y98: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.']"
            ]
          },
          "metadata": {},
          "execution_count": 118
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "len(sentences)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "-2fTQRf2sEAu",
        "outputId": "b7489d5c-a01b-47f0-e5f2-36106082e3fa"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "203"
            ]
          },
          "metadata": {},
          "execution_count": 119
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "nltk.download('stopwords')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Uld463JGsIqL",
        "outputId": "61940f7a-dc54-49ee-a9af-cd2f3941338e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
            "[nltk_data]   Package stopwords is already up-to-date!\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "metadata": {},
          "execution_count": 120
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "stop_words = nltk.corpus.stopwords.words('english')"
      ],
      "metadata": {
        "id": "7r9Vf3sSsKlj"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "stop_words"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "8YWnUIAGsLVJ",
        "outputId": "11f52075-bf78-44bc-962f-656e0fdd94eb"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['i',\n",
              " 'me',\n",
              " 'my',\n",
              " 'myself',\n",
              " 'we',\n",
              " 'our',\n",
              " 'ours',\n",
              " 'ourselves',\n",
              " 'you',\n",
              " \"you're\",\n",
              " \"you've\",\n",
              " \"you'll\",\n",
              " \"you'd\",\n",
              " 'your',\n",
              " 'yours',\n",
              " 'yourself',\n",
              " 'yourselves',\n",
              " 'he',\n",
              " 'him',\n",
              " 'his',\n",
              " 'himself',\n",
              " 'she',\n",
              " \"she's\",\n",
              " 'her',\n",
              " 'hers',\n",
              " 'herself',\n",
              " 'it',\n",
              " \"it's\",\n",
              " 'its',\n",
              " 'itself',\n",
              " 'they',\n",
              " 'them',\n",
              " 'their',\n",
              " 'theirs',\n",
              " 'themselves',\n",
              " 'what',\n",
              " 'which',\n",
              " 'who',\n",
              " 'whom',\n",
              " 'this',\n",
              " 'that',\n",
              " \"that'll\",\n",
              " 'these',\n",
              " 'those',\n",
              " 'am',\n",
              " 'is',\n",
              " 'are',\n",
              " 'was',\n",
              " 'were',\n",
              " 'be',\n",
              " 'been',\n",
              " 'being',\n",
              " 'have',\n",
              " 'has',\n",
              " 'had',\n",
              " 'having',\n",
              " 'do',\n",
              " 'does',\n",
              " 'did',\n",
              " 'doing',\n",
              " 'a',\n",
              " 'an',\n",
              " 'the',\n",
              " 'and',\n",
              " 'but',\n",
              " 'if',\n",
              " 'or',\n",
              " 'because',\n",
              " 'as',\n",
              " 'until',\n",
              " 'while',\n",
              " 'of',\n",
              " 'at',\n",
              " 'by',\n",
              " 'for',\n",
              " 'with',\n",
              " 'about',\n",
              " 'against',\n",
              " 'between',\n",
              " 'into',\n",
              " 'through',\n",
              " 'during',\n",
              " 'before',\n",
              " 'after',\n",
              " 'above',\n",
              " 'below',\n",
              " 'to',\n",
              " 'from',\n",
              " 'up',\n",
              " 'down',\n",
              " 'in',\n",
              " 'out',\n",
              " 'on',\n",
              " 'off',\n",
              " 'over',\n",
              " 'under',\n",
              " 'again',\n",
              " 'further',\n",
              " 'then',\n",
              " 'once',\n",
              " 'here',\n",
              " 'there',\n",
              " 'when',\n",
              " 'where',\n",
              " 'why',\n",
              " 'how',\n",
              " 'all',\n",
              " 'any',\n",
              " 'both',\n",
              " 'each',\n",
              " 'few',\n",
              " 'more',\n",
              " 'most',\n",
              " 'other',\n",
              " 'some',\n",
              " 'such',\n",
              " 'no',\n",
              " 'nor',\n",
              " 'not',\n",
              " 'only',\n",
              " 'own',\n",
              " 'same',\n",
              " 'so',\n",
              " 'than',\n",
              " 'too',\n",
              " 'very',\n",
              " 's',\n",
              " 't',\n",
              " 'can',\n",
              " 'will',\n",
              " 'just',\n",
              " 'don',\n",
              " \"don't\",\n",
              " 'should',\n",
              " \"should've\",\n",
              " 'now',\n",
              " 'd',\n",
              " 'll',\n",
              " 'm',\n",
              " 'o',\n",
              " 're',\n",
              " 've',\n",
              " 'y',\n",
              " 'ain',\n",
              " 'aren',\n",
              " \"aren't\",\n",
              " 'couldn',\n",
              " \"couldn't\",\n",
              " 'didn',\n",
              " \"didn't\",\n",
              " 'doesn',\n",
              " \"doesn't\",\n",
              " 'hadn',\n",
              " \"hadn't\",\n",
              " 'hasn',\n",
              " \"hasn't\",\n",
              " 'haven',\n",
              " \"haven't\",\n",
              " 'isn',\n",
              " \"isn't\",\n",
              " 'ma',\n",
              " 'mightn',\n",
              " \"mightn't\",\n",
              " 'mustn',\n",
              " \"mustn't\",\n",
              " 'needn',\n",
              " \"needn't\",\n",
              " 'shan',\n",
              " \"shan't\",\n",
              " 'shouldn',\n",
              " \"shouldn't\",\n",
              " 'wasn',\n",
              " \"wasn't\",\n",
              " 'weren',\n",
              " \"weren't\",\n",
              " 'won',\n",
              " \"won't\",\n",
              " 'wouldn',\n",
              " \"wouldn't\"]"
            ]
          },
          "metadata": {},
          "execution_count": 122
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "len(stop_words)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "FDnkfP_-samv",
        "outputId": "4661c05a-e462-47e6-dbbb-ce256b65f852"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "179"
            ]
          },
          "metadata": {},
          "execution_count": 123
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "clean_text"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 139
        },
        "id": "QOfJyl4IsdAb",
        "outputId": "b2304861-9f12-4cc1-b22f-c5ebbe16ec59"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'jm    jnx   n o   oqa   t     t     t u   t v   y     ing   coj   k h   k k   k     pxa   pxb   pxc   pxd   pxe   ifi   igk   jlu   ofb   u a   y     y g        ensg           ensmusg           p     p     nm_      nm_      nm_      nm_      nm_      nm_      nm_      nm_      np_      np_      np_      np_      np_      np_      breast cancer type   susceptibility protein is a protein that in humans is encoded by the brca    ˌbrækəˈwʌn   gene  orthologs are common in other vertebrate species  whereas invertebrate genomes may encode a more distantly related gene  brca  is a human tumor suppressor gene  also known as a caretaker gene  and is responsible for repairing dna  brca  and brca  are unrelated proteins  but both are normally expressed in the cells of breast and other tissue  where they help repair damaged dna  or destroy cells if dna cannot be repaired  they are involved in the repair of chromosomal damage with an important role in the error free repair of dna double strand breaks  if brca  or brca  itself is damaged by a brca mutation  damaged dna is not repaired properly  and this increases the risk for breast cancer  brca  and brca  have been described as  breast cancer susceptibility genes  and  breast cancer susceptibility proteins   the predominant allele has a normal  tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer  brca  combines with other tumor suppressors  dna damage sensors and signal transducers to form a large multi subunit protein complex known as the brca  associated genome surveillance complex  basc   the brca  protein associates with rna polymerase ii  and through the c terminal domain  also interacts with histone deacetylase complexes  thus  this protein plays a role in transcription  and dna repair of double strand dna breaks ubiquitination  transcriptional regulation as well as other functions  methods to test for the likelihood of a patient with mutations in brca  and brca  developing cancer were covered by patents owned or controlled by myriad genetics  myriad s business model of offering the diagnostic test exclusively led from myriad being a startup in      to being a publicly traded company with      employees and about     m in annual revenue in       it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs  which in turn led to the landmark association for molecular pathology v  myriad genetics lawsuit  the first evidence for the existence of a gene encoding a dna repair enzyme involved in breast cancer susceptibility was provided by mary claire king s laboratory at uc berkeley in       four years later  after an international race to find it  the gene was cloned in      by scientists at university of utah  national institute of environmental health sciences  niehs  and myriad genetics  the human brca  gene is located on the long  q  arm of chromosome    at region   band    from base pair            to base pair             build grch   hg     map   brca  orthologs have been identified in most vertebrates for which complete genome data are available  the brca  protein contains the following domains  this protein also contains nuclear localization signals and nuclear export signal motifs  the human brca  protein consists of four major protein domains  the znf c hc   ring domain  the brca  serine domain and two brct domains  these domains encode approximately     of brca  protein  there are six known isoforms of brca   with isoforms   and   comprising      amino acids each  citation needed  brca  is unrelated to brca   i e  they are not homologs or paralogs  the ring motif  a zn finger found in eukaryotic peptides  is       amino acids long and consists of eight conserved metal binding residues  two quartets of cysteine or histidine residues that coordinate two zinc atoms  this motif contains a short anti parallel beta sheet  two zinc binding loops and a central alpha helix in a small domain  this ring domain interacts with associated proteins  including bard   which also contains a ring motif  to form a heterodimer  the brca  ring motif is flanked by alpha helices formed by residues      and       of the brca  protein  it interacts with a homologous region in bard  also consisting of a ring finger flanked by two alpha helices formed from residues       and          these four helices combine to form a heterodimerization interface and stabilize the brca  bard  heterodimer complex  additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions  the bard  brca  interaction is disrupted by tumorigenic amino acid substitutions in brca   implying that the formation of a stable complex between these proteins may be an essential aspect of brca  tumor suppression  the ring domain is an important element of ubiquitin e  ligases  which catalyze protein ubiquitination  ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell  brca  polypeptides  in particular  lys    linked polyubiquitin chains are dispersed throughout the resting cell nucleus  but at the start of dna replication  they gather in restrained groups that also contain brca  and bard   bard  is thought to be involved in the recognition and binding of protein targets for ubiquitination  it attaches to proteins and labels them for destruction  ubiquitination occurs via the brca  fusion protein and is abolished by zinc chelation  the enzyme activity of the fusion protein is dependent on the proper folding of the ring domain  citation needed  brca  serine cluster domain  scd  spans amino acids            a portion of the domain is located in exons        high rates of mutation occur in exons        reported phosphorylation sites of brca  are concentrated in the scd  where they are phosphorylated by atm atr kinases both in vitro and in vivo  atm atr are kinases activated by dna damage  mutation of serine residues may affect localization of brca  to sites of dna damage and dna damage response function  the dual repeat brct domain of the brca  protein is an elongated structure approximately    å long and       å wide  the       amino acid domains in brct can be found as single modules or as multiple tandem repeats containing two domains  both of these possibilities can occur in a single protein in a variety of different conformations  the c terminal brct region of the brca  protein is essential for repair of dna  transcription regulation and tumor suppressor function  in brca  the dual tandem repeat brct domains are arranged in a head to tail fashion in the three dimensional structure  burying      å of hydrophobic  solvent accessible surface area in the interface  these all contribute to the tightly packed knob in hole structure that comprises the interface  these homologous domains interact to control cellular responses to dna damage  a missense mutation at the interface of these two proteins can perturb the cell cycle  resulting a greater risk of developing cancer  citation needed  brca  is part of a complex that repairs double strand breaks in dna  the strands of the dna double helix are continuously breaking as they become damaged  sometimes only one strand is broken  sometimes both strands are broken simultaneously  dna cross linking agents are an important source of chromosome dna damage  double strand breaks occur as intermediates after the crosslinks are removed  and indeed  biallelic mutations in brca  have been identified to be responsible for fanconi anemia  complementation group s  fa s   a genetic disease associated with hypersensitivity to dna crosslinking agents  brca  is part of a protein complex that repairs dna when both strands are broken  when this happens  it is difficult for the repair mechanism to  know  how to replace the correct dna sequence  and there are multiple ways to attempt the repair  the double strand repair mechanism in which brca  participates is homology directed repair  where the repair proteins copy the identical sequence from the intact sister chromatid  fa s is almost always a lethal condition in utero  only a handful cases of biallelic brca  mutations have been reported in literature despite the high carrier frequencies in the ashkenazim  and none since       in the nucleus of many types of normal cells  the brca  protein interacts with rad   during repair of dna double strand breaks  these breaks can be caused by natural radiation or other exposures  but also occur when chromosomes exchange genetic material  homologous recombination  e g    crossing over  during meiosis   the brca  protein  which has a function similar to that of brca   also interacts with the rad   protein  by influencing dna damage repair  these three proteins play a role in maintaining the stability of the human genome  citation needed  brca  is also involved in another type of dna repair  termed mismatch repair  brca  interacts with the dna mismatch repair protein msh   msh   msh   parp and some other proteins involved in single strand repair are reported to be elevated in brca  deficient mammary tumors  a protein called valosin containing protein  vcp  also known as p    plays a role to recruit brca  to the damaged dna sites  after ionizing radiation  vcp is recruited to dna lesions and cooperates with the ubiquitin ligase rnf  to orchestrate assembly of signaling complexes for efficient dsb repair  brca  interacts with vcp  brca  also interacts with c myc  and other proteins that are critical to maintain genome stability  brca  directly binds to dna  with higher affinity for branched dna structures  this ability to bind to dna contributes to its ability to inhibit the nuclease activity of the mrn complex as well as the nuclease activity of mre   alone  this may explain a role for brca  to promote lower fidelity dna repair by non homologous end joining  nhej   brca  also colocalizes with γ h ax  histone h ax phosphorylated on serine      in dna double strand break repair foci  indicating it may play a role in recruiting repair factors  formaldehyde and acetaldehyde are common environmental sources of dna cross links that often require repairs mediated by brca  containing pathways  this dna repair function is essential  mice with loss of function mutations in both brca  alleles are not viable  and as of      only two adults were known to have loss of function mutations in both alleles  leading to fa s   both had congenital or developmental issues  and both had cancer  one was presumed to have survived to adulthood because one of the brca  mutations was hypomorphic  brca  was shown to co purify with the human rna polymerase ii holoenzyme in hela extracts  implying it is a component of the holoenzyme  later research  however  contradicted this assumption  instead showing that the predominant complex including brca  in hela cells is a   megadalton complex containing swi snf  swi snf is a chromatin remodeling complex  artificial tethering of brca  to chromatin was shown to decondense heterochromatin  though the swi snf interacting domain was not necessary for this role  brca  interacts with the nelf b  cobra   subunit of the nelf complex  certain variations of the brca  gene lead to an increased risk for breast cancer as part of a hereditary breast ovarian cancer syndrome  researchers have identified hundreds of mutations in the brca  gene  many of which are associated with an increased risk of cancer  females with an abnormal brca  or brca  gene have up to an     risk of developing breast cancer by age     increased risk of developing ovarian cancer is about     for females with brca  mutations and about     for females with brca  mutations  these mutations can be changes in one or a small number of dna base pairs  the building blocks of dna   and can be identified with pcr and dna sequencing  in some cases  large segments of dna are rearranged  those large segments  also called large rearrangements  can be a deletion or a duplication of one or several exons in the gene  classical methods for mutation detection  sequencing  are unable to reveal these types of mutation  other methods have been proposed  traditional quantitative pcr  multiplex ligation dependent probe amplification  mlpa   and quantitative multiplex pcr of short fluorescent fragments  qmpsf   newer methods have also been recently proposed  heteroduplex analysis  hda  by multi capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization  array cgh   some results suggest that hypermethylation of the brca  promoter  which has been reported in some cancers  could be considered as an inactivating mechanism for brca  expression  a mutated brca  gene usually makes a protein that does not function properly  researchers believe that the defective brca  protein is unable to help fix dna damage leading to mutations in other genes  these mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor  thus  brca  inactivating mutations lead to a predisposition for cancer  citation needed  brca  mrna    utr can be bound by an mirna  mir    microrna  it has been suggested that variations in this mirna along with mir    microrna could confer susceptibility to breast cancer  in addition to breast cancer  mutations in the brca  gene also increase the risk of ovarian and prostate cancers  moreover  precancerous lesions  dysplasia  within the fallopian tube have been linked to brca  gene mutations  pathogenic mutations anywhere in a model pathway containing brca  and brca  greatly increase risks for a subset of leukemias and lymphomas  women who have inherited a defective brca  or brca  gene are at a greatly elevated risk to develop breast and ovarian cancer  their risk of developing breast and or ovarian cancer is so high  and so specific to those cancers  that many mutation carriers choose to have prophylactic surgery  there has been much conjecture to explain such apparently striking tissue specificity  major determinants of where brca    hereditary cancers occur are related to tissue specificity of the cancer pathogen  the agent that causes chronic inflammation or the carcinogen  the target tissue may have receptors for the pathogen  may become selectively exposed to an inflammatory process or to a carcinogen  an innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets  this theory also fits data for several tumor suppressors beyond brca  or brca   a major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery  as aforementioned  biallelic and homozygous inheritance of the brca  gene leads to fa s  which is almost always an embryonically lethal condition  brca  expression is reduced or undetectable in the majority of high grade  ductal breast cancers  it has long been noted that loss of brca  activity  either by germ line mutations or by down regulation of gene expression  leads to tumor formation in specific target tissues  in particular  decreased brca  expression contributes to both sporadic and inherited breast tumor progression  reduced expression of brca  is tumorigenic because it plays an important role in the repair of dna damages  especially double strand breaks  by the potentially error free pathway of homologous recombination  since cells that lack the brca  protein tend to repair dna damages by alternative more error prone mechanisms  the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer  similarly  brca  expression is low in the majority       of sporadic epithelial ovarian cancers  eocs  where eocs are the most common type of ovarian cancer  representing approximately     of ovarian cancers  in serous ovarian carcinomas  a sub category constituting about     of eocs  low brca  expression occurs in more than     of cases  bowtell reviewed the literature indicating that deficient homologous recombination repair caused by brca  deficiency is tumorigenic  in particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high grade serous ovarian cancer and dictate its response to therapy  especially noted was that brca  deficiency could be the cause of tumorigenesis whether due to brca  mutation or any other event that causes a deficiency of brca  expression  only about       of all women with breast cancer carry a mutation in brca  or brca   similarly  brca  mutations are only seen in about     of ovarian cancers      germline mutations and    somatic mutations   thus  while brca  expression is low in the majority of these cancers  brca  mutation is not a major cause of reduced expression  certain latent viruses  which are frequently detected in breast cancer tumors  can decrease the expression of the brca  gene and cause the development of breast tumors  brca  promoter hypermethylation was present in only     of unselected primary breast carcinomas  similarly  brca  promoter hypermethylation was present in only    to     of eoc cases  thus  while brca  expression is low in these cancers  brca  promoter methylation is only a minor cause of reduced expression  there are a number of specific micrornas  when overexpressed  that directly reduce expression of specific dna repair proteins  see microrna section dna repair and cancer  in the case of breast cancer  microrna      mir      specifically targets brca   breast cancers can be classified based on receptor status or histology  with triple negative breast cancer          of breast cancers   her            of breast cancers   er  pr   about     of breast cancers   and invasive lobular carcinoma  about        of invasive breast cancer   all four types of breast cancer were found to have an average of about     fold increase in mir      compared to normal breast tissue  in breast cancer cell lines  there is an inverse correlation of brca  protein levels with mir     expression  thus it appears that much of the reduction or absence of brca  in high grade ductal breast cancers may be due to over expressed mir      in addition to mir      a pair of almost identical micrornas  mir    a and mir    b  p  also repress brca  expression  these two micrornas are over expressed in triple negative tumors and their over expression results in brca  inactivation  thus  mir    a and or mir    b  p may also contribute to reduced expression of brca  in these triple negative breast cancers  in both serous tubal intraepithelial carcinoma  the precursor lesion to high grade serous ovarian carcinoma  hg soc    and in hg soc itself  mir     is overexpressed in about     of cases  in cells with over expressed mir      brca  remained low  even after exposure to ionizing radiation  which normally raises brca  expression   thus much of the reduced or absent brca  in hg soc may be due to over expressed mir      another microrna known to reduce expression of brca  in ovarian cancer cells is mir    among    tumors from patients with stage iiic or stage iv serous ovarian cancers  hg sog   an inverse correlation was found between expressions of mir   and brca   so that increased mir   may also contribute to reduced expression of brca  in these ovarian cancers  dna damage appears to be the primary underlying cause of cancer  and deficiencies in dna repair appears to underlie many forms of cancer  if dna repair is deficient  dna damage tends to accumulate  such excess dna damage may increase mutational errors during dna replication due to error prone translesion synthesis  excess dna damage may also increase epigenetic alterations due to errors during dna repair  such mutations and epigenetic alterations may give rise to cancer  the frequent microrna induced deficiency of brca  in breast and ovarian cancers likely contribute to the progression of those cancers  all germ line brca  mutations identified to date have been inherited  suggesting the possibility of a large  founder  effect in which a certain mutation is common to a well defined population group and can  in theory  be traced back to a common ancestor  given the complexity of mutation screening for brca   these common mutations may simplify the methods required for mutation screening in certain populations  analysis of mutations that occur with high frequency also permits the study of their clinical expression  examples of manifestations of a founder effect are seen among ashkenazi jews  three mutations in brca  have been reported to account for the majority of ashkenazi jewish patients with inherited brca  related breast and or ovarian cancer     delag     del   and     insc in the brca  gene  in fact  it has been shown that if a jewish woman does not carry a brca     delag  brca      insc founder mutation  it is highly unlikely that a different brca  mutation will be found  additional examples of founder mutations in brca  are given in table    mainly derived from    as women age  reproductive performance declines  leading to menopause  this decline is tied to a reduction in the number of ovarian follicles  although about   million oocytes are present at birth in the human ovary  only about      about        of these ovulate  the decline in ovarian reserve appears to occur at a constantly increasing rate with age  and leads to nearly complete exhaustion of the reserve by about age     as ovarian reserve and fertility decline with age  there is also a parallel increase in pregnancy failure and meiotic errors  resulting in chromosomally abnormal conceptions  women with a germ line brca  mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women  furthermore  women with an inherited brca  mutation undergo menopause prematurely  since brca  is a key dna repair protein  these findings suggest that naturally occurring dna damages in oocytes are repaired less efficiently in women with a brca  defect  and that this repair inefficiency leads to early reproductive failure  as noted above  the brca  protein plays a key role in homologous recombinational repair  this is the only known cellular process that can accurately repair dna double strand breaks  dna double strand breaks accumulate with age in humans and mice in primordial follicles  primordial follicles contain oocytes that are at an intermediate  prophase i  stage of meiosis  meiosis is the general process in eukaryotic organisms by which germ cells are formed  and it is likely an adaptation for removing dna damages  especially double strand breaks  from germ line dna   also see article meiosis   homologous recombinational repair employing brca  is especially promoted during meiosis  it was found that expression of four key genes necessary for homologous recombinational repair of dna double strand breaks  brca   mre    rad   and atm  decline with age in the oocytes of humans and mice  leading to the hypothesis that dna double strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging  non small cell lung cancer  nsclc  is the leading cause of cancer deaths worldwide  at diagnosis  almost     of persons with nsclc have locally advanced or metastatic disease  persons with nsclc are often treated with therapeutic platinum compounds  e g  cisplatin  carboplatin or oxaliplatin  that cause inter strand cross links in dna  among individuals with nsclc  low expression of brca  in the primary tumor correlated with improved survival after platinum containing chemotherapy  this correlation implies that low brca  in cancer  and the consequent low level of dna repair  causes vulnerability of cancer to treatment by the dna cross linking agents  high brca  may protect cancer cells by acting in a pathway that removes the damages in dna introduced by the platinum drugs  thus the level of brca  expression is a potentially important tool for tailoring chemotherapy in lung cancer management  level of brca  expression is also relevant to ovarian cancer treatment  patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their brca  expression was low compared to patients with higher brca  expression     compared to    months   a patent application for the isolated brca  gene and cancer promoting mutations discussed above  as well as methods to diagnose the likelihood of getting breast cancer  was filed by the university of utah  national institute of environmental health sciences  niehs  and myriad genetics in       over the next year  myriad   in collaboration with investigators at endo recherche  inc   hsc research   development limited partnership  and university of pennsylvania   isolated and sequenced the brca  gene and identified key mutations  and the first brca  patent was filed in the u s  by myriad and other institutions in       myriad is the exclusive licensee of these patents and has enforced them in the us against clinical diagnostic labs  this business model led from myriad being a startup in      to being a publicly traded company with      employees and about     m in annual revenue in       it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs  which in turn led to the landmark association for molecular pathology v  myriad genetics lawsuit  the patents began to expire in       according to an article published in the journal  genetic medicine  in        the patent story outside the united states is more complicated     for example  patents have been obtained but the patents are being ignored by provincial health systems in canada  in australia and the uk  myriad s licensee permitted use by health systems but announced a change of plans in august       only a single mutation has been patented in myriad s lone european wide patent  although some patents remain under review of an opposition proceeding  in effect  the united states is the only jurisdiction where myriad s strong patent position has conferred sole provider status   peter meldrum  ceo of myriad genetics  has acknowledged that myriad has  other competitive advantages that may make such  patent  enforcement unnecessary  in europe  as with any gene  finding variation in brca  is not hard  the real value comes from understanding what the clinical consequences of any particular variant are  myriad has a large  proprietary database of such genotype phenotype correlations  in response  parallel open source databases are being developed  legal decisions surrounding the brca  and brca  patents will affect the field of genetic testing in general  a june      article  in association for molecular pathology v  myriad genetics  no           quoted the us supreme court s unanimous ruling that   a naturally occurring dna segment is a product of nature and not patent eligible merely because it has been isolated   invalidating myriad s patents on the brca  and brca  genes  however  the court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection  the federal court of australia came to the opposite conclusion  upholding the validity of an australian myriad genetics patent over the brca  gene in february       the federal court also rejected an appeal in september       yvonne d arcy won her case against us based biotech company myriad genetics in the high court of australia  in their unanimous decision on october          the  high court found that an isolated nucleic acid  coding for a brca  protein  with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a  patentable invention    brca  has been shown to interact with the following proteins   jm   solution structure of the brca  bard  ring domain heterodimer  jnx  crystal structure of the brct repeat region from the breast cancer associated protein  brca   n o  structural consequences of a cancer causing brca  brct missense mutation  oqa  solution structure of the brct c domain from human brca   t    crystal structure of the brca  brct domains in complex with the phosphorylated interacting region from bach  helicase  t    crystal structure of the brca  brct repeats bound to a phosphorylated bach  peptide  t u  structural basis of phosphopeptide recognition by the brct domain of brca   structure of brca  missense variant v    f  t v  structural basis of phospho peptide recognition by the brct domain of brca   structure with phosphopeptide  y    structure of the brct repeats of brca  bound to a ctip phosphopeptide'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 124
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "word2count = {}\n",
        "for word in nltk.word_tokenize(clean_text):\n",
        "    if word not in stop_words:\n",
        "        if word not in word2count.keys():\n",
        "            word2count[word] = 1\n",
        "        else:\n",
        "            word2count[word] +=1"
      ],
      "metadata": {
        "id": "NpIdKNj9seVN"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "word2count"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "fdKVU2assgV4",
        "outputId": "70686ee0-8234-4549-a66d-e472871fe24c"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'jm': 2,\n",
              " 'jnx': 2,\n",
              " 'n': 2,\n",
              " 'oqa': 2,\n",
              " 'u': 4,\n",
              " 'v': 6,\n",
              " 'ing': 1,\n",
              " 'coj': 1,\n",
              " 'k': 4,\n",
              " 'h': 3,\n",
              " 'pxa': 1,\n",
              " 'pxb': 1,\n",
              " 'pxc': 1,\n",
              " 'pxd': 1,\n",
              " 'pxe': 1,\n",
              " 'ifi': 1,\n",
              " 'igk': 1,\n",
              " 'jlu': 1,\n",
              " 'ofb': 1,\n",
              " 'g': 3,\n",
              " 'ensg': 1,\n",
              " 'ensmusg': 1,\n",
              " 'p': 5,\n",
              " 'nm_': 8,\n",
              " 'np_': 6,\n",
              " 'breast': 38,\n",
              " 'cancer': 50,\n",
              " 'type': 3,\n",
              " 'susceptibility': 7,\n",
              " 'protein': 35,\n",
              " 'humans': 3,\n",
              " 'encoded': 1,\n",
              " 'brca': 162,\n",
              " 'ˌbrækəˈwʌn': 1,\n",
              " 'gene': 25,\n",
              " 'orthologs': 2,\n",
              " 'common': 6,\n",
              " 'vertebrate': 1,\n",
              " 'species': 1,\n",
              " 'whereas': 2,\n",
              " 'invertebrate': 1,\n",
              " 'genomes': 1,\n",
              " 'may': 19,\n",
              " 'encode': 2,\n",
              " 'distantly': 1,\n",
              " 'related': 3,\n",
              " 'human': 7,\n",
              " 'tumor': 12,\n",
              " 'suppressor': 3,\n",
              " 'also': 29,\n",
              " 'known': 7,\n",
              " 'caretaker': 1,\n",
              " 'responsible': 2,\n",
              " 'repairing': 1,\n",
              " 'dna': 65,\n",
              " 'unrelated': 2,\n",
              " 'proteins': 13,\n",
              " 'normally': 3,\n",
              " 'expressed': 5,\n",
              " 'cells': 10,\n",
              " 'tissue': 5,\n",
              " 'help': 2,\n",
              " 'repair': 39,\n",
              " 'damaged': 5,\n",
              " 'destroy': 1,\n",
              " 'repaired': 3,\n",
              " 'involved': 5,\n",
              " 'chromosomal': 2,\n",
              " 'damage': 13,\n",
              " 'important': 5,\n",
              " 'role': 10,\n",
              " 'error': 4,\n",
              " 'free': 2,\n",
              " 'double': 14,\n",
              " 'strand': 16,\n",
              " 'breaks': 11,\n",
              " 'mutation': 19,\n",
              " 'properly': 2,\n",
              " 'increases': 1,\n",
              " 'risk': 10,\n",
              " 'described': 1,\n",
              " 'genes': 5,\n",
              " 'predominant': 2,\n",
              " 'allele': 1,\n",
              " 'normal': 4,\n",
              " 'suppressive': 2,\n",
              " 'function': 9,\n",
              " 'high': 14,\n",
              " 'penetrance': 1,\n",
              " 'mutations': 30,\n",
              " 'cause': 8,\n",
              " 'loss': 4,\n",
              " 'correlates': 1,\n",
              " 'increased': 5,\n",
              " 'combines': 1,\n",
              " 'suppressors': 2,\n",
              " 'sensors': 1,\n",
              " 'signal': 2,\n",
              " 'transducers': 1,\n",
              " 'form': 4,\n",
              " 'large': 6,\n",
              " 'multi': 2,\n",
              " 'subunit': 2,\n",
              " 'complex': 12,\n",
              " 'associated': 5,\n",
              " 'genome': 4,\n",
              " 'surveillance': 1,\n",
              " 'basc': 1,\n",
              " 'associates': 1,\n",
              " 'rna': 2,\n",
              " 'polymerase': 2,\n",
              " 'ii': 2,\n",
              " 'c': 5,\n",
              " 'terminal': 2,\n",
              " 'domain': 15,\n",
              " 'interacts': 9,\n",
              " 'histone': 2,\n",
              " 'deacetylase': 1,\n",
              " 'complexes': 2,\n",
              " 'thus': 8,\n",
              " 'plays': 5,\n",
              " 'transcription': 2,\n",
              " 'ubiquitination': 4,\n",
              " 'transcriptional': 1,\n",
              " 'regulation': 3,\n",
              " 'well': 4,\n",
              " 'functions': 1,\n",
              " 'methods': 6,\n",
              " 'test': 2,\n",
              " 'likelihood': 2,\n",
              " 'patient': 1,\n",
              " 'developing': 5,\n",
              " 'covered': 1,\n",
              " 'patents': 8,\n",
              " 'owned': 1,\n",
              " 'controlled': 1,\n",
              " 'myriad': 21,\n",
              " 'genetics': 9,\n",
              " 'business': 2,\n",
              " 'model': 4,\n",
              " 'offering': 1,\n",
              " 'diagnostic': 4,\n",
              " 'exclusively': 1,\n",
              " 'led': 6,\n",
              " 'startup': 2,\n",
              " 'publicly': 2,\n",
              " 'traded': 2,\n",
              " 'company': 3,\n",
              " 'employees': 2,\n",
              " 'annual': 2,\n",
              " 'revenue': 2,\n",
              " 'controversy': 2,\n",
              " 'prices': 2,\n",
              " 'inability': 2,\n",
              " 'obtain': 1,\n",
              " 'second': 2,\n",
              " 'opinions': 2,\n",
              " 'labs': 3,\n",
              " 'turn': 2,\n",
              " 'landmark': 2,\n",
              " 'association': 3,\n",
              " 'molecular': 4,\n",
              " 'pathology': 3,\n",
              " 'lawsuit': 2,\n",
              " 'first': 2,\n",
              " 'evidence': 1,\n",
              " 'existence': 1,\n",
              " 'encoding': 1,\n",
              " 'enzyme': 2,\n",
              " 'provided': 1,\n",
              " 'mary': 1,\n",
              " 'claire': 1,\n",
              " 'king': 1,\n",
              " 'laboratory': 1,\n",
              " 'uc': 1,\n",
              " 'berkeley': 1,\n",
              " 'four': 5,\n",
              " 'years': 1,\n",
              " 'later': 2,\n",
              " 'international': 1,\n",
              " 'race': 1,\n",
              " 'find': 1,\n",
              " 'cloned': 1,\n",
              " 'scientists': 1,\n",
              " 'university': 3,\n",
              " 'utah': 2,\n",
              " 'national': 2,\n",
              " 'institute': 2,\n",
              " 'environmental': 3,\n",
              " 'health': 4,\n",
              " 'sciences': 2,\n",
              " 'niehs': 2,\n",
              " 'located': 2,\n",
              " 'long': 4,\n",
              " 'q': 1,\n",
              " 'arm': 1,\n",
              " 'chromosome': 2,\n",
              " 'region': 6,\n",
              " 'band': 1,\n",
              " 'base': 3,\n",
              " 'pair': 3,\n",
              " 'build': 1,\n",
              " 'grch': 1,\n",
              " 'hg': 5,\n",
              " 'map': 1,\n",
              " 'identified': 6,\n",
              " 'vertebrates': 1,\n",
              " 'complete': 2,\n",
              " 'data': 2,\n",
              " 'available': 1,\n",
              " 'contains': 4,\n",
              " 'following': 2,\n",
              " 'domains': 9,\n",
              " 'nuclear': 2,\n",
              " 'localization': 2,\n",
              " 'signals': 1,\n",
              " 'export': 1,\n",
              " 'motifs': 1,\n",
              " 'consists': 2,\n",
              " 'major': 4,\n",
              " 'znf': 1,\n",
              " 'hc': 1,\n",
              " 'ring': 9,\n",
              " 'serine': 4,\n",
              " 'two': 9,\n",
              " 'brct': 13,\n",
              " 'approximately': 3,\n",
              " 'six': 1,\n",
              " 'isoforms': 2,\n",
              " 'comprising': 1,\n",
              " 'amino': 5,\n",
              " 'acids': 3,\n",
              " 'citation': 5,\n",
              " 'needed': 5,\n",
              " 'e': 4,\n",
              " 'homologs': 1,\n",
              " 'paralogs': 1,\n",
              " 'motif': 4,\n",
              " 'zn': 1,\n",
              " 'finger': 2,\n",
              " 'found': 9,\n",
              " 'eukaryotic': 2,\n",
              " 'peptides': 1,\n",
              " 'eight': 1,\n",
              " 'conserved': 1,\n",
              " 'metal': 1,\n",
              " 'binding': 3,\n",
              " 'residues': 6,\n",
              " 'quartets': 1,\n",
              " 'cysteine': 1,\n",
              " 'histidine': 1,\n",
              " 'coordinate': 1,\n",
              " 'zinc': 3,\n",
              " 'atoms': 1,\n",
              " 'short': 2,\n",
              " 'anti': 1,\n",
              " 'parallel': 3,\n",
              " 'beta': 1,\n",
              " 'sheet': 1,\n",
              " 'loops': 1,\n",
              " 'central': 1,\n",
              " 'alpha': 3,\n",
              " 'helix': 2,\n",
              " 'small': 4,\n",
              " 'including': 2,\n",
              " 'bard': 7,\n",
              " 'heterodimer': 3,\n",
              " 'flanked': 2,\n",
              " 'helices': 3,\n",
              " 'formed': 3,\n",
              " 'homologous': 9,\n",
              " 'consisting': 1,\n",
              " 'combine': 1,\n",
              " 'heterodimerization': 1,\n",
              " 'interface': 4,\n",
              " 'stabilize': 1,\n",
              " 'additional': 2,\n",
              " 'stabilization': 1,\n",
              " 'achieved': 1,\n",
              " 'interactions': 2,\n",
              " 'adjacent': 1,\n",
              " 'flanking': 1,\n",
              " 'hydrophobic': 2,\n",
              " 'interaction': 1,\n",
              " 'disrupted': 1,\n",
              " 'tumorigenic': 3,\n",
              " 'acid': 3,\n",
              " 'substitutions': 1,\n",
              " 'implying': 2,\n",
              " 'formation': 2,\n",
              " 'stable': 1,\n",
              " 'essential': 3,\n",
              " 'aspect': 1,\n",
              " 'suppression': 1,\n",
              " 'element': 1,\n",
              " 'ubiquitin': 3,\n",
              " 'ligases': 1,\n",
              " 'catalyze': 1,\n",
              " 'regulatory': 1,\n",
              " 'tissues': 2,\n",
              " 'direct': 1,\n",
              " 'compartments': 1,\n",
              " 'within': 2,\n",
              " 'cell': 5,\n",
              " 'polypeptides': 1,\n",
              " 'particular': 4,\n",
              " 'lys': 1,\n",
              " 'linked': 2,\n",
              " 'polyubiquitin': 1,\n",
              " 'chains': 1,\n",
              " 'dispersed': 1,\n",
              " 'throughout': 1,\n",
              " 'resting': 1,\n",
              " 'nucleus': 2,\n",
              " 'start': 1,\n",
              " 'replication': 2,\n",
              " 'gather': 1,\n",
              " 'restrained': 1,\n",
              " 'groups': 1,\n",
              " 'contain': 2,\n",
              " 'thought': 1,\n",
              " 'recognition': 3,\n",
              " 'targets': 3,\n",
              " 'attaches': 1,\n",
              " 'labels': 1,\n",
              " 'destruction': 1,\n",
              " 'occurs': 2,\n",
              " 'via': 1,\n",
              " 'fusion': 2,\n",
              " 'abolished': 1,\n",
              " 'chelation': 1,\n",
              " 'activity': 4,\n",
              " 'dependent': 2,\n",
              " 'proper': 1,\n",
              " 'folding': 1,\n",
              " 'cluster': 1,\n",
              " 'scd': 2,\n",
              " 'spans': 1,\n",
              " 'portion': 1,\n",
              " 'exons': 3,\n",
              " 'rates': 1,\n",
              " 'occur': 7,\n",
              " 'reported': 5,\n",
              " 'phosphorylation': 1,\n",
              " 'sites': 3,\n",
              " 'concentrated': 1,\n",
              " 'phosphorylated': 4,\n",
              " 'atm': 3,\n",
              " 'atr': 2,\n",
              " 'kinases': 2,\n",
              " 'vitro': 1,\n",
              " 'vivo': 1,\n",
              " 'activated': 1,\n",
              " 'affect': 2,\n",
              " 'response': 3,\n",
              " 'dual': 2,\n",
              " 'repeat': 3,\n",
              " 'elongated': 1,\n",
              " 'structure': 11,\n",
              " 'å': 3,\n",
              " 'wide': 2,\n",
              " 'single': 4,\n",
              " 'modules': 1,\n",
              " 'multiple': 2,\n",
              " 'tandem': 2,\n",
              " 'repeats': 3,\n",
              " 'containing': 6,\n",
              " 'possibilities': 1,\n",
              " 'variety': 1,\n",
              " 'different': 2,\n",
              " 'conformations': 1,\n",
              " 'arranged': 1,\n",
              " 'head': 1,\n",
              " 'tail': 1,\n",
              " 'fashion': 1,\n",
              " 'three': 3,\n",
              " 'dimensional': 1,\n",
              " 'burying': 1,\n",
              " 'solvent': 1,\n",
              " 'accessible': 1,\n",
              " 'surface': 1,\n",
              " 'area': 1,\n",
              " 'contribute': 4,\n",
              " 'tightly': 1,\n",
              " 'packed': 1,\n",
              " 'knob': 1,\n",
              " 'hole': 1,\n",
              " 'comprises': 1,\n",
              " 'interact': 2,\n",
              " 'control': 1,\n",
              " 'cellular': 2,\n",
              " 'responses': 2,\n",
              " 'missense': 3,\n",
              " 'perturb': 1,\n",
              " 'cycle': 1,\n",
              " 'resulting': 2,\n",
              " 'greater': 1,\n",
              " 'part': 3,\n",
              " 'repairs': 3,\n",
              " 'strands': 3,\n",
              " 'continuously': 1,\n",
              " 'breaking': 1,\n",
              " 'become': 2,\n",
              " 'sometimes': 2,\n",
              " 'one': 5,\n",
              " 'broken': 3,\n",
              " 'simultaneously': 1,\n",
              " 'cross': 4,\n",
              " 'linking': 2,\n",
              " 'agents': 3,\n",
              " 'source': 2,\n",
              " 'intermediates': 1,\n",
              " 'crosslinks': 1,\n",
              " 'removed': 1,\n",
              " 'indeed': 1,\n",
              " 'biallelic': 3,\n",
              " 'fanconi': 1,\n",
              " 'anemia': 1,\n",
              " 'complementation': 1,\n",
              " 'group': 2,\n",
              " 'fa': 4,\n",
              " 'genetic': 4,\n",
              " 'disease': 3,\n",
              " 'hypersensitivity': 1,\n",
              " 'crosslinking': 1,\n",
              " 'happens': 1,\n",
              " 'difficult': 1,\n",
              " 'mechanism': 3,\n",
              " 'know': 1,\n",
              " 'replace': 1,\n",
              " 'correct': 1,\n",
              " 'sequence': 2,\n",
              " 'ways': 1,\n",
              " 'attempt': 1,\n",
              " 'participates': 1,\n",
              " 'homology': 1,\n",
              " 'directed': 1,\n",
              " 'copy': 1,\n",
              " 'identical': 2,\n",
              " 'intact': 1,\n",
              " 'sister': 1,\n",
              " 'chromatid': 1,\n",
              " 'almost': 4,\n",
              " 'always': 2,\n",
              " 'lethal': 2,\n",
              " 'condition': 2,\n",
              " 'utero': 1,\n",
              " 'handful': 1,\n",
              " 'cases': 5,\n",
              " 'literature': 2,\n",
              " 'despite': 1,\n",
              " 'carrier': 1,\n",
              " 'frequencies': 1,\n",
              " 'ashkenazim': 1,\n",
              " 'none': 1,\n",
              " 'since': 3,\n",
              " 'many': 4,\n",
              " 'types': 3,\n",
              " 'rad': 3,\n",
              " 'caused': 2,\n",
              " 'natural': 1,\n",
              " 'radiation': 3,\n",
              " 'exposures': 1,\n",
              " 'chromosomes': 1,\n",
              " 'exchange': 1,\n",
              " 'material': 1,\n",
              " 'recombination': 3,\n",
              " 'crossing': 1,\n",
              " 'meiosis': 5,\n",
              " 'similar': 1,\n",
              " 'influencing': 1,\n",
              " 'play': 2,\n",
              " 'maintaining': 1,\n",
              " 'stability': 2,\n",
              " 'another': 2,\n",
              " 'termed': 1,\n",
              " 'mismatch': 2,\n",
              " 'msh': 3,\n",
              " 'parp': 1,\n",
              " 'elevated': 2,\n",
              " 'deficient': 3,\n",
              " 'mammary': 1,\n",
              " 'tumors': 5,\n",
              " 'called': 2,\n",
              " 'valosin': 1,\n",
              " 'vcp': 3,\n",
              " 'recruit': 1,\n",
              " 'ionizing': 2,\n",
              " 'recruited': 1,\n",
              " 'lesions': 2,\n",
              " 'cooperates': 1,\n",
              " 'ligase': 1,\n",
              " 'rnf': 1,\n",
              " 'orchestrate': 1,\n",
              " 'assembly': 1,\n",
              " 'signaling': 1,\n",
              " 'efficient': 1,\n",
              " 'dsb': 1,\n",
              " 'myc': 1,\n",
              " 'critical': 1,\n",
              " 'maintain': 1,\n",
              " 'directly': 2,\n",
              " 'binds': 1,\n",
              " 'higher': 2,\n",
              " 'affinity': 1,\n",
              " 'branched': 1,\n",
              " 'structures': 1,\n",
              " 'ability': 2,\n",
              " 'bind': 1,\n",
              " 'contributes': 2,\n",
              " 'inhibit': 1,\n",
              " 'nuclease': 2,\n",
              " 'mrn': 1,\n",
              " 'mre': 2,\n",
              " 'alone': 1,\n",
              " 'explain': 2,\n",
              " 'promote': 1,\n",
              " 'lower': 1,\n",
              " 'fidelity': 1,\n",
              " 'non': 2,\n",
              " 'end': 1,\n",
              " 'joining': 1,\n",
              " 'nhej': 1,\n",
              " 'colocalizes': 1,\n",
              " 'γ': 1,\n",
              " 'ax': 2,\n",
              " 'break': 2,\n",
              " 'foci': 1,\n",
              " 'indicating': 2,\n",
              " 'recruiting': 1,\n",
              " 'factors': 1,\n",
              " 'formaldehyde': 1,\n",
              " 'acetaldehyde': 1,\n",
              " 'sources': 1,\n",
              " 'links': 2,\n",
              " 'often': 2,\n",
              " 'require': 1,\n",
              " 'mediated': 1,\n",
              " 'pathways': 1,\n",
              " 'mice': 3,\n",
              " 'alleles': 2,\n",
              " 'viable': 1,\n",
              " 'adults': 1,\n",
              " 'leading': 5,\n",
              " 'congenital': 1,\n",
              " 'developmental': 1,\n",
              " 'issues': 1,\n",
              " 'presumed': 1,\n",
              " 'survived': 1,\n",
              " 'adulthood': 1,\n",
              " 'hypomorphic': 1,\n",
              " 'shown': 4,\n",
              " 'co': 1,\n",
              " 'purify': 1,\n",
              " 'holoenzyme': 2,\n",
              " 'hela': 2,\n",
              " 'extracts': 1,\n",
              " 'component': 1,\n",
              " 'research': 2,\n",
              " 'however': 2,\n",
              " 'contradicted': 1,\n",
              " 'assumption': 1,\n",
              " 'instead': 1,\n",
              " 'showing': 1,\n",
              " 'megadalton': 1,\n",
              " 'swi': 3,\n",
              " 'snf': 3,\n",
              " 'chromatin': 2,\n",
              " 'remodeling': 1,\n",
              " 'artificial': 1,\n",
              " 'tethering': 1,\n",
              " 'decondense': 1,\n",
              " 'heterochromatin': 1,\n",
              " 'though': 1,\n",
              " 'interacting': 2,\n",
              " 'necessary': 3,\n",
              " 'nelf': 2,\n",
              " 'b': 3,\n",
              " 'cobra': 1,\n",
              " 'certain': 4,\n",
              " 'variations': 3,\n",
              " 'lead': 3,\n",
              " 'hereditary': 2,\n",
              " 'ovarian': 24,\n",
              " 'syndrome': 1,\n",
              " 'researchers': 2,\n",
              " 'hundreds': 1,\n",
              " 'females': 3,\n",
              " 'abnormal': 2,\n",
              " 'age': 8,\n",
              " 'changes': 1,\n",
              " 'number': 3,\n",
              " 'pairs': 1,\n",
              " 'building': 1,\n",
              " 'blocks': 1,\n",
              " 'pcr': 3,\n",
              " 'sequencing': 2,\n",
              " 'segments': 2,\n",
              " 'rearranged': 1,\n",
              " 'rearrangements': 2,\n",
              " 'deletion': 1,\n",
              " 'duplication': 1,\n",
              " 'several': 2,\n",
              " 'classical': 1,\n",
              " 'detection': 1,\n",
              " 'unable': 2,\n",
              " 'reveal': 1,\n",
              " 'proposed': 2,\n",
              " 'traditional': 1,\n",
              " 'quantitative': 2,\n",
              " 'multiplex': 2,\n",
              " 'ligation': 1,\n",
              " 'probe': 1,\n",
              " 'amplification': 1,\n",
              " 'mlpa': 1,\n",
              " 'fluorescent': 1,\n",
              " 'fragments': 1,\n",
              " 'qmpsf': 1,\n",
              " 'newer': 1,\n",
              " 'recently': 1,\n",
              " 'heteroduplex': 1,\n",
              " 'analysis': 2,\n",
              " 'hda': 1,\n",
              " 'capillary': 1,\n",
              " 'electrophoresis': 1,\n",
              " 'dedicated': 1,\n",
              " 'oligonucleotides': 1,\n",
              " 'array': 2,\n",
              " 'based': 3,\n",
              " 'comparative': 1,\n",
              " 'genomic': 2,\n",
              " 'hybridization': 1,\n",
              " 'cgh': 1,\n",
              " 'results': 2,\n",
              " 'suggest': 2,\n",
              " 'hypermethylation': 3,\n",
              " 'promoter': 4,\n",
              " 'cancers': 20,\n",
              " 'could': 4,\n",
              " 'considered': 1,\n",
              " 'inactivating': 2,\n",
              " 'expression': 28,\n",
              " 'mutated': 1,\n",
              " 'usually': 1,\n",
              " 'makes': 1,\n",
              " 'believe': 1,\n",
              " 'defective': 2,\n",
              " 'fix': 1,\n",
              " 'accumulate': 3,\n",
              " 'allow': 1,\n",
              " 'grow': 1,\n",
              " 'divide': 1,\n",
              " 'uncontrollably': 1,\n",
              " 'predisposition': 1,\n",
              " 'mrna': 1,\n",
              " 'utr': 1,\n",
              " 'bound': 3,\n",
              " 'mirna': 2,\n",
              " 'mir': 17,\n",
              " 'microrna': 6,\n",
              " 'suggested': 1,\n",
              " 'along': 1,\n",
              " 'confer': 1,\n",
              " 'addition': 3,\n",
              " 'increase': 6,\n",
              " 'prostate': 1,\n",
              " 'moreover': 1,\n",
              " 'precancerous': 1,\n",
              " 'dysplasia': 1,\n",
              " 'fallopian': 1,\n",
              " 'tube': 1,\n",
              " 'pathogenic': 1,\n",
              " 'anywhere': 1,\n",
              " 'pathway': 3,\n",
              " 'greatly': 2,\n",
              " 'risks': 1,\n",
              " 'subset': 1,\n",
              " 'leukemias': 1,\n",
              " 'lymphomas': 1,\n",
              " 'women': 7,\n",
              " 'inherited': 5,\n",
              " 'develop': 1,\n",
              " 'specific': 5,\n",
              " 'carriers': 1,\n",
              " 'choose': 1,\n",
              " 'prophylactic': 2,\n",
              " 'surgery': 2,\n",
              " 'much': 3,\n",
              " 'conjecture': 1,\n",
              " 'apparently': 1,\n",
              " 'striking': 1,\n",
              " 'specificity': 2,\n",
              " 'determinants': 1,\n",
              " 'pathogen': 2,\n",
              " 'agent': 1,\n",
              " 'causes': 3,\n",
              " 'chronic': 1,\n",
              " 'inflammation': 1,\n",
              " 'carcinogen': 2,\n",
              " 'target': 2,\n",
              " 'receptors': 1,\n",
              " 'selectively': 1,\n",
              " 'exposed': 1,\n",
              " 'inflammatory': 1,\n",
              " 'process': 3,\n",
              " 'innate': 1,\n",
              " 'deficit': 1,\n",
              " 'impairs': 1,\n",
              " 'exacerbates': 1,\n",
              " 'organ': 1,\n",
              " 'theory': 2,\n",
              " 'fits': 1,\n",
              " 'beyond': 1,\n",
              " 'advantage': 1,\n",
              " 'suggests': 1,\n",
              " 'options': 1,\n",
              " 'aforementioned': 1,\n",
              " 'homozygous': 1,\n",
              " 'inheritance': 1,\n",
              " 'leads': 4,\n",
              " 'embryonically': 1,\n",
              " 'reduced': 7,\n",
              " 'undetectable': 1,\n",
              " 'majority': 4,\n",
              " 'grade': 4,\n",
              " 'ductal': 2,\n",
              " 'noted': 3,\n",
              " 'either': 1,\n",
              " 'germ': 5,\n",
              " 'line': 4,\n",
              " 'decreased': 2,\n",
              " 'sporadic': 3,\n",
              " 'progression': 3,\n",
              " 'damages': 5,\n",
              " 'especially': 4,\n",
              " 'potentially': 2,\n",
              " 'lack': 1,\n",
              " 'tend': 1,\n",
              " 'alternative': 1,\n",
              " 'prone': 2,\n",
              " 'mechanisms': 1,\n",
              " 'reduction': 3,\n",
              " 'silencing': 1,\n",
              " 'generates': 1,\n",
              " 'gross': 1,\n",
              " 'similarly': 3,\n",
              " 'low': 9,\n",
              " 'epithelial': 1,\n",
              " 'eocs': 3,\n",
              " 'representing': 1,\n",
              " 'serous': 5,\n",
              " 'carcinomas': 2,\n",
              " 'sub': 1,\n",
              " 'category': 1,\n",
              " 'constituting': 1,\n",
              " 'bowtell': 1,\n",
              " 'reviewed': 1,\n",
              " 'deficiency': 5,\n",
              " 'initiates': 1,\n",
              " 'cascade': 1,\n",
              " 'events': 1,\n",
              " 'sculpt': 1,\n",
              " 'evolution': 1,\n",
              " 'dictate': 1,\n",
              " 'therapy': 1,\n",
              " 'tumorigenesis': 1,\n",
              " 'whether': 1,\n",
              " 'due': 5,\n",
              " 'event': 1,\n",
              " 'carry': 2,\n",
              " 'seen': 2,\n",
              " 'germline': 1,\n",
              " 'somatic': 1,\n",
              " 'latent': 1,\n",
              " 'viruses': 1,\n",
              " 'frequently': 1,\n",
              " 'detected': 1,\n",
              " 'decrease': 1,\n",
              " 'development': 2,\n",
              " 'present': 3,\n",
              " 'unselected': 1,\n",
              " 'primary': 3,\n",
              " 'eoc': 1,\n",
              " 'methylation': 1,\n",
              " 'minor': 1,\n",
              " 'micrornas': 3,\n",
              " 'overexpressed': 2,\n",
              " 'reduce': 2,\n",
              " 'see': 2,\n",
              " 'section': 1,\n",
              " 'case': 2,\n",
              " 'specifically': 1,\n",
              " 'classified': 1,\n",
              " 'receptor': 1,\n",
              " 'status': 2,\n",
              " 'histology': 1,\n",
              " 'triple': 3,\n",
              " 'negative': 3,\n",
              " 'er': 1,\n",
              " 'pr': 1,\n",
              " 'invasive': 2,\n",
              " 'lobular': 1,\n",
              " 'carcinoma': 3,\n",
              " 'average': 1,\n",
              " 'fold': 1,\n",
              " 'compared': 4,\n",
              " 'lines': 1,\n",
              " 'inverse': 2,\n",
              " 'correlation': 3,\n",
              " 'levels': 1,\n",
              " 'appears': 4,\n",
              " 'absence': 1,\n",
              " 'repress': 1,\n",
              " 'inactivation': 1,\n",
              " 'tubal': 1,\n",
              " 'intraepithelial': 1,\n",
              " 'precursor': 1,\n",
              " 'lesion': 1,\n",
              " 'soc': 3,\n",
              " 'remained': 1,\n",
              " 'even': 1,\n",
              " 'exposure': 1,\n",
              " 'raises': 1,\n",
              " 'absent': 1,\n",
              " 'among': 3,\n",
              " 'patients': 4,\n",
              " 'stage': 3,\n",
              " 'iiic': 1,\n",
              " 'iv': 1,\n",
              " 'sog': 1,\n",
              " 'expressions': 1,\n",
              " 'underlying': 1,\n",
              " 'deficiencies': 1,\n",
              " 'underlie': 1,\n",
              " 'forms': 1,\n",
              " 'tends': 1,\n",
              " 'excess': 2,\n",
              " 'mutational': 1,\n",
              " 'errors': 3,\n",
              " 'translesion': 1,\n",
              " 'synthesis': 1,\n",
              " 'epigenetic': 2,\n",
              " 'alterations': 2,\n",
              " 'give': 1,\n",
              " 'rise': 1,\n",
              " 'frequent': 1,\n",
              " 'induced': 1,\n",
              " 'likely': 2,\n",
              " 'date': 1,\n",
              " 'suggesting': 1,\n",
              " 'possibility': 1,\n",
              " 'founder': 4,\n",
              " 'effect': 3,\n",
              " 'defined': 1,\n",
              " 'population': 1,\n",
              " 'traced': 1,\n",
              " 'back': 1,\n",
              " 'ancestor': 1,\n",
              " 'given': 2,\n",
              " 'complexity': 1,\n",
              " 'screening': 2,\n",
              " 'simplify': 1,\n",
              " 'required': 1,\n",
              " 'populations': 1,\n",
              " 'frequency': 1,\n",
              " 'permits': 1,\n",
              " 'study': 1,\n",
              " 'clinical': 3,\n",
              " 'examples': 2,\n",
              " 'manifestations': 1,\n",
              " 'ashkenazi': 2,\n",
              " 'jews': 1,\n",
              " 'account': 1,\n",
              " 'jewish': 2,\n",
              " 'delag': 2,\n",
              " 'del': 1,\n",
              " 'insc': 2,\n",
              " 'fact': 1,\n",
              " 'woman': 1,\n",
              " 'highly': 1,\n",
              " 'unlikely': 1,\n",
              " 'table': 1,\n",
              " 'mainly': 1,\n",
              " 'derived': 1,\n",
              " 'reproductive': 2,\n",
              " 'performance': 1,\n",
              " 'declines': 1,\n",
              " 'menopause': 2,\n",
              " 'decline': 5,\n",
              " 'tied': 1,\n",
              " 'follicles': 3,\n",
              " 'although': 2,\n",
              " 'million': 1,\n",
              " 'oocytes': 4,\n",
              " 'birth': 1,\n",
              " 'ovary': 1,\n",
              " 'ovulate': 1,\n",
              " 'reserve': 5,\n",
              " 'constantly': 1,\n",
              " 'increasing': 1,\n",
              " 'rate': 1,\n",
              " 'nearly': 1,\n",
              " 'exhaustion': 1,\n",
              " 'fertility': 2,\n",
              " 'pregnancy': 1,\n",
              " 'failure': 2,\n",
              " 'meiotic': 1,\n",
              " 'chromosomally': 1,\n",
              " 'conceptions': 1,\n",
              " 'appear': 1,\n",
              " 'diminished': 1,\n",
              " 'oocyte': 2,\n",
              " 'aging': 2,\n",
              " 'furthermore': 1,\n",
              " 'undergo': 1,\n",
              " 'prematurely': 1,\n",
              " 'key': 4,\n",
              " 'findings': 1,\n",
              " 'naturally': 2,\n",
              " 'occurring': 2,\n",
              " 'less': 1,\n",
              " 'efficiently': 1,\n",
              " 'defect': 1,\n",
              " 'inefficiency': 1,\n",
              " 'early': 1,\n",
              " 'recombinational': 3,\n",
              " 'accurately': 1,\n",
              " 'primordial': 2,\n",
              " 'intermediate': 1,\n",
              " 'prophase': 1,\n",
              " 'general': 2,\n",
              " 'organisms': 1,\n",
              " 'adaptation': 1,\n",
              " 'removing': 1,\n",
              " 'article': 3,\n",
              " 'employing': 1,\n",
              " 'promoted': 1,\n",
              " 'hypothesis': 1,\n",
              " 'maintenance': 1,\n",
              " 'efficiency': 1,\n",
              " 'lung': 2,\n",
              " 'nsclc': 4,\n",
              " 'deaths': 1,\n",
              " 'worldwide': 1,\n",
              " 'diagnosis': 1,\n",
              " 'persons': 2,\n",
              " 'locally': 1,\n",
              " 'advanced': 1,\n",
              " 'metastatic': 1,\n",
              " 'treated': 2,\n",
              " 'therapeutic': 1,\n",
              " 'platinum': 4,\n",
              " 'compounds': 1,\n",
              " 'cisplatin': 1,\n",
              " 'carboplatin': 1,\n",
              " 'oxaliplatin': 1,\n",
              " 'inter': 1,\n",
              " 'individuals': 1,\n",
              " 'correlated': 1,\n",
              " 'improved': 1,\n",
              " 'survival': 2,\n",
              " 'chemotherapy': 2,\n",
              " 'implies': 1,\n",
              " 'consequent': 1,\n",
              " 'level': 3,\n",
              " 'vulnerability': 1,\n",
              " 'treatment': 2,\n",
              " 'protect': 1,\n",
              " 'acting': 1,\n",
              " 'removes': 1,\n",
              " 'introduced': 1,\n",
              " 'drugs': 2,\n",
              " 'tool': 1,\n",
              " 'tailoring': 1,\n",
              " 'management': 1,\n",
              " 'relevant': 1,\n",
              " 'longer': 1,\n",
              " 'median': 1,\n",
              " 'times': 1,\n",
              " 'months': 1,\n",
              " 'patent': 9,\n",
              " 'application': 1,\n",
              " 'isolated': 4,\n",
              " 'promoting': 1,\n",
              " 'discussed': 1,\n",
              " 'diagnose': 1,\n",
              " 'getting': 1,\n",
              " 'filed': 2,\n",
              " 'next': 1,\n",
              " 'year': 1,\n",
              " 'collaboration': 1,\n",
              " 'investigators': 1,\n",
              " 'endo': 1,\n",
              " 'recherche': 1,\n",
              " 'inc': 1,\n",
              " 'hsc': 1,\n",
              " 'limited': 1,\n",
              " 'partnership': 1,\n",
              " 'pennsylvania': 1,\n",
              " 'sequenced': 1,\n",
              " ...}"
            ]
          },
          "metadata": {},
          "execution_count": 126
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "max(word2count.values())"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "cBXfNu9DshVE",
        "outputId": "8c55dc5d-ecc6-4dfd-bbbe-4f2c26528002"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "162"
            ]
          },
          "metadata": {},
          "execution_count": 127
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "for key in word2count.keys():\n",
        "    word2count[key] = word2count[key]/max(word2count.values())"
      ],
      "metadata": {
        "id": "hZ1fHPcpsnDr"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "word2count"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "szwGyKCbspYs",
        "outputId": "b55f2429-3798-45fb-9813-9f380b1b963a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'jm': 0.012345679012345678,\n",
              " 'jnx': 0.012345679012345678,\n",
              " 'n': 0.012345679012345678,\n",
              " 'oqa': 0.012345679012345678,\n",
              " 'u': 0.024691358024691357,\n",
              " 'v': 0.037037037037037035,\n",
              " 'ing': 0.006172839506172839,\n",
              " 'coj': 0.006172839506172839,\n",
              " 'k': 0.024691358024691357,\n",
              " 'h': 0.018518518518518517,\n",
              " 'pxa': 0.006172839506172839,\n",
              " 'pxb': 0.006172839506172839,\n",
              " 'pxc': 0.006172839506172839,\n",
              " 'pxd': 0.006172839506172839,\n",
              " 'pxe': 0.006172839506172839,\n",
              " 'ifi': 0.006172839506172839,\n",
              " 'igk': 0.006172839506172839,\n",
              " 'jlu': 0.006172839506172839,\n",
              " 'ofb': 0.006172839506172839,\n",
              " 'g': 0.018518518518518517,\n",
              " 'ensg': 0.006172839506172839,\n",
              " 'ensmusg': 0.006172839506172839,\n",
              " 'p': 0.030864197530864196,\n",
              " 'nm_': 0.04938271604938271,\n",
              " 'np_': 0.037037037037037035,\n",
              " 'breast': 0.2345679012345679,\n",
              " 'cancer': 0.30864197530864196,\n",
              " 'type': 0.018518518518518517,\n",
              " 'susceptibility': 0.043209876543209874,\n",
              " 'protein': 0.21604938271604937,\n",
              " 'humans': 0.018518518518518517,\n",
              " 'encoded': 0.006172839506172839,\n",
              " 'brca': 1.0,\n",
              " 'ˌbrækəˈwʌn': 0.015384615384615385,\n",
              " 'gene': 0.38461538461538464,\n",
              " 'orthologs': 0.03076923076923077,\n",
              " 'common': 0.09230769230769231,\n",
              " 'vertebrate': 0.015384615384615385,\n",
              " 'species': 0.015384615384615385,\n",
              " 'whereas': 0.03076923076923077,\n",
              " 'invertebrate': 0.015384615384615385,\n",
              " 'genomes': 0.015384615384615385,\n",
              " 'may': 0.2923076923076923,\n",
              " 'encode': 0.03076923076923077,\n",
              " 'distantly': 0.015384615384615385,\n",
              " 'related': 0.046153846153846156,\n",
              " 'human': 0.1076923076923077,\n",
              " 'tumor': 0.18461538461538463,\n",
              " 'suppressor': 0.046153846153846156,\n",
              " 'also': 0.4461538461538462,\n",
              " 'known': 0.1076923076923077,\n",
              " 'caretaker': 0.015384615384615385,\n",
              " 'responsible': 0.03076923076923077,\n",
              " 'repairing': 0.015384615384615385,\n",
              " 'dna': 1.0,\n",
              " 'unrelated': 0.05128205128205128,\n",
              " 'proteins': 0.3333333333333333,\n",
              " 'normally': 0.07692307692307693,\n",
              " 'expressed': 0.1282051282051282,\n",
              " 'cells': 0.2564102564102564,\n",
              " 'tissue': 0.1282051282051282,\n",
              " 'help': 0.05128205128205128,\n",
              " 'repair': 1.0,\n",
              " 'damaged': 0.16666666666666666,\n",
              " 'destroy': 0.03333333333333333,\n",
              " 'repaired': 0.1,\n",
              " 'involved': 0.16666666666666666,\n",
              " 'chromosomal': 0.06666666666666667,\n",
              " 'damage': 0.43333333333333335,\n",
              " 'important': 0.16666666666666666,\n",
              " 'role': 0.3333333333333333,\n",
              " 'error': 0.13333333333333333,\n",
              " 'free': 0.06666666666666667,\n",
              " 'double': 0.4666666666666667,\n",
              " 'strand': 0.5333333333333333,\n",
              " 'breaks': 0.36666666666666664,\n",
              " 'mutation': 0.6333333333333333,\n",
              " 'properly': 0.06666666666666667,\n",
              " 'increases': 0.03333333333333333,\n",
              " 'risk': 0.3333333333333333,\n",
              " 'described': 0.03333333333333333,\n",
              " 'genes': 0.16666666666666666,\n",
              " 'predominant': 0.06666666666666667,\n",
              " 'allele': 0.03333333333333333,\n",
              " 'normal': 0.13333333333333333,\n",
              " 'suppressive': 0.06666666666666667,\n",
              " 'function': 0.3,\n",
              " 'high': 0.4666666666666667,\n",
              " 'penetrance': 0.03333333333333333,\n",
              " 'mutations': 1.0,\n",
              " 'cause': 0.2857142857142857,\n",
              " 'loss': 0.14285714285714285,\n",
              " 'correlates': 0.03571428571428571,\n",
              " 'increased': 0.17857142857142858,\n",
              " 'combines': 0.03571428571428571,\n",
              " 'suppressors': 0.07142857142857142,\n",
              " 'sensors': 0.03571428571428571,\n",
              " 'signal': 0.07142857142857142,\n",
              " 'transducers': 0.03571428571428571,\n",
              " 'form': 0.14285714285714285,\n",
              " 'large': 0.21428571428571427,\n",
              " 'multi': 0.07142857142857142,\n",
              " 'subunit': 0.07142857142857142,\n",
              " 'complex': 0.42857142857142855,\n",
              " 'associated': 0.17857142857142858,\n",
              " 'genome': 0.14285714285714285,\n",
              " 'surveillance': 0.03571428571428571,\n",
              " 'basc': 0.03571428571428571,\n",
              " 'associates': 0.03571428571428571,\n",
              " 'rna': 0.07142857142857142,\n",
              " 'polymerase': 0.07142857142857142,\n",
              " 'ii': 0.07142857142857142,\n",
              " 'c': 0.17857142857142858,\n",
              " 'terminal': 0.07142857142857142,\n",
              " 'domain': 0.5357142857142857,\n",
              " 'interacts': 0.32142857142857145,\n",
              " 'histone': 0.07142857142857142,\n",
              " 'deacetylase': 0.03571428571428571,\n",
              " 'complexes': 0.07142857142857142,\n",
              " 'thus': 0.2857142857142857,\n",
              " 'plays': 0.17857142857142858,\n",
              " 'transcription': 0.07142857142857142,\n",
              " 'ubiquitination': 0.14285714285714285,\n",
              " 'transcriptional': 0.03571428571428571,\n",
              " 'regulation': 0.10714285714285714,\n",
              " 'well': 0.14285714285714285,\n",
              " 'functions': 0.03571428571428571,\n",
              " 'methods': 0.21428571428571427,\n",
              " 'test': 0.07142857142857142,\n",
              " 'likelihood': 0.07142857142857142,\n",
              " 'patient': 0.03571428571428571,\n",
              " 'developing': 0.17857142857142858,\n",
              " 'covered': 0.03571428571428571,\n",
              " 'patents': 0.2857142857142857,\n",
              " 'owned': 0.03571428571428571,\n",
              " 'controlled': 0.03571428571428571,\n",
              " 'myriad': 0.75,\n",
              " 'genetics': 0.32142857142857145,\n",
              " 'business': 0.07142857142857142,\n",
              " 'model': 0.14285714285714285,\n",
              " 'offering': 0.03571428571428571,\n",
              " 'diagnostic': 0.14285714285714285,\n",
              " 'exclusively': 0.03571428571428571,\n",
              " 'led': 0.21428571428571427,\n",
              " 'startup': 0.07142857142857142,\n",
              " 'publicly': 0.07142857142857142,\n",
              " 'traded': 0.07142857142857142,\n",
              " 'company': 0.10714285714285714,\n",
              " 'employees': 0.07142857142857142,\n",
              " 'annual': 0.07142857142857142,\n",
              " 'revenue': 0.07142857142857142,\n",
              " 'controversy': 0.07142857142857142,\n",
              " 'prices': 0.07142857142857142,\n",
              " 'inability': 0.07142857142857142,\n",
              " 'obtain': 0.03571428571428571,\n",
              " 'second': 0.07142857142857142,\n",
              " 'opinions': 0.07142857142857142,\n",
              " 'labs': 0.10714285714285714,\n",
              " 'turn': 0.07142857142857142,\n",
              " 'landmark': 0.07142857142857142,\n",
              " 'association': 0.10714285714285714,\n",
              " 'molecular': 0.14285714285714285,\n",
              " 'pathology': 0.10714285714285714,\n",
              " 'lawsuit': 0.07142857142857142,\n",
              " 'first': 0.07142857142857142,\n",
              " 'evidence': 0.03571428571428571,\n",
              " 'existence': 0.03571428571428571,\n",
              " 'encoding': 0.03571428571428571,\n",
              " 'enzyme': 0.07142857142857142,\n",
              " 'provided': 0.03571428571428571,\n",
              " 'mary': 0.03571428571428571,\n",
              " 'claire': 0.03571428571428571,\n",
              " 'king': 0.03571428571428571,\n",
              " 'laboratory': 0.03571428571428571,\n",
              " 'uc': 0.03571428571428571,\n",
              " 'berkeley': 0.03571428571428571,\n",
              " 'four': 0.17857142857142858,\n",
              " 'years': 0.03571428571428571,\n",
              " 'later': 0.07142857142857142,\n",
              " 'international': 0.03571428571428571,\n",
              " 'race': 0.03571428571428571,\n",
              " 'find': 0.03571428571428571,\n",
              " 'cloned': 0.03571428571428571,\n",
              " 'scientists': 0.03571428571428571,\n",
              " 'university': 0.10714285714285714,\n",
              " 'utah': 0.07142857142857142,\n",
              " 'national': 0.07142857142857142,\n",
              " 'institute': 0.07142857142857142,\n",
              " 'environmental': 0.10714285714285714,\n",
              " 'health': 0.14285714285714285,\n",
              " 'sciences': 0.07142857142857142,\n",
              " 'niehs': 0.07142857142857142,\n",
              " 'located': 0.07142857142857142,\n",
              " 'long': 0.14285714285714285,\n",
              " 'q': 0.03571428571428571,\n",
              " 'arm': 0.03571428571428571,\n",
              " 'chromosome': 0.07142857142857142,\n",
              " 'region': 0.21428571428571427,\n",
              " 'band': 0.03571428571428571,\n",
              " 'base': 0.10714285714285714,\n",
              " 'pair': 0.10714285714285714,\n",
              " 'build': 0.03571428571428571,\n",
              " 'grch': 0.03571428571428571,\n",
              " 'hg': 0.17857142857142858,\n",
              " 'map': 0.03571428571428571,\n",
              " 'identified': 0.21428571428571427,\n",
              " 'vertebrates': 0.03571428571428571,\n",
              " 'complete': 0.07142857142857142,\n",
              " 'data': 0.07142857142857142,\n",
              " 'available': 0.03571428571428571,\n",
              " 'contains': 0.14285714285714285,\n",
              " 'following': 0.07142857142857142,\n",
              " 'domains': 0.32142857142857145,\n",
              " 'nuclear': 0.07142857142857142,\n",
              " 'localization': 0.07142857142857142,\n",
              " 'signals': 0.03571428571428571,\n",
              " 'export': 0.03571428571428571,\n",
              " 'motifs': 0.03571428571428571,\n",
              " 'consists': 0.07142857142857142,\n",
              " 'major': 0.14285714285714285,\n",
              " 'znf': 0.03571428571428571,\n",
              " 'hc': 0.03571428571428571,\n",
              " 'ring': 0.32142857142857145,\n",
              " 'serine': 0.14285714285714285,\n",
              " 'two': 0.32142857142857145,\n",
              " 'brct': 0.4642857142857143,\n",
              " 'approximately': 0.10714285714285714,\n",
              " 'six': 0.03571428571428571,\n",
              " 'isoforms': 0.07142857142857142,\n",
              " 'comprising': 0.03571428571428571,\n",
              " 'amino': 0.17857142857142858,\n",
              " 'acids': 0.10714285714285714,\n",
              " 'citation': 0.17857142857142858,\n",
              " 'needed': 0.17857142857142858,\n",
              " 'e': 0.14285714285714285,\n",
              " 'homologs': 0.03571428571428571,\n",
              " 'paralogs': 0.03571428571428571,\n",
              " 'motif': 0.14285714285714285,\n",
              " 'zn': 0.03571428571428571,\n",
              " 'finger': 0.07142857142857142,\n",
              " 'found': 0.32142857142857145,\n",
              " 'eukaryotic': 0.07142857142857142,\n",
              " 'peptides': 0.03571428571428571,\n",
              " 'eight': 0.03571428571428571,\n",
              " 'conserved': 0.03571428571428571,\n",
              " 'metal': 0.03571428571428571,\n",
              " 'binding': 0.10714285714285714,\n",
              " 'residues': 0.21428571428571427,\n",
              " 'quartets': 0.03571428571428571,\n",
              " 'cysteine': 0.03571428571428571,\n",
              " 'histidine': 0.03571428571428571,\n",
              " 'coordinate': 0.03571428571428571,\n",
              " 'zinc': 0.10714285714285714,\n",
              " 'atoms': 0.03571428571428571,\n",
              " 'short': 0.07142857142857142,\n",
              " 'anti': 0.03571428571428571,\n",
              " 'parallel': 0.10714285714285714,\n",
              " 'beta': 0.03571428571428571,\n",
              " 'sheet': 0.03571428571428571,\n",
              " 'loops': 0.03571428571428571,\n",
              " 'central': 0.03571428571428571,\n",
              " 'alpha': 0.10714285714285714,\n",
              " 'helix': 0.07142857142857142,\n",
              " 'small': 0.14285714285714285,\n",
              " 'including': 0.07142857142857142,\n",
              " 'bard': 0.25,\n",
              " 'heterodimer': 0.10714285714285714,\n",
              " 'flanked': 0.07142857142857142,\n",
              " 'helices': 0.10714285714285714,\n",
              " 'formed': 0.10714285714285714,\n",
              " 'homologous': 0.32142857142857145,\n",
              " 'consisting': 0.03571428571428571,\n",
              " 'combine': 0.03571428571428571,\n",
              " 'heterodimerization': 0.03571428571428571,\n",
              " 'interface': 0.14285714285714285,\n",
              " 'stabilize': 0.03571428571428571,\n",
              " 'additional': 0.07142857142857142,\n",
              " 'stabilization': 0.03571428571428571,\n",
              " 'achieved': 0.03571428571428571,\n",
              " 'interactions': 0.07142857142857142,\n",
              " 'adjacent': 0.03571428571428571,\n",
              " 'flanking': 0.03571428571428571,\n",
              " 'hydrophobic': 0.07142857142857142,\n",
              " 'interaction': 0.03571428571428571,\n",
              " 'disrupted': 0.03571428571428571,\n",
              " 'tumorigenic': 0.10714285714285714,\n",
              " 'acid': 0.10714285714285714,\n",
              " 'substitutions': 0.03571428571428571,\n",
              " 'implying': 0.07142857142857142,\n",
              " 'formation': 0.07142857142857142,\n",
              " 'stable': 0.03571428571428571,\n",
              " 'essential': 0.10714285714285714,\n",
              " 'aspect': 0.03571428571428571,\n",
              " 'suppression': 0.03571428571428571,\n",
              " 'element': 0.03571428571428571,\n",
              " 'ubiquitin': 0.10714285714285714,\n",
              " 'ligases': 0.03571428571428571,\n",
              " 'catalyze': 0.03571428571428571,\n",
              " 'regulatory': 0.03571428571428571,\n",
              " 'tissues': 0.07142857142857142,\n",
              " 'direct': 0.03571428571428571,\n",
              " 'compartments': 0.03571428571428571,\n",
              " 'within': 0.07142857142857142,\n",
              " 'cell': 0.17857142857142858,\n",
              " 'polypeptides': 0.03571428571428571,\n",
              " 'particular': 0.14285714285714285,\n",
              " 'lys': 0.03571428571428571,\n",
              " 'linked': 0.07142857142857142,\n",
              " 'polyubiquitin': 0.03571428571428571,\n",
              " 'chains': 0.03571428571428571,\n",
              " 'dispersed': 0.03571428571428571,\n",
              " 'throughout': 0.03571428571428571,\n",
              " 'resting': 0.03571428571428571,\n",
              " 'nucleus': 0.07142857142857142,\n",
              " 'start': 0.03571428571428571,\n",
              " 'replication': 0.07142857142857142,\n",
              " 'gather': 0.03571428571428571,\n",
              " 'restrained': 0.03571428571428571,\n",
              " 'groups': 0.03571428571428571,\n",
              " 'contain': 0.07142857142857142,\n",
              " 'thought': 0.03571428571428571,\n",
              " 'recognition': 0.10714285714285714,\n",
              " 'targets': 0.10714285714285714,\n",
              " 'attaches': 0.03571428571428571,\n",
              " 'labels': 0.03571428571428571,\n",
              " 'destruction': 0.03571428571428571,\n",
              " 'occurs': 0.07142857142857142,\n",
              " 'via': 0.03571428571428571,\n",
              " 'fusion': 0.07142857142857142,\n",
              " 'abolished': 0.03571428571428571,\n",
              " 'chelation': 0.03571428571428571,\n",
              " 'activity': 0.14285714285714285,\n",
              " 'dependent': 0.07142857142857142,\n",
              " 'proper': 0.03571428571428571,\n",
              " 'folding': 0.03571428571428571,\n",
              " 'cluster': 0.03571428571428571,\n",
              " 'scd': 0.07142857142857142,\n",
              " 'spans': 0.03571428571428571,\n",
              " 'portion': 0.03571428571428571,\n",
              " 'exons': 0.10714285714285714,\n",
              " 'rates': 0.03571428571428571,\n",
              " 'occur': 0.25,\n",
              " 'reported': 0.17857142857142858,\n",
              " 'phosphorylation': 0.03571428571428571,\n",
              " 'sites': 0.10714285714285714,\n",
              " 'concentrated': 0.03571428571428571,\n",
              " 'phosphorylated': 0.14285714285714285,\n",
              " 'atm': 0.10714285714285714,\n",
              " 'atr': 0.07142857142857142,\n",
              " 'kinases': 0.07142857142857142,\n",
              " 'vitro': 0.03571428571428571,\n",
              " 'vivo': 0.03571428571428571,\n",
              " 'activated': 0.03571428571428571,\n",
              " 'affect': 0.07142857142857142,\n",
              " 'response': 0.10714285714285714,\n",
              " 'dual': 0.07142857142857142,\n",
              " 'repeat': 0.10714285714285714,\n",
              " 'elongated': 0.03571428571428571,\n",
              " 'structure': 0.39285714285714285,\n",
              " 'å': 0.10714285714285714,\n",
              " 'wide': 0.07142857142857142,\n",
              " 'single': 0.14285714285714285,\n",
              " 'modules': 0.03571428571428571,\n",
              " 'multiple': 0.07142857142857142,\n",
              " 'tandem': 0.07142857142857142,\n",
              " 'repeats': 0.10714285714285714,\n",
              " 'containing': 0.21428571428571427,\n",
              " 'possibilities': 0.03571428571428571,\n",
              " 'variety': 0.03571428571428571,\n",
              " 'different': 0.07142857142857142,\n",
              " 'conformations': 0.03571428571428571,\n",
              " 'arranged': 0.03571428571428571,\n",
              " 'head': 0.03571428571428571,\n",
              " 'tail': 0.03571428571428571,\n",
              " 'fashion': 0.03571428571428571,\n",
              " 'three': 0.10714285714285714,\n",
              " 'dimensional': 0.03571428571428571,\n",
              " 'burying': 0.03571428571428571,\n",
              " 'solvent': 0.03571428571428571,\n",
              " 'accessible': 0.03571428571428571,\n",
              " 'surface': 0.03571428571428571,\n",
              " 'area': 0.03571428571428571,\n",
              " 'contribute': 0.14285714285714285,\n",
              " 'tightly': 0.03571428571428571,\n",
              " 'packed': 0.03571428571428571,\n",
              " 'knob': 0.03571428571428571,\n",
              " 'hole': 0.03571428571428571,\n",
              " 'comprises': 0.03571428571428571,\n",
              " 'interact': 0.07142857142857142,\n",
              " 'control': 0.03571428571428571,\n",
              " 'cellular': 0.07142857142857142,\n",
              " 'responses': 0.07142857142857142,\n",
              " 'missense': 0.10714285714285714,\n",
              " 'perturb': 0.03571428571428571,\n",
              " 'cycle': 0.03571428571428571,\n",
              " 'resulting': 0.07142857142857142,\n",
              " 'greater': 0.03571428571428571,\n",
              " 'part': 0.10714285714285714,\n",
              " 'repairs': 0.10714285714285714,\n",
              " 'strands': 0.10714285714285714,\n",
              " 'continuously': 0.03571428571428571,\n",
              " 'breaking': 0.03571428571428571,\n",
              " 'become': 0.07142857142857142,\n",
              " 'sometimes': 0.07142857142857142,\n",
              " 'one': 0.17857142857142858,\n",
              " 'broken': 0.10714285714285714,\n",
              " 'simultaneously': 0.03571428571428571,\n",
              " 'cross': 0.14285714285714285,\n",
              " 'linking': 0.07142857142857142,\n",
              " 'agents': 0.10714285714285714,\n",
              " 'source': 0.07142857142857142,\n",
              " 'intermediates': 0.03571428571428571,\n",
              " 'crosslinks': 0.03571428571428571,\n",
              " 'removed': 0.03571428571428571,\n",
              " 'indeed': 0.03571428571428571,\n",
              " 'biallelic': 0.10714285714285714,\n",
              " 'fanconi': 0.03571428571428571,\n",
              " 'anemia': 0.03571428571428571,\n",
              " 'complementation': 0.03571428571428571,\n",
              " 'group': 0.07142857142857142,\n",
              " 'fa': 0.14285714285714285,\n",
              " 'genetic': 0.14285714285714285,\n",
              " 'disease': 0.10714285714285714,\n",
              " 'hypersensitivity': 0.03571428571428571,\n",
              " 'crosslinking': 0.03571428571428571,\n",
              " 'happens': 0.03571428571428571,\n",
              " 'difficult': 0.03571428571428571,\n",
              " 'mechanism': 0.10714285714285714,\n",
              " 'know': 0.03571428571428571,\n",
              " 'replace': 0.03571428571428571,\n",
              " 'correct': 0.03571428571428571,\n",
              " 'sequence': 0.07142857142857142,\n",
              " 'ways': 0.03571428571428571,\n",
              " 'attempt': 0.03571428571428571,\n",
              " 'participates': 0.03571428571428571,\n",
              " 'homology': 0.03571428571428571,\n",
              " 'directed': 0.03571428571428571,\n",
              " 'copy': 0.03571428571428571,\n",
              " 'identical': 0.07142857142857142,\n",
              " 'intact': 0.03571428571428571,\n",
              " 'sister': 0.03571428571428571,\n",
              " 'chromatid': 0.03571428571428571,\n",
              " 'almost': 0.14285714285714285,\n",
              " 'always': 0.07142857142857142,\n",
              " 'lethal': 0.07142857142857142,\n",
              " 'condition': 0.07142857142857142,\n",
              " 'utero': 0.03571428571428571,\n",
              " 'handful': 0.03571428571428571,\n",
              " 'cases': 0.17857142857142858,\n",
              " 'literature': 0.07142857142857142,\n",
              " 'despite': 0.03571428571428571,\n",
              " 'carrier': 0.03571428571428571,\n",
              " 'frequencies': 0.03571428571428571,\n",
              " 'ashkenazim': 0.03571428571428571,\n",
              " 'none': 0.03571428571428571,\n",
              " 'since': 0.10714285714285714,\n",
              " 'many': 0.14285714285714285,\n",
              " 'types': 0.10714285714285714,\n",
              " 'rad': 0.10714285714285714,\n",
              " 'caused': 0.07142857142857142,\n",
              " 'natural': 0.03571428571428571,\n",
              " 'radiation': 0.10714285714285714,\n",
              " 'exposures': 0.03571428571428571,\n",
              " 'chromosomes': 0.03571428571428571,\n",
              " 'exchange': 0.03571428571428571,\n",
              " 'material': 0.03571428571428571,\n",
              " 'recombination': 0.10714285714285714,\n",
              " 'crossing': 0.03571428571428571,\n",
              " 'meiosis': 0.17857142857142858,\n",
              " 'similar': 0.03571428571428571,\n",
              " 'influencing': 0.03571428571428571,\n",
              " 'play': 0.07142857142857142,\n",
              " 'maintaining': 0.03571428571428571,\n",
              " 'stability': 0.07142857142857142,\n",
              " 'another': 0.07142857142857142,\n",
              " 'termed': 0.03571428571428571,\n",
              " 'mismatch': 0.07142857142857142,\n",
              " 'msh': 0.10714285714285714,\n",
              " 'parp': 0.03571428571428571,\n",
              " 'elevated': 0.07142857142857142,\n",
              " 'deficient': 0.10714285714285714,\n",
              " 'mammary': 0.03571428571428571,\n",
              " 'tumors': 0.17857142857142858,\n",
              " 'called': 0.07142857142857142,\n",
              " 'valosin': 0.03571428571428571,\n",
              " 'vcp': 0.10714285714285714,\n",
              " 'recruit': 0.03571428571428571,\n",
              " 'ionizing': 0.07142857142857142,\n",
              " 'recruited': 0.03571428571428571,\n",
              " 'lesions': 0.07142857142857142,\n",
              " 'cooperates': 0.03571428571428571,\n",
              " 'ligase': 0.03571428571428571,\n",
              " 'rnf': 0.03571428571428571,\n",
              " 'orchestrate': 0.03571428571428571,\n",
              " 'assembly': 0.03571428571428571,\n",
              " 'signaling': 0.03571428571428571,\n",
              " 'efficient': 0.03571428571428571,\n",
              " 'dsb': 0.03571428571428571,\n",
              " 'myc': 0.03571428571428571,\n",
              " 'critical': 0.03571428571428571,\n",
              " 'maintain': 0.03571428571428571,\n",
              " 'directly': 0.07142857142857142,\n",
              " 'binds': 0.03571428571428571,\n",
              " 'higher': 0.07142857142857142,\n",
              " 'affinity': 0.03571428571428571,\n",
              " 'branched': 0.03571428571428571,\n",
              " 'structures': 0.03571428571428571,\n",
              " 'ability': 0.07142857142857142,\n",
              " 'bind': 0.03571428571428571,\n",
              " 'contributes': 0.07142857142857142,\n",
              " 'inhibit': 0.03571428571428571,\n",
              " 'nuclease': 0.07142857142857142,\n",
              " 'mrn': 0.03571428571428571,\n",
              " 'mre': 0.07142857142857142,\n",
              " 'alone': 0.03571428571428571,\n",
              " 'explain': 0.07142857142857142,\n",
              " 'promote': 0.03571428571428571,\n",
              " 'lower': 0.03571428571428571,\n",
              " 'fidelity': 0.03571428571428571,\n",
              " 'non': 0.07142857142857142,\n",
              " 'end': 0.03571428571428571,\n",
              " 'joining': 0.03571428571428571,\n",
              " 'nhej': 0.03571428571428571,\n",
              " 'colocalizes': 0.03571428571428571,\n",
              " 'γ': 0.03571428571428571,\n",
              " 'ax': 0.07142857142857142,\n",
              " 'break': 0.07142857142857142,\n",
              " 'foci': 0.03571428571428571,\n",
              " 'indicating': 0.07142857142857142,\n",
              " 'recruiting': 0.03571428571428571,\n",
              " 'factors': 0.03571428571428571,\n",
              " 'formaldehyde': 0.03571428571428571,\n",
              " 'acetaldehyde': 0.03571428571428571,\n",
              " 'sources': 0.03571428571428571,\n",
              " 'links': 0.07142857142857142,\n",
              " 'often': 0.07142857142857142,\n",
              " 'require': 0.03571428571428571,\n",
              " 'mediated': 0.03571428571428571,\n",
              " 'pathways': 0.03571428571428571,\n",
              " 'mice': 0.10714285714285714,\n",
              " 'alleles': 0.07142857142857142,\n",
              " 'viable': 0.03571428571428571,\n",
              " 'adults': 0.03571428571428571,\n",
              " 'leading': 0.17857142857142858,\n",
              " 'congenital': 0.03571428571428571,\n",
              " 'developmental': 0.03571428571428571,\n",
              " 'issues': 0.03571428571428571,\n",
              " 'presumed': 0.03571428571428571,\n",
              " 'survived': 0.03571428571428571,\n",
              " 'adulthood': 0.03571428571428571,\n",
              " 'hypomorphic': 0.03571428571428571,\n",
              " 'shown': 0.14285714285714285,\n",
              " 'co': 0.03571428571428571,\n",
              " 'purify': 0.03571428571428571,\n",
              " 'holoenzyme': 0.07142857142857142,\n",
              " 'hela': 0.07142857142857142,\n",
              " 'extracts': 0.03571428571428571,\n",
              " 'component': 0.03571428571428571,\n",
              " 'research': 0.07142857142857142,\n",
              " 'however': 0.07142857142857142,\n",
              " 'contradicted': 0.03571428571428571,\n",
              " 'assumption': 0.03571428571428571,\n",
              " 'instead': 0.03571428571428571,\n",
              " 'showing': 0.03571428571428571,\n",
              " 'megadalton': 0.03571428571428571,\n",
              " 'swi': 0.10714285714285714,\n",
              " 'snf': 0.10714285714285714,\n",
              " 'chromatin': 0.07142857142857142,\n",
              " 'remodeling': 0.03571428571428571,\n",
              " 'artificial': 0.03571428571428571,\n",
              " 'tethering': 0.03571428571428571,\n",
              " 'decondense': 0.03571428571428571,\n",
              " 'heterochromatin': 0.03571428571428571,\n",
              " 'though': 0.03571428571428571,\n",
              " 'interacting': 0.07142857142857142,\n",
              " 'necessary': 0.10714285714285714,\n",
              " 'nelf': 0.07142857142857142,\n",
              " 'b': 0.10714285714285714,\n",
              " 'cobra': 0.03571428571428571,\n",
              " 'certain': 0.14285714285714285,\n",
              " 'variations': 0.10714285714285714,\n",
              " 'lead': 0.10714285714285714,\n",
              " 'hereditary': 0.07142857142857142,\n",
              " 'ovarian': 0.8571428571428571,\n",
              " 'syndrome': 0.03571428571428571,\n",
              " 'researchers': 0.07142857142857142,\n",
              " 'hundreds': 0.03571428571428571,\n",
              " 'females': 0.10714285714285714,\n",
              " 'abnormal': 0.07142857142857142,\n",
              " 'age': 0.2857142857142857,\n",
              " 'changes': 0.03571428571428571,\n",
              " 'number': 0.10714285714285714,\n",
              " 'pairs': 0.03571428571428571,\n",
              " 'building': 0.03571428571428571,\n",
              " 'blocks': 0.03571428571428571,\n",
              " 'pcr': 0.10714285714285714,\n",
              " 'sequencing': 0.07142857142857142,\n",
              " 'segments': 0.07142857142857142,\n",
              " 'rearranged': 0.03571428571428571,\n",
              " 'rearrangements': 0.07142857142857142,\n",
              " 'deletion': 0.03571428571428571,\n",
              " 'duplication': 0.03571428571428571,\n",
              " 'several': 0.07142857142857142,\n",
              " 'classical': 0.03571428571428571,\n",
              " 'detection': 0.03571428571428571,\n",
              " 'unable': 0.07142857142857142,\n",
              " 'reveal': 0.03571428571428571,\n",
              " 'proposed': 0.07142857142857142,\n",
              " 'traditional': 0.03571428571428571,\n",
              " 'quantitative': 0.07142857142857142,\n",
              " 'multiplex': 0.07142857142857142,\n",
              " 'ligation': 0.03571428571428571,\n",
              " 'probe': 0.03571428571428571,\n",
              " 'amplification': 0.03571428571428571,\n",
              " 'mlpa': 0.03571428571428571,\n",
              " 'fluorescent': 0.03571428571428571,\n",
              " 'fragments': 0.03571428571428571,\n",
              " 'qmpsf': 0.03571428571428571,\n",
              " 'newer': 0.03571428571428571,\n",
              " 'recently': 0.03571428571428571,\n",
              " 'heteroduplex': 0.03571428571428571,\n",
              " 'analysis': 0.07142857142857142,\n",
              " 'hda': 0.03571428571428571,\n",
              " 'capillary': 0.03571428571428571,\n",
              " 'electrophoresis': 0.03571428571428571,\n",
              " 'dedicated': 0.03571428571428571,\n",
              " 'oligonucleotides': 0.03571428571428571,\n",
              " 'array': 0.07142857142857142,\n",
              " 'based': 0.10714285714285714,\n",
              " 'comparative': 0.03571428571428571,\n",
              " 'genomic': 0.07142857142857142,\n",
              " 'hybridization': 0.03571428571428571,\n",
              " 'cgh': 0.03571428571428571,\n",
              " 'results': 0.07142857142857142,\n",
              " 'suggest': 0.07142857142857142,\n",
              " 'hypermethylation': 0.10714285714285714,\n",
              " 'promoter': 0.14285714285714285,\n",
              " 'cancers': 0.7142857142857143,\n",
              " 'could': 0.14285714285714285,\n",
              " 'considered': 0.03571428571428571,\n",
              " 'inactivating': 0.07142857142857142,\n",
              " 'expression': 1.0,\n",
              " 'mutated': 0.058823529411764705,\n",
              " 'usually': 0.058823529411764705,\n",
              " 'makes': 0.058823529411764705,\n",
              " 'believe': 0.058823529411764705,\n",
              " 'defective': 0.11764705882352941,\n",
              " 'fix': 0.058823529411764705,\n",
              " 'accumulate': 0.17647058823529413,\n",
              " 'allow': 0.058823529411764705,\n",
              " 'grow': 0.058823529411764705,\n",
              " 'divide': 0.058823529411764705,\n",
              " 'uncontrollably': 0.058823529411764705,\n",
              " 'predisposition': 0.058823529411764705,\n",
              " 'mrna': 0.058823529411764705,\n",
              " 'utr': 0.058823529411764705,\n",
              " 'bound': 0.17647058823529413,\n",
              " 'mirna': 0.11764705882352941,\n",
              " 'mir': 1.0,\n",
              " 'microrna': 0.6666666666666666,\n",
              " 'suggested': 0.1111111111111111,\n",
              " 'along': 0.1111111111111111,\n",
              " 'confer': 0.1111111111111111,\n",
              " 'addition': 0.3333333333333333,\n",
              " 'increase': 0.6666666666666666,\n",
              " 'prostate': 0.1111111111111111,\n",
              " 'moreover': 0.1111111111111111,\n",
              " 'precancerous': 0.1111111111111111,\n",
              " 'dysplasia': 0.1111111111111111,\n",
              " 'fallopian': 0.1111111111111111,\n",
              " 'tube': 0.1111111111111111,\n",
              " 'pathogenic': 0.1111111111111111,\n",
              " 'anywhere': 0.1111111111111111,\n",
              " 'pathway': 0.3333333333333333,\n",
              " 'greatly': 0.2222222222222222,\n",
              " 'risks': 0.1111111111111111,\n",
              " 'subset': 0.1111111111111111,\n",
              " 'leukemias': 0.1111111111111111,\n",
              " 'lymphomas': 0.1111111111111111,\n",
              " 'women': 0.7777777777777778,\n",
              " 'inherited': 0.5555555555555556,\n",
              " 'develop': 0.1111111111111111,\n",
              " 'specific': 0.5555555555555556,\n",
              " 'carriers': 0.1111111111111111,\n",
              " 'choose': 0.1111111111111111,\n",
              " 'prophylactic': 0.2222222222222222,\n",
              " 'surgery': 0.2222222222222222,\n",
              " 'much': 0.3333333333333333,\n",
              " 'conjecture': 0.1111111111111111,\n",
              " 'apparently': 0.1111111111111111,\n",
              " 'striking': 0.1111111111111111,\n",
              " 'specificity': 0.2222222222222222,\n",
              " 'determinants': 0.1111111111111111,\n",
              " 'pathogen': 0.2222222222222222,\n",
              " 'agent': 0.1111111111111111,\n",
              " 'causes': 0.3333333333333333,\n",
              " 'chronic': 0.1111111111111111,\n",
              " 'inflammation': 0.1111111111111111,\n",
              " 'carcinogen': 0.2222222222222222,\n",
              " 'target': 0.2222222222222222,\n",
              " 'receptors': 0.1111111111111111,\n",
              " 'selectively': 0.1111111111111111,\n",
              " 'exposed': 0.1111111111111111,\n",
              " 'inflammatory': 0.1111111111111111,\n",
              " 'process': 0.3333333333333333,\n",
              " 'innate': 0.1111111111111111,\n",
              " 'deficit': 0.1111111111111111,\n",
              " 'impairs': 0.1111111111111111,\n",
              " 'exacerbates': 0.1111111111111111,\n",
              " 'organ': 0.1111111111111111,\n",
              " 'theory': 0.2222222222222222,\n",
              " 'fits': 0.1111111111111111,\n",
              " 'beyond': 0.1111111111111111,\n",
              " 'advantage': 0.1111111111111111,\n",
              " 'suggests': 0.1111111111111111,\n",
              " 'options': 0.1111111111111111,\n",
              " 'aforementioned': 0.1111111111111111,\n",
              " 'homozygous': 0.1111111111111111,\n",
              " 'inheritance': 0.1111111111111111,\n",
              " 'leads': 0.4444444444444444,\n",
              " 'embryonically': 0.1111111111111111,\n",
              " 'reduced': 0.7777777777777778,\n",
              " 'undetectable': 0.1111111111111111,\n",
              " 'majority': 0.4444444444444444,\n",
              " 'grade': 0.4444444444444444,\n",
              " 'ductal': 0.2222222222222222,\n",
              " 'noted': 0.3333333333333333,\n",
              " 'either': 0.1111111111111111,\n",
              " 'germ': 0.5555555555555556,\n",
              " 'line': 0.4444444444444444,\n",
              " 'decreased': 0.2222222222222222,\n",
              " 'sporadic': 0.3333333333333333,\n",
              " 'progression': 0.3333333333333333,\n",
              " 'damages': 0.5555555555555556,\n",
              " 'especially': 0.4444444444444444,\n",
              " 'potentially': 0.2222222222222222,\n",
              " 'lack': 0.1111111111111111,\n",
              " 'tend': 0.1111111111111111,\n",
              " 'alternative': 0.1111111111111111,\n",
              " 'prone': 0.2222222222222222,\n",
              " 'mechanisms': 0.1111111111111111,\n",
              " 'reduction': 0.3333333333333333,\n",
              " 'silencing': 0.1111111111111111,\n",
              " 'generates': 0.1111111111111111,\n",
              " 'gross': 0.1111111111111111,\n",
              " 'similarly': 0.3333333333333333,\n",
              " 'low': 1.0,\n",
              " 'epithelial': 0.1111111111111111,\n",
              " 'eocs': 0.3333333333333333,\n",
              " 'representing': 0.1111111111111111,\n",
              " 'serous': 0.5555555555555556,\n",
              " 'carcinomas': 0.2222222222222222,\n",
              " 'sub': 0.1111111111111111,\n",
              " 'category': 0.1111111111111111,\n",
              " 'constituting': 0.1111111111111111,\n",
              " 'bowtell': 0.1111111111111111,\n",
              " 'reviewed': 0.1111111111111111,\n",
              " 'deficiency': 0.5555555555555556,\n",
              " 'initiates': 0.1111111111111111,\n",
              " 'cascade': 0.1111111111111111,\n",
              " 'events': 0.1111111111111111,\n",
              " 'sculpt': 0.1111111111111111,\n",
              " 'evolution': 0.1111111111111111,\n",
              " 'dictate': 0.1111111111111111,\n",
              " 'therapy': 0.1111111111111111,\n",
              " 'tumorigenesis': 0.1111111111111111,\n",
              " 'whether': 0.1111111111111111,\n",
              " 'due': 0.5555555555555556,\n",
              " 'event': 0.1111111111111111,\n",
              " 'carry': 0.2222222222222222,\n",
              " 'seen': 0.2222222222222222,\n",
              " 'germline': 0.1111111111111111,\n",
              " 'somatic': 0.1111111111111111,\n",
              " 'latent': 0.1111111111111111,\n",
              " 'viruses': 0.1111111111111111,\n",
              " 'frequently': 0.1111111111111111,\n",
              " 'detected': 0.1111111111111111,\n",
              " 'decrease': 0.1111111111111111,\n",
              " 'development': 0.2222222222222222,\n",
              " 'present': 0.3333333333333333,\n",
              " 'unselected': 0.1111111111111111,\n",
              " 'primary': 0.3333333333333333,\n",
              " 'eoc': 0.1111111111111111,\n",
              " 'methylation': 0.1111111111111111,\n",
              " 'minor': 0.1111111111111111,\n",
              " 'micrornas': 0.3333333333333333,\n",
              " 'overexpressed': 0.2222222222222222,\n",
              " 'reduce': 0.2222222222222222,\n",
              " 'see': 0.2222222222222222,\n",
              " 'section': 0.1111111111111111,\n",
              " 'case': 0.2222222222222222,\n",
              " 'specifically': 0.1111111111111111,\n",
              " 'classified': 0.1111111111111111,\n",
              " 'receptor': 0.1111111111111111,\n",
              " 'status': 0.2222222222222222,\n",
              " 'histology': 0.1111111111111111,\n",
              " 'triple': 0.3333333333333333,\n",
              " 'negative': 0.3333333333333333,\n",
              " 'er': 0.1111111111111111,\n",
              " 'pr': 0.1111111111111111,\n",
              " 'invasive': 0.2222222222222222,\n",
              " 'lobular': 0.1111111111111111,\n",
              " 'carcinoma': 0.3333333333333333,\n",
              " 'average': 0.1111111111111111,\n",
              " 'fold': 0.1111111111111111,\n",
              " 'compared': 0.4444444444444444,\n",
              " 'lines': 0.1111111111111111,\n",
              " 'inverse': 0.2222222222222222,\n",
              " 'correlation': 0.3333333333333333,\n",
              " 'levels': 0.1111111111111111,\n",
              " 'appears': 0.4444444444444444,\n",
              " 'absence': 0.1111111111111111,\n",
              " 'repress': 0.1111111111111111,\n",
              " 'inactivation': 0.1111111111111111,\n",
              " 'tubal': 0.1111111111111111,\n",
              " 'intraepithelial': 0.1111111111111111,\n",
              " 'precursor': 0.1111111111111111,\n",
              " 'lesion': 0.1111111111111111,\n",
              " 'soc': 0.3333333333333333,\n",
              " 'remained': 0.1111111111111111,\n",
              " 'even': 0.1111111111111111,\n",
              " 'exposure': 0.1111111111111111,\n",
              " 'raises': 0.1111111111111111,\n",
              " 'absent': 0.1111111111111111,\n",
              " 'among': 0.3333333333333333,\n",
              " 'patients': 0.4444444444444444,\n",
              " 'stage': 0.3333333333333333,\n",
              " 'iiic': 0.1111111111111111,\n",
              " 'iv': 0.1111111111111111,\n",
              " 'sog': 0.1111111111111111,\n",
              " 'expressions': 0.1111111111111111,\n",
              " 'underlying': 0.1111111111111111,\n",
              " 'deficiencies': 0.1111111111111111,\n",
              " 'underlie': 0.1111111111111111,\n",
              " 'forms': 0.1111111111111111,\n",
              " 'tends': 0.1111111111111111,\n",
              " 'excess': 0.2222222222222222,\n",
              " 'mutational': 0.1111111111111111,\n",
              " 'errors': 0.3333333333333333,\n",
              " 'translesion': 0.1111111111111111,\n",
              " 'synthesis': 0.1111111111111111,\n",
              " 'epigenetic': 0.2222222222222222,\n",
              " 'alterations': 0.2222222222222222,\n",
              " 'give': 0.1111111111111111,\n",
              " 'rise': 0.1111111111111111,\n",
              " 'frequent': 0.1111111111111111,\n",
              " 'induced': 0.1111111111111111,\n",
              " 'likely': 0.2222222222222222,\n",
              " 'date': 0.1111111111111111,\n",
              " 'suggesting': 0.1111111111111111,\n",
              " 'possibility': 0.1111111111111111,\n",
              " 'founder': 0.4444444444444444,\n",
              " 'effect': 0.3333333333333333,\n",
              " 'defined': 0.1111111111111111,\n",
              " 'population': 0.1111111111111111,\n",
              " 'traced': 0.1111111111111111,\n",
              " 'back': 0.1111111111111111,\n",
              " 'ancestor': 0.1111111111111111,\n",
              " 'given': 0.2222222222222222,\n",
              " 'complexity': 0.1111111111111111,\n",
              " 'screening': 0.2222222222222222,\n",
              " 'simplify': 0.1111111111111111,\n",
              " 'required': 0.1111111111111111,\n",
              " 'populations': 0.1111111111111111,\n",
              " 'frequency': 0.1111111111111111,\n",
              " 'permits': 0.1111111111111111,\n",
              " 'study': 0.1111111111111111,\n",
              " 'clinical': 0.3333333333333333,\n",
              " 'examples': 0.2222222222222222,\n",
              " 'manifestations': 0.1111111111111111,\n",
              " 'ashkenazi': 0.2222222222222222,\n",
              " 'jews': 0.1111111111111111,\n",
              " 'account': 0.1111111111111111,\n",
              " 'jewish': 0.2222222222222222,\n",
              " 'delag': 0.2222222222222222,\n",
              " 'del': 0.1111111111111111,\n",
              " 'insc': 0.2222222222222222,\n",
              " 'fact': 0.1111111111111111,\n",
              " 'woman': 0.1111111111111111,\n",
              " 'highly': 0.1111111111111111,\n",
              " 'unlikely': 0.1111111111111111,\n",
              " 'table': 0.1111111111111111,\n",
              " 'mainly': 0.1111111111111111,\n",
              " 'derived': 0.1111111111111111,\n",
              " 'reproductive': 0.2222222222222222,\n",
              " 'performance': 0.1111111111111111,\n",
              " 'declines': 0.1111111111111111,\n",
              " 'menopause': 0.2222222222222222,\n",
              " 'decline': 0.5555555555555556,\n",
              " 'tied': 0.1111111111111111,\n",
              " 'follicles': 0.3333333333333333,\n",
              " 'although': 0.2222222222222222,\n",
              " 'million': 0.1111111111111111,\n",
              " 'oocytes': 0.4444444444444444,\n",
              " 'birth': 0.1111111111111111,\n",
              " 'ovary': 0.1111111111111111,\n",
              " 'ovulate': 0.1111111111111111,\n",
              " 'reserve': 0.5555555555555556,\n",
              " 'constantly': 0.1111111111111111,\n",
              " 'increasing': 0.1111111111111111,\n",
              " 'rate': 0.1111111111111111,\n",
              " 'nearly': 0.1111111111111111,\n",
              " 'exhaustion': 0.1111111111111111,\n",
              " 'fertility': 0.2222222222222222,\n",
              " 'pregnancy': 0.1111111111111111,\n",
              " 'failure': 0.2222222222222222,\n",
              " 'meiotic': 0.1111111111111111,\n",
              " 'chromosomally': 0.1111111111111111,\n",
              " 'conceptions': 0.1111111111111111,\n",
              " 'appear': 0.1111111111111111,\n",
              " 'diminished': 0.1111111111111111,\n",
              " 'oocyte': 0.2222222222222222,\n",
              " 'aging': 0.2222222222222222,\n",
              " 'furthermore': 0.1111111111111111,\n",
              " 'undergo': 0.1111111111111111,\n",
              " 'prematurely': 0.1111111111111111,\n",
              " 'key': 0.4444444444444444,\n",
              " 'findings': 0.1111111111111111,\n",
              " 'naturally': 0.2222222222222222,\n",
              " 'occurring': 0.2222222222222222,\n",
              " 'less': 0.1111111111111111,\n",
              " 'efficiently': 0.1111111111111111,\n",
              " 'defect': 0.1111111111111111,\n",
              " 'inefficiency': 0.1111111111111111,\n",
              " 'early': 0.1111111111111111,\n",
              " 'recombinational': 0.3333333333333333,\n",
              " 'accurately': 0.1111111111111111,\n",
              " 'primordial': 0.2222222222222222,\n",
              " 'intermediate': 0.1111111111111111,\n",
              " 'prophase': 0.1111111111111111,\n",
              " 'general': 0.2222222222222222,\n",
              " 'organisms': 0.1111111111111111,\n",
              " 'adaptation': 0.1111111111111111,\n",
              " 'removing': 0.1111111111111111,\n",
              " 'article': 0.3333333333333333,\n",
              " 'employing': 0.1111111111111111,\n",
              " 'promoted': 0.1111111111111111,\n",
              " 'hypothesis': 0.1111111111111111,\n",
              " 'maintenance': 0.1111111111111111,\n",
              " 'efficiency': 0.1111111111111111,\n",
              " 'lung': 0.2222222222222222,\n",
              " 'nsclc': 0.4444444444444444,\n",
              " 'deaths': 0.1111111111111111,\n",
              " 'worldwide': 0.1111111111111111,\n",
              " 'diagnosis': 0.1111111111111111,\n",
              " 'persons': 0.2222222222222222,\n",
              " 'locally': 0.1111111111111111,\n",
              " 'advanced': 0.1111111111111111,\n",
              " 'metastatic': 0.1111111111111111,\n",
              " 'treated': 0.2222222222222222,\n",
              " 'therapeutic': 0.1111111111111111,\n",
              " 'platinum': 0.4444444444444444,\n",
              " 'compounds': 0.1111111111111111,\n",
              " 'cisplatin': 0.1111111111111111,\n",
              " 'carboplatin': 0.1111111111111111,\n",
              " 'oxaliplatin': 0.1111111111111111,\n",
              " 'inter': 0.1111111111111111,\n",
              " 'individuals': 0.1111111111111111,\n",
              " 'correlated': 0.1111111111111111,\n",
              " 'improved': 0.1111111111111111,\n",
              " 'survival': 0.2222222222222222,\n",
              " 'chemotherapy': 0.2222222222222222,\n",
              " 'implies': 0.1111111111111111,\n",
              " 'consequent': 0.1111111111111111,\n",
              " 'level': 0.3333333333333333,\n",
              " 'vulnerability': 0.1111111111111111,\n",
              " 'treatment': 0.2222222222222222,\n",
              " 'protect': 0.1111111111111111,\n",
              " 'acting': 0.1111111111111111,\n",
              " 'removes': 0.1111111111111111,\n",
              " 'introduced': 0.1111111111111111,\n",
              " 'drugs': 0.2222222222222222,\n",
              " 'tool': 0.1111111111111111,\n",
              " 'tailoring': 0.1111111111111111,\n",
              " 'management': 0.1111111111111111,\n",
              " 'relevant': 0.1111111111111111,\n",
              " 'longer': 0.1111111111111111,\n",
              " 'median': 0.1111111111111111,\n",
              " 'times': 0.1111111111111111,\n",
              " 'months': 0.1111111111111111,\n",
              " 'patent': 1.0,\n",
              " 'application': 0.16666666666666666,\n",
              " 'isolated': 0.6666666666666666,\n",
              " 'promoting': 0.16666666666666666,\n",
              " 'discussed': 0.16666666666666666,\n",
              " 'diagnose': 0.16666666666666666,\n",
              " 'getting': 0.16666666666666666,\n",
              " 'filed': 0.3333333333333333,\n",
              " 'next': 0.16666666666666666,\n",
              " 'year': 0.16666666666666666,\n",
              " 'collaboration': 0.16666666666666666,\n",
              " 'investigators': 0.16666666666666666,\n",
              " 'endo': 0.16666666666666666,\n",
              " 'recherche': 0.16666666666666666,\n",
              " 'inc': 0.16666666666666666,\n",
              " 'hsc': 0.16666666666666666,\n",
              " 'limited': 0.16666666666666666,\n",
              " 'partnership': 0.16666666666666666,\n",
              " 'pennsylvania': 0.16666666666666666,\n",
              " 'sequenced': 0.16666666666666666,\n",
              " ...}"
            ]
          },
          "metadata": {},
          "execution_count": 129
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "sentences"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "W0utmvH4sqWo",
        "outputId": "849eb040-225b-4763-e267-5f5c94976d77"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['1JM7, 1JNX, 1N5O, 1OQA, 1T15, 1T29, 1T2U, 1T2V, 1Y98, 2ING, 3COJ, 3K0H, 3K0K, 3K15, 3PXA, 3PXB, 3PXC, 3PXD, 3PXE, 4IFI, 4IGK, 4JLU, 4OFB, 4U4A, 4Y18, 4Y2G67212189ENSG00000012048ENSMUSG00000017146P38398P48754NM_007299NM_007300NM_007301NM_007302NM_007303NM_007305NM_007306NM_009764NP_009225NP_009228NP_009229NP_009230NP_009231NP_033894Breast cancer type 1 susceptibility protein is a protein that in humans is encoded by the BRCA1 (/ˌbrækəˈwʌn/) gene.',\n",
              " 'Orthologs are common in other vertebrate species, whereas invertebrate genomes may encode a more distantly related gene.',\n",
              " 'BRCA1 is a human tumor suppressor gene (also known as a caretaker gene) and is responsible for repairing DNA.',\n",
              " 'BRCA1 and BRCA2 are unrelated proteins, but both are normally expressed in the cells of breast and other tissue, where they help repair damaged DNA, or destroy cells if DNA cannot be repaired.',\n",
              " 'They are involved in the repair of chromosomal damage with an important role in the error-free repair of DNA double-strand breaks.',\n",
              " 'If BRCA1 or BRCA2 itself is damaged by a BRCA mutation, damaged DNA is not repaired properly, and this increases the risk for breast cancer.',\n",
              " 'BRCA1 and BRCA2 have been described as \"breast cancer susceptibility genes\" and \"breast cancer susceptibility proteins\".',\n",
              " 'The predominant allele has a normal, tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer.',\n",
              " 'BRCA1 combines with other tumor suppressors, DNA damage sensors and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC).',\n",
              " 'The BRCA1 protein associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes.',\n",
              " 'Thus, this protein plays a role in transcription, and DNA repair of double-strand DNA breaks ubiquitination, transcriptional regulation as well as other functions.',\n",
              " 'Methods to test for the likelihood of a patient with mutations in BRCA1 and BRCA2 developing cancer were covered by patents owned or controlled by Myriad Genetics.',\n",
              " \"Myriad's business model of offering the diagnostic test exclusively led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012; it also led to controversy over high prices and the inability to obtain second opinions from other diagnostic labs, which in turn led to the landmark Association for Molecular Pathology v. Myriad Genetics lawsuit.\",\n",
              " \"The first evidence for the existence of a gene encoding a DNA repair enzyme involved in breast cancer susceptibility was provided by Mary-Claire King's laboratory at UC Berkeley in 1990.\",\n",
              " 'Four years later, after an international race to find it, the gene was cloned in 1994 by scientists at University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics.',\n",
              " 'The human BRCA1 gene is located on the long (q) arm of chromosome 17 at region 2 band 1, from base pair 41,196,312 to base pair 41,277,500 (Build GRCh37/hg19) (map).',\n",
              " 'BRCA1 orthologs have been identified in most vertebrates for which complete genome data are available.',\n",
              " 'The BRCA1 protein contains the following domains: This protein also contains nuclear localization signals and nuclear export signal motifs.',\n",
              " 'The human BRCA1 protein consists of four major protein domains; the Znf C3HC4- RING domain, the BRCA1 serine domain and two BRCT domains.',\n",
              " 'These domains encode approximately 27% of BRCA1 protein.',\n",
              " 'There are six known isoforms of BRCA1, with isoforms 1 and 2 comprising 1863 amino acids each.',\n",
              " '[citation needed] BRCA1 is unrelated to BRCA2, i.e.',\n",
              " 'they are not homologs or paralogs.',\n",
              " 'The RING motif, a Zn finger found in eukaryotic peptides, is 40–60 amino acids long and consists of eight conserved metal-binding residues, two quartets of cysteine or histidine residues that coordinate two zinc atoms.',\n",
              " 'This motif contains a short anti-parallel beta-sheet, two zinc-binding loops and a central alpha helix in a small domain.',\n",
              " 'This RING domain interacts with associated proteins, including BARD1, which also contains a RING motif, to form a heterodimer.',\n",
              " 'The BRCA1 RING motif is flanked by alpha helices formed by residues 8–22 and 81–96 of the BRCA1 protein.',\n",
              " 'It interacts with a homologous region in BARD1 also consisting of a RING finger flanked by two alpha-helices formed from residues 36–48 and 101–116.',\n",
              " 'These four helices combine to form a heterodimerization interface and stabilize the BRCA1-BARD1 heterodimer complex.',\n",
              " 'Additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions.',\n",
              " 'The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression.',\n",
              " 'The ring domain is an important element of ubiquitin E3 ligases, which catalyze protein ubiquitination.',\n",
              " 'Ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell.',\n",
              " 'BRCA1 polypeptides, in particular, Lys-48-linked polyubiquitin chains are dispersed throughout the resting cell nucleus, but at the start of DNA replication, they gather in restrained groups that also contain BRCA2 and BARD1.',\n",
              " 'BARD1 is thought to be involved in the recognition and binding of protein targets for ubiquitination.',\n",
              " 'It attaches to proteins and labels them for destruction.',\n",
              " 'Ubiquitination occurs via the BRCA1 fusion protein and is abolished by zinc chelation.',\n",
              " 'The enzyme activity of the fusion protein is dependent on the proper folding of the ring domain.',\n",
              " '[citation needed] BRCA1 serine cluster domain (SCD) spans amino acids 1280–1524.',\n",
              " 'A portion of the domain is located in exons 11–13.',\n",
              " 'High rates of mutation occur in exons 11–13.',\n",
              " 'Reported phosphorylation sites of BRCA1 are concentrated in the SCD, where they are phosphorylated by ATM/ATR kinases both in vitro and in vivo.',\n",
              " 'ATM/ATR are kinases activated by DNA damage.',\n",
              " 'Mutation of serine residues may affect localization of BRCA1 to sites of DNA damage and DNA damage response function.',\n",
              " 'The dual repeat BRCT domain of the BRCA1 protein is an elongated structure approximately 70 Å long and 30–35 Å wide.',\n",
              " 'The 85–95 amino acid domains in BRCT can be found as single modules or as multiple tandem repeats containing two domains.',\n",
              " 'Both of these possibilities can occur in a single protein in a variety of different conformations.',\n",
              " 'The C-terminal BRCT region of the BRCA1 protein is essential for repair of DNA, transcription regulation and tumor suppressor function.',\n",
              " 'In BRCA1 the dual tandem repeat BRCT domains are arranged in a head-to-tail-fashion in the three-dimensional structure, burying 1600 Å of hydrophobic, solvent-accessible surface area in the interface.',\n",
              " 'These all contribute to the tightly packed knob-in-hole structure that comprises the interface.',\n",
              " 'These homologous domains interact to control cellular responses to DNA damage.',\n",
              " 'A missense mutation at the interface of these two proteins can perturb the cell cycle, resulting a greater risk of developing cancer.',\n",
              " '[citation needed] BRCA1 is part of a complex that repairs double-strand breaks in DNA.',\n",
              " 'The strands of the DNA double helix are continuously breaking as they become damaged.',\n",
              " 'Sometimes only one strand is broken, sometimes both strands are broken simultaneously.',\n",
              " 'DNA cross-linking agents are an important source of chromosome/DNA damage.',\n",
              " 'Double-strand breaks occur as intermediates after the crosslinks are removed, and indeed, biallelic mutations in BRCA1 have been identified to be responsible for Fanconi Anemia, Complementation Group S (FA-S), a genetic disease associated with hypersensitivity to DNA crosslinking agents.',\n",
              " 'BRCA1 is part of a protein complex that repairs DNA when both strands are broken.',\n",
              " 'When this happens, it is difficult for the repair mechanism to \"know\" how to replace the correct DNA sequence, and there are multiple ways to attempt the repair.',\n",
              " 'The double-strand repair mechanism in which BRCA1 participates is homology-directed repair, where the repair proteins copy the identical sequence from the intact sister chromatid.',\n",
              " 'FA-S is almost always a lethal condition in utero; only a handful cases of biallelic BRCA1 mutations have been reported in literature despite the high carrier frequencies in the Ashkenazim, and none since 2013.',\n",
              " 'In the nucleus of many types of normal cells, the BRCA1 protein interacts with RAD51 during repair of DNA double-strand breaks.',\n",
              " 'These breaks can be caused by natural radiation or other exposures, but also occur when chromosomes exchange genetic material (homologous recombination, e.g., \"crossing over\" during meiosis).',\n",
              " 'The BRCA2 protein, which has a function similar to that of BRCA1, also interacts with the RAD51 protein.',\n",
              " 'By influencing DNA damage repair, these three proteins play a role in maintaining the stability of the human genome.',\n",
              " '[citation needed] BRCA1 is also involved in another type of DNA repair, termed mismatch repair.',\n",
              " 'BRCA1 interacts with the DNA mismatch repair protein MSH2.',\n",
              " 'MSH2, MSH6, PARP and some other proteins involved in single-strand repair are reported to be elevated in BRCA1-deficient mammary tumors.',\n",
              " 'A protein called valosin-containing protein (VCP, also known as p97) plays a role to recruit BRCA1 to the damaged DNA sites.',\n",
              " 'After ionizing radiation, VCP is recruited to DNA lesions and cooperates with the ubiquitin ligase RNF8 to orchestrate assembly of signaling complexes for efficient DSB repair.',\n",
              " 'BRCA1 interacts with VCP.',\n",
              " 'BRCA1 also interacts with c-Myc, and other proteins that are critical to maintain genome stability.',\n",
              " 'BRCA1 directly binds to DNA, with higher affinity for branched DNA structures.',\n",
              " 'This ability to bind to DNA contributes to its ability to inhibit the nuclease activity of the MRN complex as well as the nuclease activity of Mre11 alone.',\n",
              " 'This may explain a role for BRCA1 to promote lower fidelity DNA repair by non-homologous end joining (NHEJ).',\n",
              " 'BRCA1 also colocalizes with γ-H2AX (histone H2AX phosphorylated on serine-139) in DNA double-strand break repair foci, indicating it may play a role in recruiting repair factors.',\n",
              " 'Formaldehyde and acetaldehyde are common environmental sources of DNA cross links that often require repairs mediated by BRCA1 containing pathways.',\n",
              " 'This DNA repair function is essential; mice with loss-of-function mutations in both BRCA1 alleles are not viable, and as of 2015 only two adults were known to have loss-of-function mutations in both alleles (leading to FA-S); both had congenital or developmental issues, and both had cancer.',\n",
              " 'One was presumed to have survived to adulthood because one of the BRCA1 mutations was hypomorphic.',\n",
              " 'BRCA1 was shown to co-purify with the human RNA Polymerase II holoenzyme in HeLa extracts, implying it is a component of the holoenzyme.',\n",
              " 'Later research, however, contradicted this assumption, instead showing that the predominant complex including BRCA1 in HeLa cells is a 2 megadalton complex containing SWI/SNF.',\n",
              " 'SWI/SNF is a chromatin remodeling complex.',\n",
              " 'Artificial tethering of BRCA1 to chromatin was shown to decondense heterochromatin, though the SWI/SNF interacting domain was not necessary for this role.',\n",
              " 'BRCA1 interacts with the NELF-B (COBRA1) subunit of the NELF complex.',\n",
              " 'Certain variations of the BRCA1 gene lead to an increased risk for breast cancer as part of a hereditary breast–ovarian cancer syndrome.',\n",
              " 'Researchers have identified hundreds of mutations in the BRCA1 gene, many of which are associated with an increased risk of cancer.',\n",
              " 'Females with an abnormal BRCA1 or BRCA2 gene have up to an 80% risk of developing breast cancer by age 90; increased risk of developing ovarian cancer is about 55% for females with BRCA1 mutations and about 25% for females with BRCA2 mutations.',\n",
              " 'These mutations can be changes in one or a small number of DNA base pairs (the building-blocks of DNA), and can be identified with PCR and DNA sequencing.',\n",
              " 'In some cases, large segments of DNA are rearranged.',\n",
              " 'Those large segments, also called large rearrangements, can be a deletion or a duplication of one or several exons in the gene.',\n",
              " 'Classical methods for mutation detection (sequencing) are unable to reveal these types of mutation.',\n",
              " 'Other methods have been proposed: traditional quantitative PCR, multiplex ligation-dependent probe amplification (MLPA), and Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF).',\n",
              " 'Newer methods have also been recently proposed: heteroduplex analysis (HDA) by multi-capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization (array-CGH).',\n",
              " 'Some results suggest that hypermethylation of the BRCA1 promoter, which has been reported in some cancers, could be considered as an inactivating mechanism for BRCA1 expression.',\n",
              " 'A mutated BRCA1 gene usually makes a protein that does not function properly.',\n",
              " 'Researchers believe that the defective BRCA1 protein is unable to help fix DNA damage leading to mutations in other genes.',\n",
              " 'These mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor.',\n",
              " 'Thus, BRCA1 inactivating mutations lead to a predisposition for cancer.',\n",
              " \"[citation needed] BRCA1 mRNA 3' UTR can be bound by an miRNA, Mir-17 microRNA.\",\n",
              " 'It has been suggested that variations in this miRNA along with Mir-30 microRNA could confer susceptibility to breast cancer.',\n",
              " 'In addition to breast cancer, mutations in the BRCA1 gene also increase the risk of ovarian and prostate cancers.',\n",
              " 'Moreover, precancerous lesions (dysplasia) within the Fallopian tube have been linked to BRCA1 gene mutations.',\n",
              " 'Pathogenic mutations anywhere in a model pathway containing BRCA1 and BRCA2 greatly increase risks for a subset of leukemias and lymphomas.',\n",
              " 'Women who have inherited a defective BRCA1 or BRCA2 gene are at a greatly elevated risk to develop breast and ovarian cancer.',\n",
              " 'Their risk of developing breast and/or ovarian cancer is so high, and so specific to those cancers, that many mutation carriers choose to have prophylactic surgery.',\n",
              " 'There has been much conjecture to explain such apparently striking tissue specificity.',\n",
              " 'Major determinants of where BRCA1/2 hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation or the carcinogen.',\n",
              " 'The target tissue may have receptors for the pathogen, may become selectively exposed to an inflammatory process or to a carcinogen.',\n",
              " 'An innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets.',\n",
              " 'This theory also fits data for several tumor suppressors beyond BRCA1 or BRCA2.',\n",
              " 'A major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery.',\n",
              " 'As aforementioned, biallelic and homozygous inheritance of the BRCA1 gene leads to FA-S, which is almost always an embryonically lethal condition.',\n",
              " 'BRCA1 expression is reduced or undetectable in the majority of high grade, ductal breast cancers.',\n",
              " 'It has long been noted that loss of BRCA1 activity, either by germ-line mutations or by down-regulation of gene expression, leads to tumor formation in specific target tissues.',\n",
              " 'In particular, decreased BRCA1 expression contributes to both sporadic and inherited breast tumor progression.',\n",
              " 'Reduced expression of BRCA1 is tumorigenic because it plays an important role in the repair of DNA damages, especially double-strand breaks, by the potentially error-free pathway of homologous recombination.',\n",
              " 'Since cells that lack the BRCA1 protein tend to repair DNA damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer.',\n",
              " 'Similarly, BRCA1 expression is low in the majority (55%) of sporadic epithelial ovarian cancers (EOCs) where EOCs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers.',\n",
              " 'In serous ovarian carcinomas, a sub-category constituting about 2/3 of EOCs, low BRCA1 expression occurs in more than 50% of cases.',\n",
              " 'Bowtell reviewed the literature indicating that deficient homologous recombination repair caused by BRCA1 deficiency is tumorigenic.',\n",
              " 'In particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy.',\n",
              " 'Especially noted was that BRCA1 deficiency could be the cause of tumorigenesis whether due to BRCA1 mutation or any other event that causes a deficiency of BRCA1 expression.',\n",
              " 'Only about 3%–8% of all women with breast cancer carry a mutation in BRCA1 or BRCA2.',\n",
              " 'Similarly, BRCA1 mutations are only seen in about 18% of ovarian cancers (13% germline mutations and 5% somatic mutations).',\n",
              " 'Thus, while BRCA1 expression is low in the majority of these cancers, BRCA1 mutation is not a major cause of reduced expression.',\n",
              " 'Certain latent viruses, which are frequently detected in breast cancer tumors, can decrease the expression of the BRCA1 gene and cause the development of breast tumors.',\n",
              " 'BRCA1 promoter hypermethylation was present in only 13% of unselected primary breast carcinomas.',\n",
              " 'Similarly, BRCA1 promoter hypermethylation was present in only 5% to 15% of EOC cases.',\n",
              " 'Thus, while BRCA1 expression is low in these cancers, BRCA1 promoter methylation is only a minor cause of reduced expression.',\n",
              " 'There are a number of specific microRNAs, when overexpressed, that directly reduce expression of specific DNA repair proteins (see MicroRNA section DNA repair and cancer) In the case of breast cancer, microRNA-182 (miR-182) specifically targets BRCA1.',\n",
              " 'Breast cancers can be classified based on receptor status or histology, with triple-negative breast cancer (15%–25% of breast cancers), HER2+ (15%–30% of breast cancers), ER+/PR+ (about 70% of breast cancers), and Invasive lobular carcinoma (about 5%–10% of invasive breast cancer).',\n",
              " 'All four types of breast cancer were found to have an average of about 100-fold increase in miR-182, compared to normal breast tissue.',\n",
              " 'In breast cancer cell lines, there is an inverse correlation of BRCA1 protein levels with miR-182 expression.',\n",
              " 'Thus it appears that much of the reduction or absence of BRCA1 in high grade ductal breast cancers may be due to over-expressed miR-182.',\n",
              " 'In addition to miR-182, a pair of almost identical microRNAs, miR-146a and miR-146b-5p, also repress BRCA1 expression.',\n",
              " 'These two microRNAs are over-expressed in triple-negative tumors and their over-expression results in BRCA1 inactivation.',\n",
              " 'Thus, miR-146a and/or miR-146b-5p may also contribute to reduced expression of BRCA1 in these triple-negative breast cancers.',\n",
              " 'In both serous tubal intraepithelial carcinoma (the precursor lesion to high grade serous ovarian carcinoma (HG-SOC)), and in HG-SOC itself, miR-182 is overexpressed in about 70% of cases.',\n",
              " 'In cells with over-expressed miR-182, BRCA1 remained low, even after exposure to ionizing radiation (which normally raises BRCA1 expression).',\n",
              " 'Thus much of the reduced or absent BRCA1 in HG-SOC may be due to over-expressed miR-182.',\n",
              " 'Another microRNA known to reduce expression of BRCA1 in ovarian cancer cells is miR-9.',\n",
              " 'Among 58 tumors from patients with stage IIIC or stage IV serous ovarian cancers (HG-SOG), an inverse correlation was found between expressions of miR-9 and BRCA1, so that increased miR-9 may also contribute to reduced expression of BRCA1 in these ovarian cancers.',\n",
              " 'DNA damage appears to be the primary underlying cause of cancer, and deficiencies in DNA repair appears to underlie many forms of cancer.',\n",
              " 'If DNA repair is deficient, DNA damage tends to accumulate.',\n",
              " 'Such excess DNA damage may increase mutational errors during DNA replication due to error-prone translesion synthesis.',\n",
              " 'Excess DNA damage may also increase epigenetic alterations due to errors during DNA repair.',\n",
              " 'Such mutations and epigenetic alterations may give rise to cancer.',\n",
              " 'The frequent microRNA-induced deficiency of BRCA1 in breast and ovarian cancers likely contribute to the progression of those cancers.',\n",
              " 'All germ-line BRCA1 mutations identified to date have been inherited, suggesting the possibility of a large \"founder\" effect in which a certain mutation is common to a well-defined population group and can, in theory, be traced back to a common ancestor.',\n",
              " 'Given the complexity of mutation screening for BRCA1, these common mutations may simplify the methods required for mutation screening in certain populations.',\n",
              " 'Analysis of mutations that occur with high frequency also permits the study of their clinical expression.',\n",
              " 'Examples of manifestations of a founder effect are seen among Ashkenazi Jews.',\n",
              " 'Three mutations in BRCA1 have been reported to account for the majority of Ashkenazi Jewish patients with inherited BRCA1-related breast and/or ovarian cancer: 185delAG, 188del11 and 5382insC in the BRCA1 gene.',\n",
              " 'In fact, it has been shown that if a Jewish woman does not carry a BRCA1 185delAG, BRCA1 5382insC founder mutation, it is highly unlikely that a different BRCA1 mutation will be found.',\n",
              " 'Additional examples of founder mutations in BRCA1 are given in Table 1 (mainly derived from ).',\n",
              " 'As women age, reproductive performance declines, leading to menopause.',\n",
              " 'This decline is tied to a reduction in the number of ovarian follicles.',\n",
              " 'Although about 1 million oocytes are present at birth in the human ovary, only about 500 (about 0.05%) of these ovulate.',\n",
              " 'The decline in ovarian reserve appears to occur at a constantly increasing rate with age, and leads to nearly complete exhaustion of the reserve by about age 52.',\n",
              " 'As ovarian reserve and fertility decline with age, there is also a parallel increase in pregnancy failure and meiotic errors, resulting in chromosomally abnormal conceptions.',\n",
              " 'Women with a germ-line BRCA1 mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women.',\n",
              " 'Furthermore, women with an inherited BRCA1 mutation undergo menopause prematurely.',\n",
              " 'Since BRCA1 is a key DNA repair protein, these findings suggest that naturally occurring DNA damages in oocytes are repaired less efficiently in women with a BRCA1 defect, and that this repair inefficiency leads to early reproductive failure.',\n",
              " 'As noted above, the BRCA1 protein plays a key role in homologous recombinational repair.',\n",
              " 'This is the only known cellular process that can accurately repair DNA double-strand breaks.',\n",
              " 'DNA double-strand breaks accumulate with age in humans and mice in primordial follicles.',\n",
              " 'Primordial follicles contain oocytes that are at an intermediate (prophase I) stage of meiosis.',\n",
              " 'Meiosis is the general process in eukaryotic organisms by which germ cells are formed, and it is likely an adaptation for removing DNA damages, especially double-strand breaks, from germ line DNA.',\n",
              " '(Also see article Meiosis).',\n",
              " 'Homologous recombinational repair employing BRCA1 is especially promoted during meiosis.',\n",
              " 'It was found that expression of four key genes necessary for homologous recombinational repair of DNA double-strand breaks (BRCA1, MRE11, RAD51 and ATM) decline with age in the oocytes of humans and mice, leading to the hypothesis that DNA double-strand break repair is necessary for the maintenance of oocyte reserve and that a decline in efficiency of repair with age plays a role in ovarian aging.',\n",
              " 'Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide.',\n",
              " 'At diagnosis, almost 70% of persons with NSCLC have locally advanced or metastatic disease.',\n",
              " 'Persons with NSCLC are often treated with therapeutic platinum compounds (e.g.',\n",
              " 'cisplatin, carboplatin or oxaliplatin) that cause inter-strand cross-links in DNA.',\n",
              " 'Among individuals with NSCLC, low expression of BRCA1 in the primary tumor correlated with improved survival after platinum-containing chemotherapy.',\n",
              " 'This correlation implies that low BRCA1 in cancer, and the consequent low level of DNA repair, causes vulnerability of cancer to treatment by the DNA cross-linking agents.',\n",
              " 'High BRCA1 may protect cancer cells by acting in a pathway that removes the damages in DNA introduced by the platinum drugs.',\n",
              " 'Thus the level of BRCA1 expression is a potentially important tool for tailoring chemotherapy in lung cancer management.',\n",
              " 'Level of BRCA1 expression is also relevant to ovarian cancer treatment.',\n",
              " 'Patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their BRCA1 expression was low compared to patients with higher BRCA1 expression (46 compared to 33 months).',\n",
              " 'A patent application for the isolated BRCA1 gene and cancer promoting mutations discussed above, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics in 1994; over the next year, Myriad, (in collaboration with investigators at Endo Recherche, Inc., HSC Research & Development Limited Partnership, and University of Pennsylvania), isolated and sequenced the BRCA2 gene and identified key mutations, and the first BRCA2 patent was filed in the U.S. by Myriad and other institutions in 1995.',\n",
              " 'Myriad is the exclusive licensee of these patents and has enforced them in the US against clinical diagnostic labs.',\n",
              " 'This business model led from Myriad being a startup in 1994 to being a publicly traded company with 1200 employees and about $500M in annual revenue in 2012; it also led to controversy over high prices and the inability to get second opinions from other diagnostic labs, which in turn led to the landmark Association for Molecular Pathology v. Myriad Genetics lawsuit.',\n",
              " 'The patents began to expire in 2014.',\n",
              " 'According to an article published in the journal, Genetic Medicine, in 2010, \"The patent story outside the United States is more complicated.... For example, patents have been obtained but the patents are being ignored by provincial health systems in Canada.',\n",
              " \"In Australia and the UK, Myriad's licensee permitted use by health systems but announced a change of plans in August 2008.\",\n",
              " \"Only a single mutation has been patented in Myriad's lone European-wide patent, although some patents remain under review of an opposition proceeding.\",\n",
              " 'In effect, the United States is the only jurisdiction where Myriad\\'s strong patent position has conferred sole-provider status.\"',\n",
              " 'Peter Meldrum, CEO of Myriad Genetics, has acknowledged that Myriad has \"other competitive advantages that may make such [patent] enforcement unnecessary\" in Europe.',\n",
              " 'As with any gene, finding variation in BRCA1 is not hard.',\n",
              " 'The real value comes from understanding what the clinical consequences of any particular variant are.',\n",
              " 'Myriad has a large, proprietary database of such genotype-phenotype correlations.',\n",
              " 'In response, parallel open-source databases are being developed.',\n",
              " 'Legal decisions surrounding the BRCA1 and BRCA2 patents will affect the field of genetic testing in general.',\n",
              " 'A June 2013 article, in Association for Molecular Pathology v. Myriad Genetics (No.',\n",
              " '12-398), quoted the US Supreme Court\\'s unanimous ruling that, \"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating Myriad\\'s patents on the BRCA1 and BRCA2 genes.',\n",
              " 'However, the Court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection.',\n",
              " 'The Federal Court of Australia came to the opposite conclusion, upholding the validity of an Australian Myriad Genetics patent over the BRCA1 gene in February 2013.',\n",
              " 'The Federal Court also rejected an appeal in September 2014.',\n",
              " \"Yvonne D'Arcy won her case against US-based biotech company Myriad Genetics in the High Court of Australia.\",\n",
              " 'In their unanimous decision on October 7, 2015, the \"high court found that an isolated nucleic acid, coding for a BRCA1 protein, with specific variations from the norm that are indicative of susceptibility to breast cancer and ovarian cancer was not a \\'patentable invention.\\'\"',\n",
              " 'BRCA1 has been shown to interact with the following proteins: 1jm7: Solution structure of the BRCA1/BARD1 RING-domain heterodimer 1jnx: Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1 1n5o: Structural consequences of a cancer-causing BRCA1-BRCT missense mutation 1oqa: Solution structure of the BRCT-c domain from human BRCA1 1t15: Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase 1t29: Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide 1t2u: Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F 1t2v: Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide 1y98: Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.']"
            ]
          },
          "metadata": {},
          "execution_count": 130
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "sent2score = {}\n",
        "for sentence in sentences:\n",
        "    for word in nltk.word_tokenize(sentence):\n",
        "        if word in word2count.keys():\n",
        "            if len(sentence.split(' ')) < 40:\n",
        "                if sentence not in sent2score.keys():\n",
        "                    sent2score[sentence] = word2count[word]\n",
        "                else:\n",
        "                    sent2score[sentence] += word2count[word]"
      ],
      "metadata": {
        "id": "_LWVqphzsuv5"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "sent2score"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "UIK_a0pmsye3",
        "outputId": "a12d84dd-83aa-43d8-a775-dd03087f0b8f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'Orthologs are common in other vertebrate species, whereas invertebrate genomes may encode a more distantly related gene.': 0.9538461538461538,\n",
              " 'BRCA1 is a human tumor suppressor gene (also known as a caretaker gene) and is responsible for repairing DNA.': 1.7230769230769232,\n",
              " 'BRCA1 and BRCA2 are unrelated proteins, but both are normally expressed in the cells of breast and other tissue, where they help repair damaged DNA, or destroy cells if DNA cannot be repaired.': 2.81661918328585,\n",
              " 'They are involved in the repair of chromosomal damage with an important role in the error-free repair of DNA double-strand breaks.': 3.5333333333333337,\n",
              " 'If BRCA1 or BRCA2 itself is damaged by a BRCA mutation, damaged DNA is not repaired properly, and this increases the risk for breast cancer.': 2.0432098765432096,\n",
              " 'BRCA1 and BRCA2 have been described as \"breast cancer susceptibility genes\" and \"breast cancer susceptibility proteins\".': 1.7061728395061726,\n",
              " 'The predominant allele has a normal, tumor suppressive function whereas high penetrance mutations in these genes cause a loss of tumor suppressive function which correlates with an increased risk of breast cancer.': 4.552733686067018,\n",
              " 'BRCA1 combines with other tumor suppressors, DNA damage sensors and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC).': 2.5845475512142175,\n",
              " 'The BRCA1 protein associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes.': 1.8050603717270384,\n",
              " 'Thus, this protein plays a role in transcription, and DNA repair of double-strand DNA breaks ubiquitination, transcriptional regulation as well as other functions.': 2.630335097001763,\n",
              " 'Methods to test for the likelihood of a patient with mutations in BRCA1 and BRCA2 developing cancer were covered by patents owned or controlled by Myriad Genetics.': 2.058641975308642,\n",
              " \"The first evidence for the existence of a gene encoding a DNA repair enzyme involved in breast cancer susceptibility was provided by Mary-Claire King's laboratory at UC Berkeley in 1990.\": 2.4591303757970424,\n",
              " 'Four years later, after an international race to find it, the gene was cloned in 1994 by scientists at University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics.': 0.6703296703296703,\n",
              " 'The human BRCA1 gene is located on the long (q) arm of chromosome 17 at region 2 band 1, from base pair 41,196,312 to base pair 41,277,500 (Build GRCh37/hg19) (map).': 1.563736263736264,\n",
              " 'BRCA1 orthologs have been identified in most vertebrates for which complete genome data are available.': 0.6021978021978022,\n",
              " 'The BRCA1 protein contains the following domains: This protein also contains nuclear localization signals and nuclear export signal motifs.': 1.9496811830145164,\n",
              " 'The human BRCA1 protein consists of four major protein domains; the Znf C3HC4- RING domain, the BRCA1 serine domain and two BRCT domains.': 3.1112196445529783,\n",
              " 'These domains encode approximately 27% of BRCA1 protein.': 0.6753900420567087,\n",
              " 'There are six known isoforms of BRCA1, with isoforms 1 and 2 comprising 1863 amino acids each.': 0.6076923076923076,\n",
              " '[citation needed] BRCA1 is unrelated to BRCA2, i.e.': 0.4084249084249084,\n",
              " 'they are not homologs or paralogs.': 0.07142857142857142,\n",
              " 'The RING motif, a Zn finger found in eukaryotic peptides, is 40–60 amino acids long and consists of eight conserved metal-binding residues, two quartets of cysteine or histidine residues that coordinate two zinc atoms.': 2.5714285714285716,\n",
              " 'This motif contains a short anti-parallel beta-sheet, two zinc-binding loops and a central alpha helix in a small domain.': 1.6071428571428572,\n",
              " 'This RING domain interacts with associated proteins, including BARD1, which also contains a RING motif, to form a heterodimer.': 2.422344322344322,\n",
              " 'The BRCA1 RING motif is flanked by alpha helices formed by residues 8–22 and 81–96 of the BRCA1 protein.': 0.9660493827160493,\n",
              " 'It interacts with a homologous region in BARD1 also consisting of a RING finger flanked by two alpha-helices formed from residues 36–48 and 101–116.': 2.1247252747252747,\n",
              " 'These four helices combine to form a heterodimerization interface and stabilize the BRCA1-BARD1 heterodimer complex.': 1.2142857142857142,\n",
              " 'Additional stabilization is achieved by interactions between adjacent residues in the flanking region and hydrophobic interactions.': 0.7857142857142856,\n",
              " 'The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression.': 2.0959706959706956,\n",
              " 'The ring domain is an important element of ubiquitin E3 ligases, which catalyze protein ubiquitination.': 1.5970017636684308,\n",
              " 'Ubiquitin is a small regulatory protein found in all tissues that direct proteins to compartments within the cell.': 1.4422398589065257,\n",
              " 'BRCA1 polypeptides, in particular, Lys-48-linked polyubiquitin chains are dispersed throughout the resting cell nucleus, but at the start of DNA replication, they gather in restrained groups that also contain BRCA2 and BARD1.': 1.3390109890109887,\n",
              " 'BARD1 is thought to be involved in the recognition and binding of protein targets for ubiquitination.': 0.882716049382716,\n",
              " 'It attaches to proteins and labels them for destruction.': 0.4404761904761904,\n",
              " 'Ubiquitination occurs via the BRCA1 fusion protein and is abolished by zinc chelation.': 0.5731922398589064,\n",
              " 'The enzyme activity of the fusion protein is dependent on the proper folding of the ring domain.': 1.501763668430335,\n",
              " '[citation needed] BRCA1 serine cluster domain (SCD) spans amino acids 1280–1524.': 1.392857142857143,\n",
              " 'A portion of the domain is located in exons 11–13.': 0.7499999999999999,\n",
              " 'High rates of mutation occur in exons 11–13.': 1.026190476190476,\n",
              " 'Reported phosphorylation sites of BRCA1 are concentrated in the SCD, where they are phosphorylated by ATM/ATR kinases both in vitro and in vivo.': 0.4642857142857142,\n",
              " 'ATM/ATR are kinases activated by DNA damage.': 0.5404761904761904,\n",
              " 'Mutation of serine residues may affect localization of BRCA1 to sites of DNA damage and DNA damage response function.': 2.173260073260073,\n",
              " 'The dual repeat BRCT domain of the BRCA1 protein is an elongated structure approximately 70 Å long and 30–35 Å wide.': 1.6803350970017634,\n",
              " 'The 85–95 amino acid domains in BRCT can be found as single modules or as multiple tandem repeats containing two domains.': 2.2142857142857144,\n",
              " 'Both of these possibilities can occur in a single protein in a variety of different conformations.': 0.7874779541446207,\n",
              " 'The C-terminal BRCT region of the BRCA1 protein is essential for repair of DNA, transcription regulation and tumor suppressor function.': 2.24681861348528,\n",
              " 'In BRCA1 the dual tandem repeat BRCT domains are arranged in a head-to-tail-fashion in the three-dimensional structure, burying 1600 Å of hydrophobic, solvent-accessible surface area in the interface.': 1.3214285714285716,\n",
              " 'These all contribute to the tightly packed knob-in-hole structure that comprises the interface.': 0.7857142857142856,\n",
              " 'These homologous domains interact to control cellular responses to DNA damage.': 1.3261904761904761,\n",
              " 'A missense mutation at the interface of these two proteins can perturb the cell cycle, resulting a greater risk of developing cancer.': 2.715784832451499,\n",
              " '[citation needed] BRCA1 is part of a complex that repairs double-strand breaks in DNA.': 1.3666666666666665,\n",
              " 'The strands of the DNA double helix are continuously breaking as they become damaged.': 0.9547619047619046,\n",
              " 'Sometimes only one strand is broken, sometimes both strands are broken simultaneously.': 1.1404761904761904,\n",
              " 'DNA cross-linking agents are an important source of chromosome/DNA damage.': 0.7785714285714286,\n",
              " 'Double-strand breaks occur as intermediates after the crosslinks are removed, and indeed, biallelic mutations in BRCA1 have been identified to be responsible for Fanconi Anemia, Complementation Group S (FA-S), a genetic disease associated with hypersensitivity to DNA crosslinking agents.': 2.7188644688644685,\n",
              " 'BRCA1 is part of a protein complex that repairs DNA when both strands are broken.': 1.0731922398589064,\n",
              " 'When this happens, it is difficult for the repair mechanism to \"know\" how to replace the correct DNA sequence, and there are multiple ways to attempt the repair.': 2.5000000000000004,\n",
              " 'The double-strand repair mechanism in which BRCA1 participates is homology-directed repair, where the repair proteins copy the identical sequence from the intact sister chromatid.': 3.7619047619047623,\n",
              " 'FA-S is almost always a lethal condition in utero; only a handful cases of biallelic BRCA1 mutations have been reported in literature despite the high carrier frequencies in the Ashkenazim, and none since 2013.': 2.6809523809523808,\n",
              " 'In the nucleus of many types of normal cells, the BRCA1 protein interacts with RAD51 during repair of DNA double-strand breaks.': 2.6153167819834486,\n",
              " 'These breaks can be caused by natural radiation or other exposures, but also occur when chromosomes exchange genetic material (homologous recombination, e.g., \"crossing over\" during meiosis).': 2.205677655677656,\n",
              " 'The BRCA2 protein, which has a function similar to that of BRCA1, also interacts with the RAD51 protein.': 1.535395468728802,\n",
              " 'By influencing DNA damage repair, these three proteins play a role in maintaining the stability of the human genome.': 2.6719780219780223,\n",
              " '[citation needed] BRCA1 is also involved in another type of DNA repair, termed mismatch repair.': 3.1670533170533175,\n",
              " 'BRCA1 interacts with the DNA mismatch repair protein MSH2.': 1.6089065255731922,\n",
              " 'MSH2, MSH6, PARP and some other proteins involved in single-strand repair are reported to be elevated in BRCA1-deficient mammary tumors.': 1.9642857142857144,\n",
              " 'A protein called valosin-containing protein (VCP, also known as p97) plays a role to recruit BRCA1 to the damaged DNA sites.': 1.8788020621353958,\n",
              " 'After ionizing radiation, VCP is recruited to DNA lesions and cooperates with the ubiquitin ligase RNF8 to orchestrate assembly of signaling complexes for efficient DSB repair.': 1.6785714285714284,\n",
              " 'BRCA1 interacts with VCP.': 0.32142857142857145,\n",
              " 'BRCA1 also interacts with c-Myc, and other proteins that are critical to maintain genome stability.': 1.3866300366300368,\n",
              " 'BRCA1 directly binds to DNA, with higher affinity for branched DNA structures.': 0.28571428571428564,\n",
              " 'This ability to bind to DNA contributes to its ability to inhibit the nuclease activity of the MRN complex as well as the nuclease activity of Mre11 alone.': 1.3214285714285714,\n",
              " 'This may explain a role for BRCA1 to promote lower fidelity DNA repair by non-homologous end joining (NHEJ).': 1.8756410256410256,\n",
              " 'BRCA1 also colocalizes with γ-H2AX (histone H2AX phosphorylated on serine-139) in DNA double-strand break repair foci, indicating it may play a role in recruiting repair factors.': 3.643223443223443,\n",
              " 'Formaldehyde and acetaldehyde are common environmental sources of DNA cross links that often require repairs mediated by BRCA1 containing pathways.': 0.985164835164835,\n",
              " 'One was presumed to have survived to adulthood because one of the BRCA1 mutations was hypomorphic.': 1.3214285714285714,\n",
              " 'BRCA1 was shown to co-purify with the human RNA Polymerase II holoenzyme in HeLa extracts, implying it is a component of the holoenzyme.': 0.5362637362637361,\n",
              " 'Later research, however, contradicted this assumption, instead showing that the predominant complex including BRCA1 in HeLa cells is a 2 megadalton complex containing SWI/SNF.': 1.7873626373626372,\n",
              " 'SWI/SNF is a chromatin remodeling complex.': 0.5357142857142857,\n",
              " 'Artificial tethering of BRCA1 to chromatin was shown to decondense heterochromatin, though the SWI/SNF interacting domain was not necessary for this role.': 1.4047619047619047,\n",
              " 'BRCA1 interacts with the NELF-B (COBRA1) subunit of the NELF complex.': 0.8214285714285714,\n",
              " 'Certain variations of the BRCA1 gene lead to an increased risk for breast cancer as part of a hereditary breast–ovarian cancer syndrome.': 2.176943426943427,\n",
              " 'Researchers have identified hundreds of mutations in the BRCA1 gene, many of which are associated with an increased risk of cancer.': 2.77659069325736,\n",
              " 'These mutations can be changes in one or a small number of DNA base pairs (the building-blocks of DNA), and can be identified with PCR and DNA sequencing.': 1.892857142857143,\n",
              " 'In some cases, large segments of DNA are rearranged.': 0.5,\n",
              " 'Those large segments, also called large rearrangements, can be a deletion or a duplication of one or several exons in the gene.': 1.9021978021978023,\n",
              " 'Classical methods for mutation detection (sequencing) are unable to reveal these types of mutation.': 1.8023809523809524,\n",
              " 'Other methods have been proposed: traditional quantitative PCR, multiplex ligation-dependent probe amplification (MLPA), and Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF).': 0.5357142857142856,\n",
              " 'Newer methods have also been recently proposed: heteroduplex analysis (HDA) by multi-capillary electrophoresis or also dedicated oligonucleotides array based on comparative genomic hybridization (array-CGH).': 1.7494505494505497,\n",
              " 'Some results suggest that hypermethylation of the BRCA1 promoter, which has been reported in some cancers, could be considered as an inactivating mechanism for BRCA1 expression.': 2.642857142857143,\n",
              " 'A mutated BRCA1 gene usually makes a protein that does not function properly.': 1.1438020222333947,\n",
              " 'Researchers believe that the defective BRCA1 protein is unable to help fix DNA damage leading to mutations in other genes.': 2.352625551645159,\n",
              " 'These mutations can accumulate and may allow cells to grow and divide uncontrollably to form a tumor.': 2.287955182072829,\n",
              " 'Thus, BRCA1 inactivating mutations lead to a predisposition for cancer.': 1.5460369332918353,\n",
              " \"[citation needed] BRCA1 mRNA 3' UTR can be bound by an miRNA, Mir-17 microRNA.\": 0.5336134453781513,\n",
              " 'It has been suggested that variations in this miRNA along with Mir-30 microRNA could confer susceptibility to breast cancer.': 1.169753086419753,\n",
              " 'In addition to breast cancer, mutations in the BRCA1 gene also increase the risk of ovarian and prostate cancers.': 5.389852123185456,\n",
              " 'Moreover, precancerous lesions (dysplasia) within the Fallopian tube have been linked to BRCA1 gene mutations.': 1.9322344322344323,\n",
              " 'Pathogenic mutations anywhere in a model pathway containing BRCA1 and BRCA2 greatly increase risks for a subset of leukemias and lymphomas.': 3.134920634920635,\n",
              " 'Women who have inherited a defective BRCA1 or BRCA2 gene are at a greatly elevated risk to develop breast and ovarian cancer.': 3.196265970775775,\n",
              " 'Their risk of developing breast and/or ovarian cancer is so high, and so specific to those cancers, that many mutation carriers choose to have prophylactic surgery.': 5.091622574955908,\n",
              " 'There has been much conjecture to explain such apparently striking tissue specificity.': 1.0885225885225887,\n",
              " 'Major determinants of where BRCA1/2 hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation or the carcinogen.': 2.963159679826347,\n",
              " 'The target tissue may have receptors for the pathogen, may become selectively exposed to an inflammatory process or to a carcinogen.': 2.2286935286935288,\n",
              " 'An innate genomic deficit in a tumor suppressor gene impairs normal responses and exacerbates the susceptibility to disease in organ targets.': 1.7046262379595714,\n",
              " 'This theory also fits data for several tumor suppressors beyond BRCA1 or BRCA2.': 1.2894993894993896,\n",
              " 'A major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery.': 1.6891330891330893,\n",
              " 'As aforementioned, biallelic and homozygous inheritance of the BRCA1 gene leads to FA-S, which is almost always an embryonically lethal condition.': 1.7377899877899876,\n",
              " 'BRCA1 expression is reduced or undetectable in the majority of high grade, ductal breast cancers.': 4.415520282186949,\n",
              " 'It has long been noted that loss of BRCA1 activity, either by germ-line mutations or by down-regulation of gene expression, leads to tumor formation in specific target tissues.': 4.807326007326008,\n",
              " 'In particular, decreased BRCA1 expression contributes to both sporadic and inherited breast tumor progression.': 3.0779134445801115,\n",
              " 'Reduced expression of BRCA1 is tumorigenic because it plays an important role in the repair of DNA damages, especially double-strand breaks, by the potentially error-free pathway of homologous recombination.': 5.136507936507935,\n",
              " 'Since cells that lack the BRCA1 protein tend to repair DNA damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer.': 5.476956993623658,\n",
              " 'Similarly, BRCA1 expression is low in the majority (55%) of sporadic epithelial ovarian cancers (EOCs) where EOCs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers.': 7.526611043277708,\n",
              " 'In serous ovarian carcinomas, a sub-category constituting about 2/3 of EOCs, low BRCA1 expression occurs in more than 50% of cases.': 3.996031746031746,\n",
              " 'Bowtell reviewed the literature indicating that deficient homologous recombination repair caused by BRCA1 deficiency is tumorigenic.': 2.5238095238095237,\n",
              " 'In particular this deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy.': 3.4475308641975313,\n",
              " 'Especially noted was that BRCA1 deficiency could be the cause of tumorigenesis whether due to BRCA1 mutation or any other event that causes a deficiency of BRCA1 expression.': 4.728571428571429,\n",
              " 'Only about 3%–8% of all women with breast cancer carry a mutation in BRCA1 or BRCA2.': 2.1765432098765434,\n",
              " 'Similarly, BRCA1 mutations are only seen in about 18% of ovarian cancers (13% germline mutations and 5% somatic mutations).': 5.015873015873016,\n",
              " 'Thus, while BRCA1 expression is low in the majority of these cancers, BRCA1 mutation is not a major cause of reduced expression.': 5.998412698412698,\n",
              " 'Certain latent viruses, which are frequently detected in breast cancer tumors, can decrease the expression of the BRCA1 gene and cause the development of breast tumors.': 3.5830280830280827,\n",
              " 'BRCA1 promoter hypermethylation was present in only 13% of unselected primary breast carcinomas.': 1.4845679012345676,\n",
              " 'Similarly, BRCA1 promoter hypermethylation was present in only 5% to 15% of EOC cases.': 0.7619047619047619,\n",
              " 'Thus, while BRCA1 expression is low in these cancers, BRCA1 promoter methylation is only a minor cause of reduced expression.': 5.142857142857143,\n",
              " 'There are a number of specific microRNAs, when overexpressed, that directly reduce expression of specific DNA repair proteins (see MicroRNA section DNA repair and cancer) In the case of breast cancer, microRNA-182 (miR-182) specifically targets BRCA1.': 6.693121693121691,\n",
              " 'All four types of breast cancer were found to have an average of about 100-fold increase in miR-182, compared to normal breast tissue.': 2.868681318681319,\n",
              " 'In breast cancer cell lines, there is an inverse correlation of BRCA1 protein levels with miR-182 expression.': 2.715608465608466,\n",
              " 'Thus it appears that much of the reduction or absence of BRCA1 in high grade ductal breast cancers may be due to over-expressed miR-182.': 4.152272418939085,\n",
              " 'In addition to miR-182, a pair of almost identical microRNAs, miR-146a and miR-146b-5p, also repress BRCA1 expression.': 2.212026862026862,\n",
              " 'These two microRNAs are over-expressed in triple-negative tumors and their over-expression results in BRCA1 inactivation.': 0.6825396825396826,\n",
              " 'Thus, miR-146a and/or miR-146b-5p may also contribute to reduced expression of BRCA1 in these triple-negative breast cancers.': 3.6079500746167414,\n",
              " 'In both serous tubal intraepithelial carcinoma (the precursor lesion to high grade serous ovarian carcinoma (HG-SOC)), and in HG-SOC itself, miR-182 is overexpressed in about 70% of cases.': 4.391269841269842,\n",
              " 'In cells with over-expressed miR-182, BRCA1 remained low, even after exposure to ionizing radiation (which normally raises BRCA1 expression).': 2.9563492063492065,\n",
              " 'Thus much of the reduced or absent BRCA1 in HG-SOC may be due to over-expressed miR-182.': 2.0700854700854703,\n",
              " 'Another microRNA known to reduce expression of BRCA1 in ovarian cancer cells is miR-9.': 2.7521096187762852,\n",
              " 'DNA damage appears to be the primary underlying cause of cancer, and deficiencies in DNA repair appears to underlie many forms of cancer.': 4.1458553791887125,\n",
              " 'If DNA repair is deficient, DNA damage tends to accumulate.': 1.8280578898225959,\n",
              " 'Such excess DNA damage may increase mutational errors during DNA replication due to error-prone translesion synthesis.': 2.9081807081807085,\n",
              " 'Excess DNA damage may also increase epigenetic alterations due to errors during DNA repair.': 4.171794871794873,\n",
              " 'Such mutations and epigenetic alterations may give rise to cancer.': 2.267616334283001,\n",
              " 'The frequent microRNA-induced deficiency of BRCA1 in breast and ovarian cancers likely contribute to the progression of those cancers.': 3.885361552028219,\n",
              " 'Given the complexity of mutation screening for BRCA1, these common mutations may simplify the methods required for mutation screening in certain populations.': 3.8973137973137972,\n",
              " 'Analysis of mutations that occur with high frequency also permits the study of their clinical expression.': 3.82948717948718,\n",
              " 'Examples of manifestations of a founder effect are seen among Ashkenazi Jews.': 1.4444444444444444,\n",
              " 'Three mutations in BRCA1 have been reported to account for the majority of Ashkenazi Jewish patients with inherited BRCA1-related breast and/or ovarian cancer: 185delAG, 188del11 and 5382insC in the BRCA1 gene.': 4.5190951024284365,\n",
              " 'In fact, it has been shown that if a Jewish woman does not carry a BRCA1 185delAG, BRCA1 5382insC founder mutation, it is highly unlikely that a different BRCA1 mutation will be found.': 2.9134920634920634,\n",
              " 'Additional examples of founder mutations in BRCA1 are given in Table 1 (mainly derived from ).': 2.111111111111111,\n",
              " 'As women age, reproductive performance declines, leading to menopause.': 1.9087301587301586,\n",
              " 'This decline is tied to a reduction in the number of ovarian follicles.': 2.297619047619048,\n",
              " 'Although about 1 million oocytes are present at birth in the human ovary, only about 500 (about 0.05%) of these ovulate.': 1.32991452991453,\n",
              " 'The decline in ovarian reserve appears to occur at a constantly increasing rate with age, and leads to nearly complete exhaustion of the reserve by about age 52.': 4.861111111111111,\n",
              " 'As ovarian reserve and fertility decline with age, there is also a parallel increase in pregnancy failure and meiotic errors, resulting in chromosomally abnormal conceptions.': 4.839010989010987,\n",
              " 'Women with a germ-line BRCA1 mutation appear to have a diminished oocyte reserve and decreased fertility compared to normally aging women.': 3.5991452991452992,\n",
              " 'Furthermore, women with an inherited BRCA1 mutation undergo menopause prematurely.': 2.4111111111111114,\n",
              " 'Since BRCA1 is a key DNA repair protein, these findings suggest that naturally occurring DNA damages in oocytes are repaired less efficiently in women with a BRCA1 defect, and that this repair inefficiency leads to early reproductive failure.': 6.609700176366843,\n",
              " 'As noted above, the BRCA1 protein plays a key role in homologous recombinational repair.': 3.1604938271604937,\n",
              " 'This is the only known cellular process that can accurately repair DNA double-strand breaks.': 1.9902319902319903,\n",
              " 'DNA double-strand breaks accumulate with age in humans and mice in primordial follicles.': 1.5100684718331776,\n",
              " 'Primordial follicles contain oocytes that are at an intermediate (prophase I) stage of meiosis.': 1.5833333333333333,\n",
              " 'Meiosis is the general process in eukaryotic organisms by which germ cells are formed, and it is likely an adaptation for removing DNA damages, especially double-strand breaks, from germ line DNA.': 4.468315018315019,\n",
              " '(Also see article Meiosis).': 0.5555555555555556,\n",
              " 'Homologous recombinational repair employing BRCA1 is especially promoted during meiosis.': 2.1785714285714284,\n",
              " 'Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide.': 1.7045855379188715,\n",
              " 'At diagnosis, almost 70% of persons with NSCLC have locally advanced or metastatic disease.': 0.9166666666666666,\n",
              " 'Persons with NSCLC are often treated with therapeutic platinum compounds (e.g.': 0.9603174603174602,\n",
              " 'cisplatin, carboplatin or oxaliplatin) that cause inter-strand cross-links in DNA.': 0.6190476190476191,\n",
              " 'Among individuals with NSCLC, low expression of BRCA1 in the primary tumor correlated with improved survival after platinum-containing chemotherapy.': 3.2957264957264965,\n",
              " 'This correlation implies that low BRCA1 in cancer, and the consequent low level of DNA repair, causes vulnerability of cancer to treatment by the DNA cross-linking agents.': 5.279982363315696,\n",
              " 'High BRCA1 may protect cancer cells by acting in a pathway that removes the damages in DNA introduced by the platinum drugs.': 2.857359924026591,\n",
              " 'Thus the level of BRCA1 expression is a potentially important tool for tailoring chemotherapy in lung cancer management.': 2.808641975308642,\n",
              " 'Level of BRCA1 expression is also relevant to ovarian cancer treatment.': 2.9452720119386786,\n",
              " 'Patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their BRCA1 expression was low compared to patients with higher BRCA1 expression (46 compared to 33 months).': 7.459435626102293,\n",
              " 'Myriad is the exclusive licensee of these patents and has enforced them in the US against clinical diagnostic labs.': 1.5357142857142856,\n",
              " 'The patents began to expire in 2014.': 0.619047619047619,\n",
              " \"In Australia and the UK, Myriad's licensee permitted use by health systems but announced a change of plans in August 2008.\": 1.642857142857143,\n",
              " \"Only a single mutation has been patented in Myriad's lone European-wide patent, although some patents remain under review of an opposition proceeding.\": 3.284126984126983,\n",
              " 'In effect, the United States is the only jurisdiction where Myriad\\'s strong patent position has conferred sole-provider status.\"': 2.2222222222222223,\n",
              " 'Peter Meldrum, CEO of Myriad Genetics, has acknowledged that Myriad has \"other competitive advantages that may make such [patent] enforcement unnecessary\" in Europe.': 2.292307692307692,\n",
              " 'As with any gene, finding variation in BRCA1 is not hard.': 0.8846153846153846,\n",
              " 'The real value comes from understanding what the clinical consequences of any particular variant are.': 1.8095238095238093,\n",
              " 'Myriad has a large, proprietary database of such genotype-phenotype correlations.': 0.7142857142857142,\n",
              " 'In response, parallel open-source databases are being developed.': 0.5476190476190476,\n",
              " 'Legal decisions surrounding the BRCA1 and BRCA2 patents will affect the field of genetic testing in general.': 1.3888888888888888,\n",
              " 'A June 2013 article, in Association for Molecular Pathology v. Myriad Genetics (No.': 0.3333333333333333,\n",
              " '12-398), quoted the US Supreme Court\\'s unanimous ruling that, \"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating Myriad\\'s patents on the BRCA1 and BRCA2 genes.': 6.396825396825396,\n",
              " 'However, the Court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection.': 5.628388278388278,\n",
              " 'The Federal Court of Australia came to the opposite conclusion, upholding the validity of an Australian Myriad Genetics patent over the BRCA1 gene in February 2013.': 3.051282051282051,\n",
              " 'The Federal Court also rejected an appeal in September 2014.': 1.1128205128205129,\n",
              " \"Yvonne D'Arcy won her case against US-based biotech company Myriad Genetics in the High Court of Australia.\": 0.6626984126984127}"
            ]
          },
          "metadata": {},
          "execution_count": 132
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import heapq"
      ],
      "metadata": {
        "id": "B8funEcZszma"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "best_sentences = heapq.nlargest(10,sent2score,key=sent2score.get)"
      ],
      "metadata": {
        "id": "pidfYPcds2j0"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "best_sentences"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "tlM8ZtHSs5mn",
        "outputId": "5b59b66b-1b39-499a-8f97-154e8e6df45d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['Similarly, BRCA1 expression is low in the majority (55%) of sporadic epithelial ovarian cancers (EOCs) where EOCs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers.',\n",
              " 'Patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their BRCA1 expression was low compared to patients with higher BRCA1 expression (46 compared to 33 months).',\n",
              " 'There are a number of specific microRNAs, when overexpressed, that directly reduce expression of specific DNA repair proteins (see MicroRNA section DNA repair and cancer) In the case of breast cancer, microRNA-182 (miR-182) specifically targets BRCA1.',\n",
              " 'Since BRCA1 is a key DNA repair protein, these findings suggest that naturally occurring DNA damages in oocytes are repaired less efficiently in women with a BRCA1 defect, and that this repair inefficiency leads to early reproductive failure.',\n",
              " '12-398), quoted the US Supreme Court\\'s unanimous ruling that, \"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating Myriad\\'s patents on the BRCA1 and BRCA2 genes.',\n",
              " 'Thus, while BRCA1 expression is low in the majority of these cancers, BRCA1 mutation is not a major cause of reduced expression.',\n",
              " 'However, the Court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection.',\n",
              " 'Since cells that lack the BRCA1 protein tend to repair DNA damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer.',\n",
              " 'In addition to breast cancer, mutations in the BRCA1 gene also increase the risk of ovarian and prostate cancers.',\n",
              " 'This correlation implies that low BRCA1 in cancer, and the consequent low level of DNA repair, causes vulnerability of cancer to treatment by the DNA cross-linking agents.']"
            ]
          },
          "metadata": {},
          "execution_count": 135
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "' '.join(best_sentences)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 244
        },
        "id": "TUskwrIds7qe",
        "outputId": "3fdfe5ed-de0d-4652-f463-cfc17e536dc9"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'Similarly, BRCA1 expression is low in the majority (55%) of sporadic epithelial ovarian cancers (EOCs) where EOCs are the most common type of ovarian cancer, representing approximately 90% of ovarian cancers. Patients having sporadic ovarian cancer who were treated with platinum drugs had longer median survival times if their BRCA1 expression was low compared to patients with higher BRCA1 expression (46 compared to 33 months). There are a number of specific microRNAs, when overexpressed, that directly reduce expression of specific DNA repair proteins (see MicroRNA section DNA repair and cancer) In the case of breast cancer, microRNA-182 (miR-182) specifically targets BRCA1. Since BRCA1 is a key DNA repair protein, these findings suggest that naturally occurring DNA damages in oocytes are repaired less efficiently in women with a BRCA1 defect, and that this repair inefficiency leads to early reproductive failure. 12-398), quoted the US Supreme Court\\'s unanimous ruling that, \"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,\" invalidating Myriad\\'s patents on the BRCA1 and BRCA2 genes. Thus, while BRCA1 expression is low in the majority of these cancers, BRCA1 mutation is not a major cause of reduced expression. However, the Court also held that manipulation of a gene to create something not found in nature could still be eligible for patent protection. Since cells that lack the BRCA1 protein tend to repair DNA damages by alternative more error-prone mechanisms, the reduction or silencing of this protein generates mutations and gross chromosomal rearrangements that can lead to progression to breast cancer. In addition to breast cancer, mutations in the BRCA1 gene also increase the risk of ovarian and prostate cancers. This correlation implies that low BRCA1 in cancer, and the consequent low level of DNA repair, causes vulnerability of cancer to treatment by the DNA cross-linking agents.'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 136
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "hN5jdU8Is8yF"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}